Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AARS2	"AARSL, bA444E17.1, KIAA1270"	ENSG00000124608	"Alanyl-tRNA synthetase 2, mitochondrial"	Q5JTZ9	6	44298731-44313347	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration, Premature ovarian failure, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035636, HPA061396"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA035636: AB_10670837, HPA061396: AB_2684502"	"unprognostic (1.56e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.83e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	4.7	5.2	6.5	5.6	6.2	5.4	4.9	9.4	6.7	7.6	6.7	5.8	6.5	6.1	3.2	9.2	6.4	4.6	6.0	6.8	5.1	5.7	6.9	4.3	6.0	6.1	5.8	8.3	6.5	5.9	6.3	4.1	6.4	7.0	4.1	5.4	6.2	4.3	4.8	7.2	7.9	4.1	5.4	7.2	5.4	3.7	6.0	6.2	6.2	3.3	5.3	5.6	7.4	6.7	14.6	9.9	13.9	23.8	8.1	7.2	18.3	10.9	5.7	11.2	10.6	11.4	7.1	16.3	16.2	4.8	12.2	10.0	14.7	16.0	4.7	10.9	23.7	18.9	10.6	14.5	4.8	17.9	16.0	5.9	9.8	9.0	10.2	7.3	9.5	21.8	21.0	15.4	6.2	16.0	14.2	15.9	9.9	40.3	9.8	16.4	8.7	10.4	6.7	12.7	32.0	11.4	9.4	10.9	15.5	9.7	9.9	21.6	8.4	12.1	13.5	7.6	13.9	8.8	8.7	16.5	6.8	15.9	22.1	2.2	1.1	0.1	1.3	1.3	2.1	1.5	1.9	1.7	1.0	2.9	1.8	1.7	0.2	1.9	1.4	1.3	1.2	1.3	6.5	6.2	9.4	6.7	6.8	5.1	6.1	5.8	6.4	5.4	6.0	6.7	2.6	6.4	3.3	5.2	3.7	0.6	2.1	1.9	4.0	6.6	2.8	2.7	3.5	5.7	2.8	0.0	12.5	5.0	4.9	3.0	0.0	2.3	10.1	3.5	5.4	3.0	0.0	8.2	5.5	0.4	5.0	3.4	5.1	6.2	0.0	5.9	3.9	2.5	3.3	0.0	9.0	2.2	2.0	2.8	1.8	1.0	4.7	2.5	0.0	1.9	3.9	2.0	4.1	3.0	3.6	1.4	0.7	4.5	6.9	1.6	6.3	1.0	3.0	7.1	0.0	4.7	2.8	4.3	6.1	4.4	0.4	5.3	4.1	4.5	3.7	1.6
ABCC10	"EST182763, MRP7, SIMRP7"	ENSG00000124574	"ATP binding cassette subfamily C member 10"	Q5T3U5	6	43427366-43450427	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041607, HPA045464"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"			"HPA041607: AB_2677579, HPA045464: AB_2679336"	"unprognostic (2.41e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.80e-2)"	9.2	17.7	18.0	8.2	17.9	7.5	8.9	19.6	24.2	14.4	16.6	12.7	9.4	13.2	8.3	16.3	11.8	6.8	12.4	17.5	17.0	15.5	10.1	10.8	8.7	17.0	17.0	17.6	19.5	5.0	19.6	7.7	17.3	17.3	7.6	4.5	12.7	7.6	7.8	11.0	13.0	8.6	15.7	15.5	13.5	9.2	17.6	8.3	12.8	3.4	7.4	16.2	13.8	17.3	13.3	6.7	8.7	19.9	18.8	12.0	9.0	13.7	9.6	10.1	8.6	14.9	5.6	2.8	15.9	16.7	7.9	16.5	5.8	10.6	7.2	17.1	11.7	9.5	8.4	29.8	11.5	13.2	13.7	20.9	13.9	13.5	7.4	10.0	13.8	8.9	11.3	14.9	12.1	13.1	7.8	20.3	5.6	32.1	8.0	3.9	2.3	9.8	11.7	21.6	12.1	9.8	8.1	11.5	10.2	7.6	11.3	12.8	14.4	12.4	4.2	11.6	16.6	13.3	6.2	6.9	5.8	9.4	5.9	5.0	1.9	2.2	2.9	0.6	1.3	1.0	2.2	2.6	1.1	0.9	1.2	1.8	0.7	1.3	1.5	0.8	2.8	1.8	18.0	17.9	19.6	24.2	17.5	17.0	17.0	17.0	17.3	15.7	17.6	17.3	4.6	3.2	5.6	15.7	5.6	1.1	5.9	6.7	10.2	9.3	3.2	3.8	2.5	4.3	3.4	0.0	10.4	7.1	6.6	5.4	1.9	4.5	1.3	4.9	5.5	5.1	7.8	1.7	16.0	3.3	6.0	4.1	15.3	4.9	6.3	11.8	6.1	2.0	6.9	11.8	14.9	3.6	4.1	4.1	3.3	0.8	7.5	5.2	3.6	9.4	3.4	2.1	13.4	13.6	11.1	4.7	6.1	6.0	7.1	2.1	5.4	3.4	9.9	5.6	0.0	3.3	3.7	2.2	4.5	4.7	1.8	4.4	7.9	14.4	5.4	2.8
ABCC3	"cMOAT2, EST90757, MLP2, MOAT-D, MRP3"	ENSG00000108846	"ATP binding cassette subfamily C member 3"	O15438	17	50634777-50692253	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 59.1;liver: 50.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 231.6;Distal enterocytes: 265.1;Gastric mucus-secreting cells: 271.7;Hepatocytes: 192.9;Paneth cells: 194.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 5.1;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"A549: 79.4;CAPAN-2: 60.6;HeLa: 36.9;OE19: 89.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037136, HPA048483"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB037136: AB_477165, HPA048483: AB_2680414"	"unprognostic (1.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.67e-3)"	"unprognostic (6.19e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.60e-3)"	"prognostic unfavorable (4.68e-6)"	"unprognostic (3.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.57e-3)"	3.1	59.1	0.1	3.4	1.8	0.8	4.2	0.2	0.7	2.1	0.0	18.9	12.0	1.1	1.8	7.5	1.0	11.9	0.9	0.3	0.3	8.0	50.4	4.8	1.9	5.9	0.8	0.7	22.6	0.8	0.8	1.1	3.5	5.9	8.7	0.4	7.0	5.5	0.2	7.1	11.9	1.3	1.7	3.4	17.1	1.0	2.5	0.3	5.5	0.0	1.7	6.3	3.6	2.4	5.7	79.4	0.0	0.3	4.4	6.9	0.1	10.4	13.1	0.7	0.7	4.2	60.6	0.0	8.0	20.6	14.5	14.5	0.0	1.0	1.0	0.0	0.0	1.7	36.9	24.2	17.2	0.0	0.0	7.5	5.6	2.9	6.2	8.5	1.4	0.0	0.2	0.0	8.0	18.9	0.0	0.0	0.1	89.7	10.1	0.1	0.0	0.3	33.4	34.2	0.1	0.6	19.2	3.1	0.0	0.1	2.6	0.0	17.3	0.5	3.4	0.2	8.5	0.1	0.0	0.0	8.2	0.0	0.9	0.2	2.3	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.3	6.4	0.1	0.5	5.4	0.1	1.8	0.2	0.7	0.3	0.3	5.9	0.8	3.5	1.7	2.5	2.4	0.7	19.2	5.5	0.0	1.8	9.4	122.2	47.1	42.7	1.6	1.9	6.9	3.1	231.6	19.5	14.7	0.0	0.4	0.0	265.1	5.9	100.1	82.9	5.9	8.8	2.7	23.5	0.0	4.3	106.1	3.7	3.6	271.7	30.5	0.0	3.1	3.9	192.9	26.1	1.7	0.9	96.2	12.2	33.0	11.4	118.6	9.0	31.6	3.6	2.8	8.7	2.9	1.0	0.5	0.5	105.9	194.7	3.0	2.1	104.6	57.2	10.8	2.7	0.3	0.0	1.9	5.6	0.9	0.8	12.7	10.5	1.0	2.6	0.1	111.0	118.4
ABCG1	ABC8	ENSG00000160179	"ATP binding cassette subfamily G member 1"	P45844	21	42199689-42297244	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 122.6;Syncytiotrophoblasts: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 35.5;neutrophil: 36.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 36.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 25.5;JURKAT: 38.4;MCF7: 33.2;MOLT-4: 31.5;OE19: 54.9;RPMI-8226: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031470, HPA031471"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"		"HPA031470: AB_10599188, HPA031471: AB_10600201"	"unprognostic (2.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.37e-2)"	"prognostic favorable (7.16e-6)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.42e-2)"	17.2	37.7	18.3	12.1	25.5	8.1	15.2	14.4	20.2	8.1	20.0	14.1	17.5	4.9	3.9	4.1	6.3	13.8	10.5	15.5	17.0	10.2	6.3	29.4	18.1	12.0	19.9	6.3	5.3	24.4	10.7	13.7	13.3	6.2	15.0	29.1	16.1	7.0	19.6	16.8	22.0	4.0	12.2	31.2	15.9	1.1	20.3	18.9	8.5	6.2	12.1	12.9	5.0	24.7	0.0	6.0	4.6	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	3.1	1.9	0.8	0.0	0.7	0.9	0.0	8.8	0.0	8.5	0.5	10.2	19.2	0.0	17.4	0.0	0.4	2.0	25.5	0.1	3.9	0.0	18.2	38.4	0.0	0.1	0.0	33.2	31.5	0.2	1.4	54.9	10.3	0.4	0.0	25.8	0.0	2.8	22.3	5.8	3.7	13.5	0.0	0.4	5.7	0.9	11.8	0.0	4.7	0.1	0.0	13.1	4.2	0.0	0.1	3.3	0.5	1.7	1.7	35.5	3.0	0.5	5.6	5.5	6.1	6.0	1.1	7.0	5.8	5.0	36.6	7.4	0.3	2.5	7.4	2.1	18.3	25.5	14.4	20.2	15.5	17.0	12.0	19.9	13.3	12.2	20.3	24.7	38.2	6.4	8.2	0.3	21.3	8.9	6.9	3.2	5.7	48.4	4.1	6.9	9.5	4.3	5.9	25.8	50.1	7.0	7.0	33.4	3.9	2.6	4.5	21.6	6.3	33.8	3.5	5.7	13.2	1.2	1.8	7.5	11.2	45.3	0.0	1.2	42.8	0.6	16.0	11.8	17.8	12.1	8.2	44.5	23.4	7.6	0.3	20.9	3.6	7.5	4.3	16.1	3.1	43.2	40.6	2.3	8.3	1.9	4.0	3.0	36.6	1.1	4.5	122.6	6.6	1.6	3.5	0.6	0.5	1.0	6.7	63.1	21.4	10.4	1.1	9.1
ABHD16A	"BAT5, D6S82E, NG26"	ENSG00000204427	"Abhydrolase domain containing 16A, phospholipase"	O95870	6	31686955-31703356	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.2;OE19: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058606	Approved					NA	NA		37000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"			"HPA058606: AB_2683774"	"unprognostic (1.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (3.14e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.60e-3)"	16.2	22.1	1.1	11.7	1.3	6.7	13.3	1.2	4.1	20.5	0.9	20.9	0.0	21.5	19.0	21.1	18.9	9.9	17.4	1.2	1.2	17.0	30.0	16.0	13.0	1.6	2.0	15.0	18.7	5.8	40.0	7.9	1.4	19.6	7.3	6.7	17.4	4.2	35.0	12.9	17.6	0.0	1.5	18.5	21.5	31.6	1.5	4.5	21.3	0.0	0.0	20.7	15.0	1.5	0.0	15.7	0.0	41.2	29.0	11.7	0.0	14.5	16.2	16.5	15.6	0.0	26.1	16.5	33.7	21.2	0.0	0.0	0.0	19.7	9.0	16.0	12.7	0.0	0.0	0.0	34.7	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.3	0.0	0.0	0.0	0.5	0.0	42.4	0.0	0.7	0.0	29.3	21.0	0.0	0.2	20.0	0.9	0.5	0.4	0.0	0.0	0.0	14.9	19.6	14.5	0.0	0.0	10.5	21.1	8.5	13.6	0.1	16.1	2.5	6.8	8.4	4.1	8.9	1.9	2.8	1.2	4.2	6.2	2.8	3.5	2.7	13.3	5.9	0.5	4.1	4.1	6.3	1.1	1.3	1.2	4.1	1.2	1.2	1.6	2.0	1.4	1.5	1.5	1.5	1.2	0.0	8.2	11.4	10.7	0.4	0.3	1.7	15.4	1.2	1.5	1.0	0.5	0.0	1.6	0.0	0.0	3.9	2.2	12.0	3.9	18.3	1.3	1.4	1.7	2.7	12.5	14.9	13.4	13.3	1.5	5.3	12.2	1.2	1.3	0.5	0.7	0.8	3.3	0.0	14.6	9.7	2.0	2.2	2.1	0.4	0.9	8.8	3.6	13.1	8.1	1.0	5.2	15.6	21.1	12.7	16.0	0.4	16.4	0.4	16.5	0.7	1.7	1.4	0.0	0.7	4.9	2.5	1.6	16.8	1.0	5.3	7.6	0.2	12.1	0.3
ABHD17C	FAM108C1	ENSG00000136379	"Abhydrolase domain containing 17C, depalmitoylase"	Q6PCB6	15	80679684-80755621	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 65.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 201.4;Intestinal goblet cells: 103.7;Urothelial cells: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 127.1;RT4: 102.6;SK-MEL-30: 119.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048890	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA048890: AB_2680546"	"unprognostic (3.60e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.08e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.75e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.89e-3)"	2.5	4.7	17.6	10.3	17.7	5.9	11.7	14.3	18.4	19.3	13.6	65.3	23.3	6.1	2.1	46.5	10.9	6.3	4.2	19.2	16.3	15.6	5.6	19.5	7.2	16.4	16.2	2.0	7.9	7.0	6.0	4.7	14.5	18.1	56.2	16.8	23.6	3.4	1.8	18.7	30.6	5.5	17.0	8.1	36.0	5.2	18.2	5.6	8.0	2.8	23.0	28.7	21.3	16.2	26.4	24.7	15.7	19.8	5.7	11.6	26.8	24.9	93.0	20.7	20.0	20.6	57.7	8.7	9.9	26.4	14.7	52.7	44.1	23.0	18.5	62.0	25.0	0.1	17.7	22.1	9.9	8.0	12.3	24.9	27.1	15.0	7.4	17.9	22.6	9.1	0.2	10.8	12.1	73.3	0.7	0.8	23.3	127.1	9.2	17.4	13.4	24.5	17.0	102.6	13.9	5.7	19.8	33.7	119.9	6.8	16.8	13.5	7.7	12.8	10.5	14.1	22.4	0.8	0.3	8.6	8.3	71.6	14.3	0.0	0.0	0.0	0.7	0.0	0.5	0.3	0.5	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	17.6	17.7	14.3	18.4	19.2	16.3	16.4	16.2	14.5	17.0	18.2	16.2	2.0	12.8	12.5	32.3	1.4	7.1	13.2	14.3	9.6	4.8	15.7	9.4	5.3	17.2	11.1	7.3	8.4	2.2	2.8	201.4	45.0	6.5	0.3	13.4	7.8	6.9	14.5	0.8	18.4	8.9	5.8	3.1	39.8	35.4	0.0	3.0	6.4	6.0	1.1	10.1	20.1	103.7	10.2	1.3	1.5	0.7	1.2	5.9	8.8	6.5	1.4	4.8	0.0	12.1	3.1	28.1	58.6	0.0	2.4	34.5	46.3	5.6	10.5	22.4	0.0	1.0	2.0	0.7	6.0	19.3	22.7	1.0	2.6	19.6	53.2	86.1
ABITRAM	"C9orf6, CG-8, FAM206A, FLJ20457, Simiate"	ENSG00000119328	"Actin binding transcription modulator"	Q9NX38	9	108934400-108950744	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.7;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 10.6;Fibroblasts: 4.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035917, HPA035918"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA035917: AB_2674860, HPA035918: AB_10670593"	"unprognostic (4.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	14.2	11.9	17.2	10.0	18.7	15.6	17.2	16.8	21.9	12.5	18.7	14.9	14.4	13.6	25.1	16.4	21.5	10.9	15.8	17.7	17.3	13.6	14.6	12.7	9.0	16.8	17.1	13.5	13.3	23.2	13.9	12.5	17.2	12.1	16.2	24.7	15.3	14.2	13.2	24.5	13.1	12.5	17.5	8.5	14.5	20.2	17.5	11.9	19.0	11.8	12.0	11.9	11.4	18.3	18.5	19.8	19.5	23.4	36.2	44.6	28.1	17.1	20.0	17.0	13.9	29.5	9.7	17.0	9.8	16.6	22.3	41.3	17.2	18.3	16.0	10.4	17.6	10.5	25.8	27.0	30.7	40.4	13.3	25.3	33.6	20.7	47.6	20.9	23.7	26.1	39.7	16.6	20.3	53.0	28.9	16.3	22.6	55.9	28.7	13.9	33.9	18.9	22.5	19.2	26.7	13.7	27.0	23.3	30.1	20.0	31.6	21.4	14.9	9.2	16.9	39.3	21.7	14.7	38.5	12.6	30.1	15.6	13.4	38.8	31.2	31.0	14.8	33.4	22.6	16.5	23.1	19.6	35.5	10.8	22.9	17.6	37.4	21.1	34.6	37.0	21.1	20.1	17.2	18.7	16.8	21.9	17.7	17.3	16.8	17.1	17.2	17.5	17.5	18.3	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	6.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	10.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0
AC007325.2		ENSG00000277196	"Proline dehydrogenase 1, mitochondrial"		Unmapped	138082-161852	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"brain: 113.8;choroid plexus: 218.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 5.9;Distal tubular cells: 7.9;Endometrial ciliated cells: 2.5;Proximal enterocytes: 5.6;Squamous epithelial cells: 2.3"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"OE19: 345.1;RPTEC TERT1: 183.1"									HPA020361	Uncertain		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA					"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"																		2.2	0.6	83.9	0.8	83.5	0.7	3.3	75.2	113.8	1.0	218.6	1.1	28.9	0.5	0.1	6.8	1.4	0.4	9.5	90.0	76.6	12.3	6.0	18.8	1.0	87.3	82.6	0.0	0.1	0.1		0.9	72.0	0.9	1.4	1.9	0.7	2.4	10.2	32.6	33.2	0.2	74.5	0.7	0.8	1.9	85.0	5.6	4.5	24.0	6.4	1.9		72.3	0.0	8.3	0.3	2.5	5.0	0.0	1.6	0.0	0.0	0.0	0.0	5.3	1.8	0.0	0.5	0.0	0.2	10.0	18.8	0.5	0.0	0.0	0.7	0.0	0.2	0.9	3.6	0.0	0.1	0.4	18.5	0.0	1.0	0.0	0.0	0.3	0.0	0.1	0.0	1.5	0.2	0.0	17.5	345.1	0.0	0.1	0.1	0.0	183.1	0.7	0.4	0.5	0.0	6.9	1.5	18.8	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.9	83.5	75.2	113.8	90.0	76.6	87.3	82.6	72.0	74.5	85.0	72.3	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	2.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.2	0.1
AC008397.1		ENSG00000284797	"Novel protein"		19	18249950-18255419	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	5	"intestine: 3.1"	"Group enriched"	"Detected in some"	7	"Collecting duct cells: 36.8;Pancreatic endocrine cells: 10.6"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	535	"OE19: 204.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA					"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"																					0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	204.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	0.0	0.0	0.0	36.8	0.0	0.0	0.7	0.0	0.0	1.2	0.0	1.6	0.4	0.1	0.0	0.0	0.0	3.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0
AC243967.1		ENSG00000267881	"Novel protein, readthrough between CEACAM5-CEACAM6"		19	41708657-41756737	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	4	"intestine: 3.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.3"															NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"							"unprognostic (1.55e-2)"								"unprognostic (1.15e-2)"			"unprognostic (9.59e-3)"				0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.4	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACAD8		ENSG00000151498	"Acyl-CoA dehydrogenase family member 8"	Q9UKU7	11	134253548-134265855	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Branched-chain amino acid catabolism, Transcription, Transcription regulation"	"Activator, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040689, HPA043903"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA040689: AB_2677080, HPA043903: AB_2678724"	"unprognostic (5.00e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.62e-4)"	"unprognostic (7.57e-3)"	"unprognostic (9.83e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (4.10e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (6.42e-10)"	"unprognostic (1.08e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.03e-2)"	11.0	18.1	13.9	3.5	14.2	6.8	11.3	14.3	15.4	7.5	18.7	11.6	11.3	6.3	12.6	9.6	9.4	5.2	27.2	14.7	14.3	31.6	24.8	7.8	5.0	14.3	14.1	6.9	16.7	12.4	6.5	4.8	13.8	20.5	10.9	5.0	12.6	7.5	32.5	14.3	8.4	8.3	14.5	8.6	12.6	6.3	14.8	8.5	27.7	39.2	8.9	8.4	6.9	14.8	5.9	5.9	11.8	17.6	20.2	11.5	13.5	11.3	14.0	14.7	10.3	16.2	10.8	14.2	21.1	11.7	15.5	6.0	14.6	14.3	10.2	13.0	4.7	29.4	5.8	11.3	17.0	16.5	18.3	13.8	4.4	14.8	4.5	13.3	16.3	20.8	13.8	7.0	12.4	7.5	12.2	18.1	17.0	49.8	9.7	9.8	11.9	8.5	20.1	17.5	3.7	11.7	19.5	14.8	7.3	11.9	31.0	15.0	11.3	7.1	7.5	6.2	11.2	7.8	3.8	12.7	7.2	15.4	11.2	36.2	13.4	23.1	11.8	13.5	11.5	11.6	11.1	11.7	12.7	9.2	13.0	11.7	12.1	31.5	12.9	10.8	15.1	12.3	13.9	14.2	14.3	15.4	14.7	14.3	14.3	14.1	13.8	14.5	14.8	14.8	11.7	3.2	12.2	15.3	8.8	6.0	4.7	23.5	7.4	11.2	17.5	11.9	24.6	4.3	19.7	18.4	14.6	19.7	14.0	20.0	52.8	12.1	5.3	8.2	11.8	9.7	3.6	12.0	21.5	11.9	10.6	9.8	10.2	8.5	3.8	15.7	10.8	36.7	12.9	15.2	16.0	14.3	48.8	14.2	6.9	6.1	11.5	10.0	28.4	13.1	12.7	11.8	9.2	12.1	15.8	12.6	15.8	10.1	14.6	5.9	17.4	59.8	20.1	17.1	6.6	8.7	9.6	22.4	17.3	10.9	7.7	8.3	10.5	36.0	14.9	5.3
ACO2	ACONM	ENSG00000100412	"Aconitase 2"	Q99798	22	41447830-41529273	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Lyase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 567.7;skeletal muscle: 660.4;tongue: 695.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 374.2;Proximal tubular cells: 285.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001097	Enhanced	Approved	Approved	Mitochondria		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA001097: AB_1078092"	"unprognostic (1.95e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.07e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.46e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.12e-2)"	88.8	81.6	154.2	38.6	152.2	32.0	52.4	153.0	190.0	39.5	160.1	94.4	162.9	42.0	26.1	60.4	53.6	36.5	567.7	155.2	153.1	138.9	73.9	40.7	40.5	146.1	145.3	30.8	53.8	233.8	33.6	30.5	147.8	41.2	69.6	46.9	72.0	49.5	660.4	45.5	158.5	43.7	152.5	44.7	110.2	35.1	186.3	38.0	53.7	695.8	43.3	52.5	42.4	159.6	47.2	55.8	56.5	116.3	101.2	69.8	78.7	43.7	60.9	79.0	71.9	81.2	63.5	115.7	72.2	70.6	60.3	109.8	108.8	88.3	42.8	75.8	80.2	51.0	73.7	95.0	86.7	147.8	77.8	120.8	64.4	78.9	83.2	61.7	81.2	61.5	72.9	118.4	65.4	91.7	73.7	47.9	37.0	282.6	115.1	102.3	37.8	162.1	106.8	97.3	37.8	33.9	112.2	128.7	82.0	44.9	74.9	74.7	55.5	60.0	68.7	50.2	45.0	64.7	92.1	80.6	102.0	64.0	66.5	10.3	52.9	18.1	32.0	76.4	29.3	49.4	25.5	34.9	69.0	46.4	29.2	30.8	9.0	39.4	97.1	24.0	41.2	58.6	154.2	152.2	153.0	190.0	155.2	153.1	146.1	145.3	147.8	152.5	186.3	159.6	26.3	25.6	31.8	45.4	49.4	18.7	54.5	102.7	31.3	60.6	28.0	23.2	9.1	64.3	63.5	60.7	81.3	100.3	33.3	190.8	131.0	58.3	14.5	37.2	17.7	26.1	53.2	30.3	28.8	42.6	60.0	24.0	77.5	37.1	40.6	56.7	20.7	64.6	91.5	53.8	34.0	99.1	89.5	35.5	26.4	8.9	24.2	39.2	35.6	7.5	68.3	73.9	34.0	12.1	20.9	43.9	103.5	27.8	63.2	34.4	374.2	285.7	59.2	73.5	59.2	28.6	38.4	26.4	38.2	35.8	16.1	193.2	30.7	54.4	113.6	64.9
ACSS1	"ACAS2L, AceCS2L, dJ568C11.3, MGC33843"	ENSG00000154930	"Acyl-CoA synthetase short chain family member 1"	Q9NUB1	20	25006230-25058980	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 300.4;Cytotrophoblasts: 329.7;Syncytiotrophoblasts: 419.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 50.3;JURKAT: 51.2;MOLT-4: 49.6;OE19: 64.6;RPMI-8226: 75.1;U-937: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041014, HPA043228"	Enhanced					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA041014: AB_2677251, HPA043228: AB_2678372"	"unprognostic (6.87e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.20e-3)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.44e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.58e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.60e-1)"	12.8	9.5	65.0	15.5	70.2	33.4	14.1	55.8	66.9	16.1	124.7	28.1	49.3	16.1	19.7	14.3	18.8	15.0	91.3	64.5	55.7	49.9	13.9	20.2	25.5	57.9	65.0	22.6	57.4	34.0	11.3	118.4	53.8	29.1	20.6	4.0	39.8	12.0	44.6	18.0	46.8	13.1	53.4	33.6	62.9	38.6	67.7	30.9	29.8	41.4	21.3	15.7	14.5	60.8	0.1	11.8	3.4	0.0	10.6	4.0	0.2	1.3	5.1	5.0	3.3	12.0	1.6	21.0	2.0	4.8	21.5	5.9	17.1	2.6	1.0	0.0	1.6	36.0	0.2	50.3	11.1	8.5	0.4	7.0	8.6	0.5	0.0	0.0	10.9	51.2	1.9	39.0	0.4	1.3	49.6	14.6	0.2	64.6	18.9	38.2	1.1	75.1	7.3	9.4	8.3	0.2	2.3	4.6	33.5	0.2	22.5	19.1	1.7	0.1	0.1	0.1	0.6	26.7	1.9	0.0	0.5	51.5	13.0	5.6	2.8	7.2	4.2	5.1	3.3	4.0	2.7	3.6	3.5	5.1	2.3	3.5	0.5	10.2	3.4	2.1	2.7	2.3	65.0	70.2	55.8	66.9	64.5	55.7	57.9	65.0	53.8	53.4	67.7	60.8	10.8	12.8	15.1	300.4	29.8	5.2	6.7	3.1	5.2	2.2	15.1	8.0	73.0	45.8	7.7	11.0	0.0	329.7	26.4	27.2	76.3	6.5	87.7	14.3	5.0	9.7	0.0	42.9	0.9	7.7	10.9	14.0	26.5	7.2	5.7	20.4	9.3	6.2	53.2	0.0	1.8	28.5	10.2	11.2	8.8	16.2	34.5	12.0	7.2	41.2	12.3	14.8	25.7	32.2	31.4	1.9	15.8	32.4	42.2	14.0	90.6	16.7	13.8	1.0	19.7	8.8	12.0	1.1	2.0	9.5	4.3	419.5	22.6	60.2	23.4	4.1
ADAP1	"CENTA1, GCS1L"	ENSG00000105963	"ArfGAP with dual PH domains 1"	O75689	7	897900-955407	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.9;intestine: 43.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 97.7;Intestinal goblet cells: 42.5;Oligodendrocytes: 43.6;Paneth cells: 64.4;Proximal enterocytes: 48.5;Undifferentiated cells: 50.6"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 15.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 108.1;CAPAN-2: 74.1;HMC-1: 71.0;OE19: 191.5;THP-1: 122.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007033, HPA012049"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA007033: AB_1846529, HPA012049: AB_1846527"	"unprognostic (2.45e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (3.06e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-2)"	4.9	3.8	51.2	11.2	55.8	9.8	3.4	57.3	73.6	4.1	11.2	43.2	19.7	6.0	0.6	9.0	8.8	6.0	8.1	59.4	42.9	22.3	3.6	10.4	3.8	63.5	63.1	1.5	13.3	6.1	4.7	2.7	56.9	6.6	22.8	1.6	4.6	2.9	0.7	3.9	26.8	8.3	48.7	17.2	19.6	1.1	55.4	0.9	7.6	0.5	2.1	8.9	3.8	85.9	108.1	4.0	0.1	3.7	1.4	0.2	1.1	3.6	0.1	0.7	0.1	43.1	74.1	0.2	10.3	0.5	0.2	44.5	5.9	8.1	0.5	0.6	4.7	0.0	6.0	25.4	1.7	0.7	71.0	1.8	21.4	0.2	0.0	0.1	0.0	3.1	0.4	0.0	0.0	33.2	0.1	30.1	3.2	191.5	0.0	14.4	0.2	0.4	4.7	25.0	3.1	1.0	3.3	1.3	0.5	0.4	25.9	122.6	0.6	0.8	2.8	0.1	0.3	0.0	0.2	0.0	0.2	22.3	3.3	1.0	6.5	3.3	6.0	7.3	2.8	1.1	1.6	5.5	5.1	0.9	0.5	2.6	3.1	1.6	11.7	0.3	0.8	4.0	51.2	55.8	57.3	73.6	59.4	42.9	63.5	63.1	56.9	48.7	55.4	85.9	0.4	0.0	10.3	2.9	3.6	1.0	2.9	3.3	2.8	4.7	2.5	1.5	8.5	7.2	2.9	7.3	0.0	0.3	19.4	97.7	9.8	3.9	0.2	8.6	0.9	0.5	16.2	0.0	13.2	4.6	0.9	1.5	17.9	7.6	7.0	1.3	0.0	0.6	12.2	0.0	12.6	42.5	4.1	23.0	15.7	0.4	0.0	22.1	10.6	2.8	13.2	1.3	15.5	3.0	43.6	17.5	64.4	0.0	2.6	3.0	48.5	7.1	8.2	1.1	0.0	0.1	1.9	0.3	1.2	1.1	1.3	0.7	9.0	0.0	50.6	5.5
ADSS1	"ADSSL1, FLJ38602"	ENSG00000185100	"Adenylosuccinate synthase 1"	Q8N142	14	104724229-104747325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 1273.1;tongue: 609.8"	"Cell type enriched"	"Detected in some"	20	"Cardiomyocytes: 137.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 15.2;MCF7: 14.2;OE19: 23.2;SiHa: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052621	Enhanced					NA	NA		290000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA052621: "	"unprognostic (2.23e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	8.1	5.1	3.8	1.0	6.8	0.9	4.4	6.6	5.6	4.1	7.6	3.0	2.7	3.3	4.5	18.5	6.5	5.7	100.2	3.7	6.7	14.8	28.8	3.1	1.1	6.0	6.0	2.7	7.9	7.3	10.0	7.3	6.1	7.6	1.4	10.1	10.7	4.0	1273.1	5.5	2.8	2.3	5.2	2.0	6.5	18.5	5.5	1.0	7.4	609.8	0.8	6.5	5.4	7.7	0.1	3.2	2.4	7.1	1.7	1.1	0.8	0.9	1.3	0.2	0.7	0.2	2.5	0.0	15.2	0.8	0.5	1.3	0.2	0.5	0.6	1.0	0.5	0.1	7.9	1.1	1.8	0.0	6.0	3.2	2.3	0.0	2.6	2.7	0.4	0.3	2.9	0.1	1.2	14.2	0.0	0.7	2.1	23.2	1.3	0.2	0.3	0.9	0.5	1.7	2.0	4.2	23.1	1.0	3.3	1.8	7.1	2.1	0.8	0.1	0.6	1.6	0.1	4.4	3.5	0.0	2.2	1.0	1.5	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.8	6.8	6.6	5.6	3.7	6.7	6.0	6.0	6.1	5.2	5.5	7.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.4	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0
AFG3L2	"SCA28, SPAX5"	ENSG00000141385	"AFG3 like matrix AAA peptidase subunit 2"	Q9Y4W6	18	12328944-12377227	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004479, HPA004480"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA004479: AB_1078109, HPA004480: AB_1078108"	"unprognostic (1.11e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.31e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (6.05e-14)"	"unprognostic (5.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.22e-1)"	26.1	25.9	16.4	21.9	17.0	32.4	29.2	18.2	19.0	24.1	30.8	60.8	79.9	22.1	17.5	41.5	23.8	18.3	88.0	17.0	18.7	62.7	51.0	21.8	23.7	17.7	16.6	24.1	41.1	76.0	18.6	23.5	18.8	24.6	54.1	20.3	30.8	24.4	145.4	29.8	58.7	25.4	15.8	18.5	39.1	18.5	19.0	24.3	39.2	155.8	31.0	30.9	19.6	17.6	56.5	56.6	39.7	44.8	45.2	48.6	52.7	61.9	61.1	86.6	63.1	88.1	34.1	161.3	66.3	56.6	76.8	55.6	101.4	71.3	70.3	38.1	43.5	48.5	59.3	83.5	61.1	185.0	69.8	54.3	76.3	82.1	107.7	47.8	64.0	57.0	111.3	92.8	43.6	89.0	66.7	58.5	55.3	277.4	41.9	74.0	125.1	135.2	74.9	123.6	73.7	51.3	97.0	103.8	90.0	50.5	47.8	84.5	49.0	102.4	88.6	98.7	81.7	64.7	80.7	104.1	56.2	71.4	48.0	3.8	16.5	12.4	11.6	17.6	13.9	14.0	13.8	17.9	21.8	10.3	17.2	20.2	1.1	28.4	16.2	11.5	9.5	13.4	16.4	17.0	18.2	19.0	17.0	18.7	17.7	16.6	18.8	15.8	19.0	17.6	24.3	41.7	49.2	23.2	36.6	22.2	45.3	21.5	42.7	50.2	36.5	36.2	74.9	50.1	28.1	35.0	50.1	58.5	29.1	85.2	72.4	39.5	5.5	37.8	52.3	27.7	39.1	61.0	21.1	37.4	37.9	31.2	53.5	46.1	14.5	41.3	21.8	85.6	37.0	30.3	26.8	82.6	18.3	32.6	14.4	5.5	32.9	34.2	23.2	12.2	27.6	26.9	40.2	14.1	17.7	47.8	43.1	30.1	38.8	43.1	88.7	100.0	22.1	58.3	26.3	53.6	26.9	50.9	65.0	75.8	31.3	92.8	28.4	60.8	94.9	38.2
AGR2	"AG2, HAG-2, PDIA17, XAG-2"	ENSG00000106541	"Anterior gradient 2, protein disulphide isomerase family member"	O95994	7	16791811-16833433	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 638.7;intestine: 1224.0;stomach 1: 1402.3"	"Cell type enhanced"	"Detected in many"		"Club cells: 1515.8;Distal enterocytes: 1026.4;Gastric mucus-secreting cells: 2605.5;Intestinal goblet cells: 3710.4;Paneth cells: 1101.6;Undifferentiated cells: 1543.1;Urothelial cells: 1017.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 475.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	15	"OE19: 20084.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007912	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		38000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum"		"HPA007912: AB_1844879"	"unprognostic (6.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (8.79e-5)"	"unprognostic (6.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.22e-3)"	2.1	0.7	0.0	66.6	0.0	0.0	72.3	0.2	0.5	638.7	0.0	768.1	486.0	14.1	389.1	16.2	306.4	275.8	0.2	0.1	0.0	11.2	0.9	50.7	0.6	0.0	0.1	0.3	22.1	0.1	31.4	1.6	0.0	227.3	1224.0	0.0	475.3	181.0	0.2	2.5	379.2	45.2	0.0	0.9	1402.3	0.9	0.0	1.7	7.4	0.1	7.2	160.8	4.0	0.1	0.3	265.5	0.0	0.3	0.0	0.1	2.6	0.0	0.0	0.0	0.0	43.5	39.7	0.0	0.2	0.0	6.6	25.2	0.0	34.5	0.2	0.0	0.0	0.0	0.9	3.8	0.0	0.0	1.0	0.0	88.5	0.0	11.4	0.4	0.4	0.3	0.0	0.0	0.2	44.7	1.3	1.8	0.8	20084.0	154.2	1.0	0.0	5.2	631.3	371.6	1.7	2.1	0.0	98.8	0.0	1.0	1319.9	0.0	0.0	0.7	1.2	0.9	0.2	1.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	51.3	293.1	0.0	19.0	2.8	127.1	539.8	0.6	0.0	169.3	137.4	0.2	268.8	1515.8	80.9	0.0	6.0	0.4	1026.4	0.0	74.1	4.6	301.9	33.9	4.8	522.1	0.0	0.1	835.1	4.5	6.0	2605.5	365.3	43.9	0.0	0.0	1.7	240.8	0.0	0.1	3710.4	386.6	0.8	0.3	0.4	0.3	6.5	3.6	0.0	1.0	0.0	0.0	0.0	0.0	303.1	1101.6	0.0	2.6	426.9	517.9	0.2	781.0	0.0	0.0	0.0	76.9	0.4	0.2	5.3	2.8	3.3	13.1	0.0	1543.1	1017.8
AIPL1	LCA4	ENSG00000129221	"Aryl hydrocarbon receptor interacting protein like 1"	Q9NZN9	17	6393693-6435199	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1012	"retina: 836.0"	"Cell type enriched"	"Detected in some"	4	"Rod photoreceptor cells: 1926.4"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;OE19: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026578	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA026578: AB_2671905"		"unprognostic (2.42e-2)"		"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.68e-3)"		"unprognostic (3.24e-1)"		"unprognostic (1.13e-3)"				"unprognostic (3.76e-1)"	"unprognostic (5.35e-2)"			0.0	0.0	0.2	0.1	0.3	0.7	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	836.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	2.8	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.3	0.1	0.8	0.2	0.1	0.3	0.0	0.3	0.6	0.0	3.2	1.1	0.0	0.0	0.8	1.0	0.0	0.0	139.2	0.1	0.0	0.6	0.0	1.4	0.0	412.8	0.1	0.1	0.2	0.0	0.0	7.8	0.4	0.2	8.5	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.4	0.0	0.1	1.4	0.0	0.1	65.6	0.2	0.2	0.0	0.3	1.1	1.3	0.0	0.3	1.8	0.0	0.0	256.1	0.0	0.5	0.1	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1926.4	0.0	1.8	0.3	0.4	0.2	0.0	0.4	0.3	0.4	0.1	0.0	1.7
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527567-134541412	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 224.5;intestine: 614.8;stomach 1: 432.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 193.0;Distal enterocytes: 201.0;Gastric mucus-secreting cells: 542.3;Proximal enterocytes: 327.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	104	"A549: 2959.1;Hep G2: 835.6;OE19: 3141.0"	"Low region specificity"	"Detected in all"							"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted to digestive system"	NA	NA		67000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.9	5.5	0.1	7.9	0.0	0.2	0.4	0.3	0.1	73.9	0.0	73.4	614.8	0.5	0.1	224.5	0.9	176.1	0.2	0.1	0.1	12.2	40.0	0.4	0.3	0.0	0.0	0.2	0.7	0.0	4.8	0.1	0.1	1.3	45.6	0.1	32.4	0.2	3.7	7.7	354.8	3.2	0.1	0.1	432.5	0.6	0.0	5.5	0.6	5.9	7.7	65.8	145.6	0.2	0.0	2959.1	0.0	0.0	0.7	2.3	9.0	0.3	1.1	0.2	0.0	5.9	0.9	0.0	1.1	1.6	4.6	6.2	0.0	4.0	0.2	0.1	0.0	0.0	1.9	835.6	0.7	0.0	0.6	0.1	13.8	0.7	0.0	4.0	0.5	0.0	0.0	0.0	0.6	5.4	0.1	1.3	0.5	3141.0	2.3	0.3	0.0	2.7	1.5	2.7	1.0	1.5	1.8	1.3	0.1	0.1	0.0	0.1	1.9	1.2	1.2	0.2	1.0	0.4	0.1	0.0	22.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.0	2.8	2.1	52.1	3.4	0.0	0.1	0.0	0.7	193.0	13.5	0.0	0.0	0.3	0.0	201.0	0.0	31.5	0.7	2.9	0.1	0.2	3.5	2.7	0.0	27.5	0.1	4.4	542.3	1.0	0.0	0.0	2.2	62.9	0.0	0.0	0.1	29.5	4.1	0.6	0.3	0.7	3.4	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	66.9	42.5	1.9	1.7	1.0	327.1	3.8	4.8	0.0	0.0	3.7	1.5	0.0	0.1	96.0	10.4	0.3	0.5	0.0	73.0	11.4
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 441.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 393.1;Exocrine glandular cells: 722.5;Proximal enterocytes: 576.9;Proximal tubular cells: 601.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 83.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 244.0;gdT-cell: 102.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 244.0;T-cells: 102.6"	"Cell line enhanced"	"Detected in many"		"A549: 1615.1;ASC diff: 811.9;Hep G2: 699.6;OE19: 3025.3;RT4: 639.2"									"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: AB_2685966"	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	164.4	50.2	31.1	25.4	34.6	42.3	115.2	32.1	42.4	21.9	30.2	185.9	441.3	25.9	4.4	53.2	42.1	261.1	42.9	31.5	35.6	177.7	268.0	48.3	7.6	30.3	33.9	17.8	36.4	22.5	10.4	4.7	32.3	10.3	98.0	19.1	40.5	19.4	116.9	27.0	270.9	39.2	30.3	3.8	237.4	10.0	31.5	37.4	26.4	34.8	6.6	84.7	22.2	31.1	0.1	1615.1	1.1	413.0	811.9	292.2	1.0	0.0	21.4	0.4	1.4	47.6	24.5	0.2	78.7	19.4	45.0	11.5	1.5	28.8	1.1	3.0	0.5	3.2	438.4	699.6	4.3	0.7	0.2	160.9	57.1	20.0	0.7	25.8	28.1	3.4	10.8	0.0	42.6	3.8	9.8	2.6	0.7	3025.3	4.3	3.3	9.6	43.7	149.0	639.2	1.0	2.9	232.2	0.0	0.3	0.9	0.5	0.2	221.7	5.2	4.7	87.8	3.1	0.7	0.7	0.3	45.8	62.8	4.4	244.0	2.9	4.8	102.6	0.9	6.9	0.0	19.0	18.7	2.1	0.5	11.6	8.9	7.3	21.1	1.4	39.6	21.4	42.4	31.1	34.6	32.1	42.4	31.5	35.6	30.3	33.9	32.3	30.3	31.5	31.1	144.2	44.8	5.3	4.9	4.3	12.0	3.7	393.1	2.8	2.0	15.8	5.5	3.9	0.0	172.9	36.8	0.0	0.4	64.4	133.8	43.0	114.6	3.3	67.5	4.5	67.5	19.2	34.9	2.5	722.5	0.0	44.3	158.0	66.4	5.7	0.1	0.0	0.0	1.6	1.7	3.2	65.9	61.1	0.0	14.0	4.9	78.3	14.8	21.4	7.5	4.1	132.7	202.9	14.6	0.0	266.1	219.6	106.8	3.1	1.3	576.9	601.8	112.8	5.3	26.3	15.5	20.3	0.5	4.3	20.2	10.7	0.0	14.4	7.8	196.9	46.4
AL159163.1		ENSG00000249141	"Novel protein"		6	166858094-166956124	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"pancreas: 3.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.3;Hofbauer cells: 4.6;Pancreatic endocrine cells: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 4.7;OE19: 6.2;U-937: 2.6"															NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.76e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.52e-1)"	"unprognostic (9.28e-3)"	0.5	0.6	1.1	0.4	1.6	0.6	0.3	0.2	1.1	0.8	0.2	2.6	1.0	0.2	2.1	0.5	0.0	1.0	0.0	1.0	1.0	0.2	0.4	0.4	1.0	0.7	0.9	0.0	3.5	0.1	0.4	0.4	0.6	0.1	2.1	0.4	1.5	0.1	0.4	0.3	0.4	0.6	0.7	1.0	1.3	0.2	1.5	0.1	0.2	0.0	1.7	0.4	0.1	0.9	0.3	0.0	0.7	0.4	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.6	1.1	0.2	0.0	0.6	0.6	0.5	1.1	0.4	1.2	0.0	0.6	2.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.3	1.0	4.7	0.1	6.2	0.0	0.0	0.0	1.2	1.5	0.2	0.2	0.5	0.0	2.5	0.0	0.5	0.2	1.0	0.0	0.0	0.6	2.4	0.0	0.9	1.9	0.0	0.7	2.6	0.0	1.7	3.5	0.2	0.5	5.0	0.8	0.9	1.8	0.6	5.5	1.8	1.1	0.2	1.6	0.2	7.9	5.5	2.1	1.7	1.1	1.6	0.2	1.1	1.0	1.0	0.7	0.9	0.6	0.7	1.5	0.9	0.1	0.0	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.7	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
AL163636.1		ENSG00000259171	"Novel protein, ANG-RNASE4 readthrough"		14	20684587-20700576	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"liver: 115.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"liver cancer: 0.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 9.9;memory B-cell: 3.6;myeloid DC: 5.8"	"Group enriched"	"Detected in many"	12	"B-cells: 3.6;dendritic cells: 5.8;monocytes: 9.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 17.2;ASC TERT1: 38.5;Hep G2: 26.0;HSkMC: 16.9;OE19: 75.0"															NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"					"unprognostic (1.88e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.34e-1)"		"unprognostic (1.08e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.61e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.58e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.11e-2)"	45.2	5.8	1.0	6.8	0.7	0.1	34.7	0.6	1.6	31.7	1.5	29.5	26.5	25.1	10.6	11.8	27.3	48.0	14.9	0.8	1.5	15.6	115.1	23.7	5.4	1.2	0.9	69.7	19.4	3.3	3.1	2.6	1.1	41.4	35.1	0.3	35.1	16.5	6.7	17.9	31.7	17.9	1.3	3.6	58.4	7.1	0.8	1.5	8.2	14.6	5.1	24.7	25.7	1.6	2.6	0.8	2.0	0.0	17.2	38.5	0.0	2.4	6.4	0.0	1.7	0.0	2.7	0.0	0.0	10.2	2.7	0.8	0.6	0.2	0.0	6.4	0.4	0.4	0.0	26.0	1.3	0.0	0.0	16.9	1.4	0.0	0.9	12.1	0.5	1.8	0.0	11.6	2.9	0.0	0.2	0.5	0.0	75.0	0.3	0.3	1.4	2.1	0.1	0.9	0.0	0.2	4.0	1.6	2.0	0.0	1.9	0.2	1.8	3.3	0.6	2.0	0.4	2.2	1.6	0.0	3.2	0.4	3.8	0.0	9.9	0.0	0.0	0.5	0.3	3.6	0.4	0.2	5.8	1.2	0.2	0.0	0.1	0.0	0.0	1.0	0.5	2.4	1.0	0.7	0.6	1.6	0.8	1.5	1.2	0.9	1.1	1.3	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL445524.2		ENSG00000287856	"Novel protein"		1	231363797-231528603	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 59.5;neutrophil: 43.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 59.5"	"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 38: Basophils - Unknown function"		"Cluster 21: OE19 - Mitochondria"																						4.6	4.4	2.4	3.7	2.6	3.4	4.6	2.6	3.6	1.5	2.1	4.8	4.6	1.2	5.1	2.8	1.5	1.4	1.9	2.4	2.7	4.2	7.3	1.5	1.7	2.7	2.7	1.2	1.9	7.5		2.4	2.8	1.8	5.2	1.1	4.2	1.9	7.1	12.3	6.2	3.2	2.5	2.5	3.0	7.3	2.7	2.3	2.0	5.9	4.8	4.1		3.0	15.9	19.3	5.5	7.1	9.6	9.4	6.0	9.9	7.6	7.2	8.6	12.4	15.7	3.9	3.2	11.1	9.3	6.3	8.5	19.5	13.6	20.4	33.9	7.1	14.0	29.5	10.6	8.9	13.0	13.5	13.3	19.7	15.2	11.1	10.1	7.1	8.9	7.5	5.7	3.7	3.1	4.0	8.4	44.9	14.8	2.4	9.6	5.6	15.3	13.6	4.9	7.8	9.6	9.4	28.7	6.6	8.0	19.0	7.2	7.8	8.4	11.6	27.3	7.0	9.9	3.9	12.9	8.4	17.5	59.5	10.3	18.5	1.1	7.2	0.9	2.1	2.2	1.2	6.2	2.0	2.4	1.7	43.9	1.4	8.2	1.3	2.5	3.2	2.4	2.6	2.6	3.6	2.4	2.7	2.7	2.7	2.8	2.5	2.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 496.1;salivary gland: 128.0;stomach 1: 224.8"	"Group enriched"	"Detected in many"	4	"Basal respiratory cells: 389.5;Basal squamous epithelial cells: 274.3;Club cells: 150.1;Gastric mucus-secreting cells: 437.9;Respiratory ciliated cells: 412.7;Squamous epithelial cells: 342.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.4;lung cancer: 60.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"A549: 5094.7;OE19: 6071.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		52000	"Cluster 22: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	1.7	1.0	0.4	1.3	0.7	0.1	3.2	0.3	0.4	6.7	17.5	4.5	6.2	0.3	0.2	496.1	5.5	10.3	0.3	1.0	0.4	1.3	1.9	10.9	0.5	0.6	2.1	0.4	0.5	0.0	0.9	0.0	0.5	1.9	3.3	0.1	128.0	1.5	1.3	72.6	3.5	0.4	0.9	0.9	224.8	1.6	1.3	0.6	0.5	0.3	33.7	6.2	22.3	0.9	0.1	5094.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	10.7	246.5	0.0	2.7	0.5	2.0	29.3	0.7	12.8	0.0	0.0	0.8	0.1	116.6	1.0	0.3	0.1	0.5	0.0	14.9	0.5	0.4	0.2	0.5	0.0	0.0	0.0	0.0	9.7	0.1	0.3	0.4	6071.6	19.8	0.0	0.0	0.0	0.0	87.0	0.2	0.6	24.8	0.0	0.0	0.2	0.2	0.9	0.6	0.3	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.7	0.3	0.4	1.0	0.4	0.6	2.1	0.5	0.9	1.3	0.9	0.7	3.2	5.5	0.0	0.7	44.1	46.8	389.5	274.3	0.0	0.1	1.5	0.4	2.8	150.1	0.0	0.0	0.0	0.0	5.1	0.0	1.4	1.5	12.4	0.2	1.3	1.8	0.0	0.1	0.5	0.0	1.6	437.9	0.8	2.5	0.3	1.4	3.2	0.2	0.0	0.0	4.8	83.4	0.3	1.8	5.2	0.9	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	9.5	4.7	1.9	3.2	5.8	3.4	5.0	412.7	0.2	0.0	1.7	20.1	1.7	8.6	342.2	32.0	0.0	0.5	0.2	8.4	64.3
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19685760	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 288.6"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 287.4;Squamous epithelial cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 285.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		32000	"Cluster 14: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Endoplasmic reticulum, Cytosol"		"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	75.2	203.0	23.1	15.2	32.5	9.3	34.9	24.8	27.7	49.4	71.7	49.6	68.1	29.4	41.7	131.3	38.3	70.5	44.6	29.0	27.9	173.0	288.6	59.1	14.9	23.3	26.3	32.3	52.3	40.6	21.9	11.8	23.5	75.0	36.5	40.8	61.7	41.5	53.0	207.6	71.8	30.2	25.1	19.4	81.5	26.9	24.8	23.0	75.1	100.9	36.4	24.2	40.5	33.6	27.7	147.0	29.2	58.5	88.7	89.4	19.1	12.3	29.9	24.4	27.6	63.2	52.5	12.3	35.9	50.5	29.3	99.0	59.8	125.2	19.9	36.2	42.5	5.3	120.9	142.8	12.2	30.6	5.4	42.9	137.6	22.9	12.2	49.7	49.2	25.5	2.2	0.6	37.3	45.3	0.7	25.2	32.3	285.4	78.5	38.6	64.1	25.3	17.5	132.3	46.3	30.4	98.9	38.4	35.3	152.2	78.1	35.0	46.7	10.1	28.7	68.8	45.6	11.3	28.6	15.5	47.4	0.3	48.3	0.8	21.1	17.5	6.3	18.3	9.9	5.2	6.0	6.1	20.7	4.9	6.8	6.3	2.2	15.0	20.6	1.3	11.3	11.0	23.1	32.5	24.8	27.7	29.0	27.9	23.3	26.3	23.5	25.1	24.8	33.6	22.1	176.3	86.5	14.7	13.3	57.1	143.9	85.1	287.4	15.3	13.6	24.0	54.1	105.8	86.5	33.1	12.5	12.5	8.2	48.9	43.0	97.5	79.6	47.5	13.4	19.5	16.2	8.2	30.5	52.0	4.6	39.9	87.7	36.9	29.7	34.6	13.6	116.7	24.6	6.7	20.1	27.7	26.4	21.7	15.1	19.5	55.9	23.5	7.2	13.1	25.7	105.9	8.2	19.6	29.1	43.9	28.7	80.5	28.6	104.2	90.6	119.2	59.2	21.4	13.1	70.1	22.1	15.5	24.0	232.6	90.2	1.4	13.2	29.1	46.0	51.4
ALG5	bA421P11.2	ENSG00000120697	"ALG5 dolichyl-phosphate beta-glucosyltransferase"	Q9Y673	13	36949738-37000763	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007989	Approved		Approved	Cytosol		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA007989: AB_1078132"	"unprognostic (1.87e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.40e-5)"	"unprognostic (7.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.86e-1)"	29.1	32.3	12.1	19.6	13.3	26.9	41.6	13.4	25.7	34.2	14.9	36.0	27.1	23.5	77.9	21.7	23.3	23.2	18.5	12.4	13.7	41.2	61.9	24.5	20.7	13.5	13.1	20.6	90.1	40.2	18.7	25.4	14.0	26.5	46.4	11.2	51.9	30.9	18.5	20.9	27.6	23.4	13.6	23.6	36.6	15.2	12.6	22.7	54.9	10.5	28.9	30.5	21.6	14.8	24.3	35.0	31.5	29.4	95.1	61.8	22.5	63.9	81.1	63.7	53.7	71.0	84.1	35.2	25.9	45.7	55.0	57.5	41.9	55.0	62.6	37.4	77.7	77.2	27.5	40.1	85.1	69.6	43.7	62.7	88.8	49.4	60.6	41.5	47.7	43.9	39.8	49.7	59.9	45.6	47.4	59.8	29.1	188.2	27.5	54.3	30.4	102.5	71.5	49.8	25.2	45.5	29.2	62.8	34.2	25.4	34.4	79.1	36.1	32.7	20.4	37.2	45.8	35.8	28.8	37.4	51.2	41.9	57.1	59.1	55.7	26.2	53.4	62.3	54.4	44.1	49.1	55.6	57.1	40.2	46.4	47.2	5.8	54.7	53.0	109.0	65.7	69.2	12.1	13.3	13.4	25.7	12.4	13.7	13.5	13.1	14.0	13.6	12.6	14.8	52.0	51.3	51.9	11.1	51.5	34.7	45.9	142.9	27.3	19.8	50.2	42.5	14.2	61.5	86.0	53.3	10.4	81.4	49.4	28.9	23.5	93.5	33.7	31.5	44.1	45.5	36.1	25.9	19.5	140.2	74.4	46.0	32.1	40.1	29.2	25.9	37.9	77.3	69.7	11.8	22.4	76.3	111.9	37.1	52.1	25.8	40.0	39.4	80.0	14.0	45.2	36.6	25.7	18.1	30.6	85.9	50.9	38.4	166.6	56.4	51.4	62.7	43.8	25.2	46.0	34.4	70.7	57.6	23.7	33.6	30.3	81.3	43.0	58.5	62.2	50.7
ALG8	MGC2840	ENSG00000159063	"ALG8 alpha-1,3-glucosyltransferase"	Q9BVK2	11	78095244-78139660	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051898	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA051898: AB_2681656"	"unprognostic (1.37e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.38e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.37e-2)"	22.8	33.0	12.7	13.4	14.3	9.2	25.6	13.9	16.4	18.7	15.4	17.5	13.3	15.9	33.2	19.0	18.8	12.0	17.9	12.9	13.3	24.9	47.1	15.0	14.6	14.1	13.1	22.1	23.8	23.7	19.8	18.7	13.8	19.1	21.8	10.4	21.7	18.0	12.1	16.6	15.5	16.4	13.5	18.3	20.2	43.5	13.1	17.8	22.4	8.9	19.8	18.4	16.0	15.2	27.8	74.4	62.8	56.6	63.7	42.5	37.6	38.6	57.8	68.6	67.4	127.9	102.0	61.4	74.5	51.5	92.3	86.5	87.0	56.5	111.9	46.3	50.8	74.3	56.5	62.2	38.9	71.8	39.6	34.4	36.4	81.8	37.9	37.5	50.3	58.0	98.2	65.8	97.7	38.6	53.3	61.9	81.9	200.5	38.1	63.6	32.6	168.3	70.0	40.4	20.2	44.8	62.0	102.2	29.4	65.6	106.5	50.8	32.0	43.5	50.6	102.5	35.1	46.6	88.0	80.3	26.7	71.4	84.4	1.2	30.0	5.4	25.1	34.5	29.1	37.2	25.5	25.7	34.2	31.3	29.7	26.2	2.6	29.1	39.9	33.1	22.5	27.6	12.7	14.3	13.9	16.4	12.9	13.3	14.1	13.1	13.8	13.5	13.1	15.2	11.9	12.8	11.6	12.4	21.0	10.5	23.3	49.6	26.2	14.7	18.3	16.3	6.9	20.0	35.2	20.2	18.8	53.8	9.1	7.0	5.9	24.4	18.9	11.0	16.9	17.2	7.8	9.9	21.3	25.4	59.5	19.4	11.7	13.8	11.4	36.4	9.3	40.2	31.4	16.8	18.0	15.9	32.6	17.0	10.8	14.0	18.0	15.3	26.6	12.2	12.3	8.2	21.6	13.0	20.7	17.7	6.4	15.8	43.1	16.9	7.7	15.8	21.7	13.5	0.0	14.2	19.6	105.0	37.8	20.9	8.9	32.7	15.2	16.9	16.8	15.2
ALOX12B	12R-LOX	ENSG00000179477	"Arachidonate 12-lipoxygenase, 12R type"	O75342	17	8072636-8087716	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 90.2"	"Cell type enhanced"	"Detected in some"		"Horizontal cells: 1.7;Rod photoreceptor cells: 1.2;Spermatogonia: 1.2;Suprabasal keratinocytes: 1.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 11.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"A549: 1.1;HEK 293: 1.3;hTCEpi: 1.6;JURKAT: 2.7;OE19: 1.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024002	Supported		Supported	Vesicles,Cytosol		NA	NA		7000	"Cluster 46: Basophils - DNA binding"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	Vesicles	"HPA024002: AB_1844757"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.18e-2)"		"unprognostic (1.26e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.46e-2)"	0.0	0.0	0.4	0.1	0.5	0.1	2.1	0.4	0.6	5.7	0.0	0.1	0.3	0.0	0.0	5.6	0.2	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.5	0.4	0.2	0.0	0.2	1.2	0.1	0.0	0.5	0.4	0.1	0.6	0.8	0.0	0.4	90.2	0.2	0.0	0.1	0.2	0.2	0.2	0.4	0.6	0.0	0.0	19.1	0.0	15.0	0.1	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.2	0.3	0.0	0.0	0.0	1.3	0.0	0.4	0.1	0.0	0.2	0.0	0.0	1.6	0.1	0.5	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.8	0.0	0.9	0.0	0.4	0.4	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.2	0.0	0.4	0.6	0.1	0.2	0.0	0.1	0.5	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.5	0.4	0.6	0.4	0.2	0.4	0.2	0.5	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.5	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.8	1.2	0.0	1.8	0.0	0.0	0.0	0.1	0.1
ANKS6	"ANKRD14, FLJ36928, NPHP16, SAMD6"	ENSG00000165138	"Ankyrin repeat and sterile alpha motif domain containing 6"	Q68DC2	9	98731329-98796965	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.8;Inhibitory neurons: 48.6;Oligodendrocytes: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA008355	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA008355: AB_2058277"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.31e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.29e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.94e-2)"	"prognostic favorable (3.44e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.68e-1)"	5.7	4.8	8.0	3.2	8.8	1.5	4.7	14.3	10.0	9.5	7.6	10.5	4.2	8.9	4.9	8.7	10.2	3.3	3.9	8.1	7.7	9.4	2.7	6.6	2.4	12.5	8.9	10.3	12.8	5.5	4.8	2.0	12.4	5.5	4.9	2.2	5.4	2.3	3.7	5.3	7.7	4.9	8.2	3.2	11.5	5.7	10.1	2.6	13.6	1.0	2.9	8.7	5.2	9.7	8.2	12.3	10.9	19.3	9.0	7.3	7.4	5.9	10.0	6.5	7.7	6.7	5.8	15.2	4.4	8.4	9.2	23.9	8.1	9.9	3.4	21.2	8.3	3.6	7.7	2.9	8.8	2.0	2.3	8.9	12.0	8.7	8.9	7.9	7.4	13.8	26.0	3.5	5.0	13.5	0.9	3.9	17.3	36.3	12.2	10.2	26.8	1.2	11.7	5.1	7.1	8.1	2.5	14.2	6.7	8.8	0.0	4.1	7.6	6.5	7.2	18.4	5.8	6.8	12.1	2.4	9.4	6.8	9.8	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	8.0	8.8	14.3	10.0	8.1	7.7	12.5	8.9	12.4	8.2	10.1	9.7	3.5	6.4	10.5	16.0	2.4	1.8	0.9	8.2	5.2	12.0	1.5	2.2	4.4	10.0	7.7	12.9	8.4	3.1	1.5	5.1	3.9	4.2	3.0	3.7	5.3	3.2	4.9	0.8	52.8	8.9	2.7	4.9	7.7	3.9	1.3	6.2	1.8	1.7	1.9	0.0	48.6	7.1	0.0	1.3	0.9	5.8	2.8	0.9	0.0	9.4	0.7	1.9	2.1	14.1	54.2	9.3	3.1	4.5	1.4	3.9	4.8	5.9	11.1	0.8	0.0	2.7	3.2	3.8	5.9	5.6	1.1	1.1	2.4	6.2	10.4	2.9
ANKUB1	C3orf16	ENSG00000206199	"Ankyrin repeat and ubiquitin domain containing 1"	A6NFN9	3	149761100-149968385	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 5.1;choroid plexus: 6.9;fallopian tube: 5.9"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 124.3;Respiratory ciliated cells: 118.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in single"		"OE19: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053749	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA053749: AB_2682248"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-9)"	"unprognostic (3.06e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.07e-4)"	0.0	0.0	0.8	0.1	0.6	0.3	0.0	0.3	0.3	0.6	6.9	0.0	0.1	0.2	0.0	0.0	5.9	0.0	0.0	0.7	0.5	0.0	0.0	1.1	0.0	2.9	5.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.4	0.1	0.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.3	0.3	0.7	0.5	2.9	5.1	2.5	1.4	0.3	1.3	0.0	0.0	1.7	0.3	0.0	0.5	0.8	7.3	0.0	0.0	0.0	0.0	0.2	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	124.3	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	10.2	1.6	0.3	5.4	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	118.9	0.0	0.0	0.2	1.4	4.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.7
ANXA10	ANX14	ENSG00000109511	"Annexin A10"	Q9UJ72	4	168092537-168187736	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"stomach 1: 486.3"	"Group enriched"	"Detected in some"	5	"Exocrine glandular cells: 172.6;Gastric mucus-secreting cells: 667.7;Pancreatic endocrine cells: 315.0"	"Group enriched"	"Detected in many"	5	"pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"OE19: 284.8;PC-3: 125.5;RT4: 172.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005469, HPA074650"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Nucleoli"	Vesicles	"HPA005469: AB_1844849, HPA074650: "	"unprognostic (2.29e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.29e-2)"	"prognostic favorable (3.64e-6)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-1)"	"unprognostic (8.61e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-3)"	"unprognostic (8.41e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.89e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	19.6	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	486.3	0.9	0.0	0.0	0.0	0.0	0.0	89.6	0.1	0.0	0.0	4.6	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.6	0.5	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.4	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.4	0.1	9.7	0.0	4.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	284.8	125.5	0.0	0.6	0.0	0.0	172.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.3	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	1.5	0.0	0.5	15.5	0.0	0.4	0.1	0.0	0.2	7.2	3.2	0.0	2.1	0.0	0.0	0.1	0.0	21.1	11.0	0.1	0.1	0.3	0.0	2.7	0.2	172.6	0.0	0.4	667.7	0.1	0.0	0.0	1.8	72.6	0.0	0.0	0.2	0.5	0.0	2.8	0.0	0.8	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.5	0.0	315.0	1.1	0.0	1.4	0.6	0.0	0.2	0.3	0.6	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.1	14.7
AP000311.1		ENSG00000249209	"Novel protein similar to ATP synthase delta (OSCP) subunit domain"		21	33584687-33931607	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	6	"T-cells: 12.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 5.7"									HPA039558	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA039558: AB_2676570"												"unprognostic (4.72e-1)"						0.4	0.3	0.7	0.6	0.9	0.1	0.2	0.6	1.2	0.1	0.4	0.4	0.3	0.3	0.4	0.5	0.3	0.3	0.9	1.0	0.6	0.3	0.4	0.4	1.1	0.9	0.8	0.3	0.0	0.2	0.0	0.9	0.9	0.4	0.5	0.1	0.7	0.0	0.8	0.3	0.4	0.0	0.5	0.2	0.5	0.9	0.7	0.4	0.3	1.0	0.1	0.1	0.0	1.0	2.6	0.2	0.6	0.2	0.3	0.0	1.0	0.3	0.5	0.3	0.2	3.7	1.4	0.3	2.2	0.1	0.5	1.5	1.2	1.5	0.0	1.7	3.3	1.2	0.7	0.4	0.5	1.1	0.7	0.4	0.0	0.5	0.5	0.1	0.1	2.4	1.8	3.2	0.6	0.7	1.7	0.5	3.3	5.0	2.9	2.2	0.5	1.3	0.1	1.2	2.5	0.1	2.8	1.3	0.4	2.8	1.7	1.6	0.3	0.3	5.7	0.9	0.2	1.5	1.7	0.8	1.8	0.9	0.0	1.7	1.4	1.2	5.8	1.0	7.8	2.0	8.2	8.6	1.6	2.2	7.2	7.2	0.8	1.0	1.1	1.7	12.8	3.9	0.7	0.9	0.6	1.2	1.0	0.6	0.9	0.8	0.9	0.5	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
AP001273.2		ENSG00000284057	"Novel protein, C11orf54-MED17 readthrough"		11	93741664-93812378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"kidney: 9.5"	"Cell type enriched"	"Detected in single"	7	"Respiratory ciliated cells: 4.4"					"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA040511, HPA046619"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	Cytosol	"HPA040511: AB_10795369, HPA046619: "																		1.3	2.1	0.6	2.1	0.5	0.0	1.1	0.5	1.0	1.5	0.3	1.8	4.9	1.2	0.4	0.3	1.4	1.9	1.5	0.4	0.6	9.5	4.6	1.1	0.8	0.6	0.5	2.3	0.3	2.0	0.5	1.7	0.7	2.3	1.6	1.4	1.6	1.0	1.1	1.6	3.3	0.5	0.5	0.7	1.8	1.3	0.5	1.6	1.5	1.8	1.2	0.9	0.2	0.7	0.6	0.0	3.3	0.6	1.9	0.0	1.9	0.0	1.0	0.7	1.3	0.6	1.4	2.2	4.0	2.5	1.0	2.2	4.0	0.9	0.4	3.3	0.3	0.7	1.4	0.0	1.4	0.0	0.7	1.4	0.6	0.0	1.5	2.9	1.0	1.7	1.3	0.5	3.9	0.0	2.6	2.2	1.4	6.0	0.1	0.8	2.3	1.3	3.5	0.0	0.7	0.3	2.1	2.4	4.9	2.8	2.5	0.9	2.8	0.3	0.8	0.4	1.3	0.6	1.3	2.9	0.2	1.8	1.3	1.9	1.2	1.8	1.1	1.2	1.3	1.0	1.1	1.4	1.5	0.4	1.1	1.4	1.8	1.2	1.4	0.8	2.1	1.2	0.6	0.5	0.5	1.0	0.4	0.6	0.6	0.5	0.7	0.5	0.5	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP003419.1		ENSG00000256514	"Novel protein"		11	67351572-67373584	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.5;Club cells: 1.8;granulocytes: 3.8;Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 160.8"									HPA078008			Approved	"Centriolar satellite"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Centriolar satellite"		"HPA078008: "										"unprognostic (1.64e-3)"			"unprognostic (1.63e-1)"			"unprognostic (2.44e-1)"		23.9	26.6	48.0	45.6	50.8	38.9	26.6	51.4	57.0	28.9	47.4	68.1	46.8	14.8	38.4	46.1	25.4	49.9	44.4	47.0	50.4	32.0	91.9	36.6	83.5	51.9	49.9	23.6	68.1	20.1	14.6	28.7	51.2	36.7	71.9	8.2	42.0	32.1	37.4	30.6	44.0	34.1	51.8	38.5	45.9	20.5	53.9	58.0	25.9	75.0	123.1	47.0	11.3	54.3	14.4	14.9	8.1	12.1	81.4	124.2	3.4	18.9	82.0	26.0	26.9	0.0	160.8	15.4	49.2	122.4	48.9	19.3	8.1	102.3	15.5	10.1	0.2	17.3	2.3	0.0	122.6	5.4	40.2	122.2	96.3	64.0	111.7	115.7	80.3	31.0	7.1	41.8	94.7	3.9	13.5	15.4	3.3	138.1	1.0	15.7	22.0	18.9	80.9	2.5	1.4	6.1	13.9	17.6	53.9	34.4	50.4	19.4	45.8	42.5	7.0	42.8	8.6	16.5	2.4	25.6	99.3	12.2	25.8	43.2	39.6	74.0	45.8	48.6	43.7	87.9	60.8	60.3	39.1	96.3	61.9	51.7	34.6	24.3	90.4	72.9	84.0	62.0	48.0	50.8	51.4	57.0	47.0	50.4	51.9	49.9	51.2	51.8	53.9	54.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
APOBEC1	"APOBEC-1, BEDP, CDAR1, HEPR"	ENSG00000111701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 1"	P41238	12	7649400-7665908	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"intestine: 29.0"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 153.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 6.2;pancreatic cancer: 6.1;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"CAPAN-2: 1.7;OE19: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"						"unprognostic (2.35e-1)"					"unprognostic (3.80e-4)"			"unprognostic (7.96e-3)"			"unprognostic (1.79e-1)"	"unprognostic (4.38e-1)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	28.2	0.0	0.0	0.0	153.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0
AQP2		ENSG00000167580	"Aquaporin 2"	P41181	12	49950737-49958878	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Diabetes insipidus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	92	"kidney: 386.9;seminal vesicle: 212.4"	"Cell type enriched"	"Detected in some"	440	"Collecting duct cells: 4143.6"	"Group enriched"	"Detected in some"	6	"renal cancer: 1.7;stomach cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;HEL: 1.1;HMC-1: 2.2;OE19: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046834	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA046834: AB_2679830"	"unprognostic (2.10e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.60e-2)"			"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.38e-3)"	"unprognostic (5.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.11e-1)"		0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.2	1.5	0.0	0.0	386.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	212.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4143.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.1	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0
AQP5		ENSG00000161798	"Aquaporin 5"	P55064	12	49961872-49965682	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 622.6;testis: 222.0"	"Group enriched"	"Detected in many"	7	"Early spermatids: 1542.9;Late spermatids: 4265.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 87.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"OE19: 223.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065008	Enhanced		Approved	"Plasma membrane"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA065008: AB_2685401"	"unprognostic (4.67e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.92e-3)"	"prognostic favorable (1.75e-5)"	"unprognostic (4.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.88e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.69e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (9.11e-3)"	2.9	0.8	2.7	0.1	3.7	0.2	17.1	3.3	2.7	12.9	1.5	0.4	15.3	2.7	0.2	16.5	0.7	2.8	4.0	2.4	2.9	1.9	0.1	7.6	0.0	3.3	3.9	0.2	2.0	3.0	1.2	0.0	3.1	1.3	0.0	1.0	622.6	1.0	0.2	112.7	0.1	0.3	2.6	0.4	52.3	222.0	3.8	0.0	1.6	0.0	0.1	0.3	0.4	2.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.7	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.7	223.2	0.0	10.1	0.0	0.0	0.3	0.0	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.7	3.3	2.7	2.4	2.9	3.3	3.9	3.1	2.6	3.8	2.6	0.5	57.7	3.1	0.0	0.1	1.3	0.5	18.3	0.0	0.8	53.9	48.0	0.3	0.0	56.4	7.3	0.0	0.0	0.1	0.0	0.0	0.1	1542.9	1.5	0.1	1.8	0.0	0.0	0.0	0.2	0.0	1.4	34.7	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	26.4	0.0	1.6	4265.6	28.6	1.7	295.3	0.0	0.0	53.7	0.0	3.0	0.1	7.2	0.0	19.2	0.3	1.6	0.0	0.0	9.7	1.7	19.7	0.0	1.8	403.9	15.9	1.3	0.9	0.0	0.6	18.7	0.0	0.6
AQP6	AQP2L	ENSG00000086159	"Aquaporin 6"	Q13520	12	49967194-49977139	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 52.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.2;Cardiomyocytes: 8.3;Collecting duct cells: 5.5;Ionocytes: 2.0"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 9.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.4"	"Region enriched"	"Detected in some"	7	"cerebellum: 21.0"	"Not detected"	"Not detected"			HPA015278	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA015278: AB_10600982"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.77e-1)"	0.1	0.2	2.8	0.1	4.1	0.0	0.1	5.6	2.6	0.3	1.6	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.2	2.7	2.5	52.7	0.3	0.1	0.0	4.9	4.6	0.0	0.1	0.2	0.2	0.0	5.2	0.2	0.0	0.2	1.0	0.2	0.0	0.3	0.2	0.1	3.4	0.0	0.4	2.4	6.1	0.0	0.0	0.0	0.0	0.1	0.1	3.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	1.4	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.1	5.6	2.6	2.7	2.5	4.9	4.6	5.2	3.4	6.1	3.3	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.6	0.0	0.1	0.4	0.3	8.3	0.0	0.9	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	1.6	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.2	0.6	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ATP1B1	ATP1B	ENSG00000143153	"ATPase Na+/K+ transporting subunit beta 1"	P05026	1	169105697-169132722	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 1337.8"	"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 1723.3;Proximal tubular cells: 1070.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 919.7;RPTEC TERT1: 513.0;SH-SY5Y: 382.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012911	Enhanced					NA	NA		2100000	"Cluster 27: Non-specific - Gene expression"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA012911: AB_1845173"	"unprognostic (4.20e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (7.08e-7)"	"unprognostic (1.11e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.97e-3)"	"unprognostic (9.39e-2)"	12.4	146.9	197.7	48.0	216.2	4.4	79.4	370.0	451.1	37.5	369.3	246.1	336.6	108.8	64.3	159.8	48.8	178.7	160.5	326.4	332.1	1337.8	180.1	92.6	8.5	558.7	264.3	58.1	178.5	732.7	79.8	44.1	540.2	48.6	201.1	99.3	314.1	72.6	342.9	67.0	284.4	96.6	248.8	52.6	402.1	46.3	375.1	19.2	330.2	337.8	84.0	101.2	52.1	382.2	89.7	215.8	73.3	56.3	15.9	3.3	23.8	45.3	33.1	41.7	43.3	276.8	183.5	0.1	158.3	35.1	50.8	102.4	38.1	83.2	45.1	1.1	16.6	5.7	152.6	138.9	26.6	4.0	7.5	9.1	21.1	31.8	42.5	79.7	40.5	6.6	1.3	1.4	52.6	38.0	7.9	16.0	28.1	919.7	47.4	1.3	89.3	15.6	513.0	118.6	54.3	382.5	263.1	271.3	12.5	85.4	55.7	9.8	92.0	35.2	90.4	60.9	159.3	4.8	6.8	2.0	42.0	13.9	47.9	13.2	1.0	0.2	2.7	3.2	1.5	1.5	3.3	1.3	9.3	0.2	1.0	1.1	0.3	6.2	1.1	0.4	10.1	1.4	197.7	216.2	370.0	451.1	326.4	332.1	558.7	264.3	540.2	248.8	375.1	382.2	14.4	240.4	251.5	79.0	18.4	52.5	156.5	490.4	153.1	86.9	274.2	166.5	147.3	664.8	425.7	1723.3	14.6	4.8	21.0	817.1	923.4	629.9	3.8	199.6	11.6	18.6	160.9	6.9	344.7	591.9	9.0	78.7	353.7	190.6	23.4	89.0	45.7	273.3	385.3	580.5	602.3	296.7	370.2	99.5	676.1	9.0	89.8	101.5	247.3	81.5	27.1	23.4	1.0	94.5	514.7	377.9	666.4	149.0	16.9	84.4	646.8	1070.2	332.5	64.9	6.6	93.6	32.5	10.6	66.9	142.8	31.7	9.9	48.2	111.8	436.0	322.8
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.4;skin 1: 26.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 56.2;Club cells: 50.0;Intestinal goblet cells: 82.3;Oligodendrocyte precursor cells: 58.8;Respiratory ciliated cells: 78.2;Undifferentiated cells: 77.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 24.5;OE19: 44.4;RT4: 19.3;SK-BR-3: 33.0;T-47d: 11.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Focal adhesion sites"		"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.0	0.0	1.4	2.4	1.4	11.0	2.5	0.5	1.3	6.4	0.5	30.1	27.3	1.0	0.1	4.7	6.8	4.6	0.0	1.3	1.1	1.8	0.1	10.5	0.0	1.0	0.9	0.0	0.7	3.3	1.0	0.9	1.0	12.5	37.4	0.9	19.6	0.2	0.1	26.0	20.3	0.6	0.6	0.4	5.9	0.4	1.1	0.0	8.9	0.0	0.5	4.0	4.6	0.8	6.2	0.4	0.9	0.1	0.0	0.0	6.4	0.2	0.0	0.0	0.0	5.8	5.2	0.0	0.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.5	0.0	0.0	0.0	44.4	0.1	0.0	0.0	0.2	0.0	19.3	4.9	0.0	0.0	33.0	0.2	0.9	11.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	1.4	0.5	1.3	1.3	1.1	1.0	0.9	1.0	0.6	1.1	0.8	0.0	32.1	56.2	4.2	0.0	0.6	14.3	39.9	0.6	1.3	20.8	3.2	0.8	5.7	50.0	0.0	0.0	2.0	0.1	44.4	0.0	9.0	3.2	26.8	2.5	0.7	34.2	0.0	8.3	2.5	2.4	0.5	22.4	28.0	8.9	0.0	0.0	0.1	0.3	0.0	1.8	82.3	8.2	0.0	1.2	1.9	0.0	0.6	1.8	1.0	0.0	1.9	0.0	58.8	2.4	4.7	29.2	0.0	0.0	13.8	10.2	1.8	78.2	5.2	0.0	0.1	1.8	0.8	1.0	1.5	1.1	24.1	0.9	0.2	77.1	9.9
ATP5MC1	"ATP5G, ATP5G1"	ENSG00000159199	"ATP synthase membrane subunit c locus 1"	P05496	17	48892765-48895871	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1296.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 387.6;Distal tubular cells: 1449.8;Proximal tubular cells: 913.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 2026.7"					"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (3.43e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (6.60e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.73e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (9.42e-3)"	"unprognostic (9.78e-2)"	"prognostic favorable (8.24e-6)"	"unprognostic (2.07e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.33e-1)"	99.1	160.4	210.3	97.5	218.8	116.5	134.1	230.6	265.5	101.7	218.0	359.5	215.2	113.2	179.8	197.7	121.4	58.8	764.0	221.0	230.8	284.4	258.2	81.4	103.5	219.4	211.3	88.4	117.3	268.3	125.6	82.4	217.5	101.2	344.4	117.1	127.1	118.4	874.7	130.9	187.1	149.9	213.2	99.0	195.4	47.2	220.7	129.5	133.2	1296.3	173.1	113.9	118.7	213.2	477.3	631.0	196.6	287.1	212.4	257.7	284.6	257.0	214.9	334.5	329.8	415.1	333.9	514.1	597.5	224.2	357.5	422.5	353.9	449.8	496.5	434.6	475.0	507.8	379.7	848.2	148.9	611.0	244.4	209.4	302.3	353.7	393.3	180.4	384.8	420.5	305.4	344.4	393.5	484.9	586.6	285.5	122.5	2026.7	617.4	364.0	511.3	832.9	645.8	266.7	290.8	210.7	192.0	409.1	227.3	296.6	602.2	411.3	214.2	210.3	288.3	322.3	333.1	309.0	382.7	706.8	302.5	476.7	255.7	75.4	328.5	91.8	193.7	299.5	236.9	463.9	220.0	209.5	448.5	375.2	293.6	253.9	18.2	270.6	179.2	555.2	211.7	341.6	210.3	218.8	230.6	265.5	221.0	230.8	219.4	211.3	217.5	213.2	220.7	213.2	139.6	48.1	87.9	0.0	43.2	0.0	0.0	0.0	0.0	0.0	214.6	312.5	0.0	0.0	49.5	274.0	0.0	387.6	48.6	0.0	1449.8	185.5	0.0	101.4	144.9	61.6	0.0	0.0	0.0	298.1	283.3	82.6	0.0	126.3	73.2	129.8	0.0	0.0	270.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.9	0.0	0.0	72.4	0.0	0.0	0.0	0.0	196.4	0.0	0.0	11.4	0.0	0.0	913.9	53.2	0.0	0.0	0.0	74.6	0.0	0.0	0.0	0.0	222.3	36.5	327.9	0.0	0.0
ATP5PD	"ATP5H, ATP5JD, ATPQ"	ENSG00000167863	"ATP synthase peripheral stalk subunit d"	O75947	17	75038863-75046985	"Metabolic proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 1142.6;Hofbauer cells: 465.0;Proximal tubular cells: 1059.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042777, HPA048459"	Enhanced		Supported	Mitochondria		NA	NA		60000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA042777: AB_2678160, HPA048459: AB_2680402"	"unprognostic (1.37e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.29e-2)"	253.8	271.0	253.5	156.0	260.5	187.2	228.8	270.5	385.7	190.7	282.9	337.1	295.1	170.7	279.9	355.9	173.5	140.1	985.5	261.9	271.1	465.2	454.2	174.0	166.0	264.8	256.9	147.5	222.2	427.1	203.9	174.1	260.8	177.9	323.6	256.0	240.8	200.5	1102.8	264.7	257.4	211.3	260.2	155.0	307.4	93.8	262.3	175.2	263.7	1025.5	221.2	230.3	221.5	261.7	522.8	445.4	335.6	439.8	532.6	647.4	449.1	437.2	571.3	478.5	452.2	351.8	397.1	349.8	282.5	550.2	450.2	462.2	409.0	571.6	637.5	171.6	346.0	359.1	340.2	703.1	524.2	463.5	225.8	555.3	444.8	390.7	552.7	380.9	646.8	268.5	380.1	462.6	595.1	503.3	461.8	515.6	257.1	1185.3	626.9	322.3	970.4	652.3	1007.3	499.7	335.8	368.5	515.5	811.0	730.7	496.9	805.1	463.2	337.4	591.1	413.2	520.0	520.4	369.0	315.5	360.8	530.2	455.4	390.3	410.8	440.7	481.0	274.8	540.9	320.8	364.5	467.5	341.7	509.7	292.8	416.1	388.9	253.0	301.6	458.0	453.6	492.8	495.9	253.5	260.5	270.5	385.7	261.9	271.1	264.8	256.9	260.8	260.2	262.3	261.7	173.8	173.1	156.4	0.0	35.0	0.0	0.0	0.0	0.0	0.0	159.6	234.2	0.0	0.0	102.8	259.3	0.0	384.3	74.0	0.0	1142.6	313.6	0.0	188.2	153.6	70.4	0.0	0.0	0.0	379.5	328.4	82.7	0.0	207.6	88.3	84.6	0.0	0.0	465.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	125.1	0.0	0.0	208.8	0.0	0.0	0.0	0.0	284.3	0.0	0.0	13.8	0.0	0.0	1059.2	101.3	0.0	0.0	0.0	88.3	0.0	0.0	0.0	0.0	336.3	54.4	155.9	0.0	0.0
ATP6V0B	"ATP6F, HATPL, VMA16"	ENSG00000117410	"ATPase H+ transporting V0 subunit b"	Q99437	1	43974487-43978295	"Metabolic proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ionocytes: 1694.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 2268.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 769.4;granulocytes: 2268.9;monocytes: 1046.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044281			Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA044281: "	"unprognostic (1.38e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.23e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (6.13e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (5.55e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (8.87e-4)"	78.9	162.2	222.2	68.3	225.4	286.4	79.4	234.5	267.0	63.8	253.8	94.8	61.1	57.5	97.3	101.0	61.5	64.5	107.2	231.3	256.2	233.8	168.3	115.8	71.6	235.4	232.9	49.7	172.0	182.0	157.5	76.6	251.1	101.4	90.8	106.6	112.1	60.7	138.6	98.9	83.8	55.7	232.2	143.7	124.9	56.7	244.0	60.1	101.7	84.0	74.7	92.6	70.9	255.4	150.4	135.9	99.4	129.1	149.3	78.0	142.9	134.1	168.5	217.1	183.6	143.2	144.5	140.3	119.7	119.0	253.2	118.4	233.4	170.1	99.8	135.4	266.4	175.0	209.7	195.1	238.0	262.7	307.9	97.4	219.6	235.3	206.5	136.7	105.1	167.3	189.5	260.9	177.1	147.3	103.2	411.3	182.4	184.8	271.1	150.7	108.1	371.7	225.2	159.1	260.9	137.2	89.0	303.1	319.0	111.4	128.8	419.5	62.8	119.0	105.7	222.6	311.4	241.9	397.5	150.3	161.2	355.5	188.5	528.7	1046.6	892.1	161.2	652.9	161.5	321.1	171.0	156.8	630.7	271.9	129.7	130.1	2268.9	124.4	618.8	769.4	187.2	1450.9	222.2	225.4	234.5	267.0	231.3	256.2	235.4	232.9	251.1	232.2	244.0	255.4	125.1	80.1	126.9	26.4	176.6	335.9	161.9	577.2	173.6	238.7	241.5	219.1	101.7	144.4	367.7	283.3	102.2	197.4	216.0	242.1	201.5	347.8	4.4	186.6	93.6	136.9	224.0	114.6	36.5	328.5	223.3	118.9	114.7	207.9	206.7	77.0	102.1	241.0	815.7	129.5	40.5	306.2	1694.7	347.6	454.5	12.9	78.9	489.8	281.1	24.4	379.2	220.2	103.0	28.6	62.4	379.0	382.7	65.5	301.2	355.1	186.0	223.5	244.1	231.7	78.9	77.4	444.3	116.6	197.9	192.9	358.3	496.5	121.2	135.9	241.8	337.5
AVL9	KIAA0241	ENSG00000105778	"AVL9 cell migration associated"	Q8NBF6	7	32495426-32588726	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 93.9;Inhibitory neurons: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050957	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA050957: AB_2681289"	"unprognostic (2.33e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.14e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.21e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.05e-1)"	7.5	9.0	9.3	10.2	11.4	9.4	10.7	8.6	10.2	9.0	9.2	15.9	13.3	8.2	12.2	8.0	8.5	7.6	5.2	12.0	10.1	10.5	8.3	8.0	10.6	7.6	8.6	8.2	11.0	9.3	7.0	10.8	9.1	9.5	17.9	22.4	9.2	7.1	8.0	7.6	13.3	8.3	5.4	8.6	12.2	7.0	11.8	12.7	13.2	6.2	11.3	9.1	7.0	9.2	19.6	17.0	17.4	23.6	10.3	14.8	12.1	17.3	22.8	16.7	22.3	13.4	25.8	24.7	0.3	15.3	64.4	15.8	16.7	17.1	28.1	10.8	10.3	18.5	11.8	14.6	37.8	31.8	23.3	16.1	16.5	21.4	24.3	18.5	25.0	19.6	45.9	22.1	52.9	20.2	12.9	26.5	19.6	27.1	14.8	12.4	19.3	18.9	17.8	32.7	37.4	23.8	14.6	35.5	15.4	23.2	25.4	28.8	19.2	17.3	20.2	13.8	15.2	50.6	47.4	38.8	34.2	29.5	38.6	21.0	15.0	23.3	13.8	11.8	11.7	12.9	11.5	13.1	11.5	16.0	14.1	12.8	37.9	7.0	11.5	13.6	11.5	16.2	9.3	11.4	8.6	10.2	12.0	10.1	7.6	8.6	9.1	5.4	11.8	9.2	11.0	6.4	11.7	85.5	23.8	11.5	12.4	12.4	13.6	31.6	16.2	8.1	9.5	15.7	15.2	12.9	62.6	16.2	21.4	46.7	3.9	12.8	5.8	14.9	11.6	13.1	22.3	9.0	93.9	17.2	15.7	11.1	28.5	19.4	17.7	25.5	16.8	13.4	15.1	32.0	92.6	27.6	6.1	24.6	14.2	2.8	10.2	17.8	12.4	78.7	18.3	12.5	19.6	56.8	88.6	24.5	24.8	9.4	22.3	21.1	22.5	15.8	18.4	36.8	6.6	9.7	12.7	9.9	8.4	12.2	10.5	17.5	16.6	15.7	29.0	23.3
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976042	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 2809.6;salivary gland: 3847.3"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1315.5;Breast myoepithelial cells: 704.8;Hepatocytes: 4270.8;Ionocytes: 901.3;Prostatic glandular cells: 1691.9;Urothelial cells: 674.2"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 56.6;OE19: 158.9;RPMI-8226: 130.4;T-47d: 41.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	74000000000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	128.6	3.9	17.1	2.7	28.8	0.4	1061.4	23.1	18.8	3.4	16.0	6.7	30.9	1.5	2.5	22.0	3.0	38.7	114.7	14.9	22.2	326.8	2809.6	14.8	0.4	20.2	23.3	6.0	752.1	0.1	1.3	0.5	27.1	1051.4	4.2	3.6	3847.3	40.2	1.7	206.8	28.6	0.3	14.0	1.4	315.2	25.9	21.4	0.8	1.9	2.3	1.5	5.8	7.5	24.5	0.2	0.0	0.0	0.0	11.3	0.0	5.5	0.0	0.0	0.0	0.0	0.1	4.0	14.2	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.3	0.1	56.6	4.9	1.5	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.3	29.9	0.0	0.0	0.0	5.1	0.2	158.9	0.0	0.0	1.7	130.4	0.0	0.0	0.0	2.0	1.0	25.4	13.0	0.0	41.8	0.0	0.0	0.5	0.1	1.8	0.9	1.9	0.8	0.4	0.0	0.5	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	28.8	23.1	18.8	14.9	22.2	20.2	23.3	27.1	14.0	21.4	24.5	9.9	22.4	276.8	0.0	14.7	4.2	422.1	25.3	0.0	0.0	1315.5	704.8	115.9	451.8	63.0	5.5	2.1	0.0	10.4	5.5	46.9	11.7	1.9	1.4	1.2	14.2	12.4	85.5	0.1	254.2	0.0	7.7	94.8	5.5	3.8	1.2	65.3	4270.8	0.0	0.0	0.1	13.1	901.3	93.1	0.7	4.2	0.9	14.8	62.2	1.0	2.0	23.7	0.0	7.5	7.3	221.5	6.4	0.0	0.3	1691.9	15.3	596.1	6.3	0.3	0.0	0.0	11.9	7.4	0.4	9.9	9.7	0.0	12.3	0.1	12.6	674.2
BICRAL	"GLTSCR1L, KIAA0240"	ENSG00000112624	"BRD4 interacting chromatin remodeling complex associated protein like"	Q6AI39	6	42746958-42868560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 10.3;Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.4;Breast glandular cells: 10.2;Breast myoepithelial cells: 9.1;dendritic cells: 11.6;Endometrial stromal cells: 9.6;Glandular and luminal cells: 9.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029390, HPA029391"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA029390: AB_10599730, HPA029391: AB_10599949"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (2.74e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.54e-2)"	8.5	5.7	4.5	8.3	4.4	7.7	9.5	15.9	6.9	9.4	1.1	7.6	6.1	11.3	7.7	6.5	10.2	7.2	7.0	4.2	5.0	6.1	5.7	7.8	12.2	4.8	4.0	16.2	7.0	10.4	5.8	5.2	5.1	9.2	9.5	14.3	8.3	8.1	8.0	8.7	6.7	9.6	2.9	9.8	7.5	5.0	4.0	11.6	11.3	9.4	12.2	7.7	7.3	7.4	6.2	4.9	4.3	6.9	8.7	10.0	3.7	5.4	5.6	4.7	3.6	2.2	4.4	14.4	4.8	9.1	7.2	4.8	4.2	5.6	7.7	10.8	2.7	10.1	4.9	6.3	4.6	8.6	8.8	6.2	10.6	4.6	8.4	8.9	4.9	8.4	9.8	12.5	5.6	7.4	1.4	4.9	4.8	24.3	3.0	8.9	2.5	14.3	4.8	4.0	14.6	7.8	6.1	8.7	6.1	4.1	7.6	10.0	5.7	6.5	6.4	4.3	5.4	11.3	7.0	21.6	3.9	10.8	4.7	2.3	0.5	2.8	2.2	0.4	1.9	1.2	1.3	2.1	0.4	1.3	1.2	1.6	3.7	1.6	0.8	0.7	1.6	0.6	4.5	4.4	15.9	6.9	4.2	5.0	4.8	4.0	5.1	2.9	4.0	7.4	10.3	9.6	9.4	0.0	4.2	0.0	0.0	0.0	0.0	0.0	10.2	9.1	0.0	0.0	4.3	3.7	0.0	2.3	11.6	0.0	0.0	3.8	0.0	6.2	9.6	3.1	0.0	0.0	0.0	3.8	2.1	3.9	0.0	9.8	1.3	8.4	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	3.5	0.0	0.0	4.3	2.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.4	5.0	5.2	0.0	0.0
BIN1	"AMPH2, AMPHL, SH3P9"	ENSG00000136717	"Bridging integrator 1"	O00499	2	127048027-127107288	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Endocytosis, Host-virus interaction"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 2105.3;tongue: 803.2"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 164.9;NK-cells: 176.1;Oligodendrocytes: 186.4;Proximal tubular cells: 255.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 186.6;MAIT T-cell: 163.9;memory B-cell: 165.9;memory CD4 T-cell: 192.1;memory CD8 T-cell: 187.4;naive B-cell: 181.2;naive CD4 T-cell: 177.1;naive CD8 T-cell: 171.1;NK-cell: 178.9;T-reg: 249.8"	"Group enriched"	"Detected in all"	9	"B-cells: 181.2;NK-cells: 178.9;T-cells: 249.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001945, HPA003894, HPA005437"	Enhanced		Supported	Cytosol		NA	NA		430000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284"	"unprognostic (2.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-3)"	"unprognostic (3.22e-3)"	43.7	93.2	178.8	25.7	232.8	12.0	37.3	162.6	209.6	53.8	85.9	35.2	17.4	38.7	16.8	33.5	53.5	22.6	16.5	174.2	160.6	83.4	34.7	22.7	41.0	204.2	194.8	34.4	21.5	19.6	41.0	23.5	189.8	58.1	13.1	53.7	42.6	24.0	2105.3	14.8	31.5	19.6	155.4	54.7	45.0	10.4	199.2	18.4	28.5	803.2	27.5	89.0	36.6	310.5	52.0	27.9	32.8	39.3	95.9	76.5	11.4	15.3	33.1	35.8	23.4	107.6	31.3	0.0	46.0	28.9	20.8	6.8	14.6	25.0	9.5	5.9	4.1	15.1	46.9	7.1	86.2	0.2	2.8	70.2	6.1	77.3	14.0	46.4	49.1	5.1	3.2	1.6	44.8	1.1	4.9	43.3	24.8	114.2	31.4	11.8	36.3	4.8	126.7	0.1	22.4	61.9	55.5	21.2	17.7	34.7	1.3	9.7	59.3	40.9	39.9	52.8	52.1	1.3	1.4	0.3	60.3	2.6	19.2	1.2	3.1	0.6	186.6	2.0	163.9	165.9	192.1	187.4	15.1	181.2	177.1	171.1	6.0	178.9	3.2	21.5	249.8	133.5	178.8	232.8	162.6	209.6	174.2	160.6	204.2	194.8	189.8	155.4	199.2	310.5	15.6	9.6	10.0	10.7	80.1	18.6	10.0	3.3	1.2	144.1	10.7	9.1	5.6	44.3	5.5	14.7	125.1	1.8	98.3	18.6	37.2	15.2	16.1	11.7	46.2	21.9	46.0	11.6	36.9	29.4	4.2	68.7	29.0	19.0	2.5	28.7	15.0	18.3	164.9	30.3	47.2	28.0	10.2	27.0	62.3	55.8	78.6	50.1	23.2	58.1	10.4	25.3	176.1	11.6	186.4	16.7	18.1	30.5	14.6	26.2	14.3	255.7	1.4	133.4	13.1	75.7	28.8	2.6	10.9	1.6	8.9	2.9	98.2	40.0	50.1	9.8
BNIP5	"C6orf222, DKFZp779B1540"	ENSG00000189325	"BCL2 interacting protein 5"	P0C671	6	36315761-36336888	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 24.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"colorectal cancer: 8.7;pancreatic cancer: 5.1;stomach cancer: 8.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;OE19: 2.3;REH: 1.0;U-937: 1.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA038407, HPA058189"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"		Cytosol		"HPA038407: AB_10669644, HPA058189: AB_2683634"	"unprognostic (1.97e-5)"	"unprognostic (5.46e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"		"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.66e-4)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	24.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.2	23.5	0.1	0.0	0.0	4.2	1.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFA2	"bA49G10.1, C20orf70, PSP, SPLUNC2"	ENSG00000131050	"BPI fold containing family A member 2"	Q96DR5	20	33161768-33181412	"Predicted secreted proteins"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1619	"salivary gland: 6860.0"	"Cell type enriched"	"Detected in some"	4	"Ionocytes: 649.0"	"Group enriched"	"Detected in some"	4	"lung cancer: 2.6;pancreatic cancer: 2.9;stomach cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.0;RT4: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044006	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA044006: AB_10963580"							"unprognostic (9.10e-3)"	"unprognostic (1.22e-1)"		"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"		"unprognostic (3.03e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.14e-4)"	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.8	3.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6860.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	49.3	0.0	0.0	0.0	0.0	0.2	0.0	145.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	649.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	17.3	0.0	0.0	0.0	8.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 447.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 61.9;Ductal cells: 66.8;Exocrine glandular cells: 65.8;Pancreatic endocrine cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in many"		"A-431: 41.8;CAPAN-2: 25.9;MCF7: 62.0;OE19: 70.9;RPMI-8226: 32.3;SK-BR-3: 29.9;T-47d: 30.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.8"	"HPA042889, HPA077485"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Cytosol	"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.3	3.1	3.7	2.6	11.3	5.9	14.6	5.9	4.2	6.5	1.2	12.0	8.8	1.1	10.9	30.1	4.4	4.4	1.5	2.5	3.0	14.4	0.8	5.6	0.8	2.1	4.8	0.0	41.7	447.2	8.3	1.7	1.7	5.0	11.0	6.9	81.6	4.5	0.0	26.3	7.0	0.7	1.7	0.5	24.7	2.8	5.9	1.8	30.3	0.1	3.1	3.0	7.6	2.5	41.8	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	8.6	25.9	0.0	0.4	0.0	0.0	3.6	0.4	0.0	0.0	4.6	3.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	20.8	0.3	0.0	0.0	62.0	0.7	0.0	1.0	70.9	0.0	0.9	0.0	32.3	4.0	8.8	13.7	0.0	0.0	29.9	0.0	1.7	30.3	4.3	0.0	0.0	0.0	0.1	0.0	9.7	13.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.4	0.0	0.0	3.7	11.3	5.9	4.2	2.5	3.0	2.1	4.8	1.7	1.7	5.9	2.5	0.3	6.4	6.9	0.0	2.5	1.0	2.0	4.4	0.0	1.8	61.9	31.2	2.8	17.2	9.5	27.6	6.2	9.2	9.9	20.8	39.2	66.8	0.5	11.3	1.6	0.9	20.4	15.6	1.0	65.8	1.1	0.7	21.4	17.3	3.8	1.5	0.0	0.8	1.4	0.0	3.2	19.1	12.2	0.3	0.3	0.6	0.0	0.5	10.6	0.0	1.0	0.8	3.1	0.5	0.2	48.6	14.5	0.0	2.5	13.8	13.5	21.2	9.7	12.1	0.0	0.0	1.7	0.6	4.3	26.4	14.2	6.7	1.3	0.1	24.9	17.7
BTNL8	"BTN9.2, FLJ21458"	ENSG00000113303	"Butyrophilin like 8"	Q6UX41	5	180899077-180950906	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"intestine: 119.0"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 79.6;Proximal enterocytes: 178.9"	"Group enriched"	"Detected in some"	12	"colorectal cancer: 2.6;liver cancer: 1.5;pancreatic cancer: 2.8;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	12	"neutrophil: 233.4"	"Lineage enriched"	"Detected in many"	221	"granulocytes: 233.4"	"Group enriched"	"Detected in some"	28	"CACO-2: 39.3;OE19: 56.2"									HPA039738	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA039738: AB_2676656"	"unprognostic (4.31e-1)"	"unprognostic (6.85e-6)"	"unprognostic (6.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.27e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.02e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.43e-1)"	"unprognostic (1.17e-2)"	1.6	0.3	0.2	2.1	0.2	7.3	0.5	0.2	0.4	0.0	0.1	26.7	119.0	0.1	0.0	0.2	1.3	6.9	0.3	0.2	0.3	0.6	0.6	2.6	0.3	0.3	0.3	0.1	1.7	0.2	0.2	0.2	0.4	0.1	25.7	0.0	0.1	0.0	0.3	0.0	86.5	0.6	0.2	3.1	7.2	5.5	0.3	0.2	1.1	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	39.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	56.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.0	0.0	1.6	0.0	0.2	0.4	0.0	0.1	1.0	20.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.4	0.0	0.5	0.0	0.4	0.3	0.2	0.2	0.2	0.4	0.2	0.3	0.3	0.3	0.4	0.2	0.3	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	8.6	0.1	0.0	0.0	0.0	0.0	79.6	0.0	0.2	0.3	0.0	0.0	0.6	3.6	0.0	0.3	2.6	0.0	0.2	12.2	0.0	0.0	0.0	11.7	0.1	0.8	0.0	0.1	29.6	0.0	4.5	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	26.3	0.0	0.0	0.0	178.9	0.1	0.8	0.0	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	15.6	0.1
BYSL	Enp1	ENSG00000112578	"Bystin like"	Q13895	6	41921499-41933046	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031217, HPA031219"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA031217: AB_10599488, HPA031219: AB_10601989"	"unprognostic (6.12e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (4.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-3)"	"unprognostic (5.99e-2)"	10.7	10.1	6.0	8.2	6.1	7.4	8.8	5.7	6.2	6.4	5.8	6.8	4.7	8.2	5.4	9.2	8.5	5.4	7.2	6.1	6.7	6.5	10.7	5.1	8.4	6.0	6.7	8.1	11.6	6.5	3.6	10.0	6.9	6.8	7.0	2.5	4.8	6.5	20.1	8.0	4.0	11.9	5.9	5.8	5.5	7.9	6.6	12.2	5.2	10.8	13.2	15.4	5.9	6.2	50.6	52.1	30.2	54.2	21.8	25.5	59.7	44.0	21.6	66.7	48.9	72.1	15.7	78.2	43.9	32.9	51.9	34.3	91.6	61.0	58.0	30.1	89.2	72.7	37.3	81.5	38.6	58.8	36.0	30.1	39.5	67.2	62.1	16.9	50.5	47.3	96.1	26.0	48.7	70.8	74.2	68.3	29.0	162.4	50.9	77.9	38.2	57.3	45.2	37.9	65.6	37.4	30.0	37.8	58.2	26.3	38.0	58.6	39.3	49.0	53.5	31.4	77.2	24.6	33.0	185.8	14.5	57.9	49.9	0.0	3.8	0.7	4.3	3.9	5.9	3.8	2.5	3.5	6.0	5.5	1.6	3.3	0.5	6.1	3.0	9.2	3.3	2.3	6.0	6.1	5.7	6.2	6.1	6.7	6.0	6.7	6.9	5.9	6.6	6.2	6.4	0.0	3.9	0.7	6.7	31.0	34.5	19.2	8.6	2.8	8.6	8.5	2.8	5.7	9.5	1.8	4.2	22.1	4.8	4.6	3.9	21.4	10.4	7.9	12.1	10.9	5.4	6.3	2.8	17.5	24.4	11.4	4.6	9.8	2.5	11.4	3.9	6.8	12.0	0.0	2.5	6.5	12.2	1.0	7.3	6.8	8.1	5.1	8.8	1.9	6.6	4.4	9.2	4.0	2.8	23.5	2.9	7.2	4.9	26.2	2.2	10.5	5.1	3.4	6.6	16.1	13.8	10.8	25.7	14.0	25.3	29.1	4.1	18.2	11.4	32.2
C11orf53	MGC50104	ENSG00000150750	"Chromosome 11 open reading frame 53"	Q8IXP5	11	111245726-111286401	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"stomach 1: 3.4;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 14.3;Early spermatids: 38.1;Exocrine glandular cells: 56.6;Late spermatids: 12.4;Respiratory ciliated cells: 9.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"OE19: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA056128, HPA073101"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Vesicles	"HPA056128: AB_2683046, HPA073101: "	"unprognostic (3.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.84e-2)"		"unprognostic (1.94e-1)"		"unprognostic (8.07e-3)"		"unprognostic (5.60e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.50e-1)"		"unprognostic (9.95e-2)"	"unprognostic (8.66e-2)"		"unprognostic (3.52e-2)"	0.9	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	1.4	0.9	0.9	0.0	0.0	0.9	1.4	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.5	0.6	1.3	0.4	0.7	0.0	0.3	1.0	0.0	2.1	0.0	1.8	0.0	1.2	0.0	0.0	0.0	3.4	5.5	0.0	0.4	0.0	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	4.6	0.0	0.0	0.0	0.1	0.1	14.3	3.3	0.0	0.0	0.0	0.1	1.5	0.0	1.9	38.1	0.0	1.4	0.0	7.7	0.0	0.1	56.6	0.1	1.9	3.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	3.0	8.2	0.0	0.0	12.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.4	0.2	0.3	4.0	0.0	9.9	0.0	0.0	0.1	0.6	1.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	4.4
C11orf80	"FLJ22531, TOPOVIBL"	ENSG00000173715	"Chromosome 11 open reading frame 80"	Q8N6T0	11	66744451-66843516	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 41.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 66.0;Excitatory neurons: 101.2;Inhibitory neurons: 73.8;Late spermatids: 125.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038932, HPA038933"	Approved		Approved	Centrosome		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome		"HPA038932: AB_2676275, HPA038933: AB_10671867"	"unprognostic (2.81e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.54e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.98e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.26e-1)"	4.0	10.8	5.9	5.9	6.5	5.5	11.1	14.3	8.3	8.8	1.9	9.4	9.0	4.1	14.0	23.8	5.5	2.9	5.9	5.8	5.7	24.6	3.1	6.0	6.8	1.8	2.5	4.0	5.9	10.1	12.2	3.3	3.2	13.8	9.3	12.2	14.4	7.0	1.2	41.0	14.2	4.4	0.6	9.9	5.6	23.8	5.6	13.0	4.2	1.4	15.0	5.0	13.4	3.9	16.1	8.7	17.1	11.7	0.9	5.3	3.2	6.8	7.9	7.8	9.8	28.7	19.5	26.4	3.8	5.8	5.2	28.8	7.8	9.8	7.7	6.9	4.5	4.7	12.0	7.3	2.1	3.2	4.7	1.4	35.0	6.1	11.0	11.9	25.2	9.6	7.7	10.0	4.7	17.9	10.8	9.7	26.9	46.4	11.6	6.5	8.1	20.4	33.6	5.8	12.8	12.6	11.2	30.0	24.2	15.1	21.3	2.0	11.7	5.5	9.9	6.0	9.9	7.2	16.2	19.1	6.2	5.5	6.9	2.2	0.8	3.0	1.8	0.4	3.6	10.7	3.3	2.6	0.5	7.4	3.5	3.0	1.6	1.5	0.9	9.1	4.1	0.7	5.9	6.5	14.3	8.3	5.8	5.7	1.8	2.5	3.2	0.6	5.6	3.9	2.8	19.2	3.6	9.8	17.0	11.6	3.2	11.9	4.6	3.6	9.4	7.6	0.5	4.3	8.0	35.0	18.8	1.7	6.0	10.7	9.8	17.0	66.0	5.0	2.1	3.0	13.8	5.7	101.2	11.7	2.3	2.5	5.6	4.4	4.5	3.2	2.2	2.7	3.3	0.0	73.8	12.4	14.2	1.0	5.2	125.5	2.5	1.3	3.6	14.0	4.3	2.0	8.2	9.5	8.5	14.6	12.1	0.4	43.6	2.8	46.2	4.1	4.8	8.7	6.6	2.3	3.0	22.0	22.9	20.4	20.0	1.5	5.9	0.8	10.3	3.2
C1orf131	DKFZp547B1713	ENSG00000143633	"Chromosome 1 open reading frame 131"	Q8NDD1	1	231223763-231241187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028452, HPA029920"	Enhanced					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA028452: AB_10610979, HPA029920: AB_10600423"	"unprognostic (5.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.76e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (2.64e-9)"	"unprognostic (8.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (9.84e-4)"	8.6	9.9	6.4	11.4	6.7	11.9	8.8	8.1	9.0	7.0	6.5	13.3	21.4	7.3	7.6	10.4	9.2	8.4	8.3	6.4	7.1	8.0	13.8	6.6	15.9	6.9	7.0	8.8	8.8	7.4	6.4	11.8	7.0	8.3	14.8	4.6	10.8	5.7	12.5	8.7	18.2	8.7	6.7	10.9	13.6	6.0	6.7	14.3	7.9	9.7	15.1	9.7	8.0	7.2	23.4	22.6	16.6	24.1	17.9	17.7	54.9	16.9	12.2	22.0	14.7	35.7	21.2	50.7	30.4	13.3	10.6	33.9	32.7	13.8	20.4	27.2	51.0	22.7	14.3	38.7	18.7	40.5	30.3	14.8	21.1	16.6	19.9	9.7	18.3	26.7	47.1	16.5	16.7	24.9	44.8	37.7	34.2	65.9	18.0	41.1	22.3	54.1	20.9	16.9	19.1	29.1	28.2	18.6	21.8	8.0	32.2	51.8	12.1	14.4	18.7	24.7	29.8	26.4	44.5	41.9	14.4	31.6	32.6	30.4	25.4	37.2	16.9	26.1	20.3	33.5	22.3	23.2	24.7	30.0	22.4	21.5	14.8	33.1	27.3	27.8	31.2	16.4	6.4	6.7	8.1	9.0	6.4	7.1	6.9	7.0	7.0	6.7	6.7	7.2	27.8	22.4	19.1	6.8	30.7	9.6	12.3	41.9	24.5	23.4	22.0	24.6	15.0	38.6	24.1	25.8	12.5	68.8	28.7	26.2	39.2	32.8	2.9	26.2	41.1	23.7	21.1	28.0	9.5	36.0	60.9	21.4	31.6	23.0	17.1	25.7	18.5	54.7	29.9	23.5	13.2	41.9	28.5	23.3	6.9	3.1	29.8	20.1	12.4	9.4	29.4	20.9	41.2	6.6	13.0	29.8	35.8	22.6	22.5	16.8	52.6	18.5	17.9	16.3	13.1	18.0	18.1	22.4	34.1	31.0	11.5	38.9	25.9	35.2	46.7	13.6
C1QTNF9B	CTRP9B	ENSG00000205863	"C1q and TNF related 9B"	B2RNN3	13	23891099-23897502	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.8;skin 1: 17.9;testis: 8.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.3;Early spermatids: 2.3;Endothelial cells: 1.4;Late spermatids: 2.1"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.8"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 7.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 4.8;OE19: 3.6"									HPA056632	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA056632: AB_2683197"	"unprognostic (3.43e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.04e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-1)"	1.2	0.7	1.0	0.6	0.9	0.2	0.4	0.3	1.2	0.3	0.4	0.4	0.5	0.7	0.0	1.6	0.3	0.8	3.5	7.8	1.9	0.2	0.1	0.4	0.2	0.3	0.6	0.4	0.6	0.1	1.1	0.6	0.3	4.2	0.1	0.7	1.6	0.2	4.0	17.9	0.2	0.7	0.3	1.3	0.8	8.8	0.7	0.0	0.5	2.0	0.0	0.6	0.1	0.4	0.7	1.7	0.6	0.7	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.7	1.0	0.1	0.0	0.0	1.3	1.7	0.0	0.0	0.0	1.0	1.4	0.3	0.9	0.9	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.8	0.0	4.8	0.4	0.9	0.0	1.1	0.2	0.0	1.1	3.6	1.6	0.6	0.8	1.3	0.0	0.0	2.0	0.0	1.0	0.0	1.7	0.4	0.5	0.2	0.1	1.6	0.4	0.0	1.0	1.4	0.2	0.7	1.9	0.6	0.3	0.0	0.2	0.4	0.3	0.3	0.1	0.2	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.4	0.4	0.7	0.0	0.1	1.0	0.9	0.3	1.2	7.8	1.9	0.3	0.6	0.3	0.3	0.7	0.4	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.0	0.3	0.0	0.0	0.4	0.0	0.0
C2CD4A	"FAM148A, NLF1"	ENSG00000198535	"C2 calcium dependent domain containing 4A"	Q8NCU7	15	62066977-62070917	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 5.1;pituitary gland: 13.5"	"Cell type enriched"	"Detected in many"	5	"Glandular and luminal cells: 107.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"OE19: 34.4;RPTEC TERT1: 29.9"									HPA078864			Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA078864: "	"unprognostic (3.85e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-3)"	"unprognostic (5.49e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.72e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.35e-1)"	0.2	0.4	0.2	0.6	0.2	0.2	0.2	0.2	2.2	0.7	0.3	0.5	1.0	1.3	0.0	0.1	0.0	0.4	0.1	0.2	2.5	5.1	2.4	0.5	0.2	1.0	0.8	0.1	4.0	0.0	13.5	0.1	0.7	0.6	0.6	0.2	1.2	0.1	0.3	0.5	0.5	0.0	0.1	0.1	2.0	0.1	0.3	2.1	0.1	0.0	0.5	3.6	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.4	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	34.4	0.2	0.1	0.0	0.2	29.9	0.7	1.3	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.2	2.2	0.2	2.5	1.0	0.8	0.7	0.1	0.3	0.1	0.6	0.0	0.0	0.3	0.3	0.5	1.8	3.8	0.0	0.9	4.3	6.2	1.4	0.0	2.7	0.0	0.0	0.0	0.0	1.2	1.9	2.8	0.0	11.7	14.6	3.9	20.8	0.0	0.0	6.6	0.0	1.2	3.6	107.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.2	14.2	0.0	0.8	0.0	0.0	0.8	0.0	0.0	1.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.8	2.2	0.3	0.0	1.1	0.2	0.0	1.0	1.4	0.0	0.0	0.0	1.1	0.0	1.1	0.1	1.0	1.1
C6orf132	bA7K24.2	ENSG00000188112	"Chromosome 6 open reading frame 132"	Q5T0Z8	6	42101119-42142620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 157.0;skin 1: 73.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 163.8;Pancreatic endocrine cells: 219.9;Prostatic glandular cells: 144.6;Urothelial cells: 226.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 57.8;CACO-2: 52.0;CAPAN-2: 44.0;OE19: 181.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044588	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus, Cytosol"		"HPA044588: AB_10794293"	"unprognostic (7.09e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	3.7	1.0	0.4	2.2	0.4	1.0	8.7	0.6	0.7	31.7	0.3	14.1	33.4	1.0	0.1	157.0	5.8	6.6	1.8	0.4	0.1	14.9	0.5	5.8	0.3	0.4	0.1	0.2	18.0	2.5	1.7	1.5	0.4	12.1	11.7	0.9	47.1	2.3	0.9	73.6	20.7	0.5	0.0	0.1	36.2	0.7	0.3	0.7	10.7	0.3	13.9	9.9	54.9	0.6	57.8	0.5	0.0	0.1	0.3	6.1	29.0	2.9	4.4	7.6	7.6	52.0	44.0	0.0	5.4	5.4	0.1	37.5	0.1	17.3	5.2	5.1	7.2	2.8	5.0	12.1	2.0	0.0	0.2	4.0	30.4	5.9	8.8	3.1	0.0	0.3	1.7	0.5	1.7	20.4	0.4	0.3	3.6	181.7	1.5	0.1	0.0	0.3	6.2	25.5	3.0	0.1	4.7	35.2	0.1	4.1	25.2	0.3	0.8	0.4	3.5	13.5	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.5	0.2	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.4	0.4	0.6	0.7	0.4	0.1	0.4	0.1	0.4	0.0	0.3	0.6	0.8	44.8	16.6	0.3	0.2	52.5	88.6	31.8	19.4	0.8	41.7	19.8	5.1	45.8	63.1	51.5	20.9	12.4	1.2	89.9	0.0	57.9	22.2	91.9	9.4	2.8	7.3	0.0	0.5	134.7	1.0	9.2	57.1	135.8	1.3	18.3	1.4	0.0	0.8	5.0	0.5	41.3	38.7	1.2	6.8	163.8	0.6	1.5	12.4	0.0	3.8	0.5	4.1	0.5	0.2	219.9	66.8	1.5	0.3	144.6	102.7	7.7	92.1	7.9	0.0	7.9	4.9	4.9	9.1	81.4	82.0	4.1	1.5	45.4	43.7	226.0
C8orf37	"BBS21, CORD16, FAP418, FLJ30600, MOT25, RP64"	ENSG00000156172	"Chromosome 8 open reading frame 37"	Q96NL8	8	95244913-95269201	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease variant, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024198	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Plasma membrane, Cell Junctions"	"HPA024198: AB_1845775"	"unprognostic (7.90e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (2.72e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.04e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.11e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.29e-1)"	1.7	1.8	1.7	1.2	1.9	0.9	2.3	2.3	2.2	2.3	3.2	1.0	0.9	2.4	3.1	1.0	3.9	1.4	2.7	1.7	1.8	2.4	1.8	1.5	2.2	2.3	2.9	4.8	1.2	3.5	2.3	1.8	2.2	2.0	0.9	5.0	1.5	1.7	1.1	1.5	1.0	2.3	2.7	1.7	1.1	1.7	1.8	2.4	2.4	1.8	1.9	1.2	1.4	2.9	2.8	4.5	3.6	1.9	1.2	3.3	1.0	1.2	2.7	1.5	2.0	0.7	6.0	5.6	2.8	2.0	3.8	2.3	1.5	3.1	3.3	1.8	1.4	4.4	2.7	2.0	1.4	0.9	2.3	3.3	1.4	1.8	5.0	3.9	2.3	3.3	2.3	3.2	2.0	2.1	4.8	1.1	1.1	5.6	3.0	2.5	1.9	1.4	3.4	1.2	3.5	3.4	2.5	0.5	2.1	2.7	4.2	0.8	2.0	1.9	2.4	1.6	1.2	2.9	3.0	3.8	3.6	2.1	2.4	0.3	0.3	0.1	0.2	0.2	0.5	0.4	0.3	0.3	0.5	0.8	0.3	0.5	0.4	0.7	0.1	0.2	0.1	0.2	1.7	1.9	2.3	2.2	1.7	1.8	2.3	2.9	2.2	2.7	1.8	2.9	2.4	3.2	2.6	6.8	2.5	0.9	3.7	2.9	4.0	2.7	1.3	2.4	5.3	0.0	3.3	7.3	2.1	2.5	1.8	0.1	7.9	1.8	10.2	3.4	1.3	1.5	0.0	0.4	6.8	2.7	2.9	2.8	1.1	1.0	0.0	1.9	1.1	3.8	1.3	3.3	5.2	0.1	2.0	1.6	1.2	8.7	3.1	0.8	1.8	1.9	1.8	5.3	0.0	8.5	5.7	1.2	0.2	3.0	0.7	1.9	0.1	4.7	7.9	4.1	0.0	2.5	4.2	6.0	3.5	0.9	1.8	0.8	1.1	3.0	0.5	1.8
C9orf152	bA470J20.2	ENSG00000188959	"Chromosome 9 open reading frame 152"	Q5JTZ5	9	110190048-110208159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.6;salivary gland: 25.4;stomach 1: 32.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.4;Intestinal goblet cells: 139.7;Ionocytes: 40.7;Paneth cells: 40.0;Undifferentiated cells: 79.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 27.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 149.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA050769	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Nucleoli	"HPA050769: AB_2681230"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.06e-2)"	0.1	0.0	0.5	2.1	0.4	0.0	12.4	0.2	0.4	10.4	0.1	32.8	19.0	2.3	0.0	3.0	3.7	5.5	0.0	0.4	0.1	0.2	0.8	5.8	0.0	0.6	0.4	0.0	5.1	0.0	0.1	0.0	0.6	17.0	41.6	0.0	25.4	1.4	0.0	5.4	15.1	1.2	0.2	0.1	32.9	0.0	0.5	0.1	0.1	0.0	0.2	1.2	0.4	0.6	0.0	1.3	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	149.2	0.2	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.0	9.3	0.0	0.0	18.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.4	0.1	0.6	0.4	0.6	0.2	0.5	0.6	0.4	9.6	16.3	0.3	0.2	0.3	3.4	5.9	6.2	0.0	20.5	10.8	0.1	20.0	14.5	0.0	0.0	0.0	0.1	35.4	0.0	6.0	0.0	4.0	2.0	0.5	25.9	0.0	0.1	11.1	0.0	0.2	25.0	13.9	0.0	0.0	0.0	3.3	0.1	0.0	0.1	139.7	40.7	0.0	1.0	0.0	0.0	0.6	10.6	0.0	0.0	0.0	0.0	0.0	0.1	3.9	40.0	0.0	0.0	12.4	4.4	0.0	5.2	0.0	0.0	0.4	0.9	0.0	0.0	10.9	0.4	0.0	0.4	0.0	79.8	5.5
CA13	"CAXIII, FLJ37995, MGC59868"	ENSG00000185015	"Carbonic anhydrase 13"	Q8N1Q1	8	85220587-85284073	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 14.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Proximal enterocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 15.6;OE19: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024689, CAB025567"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA		27000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoli	"Nucleoplasm, Vesicles"	"CAB025567: , HPA024689: AB_1846004"	"unprognostic (1.12e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.16e-5)"	"unprognostic (2.21e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.13e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (7.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.00e-1)"	1.8	2.1	1.2	1.2	1.2	0.3	2.3	1.4	1.3	2.1	0.7	2.5	12.0	0.9	0.6	5.0	1.1	5.4	3.6	1.0	1.7	5.7	3.7	2.4	0.6	0.9	1.5	1.1	1.1	9.0	2.9	0.3	0.8	1.2	3.0	2.3	4.8	0.7	0.4	5.6	14.6	0.8	0.6	0.7	5.9	0.7	1.1	0.7	5.0	0.3	2.9	2.1	2.5	1.3	0.2	0.4	0.8	0.1	0.5	0.6	0.4	1.0	1.1	0.1	2.9	7.2	5.4	0.4	0.5	1.2	6.0	2.3	2.2	2.9	0.2	1.6	0.9	15.6	2.0	6.7	1.4	0.2	0.6	2.2	0.5	0.2	1.2	1.8	1.6	0.6	4.0	2.9	2.6	0.0	0.3	0.2	0.4	30.6	0.4	0.2	2.2	0.1	8.1	0.3	0.2	0.0	0.5	0.0	1.6	1.0	0.5	0.8	1.5	2.8	3.9	0.1	1.6	1.1	0.6	1.9	5.7	2.2	2.6	0.7	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.2	1.2	1.2	1.4	1.3	1.0	1.7	0.9	1.5	0.8	0.6	1.1	1.3	1.7	3.2	12.4	7.2	2.9	1.8	2.7	2.7	3.4	1.8	7.0	4.7	6.4	4.3	10.5	12.9	33.3	0.3	2.1	12.3	9.8	4.0	11.3	4.7	2.5	2.7	4.8	3.2	12.2	1.6	0.3	2.9	9.7	7.7	0.0	0.3	8.6	5.8	1.1	0.0	13.7	4.3	2.0	2.5	3.3	13.1	0.0	3.0	5.4	1.9	1.0	1.9	8.2	16.1	4.4	4.4	4.3	0.0	6.9	1.9	52.6	21.0	9.5	5.1	0.0	8.1	1.9	1.3	2.1	9.1	3.1	0.3	2.2	1.0	5.4	2.4
CALCOCO2	"MGC17318, NDP52"	ENSG00000136436	"Calcium binding and coiled-coil domain 2"	Q13137	17	48831018-48866522	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 1127.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022989, HPA023019, HPA023195"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Vesicles	"HPA022989: AB_1845914, HPA023019: AB_1845915, HPA023195: AB_1845916"	"unprognostic (3.71e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.80e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.65e-2)"	117.9	59.2	36.5	55.3	43.8	62.9	95.3	41.6	50.8	81.0	72.3	101.0	68.1	69.2	61.0	88.6	82.2	66.2	139.1	35.3	45.3	75.7	120.3	91.4	53.2	48.7	42.0	86.6	56.6	76.8	46.6	63.3	49.2	55.6	101.5	76.4	52.5	72.5	158.4	68.2	75.4	87.8	39.0	68.8	71.6	136.3	41.0	74.4	75.3	170.3	67.1	80.9	76.9	52.0	126.0	79.4	33.1	64.0	241.2	173.7	95.0	120.2	160.0	135.9	151.3	150.8	80.6	42.5	117.0	146.5	115.9	68.2	81.4	101.7	162.6	193.3	66.9	40.7	48.0	59.1	276.8	137.4	196.8	258.1	148.1	144.3	103.9	129.0	101.3	130.7	74.9	124.3	119.2	36.8	119.5	73.6	10.3	278.9	97.7	77.8	161.7	81.0	52.2	39.2	13.1	27.9	37.6	24.3	106.0	66.6	154.2	76.5	97.7	147.1	44.9	91.0	85.8	110.4	165.1	30.0	89.2	69.0	61.4	108.9	115.1	115.5	56.6	121.5	54.2	54.1	49.9	58.9	67.1	46.7	50.5	55.8	132.8	105.0	132.3	33.6	107.2	89.7	36.5	43.8	41.6	50.8	35.3	45.3	48.7	42.0	49.2	39.0	41.0	52.0	166.2	115.4	98.1	20.5	42.1	36.6	73.3	40.9	40.9	16.8	34.7	32.4	169.1	37.1	48.4	33.1	50.1	50.2	48.6	124.5	37.2	47.2	1127.4	37.4	89.7	104.6	50.4	40.8	31.0	42.2	45.3	79.1	31.6	44.0	100.0	29.8	110.3	58.9	27.6	8.4	21.2	44.7	24.4	119.2	54.3	233.3	70.2	70.7	26.6	28.1	57.4	45.9	64.9	26.7	27.3	37.7	54.6	74.1	56.2	57.6	81.5	48.9	28.4	72.7	72.3	69.6	76.2	152.5	32.7	55.6	46.9	81.3	54.6	96.3	66.1	66.1
CANT1	"SCAN-1, SHAPY"	ENSG00000171302	"Calcium activated nucleotidase 1"	Q8WVQ1	17	78991716-79009867	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 139.5;Intestinal goblet cells: 155.6;Syncytiotrophoblasts: 101.5;Undifferentiated cells: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 445.4;T-47d: 282.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019627, HPA019639, HPA022818"	Enhanced		Supported	"Golgi apparatus"		NA	Yes		3300000	"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971"	"unprognostic (1.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.41e-4)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (7.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.23e-2)"	15.8	23.9	10.4	24.7	12.4	19.1	25.4	13.6	11.3	32.3	13.8	89.2	51.9	17.4	8.7	44.8	18.2	25.2	17.0	11.1	12.6	16.1	17.3	16.4	15.2	14.6	14.5	14.6	19.6	24.5	17.5	25.9	13.9	71.8	82.8	7.4	62.7	32.4	14.9	14.9	55.5	15.5	13.8	26.5	51.1	20.7	14.5	14.7	13.9	12.4	15.1	16.7	21.7	17.8	106.5	112.1	31.9	46.3	29.7	35.2	38.9	66.0	51.3	66.7	55.9	53.8	99.6	25.3	36.1	46.1	83.0	53.7	27.1	49.8	68.4	43.0	46.4	33.7	34.1	45.9	25.0	33.0	51.6	33.7	32.4	62.7	34.2	40.9	116.1	42.5	42.3	43.2	46.4	58.4	50.2	19.8	22.1	445.4	103.1	27.6	51.8	29.8	29.8	53.5	45.6	45.4	33.9	227.2	50.2	50.3	282.6	38.6	56.6	101.9	90.5	46.4	83.1	48.9	43.8	24.3	64.4	24.9	65.3	6.3	4.0	8.7	5.5	4.4	5.7	3.9	4.3	4.8	3.8	2.5	4.1	4.1	17.4	3.1	3.0	2.7	3.6	4.6	10.4	12.4	13.6	11.3	11.1	12.6	14.6	14.5	13.9	13.8	14.5	17.8	12.6	28.9	20.6	5.9	11.8	16.6	15.3	16.8	6.8	6.4	49.9	16.3	13.3	14.3	15.1	12.9	14.6	36.6	8.9	139.5	3.9	34.7	14.0	10.7	13.1	16.3	51.0	15.2	4.1	28.8	39.4	13.5	38.2	19.0	5.7	20.0	41.7	14.4	24.9	5.0	5.2	155.6	16.2	12.4	9.5	15.7	11.8	14.2	14.2	3.7	18.1	8.1	11.3	5.0	10.2	37.7	55.8	7.5	16.6	33.4	39.4	6.7	9.7	8.7	6.6	9.5	13.3	23.9	5.8	12.0	13.1	101.5	11.1	11.3	100.2	19.4
CAPN5	"ADNIV, HTRA3, nCL-3, VRNI"	ENSG00000149260	"Calpain 5"	O15484	11	77066961-77126155	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 60.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 170.3;Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 89.8;Paneth cells: 72.6;Proximal enterocytes: 75.6;Undifferentiated cells: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033237, HPA072319"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB033237: AB_2069673, HPA072319: AB_2686512"	"unprognostic (6.81e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.47e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.64e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.30e-3)"	6.7	12.2	8.5	10.9	7.9	2.7	4.9	6.4	8.6	13.5	3.5	60.5	60.7	10.0	5.7	31.6	10.8	36.3	7.2	8.5	8.7	15.1	52.1	4.8	1.9	11.7	8.2	13.2	5.6	1.0	5.1	2.8	12.5	16.0	49.9	3.8	7.7	8.9	1.6	3.1	52.4	11.3	9.9	3.5	47.9	21.5	7.9	2.8	4.7	1.7	2.7	15.4	10.5	8.1	0.8	12.5	8.6	7.8	32.0	30.4	0.7	11.8	22.9	13.4	10.0	6.9	3.6	0.4	7.7	24.5	14.4	0.5	3.8	1.0	6.4	0.5	0.8	2.1	0.5	0.9	7.9	0.2	0.4	16.1	1.4	22.6	5.2	18.8	14.4	5.1	0.2	0.0	26.9	19.9	1.8	0.3	6.6	106.6	9.3	2.0	27.0	0.4	4.6	16.4	0.5	13.5	1.0	2.7	5.9	5.7	1.7	0.1	23.9	25.4	12.3	34.8	1.3	0.8	1.7	0.1	13.1	0.3	5.7	0.0	0.2	0.0	1.3	0.3	0.1	0.0	0.1	0.5	0.2	0.0	0.6	0.8	0.0	0.0	0.0	0.1	0.0	0.7	8.5	7.9	6.4	8.6	8.5	8.7	11.7	8.2	12.5	9.9	7.9	8.1	1.6	0.0	0.5	4.2	1.0	1.7	0.3	2.2	0.0	3.1	0.5	1.8	1.7	24.3	10.3	23.9	0.0	0.1	3.4	170.3	1.9	10.3	1.1	1.9	5.9	2.4	22.3	5.7	4.6	32.7	0.4	7.6	80.0	3.5	0.0	10.2	2.9	40.4	0.9	1.7	6.7	89.8	10.2	1.6	1.8	1.3	12.5	1.2	7.2	1.0	0.3	5.8	5.2	11.6	0.7	22.4	72.6	4.5	0.9	2.0	75.6	9.9	11.1	2.1	0.0	8.3	4.1	0.5	2.3	2.5	0.9	0.0	1.5	5.3	69.2	2.4
CAPN8	nCL-2	ENSG00000203697	"Calpain 8"	A6NHC0	1	223538007-223665723	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"stomach 1: 291.1"	"Cell type enriched"	"Detected in many"	6	"Gastric mucus-secreting cells: 910.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 28.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 125.9;RT4: 76.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073939			Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA073939: AB_2686646"	"unprognostic (4.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.72e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.12e-6)"	"unprognostic (6.95e-2)"	"unprognostic (5.59e-2)"	"unprognostic (3.83e-2)"	"unprognostic (5.44e-3)"	0.3	0.2	4.7	6.3	1.0	0.1	14.9	0.1	1.7	1.1	2.3	23.6	8.0	0.1	11.1	0.6	1.3	14.3	0.0	2.3	3.6	1.7	0.3	21.3	0.1	2.7	1.5	0.2	2.9	0.0	0.1	0.3	1.1	2.9	33.0	0.3	8.5	1.4	0.8	2.3	4.6	1.1	2.0	0.3	291.1	0.6	1.8	0.0	0.2	0.0	0.3	12.3	0.7	2.5	1.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.8	0.0	4.6	0.0	0.1	0.0	0.2	8.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.2	125.9	3.8	0.1	0.0	0.0	1.3	76.8	1.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	4.7	1.0	0.1	1.7	2.3	3.6	2.7	1.5	1.1	2.0	1.8	2.5	0.4	28.9	131.7	1.6	1.8	0.1	6.5	1.9	0.0	0.0	19.9	7.9	2.6	10.0	55.9	25.8	0.0	0.2	0.2	90.9	0.0	3.8	2.3	2.0	0.3	0.7	3.0	0.0	0.6	21.6	0.0	0.3	910.8	2.1	10.8	5.2	0.0	0.3	0.6	0.0	0.1	61.9	4.1	0.0	0.8	6.7	1.8	1.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	36.1	42.6	3.4	3.5	4.0	2.1	1.5	15.0	0.0	0.0	0.3	0.8	0.4	1.0	0.0	0.0	0.1	1.4	2.9	21.2	31.2
CBY1	"C22orf2, Cby, Chibby, Chibby1, PGEA1, PIGEA-14, PIGEA14"	ENSG00000100211	"Chibby family member 1, beta catenin antagonist"	Q9Y3M2	22	38656636-38673854	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.06e-1)"	"unprognostic (4.60e-3)"	"unprognostic (2.42e-1)"	"prognostic favorable (5.22e-5)"	"unprognostic (3.46e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.35e-2)"	25.9	46.3	38.6	11.7	39.5	6.3	29.3	40.0	42.5	36.5	40.8	51.7	16.9	32.9	51.5	27.3	59.3	19.6	53.2	38.8	38.4	38.6	28.4	23.5	12.1	38.9	40.4	40.4	34.8	34.2	33.5	29.2	38.1	39.9	27.8	20.0	29.5	43.7	25.9	27.3	22.2	38.3	38.7	22.9	31.9	25.2	40.0	14.2	32.2	33.5	15.1	37.0	29.7	39.9	31.2	27.8	40.3	56.9	76.4	46.3	19.6	34.3	39.0	34.1	34.6	17.4	28.1	4.3	30.1	39.4	31.1	28.5	32.1	66.7	46.3	13.2	30.0	3.5	22.8	35.2	51.9	10.5	4.6	43.9	52.6	48.8	65.5	62.3	56.1	13.1	19.5	10.6	37.8	51.0	7.2	14.9	22.4	75.7	34.0	6.6	22.9	9.9	88.7	28.1	47.2	12.5	47.2	21.1	43.5	44.6	19.9	9.8	39.3	19.4	24.7	21.8	14.4	11.4	7.4	4.7	28.9	12.3	23.0	4.5	6.3	6.4	10.6	5.0	14.6	6.9	13.4	12.7	6.7	12.0	19.3	13.7	6.3	8.3	6.3	10.6	5.8	6.4	38.6	39.5	40.0	42.5	38.8	38.4	38.9	40.4	38.1	38.7	40.0	39.9	21.9	12.8	18.5	9.4	5.1	13.8	17.8	57.4	15.9	8.5	32.7	41.0	36.6	28.6	28.9	27.6	6.2	86.1	4.2	13.5	35.2	36.0	60.7	106.3	30.3	24.0	21.6	10.8	12.9	19.5	41.9	34.1	10.2	25.6	8.2	33.6	22.5	10.6	20.1	8.4	13.9	22.0	40.7	6.7	10.4	12.4	49.7	4.2	21.4	5.6	5.5	28.4	2.1	3.5	9.2	24.6	13.2	65.8	5.4	19.9	16.8	51.4	89.0	13.7	26.3	22.8	30.6	20.2	20.2	20.1	16.3	49.5	5.8	84.1	29.4	15.1
CCDC183	"bA216L13.7, KIAA1984, MGC15438"	ENSG00000213213	"Coiled-coil domain containing 183"	Q5T5S1	9	136796338-136807741	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 22.0"	"Group enriched"	"Detected in many"	9	"Early spermatids: 251.7;Late spermatids: 146.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in some"		"OE19: 2.8"									HPA043812	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA043812: AB_10961860"	"unprognostic (2.91e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.89e-5)"	"unprognostic (3.45e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.16e-3)"	"unprognostic (4.32e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.20e-2)"	"unprognostic (5.15e-2)"	0.2	0.5	2.2	0.2	2.2	0.3	0.7	3.2	2.5	0.4	1.3	1.0	0.3	0.4	0.7	0.1	0.7	0.5	0.7	2.0	2.5	0.3	0.2	0.4	0.4	2.5	2.9	0.7	1.0	1.2	0.7	0.8	2.5	1.9	1.1	1.6	0.5	0.5	0.4	0.3	0.3	0.4	2.0	0.4	0.7	22.0	2.3	1.4	0.6	0.1	0.4	0.3	0.0	2.5	0.0	0.0	0.6	0.3	0.5	0.3	0.4	0.6	0.2	0.0	0.0	0.3	0.3	0.0	0.1	0.3	0.0	0.5	0.2	0.0	0.0	0.5	0.4	0.0	0.8	0.8	1.0	0.2	0.5	1.1	0.5	0.0	0.3	1.2	0.0	0.6	0.2	0.2	0.0	0.3	0.2	0.0	0.0	2.8	0.0	0.1	0.4	0.9	0.7	0.0	0.6	0.4	0.2	0.2	0.1	1.1	0.7	0.2	0.3	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	2.2	2.2	3.2	2.5	2.0	2.5	2.5	2.9	2.5	2.0	2.3	2.5	2.0	0.0	3.1	2.3	0.7	0.3	0.8	0.8	0.6	4.3	2.4	2.8	0.5	2.8	1.7	1.8	0.0	2.3	16.4	5.0	1.9	1.8	251.7	1.6	0.9	0.9	7.8	0.0	3.0	0.7	1.1	1.3	1.1	1.9	0.0	2.3	0.7	0.6	0.5	5.0	3.0	7.2	4.1	0.8	1.0	146.6	2.8	0.7	3.6	1.9	0.8	3.1	0.0	3.0	3.2	0.8	21.9	3.8	2.0	2.6	3.8	0.6	2.7	4.4	6.6	1.1	1.3	3.7	0.8	0.7	0.1	7.0	1.3	1.3	5.0	0.8
CCDC90B	"MDS011, MDS025"	ENSG00000137500	"Coiled-coil domain containing 90B"	Q9GZT6	11	83259097-83286407	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 447.3;Late spermatids: 233.9;Spermatocytes: 333.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011130, HPA011931"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA011130: AB_1846170, HPA011931: AB_2072332"	"unprognostic (5.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.57e-3)"	"unprognostic (5.76e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.41e-1)"	16.4	37.3	23.2	13.0	24.5	16.1	21.3	24.2	29.8	17.1	23.3	18.1	14.7	14.7	33.8	16.2	15.6	18.2	22.1	22.9	25.4	18.4	38.9	13.5	20.5	25.3	25.0	22.3	18.3	14.9	19.4	22.2	25.0	16.0	17.3	12.6	17.1	16.3	16.2	14.1	16.6	16.7	25.2	15.5	16.9	54.5	24.4	17.2	25.6	17.7	17.0	15.3	14.2	27.1	19.1	27.3	46.1	15.2	59.6	44.7	27.7	37.4	31.6	22.7	24.3	32.2	63.0	46.7	47.7	55.0	47.5	23.5	20.1	47.3	30.3	31.9	16.0	28.2	17.7	27.3	50.1	29.2	23.5	50.2	62.3	29.5	83.8	45.3	52.3	49.6	41.9	37.9	83.7	33.5	29.4	36.7	37.9	80.2	33.4	33.1	40.9	39.3	47.3	27.5	22.2	50.9	26.4	21.0	26.1	60.8	53.9	26.4	51.6	44.8	28.8	85.9	26.0	36.3	51.2	46.8	18.1	23.2	45.5	77.7	18.7	71.6	24.2	41.3	31.2	39.8	34.7	34.2	27.0	37.9	30.2	30.2	9.8	50.7	43.8	20.4	46.0	27.4	23.2	24.5	24.2	29.8	22.9	25.4	25.3	25.0	25.0	25.2	24.4	27.1	50.8	12.8	13.1	14.0	40.5	23.6	49.6	102.8	26.7	36.3	33.5	49.7	58.0	28.6	48.3	36.8	14.6	74.0	41.4	21.0	68.4	59.4	447.3	39.5	38.0	45.8	33.6	36.2	16.0	48.5	55.4	44.5	26.5	31.4	49.4	83.0	35.7	43.3	63.7	42.1	23.3	35.2	52.9	34.6	32.4	233.9	42.6	38.6	21.4	10.3	52.8	35.3	53.5	31.2	48.2	67.6	32.9	25.6	44.6	38.9	44.1	78.0	32.6	50.0	26.3	40.3	43.5	333.0	107.8	32.5	29.0	51.7	37.1	86.8	31.2	49.9
CCK		ENSG00000187094	Cholecystokinin	P06307	3	42257825-42266185	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 317.9;choroid plexus: 89.5;intestine: 115.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.1;Excitatory neurons: 154.8;Fibroblasts: 42.5;Inhibitory neurons: 157.7;Melanocytes: 40.9;Oligodendrocytes: 40.9;Prostatic glandular cells: 63.8"	"Group enriched"	"Detected in many"	5	"glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"OE19: 236.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 74.4"	"HPA045039, HPA069515"	Enhanced	Supported			"Secreted to blood"	NA	NA	43700000			"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA045039: , HPA069515: AB_2732135"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"		"unprognostic (2.39e-3)"		"unprognostic (1.97e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.77e-2)"		"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-2)"	0.2	0.9	134.4	0.5	202.6	0.0	0.2	85.8	317.9	0.0	89.5	4.4	115.7	0.0	0.0	0.3	0.5	0.0	0.1	160.1	96.9	1.2	0.4	3.4	0.0	99.9	103.4	0.1	0.4	0.0	18.4	1.1	94.5	19.5	0.1	4.4	0.2	0.2	0.2	0.4	17.0	0.2	93.9	0.0	2.1	2.3	123.9	0.2	0.1	0.0	0.0	0.1	0.1	143.7	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	9.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	236.5	0.1	0.0	0.0	1.1	25.0	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.4	202.6	85.8	317.9	160.1	96.9	99.9	103.4	94.5	93.9	123.9	143.7	0.4	0.0	0.0	40.1	0.2	5.7	1.3	0.3	0.6	6.8	1.3	1.9	0.3	0.0	0.2	5.5	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	2.5	0.0	0.0	154.8	0.4	0.1	42.5	5.1	0.4	0.0	0.0	1.4	0.0	0.1	0.0	157.7	11.4	2.0	0.3	3.0	0.3	0.0	0.6	40.9	34.7	0.0	36.7	0.0	34.7	40.9	0.7	0.0	0.0	0.0	63.8	0.6	0.1	0.0	3.5	0.0	0.8	6.4	0.1	1.7	0.0	1.3	10.5	0.0	0.0	0.5	8.7
CCSER1	"FAM190A, KIAA1680"	ENSG00000184305	"Coiled-coil serine rich protein 1"	Q9C0I3	4	90127535-91601913	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 3.6"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 1954.8;Inhibitory neurons: 1639.5;Oligodendrocyte precursor cells: 577.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.5;OE19: 2.4;RT4: 1.2;SCLC-21H: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041880, HPA054709"	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA041880: AB_10796461, HPA054709: AB_2682581"	"unprognostic (4.03e-4)"	"unprognostic (4.21e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.61e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.64e-4)"	"unprognostic (6.94e-2)"	0.2	1.3	1.5	0.2	1.5	0.7	0.9	2.1	2.6	0.1	0.1	0.3	0.3	0.3	0.3	0.2	0.8	0.3	1.0	2.1	0.7	1.1	0.1	0.2	0.4	0.4	0.2	0.1	0.6	0.3	0.4	0.1	0.5	0.5	0.2	3.6	1.1	0.3	0.0	0.5	0.4	0.2	0.1	0.4	0.4	2.6	0.9	0.3	0.9	0.1	0.2	0.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.5	0.1	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	2.4	0.2	0.0	0.0	0.1	0.1	1.2	1.3	0.4	0.0	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.5	2.1	2.6	2.1	0.7	0.4	0.2	0.5	0.1	0.9	1.9	12.4	6.4	3.2	72.5	21.4	4.5	11.9	0.1	15.9	23.7	5.5	4.4	11.1	1.5	2.2	3.7	177.2	3.6	0.2	9.0	9.8	1.2	261.8	2.4	0.4	3.1	3.5	2.5	1954.8	3.5	5.6	0.9	23.4	4.8	5.1	0.8	3.3	0.2	1.0	5.0	1639.5	10.9	2.0	0.6	8.6	339.4	3.1	5.7	1.8	89.0	2.4	2.6	0.0	577.5	33.7	4.9	7.7	1.2	5.7	8.8	13.0	2.6	0.2	78.8	6.6	0.4	0.5	5.6	4.7	1.6	2.3	1.8	0.5	0.3	5.1	14.9
CDC26	"ANAPC12, APC12, C9orf17"	ENSG00000176386	"Cell division cycle 26"	Q8NHZ8	9	113255835-113275572	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044130	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044130: AB_10963690"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.79e-2)"	42.9	33.1	27.1	34.1	27.4	28.9	39.0	27.3	39.5	34.0	33.8	37.7	30.9	28.2	41.7	34.2	31.0	25.3	52.9	26.3	29.3	49.2	53.1	34.2	42.5	28.1	27.2	33.8	29.9	58.8	29.6	27.7	29.5	36.9	34.2	41.7	32.5	31.8	47.5	36.2	37.2	26.5	29.1	42.0	34.3	22.4	27.7	46.0	35.2	52.4	46.9	40.3	32.7	29.2	47.0	73.3	62.5	32.2	104.4	89.3	29.0	67.1	100.7	67.6	66.3	78.0	53.9	84.1	56.6	58.3	77.2	88.8	53.2	99.1	66.8	80.3	38.9	55.7	71.4	73.1	50.8	99.6	55.0	62.2	68.9	62.5	92.2	70.3	91.7	67.2	85.3	63.7	51.8	94.7	86.2	62.9	102.7	213.1	65.1	73.1	134.3	42.9	71.1	78.2	48.1	45.7	88.4	63.7	51.4	68.2	57.9	43.4	62.1	40.5	37.9	61.4	87.5	43.5	79.5	67.4	57.1	58.3	41.0	239.6	116.9	274.2	177.6	127.3	220.0	233.4	222.3	195.9	122.2	201.0	253.5	195.2	182.8	192.8	122.9	103.8	241.6	171.5	27.1	27.4	27.3	39.5	26.3	29.3	28.1	27.2	29.5	29.1	27.7	29.2	91.9	35.3	40.9	3.3	58.5	77.9	79.3	111.8	68.3	20.3	58.2	79.8	5.3	45.8	61.2	22.0	22.9	45.7	59.6	51.1	113.5	64.4	22.2	53.4	67.4	65.7	31.8	55.2	5.0	59.5	68.6	54.3	21.4	43.3	27.3	48.6	63.1	83.3	58.4	15.2	5.5	50.7	73.2	51.6	92.0	13.9	80.2	49.6	51.6	2.8	67.9	76.7	72.1	5.0	6.7	58.0	62.7	43.6	51.7	91.4	88.9	169.2	68.1	36.4	26.3	54.2	43.7	35.3	16.8	55.0	90.8	47.9	75.4	50.0	47.2	97.7
CDC5L	"CDC5, CEF1, hCDC5, PCDC5RP"	ENSG00000096401	"Cell division cycle 5 like"	Q99459	6	44387706-44450425	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 291.8;Late spermatids: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006302, HPA011361, CAB012275"	Supported		Supported	Nucleoplasm		NA	NA		22000	"Cluster 42: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB012275: , HPA006302: AB_1078488, HPA011361: AB_1846379"	"unprognostic (2.67e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.02e-5)"	"unprognostic (1.01e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	11.5	11.9	6.7	10.7	7.1	21.3	13.5	10.1	9.4	10.3	7.0	10.5	9.4	12.0	13.2	10.9	9.7	8.7	13.8	7.3	7.0	10.5	18.7	9.6	13.4	6.7	6.8	14.0	10.1	19.8	5.7	12.0	7.1	11.8	11.3	13.2	9.7	9.4	17.8	8.5	9.4	11.7	6.9	10.5	9.7	13.2	6.9	15.3	10.8	22.5	14.1	12.1	8.1	8.7	43.0	16.5	39.8	32.5	16.0	20.7	22.5	30.6	23.8	37.9	41.5	21.7	14.4	40.8	24.8	24.7	30.8	26.6	41.8	24.2	56.4	34.5	37.6	54.5	15.4	28.1	14.6	41.3	28.2	15.9	20.9	37.0	31.9	21.7	25.0	20.7	42.6	23.3	34.7	29.0	38.4	28.1	28.0	103.5	15.1	29.6	45.7	26.4	21.5	25.2	43.8	38.0	24.7	16.5	33.3	25.4	23.2	39.6	23.0	32.4	32.8	25.5	43.7	19.9	25.8	73.8	20.9	35.3	33.2	20.2	13.1	17.5	10.4	15.7	11.8	9.9	10.0	11.7	13.0	11.3	10.7	10.4	19.9	14.8	18.1	11.2	14.6	8.5	6.7	7.1	10.1	9.4	7.3	7.0	6.7	6.8	7.1	6.9	6.9	8.7	57.3	73.7	50.3	14.7	48.5	44.2	69.2	58.0	55.8	36.4	26.7	29.5	82.2	30.0	80.5	23.9	31.3	57.5	58.2	26.8	39.2	53.4	291.8	63.7	64.2	51.5	36.1	48.1	20.6	55.2	49.4	52.2	28.5	72.1	71.0	58.8	26.7	44.7	45.3	32.0	34.7	40.7	52.9	38.6	29.8	285.9	61.5	53.1	19.6	18.7	74.3	65.8	45.3	14.1	33.0	47.8	34.5	55.3	37.7	49.0	18.6	28.6	78.6	38.1	65.7	67.9	76.2	48.2	98.7	35.6	38.4	71.7	46.8	59.8	40.8	62.5
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127162-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 314.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 569.4;Enteroendocrine cells: 108.4;Intestinal goblet cells: 183.7;Paneth cells: 408.6;Proximal enterocytes: 336.9;Undifferentiated cells: 241.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 16.0"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 16.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 98.8;OE19: 430.1;U-266/70: 157.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA		7500000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.9	0.2	0.7	28.8	0.5	2.7	0.5	1.1	0.8	0.1	1.9	260.9	314.2	1.3	0.8	1.7	0.3	3.0	0.6	0.5	0.2	0.8	0.3	0.2	1.5	0.3	0.1	0.5	1.7	0.0	0.0	0.2	0.3	1.2	246.7	0.5	0.9	1.6	0.5	0.6	270.6	9.3	0.1	5.5	2.5	0.6	0.2	0.3	0.7	0.1	1.8	0.8	0.1	0.7	0.2	18.5	0.2	0.4	0.0	0.4	1.6	0.2	0.3	0.2	0.3	98.8	3.5	0.3	0.3	0.0	0.1	1.0	0.3	0.3	0.3	0.2	1.1	0.1	0.8	0.6	0.3	0.2	4.3	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.4	1.5	0.1	0.7	0.5	1.3	0.3	430.1	0.5	0.3	0.0	2.8	0.3	0.2	1.3	1.2	0.4	0.4	0.5	0.4	0.7	0.9	0.0	0.6	0.7	1.2	0.5	157.2	0.3	0.2	0.3	0.3	0.6	2.9	0.9	1.4	0.2	0.8	0.1	0.3	0.2	0.1	0.5	0.8	0.2	0.3	16.0	0.7	0.5	0.4	0.2	0.2	0.7	0.5	1.1	0.8	0.5	0.2	0.3	0.1	0.3	0.1	0.2	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	569.4	0.0	0.3	1.0	0.0	0.0	0.0	108.4	0.0	0.5	0.0	0.0	0.1	2.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	183.7	0.0	0.0	0.5	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	408.6	0.0	0.2	0.0	336.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	2.1	0.0	241.6	0.1
CDHR5	"FLJ20219, MU-PCDH, MUCDHL, MUPCDH"	ENSG00000099834	"Cadherin related family member 5"	Q9HBB8	11	616577-626078	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 296.8;liver: 129.8"	"Group enriched"	"Detected in some"	7	"Distal enterocytes: 811.5;Paneth cells: 732.4;Proximal enterocytes: 2545.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 61.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009081, HPA009173, CAB025004"	Enhanced				"Intracellular and membrane"	NA	NA		190000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429"	"unprognostic (7.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.89e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.14e-2)"	0.1	0.9	0.2	4.0	0.6	0.1	0.4	0.5	0.4	0.1	2.2	102.2	241.2	0.2	0.0	0.3	0.3	3.9	0.0	0.2	0.0	44.9	129.8	0.2	0.2	0.2	0.1	0.2	1.8	0.0	0.6	0.0	0.3	0.1	51.9	0.1	0.0	0.1	0.1	0.1	296.8	2.7	0.0	0.1	4.3	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.3	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	13.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.5	0.4	0.2	0.0	0.2	0.1	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	11.5	0.0	1.8	0.0	0.0	1.4	811.5	13.7	0.3	2.8	0.1	0.2	0.1	92.8	0.0	0.0	1.3	0.0	0.0	33.6	0.4	13.4	0.0	4.6	126.1	0.1	0.0	0.1	193.2	0.0	4.3	0.0	18.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	732.4	0.0	0.0	0.0	2545.8	107.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	154.6	0.0
CEACAM18		ENSG00000213822	"CEA cell adhesion molecule 18"	A8MTB9	19	51478622-51490952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	26	"intestine: 10.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.8;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"CACO-2: 4.3;OE19: 3.5;RT4: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059487	Uncertain		Approved	Midbody		Yes	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Midbody		"HPA059487: AB_2684036"			"unprognostic (1.12e-1)"								"unprognostic (1.87e-2)"			"unprognostic (1.00e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CEACAM5	"CD66e, CEA"	ENSG00000105388	"CEA cell adhesion molecule 5"	P06731	19	41708585-41730433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 981.2"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 1389.2;Intestinal goblet cells: 395.0;Paneth cells: 777.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 1007.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 56.9"									"CAB000021, CAB000022, HPA011041, HPA019758"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		23000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326"	"unprognostic (1.54e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.80e-1)"		"unprognostic (1.38e-2)"		"unprognostic (2.22e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.67e-9)"	"unprognostic (2.92e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.85e-1)"	3.2	0.1	0.0	185.6	0.0	0.2	4.0	0.3	0.1	38.5	0.2	981.2	22.7	1.3	0.2	232.0	0.8	0.8	0.1	0.1	0.0	0.9	0.2	30.2	0.1	0.1	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.5	942.7	0.0	29.2	3.3	0.1	3.5	61.4	28.7	0.0	0.1	163.2	0.3	0.1	0.2	1.0	0.0	36.9	10.4	71.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.1	0.0	0.0	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.3	56.9	1.1	0.2	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	32.1	4.1	0.0	2.7	0.0	1.0	12.3	0.0	0.0	0.1	0.0	0.4	0.0	34.8	0.0	0.0	0.0	0.0	1389.2	0.0	3.4	0.4	0.0	0.0	0.2	65.7	0.0	0.1	0.9	0.0	0.4	22.4	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.1	395.0	4.1	0.0	0.4	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	21.3	777.3	0.0	0.1	16.5	10.2	0.0	4.5	0.0	0.0	0.1	0.4	0.8	0.5	1.9	0.0	0.0	1.2	0.0	192.3	124.4
CEACAM6	"CD66c, NCA"	ENSG00000086548	"CEA cell adhesion molecule 6"	P40199	19	41750977-41772211	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 181.5;esophagus: 195.2;intestine: 220.3;lung: 286.7;salivary gland: 177.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 942.3;Club cells: 322.1;Distal enterocytes: 640.1;Paneth cells: 391.1;Urothelial cells: 182.3"	"Group enriched"	"Detected in many"	4	"cervical cancer: 139.4;colorectal cancer: 500.8;lung cancer: 344.1;pancreatic cancer: 437.5;stomach cancer: 231.8"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	11	"OE19: 1799.0"									"CAB008370, HPA011041"	Enhanced					NA	NA		86000000	"Cluster 24: B-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB008370: AB_592067, HPA011041: AB_1078481"	"unprognostic (1.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-4)"	"unprognostic (4.08e-1)"	"unprognostic (8.71e-3)"	"unprognostic (2.85e-1)"	"unprognostic (7.68e-2)"	2.0	0.4	0.3	29.7	1.2	181.5	2.7	0.6	0.6	39.2	0.0	195.0	33.0	0.6	1.8	195.2	8.2	130.1	0.2	0.2	0.0	0.3	0.7	286.7	0.3	0.3	0.1	0.4	5.2	0.1	0.3	0.5	0.2	2.4	220.3	0.0	177.6	1.4	0.1	6.8	24.4	6.6	0.0	2.4	15.5	0.4	0.3	2.1	0.3	0.0	32.5	9.6	79.1	0.4	0.1	162.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	5.5	4.6	0.0	0.2	0.0	0.5	19.4	0.0	0.0	0.1	0.3	0.2	0.0	0.5	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.1	11.2	0.1	0.2	0.2	1799.0	4.5	0.1	0.0	0.1	1.0	0.7	1.8	0.1	0.0	4.2	0.0	0.2	0.6	1.9	0.4	0.2	0.3	0.5	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.5	0.1	0.0	3.1	0.3	1.2	0.6	0.6	0.2	0.0	0.3	0.1	0.2	0.0	0.3	0.4	0.0	942.3	84.5	0.0	2.3	0.0	4.9	17.9	0.0	0.0	3.5	2.0	0.2	75.8	322.1	0.0	0.0	0.0	0.0	640.1	0.0	77.0	0.2	0.4	0.1	1.3	5.4	0.0	0.1	16.3	0.0	1.3	1.5	0.8	7.0	0.0	0.4	0.3	0.0	0.0	0.1	102.3	14.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.7	391.1	0.0	0.0	24.2	5.7	0.0	71.8	0.0	0.0	0.0	9.9	0.0	0.1	15.6	0.0	0.0	1.2	0.0	31.7	182.3
CEMIP2	TMEM2	ENSG00000135048	"Cell migration inducing hyaluronidase 2"	Q9UHN6	9	71683366-71816690	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 92.5;placenta: 79.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 105.8;dendritic cells: 378.1;Glandular and luminal cells: 137.3;Plasma cells: 155.1;Syncytiotrophoblasts: 89.8;T-cells: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 143.4;BEWO: 117.4;OE19: 144.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017080, HPA044889"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA		150000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA017080: , HPA044889: AB_10962641"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.15e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.16e-1)"	25.1	5.4	9.7	24.8	6.5	29.7	11.1	9.7	8.3	5.1	15.0	24.2	27.2	7.2	2.7	6.6	5.6	41.5	7.7	19.0	2.8	10.4	60.2	35.0	23.1	4.1	3.6	2.2	19.3	92.5	4.6	79.6	4.9	7.0	28.0	17.3	11.1	8.0	4.8	6.1	23.7	11.7	4.1	15.9	33.2	6.8	8.2	18.6	9.4	8.6	20.7	32.0	3.4	5.5	22.5	85.0	143.4	6.6	13.7	22.9	117.4	81.7	48.7	51.6	40.5	24.3	31.3	0.4	20.0	18.8	11.6	35.2	38.6	9.9	73.2	2.5	11.2	38.9	20.9	68.7	23.9	0.4	9.8	28.0	11.4	38.9	8.1	14.0	68.2	3.3	4.7	10.2	28.8	15.1	4.1	0.6	28.2	144.3	8.6	3.3	39.9	2.4	31.6	60.4	6.3	0.6	19.3	12.5	20.5	45.2	8.8	1.3	30.3	33.7	38.3	17.4	39.3	1.8	37.8	0.9	6.1	3.9	43.7	0.1	1.3	3.1	1.4	1.1	0.3	0.4	1.5	1.3	0.5	3.0	2.1	1.0	2.3	0.3	1.0	0.1	2.3	0.9	9.7	6.5	9.7	8.3	19.0	2.8	4.1	3.6	4.9	4.1	8.2	5.5	105.8	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	0.0	58.7	46.7	0.0	0.0	0.0	14.7	0.0	47.9	378.1	0.0	0.0	20.2	0.0	42.1	24.2	14.7	0.0	0.0	0.0	36.2	14.4	4.3	0.0	137.3	0.0	3.8	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	30.8	0.0	0.0	155.1	0.0	0.0	11.6	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	89.8	86.1	3.1	0.0	0.0
CEP192	"FLJ10352, KIAA1569, PPP1R62"	ENSG00000101639	"Centrosomal protein 192"	Q8TEP8	18	12991362-13125052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 67.6;Excitatory neurons: 94.4;Inhibitory neurons: 91.3;Oligodendrocyte precursor cells: 76.9;Oligodendrocytes: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039392, HPA040503"	Uncertain		Supported	Centrosome,Cytosol		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Centrosome, Cytosol"		"HPA039392: AB_10697549, HPA040503: AB_10670919"	"unprognostic (6.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.87e-3)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.66e-3)"	2.9	2.2	5.0	4.6	7.6	10.8	4.9	9.8	5.2	4.7	0.0	4.5	4.0	6.4	3.9	3.7	4.9	5.7	3.6	4.1	2.4	2.8	2.9	4.4	6.9	4.1	4.7	9.9	4.6	4.7	2.5	4.6	3.6	4.0	5.4	6.8	4.1	3.5	1.8	3.5	4.7	4.6	3.4	5.2	4.7	9.3	5.0	11.6	5.5	3.9	5.6	4.1	2.5	9.7	13.5	7.2	19.1	10.1	8.1	12.6	6.1	9.2	12.1	14.3	15.1	9.9	5.8	15.2	6.1	9.4	10.4	6.4	16.7	8.8	16.8	6.0	6.0	13.8	11.3	5.2	4.3	22.2	10.2	8.8	3.2	12.0	10.9	8.2	11.9	10.7	19.3	9.9	11.3	6.8	19.2	9.6	6.1	24.9	4.4	16.3	14.9	7.9	4.9	13.6	13.9	7.8	14.7	7.2	4.4	9.0	5.8	11.3	12.1	11.2	26.2	12.9	12.8	6.6	10.1	17.0	7.2	9.9	11.0	0.4	0.6	0.5	0.9	0.4	0.7	0.5	0.6	0.6	0.3	1.3	0.6	1.0	0.6	0.2	1.7	0.5	0.5	0.3	5.0	7.6	9.8	5.2	4.1	2.4	4.1	4.7	3.6	3.4	5.0	9.7	13.3	9.6	12.8	67.6	11.4	1.9	3.9	4.3	5.2	13.1	6.4	5.8	28.7	4.3	9.3	7.3	22.9	5.3	13.7	7.6	0.0	4.7	23.3	11.0	11.8	8.5	0.0	18.7	94.4	3.6	3.3	10.5	15.8	12.1	2.5	40.9	8.2	6.5	4.6	11.8	91.3	8.7	4.1	10.1	3.9	14.2	10.2	10.1	1.8	62.8	15.3	6.5	14.4	76.9	90.6	4.8	5.7	13.9	15.0	5.5	4.5	1.2	8.0	17.8	26.3	11.3	8.1	33.5	24.0	8.5	3.1	1.9	12.3	60.6	8.0	7.6
CEP76	"C18orf9, FLJ12542, HsT1705"	ENSG00000101624	"Centrosomal protein 76"	Q8TAP6	18	12661833-12702777	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 209.7;Late spermatids: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 60.5"	"Region enriched"	"Detected in all"	9	"cerebellum: 55.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 16.3"	HPA039395	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA039395: AB_10673357"	"unprognostic (3.39e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.00e-4)"	"unprognostic (7.88e-3)"	"unprognostic (2.45e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.70e-2)"	"unprognostic (8.21e-2)"	3.0	3.4	2.5	2.6	2.5	6.2	3.8	7.7	3.3	3.4	2.6	2.9	2.7	3.3	5.1	5.3	2.7	2.6	2.7	2.3	2.5	3.1	4.8	2.7	3.8	2.3	2.4	3.2	2.3	2.5	2.2	3.4	2.5	2.8	3.9	4.5	2.9	2.8	3.2	4.0	3.1	3.3	2.3	2.5	2.8	8.2	2.6	7.9	3.7	3.5	4.7	3.2	2.8	2.6	7.3	7.2	12.1	5.9	7.1	3.8	11.7	8.4	9.4	16.1	12.5	16.6	8.5	9.7	7.3	5.5	9.4	5.6	12.1	5.3	13.7	6.1	9.8	8.5	8.0	14.1	5.3	20.0	9.5	3.0	5.3	9.5	6.2	4.5	8.5	13.5	14.5	14.3	10.4	5.5	17.5	13.9	8.7	60.5	4.7	12.2	10.5	10.4	8.4	7.1	9.2	8.0	10.5	6.7	6.9	7.9	4.8	11.0	8.0	10.8	21.9	10.6	10.0	8.0	14.8	11.5	5.4	9.7	7.2	0.4	2.3	2.1	2.6	4.4	3.5	1.8	2.9	3.2	2.1	2.3	2.9	3.4	0.7	3.7	1.7	1.2	3.5	2.2	2.5	2.5	7.7	3.3	2.3	2.5	2.3	2.4	2.5	2.3	2.6	2.6	4.3	6.4	5.9	7.5	7.2	9.7	3.9	3.0	5.2	6.3	4.1	4.6	1.8	1.5	5.4	0.0	12.5	5.9	6.7	3.7	1.9	3.0	209.7	5.5	5.8	5.2	6.0	13.9	16.9	2.5	7.5	4.0	2.0	4.6	5.7	14.0	4.2	4.8	4.1	3.3	16.7	5.5	4.1	3.5	4.1	57.8	3.7	3.4	7.2	3.7	2.5	2.9	6.2	7.5	7.9	3.8	0.6	4.5	10.3	5.1	7.8	2.5	3.5	8.0	6.6	7.1	3.7	27.7	22.1	12.4	8.2	6.2	6.4	11.5	4.8	5.7
CFAP52	"FLJ37528, WDR16, WDRPUH"	ENSG00000166596	"Cilia and flagella associated protein 52"	Q8N1V2	17	9576627-9643447	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.7;choroid plexus: 18.2;fallopian tube: 57.8"	"Group enriched"	"Detected in some"	6	"Early spermatids: 32.4;Endometrial ciliated cells: 99.6;Respiratory ciliated cells: 81.6;Spermatocytes: 33.9"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.5;glioma: 1.7;lung cancer: 0.6;ovarian cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.7;MCF7: 2.1;OE19: 2.7;REH: 1.4;T-47d: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023247, HPA030635"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoplasm	"HPA023247: AB_1858797, HPA030635: "	"unprognostic (1.76e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.09e-2)"	0.0	0.3	3.8	0.0	4.3	0.0	0.1	2.3	2.9	2.3	18.2	0.1	0.7	1.1	0.1	0.2	57.8	0.2	0.0	4.0	4.1	0.3	0.2	4.4	0.0	10.7	13.7	0.2	0.2	0.3	3.2	0.2	8.4	0.3	0.0	2.4	1.2	0.2	0.0	0.2	0.7	0.0	9.9	0.0	0.1	12.2	3.9	0.3	0.6	0.3	0.0	0.1	0.1	6.6	0.8	0.8	0.0	0.3	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.6	0.9	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.1	0.0	0.3	0.1	2.7	0.0	1.4	0.0	0.0	0.2	0.4	0.3	0.0	0.3	0.5	0.0	0.3	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	4.3	2.3	2.9	4.0	4.1	10.7	13.7	8.4	9.9	3.9	6.6	0.2	0.0	2.3	1.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.3	0.0	9.9	0.0	6.2	0.8	0.0	0.0	1.9	0.1	32.4	99.6	0.9	0.3	0.0	0.0	9.7	0.2	0.2	0.3	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	6.4	1.8	0.0	0.0	1.0	0.0	0.7	0.0	7.1	1.1	0.1	0.0	1.9	0.0	0.3	0.0	0.5	81.6	3.1	0.0	0.1	0.2	33.9	0.8	0.0	0.0	1.0	0.1	0.1	0.0	0.1
CHCHD10	"C22orf16, MIX17A, N27C7-4"	ENSG00000250479	"Coiled-coil-helix-coiled-coil-helix domain containing 10"	Q8WYQ3	22	23765834-23767972	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1622.6;skeletal muscle: 1220.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1264.7;Distal tubular cells: 2498.5;Hepatocytes: 1879.9;Proximal enterocytes: 1501.3;Proximal tubular cells: 1437.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003440	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA003440: AB_1078348"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.90e-2)"	"unprognostic (9.80e-2)"	"unprognostic (7.68e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	"prognostic favorable (2.15e-7)"	"unprognostic (5.19e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.62e-3)"	216.5	136.5	181.6	30.3	188.3	12.5	144.5	183.0	248.9	77.3	262.6	261.2	92.6	35.5	32.4	147.3	43.1	10.9	1622.6	176.6	190.5	409.5	789.7	56.9	28.6	182.2	182.2	29.0	118.0	220.0	112.3	11.9	187.6	106.4	76.2	63.1	148.3	50.5	1220.9	71.8	159.0	17.9	169.5	100.3	160.2	27.8	204.8	14.0	224.7	660.7	34.5	110.2	89.1	179.3	33.1	66.4	19.7	85.9	42.1	27.7	41.9	11.9	22.8	23.5	28.4	124.1	35.1	113.5	30.7	41.2	12.9	99.8	109.2	34.1	20.5	35.9	140.6	22.5	48.8	117.1	73.8	63.6	108.2	53.3	91.9	35.6	9.3	4.9	29.0	17.2	47.7	48.0	20.6	121.8	21.8	48.2	16.9	194.9	183.5	90.0	4.0	209.0	112.7	55.3	41.3	23.8	13.9	145.7	149.7	36.6	54.9	47.0	15.3	1.0	1.1	18.3	0.2	28.8	11.1	62.5	20.5	54.9	11.2	0.2	4.1	11.2	3.0	9.1	1.9	11.7	3.2	4.0	1.8	10.6	4.9	3.5	0.0	0.8	8.2	7.3	4.3	1.2	181.6	188.3	183.0	248.9	176.6	190.5	182.2	182.2	187.6	169.5	204.8	179.3	88.7	12.8	10.5	36.2	294.8	48.2	415.4	28.2	144.5	136.2	156.9	238.2	503.8	268.8	20.5	419.3	114.7	42.5	104.7	1264.7	2498.5	88.1	27.0	76.6	229.8	47.4	310.5	74.3	38.5	54.5	255.7	67.8	300.7	94.3	84.0	171.9	78.1	1879.9	647.5	99.3	37.6	860.9	26.4	262.1	127.5	18.0	48.7	243.1	373.5	15.9	107.8	188.5	25.7	17.1	17.4	45.9	890.1	29.3	297.3	192.4	1501.3	1437.4	10.0	287.8	124.9	254.0	200.4	32.3	43.4	459.3	43.9	105.2	123.0	216.0	952.4	470.1
CHORDC1	"CHP-1, CHP1"	ENSG00000110172	"Cysteine and histidine rich domain containing 1"	Q9UHD1	11	90200429-90223077	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 94.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041040	Approved		Approved	Cytosol		NA	NA		160000	"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA041040: AB_10794185"	"unprognostic (2.29e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (4.93e-7)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.27e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-1)"	20.2	19.8	17.4	10.5	18.4	10.7	12.0	18.2	94.5	16.2	18.6	14.0	5.4	15.3	8.4	17.5	14.5	7.1	21.7	19.6	20.7	15.9	21.7	18.1	13.4	18.8	18.4	25.4	12.9	5.0	22.3	12.2	18.7	15.4	6.9	7.7	12.3	7.2	18.0	10.3	12.4	6.9	18.4	16.5	14.2	13.7	18.9	10.6	16.9	13.1	13.7	17.0	17.2	26.4	28.1	74.8	26.0	17.0	24.7	14.9	39.6	34.1	11.6	34.9	29.3	113.9	21.9	49.3	54.0	15.1	60.8	35.0	76.7	17.3	38.7	42.4	37.3	46.6	45.1	55.7	19.0	35.0	29.6	5.5	22.9	29.4	33.8	18.7	26.9	28.5	71.8	19.9	41.5	13.9	32.2	45.9	29.9	96.0	63.3	49.2	15.5	29.3	28.5	12.7	24.8	10.2	37.3	28.8	13.8	29.7	49.0	16.6	24.0	25.4	51.1	35.5	40.6	9.4	80.0	38.9	7.3	49.9	22.1	8.6	8.0	8.9	12.0	13.6	13.1	13.1	13.0	12.7	12.7	11.5	13.6	13.2	2.4	16.5	9.2	9.8	17.9	11.2	17.4	18.4	18.2	94.5	19.6	20.7	18.8	18.4	18.7	18.4	18.9	26.4	49.4	19.2	27.4	18.6	55.5	70.7	164.8	20.1	32.5	45.1	33.2	31.8	30.7	12.8	29.3	11.0	135.5	41.3	62.1	30.1	11.7	23.8	93.9	112.7	75.0	48.2	68.8	25.7	65.7	16.1	76.5	50.2	20.4	93.9	87.0	34.0	15.7	14.8	39.2	65.6	60.0	32.7	22.4	19.2	109.2	57.1	32.6	61.7	28.4	30.0	30.5	22.9	39.1	46.8	81.5	20.9	28.5	31.2	42.9	97.5	10.7	25.3	48.0	53.7	13.1	32.6	71.0	98.1	47.0	26.5	81.8	50.9	104.9	51.6	37.0	89.6
CHRM1		ENSG00000168539	"Cholinergic receptor muscarinic 1"	P11229	11	62908679-62921807	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 27.0;prostate: 29.6;salivary gland: 28.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.9;Breast myoepithelial cells: 3.6;Excitatory neurons: 8.7;Inhibitory neurons: 7.8;Intestinal goblet cells: 3.2;Melanocytes: 3.6;Oligodendrocyte precursor cells: 3.0;Prostatic glandular cells: 4.4"	"Cancer enriched"	"Detected in some"	16	"prostate cancer: 27.9"	"Group enriched"	"Detected in many"	178	"amygdala: 12.4;basal ganglia: 18.7;cerebral cortex: 27.0;hippocampal formation: 22.6;white matter: 8.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MCF7: 3.7;OE19: 12.3"	"Low region specificity"	"Detected in many"							HPA014101	Enhanced	Supported				NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA014101: AB_1854210"	"unprognostic (3.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.16e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.57e-4)"	"unprognostic (4.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.75e-1)"		0.0	3.3	12.4	0.3	18.7	0.0	2.7	0.0	27.0	0.0	0.0	0.8	0.4	0.1	0.0	0.3	0.2	0.1	0.1	22.6	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.2	0.0	29.6	0.7	0.1	28.8	0.0	0.0	2.8	0.7	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.0	12.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.4	0.1	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	18.7	0.0	27.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.1	0.0	0.0	2.9	0.0	0.1	0.2	0.0	0.0	0.0	1.8	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.8	3.2	0.0	0.0	0.3	0.0	0.0	0.0	3.6	1.0	0.0	0.0	0.0	3.0	1.0	0.0	0.1	0.0	0.0	4.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.1
CKMT1A	CKMT1	ENSG00000223572	"Creatine kinase, mitochondrial 1A"	P12532	15	43692886-43699222	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 83.9;intestine: 75.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 73.0;Distal enterocytes: 110.5;Intestinal goblet cells: 53.4;Paneth cells: 57.4;Proximal enterocytes: 94.5;Syncytiotrophoblasts: 94.0;Undifferentiated cells: 92.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 127.5;hTCEpi: 56.8;OE19: 144.3;SK-BR-3: 107.8;T-47d: 100.3"									HPA043491	Uncertain				"Intracellular and membrane"	NA	NA		2000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA043491: AB_2678510"	"unprognostic (2.04e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.80e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.78e-9)"	"unprognostic (3.52e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.73e-3)"	1.8	3.8	20.8	7.1	22.1	0.0	7.7	29.3	46.4	10.1	12.6	75.0	70.6	0.5	0.4	83.9	2.1	9.4	0.8	21.9	27.3	6.0	0.2	0.9	0.1	24.9	15.8	0.1	3.5	12.3	8.5	9.5	26.9	4.4	69.4	31.8	31.4	1.1	0.1	38.0	63.1	3.4	10.7	0.1	23.3	0.3	23.0	0.2	2.8	0.0	14.7	8.3	26.1	25.7	0.3	2.9	0.7	0.1	1.3	0.0	31.9	0.0	0.0	0.0	0.0	6.8	22.1	0.1	1.4	0.0	2.4	127.5	22.4	39.0	0.0	0.0	17.1	0.0	2.1	0.7	0.0	0.0	6.1	0.2	56.8	0.0	10.3	0.0	0.0	5.0	5.7	0.1	0.0	34.8	0.0	0.2	10.1	144.3	8.2	0.1	0.0	6.7	6.7	4.7	47.1	20.0	0.0	107.8	8.6	2.9	100.3	0.8	0.0	0.0	2.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	22.1	29.3	46.4	21.9	27.3	24.9	15.8	26.9	10.7	23.0	25.7	0.1	0.0	0.0	2.3	0.3	17.7	10.5	30.3	1.8	6.7	4.2	5.2	0.5	10.0	14.9	1.8	20.9	73.0	0.1	110.5	27.4	4.2	0.0	0.7	0.0	0.3	18.0	0.0	10.6	20.2	23.5	0.4	26.0	0.8	8.9	1.5	0.0	0.0	4.5	6.7	9.0	53.4	12.2	0.0	0.7	0.2	0.0	0.0	5.4	1.0	0.0	4.8	0.0	1.5	1.6	12.9	57.4	0.0	0.0	2.7	94.5	1.0	4.1	11.6	0.0	0.0	0.9	0.0	0.1	16.1	18.5	94.0	0.4	0.0	92.7	20.1
CLDN18	SFTPJ	ENSG00000066405	"Claudin 18"	P56856	3	137998735-138033655	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	50	"lung: 252.2;stomach 1: 724.9"	"Group enriched"	"Detected in some"	53	"Alveolar cells type 1: 1602.5;Alveolar cells type 2: 431.2;Gastric mucus-secreting cells: 1153.4;Pancreatic endocrine cells: 442.5"	"Group enriched"	"Detected in some"	11	"pancreatic cancer: 113.6;stomach cancer: 186.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"OE19: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013010, CAB013243, HPA018446"	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cell Junctions"		"CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.14e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.42e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.95e-1)"	0.3	0.3	0.3	0.4	0.4	0.1	0.2	1.0	0.5	0.4	2.2	0.7	1.5	0.2	0.5	0.6	0.5	3.3	9.7	0.3	0.2	0.2	0.1	252.2	0.0	0.9	0.9	0.5	0.8	0.0	0.5	0.3	0.5	0.2	0.2	0.7	0.3	0.4	0.1	1.1	0.8	0.1	0.7	0.5	724.9	1.3	0.5	0.1	0.1	0.0	0.7	0.2	0.3	0.2	0.1	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.5	15.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.3	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.5	0.3	0.2	0.9	0.9	0.5	0.7	0.5	0.2	0.0	1602.5	431.2	1.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	17.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.3	0.2	0.6	0.0	0.0	0.5	11.4	0.0	1.4	1153.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	2.0	0.0	1.9	0.0	0.1	0.0	0.0	0.2	442.5	0.0	0.0	1.3	0.0	0.0	0.1	0.7	1.3	0.0	0.9	0.1	15.3	11.9	0.0	0.0	0.0	1.3	0.0	0.0	0.1
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 114.7;gallbladder: 101.6;kidney: 165.2;seminal vesicle: 90.1"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 77.5;Exocrine glandular cells: 49.1;Hepatocytes: 25.9;Pancreatic endocrine cells: 30.9;Proximal enterocytes: 32.9;Proximal tubular cells: 153.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	5	"hippocampal formation: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 296.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.5;hippocampal formation: 9.5;pons and medulla: 10.3;thalamus: 8.9"	"Region enhanced"	"Detected in some"		"medulla oblongata: 1.7"	"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (9.76e-2)"	0.7	3.0	0.1	2.2	0.1	0.1	0.6	1.6	0.5	0.0	114.7	2.1	21.0	0.1	33.7	0.1	0.3	101.6	0.0	8.4	0.0	165.2	44.2	1.3	0.0	0.2	0.2	0.0	13.2	0.0	0.2	0.0	0.1	1.2	4.5	0.7	0.1	90.1	0.2	0.3	24.5	0.2	0.0	0.0	7.7	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	27.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	296.4	0.2	0.0	0.0	0.1	46.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.5	8.4	0.0	0.2	0.2	0.1	0.0	1.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	14.3	0.0	1.8	0.0	0.0	0.0	0.3	15.6	77.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	49.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.9	0.0	0.0	0.3	2.7	0.0	0.8	0.0	1.4	0.0	0.7	0.0	0.0	1.6	1.6	0.0	1.0	0.2	30.9	3.6	0.0	0.0	0.0	32.9	153.1	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	14.2	0.0
CLEC2L	FLJ32986	ENSG00000236279	"C-type lectin domain family 2 member L"	P0C7M8	7	139523685-139544985	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 36.6;parathyroid gland: 14.2;retina: 10.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 51.7;Inhibitory neurons: 49.5;Theca cells: 72.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"OE19: 12.0;U-266/84: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045050	Enhanced					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA045050: AB_10965839"	"unprognostic (1.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.20e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.29e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.31e-2)"	"unprognostic (7.94e-4)"	"unprognostic (3.57e-3)"	"unprognostic (4.03e-2)"	"unprognostic (8.42e-3)"	"unprognostic (3.02e-2)"	0.4	0.1	13.4	0.2	13.2	0.4	0.1	28.8	33.7	0.8	3.0	0.4	0.1	1.5	0.0	0.6	0.1	0.8	0.3	15.4	17.5	0.1	0.0	0.1	0.1	35.2	14.9	0.2	0.1	14.2	0.5	0.0	36.6	0.0	0.1	10.3	0.1	0.0	3.1	0.2	0.3	0.8	11.6	0.2	0.1	0.6	31.8	8.0	0.2	6.5	0.1	0.1	0.1	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.5	0.0	1.2	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.4	13.2	28.8	33.7	15.4	17.5	35.2	14.9	36.6	11.6	31.8	18.2	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	1.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	51.7	0.0	2.8	1.7	0.0	0.1	0.0	2.7	0.0	0.0	0.2	5.0	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.8	0.0	5.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.8	1.9	0.0	0.0	0.4	0.0	72.8	0.0	0.1
CLRN3	"MGC32871, TMEM12, USH3AL1"	ENSG00000180745	"Clarin 3"	Q8NCR9	10	127877841-127892941	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 89.0;kidney: 43.9;liver: 79.9"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 102.0;Enteroendocrine cells: 41.5;Hepatocytes: 43.0;Intestinal goblet cells: 75.3;Paneth cells: 95.9;Proximal enterocytes: 155.4;Proximal tubular cells: 68.3;Undifferentiated cells: 45.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.3;renal cancer: 30.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	41	"OE19: 96.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA014482	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA014482: AB_2082885"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.22e-2)"		"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"		"unprognostic (2.62e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.67e-1)"	"unprognostic (8.86e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.00e-2)"	0.6	0.1	0.4	5.6	0.4	0.0	0.3	0.3	0.5	0.0	0.3	71.1	73.4	0.1	0.0	0.0	0.0	15.2	0.0	0.4	0.3	43.9	79.9	0.0	0.1	0.3	0.3	0.0	0.3	0.0	0.2	0.0	0.4	0.0	70.3	0.0	0.0	0.2	0.0	0.0	89.0	1.7	0.3	0.1	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	96.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.4	0.3	0.5	0.4	0.3	0.3	0.3	0.4	0.3	0.4	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	102.0	15.6	0.4	0.0	0.2	0.0	0.1	41.5	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	43.0	0.0	0.0	0.1	75.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.5	95.9	0.0	0.0	0.0	155.4	68.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	45.6	0.0
CNPY3	"CAG4A, TNRC5"	ENSG00000137161	"Canopy FGF signaling regulator 3"	Q9BT09	6	42929192-42939294	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Chaperone	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 248.5;Kupffer cells: 233.3;monocytes: 207.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016560	Uncertain				"Intracellular and membrane"	NA	NA		4100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 57: B-cells - Immune response"			"HPA016560: AB_1858173"	"unprognostic (5.26e-3)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (8.15e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.70e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (9.85e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.98e-3)"	35.3	31.4	58.2	64.3	59.1	144.6	32.7	59.0	72.8	40.0	70.0	30.9	30.9	37.5	32.3	23.4	49.8	37.8	28.8	59.7	64.2	31.8	64.7	45.4	78.6	70.0	63.1	48.5	90.0	29.0	41.7	47.6	67.0	45.1	29.7	23.9	32.5	33.8	10.9	22.2	50.1	42.0	62.8	105.2	36.7	46.7	65.8	115.8	34.1	16.7	69.2	43.3	30.0	75.8	78.2	75.6	72.8	157.0	118.4	44.8	73.5	60.3	78.9	79.1	91.0	85.2	57.0	82.1	91.0	102.9	170.8	63.7	54.7	68.7	48.2	82.7	61.6	88.6	65.2	134.0	70.0	155.7	173.3	54.3	41.7	61.2	67.4	113.9	72.4	77.6	73.3	157.3	51.9	147.9	141.4	188.8	59.1	367.3	42.1	97.2	50.6	123.2	79.6	58.6	78.5	68.9	37.7	38.6	134.4	93.4	49.8	334.6	54.6	82.7	82.9	30.9	66.0	107.0	78.9	115.0	34.2	178.6	70.9	212.7	483.3	249.0	115.2	336.3	110.9	267.3	101.1	126.1	407.0	258.7	112.6	115.1	852.8	132.3	327.2	696.4	102.2	404.5	58.2	59.1	59.0	72.8	59.7	64.2	70.0	63.1	67.0	62.8	65.8	75.8	32.3	12.8	11.1	4.2	132.1	22.8	32.1	41.1	31.9	41.6	25.6	29.7	16.9	22.8	26.2	23.9	14.6	51.1	176.5	16.7	7.9	47.4	61.0	25.9	24.2	36.7	55.3	47.9	5.1	34.1	180.8	33.9	20.9	31.8	46.3	81.5	42.1	58.9	248.5	1.7	6.7	31.1	34.6	233.3	61.7	81.7	33.5	184.3	30.2	18.7	207.0	20.8	62.8	4.5	6.6	27.9	34.9	30.1	70.7	50.8	38.4	18.1	32.8	11.1	19.7	12.6	28.0	72.3	39.9	23.9	17.0	36.1	64.1	39.8	36.5	37.9
COA4	"CHCHD8, CMC3, E2IG2"	ENSG00000181924	"Cytochrome c oxidase assembly factor 4 homolog"	Q9NYJ1	11	73872667-73876901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040126	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA040126: AB_10795415"	"unprognostic (7.30e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.17e-2)"	45.1	96.2	46.9	36.8	52.5	25.4	39.0	51.6	52.0	37.1	46.2	44.5	49.0	35.8	32.5	48.0	40.2	40.3	63.1	46.0	49.4	70.4	99.7	31.3	47.3	51.0	50.4	37.8	46.5	49.6	34.2	37.6	51.0	45.1	42.2	15.7	42.7	36.2	72.2	33.1	49.6	32.4	50.6	37.1	41.6	31.6	50.3	32.3	55.7	55.9	36.0	54.6	37.4	56.9	106.4	201.9	80.2	119.0	70.6	86.6	79.3	107.4	75.5	126.0	107.2	147.4	132.5	91.3	214.7	90.2	99.9	105.7	124.2	146.1	98.3	120.6	115.1	156.3	118.1	141.8	130.5	107.2	115.0	109.4	136.1	207.0	136.6	70.9	120.0	87.0	135.3	87.5	118.3	210.8	83.7	168.1	104.3	422.7	205.9	96.2	174.3	244.0	137.5	101.3	72.5	121.3	99.0	110.7	295.3	78.8	162.3	108.0	83.8	102.8	91.7	212.9	142.8	103.3	125.1	313.1	57.0	132.0	121.4	18.5	49.6	12.7	35.9	52.2	47.0	58.1	42.0	37.8	61.1	48.5	44.6	48.2	3.4	43.1	51.4	80.2	47.7	38.6	46.9	52.5	51.6	52.0	46.0	49.4	51.0	50.4	51.0	50.6	50.3	56.9	48.9	35.3	36.0	6.8	48.6	53.5	75.7	89.7	47.8	19.5	64.3	86.1	66.7	85.8	55.5	55.2	22.9	168.8	36.7	97.8	129.1	89.2	37.3	77.2	90.9	49.7	72.6	68.3	3.6	94.9	111.3	54.2	69.3	72.0	62.1	83.9	33.2	184.1	97.5	18.5	5.8	98.6	28.5	44.8	34.2	13.3	55.0	44.7	28.4	2.8	55.2	67.5	49.4	8.5	18.8	98.2	85.1	38.4	47.3	139.5	174.2	266.2	47.1	18.5	6.6	81.6	51.0	78.7	34.2	86.3	51.3	122.3	39.9	150.7	121.2	98.7
COBL	KIAA0633	ENSG00000106078	"Cordon-bleu WH2 repeat protein"	O75128	7	51016212-51316818	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 118.2;skeletal muscle: 131.6;tongue: 107.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 198.7;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 548.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.7;HeLa: 57.0;OE19: 53.4;RPMI-8226: 45.5;SuSa: 32.6;U-266/84: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019033, HPA019167"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cell Junctions"		"HPA019033: AB_2083648, HPA019167: AB_1847070"	"unprognostic (8.09e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.21e-12)"	"unprognostic (7.64e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.41e-3)"	3.0	1.0	83.8	1.4	96.7	0.0	14.8	62.0	91.1	4.8	41.6	13.3	18.9	2.2	2.1	13.6	19.1	5.8	54.8	81.8	67.9	12.9	19.6	13.8	0.2	76.6	88.3	2.8	18.4	31.5	12.8	4.7	69.2	14.4	10.9	23.3	47.3	4.2	131.6	27.5	21.5	2.7	66.6	0.3	17.6	3.0	89.8	1.3	8.3	107.9	1.0	1.8	5.8	118.2	12.4	8.8	0.2	0.3	0.0	0.0	33.7	0.0	0.0	0.0	0.0	24.1	18.2	0.0	0.9	0.0	1.4	21.1	12.0	0.0	0.0	0.0	9.6	0.0	57.0	4.7	0.0	0.0	0.1	1.5	2.3	0.0	0.0	0.0	0.0	1.6	6.5	0.2	0.2	7.9	0.1	0.1	9.0	53.4	8.0	0.1	0.5	45.5	17.4	0.0	11.0	0.2	3.2	26.2	3.9	32.6	16.6	0.1	0.0	0.0	9.8	0.3	0.9	0.0	34.1	0.1	0.1	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	83.8	96.7	62.0	91.1	81.8	67.9	76.6	88.3	69.2	66.6	89.8	118.2	1.4	38.5	19.6	48.0	1.0	17.8	3.4	1.2	4.0	2.3	38.0	34.7	76.2	28.6	13.2	9.2	58.4	23.3	4.6	59.4	0.0	21.5	3.8	65.9	3.3	2.2	18.6	0.0	198.7	9.7	9.2	7.7	35.7	74.6	10.1	4.6	0.4	29.7	2.2	0.0	96.6	35.2	4.1	0.8	1.7	3.1	0.6	0.9	16.0	10.3	1.1	94.4	0.0	353.9	548.8	23.2	35.0	0.4	0.2	25.3	76.8	18.6	31.4	73.6	0.0	10.5	1.5	0.7	8.8	6.8	35.7	40.2	1.7	11.2	14.4	7.3
COG2	LDLC	ENSG00000135775	"Component of oligomeric golgi complex 2"	Q14746	1	230642481-230693982	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 71.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076994			Approved	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA076994: AB_2686823"	"unprognostic (2.21e-1)"	"unprognostic (7.35e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (2.91e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.62e-2)"	10.1	22.0	10.7	11.0	11.8	9.1	12.9	14.7	13.1	13.1	13.5	19.0	13.5	10.0	13.8	8.9	14.2	10.9	17.2	10.0	10.9	16.6	9.9	10.0	16.3	11.0	11.2	10.0	14.1	71.2	8.5	8.9	10.9	12.1	22.7	10.9	12.8	10.9	20.1	11.8	13.3	11.7	11.1	15.1	14.4	10.9	11.5	16.6	15.0	19.9	16.2	11.1	9.1	12.4	15.6	18.0	21.1	20.4	20.6	16.0	30.7	13.2	20.4	21.4	18.6	24.2	23.2	47.6	20.2	18.1	13.8	22.8	20.1	23.6	20.3	38.8	39.8	16.8	17.0	24.9	25.4	43.6	25.1	21.7	25.6	13.6	19.5	13.7	18.0	29.1	29.5	25.8	17.4	12.5	39.7	21.2	30.5	47.1	33.1	33.8	33.8	56.7	22.1	22.8	21.7	29.7	15.5	27.9	30.5	9.4	33.6	41.9	15.3	10.3	9.5	12.8	25.9	31.7	28.3	37.7	17.2	17.7	22.1	18.7	15.7	20.5	16.0	19.4	18.5	13.9	15.1	15.5	18.1	15.2	21.6	19.0	0.8	22.9	29.4	9.1	13.5	18.2	10.7	11.8	14.7	13.1	10.0	10.9	11.0	11.2	10.9	11.1	11.5	12.4	12.5	22.4	19.5	22.9	21.0	5.2	6.1	7.8	8.6	16.1	12.3	10.8	25.9	20.0	15.1	12.9	29.2	13.1	19.6	19.8	27.4	18.7	19.3	17.6	15.2	10.7	18.6	14.9	22.3	23.3	11.8	10.8	15.8	10.7	23.4	14.2	11.0	14.1	14.0	25.2	20.5	37.1	12.2	20.1	6.0	6.4	11.5	12.3	7.2	17.8	19.0	20.5	21.6	23.1	22.6	18.0	12.8	14.7	13.0	9.0	15.2	20.3	28.9	42.9	13.1	13.9	13.3	23.3	25.2	10.0	4.8	9.2	18.4	21.0	21.6	6.0
COG3	SEC34	ENSG00000136152	"Component of oligomeric golgi complex 3"	Q96JB2	13	45464898-45536701	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040353, HPA054470"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA040353: AB_10794027, HPA054470: AB_2732585"	"unprognostic (1.75e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.04e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.71e-1)"	11.2	15.0	7.5	9.3	7.7	11.8	15.6	10.5	9.3	15.2	10.5	16.2	12.6	13.0	16.8	12.4	12.2	9.5	11.8	7.4	7.2	12.3	29.5	10.4	10.7	7.0	7.0	15.1	20.8	12.3	14.9	13.0	7.0	18.7	18.9	10.0	18.0	12.4	11.4	13.2	13.2	12.1	6.8	12.4	14.7	9.7	7.5	12.2	17.0	9.7	10.9	12.7	13.1	9.4	8.3	7.4	13.9	12.6	17.9	20.4	13.2	13.5	19.1	15.4	12.8	10.8	14.9	11.3	5.9	16.2	11.4	17.7	11.6	13.7	23.3	8.9	9.3	12.7	9.2	19.2	22.1	18.8	11.7	15.4	20.3	10.3	36.1	18.6	15.2	11.0	8.3	6.8	18.7	12.9	10.5	17.6	11.4	41.5	8.7	12.1	8.1	10.6	14.4	13.4	6.9	12.5	8.7	17.1	18.2	13.1	11.7	19.3	14.4	7.4	5.7	13.9	8.7	9.4	5.4	11.7	14.2	9.4	13.5	3.5	1.9	3.6	3.4	2.2	3.6	2.2	2.6	2.9	1.4	2.3	2.9	2.7	1.7	2.5	1.3	3.4	3.0	1.7	7.5	7.7	10.5	9.3	7.4	7.2	7.0	7.0	7.0	6.8	7.5	9.4	15.8	9.6	31.4	23.2	18.9	15.8	15.2	13.1	14.2	9.7	22.0	17.9	19.7	24.3	19.8	12.9	14.6	14.2	35.5	32.5	15.6	11.6	24.1	15.0	20.1	16.7	22.2	11.4	39.3	37.9	18.8	14.3	26.0	30.8	17.1	22.4	18.9	72.8	10.8	10.1	34.7	54.5	6.1	20.9	9.0	9.0	14.0	13.3	10.6	22.5	13.2	7.6	15.5	34.2	36.9	22.7	32.8	13.5	31.3	26.6	29.4	17.3	11.7	11.2	6.6	12.8	11.7	12.7	8.9	17.7	16.1	32.8	21.2	21.7	24.4	37.3
COLCA2	"C11orf93, CASC13"	ENSG00000214290	"Colorectal cancer associated 2"	A8K830	11	111298555-111308735	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 25.9;Cholangiocytes: 24.3;Early spermatids: 73.2;Ionocytes: 38.7;Late spermatids: 67.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 11.7;OE19: 41.4;RT4: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (2.73e-3)"	"unprognostic (5.15e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.28e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.54e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (8.97e-6)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.46e-1)"	3.6	2.9	9.2	1.9	10.0	0.1	4.5	9.1	11.1	6.0	8.7	10.4	10.8	8.6	27.2	8.4	19.5	9.9	1.8	9.4	8.7	14.8	2.6	4.2	4.7	9.1	10.9	12.3	8.4	19.0	2.9	2.6	8.8	9.7	11.1	0.2	17.8	15.9	2.1	1.7	8.5	6.5	8.4	0.7	20.1	11.2	9.8	3.3	10.4	3.0	4.7	10.6	7.9	8.9	0.0	3.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	3.1	1.9	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	11.7	0.1	0.0	0.0	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.6	41.4	0.0	0.7	0.0	0.0	0.0	10.6	1.9	0.5	0.4	4.2	0.0	1.0	5.6	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	10.0	9.1	11.1	9.4	8.7	9.1	10.9	8.8	8.4	9.8	8.9	0.3	0.0	0.5	13.1	1.6	0.4	9.7	25.9	0.6	0.0	0.1	3.9	0.6	24.3	14.8	7.3	0.0	0.0	0.1	3.6	11.7	7.6	73.2	7.9	7.0	0.2	1.8	0.0	2.3	16.7	0.0	5.3	7.7	1.4	1.3	0.9	0.0	0.9	0.0	0.0	2.7	13.1	38.7	0.0	0.7	67.5	8.4	0.4	1.8	1.9	0.0	0.0	0.0	0.5	0.2	5.6	3.3	5.7	1.0	2.1	5.6	3.5	23.5	0.0	0.0	0.9	2.0	1.1	1.4	4.1	0.1	0.0	0.2	0.3	5.7	5.6
COMMD6	Acrg	ENSG00000188243	"COMM domain containing 6"	Q7Z4G1	13	75525219-75549439	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"				"unprognostic (8.76e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.49e-3)"	"unprognostic (5.90e-2)"	"unprognostic (9.43e-2)"	"unprognostic (9.89e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.25e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-2)"	94.0	166.3	58.1	76.5	61.0	134.1	116.6	61.7	75.2	110.5	63.0	138.5	70.0	119.2	165.0	96.9	115.1	105.0	109.1	57.0	61.8	105.4	101.0	61.0	171.0	60.7	59.7	234.2	84.7	48.7	61.2	48.9	61.6	83.0	88.9	32.0	85.0	72.1	52.2	79.6	79.0	107.3	63.8	88.0	93.7	43.9	60.8	70.1	144.9	38.9	134.4	109.4	87.7	64.9	201.4	62.2	86.5	73.3	188.8	221.2	60.4	137.5	101.2	46.8	82.0	93.0	109.5	79.2	149.1	115.7	92.4	104.4	56.1	107.3	67.1	164.0	104.3	114.3	52.3	66.8	153.4	132.0	97.2	169.0	176.0	63.8	91.2	264.1	101.3	122.7	32.2	73.1	108.0	49.3	79.3	199.1	51.8	259.7	121.1	75.0	73.7	87.2	96.0	63.7	68.9	112.1	68.5	66.2	184.2	148.4	85.6	196.3	157.6	60.4	59.2	77.2	103.9	92.2	88.7	71.3	195.3	131.2	61.2	564.9	306.4	274.0	308.3	311.8	382.3	684.4	542.9	412.2	382.5	597.2	638.6	548.9	135.4	434.8	294.8	996.5	655.4	582.7	58.1	61.0	61.7	75.2	57.0	61.8	60.7	59.7	61.6	63.8	60.8	64.9	372.1	179.5	233.1	10.1	597.3	521.4	589.4	948.8	592.4	45.9	722.0	1331.3	250.4	348.9	388.2	343.9	20.9	339.9	663.2	299.8	1054.6	353.2	170.8	282.7	338.0	331.7	401.9	153.7	19.5	327.6	434.0	330.5	224.3	222.6	412.1	354.1	418.4	554.0	493.7	42.1	23.1	541.7	360.1	510.1	737.5	77.1	491.5	451.8	338.0	14.0	613.0	287.0	677.7	19.6	19.2	327.9	390.7	348.3	172.0	401.7	324.1	903.6	287.7	54.6	164.3	455.4	363.8	181.0	218.8	457.8	599.1	271.3	614.7	190.7	554.5	500.5
COX6B1	"COX6B, COXG"	ENSG00000126267	"Cytochrome c oxidase subunit 6B1"	P14854	19	35648323-35658782	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 2453.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2710.8;Distal tubular cells: 2985.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004192	Supported		Supported	Mitochondria		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA004192: AB_1847180"	"unprognostic (5.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.10e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.48e-3)"	322.3	211.6	733.9	206.6	741.0	465.2	371.1	780.8	935.9	291.0	758.1	598.9	427.0	197.2	633.9	410.0	329.7	245.8	1284.7	749.3	761.3	519.5	582.3	201.7	316.0	768.3	740.1	241.1	292.4	850.2	169.9	222.3	757.0	249.2	690.0	276.5	356.6	328.6	1467.0	264.7	351.3	342.8	735.4	193.3	336.8	107.0	759.7	426.3	270.5	2453.4	510.5	402.2	205.1	747.2	480.3	1219.5	479.2	649.4	665.5	701.3	455.3	383.4	641.0	684.8	686.4	1018.3	478.0	555.8	663.1	656.6	413.4	341.7	836.5	700.6	683.5	632.0	570.1	929.4	626.6	1014.1	521.1	835.0	454.9	800.2	906.5	619.5	361.1	606.3	690.4	577.8	616.9	783.0	714.9	1019.4	589.2	626.8	357.0	2445.6	811.5	502.1	525.9	930.4	1567.1	1035.9	434.4	484.5	615.9	1049.3	393.4	568.5	419.6	892.9	365.9	363.8	398.0	382.3	605.6	450.5	683.3	776.7	470.9	695.0	472.7	1138.1	1099.7	998.5	628.9	1228.5	607.0	1150.2	854.9	732.8	1140.2	956.3	839.9	744.3	1115.9	672.8	1178.4	1176.1	1138.3	2058.8	733.9	741.0	780.8	935.9	749.3	761.3	768.3	740.1	757.0	735.4	759.7	747.2	324.6	243.6	227.3	27.4	409.4	427.1	436.6	1071.1	373.3	143.5	498.4	615.2	2710.8	664.8	529.6	698.9	64.6	623.0	361.5	1496.0	2985.6	711.7	328.0	427.4	293.2	312.6	625.7	436.5	21.2	808.9	735.5	360.9	484.2	397.2	280.8	277.9	338.8	1270.7	1041.1	89.2	27.9	1277.1	736.5	800.2	705.9	942.4	327.7	582.7	748.8	18.7	807.7	351.1	435.6	16.1	31.6	863.0	1445.3	273.1	523.2	548.7	2291.0	2228.5	445.5	193.3	263.0	293.8	454.2	175.7	186.6	784.8	565.6	670.7	373.1	229.1	1277.5	717.0
COX7B		ENSG00000131174	"Cytochrome c oxidase subunit 7B"	P24311	X	77899440-77907376	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1122.9;tongue: 756.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2237.0;Distal tubular cells: 2283.3;Proximal tubular cells: 1865.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058041	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA058041: AB_2683587"	"unprognostic (1.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.10e-2)"	"prognostic favorable (6.80e-6)"	"unprognostic (8.58e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.38e-2)"	"prognostic favorable (2.43e-4)"	99.1	94.8	198.6	74.5	200.9	205.6	81.5	218.2	376.7	46.2	228.4	176.5	182.4	50.2	94.4	72.1	55.3	42.0	326.8	202.2	214.7	222.6	181.5	45.7	64.3	203.2	202.9	38.7	49.1	301.3	21.3	53.6	205.4	61.6	158.5	184.1	93.5	65.9	1122.9	42.8	156.7	74.8	205.0	51.3	125.1	19.1	208.4	96.6	54.3	756.7	76.3	87.8	19.6	207.3	242.8	239.4	257.8	214.6	111.8	90.1	179.5	159.7	78.8	101.8	113.1	259.6	213.0	158.6	271.8	96.1	333.1	302.5	298.7	183.6	112.7	138.9	372.7	218.5	441.3	343.5	104.2	441.1	185.5	133.0	137.0	154.2	129.9	173.0	113.0	186.1	186.3	409.8	118.6	282.6	350.6	445.5	253.4	972.4	614.5	250.5	297.0	594.4	344.6	420.8	177.3	158.1	305.8	396.8	334.2	209.0	148.7	295.0	149.7	91.1	222.0	232.6	167.7	157.9	407.0	364.8	212.2	504.2	130.5	212.5	226.7	168.6	152.7	326.5	165.2	213.6	166.5	174.8	303.7	146.3	155.7	185.6	142.8	205.9	316.1	213.2	238.6	261.1	198.6	200.9	218.2	376.7	202.2	214.7	203.2	202.9	205.4	205.0	208.4	207.3	238.9	134.6	178.0	28.1	247.7	297.5	297.2	1151.7	225.9	111.4	204.5	244.9	2237.0	487.6	463.6	369.6	35.5	412.9	272.2	1219.8	2283.3	504.6	20.8	424.0	243.9	210.0	516.0	428.5	11.2	395.7	424.2	227.2	382.8	356.4	226.3	134.7	194.5	1179.5	718.3	47.1	14.8	922.1	734.5	438.9	432.1	43.1	199.4	368.3	538.9	10.3	488.1	214.0	258.5	12.5	19.5	425.5	1090.3	176.4	297.3	307.7	1516.9	1865.2	314.0	174.3	210.4	274.2	315.4	81.4	108.8	583.4	345.5	591.7	258.4	166.9	978.4	472.5
CPD	GP180	ENSG00000108582	"Carboxypeptidase D"	O75976	17	30378927-30469989	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 25.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052796, HPA055465"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear speckles"		NA	NA		1700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nuclear speckles"	"Nuclear membrane"	"HPA052796: AB_2681953, HPA055465: AB_2682823"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.25e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.08e-1)"	25.9	7.4	10.8	19.7	13.1	32.2	20.5	15.4	25.6	40.9	9.4	18.0	20.3	15.8	13.2	12.1	23.0	31.8	9.1	11.8	13.0	19.7	25.4	18.2	7.9	19.5	13.3	7.8	15.7	28.5	6.1	30.3	17.8	16.8	20.1	14.9	44.8	11.2	8.1	8.2	19.8	23.3	18.3	9.3	37.3	41.3	13.5	8.3	57.6	14.0	9.9	18.3	7.1	28.0	39.4	58.9	50.0	51.6	51.0	95.9	18.0	53.1	77.2	36.0	43.9	69.6	24.9	5.1	65.8	61.3	45.6	27.6	32.7	67.1	60.3	18.7	46.7	11.2	32.5	43.2	61.8	73.8	28.3	172.3	29.4	46.2	44.3	59.7	74.3	16.5	22.1	56.1	29.2	7.7	23.9	20.3	14.1	89.8	13.4	22.6	57.8	15.3	67.3	44.2	12.5	31.5	63.4	54.0	27.6	58.0	51.2	50.4	89.2	35.7	23.3	56.2	51.3	22.5	50.0	16.1	45.6	47.2	30.9	4.5	7.7	8.4	4.1	3.6	4.5	0.2	2.1	3.5	4.4	0.4	1.6	2.0	25.0	2.7	3.2	0.5	1.5	3.6	10.8	13.1	15.4	25.6	11.8	13.0	19.5	13.3	17.8	18.3	13.5	28.0	124.4	32.1	23.9	28.4	7.5	22.0	34.2	99.2	21.6	30.8	34.9	18.8	13.7	155.8	129.5	29.5	45.9	24.8	35.9	37.8	1.9	32.4	96.1	21.9	24.9	51.9	32.3	15.6	62.9	24.8	11.1	25.6	72.4	35.2	24.1	21.6	56.0	93.9	15.9	47.1	57.1	69.0	85.5	31.2	20.4	56.0	16.8	33.7	30.2	90.9	32.9	13.4	29.9	45.8	164.5	32.8	26.4	16.1	38.1	58.5	50.1	18.5	84.2	33.8	0.0	21.3	23.4	31.0	21.0	21.1	18.6	24.1	35.6	14.2	34.4	50.7
CRACR2A	"EFCAB4B, MGC4266"	ENSG00000130038	"Calcium release activated channel regulator 2A"	Q9BSW2	12	3606633-3764819	"Predicted intracellular proteins"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.0;intestine: 13.5;salivary gland: 38.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 14.9;Intestinal goblet cells: 46.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"basophil: 16.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA038686	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA038686: AB_10671748"	"unprognostic (6.78e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.96e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.11e-2)"	"prognostic favorable (2.85e-6)"	"unprognostic (4.94e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.04e-2)"	1.4	0.2	0.2	3.6	1.0	17.0	5.0	0.1	0.3	2.1	0.7	9.1	4.5	0.7	0.1	0.5	0.5	1.7	1.9	0.2	0.1	0.2	1.0	1.3	4.0	0.6	0.3	1.1	3.3	0.1	0.2	0.2	0.4	4.2	13.5	0.1	38.6	0.7	0.3	1.8	8.4	1.1	0.3	2.9	3.5	1.1	0.6	6.1	0.6	0.4	3.6	2.8	0.3	0.4	13.2	4.4	0.9	0.2	1.7	5.1	10.1	1.4	1.2	3.7	5.1	8.9	2.6	19.5	0.5	5.1	0.2	0.0	14.7	0.0	5.2	29.4	3.3	17.1	0.0	0.0	2.9	23.9	0.4	3.9	1.5	11.4	0.1	0.0	10.7	18.4	12.0	8.4	4.8	10.7	22.0	11.6	5.3	24.6	0.0	11.7	11.9	3.8	0.0	16.6	9.5	2.2	3.0	3.1	0.1	0.9	0.6	13.4	15.6	0.0	15.3	12.6	0.0	0.1	0.0	24.9	0.0	11.1	0.0	16.9	1.0	2.5	5.0	1.0	5.0	2.6	2.5	4.0	0.8	0.9	1.4	2.5	1.1	3.5	0.2	0.3	1.0	1.7	0.2	1.0	0.1	0.3	0.2	0.1	0.6	0.3	0.4	0.3	0.6	0.4	0.9	0.0	0.6	1.0	6.1	0.0	1.3	0.0	0.6	1.1	12.8	9.4	3.8	0.0	3.1	0.0	2.1	0.1	14.9	4.3	0.0	1.6	1.5	0.4	5.5	1.2	0.0	3.0	3.4	2.9	0.6	3.1	6.1	0.3	0.0	13.2	2.2	0.5	2.0	0.0	5.5	46.0	0.0	2.5	0.0	2.9	1.8	3.1	0.0	4.7	3.2	0.1	8.2	0.0	0.6	1.9	5.3	4.5	8.6	4.7	3.2	0.2	2.9	0.2	0.0	4.2	2.0	1.2	2.9	0.2	0.0	0.0	12.1	2.6	8.1	1.8
CRIP1	CRIP	ENSG00000213145	"Cysteine rich protein 1"	P50238	14	105486317-105488947	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 980.8;Endometrial ciliated cells: 1761.1;Proximal enterocytes: 2548.8;Respiratory ciliated cells: 1702.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 699.8;CAPAN-2: 415.5;HaCaT: 464.1;HDLM-2: 329.5;OE19: 1305.8;T-47d: 586.0"									HPA042462	Approved		Approved	"Nuclear speckles,Plasma membrane,Centrosome,Cytosol"		NA	NA		29000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles, Cytosol"	"Plasma membrane, Centrosome"	"HPA042462: AB_10794277"	"unprognostic (2.97e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.14e-1)"	265.2	21.7	19.2	61.1	19.7	29.4	180.8	20.0	36.4	147.4	20.3	133.9	121.7	108.0	206.6	118.7	118.2	28.1	262.6	18.5	20.3	109.7	17.8	254.6	83.9	26.9	29.1	49.8	18.3	21.2	41.5	28.3	24.6	49.6	55.4	0.2	135.7	87.9	44.7	301.1	312.5	42.4	24.7	94.5	94.2	14.3	21.0	79.6	182.1	50.2	135.7	113.7	98.9	20.3	0.0	699.8	4.8	0.6	12.1	8.3	66.8	1.3	0.4	9.0	0.1	21.0	415.5	228.0	2.4	191.0	2.6	464.1	0.1	0.0	0.0	329.5	0.0	17.7	294.7	116.3	1.8	0.1	0.2	3.8	0.0	23.1	0.0	0.9	0.5	64.6	0.5	0.9	0.0	3.7	8.1	1.6	7.4	1305.8	36.4	181.3	0.0	45.5	0.0	0.0	18.5	1.3	2.6	1.2	0.0	0.5	586.0	106.4	1.5	0.4	0.4	5.5	0.0	0.3	0.2	17.9	0.0	0.0	0.6	121.8	218.6	313.1	209.2	214.4	135.1	697.0	442.0	222.1	442.9	384.2	85.4	100.2	13.9	323.5	283.9	291.3	694.8	465.6	19.2	19.7	20.0	36.4	18.5	20.3	26.9	29.1	24.6	24.7	21.0	20.3	50.2	980.8	256.2	0.3	350.7	186.5	1.2	79.5	67.2	0.0	88.1	18.3	1.0	2.8	501.3	51.5	0.0	2.1	287.8	360.4	1.9	20.5	3.6	1761.1	124.5	86.4	76.5	27.3	0.0	3.1	4.3	313.3	210.0	491.9	521.5	0.1	24.7	1.3	52.2	0.0	0.0	243.1	30.5	168.0	577.3	26.2	25.1	523.7	370.0	1.9	461.4	0.2	83.4	0.0	0.1	34.2	659.2	9.4	584.3	0.7	2548.8	2.5	1702.1	0.0	223.5	8.2	448.0	1.0	11.4	29.4	251.6	1.5	524.7	0.1	190.7	3.0
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 329.8;liver: 254.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 485.2;Hepatocytes: 306.1;Proximal enterocytes: 509.9;Proximal tubular cells: 1033.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040403, HPA058848"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA		690000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632, HPA058848: "	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	33.7	31.8	69.5	15.4	81.3	11.2	27.1	75.4	78.1	33.0	65.6	62.1	190.2	30.5	51.7	24.7	26.5	30.0	30.4	65.2	79.0	329.8	254.1	19.9	19.4	76.3	71.9	19.8	46.9	31.4	38.1	16.1	76.1	32.2	49.3	20.7	41.6	36.5	17.0	16.3	131.6	22.8	77.2	23.3	45.2	4.9	71.9	18.0	35.0	20.7	16.3	20.9	23.6	89.8	8.1	6.9	6.4	42.7	31.6	36.1	5.8	11.1	20.0	4.8	3.9	2.6	7.8	0.1	20.6	15.5	10.9	1.9	5.7	9.9	4.9	19.4	4.7	14.2	0.8	55.1	18.1	4.6	12.2	21.5	6.4	3.9	22.0	17.1	51.7	20.3	1.0	5.8	12.7	29.2	12.7	7.2	0.4	68.7	10.2	6.4	3.8	1.0	40.8	16.9	4.2	5.0	6.6	3.1	51.0	3.0	21.2	18.0	50.1	5.8	2.6	14.3	7.1	7.6	1.6	0.0	11.1	7.9	24.5	5.8	50.7	3.2	23.2	59.6	18.9	20.5	30.6	22.1	60.5	23.1	23.5	22.2	1.7	15.6	50.6	6.4	37.5	43.8	69.5	81.3	75.4	78.1	65.2	79.0	76.3	71.9	76.1	77.2	71.9	89.8	29.2	6.4	10.3	57.8	17.7	10.3	15.9	29.7	6.2	6.1	22.0	11.6	10.5	35.8	25.6	77.3	12.5	22.0	10.0	138.5	485.2	26.1	3.6	32.5	8.8	29.1	9.1	6.9	54.5	31.6	11.2	29.8	34.1	27.2	25.3	8.8	50.7	306.1	71.4	1.7	35.3	89.0	32.6	91.6	34.3	4.3	26.1	51.3	37.4	13.1	19.3	112.2	9.2	33.7	114.1	43.2	219.1	24.0	14.3	23.0	509.9	1033.9	20.9	12.6	19.7	23.4	14.7	1.0	2.7	13.0	9.2	20.8	20.1	20.7	105.2	15.0
CSAG1	"CSAGE, CT24.1"	ENSG00000198930	"Chondrosarcoma associated gene 1"	Q6PB30	X	152727484-152733735	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.1;choroid plexus: 2.6"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 5.4;Spermatogonia: 12.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 16.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 120.2;HMC-1: 64.4;K-562: 44.4;OE19: 140.6;PC-3: 58.8;U-266/70: 103.4"															NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"				"unprognostic (2.37e-1)"	"unprognostic (4.66e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.83e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.68e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.07e-6)"	"unprognostic (5.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.70e-3)"	0.0	0.0	3.1	0.1	2.9	0.0	0.0	2.9	7.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	2.8	0.0	0.0	0.0	0.4	3.0	2.9	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	1.3	2.9	0.0	0.1	0.0	0.2	0.0	0.0	3.0	0.1	0.0	0.0	8.4	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.2	0.0	0.0	0.0	0.0	0.4	0.0	2.2	2.0	0.0	0.0	0.0	64.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	44.4	0.6	0.0	0.0	0.2	0.0	0.0	140.6	58.8	0.0	0.0	0.3	0.0	0.1	6.4	36.1	0.0	21.6	19.1	0.0	1.0	0.0	0.0	0.1	0.8	21.8	7.3	103.4	1.7	0.0	0.7	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.9	2.9	7.1	2.9	2.8	3.0	2.9	3.1	2.7	2.9	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	5.4	12.4	0.0	0.0	0.1	0.0	0.0	0.0	0.7
CSAG3	CSAG3A	ENSG00000268916	"CSAG family member 3"	Q9Y5P2	X	152753921-152760222	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.3;testis: 3.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 44.2;HMC-1: 25.7;OE19: 65.6;SH-SY5Y: 33.7;SK-BR-3: 31.5;U-266/70: 80.5;U-266/84: 44.0"															NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"						"unprognostic (1.56e-1)"			"unprognostic (9.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.12e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-2)"		"unprognostic (7.06e-2)"		"unprognostic (7.06e-2)"	"unprognostic (1.84e-1)"		"unprognostic (2.91e-2)"	0.2	0.0	0.4	0.1	0.5	0.1	0.0	0.2	1.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.1	0.1	1.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.3	2.3	0.0	3.9	0.3	0.1	0.0	0.0	0.2	0.1	0.3	0.4	0.4	0.0	0.0	4.5	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	44.2	0.0	0.0	0.0	0.0	25.5	0.0	0.2	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	21.1	0.0	0.0	0.1	0.0	0.0	65.6	0.3	0.0	0.0	2.9	0.0	0.0	7.0	33.7	0.0	31.5	1.4	0.1	0.0	1.4	0.1	0.1	24.0	0.0	0.0	80.5	44.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	1.0	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTSE		ENSG00000196188	"Cathepsin E"	P14091	1	206008535-206023909	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 1168.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 105.8;Exocrine glandular cells: 262.8;Gastric mucus-secreting cells: 553.5;Pancreatic endocrine cells: 260.0;Paneth cells: 208.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 297.4;stomach cancer: 200.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	46	"OE19: 1799.1"	"Not detected"	"Not detected"							"HPA012674, HPA012940, CAB032687"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB032687: AB_637901, HPA012674: , HPA012940: AB_2668773"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.72e-2)"		"unprognostic (1.35e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.61e-2)"	"prognostic favorable (5.26e-5)"	0.3	0.0	0.1	9.5	0.1	30.0	0.0	0.5	0.3	0.0	0.1	15.3	229.8	0.3	1.7	0.8	1.1	15.0	0.3	0.1	0.1	0.2	0.2	49.7	0.5	0.3	0.1	0.1	3.7	0.0	1.1	1.3	0.3	0.2	25.7	0.1	0.0	1.6	0.0	0.1	55.5	0.3	0.1	0.6	1168.3	0.1	0.3	0.5	8.9	0.0	10.7	5.8	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.8	0.8	0.0	3.8	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.2	2.4	0.0	1.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.8	1.5	0.7	1799.1	0.1	0.4	0.0	0.8	0.7	39.4	0.2	0.5	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.2	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.6	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.3	0.1	0.1	0.3	0.1	0.3	0.1	0.3	0.5	0.0	105.8	27.9	0.0	0.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.5	10.0	42.3	0.0	0.0	0.0	0.0	34.1	0.0	52.0	0.0	0.3	0.0	0.3	2.4	60.6	0.0	262.8	0.1	14.7	553.5	0.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	21.1	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.0	0.0	0.0	0.1	260.0	208.9	0.0	0.7	0.1	4.0	0.1	7.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	10.4	0.4
CUL9	"H7AP1, KIAA0708, PARC"	ENSG00000112659	"Cullin 9"	Q8IWT3	6	43182184-43224587	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	53	"Early spermatids: 513.7;Late spermatids: 1508.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016434, HPA052004"	Approved		Approved	Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA016434: AB_1848125, HPA052004: AB_2681690"	"prognostic favorable (5.28e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.37e-5)"	"unprognostic (3.05e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.94e-2)"	"prognostic favorable (4.87e-4)"	2.9	3.0	3.1	4.9	4.5	6.9	2.9	1.3	3.4	3.2	3.5	3.6	4.0	3.3	1.7	5.5	4.9	3.6	2.6	3.2	2.0	3.1	2.1	3.6	6.3	2.4	2.8	4.3	4.2	5.5	2.9	2.4	2.7	3.4	2.3	3.2	3.9	4.0	2.8	8.0	4.2	2.8	1.5	4.9	4.2	5.2	2.5	7.6	5.2	2.9	4.7	3.8	2.7	2.7	8.2	6.0	3.2	7.7	8.8	5.2	4.4	3.2	5.6	5.0	4.6	1.9	3.4	6.8	6.0	5.1	4.5	5.8	2.7	6.7	2.3	8.3	2.5	7.4	6.8	3.0	5.8	4.7	11.6	7.1	13.8	4.1	3.7	4.4	7.4	11.5	3.9	8.7	4.5	7.2	9.6	6.8	0.6	15.7	3.6	13.9	2.2	6.6	3.8	8.4	5.5	7.8	4.2	5.0	7.2	2.7	8.6	10.4	6.9	12.5	8.6	3.7	6.1	8.3	8.3	5.5	3.2	8.2	5.7	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	3.1	4.5	1.3	3.4	3.2	2.0	2.4	2.8	2.7	1.5	2.5	2.7	6.6	0.0	8.2	16.3	7.5	6.4	2.7	9.3	16.5	10.2	8.0	6.1	6.9	8.6	5.9	3.7	12.5	3.4	6.5	8.8	3.9	4.2	513.7	7.5	5.5	6.8	6.0	3.4	15.8	6.2	1.7	5.3	18.8	6.4	2.5	14.6	9.3	6.4	11.6	11.8	11.9	7.9	6.1	9.6	5.0	1508.3	11.1	8.5	3.6	9.4	6.3	9.6	5.2	11.6	11.2	6.5	2.1	8.2	4.1	2.3	8.5	6.7	8.5	10.0	13.1	6.4	3.6	14.5	10.1	14.2	5.5	2.6	7.1	5.6	7.2	2.9
CXCL17	"Dcip1, DMC, UNQ473, VCC1"	ENSG00000189377	"C-X-C motif chemokine ligand 17"	Q6UXB2	19	42428278-42442946	"Predicted secreted proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 120.5;lung: 149.0;salivary gland: 145.6;stomach 1: 358.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 513.8;Basal respiratory cells: 988.1;Club cells: 1743.3;Respiratory ciliated cells: 383.0;Urothelial cells: 1584.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 170.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"OE19: 8.7;RT4: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (2.74e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.03e-2)"		"unprognostic (4.46e-3)"	"unprognostic (3.77e-1)"	"prognostic favorable (4.92e-5)"	"unprognostic (6.68e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.29e-1)"	0.2	0.1	0.1	0.1	0.0	0.0	2.3	0.2	0.1	19.2	0.0	0.8	0.7	0.9	22.3	120.5	27.1	6.5	0.1	0.1	0.0	0.2	0.1	149.0	0.0	0.0	0.0	0.3	42.9	0.0	0.6	0.0	0.0	8.2	0.0	0.0	145.6	0.4	0.0	0.3	0.0	0.1	0.0	0.2	358.6	0.1	0.0	1.1	0.5	0.0	24.2	47.6	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	35.3	513.8	0.3	0.1	0.0	225.5	988.1	1.2	0.4	21.5	10.3	0.0	4.3	1743.3	5.5	0.0	0.0	0.2	0.2	0.0	8.7	0.4	3.0	0.6	3.5	0.0	0.0	1.5	187.4	0.0	4.3	302.2	8.4	16.4	0.1	0.0	0.0	0.0	0.0	1.2	0.0	227.9	0.0	0.0	1.5	0.0	3.9	0.0	0.0	2.6	0.2	0.0	0.5	0.5	339.6	0.0	0.0	0.5	221.2	0.0	0.2	383.0	0.6	0.0	0.0	67.6	0.1	0.6	91.6	0.0	0.0	2.4	0.0	0.2	1584.1
CYP2S1		ENSG00000167600	"Cytochrome P450 family 2 subfamily S member 1"	Q96SQ9	19	41193210-41207539	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 101.3;stomach 1: 120.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.0;Gastric mucus-secreting cells: 110.6;Intestinal goblet cells: 29.2;Langerhans cells: 73.0;Proximal enterocytes: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 24.7;myeloid DC: 84.4"	"Group enriched"	"Detected in many"	131	"dendritic cells: 84.4;monocytes: 24.7"	"Cell line enhanced"	"Detected in many"		"A549: 99.4;CACO-2: 49.8;HaCaT: 50.3;NTERA-2: 69.6;OE19: 158.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049227, HPA069248"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"HPA049227: AB_2680681, HPA069248: AB_2732128"	"unprognostic (1.49e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	1.8	1.1	1.4	6.7	1.4	1.8	0.9	3.1	1.5	2.7	1.2	26.7	101.3	0.5	0.2	14.5	6.3	5.5	0.5	1.3	4.1	1.1	1.4	7.1	1.7	6.3	10.0	0.3	0.6	0.7	1.2	1.6	6.1	1.3	18.6	0.2	5.0	0.9	0.2	3.7	65.3	1.7	2.2	6.1	120.4	0.8	3.6	3.2	0.6	0.2	13.2	3.6	4.0	2.5	3.8	99.4	0.0	0.1	0.0	0.0	4.5	0.6	0.8	1.0	0.2	49.8	13.6	0.2	10.4	0.7	0.1	50.3	16.6	25.0	0.4	0.0	0.3	12.9	5.1	19.1	19.4	0.0	0.4	0.8	1.4	1.4	0.8	0.2	0.8	4.3	5.8	0.2	0.0	2.0	0.3	0.2	69.6	158.6	12.5	0.2	0.0	0.9	1.5	20.4	0.1	0.6	9.1	0.0	0.0	27.8	12.2	4.7	10.6	0.1	4.0	1.7	0.0	0.5	0.0	0.0	0.5	2.1	0.1	0.0	24.7	0.0	0.0	5.9	0.4	0.0	0.0	0.1	84.4	0.0	0.0	0.0	0.2	0.1	3.7	3.2	0.0	11.4	1.4	1.4	3.1	1.5	1.3	4.1	6.3	10.0	6.1	2.2	3.6	2.5	0.3	0.0	6.9	1.0	0.7	2.5	2.0	18.2	23.3	0.0	0.1	0.3	1.2	0.0	7.6	1.8	0.0	24.9	0.1	31.0	0.0	0.7	0.3	7.4	0.3	0.4	0.0	0.0	0.4	1.0	1.1	0.8	110.6	0.3	1.3	0.1	0.4	0.0	14.5	0.0	0.5	29.2	0.0	5.7	73.0	0.0	0.0	16.0	0.0	1.0	7.2	0.0	0.0	0.5	0.1	23.7	22.3	0.0	0.4	0.5	50.7	0.2	10.8	0.0	0.0	0.3	0.9	0.1	0.4	4.0	2.8	10.3	0.3	0.0	14.1	0.5
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99679998	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 177.7;liver: 276.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 377.4;Distal enterocytes: 382.7;Gastric mucus-secreting cells: 506.6;Hepatocytes: 454.5;Paneth cells: 451.6;Proximal enterocytes: 1074.6;Urothelial cells: 380.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.7;Hep G2: 7.9;OE19: 28.3"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	3.3	14.4	0.1	3.8	0.4	0.6	6.5	0.8	0.9	5.1	0.4	28.4	127.3	3.1	3.0	22.1	3.1	32.7	1.0	0.3	0.0	10.6	276.1	9.2	1.4	0.6	0.0	0.8	47.0	0.0	0.9	0.4	0.4	21.6	21.0	0.7	2.9	5.7	0.9	20.5	177.7	1.1	0.0	0.8	86.5	0.4	0.0	2.1	1.0	0.0	3.2	10.4	13.1	0.5	1.6	3.3	1.6	1.9	0.4	0.6	0.5	1.5	0.0	0.0	0.0	9.7	7.4	1.0	1.5	0.0	1.2	1.2	0.0	0.0	0.0	1.8	1.2	1.2	0.7	7.9	0.1	2.0	0.6	0.0	2.1	0.0	0.0	1.4	0.0	0.9	3.3	2.0	0.0	0.3	2.6	3.8	0.4	28.3	0.8	0.6	1.6	2.2	0.4	1.5	1.2	1.7	0.9	0.8	3.2	1.6	0.5	0.7	1.2	1.8	1.6	1.6	1.2	1.0	2.6	1.7	1.6	2.6	1.5	0.4	0.3	0.4	0.4	0.3	0.9	0.2	0.6	0.6	0.2	0.1	0.4	0.5	0.5	0.4	0.2	0.3	0.5	0.2	0.1	0.4	0.8	0.9	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.5	0.9	12.8	14.8	1.3	4.8	46.1	112.7	31.0	59.7	13.7	1.1	0.4	1.3	377.4	27.3	3.7	12.5	1.7	1.7	382.7	0.0	63.4	2.0	3.1	2.2	6.3	54.6	21.7	8.6	50.7	1.2	8.5	506.6	10.3	10.1	1.8	8.2	454.5	0.6	8.4	11.0	140.5	6.1	9.5	4.5	0.5	2.5	4.1	3.6	2.8	4.9	4.0	10.3	7.1	6.5	80.1	451.6	2.6	6.4	156.3	1074.6	10.8	12.1	21.6	0.0	2.5	3.4	15.1	6.4	107.3	59.0	1.5	7.5	3.1	139.8	380.4
CYSTM1	"C5orf32, ORF1-FL49"	ENSG00000120306	"Cysteine rich transmembrane module containing 1"	Q9H1C7	5	140175156-140282052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 1317.5"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2568.9;Gastric mucus-secreting cells: 2148.3;Late spermatids: 1327.7;Pancreatic endocrine cells: 1331.5;Proximal tubular cells: 1301.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 425.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 425.2"	"Cell line enhanced"	"Detected in all"		"OE19: 773.7;RPTEC TERT1: 364.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050930	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA050930: AB_2681278"	"unprognostic (7.39e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.46e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.69e-5)"	"unprognostic (7.63e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.14e-2)"	86.3	187.3	111.3	53.7	112.6	161.2	61.1	114.2	131.5	48.5	148.6	184.3	320.5	36.6	53.9	28.3	139.6	150.8	114.6	110.2	121.1	264.8	74.4	96.6	23.4	117.9	117.4	29.1	141.3	128.6	53.9	64.6	119.3	31.3	166.2	35.2	81.7	41.7	293.5	23.8	168.0	60.0	112.7	33.4	1317.5	35.7	116.4	31.7	87.2	360.0	20.9	158.1	21.9	112.5	68.5	118.8	10.1	65.8	152.5	118.2	51.0	26.7	77.1	34.5	67.8	142.0	115.1	28.4	92.2	44.8	180.1	42.8	55.7	70.8	27.5	54.3	74.6	2.7	50.4	92.3	119.1	9.1	63.5	31.4	92.2	42.2	77.0	62.7	67.5	91.1	48.7	68.4	8.2	66.2	31.4	16.6	16.4	773.7	44.5	7.0	12.4	51.4	364.9	284.0	25.4	16.6	45.8	28.8	280.6	33.3	96.9	27.0	16.0	17.0	17.1	12.8	31.8	62.5	48.6	26.4	87.9	8.9	32.8	15.6	32.4	22.4	4.3	37.3	8.1	18.2	11.5	7.2	41.3	14.4	3.1	4.8	425.2	4.5	39.1	64.0	17.2	16.4	111.3	112.6	114.2	131.5	110.2	121.1	117.9	117.4	119.3	112.7	116.4	112.5	259.9	317.3	115.2	34.6	52.8	169.5	525.6	252.8	51.2	5.6	85.5	77.8	107.2	424.7	186.1	573.8	2.1	422.8	42.8	1024.7	2568.9	674.9	444.3	469.0	60.8	147.8	435.8	47.4	10.6	846.6	53.6	174.0	2148.3	218.9	119.2	9.4	120.0	88.5	205.2	11.8	12.5	285.8	205.4	45.3	150.0	1327.7	101.5	77.1	394.8	13.1	105.5	153.3	3.1	4.5	11.1	1331.5	1148.5	116.6	37.4	365.1	727.1	1301.6	576.5	18.8	144.7	115.6	190.6	208.6	81.4	28.4	113.7	393.1	53.9	30.2	429.3	736.7
DACT2	"bA503C24.7, C6orf116, DAPPER2"	ENSG00000164488	"Dishevelled binding antagonist of beta catenin 2"	Q5SW24	6	168292830-168319777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;placenta: 12.9"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 58.2;Syncytiotrophoblasts: 216.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.2;CACO-2: 2.7;hTCEpi: 1.8;NTERA-2: 2.2;OE19: 11.2;SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"basal ganglia: 16.9;cerebral cortex: 21.4;hippocampal formation: 16.8"	HPA030251	Enhanced	Supported				NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA030251: AB_10611108"	"unprognostic (5.22e-6)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.07e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.05e-3)"	"unprognostic (2.48e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-4)"	"unprognostic (4.23e-2)"	2.3	3.3	3.7	0.4	19.4	0.0	0.6	2.9	6.2	1.7	1.4	1.0	0.8	2.7	0.1	1.5	1.7	0.4	5.2	2.7	2.7	3.6	5.8	1.6	0.4	4.1	3.5	0.1	2.9	0.0	0.6	12.9	4.6	7.3	0.3	5.8	6.5	0.4	0.2	5.7	0.6	0.2	2.8	0.0	0.7	1.0	4.1	1.9	0.3	0.0	0.6	1.1	1.2	3.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	11.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	19.4	2.9	6.2	2.7	2.7	4.1	3.5	4.6	2.8	4.1	3.0	0.0	0.0	2.0	0.0	0.0	3.1	1.9	0.8	0.0	10.7	0.1	3.0	0.6	1.5	1.3	1.8	0.0	58.2	0.0	0.1	0.0	1.3	0.0	11.8	0.5	0.7	5.3	0.0	0.1	0.2	6.1	3.4	0.0	11.0	0.0	3.3	0.0	0.3	5.3	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.1	3.6	6.5	0.0	26.3	0.0	0.0	0.1	0.3	1.2	0.0	0.0	1.1	0.0	5.7	0.0	0.9	0.0	0.5	0.1	0.0	0.3	0.0	1.4	216.3	0.2	0.0	1.9	0.1
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: AB_2678963"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavorable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	16.7	19.2	10.3	22.9	11.0	15.2	23.9	11.3	15.6	17.7	12.8	20.7	16.1	16.2	19.1	21.3	18.0	12.7	16.2	10.9	11.1	32.4	20.7	12.9	24.7	10.8	13.7	13.6	18.5	20.0	15.6	18.7	11.4	14.7	21.4	13.8	14.3	12.8	18.8	15.7	14.5	18.2	11.3	14.3	15.6	32.2	10.4	24.7	18.1	16.0	30.5	33.6	14.6	11.9	96.5	84.2	76.9	79.0	54.7	62.7	57.6	70.1	53.2	64.4	65.9	83.1	90.9	132.2	116.1	73.3	64.0	69.9	105.8	89.0	124.1	127.7	74.9	183.0	48.0	95.9	62.2	76.1	75.7	51.8	59.9	95.9	157.5	40.3	91.4	89.6	125.3	56.7	99.9	78.0	144.9	79.3	118.0	268.9	129.6	92.6	93.3	136.4	95.3	78.6	97.6	92.3	43.5	67.3	83.1	67.4	103.9	51.2	60.6	65.3	105.3	85.5	94.7	61.7	116.5	188.0	88.0	162.8	85.7	19.6	37.6	22.1	35.5	46.5	48.8	60.8	37.5	38.2	54.4	50.8	37.0	38.2	4.2	52.8	35.2	28.3	58.0	44.9	10.3	11.0	11.3	15.6	10.9	11.1	10.8	13.7	11.4	11.3	10.4	11.9	40.0	16.0	17.0	9.1	39.7	79.5	76.6	92.4	38.1	19.6	21.6	24.9	20.8	12.8	53.8	33.1	25.0	57.9	34.8	11.0	39.2	55.0	54.6	26.9	35.4	39.9	14.5	22.1	9.5	48.4	75.0	37.4	17.9	24.7	40.6	49.3	17.5	16.9	42.7	16.8	9.0	17.5	69.2	14.8	23.9	16.7	24.2	22.9	26.6	11.2	28.5	28.8	27.8	16.1	20.0	43.6	12.3	17.7	30.3	51.1	24.3	79.1	36.0	23.7	13.1	50.2	48.0	102.0	86.3	37.1	77.0	33.9	33.1	41.7	28.1	56.9
DCPS	"HINT-5, HINT5, HSL1, HSPC015"	ENSG00000110063	"Decapping enzyme, scavenger"	Q96C86	11	126304060-126350005	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.7"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 46.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 79.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039632, HPA058597"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1200000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA039632: AB_10794200, HPA058597: AB_2683770"	"unprognostic (1.45e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.40e-2)"	8.3	11.4	2.8	7.4	4.0	12.1	8.5	5.0	4.5	10.9	8.1	10.1	4.7	11.0	4.1	11.3	8.6	16.0	9.9	3.9	3.2	13.5	50.7	9.0	12.1	3.3	3.4	9.2	12.1	3.5	8.2	4.0	2.9	8.1	5.9	6.3	12.0	5.3	14.6	11.3	9.4	5.5	2.7	17.3	8.7	6.1	3.6	8.9	7.5	5.8	9.6	13.3	9.2	3.4	13.9	8.5	10.2	19.8	7.9	11.2	8.9	6.5	10.3	11.5	10.8	17.5	29.1	19.5	28.0	12.2	7.5	16.2	14.4	24.4	5.9	35.8	7.1	27.1	9.9	14.7	18.8	33.3	25.4	12.5	14.0	16.0	17.6	5.9	14.1	17.0	11.6	34.8	11.2	21.6	21.1	41.5	8.0	79.8	28.7	13.7	13.8	40.6	11.4	15.1	16.1	11.0	20.3	21.1	15.8	6.3	33.8	22.1	9.3	18.7	7.3	8.9	13.7	13.4	14.6	20.0	6.0	51.0	46.7	4.2	10.5	4.3	9.3	15.2	7.8	13.0	8.5	9.7	16.6	8.6	6.4	6.7	1.3	8.9	15.3	46.6	15.4	8.9	2.8	4.0	5.0	4.5	3.9	3.2	3.3	3.4	2.9	2.7	3.6	3.4	14.2	12.8	11.2	6.2	31.2	6.9	16.4	38.7	8.0	6.7	12.2	17.1	5.0	47.1	18.8	42.3	0.0	39.9	35.3	6.4	56.7	19.7	8.1	11.1	12.1	12.4	7.3	14.5	5.8	29.2	43.8	15.9	11.2	23.2	17.1	9.8	8.6	31.4	29.2	3.3	6.0	12.0	28.5	14.1	11.7	2.2	17.1	16.8	17.8	2.8	15.3	10.1	22.6	2.5	4.6	17.1	14.9	18.4	101.1	8.7	6.1	15.0	15.7	9.4	19.7	10.8	14.6	14.8	24.9	18.3	8.9	27.1	24.3	16.2	14.4	24.0
DEFB126	"bA530N10.1, C20orf8, DEFB-26"	ENSG00000125788	"Defensin beta 126"	Q9BYW3	20	142590-145751	"Disease related genes, Predicted secreted proteins"	Fertilization	"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	297	"epididymis: 1285.4"	"Cell type enhanced"	"Detected in single"		"Prostatic glandular cells: 1.4"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.0;OE19: 3.4"														"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"									"unprognostic (1.16e-1)"		"unprognostic (1.21e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.41e-2)"			"unprognostic (2.32e-1)"		"unprognostic (1.47e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1285.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	3.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.6	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.1	0.1
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 476.0;breast: 133.6;liver: 331.8;skin 1: 151.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Hepatocytes: 116.4;Late spermatids: 64.1;Spermatocytes: 53.9;Spermatogonia: 53.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"eosinophil: 137.7;neutrophil: 348.6"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 348.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 80.4;HDLM-2: 62.5;Hep G2: 64.9;OE19: 124.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 22.0"	HPA013351			Approved	Vesicles,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"HPA013351: AB_1847630"	"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	476.0	5.1	5.8	19.4	11.7	7.2	133.6	2.9	6.1	2.6	5.3	9.0	14.5	1.2	1.8	24.1	2.1	5.8	11.7	5.7	6.4	3.4	331.8	5.6	4.0	3.7	3.9	1.8	4.6	2.1	1.6	1.5	5.5	2.2	4.9	0.6	10.5	1.6	4.1	151.5	16.5	2.8	3.4	15.0	12.8	38.1	6.9	4.3	8.8	5.6	18.2	21.3	12.6	5.1	13.3	6.4	0.4	11.2	80.4	6.4	1.0	1.3	1.7	1.6	1.0	46.6	13.5	21.1	16.8	0.3	11.9	0.5	1.8	6.5	4.4	62.5	1.2	1.5	4.0	64.9	0.9	7.4	7.2	26.8	33.6	7.3	10.6	4.4	1.2	20.9	1.2	27.6	0.7	8.5	5.1	16.7	3.6	124.0	31.5	0.0	0.1	24.8	1.2	35.8	22.6	1.4	12.3	1.9	2.9	2.7	4.4	26.6	1.6	14.1	7.0	0.3	9.1	16.3	40.0	28.8	10.2	23.7	25.3	19.4	22.1	137.7	0.0	4.4	0.4	7.4	0.4	0.0	6.1	7.6	0.1	0.2	348.6	0.0	5.0	1.8	0.0	5.7	5.8	11.7	2.9	6.1	5.7	6.4	3.7	3.9	5.5	3.4	6.9	5.1	3.2	6.4	5.4	0.3	5.0	1.1	0.9	3.0	0.6	0.9	5.2	7.0	3.5	0.0	2.7	0.0	2.1	0.5	0.3	0.6	0.0	1.7	259.3	3.3	0.2	0.5	1.2	2.7	2.9	0.5	0.1	0.7	10.7	0.2	0.0	2.1	2.9	116.4	2.2	1.7	1.3	4.8	0.0	4.1	13.1	64.1	2.1	4.2	1.8	0.0	4.0	0.4	0.0	0.0	1.0	3.7	2.2	0.7	0.9	2.8	1.2	2.2	3.4	0.0	6.6	0.6	1.0	53.9	53.5	0.3	8.0	0.8	0.5	0.2	3.0	15.7
DGCR6		ENSG00000183628	"DiGeorge syndrome critical region gene 6"	Q14129	22	18906028-18914238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 63.8;skeletal muscle: 183.4"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1045.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	8	"OE19: 46.5"															NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (9.80e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.28e-1)"	15.9	10.0	6.6	0.7	6.5	2.0	15.0	8.7	7.3	6.5	8.3	3.9	1.4	2.1	2.3	7.3	4.0	1.1	63.8	6.5	6.6	11.0	27.1	9.6	1.7	7.4	6.2	2.2	13.1	1.7	19.9	1.3	7.5	6.9	0.9	4.5	12.6	1.5	183.4	26.3	5.0	0.8	5.3	4.2	5.5	26.2	7.1	1.4	21.9	7.0	1.4	4.7	7.9	7.4	0.7	2.5	3.8	2.9	1.7	1.5	0.8	0.9	0.8	1.4	0.9	0.6	1.5	0.3	1.2	1.4	0.8	1.7	2.9	1.5	1.0	1.2	5.6	0.6	3.1	0.6	1.2	1.5	0.5	1.0	2.1	1.1	0.4	1.2	0.6	1.9	3.9	1.8	1.3	1.7	1.3	2.2	1.5	46.5	1.7	2.2	3.3	0.2	0.7	0.2	3.5	1.7	1.2	0.5	0.5	2.8	1.9	0.3	0.3	2.5	2.1	0.7	0.7	1.8	0.3	0.4	1.6	2.5	1.8	10.3	1.1	1.9	0.4	1.8	1.1	0.3	1.2	1.0	3.0	0.1	1.8	1.5	0.4	0.4	1.1	0.2	1.2	2.4	6.6	6.5	8.7	7.3	6.5	6.6	7.4	6.2	7.5	5.3	7.1	7.4	3.8	9.6	5.1	17.3	1.4	16.4	10.2	19.6	0.0	6.0	6.9	17.8	60.4	7.2	15.2	7.3	4.2	2.3	2.0	1.5	23.5	1.3	245.4	3.8	1.8	3.9	1.8	0.0	6.3	2.6	2.7	8.9	0.5	1.1	8.9	0.6	1.8	16.3	2.6	30.3	5.4	3.9	14.2	4.6	16.3	1045.2	4.4	2.3	80.0	3.7	2.5	11.3	0.0	10.6	5.4	1.9	0.1	8.2	1.1	2.9	10.5	4.9	46.4	2.7	6.6	11.0	11.6	5.1	3.2	0.0	31.7	2.3	2.9	0.9	1.6	8.5
DHRS7B	"CGI-93, DKFZp566O084, MGC8916, SDR32C1"	ENSG00000109016	"Dehydrogenase/reductase 7B"	Q6IAN0	17	21123364-21193265	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012132, HPA016873"	Uncertain		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cell Junctions, Cytosol"		"HPA012132: AB_1847658, HPA016873: AB_1847657"	"unprognostic (1.90e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.98e-8)"	"unprognostic (9.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.81e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.26e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.97e-1)"	19.0	18.8	18.5	8.1	18.6	2.9	19.2	19.6	28.3	17.8	19.9	15.1	15.6	11.4	25.7	12.8	15.9	11.9	22.2	18.6	19.2	22.8	20.2	13.4	7.7	19.3	19.2	8.4	20.2	32.9	7.9	13.2	19.4	15.1	15.8	10.8	18.3	10.2	30.8	18.7	14.5	9.6	19.3	9.2	18.1	24.0	18.3	6.8	16.6	19.5	9.0	12.4	11.1	20.7	17.2	19.9	7.1	15.6	18.5	12.7	12.4	16.0	8.9	11.4	20.7	25.2	17.6	7.2	23.8	13.7	9.0	23.7	10.6	26.2	16.1	13.8	33.9	9.9	13.8	21.8	10.2	5.5	7.0	10.0	17.0	14.6	22.1	5.6	11.3	12.5	6.0	8.6	13.5	35.2	6.0	21.6	9.9	55.4	8.5	10.0	18.8	12.7	39.1	20.5	3.9	8.3	19.8	17.4	17.9	56.8	11.7	11.2	5.6	9.4	6.4	28.7	18.3	4.7	7.9	13.6	14.9	20.3	14.4	19.2	34.3	29.3	6.7	33.9	6.0	7.6	6.5	4.6	21.6	5.9	7.0	6.1	25.0	8.4	40.8	9.4	10.9	14.4	18.5	18.6	19.6	28.3	18.6	19.2	19.3	19.2	19.4	19.3	18.3	20.7	31.1	16.0	18.1	29.4	11.9	16.3	26.7	59.0	11.4	21.3	19.8	17.4	14.1	25.8	38.5	29.5	31.3	52.9	11.3	25.9	17.6	47.2	69.5	38.1	13.6	23.7	7.2	21.9	32.9	39.0	31.8	18.9	14.3	22.2	8.8	13.8	27.5	20.5	29.4	18.5	37.3	28.5	48.8	17.9	15.5	24.4	22.4	14.3	19.6	14.0	20.8	27.6	22.6	36.7	36.2	30.0	24.8	35.0	10.5	29.0	44.4	25.2	50.7	40.1	6.6	15.1	18.2	71.5	22.3	10.7	18.6	51.6	11.2	27.3	22.2	25.1
DKK4		ENSG00000104371	"Dickkopf WNT signaling pathway inhibitor 4"	Q9UBT3	8	42374063-42377229	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;esophagus: 4.9"	"Group enriched"	"Detected in some"	5	"Basal prostatic cells: 5.2;Early spermatids: 2.1;Pancreatic endocrine cells: 4.4;Prostatic glandular cells: 3.7;Spermatocytes: 2.2;Urothelial cells: 5.3"	"Cancer enriched"	"Detected in many"	20	"endometrial cancer: 174.4"	"Group enriched"	"Detected in some"	4	"cerebellum: 3.7;midbrain: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"OE19: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052916	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA052916: AB_2681987"	"unprognostic (1.64e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.73e-2)"		"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"		"unprognostic (8.11e-2)"	0.2	0.0	0.0	0.0	0.0	0.1	0.8	3.7	0.1	1.0	0.0	0.0	2.4	0.0	0.7	4.9	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	3.1	0.0	0.0	0.0	0.9	0.0	0.6	0.1	0.0	0.1	0.9	0.1	0.1	0.1	0.4	0.3	0.0	0.0	0.8	1.4	0.5	0.3	0.0	0.0	0.4	1.1	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.1	0.7	3.1	0.6	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	0.3	5.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.7	0.1	0.3	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.2	0.1	0.4	0.0	0.0	0.0	0.0	0.1	5.3
DLST	"DLTS, KGD2, OGDC-E2"	ENSG00000119689	"Dihydrolipoamide S-succinyltransferase"	P36957	14	74881891-74903743	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003010	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		70000	"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA003010: AB_1078679"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.13e-12)"	"unprognostic (3.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.55e-3)"	64.5	85.5	33.5	32.3	34.7	75.0	59.6	35.8	34.7	62.1	43.8	63.3	58.7	47.5	43.2	62.9	46.1	36.2	129.0	30.8	35.1	100.4	78.4	48.5	36.9	35.8	34.5	45.8	44.8	78.8	35.4	44.8	34.3	41.3	59.3	37.1	46.5	43.5	144.7	64.3	58.3	52.1	33.6	46.1	57.7	29.3	37.3	42.5	42.9	224.2	45.7	58.0	49.7	32.5	79.1	81.1	63.7	45.4	98.1	110.6	97.5	106.3	107.8	106.8	99.0	80.9	88.1	81.0	44.3	118.1	48.1	87.8	109.0	105.6	112.0	61.5	43.3	68.4	66.3	74.8	101.4	49.5	45.4	114.0	90.5	103.8	126.7	95.5	106.1	36.6	53.4	55.6	110.3	112.0	59.0	69.7	55.0	146.6	79.0	73.8	93.8	46.7	125.8	100.8	75.5	64.1	100.6	129.4	71.3	54.2	121.7	70.5	90.8	63.8	83.2	79.5	74.0	38.7	43.7	73.4	93.9	47.9	68.8	3.0	1.3	2.3	2.1	2.0	1.8	1.6	1.9	1.6	2.1	1.0	1.5	2.2	1.3	3.5	1.8	2.8	2.0	1.5	33.5	34.7	35.8	34.7	30.8	35.1	35.8	34.5	34.3	33.6	37.3	32.5	24.2	6.4	4.8	14.0	22.7	26.4	23.5	19.7	21.6	19.1	25.1	20.4	28.5	21.5	10.1	20.2	31.3	41.0	27.7	41.9	56.7	37.8	7.3	10.9	20.4	19.8	14.8	22.5	21.9	25.7	38.8	25.6	30.5	18.9	21.0	19.4	23.2	43.6	32.1	13.5	24.6	31.8	12.2	20.9	19.0	6.2	18.0	18.8	23.2	13.1	27.1	10.0	20.6	18.6	18.5	44.3	28.0	20.7	20.0	28.2	49.8	73.3	8.7	20.8	26.3	18.3	24.0	12.1	15.3	34.2	28.4	79.5	23.1	19.3	40.5	27.7
DNAH6	"Dnahc6, DNHL1, FLJ37357, HL-2"	ENSG00000115423	"Dynein axonemal heavy chain 6"	Q9C0G6	2	84516455-84819589	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.6;choroid plexus: 12.1;fallopian tube: 5.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 77.5;Endometrial ciliated cells: 98.2;Excitatory neurons: 94.2;Respiratory ciliated cells: 143.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036391, HPA061401"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036391: AB_10672220, HPA061401: "	"unprognostic (4.87e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-8)"	"unprognostic (2.04e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.97e-2)"	0.3	0.2	1.4	0.1	2.4	0.0	0.4	0.0	1.7	0.2	12.1	0.1	0.0	0.5	1.2	0.0	5.4	0.1	0.0	1.5	1.1	0.4	1.1	0.8	0.1	4.4	4.6	0.3	0.2	1.6	0.4	0.0	2.4	0.1	0.2	0.8	0.0	0.2	0.0	0.0	0.1	0.1	2.7	0.0	0.5	2.7	1.6	0.5	1.2	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.4	2.4	0.0	1.7	1.5	1.1	4.4	4.6	2.4	2.7	1.6	1.6	0.6	6.4	4.1	18.6	0.6	0.1	2.2	5.4	0.0	0.8	1.4	1.8	1.2	1.5	13.7	0.0	2.1	0.9	0.3	0.3	0.0	0.3	77.5	98.2	1.5	0.9	0.0	0.4	94.2	0.9	0.2	2.7	4.1	3.0	0.0	1.6	0.0	6.9	0.1	0.0	28.2	1.0	10.2	0.3	0.2	25.0	0.6	0.3	1.8	9.4	0.0	2.0	0.0	5.5	13.7	0.3	0.3	0.7	0.1	1.0	0.2	1.0	143.6	4.8	0.0	2.1	1.7	23.3	5.1	0.0	0.0	0.3	1.3	0.3	1.1	0.3
DNPH1	"C6orf108, dJ330M21.3, rcl"	ENSG00000112667	"2'-deoxynucleoside 5'-phosphate N-hydrolase 1"	O43598	6	43225629-43229481	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 450.0;Proximal enterocytes: 818.0;Proximal tubular cells: 1091.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 547.1;RPMI-8226: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029675, HPA029676"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		540000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA029675: AB_10599998, HPA029676: AB_10599424"	"unprognostic (1.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (8.24e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.10e-2)"	46.1	103.3	42.7	29.1	45.1	23.2	37.2	40.2	66.2	45.2	66.7	68.7	104.0	50.2	8.3	62.3	57.8	13.2	46.5	41.7	45.7	172.4	136.8	31.8	33.0	39.9	42.5	40.3	100.7	75.8	37.2	9.2	41.5	42.0	17.9	6.0	45.8	18.7	89.5	42.2	88.3	11.4	43.2	61.6	57.5	10.2	46.1	17.0	35.8	44.7	18.8	39.1	39.8	42.3	189.4	135.3	20.7	86.2	14.4	44.5	64.1	44.9	16.1	29.8	38.9	55.8	67.2	134.9	69.4	15.3	1.5	95.1	16.2	35.7	8.6	72.4	318.7	63.7	127.4	161.2	34.1	54.3	40.3	28.1	44.3	9.0	26.7	12.0	39.6	96.8	147.1	232.0	24.5	311.8	52.3	135.3	41.5	547.1	81.5	87.0	27.7	347.3	52.1	63.6	79.8	96.2	41.4	108.5	95.7	6.6	149.2	177.9	49.7	22.6	39.2	51.6	90.2	160.7	79.6	109.5	14.3	71.6	36.0	1.2	109.7	4.8	42.4	237.9	78.5	219.8	138.8	74.6	178.2	194.6	122.2	83.8	4.1	42.0	176.6	135.3	269.7	92.3	42.7	45.1	40.2	66.2	41.7	45.7	39.9	42.5	41.5	43.2	46.1	42.3	16.4	28.9	38.2	5.5	73.9	61.3	91.3	147.6	68.3	11.9	138.4	181.0	91.0	163.0	80.9	115.8	2.1	53.4	12.9	164.0	450.0	201.6	0.6	159.5	66.4	30.8	64.8	78.8	4.1	107.2	66.5	60.1	88.7	39.1	33.7	108.4	28.5	231.2	308.3	6.7	4.9	216.6	93.6	75.8	62.3	3.1	67.1	63.4	110.3	1.0	36.7	78.4	10.3	5.5	5.1	157.2	155.3	59.8	81.8	112.6	818.0	1091.6	260.3	23.5	0.0	39.4	57.9	8.9	38.1	131.5	73.6	32.3	44.5	82.2	288.9	101.4
DPH7	"C9orf112, FLJ90634, RRT2, WDR85"	ENSG00000148399	"Diphthamide biosynthesis 7"	Q9BTV6	9	137554444-137578925	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 189.9;Spermatogonia: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022911	Uncertain		Approved	"Nuclear bodies"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"		"HPA022911: AB_1858823"	"unprognostic (1.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.30e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.23e-4)"	8.2	12.3	3.4	2.6	3.6	4.2	9.5	4.5	4.1	15.7	3.9	13.8	2.2	12.6	7.0	9.0	14.6	2.6	9.4	3.6	3.3	10.2	10.9	9.4	4.7	3.7	3.3	12.8	20.3	6.3	13.5	3.4	4.0	15.0	4.1	2.8	9.9	5.4	8.3	11.0	12.2	4.8	3.3	15.2	12.3	9.3	3.8	5.6	12.8	2.4	5.3	11.2	11.1	5.7	4.5	5.2	8.2	7.6	6.2	5.1	10.2	5.1	5.2	9.1	7.7	11.0	5.4	10.6	9.3	5.9	4.8	9.8	10.6	10.1	8.3	9.2	13.2	4.9	6.6	3.7	7.0	10.6	9.5	5.4	7.6	5.1	9.2	6.5	14.4	7.1	9.2	5.7	7.2	15.3	8.2	9.9	10.4	19.9	13.3	13.7	3.7	7.6	6.9	4.5	10.8	7.3	8.7	7.0	5.4	5.7	7.9	9.1	6.5	6.2	5.4	7.7	9.5	3.7	9.1	12.5	3.9	6.1	6.3	9.5	5.1	6.2	4.5	4.8	6.3	5.6	7.2	6.4	5.9	4.7	5.1	4.9	1.6	4.5	4.0	8.0	5.4	4.6	3.4	3.6	4.5	4.1	3.6	3.3	3.7	3.3	4.0	3.3	3.8	5.7	21.0	6.4	11.9	21.2	17.7	16.7	9.8	18.9	8.0	18.7	14.7	20.6	15.5	2.8	11.5	1.8	50.1	22.1	22.5	7.7	3.9	10.6	3.0	11.1	17.1	13.8	6.7	5.5	17.2	9.2	14.9	14.5	13.3	10.2	10.8	26.5	8.2	6.5	11.9	16.8	21.5	11.7	6.1	6.6	7.2	7.5	16.4	8.8	8.8	15.0	9.9	15.4	23.7	16.1	28.2	11.5	10.3	15.8	24.7	18.6	7.2	5.2	14.2	58.8	19.7	13.1	16.0	189.9	100.0	11.4	18.9	12.2	18.0	19.9	15.0	11.1
DSTN	"ACTDP, ADF"	ENSG00000125868	"Destrin, actin depolymerizing factor"	P60981	20	17570075-17609919	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 1690.3;SK-BR-3: 1421.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037094	Approved					NA	NA		3700000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB037094: AB_476911"	"unprognostic (1.05e-3)"	"unprognostic (1.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.89e-3)"	"unprognostic (6.05e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-3)"	306.9	232.5	134.0	136.7	150.8	53.3	287.0	144.0	178.0	336.8	144.5	1146.3	136.1	636.1	297.1	535.6	449.9	297.4	411.6	150.0	158.2	269.0	141.3	315.8	60.2	146.7	150.3	236.8	268.9	180.0	127.1	162.3	154.4	559.2	306.8	114.0	274.6	758.3	87.2	227.8	285.6	695.0	147.6	75.2	486.8	82.0	140.4	47.8	273.0	111.4	79.0	704.4	312.7	164.1	323.0	431.3	161.5	160.5	399.8	391.5	303.8	397.7	616.4	248.1	221.7	200.4	348.6	50.1	97.7	587.8	458.5	305.3	149.4	606.5	281.9	28.0	125.5	131.9	247.2	295.3	426.2	102.9	86.5	357.9	563.1	239.3	275.9	609.0	360.6	85.4	63.4	65.7	468.1	251.7	42.2	121.6	110.4	1690.3	322.3	28.9	248.4	103.5	686.4	291.9	244.6	72.9	363.0	1421.1	441.9	263.7	654.3	55.9	345.3	294.9	93.2	324.1	276.8	39.7	52.2	134.6	139.9	43.8	250.8	33.8	17.6	59.2	55.9	32.2	46.8	11.9	56.9	52.0	22.1	9.0	37.0	47.0	11.8	48.8	46.4	51.1	46.7	45.3	134.0	150.8	144.0	178.0	150.0	158.2	146.7	150.3	154.4	147.6	140.4	164.1	372.8	1442.3	667.9	25.1	84.9	1151.6	697.0	796.7	542.4	101.5	925.2	762.2	1131.3	739.2	696.8	678.6	50.1	576.4	336.9	549.2	1457.6	1022.2	295.0	558.3	447.3	481.7	546.5	83.1	54.7	1468.6	1165.0	533.5	275.7	540.2	183.8	199.4	425.9	602.4	222.2	176.7	43.1	643.2	533.0	147.8	361.5	111.2	496.8	133.0	610.1	57.1	191.7	779.1	224.6	30.7	44.0	1018.6	572.8	1266.8	172.4	640.3	304.4	1491.4	912.0	153.1	1216.2	271.1	1745.4	390.0	298.9	515.2	1043.5	549.5	161.6	252.0	545.8	680.2
EBAG9	"EB9, RCAS1"	ENSG00000147654	"Estrogen receptor binding site associated antigen 9"	O00559	8	109539711-109565996	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021153, HPA021154, CAB072810, CAB072811, CAB072812"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"		"CAB072810: , CAB072811: , CAB072812: , HPA021153: AB_1856151, HPA021154: AB_1856152"	"unprognostic (3.04e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.72e-1)"	"unprognostic (9.72e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.71e-2)"	23.3	28.4	18.6	17.6	19.9	16.9	32.4	23.4	26.3	36.1	19.8	28.6	23.5	22.8	44.7	17.0	27.6	19.4	24.7	19.1	20.5	37.0	45.2	28.1	25.4	18.9	19.0	22.2	36.7	34.9	20.5	18.1	19.0	23.3	31.2	32.5	42.9	27.6	53.2	17.9	21.0	17.0	19.1	20.7	27.2	25.3	19.3	20.6	57.4	42.3	27.0	17.2	15.3	20.2	36.7	25.2	25.3	17.3	15.3	24.9	19.7	19.5	14.6	27.0	25.4	25.7	38.1	51.7	33.0	13.8	21.8	25.2	24.4	31.3	28.5	57.6	26.9	56.9	15.8	39.6	34.3	20.0	16.1	19.9	60.1	23.4	47.2	21.9	25.7	45.8	59.8	37.0	24.0	55.8	58.2	31.5	15.8	70.1	25.2	30.9	20.1	43.7	31.4	23.7	27.6	22.1	21.3	22.6	27.6	18.4	44.7	25.6	17.5	20.9	15.0	19.1	14.4	54.9	38.3	48.7	21.2	52.7	19.6	5.8	13.4	14.7	19.3	19.5	34.1	40.7	27.1	27.0	22.5	40.3	33.5	30.4	2.8	29.4	17.3	23.8	33.4	14.7	18.6	19.9	23.4	26.3	19.1	20.5	18.9	19.0	19.0	19.1	19.3	20.2	32.0	121.8	102.4	12.7	40.2	21.7	28.6	51.8	44.9	34.5	36.8	46.0	37.6	54.3	65.1	29.5	6.2	50.2	24.0	33.6	64.6	47.3	134.7	42.9	26.7	34.5	31.8	36.0	16.1	65.8	34.0	28.8	22.4	33.0	46.9	16.0	23.2	48.8	32.7	50.5	16.1	39.4	50.8	24.7	22.1	115.0	29.2	27.9	19.6	11.2	25.3	53.4	27.8	18.1	16.1	38.5	41.3	23.0	53.8	36.8	50.5	58.5	61.8	34.7	32.9	35.1	32.1	101.6	50.4	40.5	19.9	22.2	28.5	34.7	46.0	31.7
EBPL	EBRP	ENSG00000123179	"EBP like"	Q9BY08	13	49660674-49691486	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 305.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049891	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum"		"HPA049891: AB_2680937"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (7.18e-8)"	"unprognostic (1.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	21.9	59.7	6.6	12.1	6.5	20.0	23.2	7.0	8.9	37.0	7.5	24.1	14.2	20.4	6.6	62.3	25.5	11.1	8.7	6.7	7.3	14.8	99.3	19.1	11.0	6.8	6.8	33.3	47.7	10.5	10.3	11.2	6.9	21.3	16.3	4.4	27.9	13.5	5.2	33.7	14.3	13.3	7.8	14.4	27.5	11.0	7.9	10.3	16.1	2.5	11.0	23.8	47.6	8.4	46.7	34.9	21.0	88.5	26.0	66.4	37.5	48.5	33.1	30.9	25.0	66.8	65.1	57.9	21.6	23.7	27.1	93.7	38.3	47.4	45.0	46.4	126.8	43.7	23.4	83.3	75.2	69.4	35.0	77.7	100.4	25.6	68.1	49.9	53.6	61.5	36.7	23.0	40.2	25.0	27.4	124.8	72.4	153.2	78.2	58.5	11.7	89.0	66.4	15.2	19.5	50.1	18.0	62.1	21.6	21.7	54.4	54.0	24.6	23.4	23.2	20.2	40.7	14.9	41.2	46.7	11.2	68.6	21.6	2.4	3.0	0.8	2.4	3.6	6.8	4.3	4.8	5.0	5.0	5.4	7.1	4.1	6.4	4.1	3.9	3.3	3.7	1.4	6.6	6.5	7.0	8.9	6.7	7.3	6.8	6.8	6.9	7.8	7.9	8.4	75.5	35.3	23.1	9.8	46.5	108.6	157.6	17.4	115.5	7.9	139.8	192.1	5.4	104.4	17.4	23.9	8.4	32.3	25.5	26.5	41.1	61.2	13.3	61.5	90.6	76.8	27.8	65.6	8.0	52.1	37.1	56.9	56.6	50.0	17.8	64.9	78.9	305.3	38.5	1.7	11.6	80.1	8.2	45.8	36.5	10.0	94.1	27.4	46.2	8.4	30.9	23.6	36.0	8.0	5.1	41.0	42.0	70.0	79.3	116.6	16.5	62.3	8.5	8.4	19.7	57.7	52.7	26.9	17.2	208.6	154.6	15.2	40.3	194.2	133.6	108.9
EED	"HEED, WAIT-1"	ENSG00000074266	"Embryonic ectoderm development"	O75530	11	86244753-86278813	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012211, HPA060089, HPA061140"	Supported		Supported	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB012211: AB_2262066, HPA060089: AB_2684201, HPA061140: AB_2684437"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.19e-3)"	"prognostic unfavorable (1.36e-7)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (2.27e-5)"	9.3	9.0	13.2	16.3	13.1	9.2	11.4	15.0	15.8	13.8	13.1	12.1	12.1	11.5	15.2	12.7	10.6	9.3	8.9	12.8	13.5	11.5	11.9	8.5	28.8	12.9	12.8	12.1	10.5	9.1	9.4	14.5	13.1	11.7	11.9	16.4	10.3	10.6	10.5	12.1	11.6	10.2	12.9	14.4	10.9	10.3	13.6	17.8	10.7	11.1	32.1	13.0	12.1	13.9	34.2	37.8	40.9	16.8	22.6	20.2	47.0	49.2	22.6	46.3	46.8	121.0	64.4	79.8	50.6	15.8	44.2	41.4	48.7	26.8	43.2	79.7	22.7	51.4	38.7	36.3	19.8	54.2	33.4	12.4	18.0	46.8	20.1	17.5	20.9	34.7	58.8	16.2	39.0	55.2	51.5	55.4	30.4	107.8	18.4	56.2	49.1	38.8	29.1	55.4	27.5	22.4	63.5	29.6	14.5	29.1	49.2	22.6	19.0	48.1	44.1	70.0	43.2	9.2	32.1	63.9	13.7	46.6	36.8	31.0	9.1	15.0	25.4	15.3	22.1	45.0	33.2	32.0	13.9	47.3	26.4	29.6	3.9	19.3	16.8	9.2	58.6	19.1	13.2	13.1	15.0	15.8	12.8	13.5	12.9	12.8	13.1	12.9	13.6	13.9	15.4	6.4	9.3	28.1	32.7	25.6	11.6	27.5	25.0	26.4	13.3	11.8	9.5	11.5	15.4	7.3	18.8	45.2	31.0	16.1	19.6	14.5	7.7	17.6	17.1	16.6	7.2	15.8	35.0	10.2	36.8	14.8	16.3	15.5	15.9	15.0	13.2	11.4	16.9	32.0	45.6	12.8	12.2	14.5	32.5	3.6	22.7	15.2	19.6	37.5	30.4	11.5	25.7	31.2	38.9	11.9	11.1	17.3	17.6	11.9	11.7	8.6	21.3	18.3	6.6	14.3	24.5	18.7	20.0	16.9	16.8	24.9	31.6	17.5	15.0	20.9
EFNA3	"Ehk1-L, EPLG3, LERK3"	ENSG00000143590	"Ephrin A3"	P52797	1	155078837-155087538	"Predicted membrane proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.9;skin 1: 102.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 63.2;Basal squamous epithelial cells: 44.3;Extravillous trophoblasts: 30.0;Squamous epithelial cells: 32.6;Suprabasal keratinocytes: 108.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 46.3;SCLC-21H: 26.8;T-47d: 25.3"	"Low region specificity"	"Detected in all"							CAB010494	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"			"CAB010494: AB_2097783"	"unprognostic (3.75e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (9.66e-10)"	"unprognostic (2.83e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-3)"	1.3	2.1	14.0	0.7	15.1	0.2	5.2	7.4	23.3	13.1	5.0	3.5	1.0	1.3	3.8	30.9	0.8	0.6	1.0	17.9	12.3	1.6	3.4	0.7	0.6	13.9	10.6	1.6	1.1	5.6	14.5	0.8	13.3	2.3	3.6	3.2	5.5	0.5	0.8	102.4	1.5	0.7	8.7	1.2	1.1	3.6	12.5	1.1	1.0	0.6	2.4	0.9	28.0	15.4	6.1	1.5	2.6	16.6	2.9	1.5	1.9	0.3	0.5	0.7	1.0	1.0	2.6	4.7	2.7	0.6	1.5	10.0	18.4	3.7	0.6	2.8	4.0	0.6	0.6	1.3	0.3	0.7	3.3	0.8	4.5	0.3	1.1	7.7	1.4	3.0	3.0	2.9	0.6	8.3	0.9	2.5	1.8	46.3	4.8	6.0	1.5	15.6	2.0	0.2	26.8	8.2	1.0	17.7	0.5	2.3	25.3	0.9	0.5	1.8	5.1	0.8	0.5	5.6	2.6	1.1	3.1	2.4	0.2	0.0	0.6	0.8	0.8	0.8	0.8	1.0	0.6	0.4	1.4	1.2	0.9	0.5	0.0	2.7	0.3	1.1	1.6	0.4	14.0	15.1	7.4	23.3	17.9	12.3	13.9	10.6	13.3	8.7	12.5	15.4	3.8	0.0	0.6	2.0	2.1	63.2	3.8	13.6	44.3	1.5	16.9	12.2	0.2	0.0	4.4	0.0	0.0	1.1	3.5	8.6	1.9	3.9	0.6	1.6	0.7	4.2	1.2	0.0	6.5	2.9	30.0	1.5	0.0	1.6	0.0	1.6	1.1	1.1	2.1	3.3	7.9	9.1	2.0	1.2	6.8	1.1	1.2	1.3	8.8	1.0	0.8	9.6	3.1	0.0	1.3	3.2	7.4	0.4	0.4	9.9	6.1	1.3	1.1	1.3	0.0	1.1	8.8	6.5	9.3	32.6	108.8	2.9	2.2	10.1	7.4	3.8
EIF1	"A121, EIF-1, EIF1A, ISO1, SUI1"	ENSG00000173812	"Eukaryotic translation initiation factor 1"	P41567	17	41688885-41692668	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 2792.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		210000	"Cluster 10: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"				"unprognostic (1.43e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.23e-3)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (9.45e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.63e-3)"	490.2	274.6	232.4	151.0	272.6	755.1	403.2	271.3	257.8	323.1	172.8	380.7	178.8	317.5	76.5	344.1	318.0	150.3	491.2	217.2	265.2	346.9	267.9	330.3	160.5	277.0	255.8	402.2	487.4	213.2	253.3	143.9	282.5	216.2	99.2	185.0	304.9	136.3	1241.1	361.9	250.4	144.8	256.2	266.7	403.5	159.9	254.7	213.3	212.6	482.9	117.5	335.2	322.9	307.4	337.2	171.6	195.0	184.8	384.8	354.8	187.7	436.7	310.0	234.8	229.0	101.2	234.3	451.1	339.9	332.1	243.6	416.3	263.7	296.2	226.3	484.8	224.2	236.8	82.7	150.2	796.8	379.4	452.6	430.2	561.0	320.0	779.6	344.4	233.5	354.9	383.9	674.5	223.1	92.7	447.8	239.5	167.9	2792.4	326.7	224.6	419.6	453.7	207.4	157.9	240.4	307.6	263.5	485.0	1017.9	185.0	342.5	273.6	370.0	230.8	354.5	483.5	441.4	993.5	895.6	358.8	326.5	235.0	296.7	1141.9	365.4	462.9	250.5	438.7	310.3	328.3	337.8	293.8	293.8	309.3	347.0	306.8	358.7	220.9	455.7	291.3	428.9	590.8	232.4	272.6	271.3	257.8	217.2	265.2	277.0	255.8	282.5	256.2	254.7	307.4	3115.6	810.9	974.8	63.0	2362.0	3078.5	4610.8	3421.0	1812.6	838.1	1828.6	2567.4	1099.6	1512.7	1918.4	776.1	310.6	1507.4	2857.7	1521.7	4188.9	2108.4	2701.8	1405.1	1228.6	2033.0	963.1	1790.4	66.7	3096.1	2381.2	2059.4	889.4	1606.5	1287.6	948.4	1680.6	1403.6	2488.3	804.2	70.2	1539.7	2063.0	3165.8	3449.2	6637.8	1358.8	2644.2	2440.4	85.3	3560.1	1514.7	1829.0	35.2	153.8	2423.6	2131.0	961.4	1762.7	3063.8	3025.9	3169.3	1107.9	958.4	959.8	3290.6	3039.9	1114.0	825.4	1521.7	2932.9	3955.5	2533.0	1059.7	1428.5	5190.4
EIF3K	"ARG134, EIF3S12, HSPC029, M9, PLAC-24, PRO1474, PTD001"	ENSG00000178982	"Eukaryotic translation initiation factor 3 subunit K"	Q9UBQ5	19	38619082-38636955	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045446, HPA054590"	Uncertain		Supported	Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA045446: AB_10962716, HPA054590: AB_2682534"	"unprognostic (7.07e-3)"	"prognostic favorable (1.31e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.69e-2)"	233.4	177.9	98.8	83.6	100.4	172.7	228.3	104.9	114.2	214.3	113.1	285.5	142.0	186.6	110.2	286.1	188.4	73.2	591.7	98.9	100.9	313.3	189.0	169.3	142.0	103.2	101.7	214.8	262.2	179.6	173.0	72.0	101.0	172.1	165.7	57.9	197.5	100.4	682.7	290.7	219.1	113.7	102.1	222.5	265.7	66.5	103.7	143.7	168.6	462.4	182.1	218.4	216.6	105.3	135.3	421.3	110.1	175.4	196.5	197.7	134.3	104.2	180.7	220.9	192.5	272.0	118.6	300.2	121.2	174.2	128.7	122.4	221.2	280.8	165.1	145.7	184.6	214.0	134.4	197.2	201.0	345.1	170.7	219.6	252.3	151.4	269.6	118.8	242.3	156.6	217.9	250.8	188.8	215.2	185.3	158.6	103.5	474.4	211.4	222.7	197.0	235.7	225.3	311.0	141.5	139.4	114.8	377.1	174.0	117.3	145.9	260.3	133.9	135.0	134.8	81.3	185.9	246.4	276.3	255.6	114.9	321.6	155.0	154.8	267.8	138.2	182.8	297.8	232.1	252.0	222.3	213.2	359.0	218.0	228.9	204.0	72.4	201.2	305.7	209.4	296.4	441.8	98.8	100.4	104.9	114.2	98.9	100.9	103.2	101.7	101.0	102.1	103.7	105.3	372.1	93.0	166.1	26.4	430.3	395.6	547.4	674.4	345.4	83.6	477.2	755.1	502.5	320.3	331.0	217.0	66.7	422.9	376.3	466.2	1097.6	345.5	160.6	182.0	231.8	309.3	326.1	284.2	23.8	453.2	484.8	267.7	231.9	180.6	248.2	239.0	311.7	278.6	660.9	23.5	25.0	567.7	305.2	640.7	552.1	274.4	265.3	470.7	466.0	10.3	572.6	276.9	415.1	14.6	24.7	330.2	487.2	199.7	386.6	461.9	874.5	974.2	198.3	174.9	203.8	331.4	450.3	109.0	83.4	594.2	457.0	454.1	424.0	319.1	719.5	622.7
ELP4	"C11orf19, PAXNEB"	ENSG00000109911	"Elongator acetyltransferase complex subunit 4"	Q96EB1	11	31509755-31790324	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 153.5;Excitatory neurons: 93.6;Inhibitory neurons: 90.2;Microglial cells: 91.8;Oligodendrocyte precursor cells: 129.2;Oligodendrocytes: 123.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038572, HPA038573"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA038572: AB_2676090, HPA038573: AB_2676091"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.63e-2)"	7.1	7.2	14.6	7.4	16.4	8.6	6.8	37.9	19.0	7.4	13.3	9.0	4.6	6.8	8.3	9.7	7.3	7.2	10.2	14.0	13.3	10.2	9.6	7.3	9.7	13.6	14.3	7.5	9.4	8.1	5.4	7.8	14.7	6.7	7.7	12.7	6.9	7.4	8.3	9.6	6.5	7.6	13.6	6.4	6.5	8.3	15.2	15.1	6.6	8.3	8.4	7.8	7.3	18.2	13.2	11.2	12.0	14.4	10.9	14.9	4.6	11.5	12.3	16.7	18.4	10.4	11.5	18.0	9.7	10.3	20.9	23.3	16.5	14.4	18.3	15.1	18.3	5.9	13.2	16.0	11.2	12.6	11.2	14.9	8.7	7.2	19.5	13.2	20.4	22.9	27.4	15.7	10.7	20.3	21.4	14.9	6.9	38.9	13.7	12.8	25.7	12.0	25.6	13.0	13.8	6.4	22.3	13.4	10.0	11.7	25.4	18.2	8.2	15.3	13.5	25.3	15.2	6.1	12.9	22.0	10.8	17.6	13.4	5.9	8.0	8.1	6.7	9.2	8.3	9.1	7.6	7.9	9.3	5.9	8.5	7.4	2.1	7.5	9.5	8.3	10.1	6.6	14.6	16.4	37.9	19.0	14.0	13.3	13.6	14.3	14.7	13.6	15.2	18.2	13.9	12.8	10.5	153.5	11.4	8.3	11.0	20.2	6.8	4.9	7.7	8.5	7.7	5.7	14.5	7.3	4.2	20.2	11.4	4.3	29.4	9.1	18.0	11.0	14.0	7.5	6.7	4.6	93.6	11.3	15.6	10.5	4.1	8.3	10.8	12.8	3.9	5.5	11.5	15.2	90.2	6.0	12.2	5.7	2.4	3.6	5.0	8.5	3.6	91.8	7.7	16.5	8.2	129.2	123.4	6.1	3.9	6.4	14.3	2.9	4.0	33.1	8.6	6.1	6.6	8.3	12.9	23.5	10.2	9.4	8.2	18.9	11.4	11.6	6.4	6.9
EPHX2	ABHD20	ENSG00000120915	"Epoxide hydrolase 2"	P34913	8	27490781-27545564	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism"	"Hydrolase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 333.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 180.0;Hepatocytes: 131.5;Proximal enterocytes: 399.0;Proximal tubular cells: 259.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 35.0;naive CD4 T-cell: 106.7;naive CD8 T-cell: 50.4;T-reg: 29.6"	"Lineage enriched"	"Detected in many"	23	"T-cells: 106.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 139.4;K-562: 51.6;OE19: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023094, HPA023660"	Enhanced		Enhanced	Cytosol		NA	NA		1100000	"Cluster 32: T-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA023094: AB_1848214, HPA023660: AB_1848215"	"unprognostic (1.30e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.26e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (1.98e-10)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.26e-1)"	19.3	74.0	14.5	9.1	15.0	1.9	30.1	14.4	14.1	21.0	42.2	61.4	112.8	17.7	27.2	38.6	41.6	9.4	29.1	13.2	15.3	166.3	333.2	11.2	17.2	16.1	17.3	38.0	64.5	54.8	35.8	8.5	15.9	64.6	57.6	21.5	36.5	27.2	16.2	43.4	128.4	15.4	15.8	10.8	23.4	9.0	15.8	65.9	22.6	13.8	20.8	19.7	23.4	15.7	15.3	10.1	6.3	8.1	0.4	0.0	4.8	1.3	0.9	0.7	0.2	8.0	10.1	0.1	5.9	4.1	3.2	10.7	1.1	2.6	0.5	0.0	4.7	22.5	1.1	24.8	3.4	0.1	4.5	8.6	10.7	0.1	1.1	2.5	0.5	139.4	51.6	0.2	0.0	4.7	14.9	0.5	10.1	102.4	17.2	0.1	0.1	0.4	8.7	2.2	5.1	16.0	12.1	14.2	15.0	4.6	21.8	4.2	0.2	0.0	3.8	1.8	0.1	12.5	10.1	0.2	0.4	0.1	0.1	0.1	0.1	0.0	7.8	0.0	11.3	4.5	35.0	12.7	0.1	2.5	106.7	50.4	0.2	4.6	0.1	0.2	29.6	20.0	14.5	15.0	14.4	14.1	13.2	15.3	16.1	17.3	15.9	15.8	15.8	15.7	6.3	6.4	17.0	16.3	6.1	11.9	18.6	10.1	29.6	34.1	17.2	18.4	23.7	20.0	9.7	27.6	79.2	22.8	1.0	82.7	180.0	8.8	7.5	6.9	4.8	9.4	23.4	3.8	3.0	6.4	2.5	12.1	15.8	1.5	5.7	17.4	17.5	131.5	2.2	33.7	7.2	63.4	2.0	4.6	1.2	4.8	29.8	3.6	5.4	2.8	2.6	91.5	3.1	7.5	5.1	3.1	83.7	18.8	4.5	20.5	399.0	259.3	24.1	52.4	0.0	11.5	10.2	1.3	13.9	39.2	18.3	8.2	11.9	78.5	101.3	10.8
EPHX3	"ABHD9, FLJ22408"	ENSG00000105131	"Epoxide hydrolase 3"	Q9H6B9	19	15226919-15233435	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 68.9;skin 1: 76.5;vagina: 36.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 15.5;Club cells: 19.3;Squamous epithelial cells: 30.7;Suprabasal keratinocytes: 43.3;Urothelial cells: 23.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 30.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	19	"dendritic cells: 1.3;monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.5;NTERA-2: 2.3;OE19: 8.4;SuSa: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012842	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA012842: AB_10601648"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (2.27e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.01e-2)"	0.5	0.3	0.8	0.2	0.8	0.2	1.5	0.6	0.9	14.7	0.7	0.2	0.2	0.4	0.3	68.9	1.7	1.3	0.5	0.7	0.9	3.3	0.3	1.7	0.1	0.9	0.8	0.7	0.2	3.0	1.8	0.4	0.8	1.5	0.2	0.2	7.6	0.9	0.4	76.5	0.3	0.4	0.8	2.6	0.8	2.1	0.9	1.7	0.4	0.1	26.7	8.6	36.6	0.8	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.2	2.5	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.3	2.3	8.4	0.3	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	1.3	0.0	0.2	0.8	0.8	0.6	0.9	0.7	0.9	0.9	0.8	0.8	0.8	0.9	0.8	0.2	0.0	1.1	0.0	0.2	7.0	2.6	15.5	0.0	0.4	0.9	0.6	0.5	5.7	19.3	5.5	0.0	1.6	0.0	0.1	1.9	0.5	0.2	0.7	0.4	0.6	0.0	0.0	0.1	0.0	3.4	0.6	0.0	1.7	0.0	0.4	1.1	0.0	0.6	0.0	0.1	0.1	2.0	3.2	1.4	0.0	0.0	1.5	0.0	0.0	0.6	2.5	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.6	0.2	0.0	3.3	0.0	0.0	0.8	2.5	4.6	2.1	30.7	43.3	2.6	0.2	0.2	0.1	23.3
EPS8L3	"FLJ21522, MGC16817"	ENSG00000198758	"EPS8 like 3"	Q8TE67	1	109750080-109764027	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"gallbladder: 35.7;intestine: 142.1;stomach 1: 50.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 254.4;Gastric mucus-secreting cells: 80.5;Intestinal goblet cells: 103.4;Late spermatids: 144.6;Paneth cells: 257.8;Proximal enterocytes: 285.3;Undifferentiated cells: 112.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 52.5;pancreatic cancer: 29.7;stomach cancer: 26.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 15.6;CAPAN-2: 14.4;Hep G2: 36.2;OE19: 67.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030998	Approved		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA030998: AB_2673691"	"unprognostic (1.73e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (5.55e-3)"		"unprognostic (3.71e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.87e-3)"	"unprognostic (3.89e-1)"		"prognostic favorable (1.82e-4)"	0.0	0.0	0.1	10.8	0.0	0.0	0.2	0.0	0.0	1.3	0.0	77.1	141.8	0.2	0.9	0.1	0.1	35.7	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	77.1	0.0	0.0	0.2	0.0	0.0	142.1	2.9	0.0	0.0	50.7	2.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.6	14.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	67.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	14.3	0.3	0.0	0.0	0.0	0.0	254.4	0.0	11.6	28.0	0.7	0.1	0.3	51.4	0.0	0.0	23.9	0.0	0.0	80.5	1.0	4.5	0.0	0.0	0.2	0.0	0.0	0.0	103.4	0.0	0.0	0.0	144.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.5	257.8	0.4	0.3	0.0	285.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.4	0.6	112.6	1.8
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 136.1;Distal enterocytes: 111.0;Proximal enterocytes: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 5.0"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.0"	"Group enriched"	"Detected in many"	41	"OE19: 6565.0;SK-BR-3: 3115.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		980000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"	13.0	5.4	16.1	12.1	20.5	1.6	56.0	14.3	13.1	37.6	23.3	68.2	63.6	25.2	26.6	102.4	64.2	31.0	57.0	13.3	16.0	73.5	31.1	36.2	4.8	22.4	22.7	23.9	37.6	81.7	17.3	27.0	17.1	55.6	48.5	8.1	68.7	50.5	20.7	91.0	67.3	25.0	18.5	6.9	49.7	11.7	15.4	7.4	56.5	15.0	28.0	40.0	52.9	16.4	38.7	45.7	50.4	31.7	59.3	41.2	67.7	27.2	44.9	58.6	48.9	34.4	102.7	2.9	54.6	62.7	31.5	117.6	2.8	61.2	26.9	5.2	38.6	1.8	36.0	56.3	35.3	0.9	1.0	41.0	56.6	36.2	21.9	56.2	24.4	1.9	6.2	2.4	43.3	59.4	7.1	3.0	90.7	6565.0	11.7	3.9	20.5	5.4	58.9	118.9	9.4	2.6	51.5	3115.9	16.9	62.2	88.1	2.2	2.9	30.2	37.7	37.7	17.6	5.3	3.3	3.6	3.0	0.9	98.5	1.1	0.2	0.4	5.0	0.1	0.3	0.6	0.2	1.4	0.2	0.6	0.5	1.4	1.2	0.4	0.1	0.1	0.2	1.7	16.1	20.5	14.3	13.1	13.3	16.0	22.4	22.7	17.1	18.5	15.4	16.4	3.9	41.7	40.1	12.7	2.2	14.0	19.0	37.1	17.6	4.6	62.7	34.9	20.7	32.9	43.8	136.1	12.5	12.0	5.1	111.0	7.9	30.9	0.3	48.7	13.9	6.1	15.6	1.3	0.9	25.5	84.8	15.7	53.5	61.3	0.0	20.3	11.7	10.7	4.0	6.7	1.0	47.5	42.7	2.2	3.1	1.0	18.3	1.7	10.6	1.0	1.2	24.1	26.8	2.0	1.0	32.5	54.8	23.0	1.1	34.9	121.7	19.5	42.0	5.8	0.0	13.1	12.7	6.8	5.7	43.5	18.9	22.7	2.8	4.4	75.4	31.3
ERGIC3	"C20orf47, CGI-54, Erv46, NY-BR-84, PRO0989, SDBCAG84"	ENSG00000125991	"ERGIC and golgi 3"	Q9Y282	20	35542038-35557634	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 711.0;Late spermatids: 708.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015242, HPA015968"	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"			"HPA015242: AB_1848238, HPA015968: AB_1848239"	"unprognostic (4.36e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (2.20e-7)"	"unprognostic (2.61e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (9.81e-5)"	"unprognostic (9.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.64e-2)"	123.3	167.5	123.4	77.7	124.6	164.5	174.9	124.4	180.6	161.8	183.3	154.6	124.2	127.4	456.9	146.9	325.4	135.1	123.8	123.8	131.5	145.3	181.0	115.1	99.4	128.2	129.9	188.3	270.3	188.0	86.9	151.3	128.2	125.9	190.9	67.0	196.9	142.3	103.5	151.4	110.4	142.6	124.7	108.3	162.0	211.6	133.9	119.9	199.8	95.2	154.6	154.0	137.5	128.2	173.2	317.5	161.8	282.4	553.6	417.1	210.1	234.4	503.7	378.3	374.0	726.9	354.2	127.4	214.4	495.4	332.8	249.5	137.7	371.9	279.0	62.8	252.5	272.6	221.1	453.2	285.2	240.1	193.2	462.8	578.1	235.1	298.7	432.5	251.1	163.0	189.8	399.3	307.0	379.1	191.4	354.0	93.4	645.1	305.1	143.1	378.8	365.5	315.6	298.7	155.4	225.5	353.4	286.0	284.7	159.8	276.5	389.0	209.8	429.5	169.0	178.0	208.1	164.7	107.0	102.5	461.2	126.4	235.5	98.5	188.7	106.7	117.9	182.2	143.3	157.9	139.2	130.4	228.7	146.6	136.0	139.9	62.0	150.7	158.9	226.6	177.0	237.8	123.4	124.6	124.4	180.6	123.8	131.5	128.2	129.9	128.2	124.7	133.9	128.2	48.1	35.3	79.9	14.4	107.1	184.2	209.7	289.4	150.2	27.1	194.3	150.2	37.1	153.0	190.7	62.5	18.8	476.5	80.6	224.5	117.4	210.6	711.0	215.5	99.4	101.8	112.6	93.2	8.9	269.8	490.7	122.7	114.7	77.5	78.0	94.7	146.3	146.4	208.1	16.8	10.1	246.9	152.5	148.2	192.5	708.4	105.3	100.4	190.3	8.4	126.7	76.8	82.4	8.0	13.6	185.0	283.1	94.0	344.1	189.8	213.4	207.5	340.2	31.3	118.3	100.5	122.0	415.9	170.5	172.6	200.6	589.4	86.8	111.3	264.6	292.3
ERN2	IRE1b	ENSG00000134398	"Endoplasmic reticulum to nucleus signaling 2"	Q76MJ5	16	23690310-23713226	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix: 19.5;gallbladder: 17.0;intestine: 28.9;salivary gland: 22.9;stomach 1: 51.9"	"Cell type enhanced"	"Detected in some"		"Club cells: 38.4;Distal enterocytes: 80.2;Gastric mucus-secreting cells: 193.7;Intestinal goblet cells: 143.9;Paneth cells: 37.2;Undifferentiated cells: 70.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 17.0;pancreatic cancer: 19.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 43.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076875	Approved		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum, Cytosol"		"HPA076875: "	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.67e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-9)"	"unprognostic (1.48e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-3)"	0.1	0.4	0.1	3.0	0.1	0.0	0.1	0.6	0.4	19.5	0.2	28.9	12.9	0.0	0.0	0.9	0.4	17.0	0.0	0.1	0.2	0.1	0.0	0.8	0.0	0.2	0.1	0.0	0.9	0.0	0.2	0.0	0.2	3.5	23.0	0.0	22.9	0.1	0.0	0.2	12.4	0.9	0.0	0.0	51.9	0.1	0.1	0.0	0.0	0.0	0.0	4.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	43.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.4	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.4	0.0	0.0	1.1	0.0	0.8	0.0	1.5	6.8	0.0	0.0	0.0	0.0	0.5	20.0	38.4	0.0	0.0	0.5	0.0	80.2	0.0	2.3	0.1	0.5	0.2	0.1	10.8	0.0	0.2	1.9	0.0	0.1	193.7	1.6	4.5	0.1	0.0	0.0	0.1	0.0	0.1	143.9	6.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	33.1	37.2	0.0	0.5	1.3	6.1	0.1	16.9	0.0	0.0	1.7	1.6	0.0	0.2	0.0	0.0	0.1	0.4	0.0	70.9	11.1
ETHE1	"HSCO, YF13H12"	ENSG00000105755	"ETHE1 persulfide dioxygenase"	O95571	19	43506719-43527230	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 256.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1037.7;Paneth cells: 788.4;Proximal enterocytes: 376.3;Undifferentiated cells: 447.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 222.6;OE19: 360.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028360, HPA029028, HPA029029"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998"	"unprognostic (8.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (7.75e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.73e-2)"	24.4	27.9	16.1	34.8	17.0	45.8	26.7	16.5	17.3	28.7	15.8	256.1	85.5	18.3	29.8	81.0	20.6	21.0	18.8	15.6	17.4	40.4	52.7	30.5	23.4	17.3	17.2	13.5	28.9	16.1	19.1	26.3	16.6	27.1	226.6	3.2	40.1	18.5	22.8	27.2	77.0	35.6	17.1	27.8	37.8	3.0	18.2	19.8	24.1	21.9	41.7	34.4	39.1	17.2	54.1	68.9	14.1	49.6	75.1	50.9	5.5	82.1	222.6	69.8	71.1	21.1	54.3	0.2	60.0	79.8	22.2	42.9	20.6	123.4	19.6	26.2	6.2	13.8	29.7	59.2	34.0	19.3	18.4	52.2	95.1	26.9	76.0	92.2	52.0	49.8	9.0	87.6	35.1	35.7	22.2	18.9	3.8	360.5	32.9	26.6	6.1	12.0	153.0	110.9	0.2	16.6	20.8	74.8	50.6	23.6	22.4	34.3	41.6	10.9	46.9	13.1	15.3	23.1	20.2	1.4	48.4	83.8	57.7	24.2	63.3	1.6	41.1	34.5	48.3	20.5	47.6	39.4	95.8	7.5	36.4	35.0	2.1	29.3	22.8	17.9	50.4	40.2	16.1	17.0	16.5	17.3	15.6	17.4	17.3	17.2	16.6	17.1	18.2	17.2	32.0	22.4	23.4	3.9	25.5	34.5	82.2	242.5	57.5	9.8	85.8	95.2	9.8	47.1	84.5	55.2	0.0	191.6	38.0	1037.7	54.8	71.7	0.9	31.0	41.2	44.9	63.7	17.4	6.2	63.6	95.7	42.1	53.5	68.2	38.0	12.6	42.1	89.2	115.1	5.0	6.8	324.2	79.3	105.0	78.5	2.1	17.7	74.6	80.0	3.7	78.5	11.7	63.8	4.0	5.6	102.7	788.4	16.1	34.9	75.0	376.3	136.4	23.1	5.8	19.7	32.0	45.1	2.1	6.2	82.8	23.2	92.5	50.4	15.8	447.5	146.5
EVX1		ENSG00000106038	"Even-skipped homeobox 1"	P49640	7	27242700-27250493	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.9;prostate: 3.8;seminal vesicle: 2.9;urinary bladder: 3.3;vagina: 3.5"	"Group enriched"	"Detected in some"	33	"Early spermatids: 62.0;Late spermatids: 73.3"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.6"	"Region enhanced"	"Detected in single"		"medulla oblongata: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"OE19: 25.2;RT4: 16.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.0"	"Not detected"	"Not detected"			HPA055132			Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA055132: AB_2682707"	"unprognostic (2.73e-2)"	"unprognostic (3.59e-1)"	"unprognostic (4.31e-1)"		"unprognostic (5.16e-2)"		"unprognostic (1.76e-3)"	"unprognostic (2.08e-2)"			"unprognostic (8.48e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.26e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.83e-2)"	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.8	0.0	0.0	0.0	0.0	0.1	0.9	3.8	0.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.3	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.2	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.8	0.9	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	62.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	73.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.1	2.0
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169511951-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"choroid plexus: 142.8;liver: 176.2;placenta: 46.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Cytotrophoblasts: 82.7;Hepatocytes: 253.4;Syncytiotrophoblasts: 59.5"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.1;eosinophil: 8.1;neutrophil: 7.0;T-reg: 6.2"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.1;monocytes: 4.1;T-cells: 6.2"	"Group enriched"	"Detected in some"	23	"Hep G2: 32.8;OE19: 125.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.7;hippocampal formation: 6.6;pons and medulla: 4.4;thalamus: 5.4"	"Group enriched"	"Detected in all"	7	"amygdala: 39.9;basal ganglia: 35.0;cerebral cortex: 67.9;hippocampal formation: 61.4;olfactory bulb: 27.6"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7670000000	13000000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.0	0.3	3.2	1.4	3.7	0.6	4.4	1.3	0.1	142.8	0.3	0.9	0.1	0.2	0.2	3.5	17.6	2.7	4.4	1.6	1.5	176.2	0.9	2.2	1.9	2.2	0.0	0.8	0.0	1.6	46.9	2.4	1.3	0.6	1.0	6.2	0.0	0.2	1.3	0.3	1.1	0.8	1.8	4.9	0.5	2.2	0.5	0.4	0.2	2.3	3.8	0.1	4.2	0.0	0.6	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	32.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	125.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	4.1	8.1	0.0	0.2	0.0	0.0	1.4	0.2	0.4	0.0	0.3	0.0	7.0	0.0	0.0	0.0	6.2	1.1	0.3	1.4	4.4	1.3	4.4	1.6	1.9	2.2	2.4	0.8	2.2	4.2	0.0	3.2	0.6	1.6	0.7	0.1	6.1	0.0	0.0	0.3	0.7	0.3	9.4	74.4	1.9	0.0	2.1	82.7	0.1	0.3	0.0	2.4	2.4	0.9	0.0	2.4	25.2	0.0	5.4	0.2	2.3	5.3	4.1	0.2	0.0	2.8	3.6	253.4	5.3	0.0	2.6	0.1	0.0	12.3	0.4	0.3	0.0	7.1	3.6	0.0	18.2	1.0	2.1	0.5	1.0	1.9	0.0	0.0	0.1	1.8	0.0	0.2	3.1	0.1	0.0	2.4	0.2	0.5	0.5	0.0	0.0	59.5	2.5	0.0	0.0	11.8
FA2H	"FAAH, FAXDC1, FLJ25287, SPG35"	ENSG00000103089	"Fatty acid 2-hydroxylase"	Q7L5A8	16	74712955-74774831	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 183.9;stomach 1: 61.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 85.1;Oligodendrocyte precursor cells: 61.3;Oligodendrocytes: 307.9;Paneth cells: 75.2;Urothelial cells: 192.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 38.1;HAP1: 48.6;JURKAT: 89.8;OE19: 61.5;SK-BR-3: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056614, HPA077840"	Approved		Uncertain	"Nuclear membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear membrane"		"HPA056614: AB_2683191, HPA077840: AB_2686858"	"unprognostic (1.33e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (6.01e-2)"	"prognostic favorable (5.01e-6)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.11e-3)"	0.3	0.3	41.7	4.3	89.1	0.3	2.8	77.9	63.0	1.9	11.7	21.2	10.3	0.2	2.2	7.9	1.8	17.8	0.3	46.1	56.1	8.2	0.2	1.4	0.7	129.2	79.6	0.0	8.4	10.1	0.6	0.7	106.0	1.9	19.4	0.4	11.0	0.7	0.0	8.5	14.4	1.1	65.2	0.5	61.1	2.9	75.2	4.7	2.0	0.1	5.9	26.3	2.2	183.9	9.2	38.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.5	0.0	20.8	21.0	0.0	0.2	0.0	2.0	3.6	48.6	0.6	0.1	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	89.8	0.0	0.0	0.0	15.2	0.8	0.0	0.9	61.5	2.1	0.0	0.0	1.6	23.4	15.6	6.5	0.0	0.0	28.8	0.0	1.3	8.6	0.0	0.0	0.0	0.1	0.0	0.2	1.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	89.1	77.9	63.0	46.1	56.1	129.2	79.6	106.0	65.2	75.2	183.9	0.0	0.0	1.3	1.0	2.6	0.5	11.1	8.5	1.8	0.0	5.0	3.3	0.2	8.6	14.6	0.0	0.0	0.5	0.2	43.0	7.9	13.5	10.8	2.4	0.5	0.2	6.7	0.0	0.7	14.2	0.2	1.1	85.1	4.5	0.0	0.1	0.0	0.0	0.1	0.0	0.9	34.8	4.1	0.0	0.0	4.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	61.3	307.9	38.4	75.2	0.4	6.2	22.9	17.6	0.2	10.5	0.0	0.0	0.0	0.6	2.4	3.3	12.4	0.9	0.1	0.2	0.0	15.3	192.8
FAM118A	"bK268H5.C22.4, C22orf8, FLJ20635"	ENSG00000100376	"Family with sequence similarity 118 member A"	Q9NWS6	22	45308968-45341955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 104.0;Early spermatids: 125.0;Syncytiotrophoblasts: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003902	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 21: OE19 - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Intermediate filaments"	Cytosol	"HPA003902: AB_1848368"	"unprognostic (6.22e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.02e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (9.76e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.16e-3)"	14.1	11.8	14.9	23.7	16.9	21.5	23.3	22.0	17.1	21.9	25.5	23.3	19.9	17.7	66.5	18.6	12.2	24.4	24.5	17.2	15.6	22.9	17.1	19.3	49.1	14.4	15.3	21.7	14.3	38.3	37.6	18.3	14.4	41.7	12.4	9.5	18.4	9.3	30.5	39.7	24.8	10.3	11.4	25.9	21.3	22.7	17.9	13.6	23.7	6.5	27.6	29.7	22.8	15.8	10.9	7.8	11.0	11.9	9.3	8.9	24.0	8.1	13.4	11.5	11.2	25.6	10.1	48.6	6.5	7.5	6.5	40.7	14.3	10.3	11.5	10.6	31.9	26.3	13.2	18.7	12.8	24.8	7.2	9.5	12.3	17.6	10.8	8.0	7.1	14.6	39.5	52.6	5.9	26.1	14.7	51.3	8.2	49.8	10.4	19.0	7.1	17.4	6.6	28.9	21.8	25.6	8.9	19.0	23.9	18.0	8.2	14.4	9.2	8.8	28.8	10.8	10.8	29.0	5.5	24.7	11.9	17.1	16.0	7.1	7.1	2.2	5.8	6.2	4.7	4.3	7.3	7.2	8.8	6.5	11.5	8.6	5.8	5.6	5.0	13.5	10.9	4.4	14.9	16.9	22.0	17.1	17.2	15.6	14.4	15.3	14.4	11.4	17.9	15.8	12.5	9.6	17.0	23.8	21.2	22.6	36.9	18.8	10.8	18.3	10.9	6.6	11.3	8.6	16.6	7.3	18.8	104.0	83.1	21.4	0.0	7.0	125.0	6.7	15.5	20.7	32.9	14.5	23.1	6.2	8.5	19.2	10.2	7.4	1.3	8.8	23.9	14.5	12.9	6.7	18.3	20.5	12.2	13.0	29.9	75.6	35.8	19.8	1.8	62.8	69.5	16.4	39.1	22.6	21.5	4.8	17.7	23.7	25.8	22.6	13.4	3.9	14.6	22.3	0.0	33.6	14.7	72.5	38.8	8.8	9.9	120.9	55.2	7.3	17.5	35.4
FAM118B	FLJ21103	ENSG00000197798	"Family with sequence similarity 118 member B"	Q9BPY3	11	126211724-126262984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041644, HPA042100"	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA041644: AB_10794303, HPA042100: AB_10795394"	"unprognostic (8.11e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.05e-3)"	"unprognostic (3.13e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (6.67e-7)"	"unprognostic (1.85e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.44e-2)"	9.3	10.5	15.1	10.3	19.2	4.3	7.6	15.7	20.4	10.4	20.2	24.0	18.5	10.0	12.3	7.6	6.7	10.5	18.2	15.5	16.2	10.3	8.9	16.3	12.7	15.1	15.3	6.2	5.7	7.7	9.0	11.1	15.3	7.3	23.6	9.0	8.0	9.3	22.0	5.4	13.1	14.2	16.0	10.5	14.9	21.4	15.6	14.1	10.2	16.3	14.0	13.6	6.2	16.3	11.7	14.3	31.5	23.6	43.4	28.5	14.0	18.5	33.2	20.4	21.2	29.0	18.5	13.0	19.2	23.5	42.4	15.2	33.5	19.7	24.8	21.2	14.5	41.3	6.8	19.5	33.7	20.7	13.0	23.7	19.9	25.0	23.0	20.5	46.8	24.9	25.8	17.8	29.6	10.9	27.8	16.2	25.6	63.3	26.4	24.1	25.1	11.6	34.4	18.3	14.5	15.2	21.5	14.0	26.8	36.8	27.3	12.4	29.2	20.7	15.2	17.9	16.3	9.3	11.7	22.0	8.9	31.0	26.9	33.8	43.4	21.9	14.6	58.8	18.6	15.2	14.4	18.9	48.1	15.9	12.9	16.0	9.0	18.9	59.6	21.9	18.0	25.2	15.1	19.2	15.7	20.4	15.5	16.2	15.1	15.3	15.3	16.0	15.6	16.3	8.6	3.2	16.4	14.4	5.6	4.1	4.2	21.9	1.2	3.1	3.3	3.6	10.4	4.3	9.6	12.9	4.2	9.3	5.0	21.9	5.9	16.0	7.5	5.0	6.0	12.4	3.6	8.6	19.1	17.2	12.4	8.3	21.4	4.1	10.8	9.1	9.7	5.5	24.2	1.7	17.6	11.4	12.2	16.7	9.4	9.2	7.8	11.0	3.6	12.2	16.9	13.5	13.4	16.1	12.7	14.0	12.8	21.8	9.5	4.1	11.4	12.9	6.8	5.7	6.6	3.4	10.2	46.0	20.6	3.5	3.4	13.0	5.3	11.0	16.6	5.7
FAM162A	"C3orf28, E2IG5"	ENSG00000114023	"Family with sequence similarity 162 member A"	Q96A26	3	122384176-122412334	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 625.3;Distal tubular cells: 540.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035856, HPA075611"	Approved		Supported	Mitochondria		NA	NA		19000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA035856: AB_10611965, HPA075611: "	"unprognostic (1.17e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.91e-3)"	"unprognostic (8.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.10e-2)"	"prognostic favorable (3.93e-4)"	49.0	105.7	54.8	31.3	60.2	39.9	43.9	57.3	82.2	84.5	57.1	145.9	56.1	49.5	59.4	207.6	49.7	46.2	174.2	57.1	58.5	107.6	200.3	32.0	32.9	55.9	57.2	84.3	133.9	116.6	51.0	17.6	55.6	74.6	149.0	83.5	59.8	49.2	141.0	89.8	56.3	44.6	56.6	31.7	93.2	43.6	58.8	34.7	44.1	142.6	42.7	76.9	131.5	55.6	132.0	27.7	40.4	75.6	72.1	66.4	20.7	52.9	46.8	49.0	123.9	69.4	58.7	142.1	89.2	18.2	40.3	89.8	73.5	128.1	130.0	74.0	55.1	115.6	44.0	125.8	47.4	114.0	39.6	77.3	65.5	46.7	97.9	164.3	66.0	137.7	79.2	55.6	71.1	52.0	116.9	137.9	59.5	294.9	144.4	69.5	57.8	186.9	144.3	314.9	60.1	48.1	39.4	92.4	114.3	59.9	57.9	55.7	47.0	48.4	34.6	28.7	55.6	108.8	39.9	144.8	143.3	109.7	22.8	9.9	25.8	75.7	58.3	68.2	86.9	75.3	79.5	74.0	84.6	68.1	85.1	88.6	8.5	50.6	75.9	70.4	80.4	38.8	54.8	60.2	57.3	82.2	57.1	58.5	55.9	57.2	55.6	56.6	58.8	55.6	55.7	28.9	46.0	41.1	68.2	128.1	155.3	625.3	82.0	31.5	80.6	109.5	338.4	84.4	188.6	130.6	47.9	51.4	47.9	477.5	540.0	148.2	102.5	82.0	30.1	49.8	106.9	47.7	33.0	177.6	47.8	78.7	84.6	79.2	85.7	59.3	44.6	280.4	92.7	38.7	30.4	374.3	240.1	66.7	108.9	33.1	134.5	61.2	104.9	7.5	108.9	79.7	45.3	22.1	21.6	141.6	313.2	148.6	61.2	121.4	186.2	466.2	95.5	29.9	105.2	83.2	315.3	146.4	68.3	315.1	132.8	47.2	66.0	121.1	358.4	210.9
FAM166C	"C2orf70, LOC339778"	ENSG00000173557	"Family with sequence similarity 166 member C"	A6NJV1	2	26562585-26579532	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 7.6;testis: 26.6"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 21.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062453	Enhanced		Approved	"Nuclear membrane,Vesicles"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear membrane, Vesicles"		"HPA062453: AB_2684769"	"unprognostic (5.44e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.99e-2)"	"unprognostic (9.40e-6)"		"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (6.49e-4)"	"unprognostic (4.58e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.08e-3)"	0.1	0.1	0.8	0.1	0.7	0.0	0.2	0.5	0.6	0.3	4.1	0.6	0.1	0.2	0.3	0.1	7.6	0.0	0.4	0.8	2.5	1.0	0.0	0.4	0.0	2.0	2.0	0.0	0.7	0.1	0.7	0.0	1.2	0.2	0.4	0.1	1.9	0.2	0.1	0.1	0.1	0.1	1.5	0.0	4.8	26.6	2.9	0.0	1.1	0.0	0.0	0.1	0.0	1.0	4.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	3.7	0.0	0.9	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.5	0.6	0.8	2.5	2.0	2.0	1.2	1.5	2.9	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM3D	"EF7, OIT1"	ENSG00000198643	"FAM3 metabolism regulating signaling molecule D"	Q96BQ1	3	58633946-58666834	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 264.8;intestine: 488.7;salivary gland: 468.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 794.8;Intestinal goblet cells: 1150.1;Paneth cells: 776.7;Proximal enterocytes: 353.1;Undifferentiated cells: 760.0"	"Cancer enriched"	"Detected in many"	4	"colorectal cancer: 151.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 3.7"	"Lineage enhanced"	"Detected in single"		"granulocytes: 3.7"	"Cell line enriched"	"Detected in some"	65	"OE19: 68.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013844	Approved				"Secreted to digestive system"	NA	NA		15000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA013844: AB_2668897"	"prognostic favorable (7.51e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.51e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (7.97e-2)"	"unprognostic (6.54e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.97e-4)"	"unprognostic (2.34e-2)"	0.9	0.1	0.2	29.6	0.1	0.0	18.5	0.0	0.5	31.3	0.1	362.0	89.2	0.6	0.2	264.8	0.8	81.6	0.2	0.2	0.1	1.1	0.2	4.8	0.6	0.1	0.2	0.1	1.7	0.0	0.4	1.0	0.1	14.8	488.7	0.0	468.4	68.4	0.1	2.6	90.4	8.3	0.1	0.2	78.2	0.3	0.3	0.4	1.5	0.0	41.1	12.7	59.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.1	0.4	0.2	68.5	0.0	0.1	0.1	0.3	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.2	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.7	0.0	0.3	0.0	0.0	0.4	0.2	0.1	0.0	0.5	0.2	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.6	0.0	1.1	0.3	3.4	0.0	9.9	223.1	0.0	0.0	29.5	53.8	0.2	47.1	133.4	14.7	0.0	0.0	1.3	794.8	0.0	1.3	0.5	0.0	0.0	2.5	152.1	0.0	0.1	0.0	0.0	0.8	114.2	0.2	8.9	0.0	0.4	0.2	0.3	0.0	0.1	1150.1	18.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	776.7	0.0	0.2	68.2	353.1	1.2	43.1	0.0	0.0	0.0	4.9	0.1	0.6	7.9	0.1	0.4	2.0	0.0	760.0	245.0
FAM47E	"FLJ42946, LOC100129583"	ENSG00000189157	"Family with sequence similarity 47 member E"	Q6ZV65	4	76214040-76283783	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 47.3;Endometrial ciliated cells: 34.0;Respiratory ciliated cells: 91.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	5	"OE19: 28.0"									HPA053331	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA053331: AB_2682115"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.01e-2)"	6.2	4.9	7.6	0.4	8.3	1.0	6.8	7.5	8.8	2.9	7.9	2.6	3.2	1.7	11.0	1.3	19.6	4.0	1.9	8.0	8.4	7.3	9.1	4.0	0.5	8.1	8.5	0.8	9.1	7.6	8.5	1.5	7.8	4.2	2.9	8.8	4.4	2.7	6.4	1.3	3.5	1.1	7.8	1.2	5.1	8.0	9.5	0.7	9.7	3.2	0.4	1.9	0.7	9.1	0.6	2.1	2.1	0.6	1.6	0.2	0.5	0.2	2.0	0.4	0.4	2.6	2.2	0.1	0.6	0.7	4.5	0.6	0.9	0.5	0.7	2.1	0.1	0.1	1.3	3.6	0.9	0.5	0.3	1.0	0.5	0.6	0.5	0.9	0.2	0.3	0.2	1.5	0.6	3.1	0.2	0.2	0.4	28.0	1.0	0.3	0.5	0.3	3.4	1.8	3.7	2.9	1.0	1.6	0.3	0.5	1.7	0.2	0.5	0.4	0.5	1.2	0.5	5.5	1.2	0.1	1.6	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	7.6	8.3	7.5	8.8	8.0	8.4	8.1	8.5	7.8	7.8	9.5	9.1	1.6	9.6	2.6	4.2	0.4	0.6	2.5	5.1	0.0	12.9	7.7	9.1	7.9	8.6	8.4	0.0	12.5	3.3	0.1	6.2	9.8	7.5	47.3	34.0	0.6	1.8	7.7	0.8	1.0	7.8	1.6	1.5	3.1	2.0	0.0	1.5	1.8	3.6	0.8	1.7	1.1	5.7	14.2	1.0	0.0	6.2	0.6	0.7	1.8	1.0	0.0	4.7	0.0	0.0	2.9	5.8	3.0	0.4	0.4	2.8	13.0	10.3	91.4	7.4	0.0	2.0	2.2	8.8	4.3	0.3	0.3	3.4	0.2	0.8	3.1	1.9
FAM47E-STBD1		ENSG00000272414	"FAM47E-STBD1 readthrough"		4	76251721-76311129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"liver: 41.5;skeletal muscle: 55.9"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 6.4;Alveolar cells type 2: 1.7;Astrocytes: 2.0;Excitatory neurons: 5.1;Inhibitory neurons: 2.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 3.4;Respiratory ciliated cells: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;OE19: 2.7"									HPA053331	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA053331: AB_2682115"	"unprognostic (3.52e-3)"		"unprognostic (3.44e-1)"		"unprognostic (1.53e-1)"		"unprognostic (8.98e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.92e-6)"	"unprognostic (5.59e-2)"		"unprognostic (1.52e-1)"	"unprognostic (3.77e-1)"	12.5	1.3	1.5	0.4	1.6	1.0	9.3	1.1	2.5	2.0	1.1	9.0	0.1	2.4	1.3	1.6	2.1	0.6	21.2	1.4	2.0	2.4	41.5	8.3	0.4	1.9	1.5	0.9	2.3	0.5	0.7	0.6	1.7	4.3	0.4	1.8	2.3	0.5	55.9	0.9	12.4	0.7	1.6	0.9	2.9	2.3	1.9	0.1	1.3	0.5	0.1	6.7	2.0	2.0	0.1	0.0	0.1	0.1	0.4	0.1	0.2	0.0	0.2	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.6	0.1	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.0	0.0	0.4	0.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.4	0.0	0.1	0.1	2.7	0.4	0.0	0.0	0.4	0.0	0.6	0.7	0.5	0.1	0.1	0.0	0.2	0.0	0.3	0.3	0.1	0.3	0.1	0.2	0.4	0.3	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	1.5	1.6	1.1	2.5	1.4	2.0	1.9	1.5	1.7	1.6	1.9	2.0	0.0	6.4	1.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM83E	FLJ20200	ENSG00000105523	"Family with sequence similarity 83 member E"	Q2M2I3	19	48599961-48615076	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.7;salivary gland: 28.5;stomach 1: 37.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 22.8;Early spermatids: 26.0;Gastric mucus-secreting cells: 74.9;Intestinal goblet cells: 26.9;Paneth cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 2.9;OE19: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049305, HPA075968"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Vesicles	"HPA049305: AB_2680705, HPA075968: "	"unprognostic (1.36e-1)"	"unprognostic (9.81e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.71e-1)"	"unprognostic (8.00e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.05e-8)"	"unprognostic (5.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.90e-3)"	0.1	0.1	0.2	3.7	0.3	0.4	1.4	0.8	0.5	10.6	0.2	32.7	30.0	1.1	0.1	7.0	3.9	6.4	0.2	0.3	0.2	0.8	0.3	8.0	0.2	0.1	0.1	0.0	1.2	0.0	0.2	0.6	0.2	3.2	16.6	0.2	28.5	0.4	2.7	1.9	30.0	1.0	0.0	0.2	37.4	2.2	0.2	0.1	0.1	0.0	1.3	1.2	4.1	0.5	0.4	0.4	0.0	0.7	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.3	2.9	0.5	0.2	0.1	0.0	0.5	0.1	0.0	0.0	0.4	0.1	0.1	0.3	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.6	0.1	0.8	1.1	9.4	0.9	0.2	0.1	0.3	0.0	0.2	0.5	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.2	0.5	0.1	0.1	0.2	0.1	1.0	0.1	0.2	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.8	0.5	0.3	0.2	0.1	0.1	0.2	0.0	0.2	0.5	0.0	9.6	13.4	1.3	0.4	0.0	1.4	0.8	0.6	0.0	1.8	0.8	2.1	8.6	6.5	1.8	0.0	0.1	0.3	22.8	0.0	0.1	26.0	4.8	0.5	0.2	5.4	0.0	0.3	1.1	0.1	0.2	74.9	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	26.9	2.0	0.0	0.0	9.3	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.3	1.6	16.5	0.0	0.4	3.3	12.7	0.0	5.1	0.0	0.0	0.2	0.2	0.8	0.5	2.3	0.0	0.1	0.3	0.1	12.8	6.9
FAM98C	FLJ44669	ENSG00000130244	"Family with sequence similarity 98 member C"	Q17RN3	19	38403135-38409088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040930, HPA041730"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA040930: AB_10795484, HPA041730: AB_10804114"	"unprognostic (3.01e-2)"	"unprognostic (6.44e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (8.51e-5)"	"unprognostic (2.82e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (5.53e-4)"	10.6	9.6	14.5	5.5	13.9	8.7	12.3	12.3	17.6	14.8	7.2	14.6	13.8	10.7	2.6	17.7	12.3	5.3	11.6	13.8	11.7	12.2	13.3	9.1	6.2	18.9	11.6	12.5	18.6	8.4	11.6	2.3	13.5	13.4	4.7	1.7	13.9	5.8	3.3	25.2	15.4	3.3	12.7	11.8	14.4	9.0	14.4	4.7	11.4	2.5	3.8	12.7	14.6	14.3	15.6	16.3	1.9	9.4	2.0	6.8	8.2	8.8	7.3	8.5	8.9	2.8	11.0	13.9	9.7	5.2	3.0	7.5	3.7	6.3	1.4	22.6	7.6	4.6	2.9	6.5	9.0	3.9	8.1	6.6	13.0	4.3	7.8	4.7	5.0	22.5	12.9	15.0	5.1	17.2	5.9	3.1	1.4	25.5	17.5	11.6	3.9	8.4	10.4	8.0	3.3	9.6	8.8	15.6	5.6	0.9	11.8	12.3	6.7	3.8	10.4	11.9	10.7	16.1	8.8	6.1	9.9	9.2	6.2	0.0	1.9	10.8	2.4	2.7	3.2	2.0	4.2	3.4	2.6	6.5	3.3	2.6	1.7	3.0	2.7	1.0	3.9	1.4	14.5	13.9	12.3	17.6	13.8	11.7	18.9	11.6	13.5	12.7	14.4	14.3	19.8	9.6	8.9	3.6	17.5	21.5	22.3	23.7	14.8	15.1	21.1	26.3	5.4	10.0	21.2	23.9	12.5	11.8	22.1	41.4	21.5	22.2	6.4	18.2	9.1	12.0	25.7	9.7	11.7	32.9	10.9	13.9	17.9	18.0	15.2	8.6	11.4	12.5	11.0	11.8	9.5	32.4	22.4	13.2	18.2	2.4	18.6	14.3	23.2	2.8	14.4	14.6	34.0	5.5	8.5	23.8	42.8	18.4	12.7	12.2	100.4	22.6	22.4	12.5	13.1	13.5	13.8	37.4	37.4	22.3	29.8	6.2	21.8	12.9	34.8	23.4
FCGRT	"alpha-chain, FCRN"	ENSG00000104870	"Fc fragment of IgG receptor and transporter"	P55899	19	49506816-49526428	"Predicted intracellular proteins, Predicted membrane proteins"		"IgG-binding protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1362.6;Kupffer cells: 877.7;Paneth cells: 883.9;Proximal enterocytes: 1787.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 2346.7"	"Group enriched"	"Detected in all"	17	"dendritic cells: 922.9;granulocytes: 2346.7;monocytes: 1364.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 153.7;Hep G2: 144.0;OE19: 165.4;THP-1: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012122, HPA015130"	Enhanced					NA	NA		24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"			"HPA012122: AB_1848474, HPA015130: AB_1848475"	"unprognostic (2.19e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.58e-2)"	"unprognostic (3.87e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.64e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.18e-3)"	263.1	127.7	67.7	99.6	73.3	147.3	198.8	68.0	102.5	217.2	111.1	209.6	304.4	143.1	48.8	60.2	155.5	144.6	123.0	66.3	75.1	177.6	401.6	177.5	143.3	74.0	69.5	193.2	129.4	114.5	79.8	137.5	74.3	104.6	149.3	4.8	106.2	94.7	64.4	112.3	299.3	91.6	73.6	318.9	126.6	28.3	78.8	62.9	111.9	77.8	39.1	136.7	132.0	78.2	0.4	37.1	4.3	123.7	153.7	78.2	6.0	32.1	73.4	20.9	22.9	50.5	22.5	0.2	59.4	45.9	10.8	8.5	1.2	1.1	11.7	0.3	45.5	74.2	0.6	144.0	95.8	1.1	14.2	95.1	1.9	17.5	0.2	86.5	81.3	48.0	12.2	10.9	53.7	0.8	0.6	14.3	2.1	165.4	22.0	2.6	35.3	3.7	96.0	9.3	2.6	23.1	5.6	0.2	4.5	18.3	26.5	196.1	28.1	52.8	11.8	0.9	1.3	2.4	13.5	9.8	10.8	70.2	7.9	566.8	1364.4	1011.5	24.7	904.8	29.8	58.0	39.8	39.7	922.9	62.5	89.4	51.0	2346.7	28.6	630.2	536.4	28.2	1276.9	67.7	73.3	68.0	102.5	66.3	75.1	74.0	69.5	74.3	73.6	78.8	78.2	479.6	67.3	89.3	21.2	44.2	126.1	130.4	130.7	52.9	0.7	125.5	151.3	30.7	158.7	79.9	73.5	4.2	12.7	83.8	652.3	60.7	86.3	6.5	29.1	89.6	259.2	158.1	55.8	0.2	61.6	24.9	269.9	108.6	24.8	70.5	181.2	587.6	343.9	1362.6	0.0	0.2	349.0	57.0	877.7	438.1	21.8	362.2	608.6	186.7	24.4	190.6	13.4	11.3	10.1	0.2	90.6	883.9	183.6	63.2	87.9	1787.7	329.5	53.4	5.2	216.9	149.2	105.6	21.1	17.6	27.7	107.1	20.7	32.4	129.9	565.1	115.4
FFAR4	"GPR120, GPR129, O3FAR1, PGR4"	ENSG00000186188	"Free fatty acid receptor 4"	Q5NUL3	10	93566665-93604480	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Differentiation, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 11.4;pituitary gland: 11.0"	"Cell type enriched"	"Detected in some"	4	"Intestinal goblet cells: 125.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 12.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042563			Uncertain	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"		"HPA042563: AB_10794762"	"unprognostic (1.96e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.98e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.87e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	4.1	0.4	1.2	0.7	1.3	0.1	1.3	0.6	1.2	0.1	0.3	8.3	0.5	0.0	0.0	0.2	1.0	0.5	0.3	1.0	1.8	0.1	0.4	3.6	0.2	0.6	0.8	0.0	0.6	0.1	11.0	0.1	0.5	0.1	11.4	0.2	0.1	0.0	0.3	0.9	0.6	0.2	0.3	0.1	0.5	1.5	2.6	0.3	0.1	0.1	0.1	0.1	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	12.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	1.2	1.3	0.6	1.2	1.0	1.8	0.6	0.8	0.5	0.3	2.6	0.7	0.2	0.0	0.5	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.2	0.8	0.4	7.2	0.6	0.0	0.0	0.2	0.0	28.1	0.0	0.8	27.8	0.1	0.0	0.3	20.9	0.0	3.2	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	7.4	0.0	2.0	125.7	0.0	7.2	4.4	16.7	0.6	7.6	1.8	3.7	0.5	0.0	0.0	0.0	0.3	0.9	23.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.9	0.3
FIBCD1	FLJ14810	ENSG00000130720	"Fibrinogen C domain containing 1"	Q8N539	9	130902438-130939286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 9.9;brain: 26.7;parathyroid gland: 12.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.6;Exocrine glandular cells: 30.1;Intestinal goblet cells: 24.5;Ionocytes: 26.4;Late spermatids: 36.1;Pancreatic endocrine cells: 28.6;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.7;MCF7: 32.8;OE19: 22.9;RPTEC TERT1: 24.4;THP-1: 12.5;U-2 OS: 14.1;U-251 MG: 13.5"	"Group enriched"	"Detected in many"	4	"basal ganglia: 17.6;hippocampal formation: 68.4"	"Region enriched"	"Detected in many"	5	"hippocampal formation: 57.3"	HPA055353	Approved		Approved	"Cell Junctions"		NA	NA		19000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cell Junctions"		"HPA055353: AB_2682791"	"unprognostic (1.18e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.42e-6)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.77e-1)"	0.1	9.9	8.0	0.0	1.8	0.0	0.5	0.0	15.8	0.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	0.2	0.5	26.7	1.4	0.1	0.0	2.1	0.0	8.3	6.3	0.1	0.0	12.5	0.1	0.9	5.2	0.1	0.7	1.3	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.1	6.6	5.4	0.0	0.0	0.0	0.0	0.9	0.1	2.7	0.3	3.5	1.2	0.0	0.1	0.0	0.0	5.9	8.7	0.4	1.2	0.0	3.7	0.0	2.3	0.3	6.3	2.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.7	0.4	0.2	0.3	0.0	0.1	3.9	0.0	13.7	0.0	0.0	0.7	0.0	0.0	32.8	0.0	2.8	2.1	22.9	0.6	0.0	5.7	0.4	24.4	0.0	0.2	0.0	1.1	0.1	0.8	0.9	2.0	12.5	0.0	1.3	14.1	0.1	13.5	0.0	0.0	0.0	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	8.0	1.8	0.0	15.8	26.7	1.4	8.3	6.3	5.2	0.0	5.4	2.7	0.2	0.0	0.0	0.3	0.0	0.0	0.9	5.0	0.0	3.2	0.8	0.0	1.3	0.0	2.3	1.8	0.0	11.6	0.0	10.4	0.0	0.3	19.6	0.0	0.1	0.4	0.0	0.0	0.3	30.1	0.9	0.9	0.0	0.0	0.0	0.8	0.0	0.0	1.1	3.3	0.3	24.5	26.4	0.0	0.0	36.1	0.6	0.5	0.0	1.9	0.4	0.6	0.0	0.0	0.1	28.6	6.3	3.4	0.0	0.7	2.5	0.1	2.1	0.2	0.0	0.0	0.8	9.5	16.3	0.0	0.0	4.0	0.0	0.9	6.7	1.5
FKBP11	FKBP19	ENSG00000134285	"FKBP prolyl isomerase 11"	Q9NYL4	12	48921518-48926474	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 495.0"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 1153.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"MAIT T-cell: 188.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 332.6;Karpas-707: 315.1;OE19: 527.2"	"Low region specificity"	"Detected in all"							HPA041709	Enhanced		Approved	Centrosome		NA	NA		170000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Centrosome		"HPA041709: AB_10794487"	"unprognostic (7.45e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.15e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.54e-1)"	25.6	17.6	4.0	60.2	4.1	34.5	34.5	3.7	4.9	42.4	5.6	57.2	70.8	17.4	86.4	16.2	19.1	25.4	13.1	3.8	12.0	13.8	59.4	23.9	55.4	5.7	6.3	13.8	495.0	4.7	47.2	15.6	5.2	28.9	53.3	2.1	160.2	32.7	2.4	8.0	55.9	26.2	3.8	76.4	70.6	6.1	9.6	16.4	22.9	0.4	77.4	49.2	17.3	4.8	13.6	24.7	3.0	4.5	116.0	141.3	3.8	123.2	183.3	128.0	154.5	78.3	88.3	192.8	2.2	226.8	1.1	60.6	31.6	60.4	77.0	39.1	7.7	6.6	24.7	0.3	332.6	3.2	3.3	165.0	109.8	99.2	171.4	67.2	75.4	53.1	3.0	315.1	49.9	44.7	26.3	5.1	7.4	527.2	33.9	76.5	3.3	280.7	21.0	2.3	35.0	10.6	36.6	66.5	24.4	4.0	2.0	7.0	49.2	21.0	2.8	2.1	2.3	132.3	122.2	108.1	16.1	3.9	33.0	6.0	1.0	2.8	115.7	1.3	188.3	50.5	80.5	92.7	1.9	25.7	38.8	69.9	4.1	26.7	1.1	39.3	33.4	36.3	4.0	4.1	3.7	4.9	3.8	12.0	5.7	6.3	5.2	3.8	9.6	4.8	22.3	16.0	19.1	5.2	229.8	28.3	56.0	48.6	39.3	5.5	45.0	43.3	2.3	30.0	42.8	9.2	39.6	21.5	130.9	23.1	7.9	23.7	18.4	19.2	117.8	32.3	25.1	20.6	5.3	171.7	80.7	64.1	31.6	31.0	12.7	34.0	40.4	96.6	10.9	1.7	3.7	227.7	16.2	15.1	26.1	17.4	27.7	10.1	272.1	0.0	8.0	1.8	158.6	1.5	1.8	59.8	14.3	13.9	1153.9	111.8	14.1	18.0	43.3	14.6	6.6	10.8	88.7	12.0	9.8	23.0	21.3	42.3	145.3	37.5	49.7	45.0
FMOD	SLRR2E	ENSG00000122176	Fibromodulin	Q06828	1	203340628-203351758	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 26.7;Fibroblasts: 52.5;Intestinal goblet cells: 80.2;Leydig cells: 28.0;Peritubular cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.6;CACO-2: 38.6;HHSteC: 11.8;HSkMC: 22.1;OE19: 45.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 71.7"						"Secreted to extracellular matrix"	NA	NA		2600000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (1.48e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (9.40e-3)"	"unprognostic (3.58e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (2.67e-4)"	122.7	13.6	1.3	31.1	2.3	0.1	64.4	1.5	3.9	100.1	9.0	39.4	49.6	105.8	17.2	19.1	85.8	123.6	149.0	1.0	1.5	24.3	11.0	60.2	28.6	2.4	0.9	125.1	33.1	28.0	21.7	81.2	1.5	58.4	62.1	9.9	49.6	49.2	12.6	25.9	21.2	106.5	2.1	18.2	135.6	6.3	1.5	9.6	71.3	25.6	33.8	45.4	60.0	1.4	0.0	0.1	0.0	0.0	10.6	0.7	0.2	7.1	8.1	0.0	1.1	38.6	0.0	0.0	0.8	7.7	0.0	0.3	0.0	0.6	0.5	0.0	0.0	0.0	0.9	0.0	11.8	0.0	0.0	22.1	0.1	0.0	0.4	5.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.3	0.0	45.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.4	0.0	0.1	1.0	0.3	2.0	0.0	0.3	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.3	1.5	3.9	1.0	1.5	2.4	0.9	1.5	2.1	1.5	1.4	9.3	0.0	6.3	0.0	0.0	6.9	5.0	1.5	6.2	0.2	10.3	26.7	1.6	2.8	2.1	7.3	0.0	1.1	0.4	2.9	0.0	1.9	0.1	1.1	12.1	8.3	6.1	0.0	0.1	0.7	0.7	52.5	12.8	1.6	0.0	0.5	19.2	0.1	1.2	0.0	0.0	80.2	0.0	0.3	9.3	0.4	28.0	0.6	12.4	7.5	0.6	11.9	0.0	0.0	0.0	1.5	2.2	28.6	0.0	11.7	0.7	0.2	0.7	1.0	6.6	1.3	15.5	0.0	0.3	0.6	4.3	3.1	1.2	2.0	8.6	1.6
FOXA3	HNF3G	ENSG00000170608	"Forkhead box A3"	P55318	19	45863989-45873797	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"intestine: 17.5;liver: 64.6;pancreas: 48.2;stomach 1: 36.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 83.3;Gastric mucus-secreting cells: 152.9;Intestinal goblet cells: 230.1;Paneth cells: 74.7;Undifferentiated cells: 46.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 19.9;liver cancer: 26.4;pancreatic cancer: 20.7;stomach cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.5;Hep G2: 29.1;K-562: 23.5;OE19: 101.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB015154, HPA054034"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"CAB015154: AB_647545, HPA054034: AB_2682349"	"unprognostic (2.88e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.11e-1)"	0.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.1	1.4	0.0	17.5	10.6	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.0	2.8	64.6	0.3	0.1	0.0	0.0	0.0	48.2	1.1	0.0	0.0	0.0	0.5	17.1	0.0	2.1	0.4	0.0	0.0	12.8	0.7	0.0	0.0	36.8	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.6	4.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	12.5	1.1	0.2	0.0	29.1	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.7	23.5	0.0	0.0	0.3	0.1	0.0	11.2	101.2	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	2.5	0.3	0.9	0.3	1.3	0.7	0.0	0.0	2.6	1.5	0.5	15.7	2.5	1.8	0.0	0.0	0.6	40.2	0.0	12.5	0.2	0.1	0.1	0.9	83.3	10.7	0.1	24.5	0.0	0.5	152.9	0.4	4.5	0.1	1.4	29.9	0.0	0.0	0.1	230.1	0.0	2.2	0.7	0.5	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.5	0.1	26.0	74.7	0.0	0.6	6.6	17.8	0.4	0.3	0.0	0.0	0.0	1.1	2.7	5.6	0.2	0.3	0.0	0.4	0.1	46.2	1.7
FOXP4	FLJ40908	ENSG00000137166	"Forkhead box P4"	Q8IVH2	6	41546381-41602384	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 40.2;Gastric mucus-secreting cells: 56.6;Intestinal goblet cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"CACO-2: 113.9;OE19: 118.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007176	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cytosol"		"HPA007176: AB_1078911"	"unprognostic (8.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.17e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.13e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-2)"	15.9	10.6	7.7	11.0	6.6	4.9	18.6	3.6	10.4	33.0	1.9	22.7	19.9	32.5	2.0	15.3	16.3	9.1	21.3	10.1	12.0	19.9	28.5	17.3	9.5	13.1	8.6	16.7	34.8	6.3	19.9	5.1	11.8	33.5	6.0	2.9	31.6	10.3	14.3	12.5	18.7	9.1	3.4	8.0	50.1	27.9	12.8	6.8	32.0	4.3	5.9	16.8	15.6	11.4	25.8	36.2	41.2	45.7	7.1	2.5	44.0	14.5	6.8	11.2	7.8	113.9	8.0	29.9	25.7	7.8	33.3	19.3	11.4	13.2	4.1	25.1	20.7	24.2	20.1	74.9	14.1	15.1	19.3	6.6	14.1	10.4	5.6	15.8	10.9	17.6	30.2	11.6	5.0	70.5	17.5	22.4	10.8	118.6	11.7	19.3	13.8	20.9	8.6	22.2	11.9	17.0	15.2	35.4	23.3	10.5	20.0	35.3	17.0	15.1	37.3	24.0	24.0	9.1	6.2	40.9	12.3	25.8	14.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	7.7	6.6	3.6	10.4	10.1	12.0	13.1	8.6	11.8	3.4	12.8	11.4	1.1	0.0	11.7	4.6	6.2	9.2	5.8	5.1	2.8	5.2	19.2	15.2	21.0	7.2	4.8	5.5	2.1	2.6	4.3	22.0	0.0	8.7	26.9	6.3	1.9	3.4	40.2	0.8	2.5	16.1	3.4	4.6	56.6	9.5	3.8	15.0	13.6	21.0	4.1	0.0	1.9	41.7	8.2	4.2	7.0	21.0	4.1	4.4	1.8	1.0	5.4	1.2	7.2	6.6	3.5	20.9	20.3	8.6	3.6	14.7	15.8	8.8	3.4	2.7	13.1	4.8	8.4	2.2	13.1	7.6	7.7	4.4	4.0	0.6	17.4	10.2
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060891	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.4;Oligodendrocytes: 97.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 18.3;RT4: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favorable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	0.8	1.1	1.3	1.2	2.1	1.5	2.4	5.8	5.0	1.8	13.7	4.6	6.2	1.0	2.5	2.9	2.6	2.6	1.8	1.8	0.0	9.0	6.8	1.8	0.7	0.3	0.1	0.9	2.8	1.0	0.4	0.8	1.0	2.2	4.8	2.9	4.0	2.4	2.2	1.9	6.3	0.8	0.2	0.9	4.9	1.9	1.1	1.2	1.0	0.8	1.6	2.1	1.0	5.7	2.5	4.0	0.5	0.9	0.2	0.2	0.6	0.5	0.1	0.0	0.1	3.1	3.8	0.9	3.5	0.5	0.5	5.8	0.2	1.1	0.1	3.3	0.3	1.3	3.3	2.7	0.2	0.9	0.7	0.2	1.5	0.3	0.4	0.4	0.2	0.6	0.6	2.3	1.0	1.3	0.7	0.5	1.0	18.3	0.7	1.1	3.3	1.2	4.8	7.6	0.7	0.8	0.7	5.1	0.5	0.9	1.5	0.7	0.8	1.0	1.0	0.7	0.5	3.6	2.7	1.6	1.1	0.6	0.6	0.9	0.2	0.2	0.4	0.1	0.5	0.2	0.3	0.4	0.1	0.4	0.2	0.3	0.8	0.3	0.2	0.3	0.2	0.0	1.3	2.1	5.8	5.0	1.8	0.0	0.3	0.1	1.0	0.2	1.1	5.7	0.4	0.0	10.3	10.4	0.5	2.7	20.8	23.3	6.8	0.6	7.3	2.9	9.2	11.5	22.6	23.9	0.0	4.4	0.1	34.9	11.7	20.3	89.4	28.1	1.7	0.7	19.8	0.0	12.2	16.4	4.3	3.5	29.0	30.4	3.8	0.2	1.4	21.9	0.9	6.7	7.7	14.5	34.6	0.6	0.4	38.1	0.6	0.6	0.0	1.0	1.0	0.2	0.0	2.5	97.8	21.9	23.3	1.2	0.5	23.4	49.3	28.4	36.6	0.3	13.1	9.9	16.2	4.6	1.0	16.4	3.1	0.8	1.0	2.3	19.1	46.2
FXYD3	"MAT-8, PLML"	ENSG00000089356	"FXYD domain containing ion transport regulator 3"	Q14802	19	35115879-35124324	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1800.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1870.8;Distal enterocytes: 5605.4;Intestinal goblet cells: 2165.8;Paneth cells: 3324.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 896.3;hTCEpi: 1603.2;OE19: 3112.0;RT4: 860.2;SK-BR-3: 830.8;WM-115: 589.7"									HPA010856	Supported		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA010856: AB_1078915"	"unprognostic (2.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.31e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (4.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.69e-3)"	5.1	1.1	7.3	59.5	7.4	1.3	225.2	7.1	7.9	168.0	7.5	1466.2	102.7	13.2	15.2	685.3	104.3	100.5	5.8	7.1	6.5	12.0	2.0	150.2	0.8	8.0	7.3	1.8	64.3	0.1	24.7	84.9	6.8	512.1	1800.0	45.4	569.1	33.3	2.1	568.3	308.9	35.7	6.7	0.6	572.4	0.6	7.0	18.7	1.5	0.1	163.3	295.6	395.8	7.4	166.3	0.0	0.0	0.4	0.6	0.4	150.5	0.0	0.0	0.0	0.0	6.0	235.3	0.3	0.5	0.0	1.3	896.3	0.1	339.5	0.0	0.1	0.3	1.0	7.7	0.6	0.1	0.1	0.6	0.0	1603.2	0.0	0.7	0.1	0.1	0.1	0.1	1.1	0.0	304.5	0.8	2.2	0.8	3112.0	1.4	0.8	0.4	1.2	0.0	860.2	190.2	2.1	1.0	830.8	61.8	2.3	155.9	0.2	0.0	0.3	0.6	0.9	0.7	0.1	0.4	0.7	1.0	0.3	589.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	7.3	7.4	7.1	7.9	7.1	6.5	8.0	7.3	6.8	6.7	7.0	7.4	3.1	762.8	262.6	0.3	11.1	576.9	792.9	1870.8	340.4	2.9	557.5	515.7	1.3	201.6	1026.4	134.3	0.0	883.5	8.3	5605.4	1.9	35.6	0.4	180.1	29.5	19.7	974.3	2.7	0.1	708.4	138.1	20.3	356.8	194.1	22.3	0.0	0.0	0.9	81.4	1.7	0.0	2165.8	587.9	0.0	68.3	0.0	0.0	15.6	412.6	0.0	1.6	422.1	0.0	0.0	0.6	556.5	3324.0	0.0	6.5	1041.7	1693.0	0.5	1627.1	13.3	0.0	0.5	66.5	0.2	0.2	541.1	865.5	1512.1	17.9	0.0	1499.3	1509.9
GABRR1		ENSG00000146276	"Gamma-aminobutyric acid type A receptor subunit rho1"	P24046	6	89177504-89231278	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	25	"retina: 24.6"	"Cell type enriched"	"Detected in some"	12	"Bipolar cells: 63.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 1.2;OE19: 2.6;SuSa: 1.6"	"Region enhanced"	"Detected in single"		"midbrain: 1.3"											NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (5.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.90e-2)"		"unprognostic (8.32e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	24.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.0	63.1	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	4.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	3.5	3.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.2
GARNL3	"bA356B19.1, DKFZp761J1523"	ENSG00000136895	"GTPase activating Rap/RanGAP domain like 3"	Q5VVW2	9	127224265-127393660	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 77.1;Excitatory neurons: 178.4;Inhibitory neurons: 184.7;Microglial cells: 48.7;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 165.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 5.3;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028757, HPA074886"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA028757: AB_2294383, HPA074886: AB_2732270"	"unprognostic (3.15e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.23e-7)"	"unprognostic (6.39e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.78e-5)"	3.1	6.0	5.7	0.3	5.7	0.0	4.4	11.6	6.0	6.0	2.0	2.9	1.8	7.4	5.2	4.4	5.4	3.7	11.3	6.9	5.2	2.1	1.8	2.4	1.3	4.7	4.5	4.5	2.1	6.6	2.0	1.4	5.8	6.2	1.9	1.3	5.0	4.0	1.5	2.8	1.8	6.7	4.6	1.8	1.8	2.9	4.2	0.6	5.7	1.8	1.3	4.6	3.3	11.2	0.5	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.1	1.0	1.2	0.3	0.0	1.0	0.1	0.4	0.6	1.8	0.0	0.1	0.0	0.8	0.0	1.9	1.2	0.4	0.4	0.1	0.1	1.5	0.0	0.0	1.5	0.7	1.9	0.8	0.7	0.1	0.5	0.0	0.3	0.4	5.3	1.6	0.1	1.1	3.4	1.9	2.5	1.2	3.9	0.8	2.7	0.4	0.6	0.9	0.0	0.0	0.2	1.0	0.0	0.4	2.3	2.4	1.0	0.4	0.5	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	5.7	5.7	11.6	6.0	6.9	5.2	4.7	4.5	5.8	4.6	4.2	11.2	1.3	0.0	0.0	77.1	0.5	2.7	1.7	0.4	2.8	8.0	3.1	4.3	6.8	4.3	2.0	3.7	0.0	0.6	0.2	0.9	1.9	0.3	2.2	1.0	21.1	1.5	1.2	0.4	178.4	0.6	0.1	4.8	5.6	1.2	0.0	2.4	1.8	2.5	0.8	1.7	184.7	0.8	0.0	1.3	1.9	1.0	7.5	1.3	1.8	48.7	0.0	4.0	0.0	45.2	165.3	0.4	1.6	3.4	0.5	3.3	0.6	1.8	0.1	1.0	0.0	7.1	4.0	3.5	3.9	2.7	2.0	0.3	0.7	1.0	0.8	1.2
GAST	GAS	ENSG00000184502	Gastrin	P01350	17	41712331-41715969	"Cancer-related genes, FDA approved drug targets, Predicted secreted proteins"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"stomach 1: 9556.1"	"Cell type enriched"	"Detected in some"	5	"Glandular and luminal cells: 103.7"	"Group enriched"	"Detected in many"	6	"pancreatic cancer: 38.8;stomach cancer: 23.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 34.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB000038	Enhanced				"Secreted to digestive system"	NA	NA		87000		"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"			"CAB000038: "		"unprognostic (1.27e-1)"	"unprognostic (4.27e-3)"		"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"		"unprognostic (2.75e-2)"		"unprognostic (5.68e-2)"	"unprognostic (2.11e-1)"			"unprognostic (2.85e-1)"	"unprognostic (3.17e-1)"		"unprognostic (9.07e-2)"	0.0	0.0	0.9	0.0	0.6	0.0	0.7	0.4	0.9	0.2	0.4	0.0	57.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	2.5	0.3	0.0	3.7	0.0	0.8	1.0	0.0	0.0	0.0	0.1	4.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	9.3	9556.1	0.3	2.5	4.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	5.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	34.8	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.4	0.9	0.5	2.5	0.8	1.0	1.0	0.6	2.5	0.6	0.8	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.3	0.9	0.4	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	2.2	13.5	18.7	0.7	0.0	0.0	0.0	0.0	0.1	1.0	0.5	103.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.8	0.2	0.2	0.0	0.0	8.8	1.0	0.0	0.0	0.4
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 220.7;Urothelial cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 205.4;Hep G2: 178.2;OE19: 287.5;RT4: 189.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		5800000	"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.30e-2)"	26.7	18.3	18.5	16.6	24.9	37.8	27.2	18.1	23.3	9.5	14.1	22.8	41.9	19.2	10.8	37.0	62.9	32.1	16.4	16.8	18.9	34.1	152.1	10.9	26.2	18.4	19.7	8.5	15.9	18.3	4.8	9.1	20.4	26.9	26.0	14.4	13.1	15.8	11.4	18.8	32.2	16.0	18.2	39.1	32.9	11.3	22.5	13.7	30.0	14.5	24.0	63.7	14.5	36.0	31.3	205.4	16.5	39.1	19.4	8.6	22.1	15.5	24.9	11.4	13.3	30.5	70.7	59.1	28.7	14.1	86.9	43.3	50.7	112.5	15.3	46.9	31.4	39.6	38.3	178.2	22.1	52.8	23.5	13.5	46.6	12.8	56.8	15.0	17.7	50.9	22.4	18.2	5.6	32.9	45.5	20.9	30.6	287.5	19.2	14.9	10.2	52.1	37.0	189.8	47.5	23.3	25.9	40.9	27.8	23.8	28.2	24.6	24.6	10.2	35.5	26.0	23.4	24.1	39.9	34.0	25.6	37.0	17.5	1.2	0.5	0.3	0.5	0.9	0.4	0.8	0.5	1.1	2.3	0.5	0.3	0.6	0.2	4.2	1.0	1.6	0.9	0.3	18.5	24.9	18.1	23.3	16.8	18.9	18.4	19.7	20.4	18.2	22.5	36.0	17.1	0.0	2.4	36.9	12.7	34.8	61.6	56.6	47.3	14.4	23.7	13.6	20.9	38.6	47.4	0.0	25.0	6.4	22.9	22.1	11.7	14.6	2.2	34.8	14.9	14.1	220.7	113.2	22.4	12.8	8.6	13.6	43.8	69.8	2.5	50.9	10.4	118.5	22.7	8.4	30.4	19.4	40.7	87.2	10.9	1.5	6.5	32.1	8.8	24.4	10.6	12.5	17.5	30.2	84.1	15.9	13.2	9.4	10.4	88.3	18.2	27.1	66.5	5.0	13.1	14.0	13.5	3.1	9.2	72.6	24.9	7.8	14.9	26.6	14.8	144.8
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.7;intestine: 94.8;kidney: 42.9;liver: 60.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 112.3;Excitatory neurons: 109.3;Glandular and luminal cells: 171.1;Paneth cells: 83.7;Proximal enterocytes: 321.3;Proximal tubular cells: 98.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 34.4;EFO-21: 127.9;HeLa: 46.4;hTCEpi: 62.3;OE19: 157.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"amygdala: 36.5;basal ganglia: 30.1;cerebral cortex: 60.0;hippocampal formation: 70.7;olfactory bulb: 18.3"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		No	NA		1500000	"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.3	2.7	57.0	1.2	66.9	0.4	0.2	19.8	79.7	1.6	23.2	10.4	94.3	3.7	0.4	0.4	8.5	15.9	0.1	62.3	52.3	42.9	60.3	0.2	0.4	19.9	26.1	0.2	2.7	8.5	2.8	2.9	25.8	0.1	9.9	0.1	0.0	6.7	1.6	2.2	94.8	0.4	20.5	0.1	3.4	1.2	60.5	0.6	0.1	0.4	4.7	4.0	0.2	42.3	34.4	4.5	0.1	0.1	0.0	0.0	0.8	0.3	24.9	0.0	0.0	3.2	19.3	0.0	127.9	0.0	0.2	2.9	0.2	0.0	0.0	0.4	0.1	0.0	46.4	0.2	0.0	0.1	0.1	0.2	62.3	0.0	0.6	0.1	0.0	0.0	9.6	0.1	0.0	0.2	0.2	0.3	0.2	157.0	0.0	0.0	0.1	1.1	1.1	7.9	0.2	0.6	2.5	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.4	0.2	0.1	0.3	0.2	0.3	0.1	0.3	0.1	0.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.4	0.3	0.1	0.1	0.1	0.0	57.0	66.9	19.8	79.7	62.3	52.3	19.9	26.1	25.8	20.5	60.5	42.3	0.0	0.0	0.5	3.9	1.9	0.0	0.7	19.0	0.0	0.0	0.0	0.0	0.8	14.3	24.7	0.0	0.0	0.2	0.0	65.5	3.9	11.7	1.2	112.3	7.4	0.4	4.8	0.0	109.3	10.7	1.9	0.3	12.2	171.1	0.0	0.0	1.1	56.9	0.2	0.0	22.8	22.1	2.0	1.9	0.4	0.6	0.3	1.2	0.0	5.6	0.6	0.0	0.0	5.0	3.8	6.7	83.7	0.0	0.1	0.8	321.3	98.2	58.6	0.0	0.0	0.8	3.0	1.4	4.7	0.0	0.1	1.9	1.2	0.2	16.1	2.2
GFUS	"FX, P35B, SDR4E1, TSTA3"	ENSG00000104522	"GDP-L-fucose synthase"	Q13630	8	143612618-143618048	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 32.1;Cytotrophoblasts: 82.1;Extravillous trophoblasts: 156.4;Hofbauer cells: 69.9;Syncytiotrophoblasts: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023361	Approved		Approved	Nucleoplasm,Cytosol		Yes	No		850000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA023361: AB_1858420"	"unprognostic (1.37e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.62e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (6.62e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.27e-2)"	36.3	37.2	21.6	27.7	21.1	52.3	34.0	21.4	25.9	28.6	21.7	45.9	69.2	24.8	19.2	88.7	24.0	29.3	32.1	20.7	21.3	37.5	86.6	28.4	29.1	23.5	21.9	19.0	99.5	22.8	44.0	24.4	22.8	45.0	37.6	6.5	70.9	24.2	30.2	81.5	52.4	19.4	20.2	35.7	111.4	49.4	21.0	26.6	32.1	18.4	27.1	31.0	36.0	22.5	85.6	67.1	29.2	99.7	28.6	26.1	54.1	70.3	73.0	50.2	38.1	78.5	94.3	37.5	64.6	52.5	21.2	60.6	47.8	100.8	23.2	101.7	53.8	58.7	103.0	93.4	57.2	42.2	67.1	30.3	47.4	31.7	127.3	42.2	84.3	61.9	66.4	57.0	41.2	267.5	39.8	53.2	45.8	267.7	87.1	47.1	26.3	122.3	106.1	94.8	67.3	45.9	53.3	100.2	73.0	23.0	133.5	58.8	75.5	34.8	132.0	35.1	67.6	34.1	30.2	29.0	52.8	91.6	54.7	34.9	27.4	42.9	40.3	38.5	43.0	35.2	43.1	46.8	30.1	40.1	31.5	38.5	31.0	63.6	33.8	54.5	57.5	45.7	21.6	21.1	21.4	25.9	20.7	21.3	23.5	21.9	22.8	20.2	21.0	22.5	32.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	82.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	156.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	69.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	87.7	1.7	0.0	0.0	0.0
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24594811-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis, Lipid metabolism"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 174.8;liver: 115.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 80.1;Cholangiocytes: 48.6;Distal enterocytes: 54.1;Ductal cells: 82.6;Hepatocytes: 40.8;Proximal enterocytes: 111.7;Proximal tubular cells: 62.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 37.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 103.6;Karpas-707: 165.8;OE19: 169.5;RPMI-8226: 210.3;RPTEC TERT1: 203.2"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	3.3	2.4	5.5	6.4	6.7	12.0	24.7	7.0	7.5	28.7	5.1	20.3	84.7	3.0	72.0	3.3	3.3	47.1	7.2	5.1	5.1	174.8	115.7	42.6	5.4	7.2	6.6	3.2	63.1	0.2	5.5	2.4	7.8	48.8	11.0	1.6	9.9	21.6	1.9	4.1	80.4	2.2	5.9	13.3	31.3	18.4	7.1	6.5	15.9	0.4	6.2	5.7	4.3	9.2	1.0	79.7	1.0	0.3	0.0	0.5	2.2	0.5	1.7	0.8	1.0	11.7	18.3	1.0	16.2	0.1	14.8	11.0	6.2	0.8	0.5	103.6	12.3	0.6	40.8	64.3	5.5	1.5	33.2	2.1	0.9	2.5	1.7	1.4	0.5	19.0	8.4	165.8	1.0	1.7	1.6	52.4	6.4	169.5	0.7	0.7	6.8	210.3	203.2	2.9	0.5	1.2	0.4	33.3	0.8	22.2	32.4	39.6	6.4	10.6	9.3	46.6	0.9	48.2	18.4	0.7	19.0	58.7	0.5	4.8	12.3	0.2	1.0	6.0	2.9	2.2	5.0	2.4	6.5	0.2	0.6	1.4	15.9	4.9	4.0	0.1	6.5	5.6	5.5	6.7	7.0	7.5	5.1	5.1	7.2	6.6	7.8	5.9	7.1	9.2	0.2	80.1	22.8	3.3	2.8	0.8	0.1	0.3	4.6	0.5	5.9	2.3	0.7	48.6	4.9	1.8	0.0	1.4	0.7	54.1	1.9	82.6	1.8	1.2	0.6	0.7	1.2	5.3	4.4	8.1	0.4	3.9	15.3	5.1	5.7	0.1	1.8	40.8	4.9	0.0	4.1	4.4	4.1	2.5	1.7	6.7	0.0	2.9	1.8	1.0	5.8	2.5	0.0	1.5	5.7	20.9	20.1	0.4	12.8	2.0	111.7	62.9	1.6	0.1	0.0	0.1	1.0	0.6	0.8	0.4	0.4	0.8	4.0	0.0	6.5	0.1
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 160.6"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 182.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 21.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.2;NK-cell: 3.1"	"Group enriched"	"Detected in many"	24	"NK-cells: 3.1;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 49.9;HaCaT: 52.6;OE19: 123.6;SCLC-21H: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054808, HPA059955"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA054808: AB_2682608, HPA059955: AB_2684178"	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	1.5	2.1	3.0	2.6	2.1	0.3	7.0	0.1	7.7	5.9	14.7	27.6	5.7	33.9	2.1	3.5	25.6	2.8	1.2	8.5	0.3	20.7	0.6	3.6	0.6	1.0	0.8	13.7	10.6	25.0	14.1	1.5	1.0	34.5	11.7	160.6	9.1	25.2	1.0	9.4	4.0	4.4	0.1	0.6	9.0	8.3	0.7	0.5	22.7	0.2	0.6	6.7	5.0	1.3	16.0	1.6	8.2	4.7	0.0	0.0	5.5	0.0	0.0	0.0	0.0	13.3	49.9	0.0	16.3	0.0	6.8	52.6	25.2	0.4	0.0	0.0	23.9	0.0	6.7	0.6	2.2	0.0	28.4	0.3	0.7	0.0	0.0	0.0	0.1	7.6	26.3	0.0	0.0	15.3	4.4	3.0	4.7	123.6	18.2	0.0	0.0	1.5	14.1	11.0	34.9	13.1	11.4	14.2	0.0	1.2	18.4	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.1	0.0	3.1	0.0	0.0	0.0	3.2	0.0	1.2	0.0	0.6	1.2	0.0	0.1	0.9	1.4	0.0	3.1	0.0	0.0	0.0	0.5	3.0	2.1	0.1	7.7	8.5	0.3	1.0	0.8	1.0	0.1	0.7	1.3	0.2	0.0	1.8	0.3	0.4	2.2	5.2	1.0	1.8	6.2	7.2	7.9	1.6	1.5	2.5	0.0	41.7	0.2	3.4	19.5	0.0	2.5	2.1	7.9	22.1	1.2	9.0	0.0	1.6	2.4	1.0	3.6	4.1	2.2	0.0	41.9	0.0	0.2	0.2	5.0	1.2	5.9	0.0	0.0	0.3	6.8	1.2	0.3	5.4	1.0	0.0	10.8	1.0	1.0	0.3	2.2	6.3	0.7	2.2	8.1	3.0	8.4	10.1	182.0	0.0	3.7	2.3	2.6	4.6	1.9	0.9	0.1	2.5	3.4	11.5	2.7
GLYCTK	"HBEBP2, HBEBP4"	ENSG00000168237	"Glycerate kinase"	Q8IVS8	3	52287089-52295257	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 275.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 183.0;Proximal enterocytes: 105.2;Proximal tubular cells: 83.0"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 52.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006913	Approved		Approved	"Golgi apparatus,Cytosol,Rods & Rings"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Golgi apparatus, Rods & Rings"	"HPA006913: AB_1078993"	"unprognostic (1.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.00e-3)"	14.8	8.3	1.0	4.5	0.9	6.7	9.3	0.5	1.5	2.9	0.9	11.4	22.4	3.2	0.6	3.8	2.7	2.2	4.4	0.9	1.2	24.9	275.1	4.2	4.6	1.4	0.9	2.4	5.9	2.5	2.9	2.2	1.2	3.7	3.6	0.6	3.1	1.0	3.6	1.9	21.7	1.6	0.4	8.9	8.5	2.3	1.2	2.3	4.1	1.0	3.2	3.3	2.5	1.2	2.9	5.8	3.4	1.2	15.7	2.4	1.8	2.4	2.6	4.6	3.9	12.1	2.4	6.7	1.6	2.7	3.7	1.6	1.7	7.8	0.8	2.0	1.8	9.3	7.5	16.2	1.7	2.8	5.0	2.4	3.5	7.6	3.2	2.1	10.2	5.2	2.4	4.5	3.6	1.9	5.9	2.7	1.5	14.2	4.2	1.9	2.5	11.1	5.8	3.9	1.9	1.9	2.6	1.4	3.0	1.0	3.2	1.7	3.8	3.5	4.1	2.4	6.1	5.1	3.9	5.4	2.7	4.9	2.2	2.2	5.2	6.6	5.6	2.8	2.6	4.4	4.2	4.9	5.6	2.6	3.3	4.3	4.4	3.6	3.5	3.4	6.6	3.7	1.0	0.9	0.5	1.5	0.9	1.2	1.4	0.9	1.2	0.4	1.2	1.2	5.4	6.4	3.2	0.7	8.2	0.4	3.2	4.1	1.8	1.6	2.1	1.4	1.6	18.6	3.0	9.2	0.0	7.9	9.2	18.4	19.6	5.4	0.3	4.4	2.7	8.3	23.4	26.5	0.6	6.2	5.3	2.9	27.0	8.6	1.3	3.4	14.6	183.0	13.2	0.0	0.4	15.8	2.0	16.6	2.4	0.0	1.2	9.1	3.6	1.0	7.7	1.2	9.2	0.5	0.7	4.0	40.6	0.0	13.5	2.8	105.2	83.0	2.4	1.5	0.0	2.7	2.7	1.8	8.3	2.1	1.3	11.1	9.3	7.7	24.9	4.3
GMDS	"GMD, SDR3E1"	ENSG00000112699	"GDP-mannose 4,6-dehydratase"	O60547	6	1623806-2245605	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 106.0;salivary gland: 105.4;stomach 1: 97.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 208.5;Gastric mucus-secreting cells: 276.8;Intestinal goblet cells: 367.6;Proximal enterocytes: 190.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 246.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031528	Enhanced					NA	NA		72000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA031528: AB_10601016"	"unprognostic (5.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (4.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.12e-1)"	10.7	7.6	8.6	30.1	7.1	9.1	14.6	5.8	7.1	29.4	9.7	87.7	106.0	7.8	10.4	65.8	11.5	20.5	9.5	7.6	7.0	19.6	31.1	9.0	14.2	6.6	6.9	6.7	43.8	20.5	12.9	7.1	6.7	18.3	82.4	1.5	105.4	8.0	5.1	10.6	87.3	10.3	6.1	11.4	97.1	9.2	7.3	13.9	11.9	4.9	20.8	13.7	14.2	6.2	45.9	10.6	7.4	52.6	11.8	32.0	17.9	12.5	25.7	22.7	21.2	23.1	26.1	21.7	37.3	13.6	22.4	18.3	22.9	43.8	26.2	30.0	28.8	21.0	11.2	110.3	13.2	34.2	22.5	35.6	14.9	18.0	37.2	21.9	26.9	73.0	13.9	9.8	14.7	26.3	49.0	40.1	11.4	246.4	36.0	24.8	16.8	112.4	55.4	59.5	41.4	9.9	11.5	17.7	28.8	33.6	16.4	21.4	11.7	17.4	13.1	17.7	22.5	22.1	33.6	23.1	11.4	23.6	23.4	7.0	12.9	1.5	7.8	8.3	10.3	10.5	9.4	7.5	14.5	5.0	7.6	10.8	3.8	13.1	6.8	6.1	13.2	8.3	8.6	7.1	5.8	7.1	7.6	7.0	6.6	6.9	6.7	6.1	7.3	6.2	19.7	0.0	4.5	40.8	19.8	4.2	20.1	38.3	27.3	3.7	33.1	19.3	2.9	12.8	40.5	38.6	0.0	18.7	6.5	104.1	119.3	36.5	5.7	7.8	7.3	23.0	111.7	9.7	208.5	69.7	30.8	12.4	276.8	11.9	4.5	13.2	18.2	19.6	13.5	8.4	167.5	367.6	50.8	10.9	7.6	4.6	12.2	11.0	23.2	143.4	14.7	3.3	9.2	83.9	50.2	47.0	85.5	16.6	53.1	40.7	190.7	38.1	38.3	0.7	13.1	5.8	16.6	6.5	33.1	20.1	6.1	16.7	18.6	13.4	165.1	43.5
GNPNAT1	"FLJ10607, Gpnat1"	ENSG00000100522	"Glucosamine-phosphate N-acetyltransferase 1"	Q96EK6	14	52775193-52791668	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 77.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044647	Approved					NA	NA		72000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA044647: AB_10795986"	"unprognostic (4.55e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.18e-3)"	"unprognostic (4.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (8.52e-5)"	"unprognostic (5.82e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.05e-2)"	21.5	7.3	4.8	11.1	5.5	3.9	16.8	6.9	6.1	14.6	5.0	18.4	15.0	9.2	9.5	8.5	8.4	11.4	5.4	5.9	5.8	13.6	77.1	6.0	7.3	4.9	4.7	9.3	25.4	8.0	5.8	10.5	5.4	15.5	22.0	5.6	19.3	7.0	11.2	6.7	14.1	10.7	4.9	5.5	19.7	15.3	5.1	5.8	8.5	7.3	8.5	13.8	6.1	6.2	99.8	37.6	30.5	34.7	32.0	73.8	49.9	63.6	41.4	53.5	54.8	43.4	59.1	56.3	34.6	64.2	26.2	40.0	59.2	64.0	92.9	32.4	31.1	38.1	36.2	55.1	46.2	42.7	19.5	29.9	53.1	92.9	99.5	27.7	62.1	35.3	36.7	13.4	70.8	85.6	52.0	21.9	31.8	129.1	67.6	34.7	14.4	33.9	51.2	51.3	30.6	42.8	54.1	70.5	46.6	20.8	83.4	14.6	70.1	55.2	56.9	97.6	50.0	14.0	28.4	24.4	26.1	27.4	32.8	6.4	1.7	0.1	5.0	2.1	6.0	4.6	5.2	4.6	4.0	5.1	5.9	4.7	0.6	5.5	5.0	2.4	6.8	3.1	4.8	5.5	6.9	6.1	5.9	5.8	4.9	4.7	5.4	4.9	5.1	6.2	14.1	16.0	12.1	5.2	10.7	19.2	33.7	19.1	10.2	9.6	23.6	16.3	3.6	18.6	18.5	12.9	4.2	23.3	10.6	13.4	33.2	40.3	43.8	16.0	25.5	17.7	5.4	13.3	16.5	37.6	74.8	25.8	32.6	39.5	7.0	16.5	12.1	89.4	15.5	3.3	10.8	61.0	10.2	6.0	9.3	11.8	19.6	8.6	7.2	8.4	5.4	5.3	18.6	9.0	9.0	45.9	14.0	18.0	13.8	42.0	8.0	16.1	13.0	6.4	19.7	18.3	24.7	71.2	7.2	22.3	21.3	12.2	10.6	13.7	30.1	38.1
GOLGA5	"golgin-84, GOLIM5, ret-II, rfg5"	ENSG00000066455	"Golgin A5"	Q8TBA6	14	92794305-92839947	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000992, HPA063876"	Enhanced	Supported	Supported	"Golgi apparatus"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA000992: AB_1079009, HPA063876: AB_2685140"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.49e-2)"	26.0	23.3	21.4	18.2	23.7	10.4	33.1	22.4	26.4	32.2	23.9	26.4	23.3	21.9	54.2	25.0	19.2	24.0	21.5	20.8	22.3	25.5	54.3	22.4	18.8	22.6	22.4	20.6	32.2	33.6	23.5	28.2	23.1	31.2	32.5	15.8	32.4	25.8	26.9	23.3	22.9	26.0	22.6	19.1	32.9	34.3	22.1	16.9	33.2	20.0	23.3	24.1	19.6	25.9	32.4	29.4	25.9	23.7	53.1	71.4	44.3	43.9	80.4	41.9	49.2	21.8	43.4	21.0	35.1	70.2	29.2	33.4	23.1	35.9	56.6	25.8	11.2	19.9	14.0	29.3	61.5	23.3	31.8	55.1	63.7	29.5	60.6	46.2	42.0	21.8	17.7	27.3	46.5	60.1	18.1	19.6	16.1	70.2	31.0	13.9	37.9	21.1	42.8	38.9	18.4	26.0	40.0	29.6	45.7	35.7	51.0	25.6	35.0	23.9	15.6	31.3	22.2	33.3	27.6	18.2	54.9	18.2	40.8	10.4	10.0	23.6	10.3	13.0	11.8	9.5	10.4	10.6	9.9	9.5	9.2	8.1	8.8	8.7	11.9	9.1	12.9	6.7	21.4	23.7	22.4	26.4	20.8	22.3	22.6	22.4	23.1	22.6	22.1	25.9	18.7	28.9	26.3	8.8	15.7	7.8	11.2	17.9	16.5	7.5	16.2	11.9	26.8	8.6	19.6	14.7	12.5	23.7	17.2	23.8	29.4	25.3	31.6	17.6	24.6	16.7	22.3	15.8	17.6	32.7	32.0	21.7	33.1	25.7	9.5	29.7	13.9	33.5	15.4	25.2	15.6	31.6	4.1	14.7	10.3	18.5	23.0	14.6	12.4	15.0	18.2	15.6	16.5	14.6	21.9	28.9	12.0	25.2	29.2	19.4	19.9	24.2	18.7	10.7	26.3	18.0	19.3	34.1	37.0	16.5	11.4	50.3	15.9	15.6	16.5	16.5
GON7	C14orf142	ENSG00000170270	"GON7 subunit of KEOPS complex"	Q9BXV9	14	93202894-93207065	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 68.4;Endometrial ciliated cells: 187.5;Proximal tubular cells: 51.8;Respiratory ciliated cells: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051832	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		41000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli rim"		"HPA051832: AB_2681628"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (3.40e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.47e-3)"	"unprognostic (7.37e-2)"	"prognostic favorable (3.08e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.77e-1)"	6.9	13.2	9.0	5.8	8.8	0.4	8.3	8.6	11.5	12.1	15.8	13.9	13.2	5.4	23.3	6.8	35.4	7.2	14.7	9.0	10.1	17.8	12.9	8.8	1.9	9.8	9.4	5.6	10.4	12.6	12.8	5.6	10.2	7.9	12.0	13.4	7.9	5.7	13.4	4.9	10.2	5.2	8.6	8.8	9.1	8.7	9.6	3.7	8.7	12.9	9.9	6.9	5.7	9.1	11.6	9.2	13.3	8.9	9.2	21.4	9.3	11.0	6.2	21.6	17.5	9.1	18.1	4.7	7.2	7.0	12.6	18.2	18.3	9.2	25.1	0.1	0.0	4.6	22.5	22.6	4.7	9.7	19.6	4.1	11.9	15.1	9.7	6.0	13.3	5.5	16.7	1.5	9.3	26.8	11.3	23.4	3.4	49.6	4.3	20.0	12.9	21.4	23.4	12.9	15.8	19.8	8.2	20.4	24.8	11.8	16.8	19.9	13.6	7.6	15.1	16.5	6.2	10.0	29.6	3.1	23.2	10.8	13.2	6.2	0.9	0.4	0.8	1.7	0.1	0.0	0.5	0.6	1.5	0.7	0.2	0.4	0.9	0.3	0.8	0.2	0.8	0.5	9.0	8.8	8.6	11.5	9.0	10.1	9.8	9.4	10.2	8.6	9.6	9.1	17.2	6.4	13.6	0.0	7.2	0.0	0.0	0.0	0.0	0.0	19.7	23.9	0.0	0.0	9.9	14.7	0.0	19.6	12.7	0.0	68.4	27.7	0.0	187.5	15.8	7.3	0.0	0.0	0.0	21.7	18.1	5.8	0.0	27.4	10.1	9.4	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	17.5	0.0	0.0	1.4	0.0	0.0	51.8	94.7	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	7.7	7.0	21.3	0.0	0.0
GPA33	A33	ENSG00000143167	"Glycoprotein A33"	Q99795	1	167052836-167166479	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"intestine: 215.9"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 775.5;Intestinal goblet cells: 211.6;Paneth cells: 420.3;Proximal enterocytes: 266.1;Undifferentiated cells: 147.2"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 84.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 24.2;T-reg: 19.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 24.2"	"Cell line enriched"	"Detected in some"	8	"OE19: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018858, CAB025943"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB025943: , HPA018858: AB_1849909"	"unprognostic (2.41e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.96e-3)"	0.4	0.0	0.0	18.5	0.0	0.7	0.2	0.0	0.2	0.0	0.4	215.9	150.0	0.3	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.1	0.0	7.1	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	196.2	0.0	0.0	0.4	0.3	0.0	136.9	7.2	0.0	0.9	1.5	0.2	0.2	2.3	0.0	0.1	1.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.3	1.8	14.4	0.0	0.0	0.8	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	3.8	1.6	0.2	10.9	5.7	2.7	2.2	24.2	3.5	0.2	0.2	2.6	0.0	19.5	6.8	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.3	775.5	0.0	0.0	3.9	0.0	0.0	0.1	26.1	0.8	0.4	0.0	0.0	0.0	0.5	0.0	4.5	0.0	0.0	0.0	0.5	0.0	0.3	211.6	0.0	1.9	1.3	2.3	0.3	1.8	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.1	420.3	0.0	0.0	0.0	266.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.1	0.0	3.1	0.0	147.2	0.2
GPX2	GSHPX-GI	ENSG00000176153	"Glutathione peroxidase 2"	P18283	14	64939152-64942905	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 497.7;intestine: 453.8;liver: 634.0;stomach 1: 374.6;urinary bladder: 350.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 386.1;Distal enterocytes: 436.6;Gastric mucus-secreting cells: 912.3;Hepatocytes: 753.4;Intestinal goblet cells: 438.6;Paneth cells: 463.0;Undifferentiated cells: 776.8;Urothelial cells: 1062.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 493.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 4748.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.2"	"Low region specificity"	"Detected in some"			HPA003545	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		82000	"Cluster 48: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA003545: AB_10962695"	"unprognostic (3.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.66e-4)"	"unprognostic (1.73e-2)"	1.9	0.2	0.1	53.8	0.3	0.3	5.3	0.5	0.3	23.5	0.1	333.5	96.7	0.7	1.7	187.7	4.9	497.7	0.3	0.2	0.5	30.6	634.0	2.6	0.1	0.4	0.2	0.2	24.5	0.0	1.2	0.2	0.4	43.3	453.8	0.0	71.8	24.9	0.3	25.4	175.7	9.7	0.1	0.6	374.6	2.5	0.3	3.3	0.5	0.0	1.2	350.5	108.2	0.7	0.0	1152.6	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	36.9	9.6	0.0	6.0	0.0	1.9	303.7	0.6	4.8	0.0	0.2	0.1	0.1	1.1	1048.6	0.0	0.1	0.4	0.0	9.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	5.6	0.6	0.3	1.3	4748.8	0.2	0.5	0.2	0.2	0.1	727.5	324.2	0.2	0.1	13.4	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.3	0.2	0.5	0.4	0.2	0.4	0.1	0.3	0.7	0.1	0.0	0.0	0.3	6.9	9.9	169.4	104.5	42.1	0.2	0.6	4.1	0.4	386.1	17.1	23.9	0.0	0.1	0.0	436.6	11.7	272.8	13.8	3.8	0.5	3.5	115.2	50.8	0.2	260.6	0.1	2.1	912.3	2.8	13.4	0.1	17.5	753.4	0.0	0.0	0.2	438.6	36.7	26.1	0.8	66.6	0.9	3.5	0.0	1.9	3.2	0.0	0.0	0.0	0.4	163.7	463.0	0.0	2.4	100.7	68.1	31.4	9.0	0.7	0.0	0.0	3.6	0.4	0.0	315.5	9.7	0.0	5.9	0.1	776.8	1062.0
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"		"Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.2;kidney: 61.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 77.1;Basal squamous epithelial cells: 104.7;Prostatic glandular cells: 79.0;Squamous epithelial cells: 124.7;Syncytiotrophoblasts: 98.6;Urothelial cells: 79.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"cerebellum: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"OE19: 1706.0"	"Region enhanced"	"Detected in many"		"cerebellum: 8.3"	"Low region specificity"	"Detected in many"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"		"CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330"	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.10e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	5.9	0.1	0.0	0.7	0.4	0.0	14.2	5.6	0.4	13.5	4.5	8.1	11.8	3.3	3.8	60.2	22.3	9.5	1.2	0.2	0.0	61.5	11.1	10.6	0.1	0.0	0.4	1.0	32.7	11.4	6.9	11.9	0.5	14.5	10.0	0.1	25.2	11.6	0.3	39.9	10.8	1.0	0.0	0.5	16.9	1.2	0.1	1.1	6.6	0.1	8.7	7.5	26.2	0.3	12.6	14.4	0.0	0.0	0.0	0.0	19.1	0.0	0.8	0.1	0.5	44.7	24.3	0.0	4.2	0.4	0.9	24.1	0.0	16.1	0.0	0.0	2.1	0.0	6.4	38.5	0.0	0.0	0.0	0.0	15.1	0.2	3.7	2.5	0.1	0.0	0.0	0.0	0.0	11.5	0.2	0.1	4.9	1706.0	3.4	0.1	0.0	18.6	18.5	14.0	9.5	0.1	18.4	370.7	0.1	17.3	14.0	0.0	0.0	0.0	1.1	0.2	0.0	0.2	0.1	1.0	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.6	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.3	0.5	22.4	15.1	0.0	0.9	38.2	77.1	20.0	104.7	0.2	48.2	30.5	2.5	17.2	18.2	22.0	0.0	35.7	0.7	25.6	9.8	35.6	0.0	30.2	5.3	2.6	14.4	0.0	0.3	19.4	27.4	3.1	27.0	41.8	1.3	0.5	0.4	5.1	2.8	0.0	0.0	19.7	40.7	0.0	2.3	0.0	2.8	1.3	5.4	0.0	1.6	0.4	0.0	0.0	0.0	26.7	26.0	1.2	0.3	79.0	28.3	13.8	20.9	0.1	0.0	0.9	2.1	0.4	0.3	124.7	41.9	98.6	1.4	0.0	21.1	79.7
GRK5	GPRK5	ENSG00000198873	"G protein-coupled receptor kinase 5"	P34947	10	119207571-119459745	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Microglial cells: 56.2;Sertoli cells: 59.2;Smooth muscle cells: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.1;HUVEC TERT2: 24.9;OE19: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025579, HPA046838"	Approved		Supported	"Nuclear membrane,Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear membrane, Nuclear speckles"	"Plasma membrane"	"CAB025579: , HPA046838: AB_2679833"	"unprognostic (1.09e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (2.38e-7)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	38.4	18.0	4.2	5.9	5.0	2.7	24.6	5.0	4.6	18.8	3.5	26.3	10.0	21.1	3.5	12.6	19.6	5.7	48.8	4.0	5.1	14.2	12.9	65.6	7.8	3.9	3.6	35.0	4.7	21.3	13.3	8.3	3.9	14.1	4.9	1.0	7.8	4.0	11.9	11.5	25.8	7.3	3.3	37.0	27.5	4.1	4.9	6.2	19.6	9.7	6.8	19.4	18.1	3.5	3.7	2.3	5.4	5.7	11.8	11.0	1.6	7.1	32.1	4.1	2.3	1.7	5.4	3.9	1.6	11.1	7.5	0.9	2.3	7.7	2.7	15.4	2.0	0.7	4.6	7.0	8.2	0.2	2.0	1.5	1.1	8.5	1.2	5.2	24.9	2.4	0.4	3.7	1.5	0.7	3.8	3.5	0.8	25.8	5.2	1.3	0.8	0.9	0.6	1.5	1.8	4.9	2.4	1.1	7.0	3.0	0.1	0.9	7.8	2.3	1.6	14.6	2.8	0.9	4.4	2.4	4.9	4.4	2.4	0.4	1.5	2.9	2.0	1.4	0.1	3.8	3.0	1.6	0.9	4.0	4.5	2.0	2.1	0.1	0.5	0.0	4.0	1.7	4.2	5.0	5.0	4.6	4.0	5.1	3.9	3.6	3.9	3.3	4.9	3.5	32.6	57.7	3.7	3.6	19.7	1.7	0.7	0.5	1.2	3.9	2.3	2.0	19.4	0.0	1.3	3.7	0.0	3.7	13.3	0.4	0.0	1.1	18.7	0.4	5.1	28.4	4.8	0.0	17.7	3.1	15.8	35.7	18.8	1.0	4.5	7.8	24.7	2.2	4.4	1.7	36.5	0.8	6.1	15.5	6.3	4.9	4.4	14.2	7.2	56.2	3.6	0.0	19.6	14.1	5.7	2.4	1.2	4.5	10.2	0.7	4.9	0.6	0.8	0.9	59.2	18.2	46.5	1.3	2.1	0.7	2.4	13.1	14.1	4.6	0.5	0.9
GSTP1	"FAEES3, GST3, GSTP"	ENSG00000084207	"Glutathione S-transferase pi 1"	P09211	11	67583742-67586656	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2087.9"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 4033.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 4998.3;OE19: 7810.3"	"Low region specificity"	"Detected in all"							"HPA019779, HPA019869"	Enhanced		Supported	Mitochondria,Cytosol		No	No		69000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Mitochondria, Cytosol"		"HPA019779: AB_1849799, HPA019869: AB_1849801"	"unprognostic (9.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.14e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.72e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.48e-1)"	290.5	276.2	346.8	232.1	370.3	601.3	288.7	358.9	425.7	641.9	695.8	329.6	394.6	331.9	280.3	2087.9	647.5	435.8	367.2	341.4	381.9	567.7	45.1	468.3	321.8	375.7	379.2	306.9	340.9	737.4	320.2	326.9	378.5	291.7	197.1	137.9	541.2	780.4	355.0	731.4	321.7	214.2	367.0	257.2	535.5	45.8	378.1	296.9	579.0	312.5	380.8	526.5	946.2	377.7	1202.5	1599.4	763.7	1198.9	577.8	645.2	705.3	511.3	678.1	761.2	589.3	2956.3	1225.0	3.3	1144.7	813.5	683.7	1707.8	2073.9	2248.5	214.4	848.0	765.3	59.9	1107.6	0.5	852.2	400.3	667.6	807.2	4998.3	609.9	583.3	560.9	1160.2	847.2	1318.2	321.8	605.7	4.3	918.2	1100.6	1475.2	7810.3	681.3	844.8	129.6	3.8	1236.8	3.6	260.6	754.3	719.1	230.9	2394.0	598.2	3.6	656.3	634.5	351.6	883.8	740.6	378.6	200.0	1353.9	447.1	400.0	652.4	747.8	56.0	3145.4	246.6	720.0	2470.8	271.9	509.2	322.4	597.7	3582.7	476.3	267.8	466.5	130.5	1443.8	1608.5	1435.1	363.3	3948.4	346.8	370.3	358.9	425.7	341.4	381.9	375.7	379.2	378.5	367.0	378.1	377.7	466.7	1153.8	872.3	25.5	296.8	865.6	1914.8	3813.8	767.2	170.0	628.7	838.3	297.3	987.9	2763.5	1230.4	33.3	2116.8	372.4	655.0	1805.9	1811.9	4.9	1381.0	589.0	431.4	368.2	166.3	6.8	1444.4	1703.9	710.5	781.9	1020.9	269.9	795.0	382.3	10.5	861.2	70.7	10.1	992.4	1930.7	597.9	1090.3	25.5	572.3	703.5	1531.5	27.2	2166.5	558.5	459.3	17.6	38.4	1412.1	948.9	400.2	591.6	2266.2	844.4	3495.5	3715.4	274.4	361.6	401.3	941.7	4.8	54.9	4033.7	1061.7	1645.5	342.5	527.8	1118.5	3418.6
GUCA2A	"GUCA2, STARA"	ENSG00000197273	"Guanylate cyclase activator 2A"	Q02747	1	42162690-42164745	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"intestine: 927.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 3728.7;Paneth cells: 17085.1;Proximal enterocytes: 12113.5"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 31.6;urothelial cancer: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 52.1"	"Not detected"	"Not detected"							HPA018215	Enhanced				"Secreted to blood"	NA	NA		18000000		"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA018215: AB_1850443"			"unprognostic (7.98e-3)"		"unprognostic (1.60e-1)"		"unprognostic (1.16e-1)"	"unprognostic (9.07e-2)"			"unprognostic (1.14e-1)"			"unprognostic (8.06e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.15e-2)"	0.8	0.1	0.0	3.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	716.9	56.5	0.9	0.0	0.2	0.4	0.3	0.1	0.0	0.0	0.4	0.2	1.2	0.7	0.0	0.0	0.1	1.2	0.0	0.2	7.3	0.0	0.1	725.9	0.0	0.0	2.0	0.1	0.0	927.5	17.2	0.0	0.2	0.7	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3728.7	0.0	2.6	0.1	0.0	0.0	0.0	47.7	0.0	0.0	1.1	4.4	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	421.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17085.1	0.0	0.0	0.0	12113.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	3.8	0.0	206.6	0.2
HABP2	"FSAP, HABP, HGFAL, PHBP"	ENSG00000148702	"Hyaluronan binding protein 2"	Q14520	10	113550837-113589602	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 437.3"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 124.4;Hepatocytes: 221.4"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 92.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"OE19: 64.7;RPTEC TERT1: 50.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019518	Uncertain				"Secreted to blood"	NA	NA	20200000000	4400000000		"Cluster 62: Liver - Hemostasis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA019518: AB_1850467"	"unprognostic (3.89e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.05e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.9	0.0	0.0	3.1	2.9	1.7	0.0	2.2	36.0	3.8	0.1	0.0	14.2	437.3	0.8	0.0	0.0	0.0	0.0	17.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.1	12.1	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	64.7	0.0	0.0	0.1	0.0	50.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	2.3	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	124.4	0.0	1.8	0.0	0.0	0.0	0.0	3.9	31.4	0.5	10.8	0.8	0.4	0.0	5.3	1.0	3.9	0.0	0.0	17.9	6.5	0.0	0.0	5.3	221.4	1.0	0.0	0.0	0.2	0.0	5.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	12.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.1
HDHD3	"C9orf158, MGC12904"	ENSG00000119431	"Haloacid dehalogenase like hydrolase domain containing 3"	Q9BSH5	9	113373419-113376999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 156.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 214.0;Exocrine glandular cells: 156.4;Paneth cells: 208.6;Proximal enterocytes: 254.0;Proximal tubular cells: 275.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020427, HPA024158, HPA024585"	Enhanced		Enhanced	Nucleoli,Vesicles		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli	Vesicles	"HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565"	"unprognostic (1.30e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.87e-2)"	"prognostic favorable (3.54e-7)"	"unprognostic (2.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.19e-3)"	12.2	156.4	16.8	11.1	18.0	8.4	19.5	16.2	19.3	19.9	14.5	59.7	82.9	13.4	14.9	42.1	16.5	17.8	22.4	15.8	17.7	56.3	122.8	10.2	10.2	15.7	17.0	19.9	53.0	68.4	23.1	5.0	16.2	30.4	35.9	8.0	52.2	16.1	8.8	28.3	68.5	7.7	15.7	17.6	50.1	7.0	18.5	6.7	38.7	5.7	7.6	17.6	21.1	15.5	7.4	20.8	4.4	12.3	10.7	4.7	37.0	5.4	10.1	8.6	9.3	38.3	36.1	16.2	6.6	3.0	17.0	28.3	7.0	8.3	2.9	22.9	16.1	22.4	12.5	24.1	12.5	1.4	16.6	7.4	17.4	7.0	19.7	9.9	4.5	14.9	18.0	4.0	4.1	48.3	10.4	6.5	9.9	73.7	16.1	8.5	0.0	13.2	11.0	15.4	11.1	7.0	9.3	39.4	14.0	9.5	24.8	4.7	4.5	1.7	0.1	1.4	1.9	9.7	20.2	6.8	2.1	0.1	1.3	0.2	3.7	8.2	12.4	2.1	14.0	14.8	14.2	11.5	6.1	16.6	14.5	11.1	2.4	8.2	0.2	14.1	17.1	8.5	16.8	18.0	16.2	19.3	15.8	17.7	15.7	17.0	16.2	15.7	18.5	15.5	4.1	9.6	10.1	24.5	19.7	9.9	20.6	26.6	10.8	10.3	38.6	31.2	15.8	80.1	32.6	23.9	10.4	29.4	11.7	214.0	86.1	84.8	0.2	20.9	6.4	9.4	40.3	15.4	9.2	156.4	16.5	8.6	112.7	22.3	7.6	122.4	9.7	85.4	20.6	1.7	10.4	80.4	28.5	6.5	3.7	2.0	14.3	6.9	10.6	6.5	13.7	12.1	15.5	5.5	4.9	104.8	208.6	9.1	9.3	23.7	254.0	275.1	33.3	13.8	6.6	5.5	11.1	0.3	6.0	42.9	14.6	31.6	14.0	26.0	94.6	51.4
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628172-120682269	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"kidney: 200.3;liver: 752.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 103.7;Endometrial ciliated cells: 113.9;Glandular and luminal cells: 127.8;Hepatocytes: 534.7;Proximal tubular cells: 477.5"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 119.8"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 55.8;EFO-21: 82.7;Hep G2: 186.6;OE19: 328.0;RPTEC TERT1: 212.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"		NA	NA		700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.4	0.3	0.4	2.5	1.9	0.5	12.5	0.6	0.8	27.4	1.5	16.7	31.6	3.1	13.0	0.4	4.2	61.7	0.3	0.5	0.4	200.3	752.6	0.8	0.4	0.4	0.4	0.2	31.2	7.0	0.2	0.2	0.4	44.5	20.3	0.7	4.2	4.2	0.1	0.9	25.6	0.5	0.4	0.6	25.5	0.1	0.5	0.7	55.1	0.2	0.1	0.2	0.1	0.6	0.0	12.3	4.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	55.8	10.7	0.1	82.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.2	186.6	0.0	0.4	1.0	0.0	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.5	0.0	0.0	0.2	0.3	328.0	0.0	0.1	0.3	0.1	212.2	0.0	0.2	0.2	0.2	0.9	0.0	0.0	0.2	1.0	0.6	0.1	0.9	0.2	0.1	0.0	0.3	0.5	0.2	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.4	1.9	0.6	0.8	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.6	0.1	0.0	2.0	0.3	5.9	0.0	0.4	0.6	0.0	0.3	7.5	1.7	0.3	81.5	4.9	27.6	2.1	0.0	0.3	18.5	103.7	7.2	0.2	113.9	17.1	1.2	43.8	24.0	3.2	17.8	0.0	0.4	19.4	127.8	1.3	0.0	16.4	534.7	0.2	0.0	0.6	16.0	2.0	16.1	0.0	0.0	0.0	21.3	0.0	1.9	2.0	4.2	0.0	0.0	0.5	12.1	35.6	0.0	0.0	12.9	54.6	477.5	4.1	0.2	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	3.8	0.4	9.1	0.4
HIKESHI	"C11orf73, HSPC138, HSPC179, OPI10"	ENSG00000149196	"Heat shock protein nuclear import factor hikeshi"	Q53FT3	11	86302211-86345943	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 129.6;Extravillous trophoblasts: 146.2;Hofbauer cells: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012708, HPA035063, HPA035064"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	"Nucleoplasm, Nuclear bodies"	"HPA012708: , HPA035063: AB_10601143, HPA035064: AB_2674441"	"unprognostic (1.10e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.01e-12)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.71e-1)"	34.7	27.0	46.1	17.8	46.7	19.0	31.4	47.8	71.5	33.9	44.5	40.8	10.4	32.3	24.7	33.4	31.0	15.0	57.1	46.1	47.2	17.0	24.7	23.9	26.0	46.6	46.0	37.5	22.8	22.9	31.5	28.3	47.1	24.5	19.1	32.5	19.8	28.6	59.9	29.5	20.8	31.1	49.1	28.5	23.5	19.0	47.1	32.9	17.7	57.8	30.8	32.8	31.8	50.9	28.6	30.5	72.7	40.5	59.9	74.2	38.2	43.2	52.0	44.2	52.6	90.8	77.8	29.0	96.9	57.4	83.9	59.9	54.2	95.1	47.0	62.0	47.6	47.0	47.5	68.2	80.8	58.0	36.8	52.7	94.9	52.8	62.5	56.9	85.9	54.7	51.1	64.6	91.5	78.0	69.6	136.7	59.5	186.3	20.1	53.0	35.7	65.4	77.2	53.2	44.8	38.7	53.8	39.8	31.1	72.7	64.1	38.5	44.2	52.1	36.4	105.8	32.7	27.7	68.3	57.6	26.6	54.4	52.6	47.8	53.4	44.4	48.6	52.5	54.3	61.8	59.1	53.6	68.9	52.9	51.1	52.3	11.2	57.9	53.9	53.7	84.5	43.2	46.1	46.7	47.8	71.5	46.1	47.2	46.6	46.0	47.1	49.1	47.1	50.9	59.9	38.5	32.1	0.0	16.1	0.0	0.0	0.0	0.0	0.0	53.4	81.3	0.0	0.0	14.9	27.6	0.0	129.6	28.7	0.0	41.1	76.1	0.0	41.4	60.4	28.7	0.0	0.0	0.0	66.3	146.2	30.2	0.0	36.8	22.7	52.1	0.0	0.0	94.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	50.1	0.0	0.0	0.0	0.0	49.8	0.0	0.0	4.1	0.0	0.0	43.2	27.7	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	77.6	18.1	59.3	0.0	0.0
HMGCL	HL	ENSG00000117305	"3-hydroxy-3-methylglutaryl-CoA lyase"	P35914	1	23801885-23838620	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 322.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 172.4;Proximal tubular cells: 216.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004727	Enhanced				"Intracellular and membrane"	NA	NA		34000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA004727: AB_1079074"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (7.67e-4)"	"unprognostic (1.23e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.05e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.07e-8)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.39e-3)"	27.5	63.0	26.3	16.8	27.5	7.5	25.8	27.5	28.3	27.5	33.0	53.3	45.7	20.2	47.2	32.8	35.6	26.3	42.5	24.6	26.9	115.5	322.5	23.6	21.7	28.0	26.2	21.6	33.4	60.2	26.3	19.9	27.7	31.7	52.9	16.1	30.3	27.9	63.7	25.5	40.0	23.3	27.4	26.8	40.9	17.9	30.1	23.4	40.5	70.2	25.1	28.6	24.2	29.6	28.5	16.0	17.7	13.4	70.6	53.5	6.8	22.0	38.3	23.3	28.2	10.2	53.7	14.8	44.3	34.6	19.0	22.4	21.3	35.7	25.2	30.4	16.1	19.8	13.8	23.5	90.9	7.8	12.7	62.4	52.0	30.8	58.5	62.5	32.2	27.4	20.6	20.3	43.3	29.3	12.2	15.3	4.6	77.4	22.1	17.2	14.5	27.9	55.4	14.5	14.8	13.2	28.6	10.8	49.3	23.3	33.9	19.3	24.3	19.3	11.6	35.5	9.7	28.7	15.2	13.3	47.7	28.7	23.0	103.5	67.0	66.0	36.3	66.0	39.8	45.9	39.1	42.1	58.0	51.2	39.6	37.7	25.5	54.4	77.5	43.9	45.5	61.7	26.3	27.5	27.5	28.3	24.6	26.9	28.0	26.2	27.7	27.4	30.1	29.6	19.9	12.8	25.7	14.0	16.3	5.9	29.9	54.3	9.6	24.6	19.9	17.1	33.7	41.5	30.6	49.7	18.8	43.0	10.0	48.1	119.3	57.7	2.3	25.0	17.5	22.5	9.0	18.7	4.3	24.0	27.3	20.8	30.5	23.1	17.7	29.7	30.4	172.4	61.6	35.3	5.3	49.5	28.5	23.5	7.7	3.6	21.8	23.5	21.4	8.4	41.4	37.1	24.7	6.0	12.5	31.2	53.8	24.5	8.3	29.4	70.9	216.8	31.5	25.5	6.6	17.1	21.6	6.6	5.4	13.8	6.5	41.3	15.2	65.6	48.9	24.3
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119748002-119768905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 2434.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 327.2;Hepatocytes: 1118.3;Intestinal goblet cells: 226.8;Paneth cells: 177.7;Undifferentiated cells: 282.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 113.6;RT4: 201.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027423, HPA027442, CAB032906"	Enhanced		Approved	Mitochondria		NA	NA		830000		"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favorable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	1.0	0.3	0.0	7.3	0.0	0.0	222.4	0.0	0.0	0.1	5.2	366.7	165.6	1.4	0.4	4.3	0.4	4.3	36.6	0.0	0.1	64.9	2434.1	2.2	0.1	0.0	0.1	0.1	20.1	0.1	0.1	0.4	0.0	34.0	228.0	0.1	50.8	0.6	6.9	14.2	151.8	23.7	0.0	0.6	101.2	35.6	0.0	0.4	0.6	3.1	0.0	36.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	113.6	0.1	0.2	0.7	0.7	0.0	201.6	0.1	0.8	0.6	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	10.8	0.0	2.4	0.1	3.7	0.0	1.2	0.0	18.8	5.6	8.7	42.9	0.1	31.3	0.0	0.8	0.0	327.2	0.0	0.0	1.9	0.6	0.1	1.1	73.1	24.0	0.0	0.0	0.2	0.2	66.8	1.4	4.5	19.5	16.4	1118.3	0.2	0.0	0.0	226.8	0.0	26.1	0.7	3.9	1.5	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	177.7	0.0	0.0	6.3	12.4	0.9	0.0	0.0	6.6	0.0	0.1	0.4	0.5	1.9	0.3	9.4	2.2	0.1	282.3	26.5
HOXC12	"HOC3F, HOX3, HOX3F"	ENSG00000123407	"Homeobox C12"	P31275	12	53954903-53958956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"adipose tissue: 1.2;brain: 1.1;skin 1: 2.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8;stomach cancer: 2.0"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 23.4;OE19: 35.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055632	Uncertain					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 21: OE19 - Mitochondria"	"Cluster 33: Fibroblasts - ECM organization"			"HPA055632: AB_2682867"	"unprognostic (6.95e-2)"	"unprognostic (2.34e-2)"				"unprognostic (1.10e-1)"		"unprognostic (4.37e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.45e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.84e-2)"	"unprognostic (2.55e-1)"			1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.6	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	1.1	0.2	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 249.9;kidney: 335.2;salivary gland: 260.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 191.3;Distal enterocytes: 476.1;Intestinal goblet cells: 288.8;Paneth cells: 226.2;Proximal enterocytes: 270.2;Syncytiotrophoblasts: 114.5;Undifferentiated cells: 170.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 62.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.4;OE19: 29.0;RPMI-8226: 13.9;RT4: 13.9;SCLC-21H: 14.9;SK-BR-3: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	"Nucleoplasm,Lipid droplets"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	2.1	5.4	1.6	13.4	4.6	0.1	14.0	2.8	2.8	15.5	0.7	249.9	40.0	11.8	4.0	10.9	10.4	6.8	1.9	1.6	1.3	335.2	5.5	3.2	1.0	2.7	1.3	9.3	7.4	3.6	0.5	13.0	3.3	12.9	102.2	0.0	260.2	6.2	0.9	66.1	141.8	18.3	1.5	7.0	9.8	2.5	2.0	0.4	11.1	0.2	0.9	5.3	23.6	2.4	3.6	1.1	0.4	1.4	0.1	1.7	3.6	0.0	0.0	0.1	0.1	6.1	1.3	0.0	2.7	0.1	0.1	7.8	5.1	0.5	0.0	0.0	1.8	0.0	0.7	6.6	0.6	0.7	0.0	1.7	3.0	0.3	0.1	0.0	0.0	4.6	0.4	0.0	0.0	3.8	0.2	0.2	11.4	29.0	1.0	0.0	0.2	13.9	0.5	13.9	14.9	1.0	0.8	13.4	0.6	1.3	6.5	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.6	2.8	2.8	1.6	1.3	2.7	1.3	3.3	1.5	2.0	2.4	0.7	0.0	0.5	0.0	1.1	1.5	7.2	1.3	1.2	0.0	4.8	2.2	0.5	30.0	2.3	191.3	0.0	1.2	0.3	476.1	45.0	2.1	0.2	17.4	25.2	0.5	26.9	0.0	1.1	3.0	0.7	7.1	7.1	43.5	8.9	43.4	1.1	1.2	1.4	0.0	0.8	288.8	4.1	0.3	0.5	0.5	25.4	0.7	1.8	0.0	0.0	0.0	0.0	0.5	0.3	0.6	226.2	6.8	0.2	13.5	270.2	16.3	0.4	0.0	13.1	0.3	3.9	0.2	1.6	3.5	3.4	114.5	1.2	16.7	170.9	10.5
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 429.0;liver: 217.9;placenta: 381.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 155.8;Distal enterocytes: 203.4;Hepatocytes: 121.9;Paneth cells: 284.2;Proximal enterocytes: 390.7"	"Group enriched"	"Detected in many"	4	"liver cancer: 10.9;pancreatic cancer: 6.5;stomach cancer: 4.2;urothelial cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 57.9;Hep G2: 47.5;hTERT-HME1: 27.1;OE19: 87.1;RT4: 96.8;TIME: 54.0"	"Group enriched"	"Detected in some"	5	"midbrain: 2.2;pons and medulla: 3.4"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.83e-4)"	1.6	0.0	0.4	4.2	0.2	0.7	26.4	0.9	0.4	4.3	0.2	74.8	429.0	1.2	0.1	9.6	0.1	21.1	0.2	0.3	0.2	9.6	217.9	2.3	0.3	0.1	0.0	0.3	23.2	0.0	1.2	381.8	0.1	2.0	56.9	17.4	22.1	0.2	0.1	4.2	188.6	2.4	0.0	0.2	20.1	0.3	0.1	0.4	0.1	0.0	3.4	78.6	1.4	0.3	0.4	0.1	0.4	0.0	0.0	0.7	0.7	0.2	57.9	0.0	0.0	10.9	1.7	0.1	11.4	0.0	0.1	0.4	0.0	2.4	0.0	0.1	0.1	0.3	0.3	47.5	0.4	0.3	0.3	0.0	3.1	0.0	27.1	0.6	0.9	0.1	0.1	0.4	8.6	0.1	0.0	0.9	0.2	87.1	21.4	0.1	0.2	1.3	1.0	96.8	0.4	1.5	0.0	2.7	0.2	0.0	0.1	0.1	54.0	0.6	0.5	0.3	0.0	0.2	0.2	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.2	0.0	0.0	0.4	0.2	0.9	0.4	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.3	1.0	3.2	3.9	0.3	0.7	0.4	2.7	16.4	2.2	0.5	45.7	12.3	0.6	155.8	21.4	0.0	0.0	2.7	0.3	203.4	0.0	73.6	0.5	5.9	5.4	21.3	3.0	2.7	0.1	6.0	1.8	38.3	15.3	41.3	0.0	0.0	2.5	121.9	3.5	0.0	0.1	26.3	6.1	3.1	0.0	0.9	0.0	0.4	1.8	0.0	0.0	45.1	0.0	0.0	0.1	20.1	284.2	0.0	0.1	2.7	390.7	1.4	5.6	0.7	0.0	0.4	2.0	0.0	0.1	0.8	1.1	6.4	0.7	0.0	47.1	14.8
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 4755.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	Yes		63000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	584.8	719.5	647.1	368.9	700.4	466.4	507.6	675.2	1529.5	581.3	651.0	425.3	215.8	594.2	540.1	463.8	708.5	332.5	783.8	699.9	811.5	494.6	396.5	526.9	427.7	707.0	738.2	1204.8	722.9	606.0	574.8	451.9	764.3	471.2	389.8	339.5	410.2	491.9	1379.0	483.7	332.6	526.8	655.1	346.0	538.8	251.6	745.8	362.1	456.8	998.8	571.4	525.0	509.4	818.8	2393.2	1495.7	1298.1	1606.0	871.2	904.4	1355.3	1049.1	1021.8	1898.3	1325.5	2254.5	708.0	3029.2	1106.3	1099.8	1928.1	1349.9	3197.5	1563.4	2326.7	1010.5	1292.5	2359.3	793.9	2978.8	628.9	2386.2	1563.2	842.6	1034.9	1495.5	1277.7	1658.4	1847.6	1533.9	3210.4	1095.1	1309.8	2404.3	2003.1	1432.6	1519.7	4378.9	1129.7	1900.7	1325.9	1658.7	1287.7	1422.1	1891.1	1154.8	816.3	1164.8	1526.2	1751.5	1518.6	1178.2	1169.0	1124.0	1875.7	931.1	2440.0	1255.6	2125.8	5370.7	1221.7	1720.8	1312.1	65.9	231.7	52.8	343.7	341.0	577.8	544.0	380.3	395.0	375.1	473.1	509.3	494.0	27.3	434.9	349.0	232.1	326.8	678.5	647.1	700.4	675.2	1529.5	699.9	811.5	707.0	738.2	764.3	655.1	745.8	818.8	1165.2	897.4	678.2	70.5	906.4	1059.3	4755.7	862.6	1331.1	329.3	938.9	1418.3	1407.0	519.0	942.6	366.0	227.2	1104.3	629.3	538.6	729.8	1011.1	185.5	1385.8	1359.6	1070.6	567.4	775.9	103.5	688.9	1107.1	1247.3	616.2	1444.8	1003.4	761.3	360.5	360.3	807.5	339.9	151.0	578.2	518.8	314.5	1262.5	198.4	686.0	896.7	736.4	76.8	573.3	326.1	200.8	69.9	127.4	811.7	504.8	611.2	725.0	1810.6	361.5	664.8	1219.1	262.1	348.4	1512.7	1437.2	266.1	694.1	1232.8	923.5	1123.3	1265.6	1350.0	739.6	2408.7
HSPH1	"HSP105A, HSP105B, KIAA0201, NY-CO-25"	ENSG00000120694	"Heat shock protein family H (Hsp110) member 1"	Q92598	13	31134973-31162388	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 1251.1"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1316.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 1251.1"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002060, HPA028675, HPA031569"	Uncertain		Enhanced	Nucleoplasm,Cytosol		No	Yes		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938"	"unprognostic (1.10e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.90e-4)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.45e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.89e-2)"	52.2	42.1	175.9	23.5	193.6	20.7	27.9	175.2	1251.1	25.0	182.5	29.3	11.3	25.9	37.6	35.8	54.8	32.3	57.3	184.9	189.3	73.5	47.6	66.6	34.9	172.7	180.7	56.3	28.6	30.3	63.8	37.8	180.9	28.4	25.3	26.7	20.1	29.3	36.6	21.7	20.4	28.0	177.2	32.3	53.1	67.8	190.2	37.4	32.2	32.6	45.1	58.8	35.4	227.4	69.9	130.7	105.1	10.2	99.1	56.0	70.0	117.8	104.6	179.0	82.8	154.9	105.4	179.6	71.9	82.4	253.7	131.2	411.7	104.8	229.2	141.6	51.7	155.7	69.3	137.2	32.3	109.1	118.8	35.5	236.5	119.6	68.3	93.0	105.4	62.0	132.7	27.8	127.4	94.7	158.1	124.2	150.3	338.6	96.6	122.5	85.8	58.9	135.0	83.5	108.5	90.1	107.4	104.0	56.6	160.6	35.0	104.7	64.4	61.3	77.4	89.2	132.4	21.8	76.0	150.6	51.0	129.8	104.7	1.4	5.0	2.7	7.6	12.2	9.4	11.1	9.7	11.8	8.4	10.6	14.7	13.8	0.5	16.7	19.6	6.6	7.0	7.7	175.9	193.6	175.2	1251.1	184.9	189.3	172.7	180.7	180.9	177.2	190.2	227.4	171.1	131.4	87.7	36.6	130.8	214.6	1316.2	44.7	175.2	38.7	152.2	143.3	163.6	40.0	123.3	46.0	417.0	23.2	78.9	153.2	29.4	49.8	100.0	346.1	140.1	132.3	227.7	58.9	121.0	35.9	64.2	249.6	94.3	250.6	248.6	61.7	26.4	25.7	90.6	30.3	77.7	159.0	65.1	38.6	452.1	36.5	33.8	281.3	163.7	55.3	42.6	28.2	26.8	30.7	53.2	45.5	154.0	39.1	142.0	426.3	18.2	31.6	290.5	79.0	39.5	98.1	153.1	161.3	164.6	151.1	143.3	42.5	363.8	58.5	166.1	511.8
IFNGR1	"CD119, IFNGR"	ENSG00000027697	"Interferon gamma receptor 1"	P15260	6	137197485-137219449	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 867.1;Club cells: 405.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025889, HPA029213, HPA063871"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB025889: , HPA029213: AB_10601023, HPA063871: AB_2685138"	"unprognostic (1.73e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.05e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.38e-3)"	155.5	59.3	54.6	131.5	57.8	146.2	121.4	64.5	72.1	74.1	56.8	74.7	97.9	58.1	67.4	65.0	55.7	88.4	103.7	53.1	59.9	44.4	104.0	153.8	140.2	71.9	60.3	43.3	44.5	47.4	26.3	86.1	75.9	53.2	74.4	40.4	57.7	57.4	58.3	66.2	101.2	75.9	69.2	165.9	51.3	27.9	59.9	69.2	58.3	75.5	135.2	112.6	58.0	85.0	23.2	23.4	25.1	33.4	166.8	86.7	23.0	67.0	90.0	38.0	53.3	148.7	39.8	24.5	99.2	36.1	55.1	130.0	24.1	62.6	51.5	49.4	37.4	36.1	23.3	192.9	97.3	112.9	46.6	195.9	232.6	33.3	51.4	36.1	48.7	29.1	32.0	34.9	29.2	27.7	17.7	47.0	22.0	191.9	18.6	51.3	28.4	32.1	65.5	104.4	27.4	39.5	77.3	41.9	57.5	47.8	15.5	68.7	71.1	36.2	27.7	48.5	31.8	25.3	25.5	23.8	19.4	69.2	36.5	158.6	518.4	356.3	106.9	502.6	224.7	91.3	60.0	90.0	309.4	98.3	39.2	43.1	736.0	48.4	375.6	85.1	48.0	519.3	54.6	57.8	64.5	72.1	53.1	59.9	71.9	60.3	75.9	69.2	59.9	85.0	298.7	80.1	59.9	21.5	76.4	127.6	177.6	867.1	84.2	15.4	49.8	37.3	49.6	37.1	405.7	27.6	12.5	78.5	240.8	111.0	7.9	74.2	11.6	91.4	52.7	110.7	13.1	25.7	21.4	101.4	67.1	94.7	33.6	112.8	63.3	10.3	62.8	56.5	149.8	10.1	24.2	25.5	270.6	326.2	220.0	6.1	44.1	261.7	49.8	147.1	138.4	23.5	52.5	25.1	44.9	76.0	57.6	49.2	74.5	129.6	82.0	17.2	150.6	28.1	13.1	45.7	75.7	14.6	22.4	47.3	113.2	209.9	121.5	48.3	33.9	140.2
IFT20		ENSG00000109083	"Intraflagellar transport 20"	Q8IY31	17	28328325-28335489	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 245.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021376	Approved		Approved	Microtubules		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Microtubules		"HPA021376: AB_1851460"	"unprognostic (1.29e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.42e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (5.09e-7)"	"unprognostic (1.67e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.71e-3)"	24.9	32.9	26.6	14.7	26.9	77.0	26.8	27.0	46.1	23.4	29.1	37.0	28.8	20.9	39.2	18.8	22.6	22.2	19.7	26.9	28.3	33.5	41.4	22.3	20.7	27.7	27.6	21.6	116.1	25.5	45.2	24.1	27.0	29.9	20.0	26.7	41.2	20.5	9.5	17.6	28.0	20.0	27.5	24.9	42.4	50.1	27.0	22.8	29.2	7.5	19.9	27.9	19.6	27.9	27.3	39.0	25.2	20.7	74.2	75.2	24.2	47.2	58.0	28.9	45.5	59.6	12.7	13.4	24.8	59.8	17.5	29.1	16.9	35.1	41.8	55.0	72.5	8.0	39.7	26.7	72.7	34.1	16.0	57.6	46.4	24.8	39.9	48.2	46.1	26.6	24.2	32.8	23.0	38.2	30.7	26.8	16.9	82.4	21.8	14.4	32.6	35.4	46.2	26.7	31.7	46.2	31.3	64.3	74.8	43.6	41.0	38.2	51.3	16.9	25.8	25.3	25.9	49.6	44.8	17.1	61.6	24.6	25.1	53.7	67.7	52.6	38.6	50.6	44.8	43.2	39.2	38.6	78.1	51.6	39.8	34.7	71.1	36.8	49.0	56.1	45.8	53.7	26.6	26.9	27.0	46.1	26.9	28.3	27.7	27.6	27.0	27.5	27.0	27.9	42.1	38.5	55.8	17.9	36.7	37.0	38.0	63.0	34.7	63.3	74.6	68.3	6.1	47.1	51.5	51.5	60.5	73.0	47.4	30.7	140.8	60.8	245.4	79.8	40.3	47.3	62.6	25.7	31.3	113.2	82.6	47.4	32.1	39.5	23.5	34.2	38.2	48.6	54.2	57.2	36.5	69.5	40.7	47.8	69.4	53.4	60.3	49.6	32.0	7.5	72.8	37.4	42.2	24.6	30.7	68.0	29.9	57.6	57.8	45.9	127.8	98.0	102.6	78.3	78.9	33.5	67.0	164.8	53.0	25.7	42.8	81.4	35.9	59.6	43.1	49.5
IGFL2	UNQ645	ENSG00000204866	"IGF like family member 2"	Q6UWQ7	19	46143106-46161299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skin 1: 41.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 17.9;Excitatory neurons: 27.1;Inhibitory neurons: 29.3;Oligodendrocytes: 38.5;Spermatocytes: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"CACO-2: 82.4;OE19: 166.9"									HPA059137	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in other tissues"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Plasma membrane"	"HPA059137: AB_2683920"	"unprognostic (1.53e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.26e-3)"	"unprognostic (9.63e-3)"	"unprognostic (4.14e-9)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.91e-3)"	2.4	0.0	0.2	0.0	0.2	0.0	2.0	0.0	0.8	0.1	0.0	0.5	0.0	0.2	0.5	1.5	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.3	2.0	0.7	0.3	0.0	0.0	1.5	0.3	0.9	0.8	0.0	0.8	0.4	1.0	0.0	0.0	41.6	0.1	0.2	0.2	0.0	0.0	4.1	0.3	1.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	1.7	0.5	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	82.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.3	0.0	0.0	1.6	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	166.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.2	0.4	0.7	0.3	0.8	0.2	0.3	2.1	0.0	0.0	0.0	17.9	0.0	2.2	0.0	1.1	0.0	1.7	2.0	1.5	0.6	0.0	0.7	0.0	0.0	4.3	0.0	0.7	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.0	27.1	0.2	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	29.3	0.4	0.0	0.0	0.3	5.4	0.0	0.0	1.8	0.0	0.0	0.2	0.0	6.0	38.5	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.0	1.9	0.0	0.0	0.7	9.8	8.7	0.0	4.7	2.6	0.2	0.0	1.4	0.0
IGFL4		ENSG00000204869	"IGF like family member 4"	Q6B9Z1	19	46039748-46077118	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"retina: 19.5;skin 1: 6.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.2;Cone photoreceptor cells: 14.6;Excitatory neurons: 9.5;Inhibitory neurons: 10.1;Rod photoreceptor cells: 42.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.9;HaCaT: 3.5;OE19: 6.1"									HPA047655	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA047655: AB_2680113"	"unprognostic (1.22e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.96e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.59e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	0.0	0.3	1.3	0.1	1.1	0.1	0.1	1.0	2.2	0.0	0.0	0.1	0.4	0.3	1.3	1.0	0.2	0.5	1.0	1.2	0.4	0.1	0.1	0.3	0.4	0.0	0.1	0.9	0.0	0.5	1.6	0.1	0.4	0.4	0.2	19.5	0.5	0.0	0.2	6.9	0.3	0.0	0.0	0.2	0.2	0.3	0.3	0.0	0.8	0.0	0.0	0.3	0.0	1.8	0.0	3.9	0.1	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.9	0.1	0.5	0.0	0.1	0.5	3.5	0.0	0.0	0.0	0.4	0.6	0.0	0.6	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.4	0.0	0.4	0.0	0.3	0.2	6.1	0.2	0.0	1.7	0.9	0.0	0.2	0.2	0.3	0.0	0.1	0.9	0.4	0.2	0.7	0.4	0.3	0.7	0.2	0.2	0.4	0.3	0.1	0.1	0.6	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	1.1	1.0	2.2	1.2	0.4	0.0	0.1	0.4	0.0	0.3	1.8	0.0	0.0	0.0	2.6	0.0	1.0	0.0	0.8	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	10.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	3.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	0.0	0.0	0.1	0.8	2.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0
IL22RA1	"CRF2-9, IL22R"	ENSG00000142677	"Interleukin 22 receptor subunit alpha 1"	Q8N6P7	1	24119771-24143140	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 199.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 34.8;Exocrine glandular cells: 12.0;Pancreatic endocrine cells: 11.3;Paneth cells: 33.4;Proximal enterocytes: 44.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 11.3;Hep G2: 8.1;OE19: 18.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.68e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.78e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.64e-2)"	0.7	0.4	0.0	1.2	0.0	0.0	2.0	0.3	0.3	4.0	0.0	11.4	20.0	0.2	0.1	17.8	1.5	2.6	0.3	0.5	0.1	2.1	7.0	0.8	0.0	0.1	0.0	0.3	199.3	0.0	2.1	0.1	0.1	0.7	10.0	0.2	2.9	0.4	0.4	40.1	28.3	0.4	0.1	0.0	3.5	0.4	0.0	0.0	2.3	0.0	2.4	0.3	7.0	0.1	2.9	2.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	1.3	1.5	11.3	4.8	0.0	0.9	0.3	4.7	5.0	0.6	3.0	0.4	3.7	0.0	0.0	1.4	8.1	0.0	0.0	0.0	0.0	1.8	0.4	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.1	0.1	18.7	1.0	0.0	0.0	0.1	0.0	0.6	0.1	0.1	1.4	0.0	1.6	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.0	4.2	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.4	0.7	2.8	0.0	0.1	0.3	0.3	1.5	0.2	0.0	0.0	0.0	0.0	34.8	0.0	1.1	0.3	0.5	0.1	0.0	0.0	0.0	0.2	12.0	0.0	0.3	3.6	0.5	0.0	0.5	0.0	5.8	0.0	0.0	0.1	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.4	0.0	0.0	0.1	11.3	33.4	0.0	0.0	0.2	44.0	1.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.3	1.1	0.0	0.0	0.0	7.0	0.2
IMMP1L	"FLJ25059, IMMP1"	ENSG00000148950	"Inner mitochondrial membrane peptidase subunit 1"	Q96LU5	11	31432401-31509645	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038372, HPA058308"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA038372: AB_10669643, HPA058308: AB_2732620"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.15e-3)"	"prognostic favorable (6.72e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.04e-3)"	11.7	15.6	42.8	6.4	43.7	11.1	19.3	45.5	66.4	13.5	41.8	12.7	8.6	11.5	29.8	11.7	10.4	5.1	26.2	42.8	42.3	27.2	18.6	8.9	9.5	42.4	42.0	17.5	16.4	17.9	23.3	6.9	42.3	14.3	10.0	37.7	11.8	14.1	50.0	12.5	9.5	10.7	42.9	10.8	15.1	16.7	43.0	24.8	13.2	42.1	13.1	10.9	12.6	43.5	22.9	26.9	95.6	21.0	14.9	9.9	15.3	19.9	8.7	16.2	11.7	21.0	17.5	20.7	18.7	15.9	32.5	25.8	37.6	28.8	23.8	24.9	52.6	29.4	45.5	32.3	15.8	29.6	19.9	8.0	27.1	8.7	19.2	29.5	17.5	48.8	38.0	23.2	15.9	28.2	48.5	48.9	15.8	114.6	26.3	41.1	72.2	20.6	54.6	26.2	22.5	27.0	32.5	11.6	32.5	61.9	37.1	35.1	2.6	15.3	27.2	16.2	42.2	17.2	58.2	47.5	24.9	24.9	18.5	21.9	3.0	32.2	28.9	3.4	26.3	34.1	25.3	29.5	8.1	32.1	32.0	39.8	0.8	37.3	3.0	40.2	35.4	13.6	42.8	43.7	45.5	66.4	42.8	42.3	42.4	42.0	42.3	42.9	43.0	43.5	29.2	35.3	14.6	30.7	22.4	18.2	26.8	60.5	12.0	30.6	44.6	55.1	56.8	18.6	26.8	60.7	33.3	36.3	17.6	21.7	119.3	17.0	39.8	30.2	16.9	19.4	56.5	47.4	40.6	24.5	32.5	19.7	20.9	33.8	22.7	22.7	18.2	45.0	21.3	43.7	48.0	30.6	52.9	7.7	11.4	10.5	13.4	9.4	8.8	24.4	10.3	85.3	30.9	51.3	60.7	15.8	26.7	20.7	22.0	26.0	18.6	98.4	28.9	38.5	32.9	19.1	51.0	61.6	23.0	19.6	27.3	23.7	24.2	16.2	34.7	26.2
IMPA2		ENSG00000141401	"Inositol monophosphatase 2"	O14732	18	11981025-12030877	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 359.1;skeletal muscle: 257.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 440.3;Extravillous trophoblasts: 272.2;Proximal tubular cells: 498.6;Squamous epithelial cells: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 26.0;neutrophil: 31.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 9.0;granulocytes: 31.3;monocytes: 11.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 258.2;OE19: 299.8;SiHa: 155.1"	"Low region specificity"	"Detected in all"							HPA029561	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Mitochondria	"HPA029561: AB_10601932"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.26e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.24e-3)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.35e-2)"	19.8	11.1	2.5	12.3	3.2	31.5	14.8	1.8	4.4	31.0	5.3	50.0	22.4	16.2	1.7	131.2	16.3	19.9	29.5	2.5	2.4	129.4	47.4	23.2	5.7	2.2	2.4	7.8	359.1	5.3	11.1	22.0	2.1	13.7	30.7	0.8	31.0	5.9	257.1	150.0	29.2	15.6	2.3	19.0	53.7	2.9	2.6	5.0	17.4	89.8	7.3	61.0	50.8	2.3	29.3	41.7	11.3	20.4	14.1	10.5	258.2	7.2	18.4	2.9	4.2	35.4	21.7	6.1	17.4	10.1	24.1	19.8	13.2	6.9	0.8	33.5	22.5	0.0	56.0	30.6	8.3	47.5	2.3	23.9	36.3	10.0	5.2	8.5	3.9	30.7	7.4	0.0	10.7	31.8	19.4	27.1	40.5	299.8	42.7	36.0	29.6	28.6	122.1	15.6	15.0	0.3	155.1	35.8	16.2	14.5	33.3	58.5	0.0	5.6	11.5	73.7	7.3	24.5	66.3	17.9	24.0	31.7	9.6	9.4	11.4	26.0	0.7	8.7	0.3	1.5	0.7	0.2	9.0	0.3	0.3	0.5	31.3	0.1	5.8	6.7	1.1	3.1	2.5	3.2	1.8	4.4	2.5	2.4	2.2	2.4	2.1	2.3	2.6	2.3	9.2	19.2	32.7	17.6	7.8	105.5	22.7	32.1	159.4	0.7	16.8	20.2	11.6	72.9	16.1	22.0	0.0	52.5	5.8	72.9	440.3	83.4	2.8	5.7	20.2	6.9	17.5	15.3	4.7	110.6	272.2	16.1	65.2	30.4	2.5	13.4	10.0	66.8	42.5	0.0	1.8	90.2	65.1	37.7	17.0	7.1	4.7	34.2	14.2	5.6	25.5	22.3	2.1	0.5	0.5	56.1	50.1	3.8	8.6	42.9	36.9	498.6	12.3	1.0	105.2	16.0	27.6	0.8	10.1	202.1	141.4	106.3	6.1	14.0	84.4	52.8
INTS4	"INT4, MGC16733, MST093"	ENSG00000149262	"Integrator complex subunit 4"	Q96HW7	11	77878720-77994671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042378	Uncertain		Supported	"Nucleoli rim"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoli rim"		"HPA042378: AB_10797388"	"unprognostic (2.72e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.44e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.20e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.20e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (9.39e-2)"	12.8	16.8	13.6	12.8	15.7	18.5	13.4	19.1	14.8	16.7	13.6	13.7	9.5	12.9	11.9	13.7	13.6	9.2	12.8	13.5	15.0	14.3	18.0	12.7	16.7	15.9	14.9	17.0	17.7	11.5	13.1	11.4	16.6	15.7	11.9	14.5	13.2	9.6	11.5	14.2	15.6	10.8	15.8	21.0	13.9	9.9	15.2	17.8	13.8	7.8	16.9	14.4	14.8	21.9	11.1	18.2	23.2	27.3	18.7	16.8	19.1	13.0	14.5	16.6	14.6	37.8	30.0	19.2	27.0	23.3	25.5	27.2	25.6	25.8	26.5	28.0	16.2	29.8	24.2	22.2	17.1	30.5	17.2	17.1	13.9	33.9	29.4	18.1	26.6	20.6	28.9	28.3	25.6	23.2	28.5	49.7	22.1	40.4	19.8	27.2	21.5	36.5	20.8	22.0	16.6	24.0	23.1	15.2	9.9	26.8	28.2	16.3	17.7	22.7	30.4	60.0	16.9	30.7	32.2	40.7	8.1	20.5	22.7	12.6	14.0	7.7	12.3	15.3	17.7	12.2	12.8	14.5	15.1	13.1	17.1	13.3	3.5	17.0	14.0	6.0	17.2	11.3	13.6	15.7	19.1	14.8	13.5	15.0	15.9	14.9	16.6	15.8	15.2	21.9	5.6	9.6	3.1	18.3	15.1	4.8	7.1	8.2	8.6	13.4	5.4	6.3	5.6	10.0	6.0	5.5	16.7	13.4	18.7	5.5	5.9	7.5	5.0	6.8	5.4	7.0	1.8	9.1	20.0	4.0	11.5	7.3	8.2	5.5	12.7	12.8	5.0	3.1	10.2	5.0	19.4	6.4	6.1	8.1	4.5	4.2	6.5	7.9	7.2	20.6	14.8	7.8	13.4	26.2	30.8	6.0	7.8	4.9	7.3	4.4	11.0	6.6	8.6	16.9	6.6	10.0	11.1	12.1	17.7	7.1	2.4	11.5	13.5	8.1	6.4	5.3
INTS8	"C8orf52, FLJ20530, INT8, MGC131633"	ENSG00000164941	"Integrator complex subunit 8"	Q75QN2	8	94813311-94881746	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057299	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA057299: AB_2683403"	"unprognostic (1.08e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.07e-2)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.24e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.96e-2)"	8.8	7.5	4.4	13.9	4.8	15.5	8.1	8.3	6.4	14.5	6.9	12.8	7.8	13.2	4.2	10.5	9.5	7.3	10.2	4.8	6.4	6.4	8.9	7.5	17.4	5.7	4.4	11.4	13.5	10.1	8.3	9.4	4.6	10.4	14.8	10.3	11.0	8.7	12.6	10.3	10.6	13.6	4.0	9.9	10.6	30.6	6.3	20.6	8.8	12.0	13.6	10.4	10.4	6.1	52.4	31.9	49.2	43.4	17.7	41.7	25.5	27.5	26.0	35.7	33.0	22.5	38.0	52.3	25.2	20.7	44.3	31.5	61.3	29.2	47.6	58.1	28.8	45.7	19.3	22.1	21.1	24.6	31.7	17.1	13.5	34.7	29.6	40.8	40.1	35.1	44.4	38.9	22.0	34.5	53.7	20.4	28.1	114.9	55.8	42.7	19.7	29.0	30.0	26.6	34.6	18.4	26.8	7.7	24.1	40.3	37.3	31.6	28.1	16.1	18.9	31.1	25.1	22.0	43.0	45.2	21.6	49.4	32.2	2.1	9.6	15.1	4.6	6.8	7.5	13.4	10.8	11.8	9.3	10.4	11.0	6.5	9.3	9.6	6.6	5.5	10.0	4.5	4.4	4.8	8.3	6.4	4.8	6.4	5.7	4.4	4.6	4.0	6.3	6.1	11.0	16.0	8.6	16.6	19.4	5.9	11.6	9.1	9.6	13.7	6.1	4.6	8.3	5.7	11.6	7.3	33.3	10.0	9.7	10.3	3.9	8.3	36.0	15.0	12.1	11.8	18.0	17.7	44.8	13.4	12.9	10.8	8.6	6.1	12.7	15.2	8.9	5.5	9.5	28.6	40.9	11.8	8.2	11.6	6.6	6.4	16.1	14.0	7.2	25.3	21.6	8.0	16.5	33.2	31.2	10.9	14.6	16.1	18.0	8.8	9.5	5.1	19.7	18.9	6.6	10.6	13.1	54.7	32.5	9.0	7.0	8.5	14.2	11.0	11.1	8.1
ITLN1	"FLJ20022, hIntL, HL-1, ITLN, LFR"	ENSG00000179914	"Intelectin 1"	Q8WWA0	1	160876540-160885180	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 757.3;intestine: 1247.8"	"Cell type enriched"	"Detected in many"	14	"Intestinal goblet cells: 1818.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 61.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 9.2;non-classical monocyte: 24.1"	"Lineage enriched"	"Detected in many"	17	"monocytes: 24.1"	"Group enriched"	"Detected in some"	4	"HEL: 2.6;HL-60: 1.9;OE19: 7.2;U-937: 7.1"	"Not detected"	"Not detected"							"CAB012652, HPA063275, HPA067326"	Enhanced				"Secreted to blood"	NA	NA	294000000	6400000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB012652: , HPA063275: AB_2684974, HPA067326: AB_2732764"	"unprognostic (9.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.28e-1)"		"unprognostic (1.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-2)"	757.3	0.3	0.0	26.4	0.0	2.6	0.5	0.0	0.0	0.3	0.0	444.2	272.7	0.5	2.1	0.4	6.2	0.8	233.8	0.0	0.0	35.5	3.1	40.3	0.3	0.0	0.0	9.7	3.3	0.0	0.4	1.3	0.0	0.6	1247.8	0.0	24.9	3.3	0.7	0.2	415.7	7.7	0.0	2.5	15.9	2.0	0.0	0.7	0.6	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	1.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.2	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	7.1	0.0	0.0	0.5	0.0	0.0	9.2	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.2	0.0	24.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	4.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.6	71.4	2.1	3.7	0.0	0.1	0.1	46.4	0.0	37.7	0.8	0.0	0.0	4.3	18.0	4.0	0.0	3.6	1.4	87.8	8.6	0.0	1.3	1.4	60.7	1.9	0.8	0.0	0.0	1818.6	0.0	124.7	0.0	0.7	14.6	1.8	0.0	0.0	0.3	0.0	1.0	0.0	0.0	7.3	17.7	3.0	0.0	0.3	15.4	0.1	0.8	0.0	0.0	0.0	10.8	0.1	0.9	0.0	0.0	0.3	2.1	15.3	59.4	0.1
JTB	"hJT, PAR"	ENSG00000143543	"Jumping translocation breakpoint"	O76095	1	153974269-153977674	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006514	Approved		Uncertain	Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA006514: AB_1079164"	"unprognostic (1.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.40e-1)"	"unprognostic (5.66e-3)"	"unprognostic (8.62e-3)"	"unprognostic (5.60e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (1.00e-3)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.58e-3)"	105.6	119.8	121.1	60.4	125.1	127.0	103.0	122.3	153.9	99.8	149.0	117.8	89.5	89.8	96.3	110.8	91.8	53.7	121.0	120.8	122.2	135.4	207.1	110.2	80.4	125.4	122.2	98.4	232.2	93.9	185.9	68.0	121.5	131.0	86.7	49.8	162.0	68.0	166.5	99.8	115.3	50.1	123.3	136.9	164.8	46.6	126.6	77.7	120.5	82.7	80.2	96.3	89.4	123.4	206.3	139.4	57.9	108.0	189.0	116.2	163.5	144.6	142.3	95.9	96.0	135.3	166.7	193.7	198.7	171.8	59.1	181.0	151.0	113.2	78.1	180.5	296.0	112.5	158.4	139.0	198.1	221.4	165.7	110.4	210.4	101.1	119.1	131.0	115.4	223.7	169.3	139.2	68.4	359.6	161.5	280.5	125.8	402.1	239.1	163.9	79.3	393.1	123.7	110.9	158.4	158.8	115.3	332.7	208.4	107.4	209.1	316.4	89.6	46.5	80.4	144.4	189.0	201.8	244.7	211.3	114.5	209.6	103.7	98.7	119.5	173.2	74.7	86.4	90.9	143.5	104.0	118.7	88.9	139.9	107.0	85.6	104.9	85.3	96.5	147.4	98.5	97.7	121.1	125.1	122.3	153.9	120.8	122.2	125.4	122.2	121.5	123.3	126.6	123.4	127.7	80.1	101.1	15.7	184.3	156.8	177.4	227.5	104.7	56.6	253.4	207.3	96.5	213.1	171.4	99.3	22.9	308.8	237.3	273.4	258.2	251.9	7.1	145.0	95.3	120.4	212.0	178.8	26.3	411.8	405.0	155.6	149.9	125.9	82.5	113.2	125.7	341.3	289.1	57.2	24.0	423.4	213.6	235.8	185.8	20.1	151.6	176.3	170.7	19.7	207.9	140.4	257.5	19.6	29.1	274.1	302.2	123.4	344.8	346.0	368.2	274.1	138.2	60.2	105.2	105.3	114.0	58.9	71.5	173.4	190.2	289.5	173.6	136.6	315.2	304.0
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 952.2;skin 1: 932.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 315.9;Pancreatic endocrine cells: 356.2;Squamous epithelial cells: 318.3;Suprabasal keratinocytes: 383.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.1;eosinophil: 28.7;intermediate monocyte: 22.6;memory B-cell: 13.5;myeloid DC: 14.5;naive B-cell: 11.7;non-classical monocyte: 43.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 1090.1;OE19: 3919.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		64000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favorable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	46.5	16.0	13.6	23.6	21.6	20.7	68.6	20.8	18.9	243.7	25.8	94.9	88.1	57.0	15.3	952.2	69.9	39.8	145.1	14.6	14.3	120.7	70.9	57.1	15.7	20.7	16.2	46.2	59.6	19.9	37.3	51.5	19.6	68.0	49.0	4.7	226.4	41.8	110.8	932.4	95.7	23.1	14.8	22.7	86.3	12.5	16.2	29.6	86.4	62.2	92.0	68.7	432.6	33.6	268.8	217.8	21.7	18.5	0.2	0.1	330.6	15.3	89.2	5.9	5.2	332.6	289.0	5.4	157.8	9.7	7.5	1090.1	31.6	242.4	1.0	0.6	74.2	11.6	165.1	74.4	34.7	7.3	113.6	0.5	538.6	0.9	43.9	64.2	96.1	7.0	99.6	94.0	0.0	342.6	1.9	96.5	42.3	3919.9	36.2	313.5	0.2	202.5	165.8	674.0	52.2	38.6	33.8	652.1	1.9	98.6	545.9	8.0	152.4	0.3	14.8	6.8	5.1	8.2	31.2	5.5	1.5	12.7	2.6	3.9	13.1	28.7	0.0	22.6	0.0	13.5	0.0	0.2	14.5	11.7	0.2	0.1	0.6	0.8	43.8	4.5	0.1	5.7	13.6	21.6	20.8	18.9	14.6	14.3	20.7	16.2	19.6	14.8	16.2	33.6	56.9	60.9	36.8	4.6	10.6	196.9	218.5	104.5	100.2	1.9	87.3	77.0	87.8	48.6	80.9	132.4	4.2	98.9	1.1	315.9	27.4	212.2	28.5	112.6	21.1	55.2	66.8	3.4	0.5	135.4	167.3	25.6	136.1	247.0	11.4	16.5	41.4	34.1	14.4	0.0	1.6	125.0	81.4	7.7	32.7	8.3	5.0	10.9	12.4	2.8	6.3	18.2	0.0	7.1	13.6	356.2	223.7	0.0	3.9	220.1	141.1	35.6	45.7	4.3	6.6	37.4	18.8	2.5	4.5	318.3	383.3	185.7	6.1	3.2	129.2	301.6
KAT2A	"GCN5, GCN5L2, PCAF-b"	ENSG00000108773	"Lysine acetyltransferase 2A"	Q92830	17	42113111-42121367	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 84.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048958	Uncertain					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"			"HPA048958: AB_2680571"	"unprognostic (1.71e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (3.57e-4)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (1.41e-8)"	"unprognostic (3.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-3)"	14.1	20.8	11.3	6.5	11.9	4.2	13.2	7.7	18.9	20.3	3.1	15.4	6.7	17.2	1.7	14.7	21.0	3.1	10.1	10.8	12.7	13.1	15.7	9.7	5.3	10.8	10.4	28.4	16.9	5.8	14.4	4.6	10.0	16.9	4.0	1.0	10.0	4.3	11.8	15.9	13.5	3.4	5.3	17.4	13.0	10.8	14.0	4.7	14.6	2.1	4.6	15.5	16.4	12.4	24.7	46.6	6.8	25.3	9.3	7.6	29.7	15.7	8.3	34.0	16.7	31.9	19.5	48.1	38.6	12.1	25.6	36.0	27.9	25.0	12.1	27.0	58.0	12.0	29.8	28.8	9.7	32.3	30.8	9.0	20.8	19.1	11.9	9.2	13.8	11.9	30.7	8.9	9.1	26.4	77.7	23.5	14.5	60.9	0.0	18.3	13.3	31.9	9.2	24.4	32.4	14.2	16.8	36.2	13.2	5.1	26.9	15.3	10.7	17.1	17.4	25.1	28.2	23.8	24.5	26.9	12.5	27.5	9.7	0.0	0.1	0.0	0.2	0.0	0.4	0.5	0.5	0.6	0.4	0.3	0.6	0.1	0.0	0.1	0.0	0.1	0.0	0.2	11.3	11.9	7.7	18.9	10.8	12.7	10.8	10.4	10.0	5.3	14.0	12.4	21.5	12.8	11.5	84.5	19.0	12.2	12.6	6.8	26.2	16.5	18.9	22.7	7.1	18.6	6.6	18.4	10.4	25.1	10.7	7.9	3.9	9.2	1.3	5.9	11.3	18.4	15.7	6.7	39.6	8.0	20.5	12.1	17.3	8.2	11.4	25.8	22.5	20.2	12.1	10.1	41.0	10.1	6.1	10.9	6.8	3.7	32.6	9.8	7.2	32.8	5.2	3.7	5.2	41.7	28.3	6.7	7.3	29.0	7.2	10.9	4.0	4.1	5.4	7.8	13.1	15.1	10.8	5.2	18.2	18.7	13.9	11.2	7.8	26.4	20.2	9.1
KCNE3	"HOKPP, MiRP2"	ENSG00000175538	"Potassium voltage-gated channel subfamily E regulatory subunit 3"	Q9Y6H6	11	74454841-74467729	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 70.5;stomach 1: 56.2"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 41.8;granulocytes: 33.7;Hofbauer cells: 40.6;Kupffer cells: 104.0;Macrophages: 37.8;monocytes: 59.0;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	48	"basophil: 51.4;classical monocyte: 38.5;eosinophil: 23.4;intermediate monocyte: 41.8;myeloid DC: 18.3;neutrophil: 53.1;non-classical monocyte: 36.6"	"Group enriched"	"Detected in many"	115	"dendritic cells: 18.3;granulocytes: 53.1;monocytes: 41.8"	"Cell line enhanced"	"Detected in some"		"HEL: 70.3;NB-4: 44.7;OE19: 155.3;THP-1: 32.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014849	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA014849: AB_1852112"	"unprognostic (1.61e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (4.67e-3)"	"unprognostic (4.89e-4)"	"unprognostic (4.12e-3)"	"unprognostic (2.56e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.45e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-1)"	7.3	2.8	2.8	20.7	2.9	8.2	5.2	2.5	3.6	9.9	7.0	34.9	70.5	8.8	1.9	4.6	9.4	24.6	5.0	3.0	3.0	20.1	5.0	13.8	5.0	3.8	3.6	14.0	10.8	3.6	3.1	12.7	3.6	8.0	47.3	8.1	15.4	3.4	1.3	1.3	40.0	11.1	3.3	12.6	56.2	1.8	4.1	1.9	33.5	3.0	3.2	6.2	4.5	4.9	0.1	0.1	0.1	0.2	8.1	2.1	7.1	0.1	0.0	1.0	0.8	23.0	2.0	0.3	21.3	0.1	0.1	0.3	1.8	0.0	0.7	0.0	0.2	70.3	0.4	4.7	2.9	0.6	12.0	7.1	0.0	0.6	0.0	0.3	0.3	0.1	1.9	0.3	0.8	0.1	0.1	44.7	0.9	155.3	0.1	7.6	0.3	0.5	1.7	0.0	0.0	0.4	0.1	0.0	0.0	5.4	0.1	32.7	0.1	0.1	0.2	0.2	0.1	0.3	0.3	0.4	0.1	12.9	0.1	51.4	38.5	23.4	0.1	41.8	0.2	0.2	0.1	0.1	18.3	0.3	0.1	0.1	53.1	0.2	36.6	0.7	0.0	13.2	2.8	2.9	2.5	3.6	3.0	3.0	3.8	3.6	3.6	3.3	4.1	4.9	4.4	0.0	6.8	0.3	0.7	0.3	0.6	1.1	3.4	0.2	0.2	0.3	0.7	8.6	5.6	1.8	0.0	0.4	0.0	8.6	3.9	0.5	0.1	3.1	3.4	8.9	2.4	2.1	0.2	7.3	7.4	4.5	41.8	5.0	33.7	0.2	5.7	2.0	40.6	0.0	0.3	27.9	4.1	104.0	2.9	0.3	3.7	37.8	0.0	8.4	59.0	22.7	1.0	0.0	0.0	3.3	8.9	2.6	0.2	0.4	8.6	23.4	4.6	1.2	0.0	4.7	0.7	0.0	0.4	2.7	0.1	2.1	1.0	8.8	44.3	0.6
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849105	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Deafness, Diabetes mellitus, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 197.1;stomach 1: 98.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 47.6;Microglial cells: 71.2;Undifferentiated cells: 57.8"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 33.4;OE19: 41.4;RPMI-8226: 23.2;U-266/70: 11.5;U-937: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018656, HPA048553, HPA071107"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	"Plasma membrane"	"CAB018656: AB_2131551, HPA048553: AB_2680438, HPA071107: "	"unprognostic (6.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.46e-3)"	"prognostic favorable (9.85e-4)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.27e-2)"	5.4	197.1	2.1	9.0	2.4	14.2	3.0	2.4	2.6	16.5	5.7	22.6	47.8	2.9	14.1	2.9	8.9	19.5	28.4	2.6	2.6	25.3	1.8	15.9	5.0	4.1	3.1	1.4	61.2	21.4	5.5	7.6	3.9	6.1	15.2	0.7	20.0	50.2	1.0	1.2	39.7	3.1	4.0	8.2	98.9	1.6	4.2	3.6	71.6	1.6	2.9	14.7	1.6	4.4	0.0	0.1	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	2.6	1.9	5.2	0.0	0.4	0.1	0.7	0.0	0.0	0.4	1.3	0.0	3.7	0.4	0.3	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.7	1.3	41.4	0.2	0.1	0.0	23.2	8.0	2.7	0.7	5.6	0.7	0.0	0.0	0.5	0.2	10.3	0.0	0.0	0.3	0.2	0.0	11.5	0.0	0.0	0.0	13.4	0.0	0.7	3.1	3.1	0.0	1.8	0.0	0.8	0.4	0.1	3.8	0.3	1.0	1.2	3.3	0.0	2.8	1.3	0.3	1.0	2.1	2.4	2.4	2.6	2.6	2.6	4.1	3.1	3.9	4.0	4.2	4.4	7.1	3.2	12.9	0.3	8.4	0.6	8.0	4.2	0.0	1.7	6.1	1.8	18.6	14.3	7.1	29.5	0.0	1.1	0.3	34.0	15.6	23.2	2.0	3.3	0.4	6.3	6.6	0.4	13.7	21.7	1.4	1.0	23.4	4.9	19.7	47.6	9.3	1.1	17.3	0.0	20.0	26.1	8.2	25.4	15.9	0.9	0.3	19.6	1.8	71.2	11.0	0.5	1.0	43.7	34.9	15.3	20.2	0.0	6.4	5.2	30.9	2.0	4.4	0.5	6.6	0.4	1.7	0.2	0.2	0.1	1.0	2.1	4.0	16.6	57.8	20.4
KDM1B	"AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2"	ENSG00000165097	"Lysine demethylase 1B"	Q8NB78	6	18155329-18223854	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 7.2;monocytes: 8.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031269, HPA055597"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA031269: AB_10601587, HPA055597: "	"unprognostic (1.93e-1)"	"unprognostic (7.53e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.32e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.53e-1)"	5.9	7.6	5.6	11.4	7.6	27.2	6.3	5.3	7.8	7.6	7.6	14.1	8.0	5.7	3.7	9.1	13.4	6.0	6.8	6.6	5.9	7.8	7.4	8.8	10.4	6.9	6.7	6.7	5.9	3.2	5.8	4.6	6.1	5.2	12.2	12.0	5.7	4.7	17.3	11.2	8.9	6.9	6.2	10.5	5.6	15.7	5.6	10.8	27.2	9.1	9.4	7.7	8.1	9.4	15.1	9.7	11.2	23.0	13.8	20.5	24.5	11.7	12.6	7.5	10.2	16.3	7.4	34.1	31.6	19.2	22.8	15.5	17.8	20.8	16.0	31.6	14.6	17.2	8.6	15.0	6.7	25.5	17.5	10.3	23.4	21.5	17.7	12.1	7.7	15.9	38.3	5.2	12.7	12.6	14.1	10.5	3.8	31.6	12.8	26.8	20.3	24.4	10.7	19.8	34.2	10.6	9.7	23.5	22.9	11.7	22.3	20.3	6.5	16.9	9.5	11.9	15.5	5.2	15.9	20.0	6.4	18.9	37.8	1.2	4.6	7.2	0.5	8.6	0.3	1.2	0.5	0.5	3.7	1.3	0.5	0.2	4.9	0.3	6.9	1.6	0.7	1.3	5.6	7.6	5.3	7.8	6.6	5.9	6.9	6.7	6.1	6.2	5.6	9.4	4.9	0.0	8.2	14.7	8.7	12.7	5.7	3.8	7.4	5.0	7.6	6.6	10.4	11.5	10.4	1.8	10.4	2.7	3.0	23.0	1.9	6.6	0.7	36.2	10.0	4.2	6.7	3.8	19.0	4.3	5.1	5.8	8.2	15.5	2.5	3.3	4.2	7.7	7.5	5.0	10.8	9.6	10.2	36.7	11.7	0.7	3.7	20.6	7.2	22.5	27.7	6.6	8.2	16.1	23.8	7.2	21.2	6.8	3.7	5.4	6.2	11.2	21.0	15.5	0.0	6.9	6.2	0.7	18.2	9.7	15.9	1.4	5.6	3.1	10.6	6.6
KLC4	"bA387M24.3, KNSL8"	ENSG00000137171	"Kinesin light chain 4"	Q9NSK0	6	43040777-43075095	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 81.9;Hepatocytes: 67.8;Paneth cells: 70.4;Proximal enterocytes: 143.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030168, HPA030169"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Cytosol	"HPA030168: AB_10599285, HPA030169: AB_10601105"	"unprognostic (2.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.63e-3)"	"unprognostic (6.36e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (6.99e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	12.3	17.2	18.8	11.2	19.6	12.4	13.4	21.8	22.8	16.6	18.6	41.1	72.5	15.1	23.0	10.9	17.7	17.9	25.1	18.7	19.0	24.2	89.9	16.5	13.5	21.2	19.2	19.7	17.8	28.7	24.1	12.2	21.2	17.0	34.2	23.8	19.9	15.8	22.9	17.5	63.7	14.0	17.5	12.5	31.8	24.8	19.6	17.1	19.7	22.8	11.1	17.3	12.9	20.9	7.5	6.0	15.9	18.9	15.0	14.7	13.7	5.5	8.5	9.5	15.6	9.8	11.5	9.9	19.7	13.4	12.6	12.3	15.8	14.9	7.2	10.0	19.1	11.4	18.2	44.0	14.5	5.4	9.1	19.3	18.2	11.8	10.8	29.8	12.1	20.5	7.9	12.8	8.0	13.0	16.2	12.2	6.1	65.4	7.9	12.6	9.0	19.3	14.3	6.5	26.7	12.8	10.3	9.6	20.3	14.9	16.4	15.0	10.2	10.6	12.8	5.4	5.9	25.8	9.9	24.1	5.8	8.5	3.9	2.6	2.6	3.2	2.6	2.6	3.4	3.7	3.7	2.5	3.0	3.2	4.5	3.3	6.5	4.9	2.6	8.7	4.5	2.3	18.8	19.6	21.8	22.8	18.7	19.0	21.2	19.2	21.2	17.5	19.6	20.9	4.1	16.0	14.4	23.5	4.3	3.7	9.2	12.5	15.9	21.8	8.0	8.8	10.6	20.0	10.8	14.7	29.2	11.8	11.4	81.9	19.6	8.7	13.4	8.9	3.8	5.8	22.3	9.3	17.2	9.8	4.9	5.9	33.6	7.9	7.0	12.2	7.5	67.8	6.5	11.8	24.2	35.3	10.2	5.7	2.9	6.5	10.2	3.6	3.6	6.5	5.3	16.3	4.1	10.6	9.7	7.6	70.4	6.8	7.4	5.0	143.4	23.5	19.0	28.0	13.1	6.0	5.5	27.3	15.6	9.4	4.5	13.5	5.3	6.2	44.0	6.6
KLHDC3	"dJ20C7.3, hPeas, PEAS"	ENSG00000124702	"Kelch domain containing 3"	Q9BQ90	6	43014103-43021298	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 395.9"	"Group enriched"	"Detected in all"	5	"Early spermatids: 552.0;Late spermatids: 1588.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030131, HPA030132, HPA030133, HPA030134"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350"	"unprognostic (3.85e-2)"	"prognostic favorable (9.15e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (9.97e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (9.08e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.52e-1)"	52.5	64.9	161.4	33.9	170.8	48.6	52.7	144.2	203.3	48.5	139.0	75.0	40.1	44.5	56.3	49.5	53.0	37.4	105.7	178.2	143.8	53.2	73.0	43.2	45.4	150.6	153.9	55.6	51.1	54.6	68.8	59.2	156.5	56.8	40.7	48.2	60.6	47.8	395.9	51.4	48.6	43.3	140.5	54.0	64.8	192.2	158.6	67.1	49.7	203.9	44.8	49.8	46.2	157.1	119.1	36.0	117.1	197.3	79.0	59.4	83.8	52.6	67.7	100.7	109.4	104.5	60.6	117.0	58.7	77.3	37.8	61.6	126.1	67.8	68.5	62.8	171.3	146.0	102.1	109.7	77.4	86.5	99.7	95.8	67.1	77.6	45.2	77.9	98.7	131.1	180.7	80.9	38.4	147.3	142.3	148.9	153.4	297.3	38.0	137.2	86.0	141.4	62.3	67.9	216.1	168.8	55.8	63.2	93.1	75.7	109.8	247.6	58.8	45.7	83.9	50.8	52.9	88.0	118.8	170.9	19.9	122.7	39.4	42.3	83.5	100.3	62.0	78.9	51.9	41.6	50.8	56.0	90.7	39.6	65.6	51.8	40.4	54.7	63.3	49.8	59.5	76.5	161.4	170.8	144.2	203.3	178.2	143.8	150.6	153.9	156.5	140.5	158.6	157.1	21.3	12.8	17.0	10.4	26.7	18.7	32.9	33.5	14.8	31.9	37.8	33.7	40.3	37.1	19.1	18.4	14.6	99.6	32.7	34.8	86.1	61.7	552.0	19.2	19.0	30.4	52.3	59.3	29.1	54.7	115.1	36.2	20.9	18.8	13.4	50.7	32.5	28.4	63.8	32.0	22.0	43.7	34.6	47.0	22.7	1588.3	44.7	31.8	33.8	11.2	54.7	55.4	55.6	11.6	14.8	46.3	44.3	59.0	31.7	44.4	72.6	55.3	16.9	25.9	52.6	30.4	32.2	180.8	35.6	22.8	20.6	107.0	28.3	71.4	53.7	36.7
KRT6B	KRTL1	ENSG00000185479	"Keratin 6B"	P04259	12	52446651-52452146	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 228.2;esophagus: 934.5;skin 1: 285.1;vagina: 229.6"	"Cell type enriched"	"Detected in some"	4	"Squamous epithelial cells: 217.5"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 1424.3;melanoma: 472.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 148.7"									"CAB000130, HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000130: , HPA045697: AB_2679422, HPA061168: AB_2684440"	"prognostic favorable (9.44e-4)"	"unprognostic (3.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.77e-2)"		"unprognostic (9.63e-2)"		"unprognostic (3.29e-1)"	"prognostic unfavorable (9.52e-4)"	0.9	0.2	0.0	2.0	0.0	0.1	16.2	0.0	0.0	228.2	0.0	0.5	0.0	0.1	0.0	934.5	0.2	0.2	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	168.6	0.0	0.3	285.1	0.2	0.0	0.0	0.1	0.7	0.2	0.0	2.1	0.1	0.0	74.3	0.2	229.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	27.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.7	1.1	0.0	0.1	13.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	20.6	1.8	40.4	0.0	0.0	28.7	16.8	0.1	0.0	16.3	0.0	0.0	0.0	0.9	0.3	0.0	46.2	1.8	0.0	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.0	1.7	1.3	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	5.6	0.0	0.0	2.8	0.0	0.0	0.0	1.4	0.0	0.2	217.5	32.7	0.0	0.3	0.0	0.6	5.9
L3MBTL2	"dJ756G23.3, DKFZP761I141, H-l(3)mbt-l"	ENSG00000100395	"L3MBTL histone methyl-lysine binding protein 2"	Q969R5	22	41205282-41231271	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000815			Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 43: Testis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA000815: AB_1079220"	"unprognostic (2.42e-1)"	"prognostic favorable (6.39e-5)"	"unprognostic (3.98e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (3.48e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.19e-1)"	9.8	14.6	15.8	12.3	16.6	11.0	10.5	14.7	16.8	12.8	12.6	13.5	8.6	13.2	12.1	12.1	19.4	9.5	13.2	15.4	16.3	14.2	16.6	11.8	17.7	16.3	16.4	14.0	11.0	17.0	16.4	9.5	17.0	14.2	10.2	10.0	13.0	13.8	11.9	13.7	11.6	13.9	14.7	15.5	12.7	14.9	16.6	15.0	12.2	9.0	18.0	13.9	10.4	24.3	21.3	20.8	17.6	35.6	20.9	15.6	20.6	19.8	22.7	37.7	31.1	13.7	15.0	34.6	15.7	26.7	22.6	20.3	40.9	26.3	23.9	42.3	52.8	14.4	35.7	32.9	22.1	65.8	31.4	21.4	10.2	29.6	27.8	16.4	27.2	26.1	24.9	27.5	18.1	37.4	33.4	22.4	23.9	75.6	23.8	34.1	14.3	39.9	19.0	20.9	14.3	10.0	35.5	25.3	21.4	17.0	16.9	36.0	21.6	20.2	19.1	16.2	22.2	22.6	43.1	28.6	23.3	29.7	26.3	10.0	13.4	10.7	21.4	16.6	19.6	15.7	16.7	17.1	17.0	11.0	20.0	18.9	2.1	21.2	18.6	12.9	18.4	21.6	15.8	16.6	14.7	16.8	15.4	16.3	16.3	16.4	17.0	14.7	16.6	24.3	9.4	16.0	19.6	7.5	12.2	2.7	5.1	8.0	2.8	24.7	9.0	8.9	10.2	15.7	17.1	11.0	16.7	17.7	15.8	9.6	11.7	9.9	13.9	14.8	9.1	9.3	15.0	10.5	9.9	7.9	17.4	9.3	13.7	8.0	11.4	12.0	7.9	14.2	13.0	16.8	10.8	8.7	22.4	11.1	4.6	30.0	7.2	11.6	3.6	3.7	11.2	13.7	12.3	9.5	8.1	7.6	5.8	9.4	13.3	6.9	7.3	8.7	22.6	15.0	6.6	9.4	13.4	21.5	14.4	6.7	3.8	17.1	13.9	17.5	9.4	6.2
LFNG	SCDO3	ENSG00000106003	"LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q8NES3	7	2512529-2529177	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 74.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 40.3;Enteroendocrine cells: 87.4;monocytes: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.7;OE19: 46.4;RH-30: 46.0;U-2 OS: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069130	Approved		Approved	"Nuclear membrane,Golgi apparatus"	"Intracellular and membrane"	NA	NA		880000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	"Nuclear membrane"	"HPA069130: AB_2686091"	"unprognostic (4.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.85e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.28e-2)"	16.7	6.5	23.3	17.3	25.9	9.8	13.7	29.3	22.4	9.9	11.1	23.1	15.5	9.4	2.2	11.4	6.1	11.8	13.1	17.4	30.1	9.0	2.5	14.4	18.6	34.1	35.6	1.8	74.4	3.0	3.7	6.5	24.8	17.1	12.0	3.0	33.4	4.6	4.6	58.2	17.2	5.8	25.0	20.9	37.8	4.2	38.1	5.8	6.7	3.6	10.8	12.2	13.8	23.6	1.5	14.3	18.4	2.5	2.0	1.7	1.2	5.4	2.8	4.7	5.9	6.0	37.7	1.1	16.7	14.8	8.1	27.1	2.9	5.1	2.3	8.6	0.6	4.3	7.7	3.2	0.1	6.2	7.7	3.3	12.6	7.8	0.8	3.2	1.9	0.3	0.7	0.2	3.6	34.5	0.1	8.7	22.4	46.4	10.3	1.8	46.0	2.9	1.8	4.5	16.9	4.2	6.2	1.4	0.3	4.7	10.2	7.3	4.5	10.5	49.7	0.4	15.4	0.2	0.0	1.4	11.8	16.4	2.0	6.3	5.3	12.7	1.8	6.9	2.0	1.1	1.7	0.9	2.3	2.0	1.8	1.8	2.8	1.3	6.6	0.6	4.2	1.7	23.3	25.9	29.3	22.4	17.4	30.1	34.1	35.6	24.8	25.0	38.1	23.6	23.3	6.4	6.0	18.9	15.6	6.8	2.5	10.6	3.4	8.5	5.3	12.4	3.6	5.7	2.8	0.0	0.0	0.1	40.3	23.1	0.0	1.2	0.1	2.4	8.5	16.0	87.4	2.7	0.0	6.4	0.3	5.7	30.5	1.2	17.7	0.1	13.9	0.6	7.0	0.0	0.1	34.5	6.1	30.4	13.8	0.5	1.8	30.6	3.6	11.2	38.2	31.3	19.6	1.5	0.1	21.7	3.1	0.0	12.6	2.2	8.8	0.4	1.2	0.8	0.0	0.6	5.0	0.3	3.1	0.6	4.0	0.0	15.9	0.5	15.3	0.7
LGALS4	GAL4	ENSG00000171747	"Galectin 4"	P56470	19	38801671-38812945	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"intestine: 1307.1"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 4349.4;Intestinal goblet cells: 3767.6;Paneth cells: 3353.0;Proximal enterocytes: 4572.2;Undifferentiated cells: 2684.6"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	205	"OE19: 987.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB025653, HPA031184, HPA031185, HPA031186"	Enhanced		Uncertain	"Plasma membrane"		NA	NA		200000		"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.71e-2)"	"prognostic favorable (3.21e-4)"	1.6	0.5	0.3	86.1	0.4	0.5	5.5	0.5	0.6	1.4	0.2	1307.1	812.2	3.2	0.2	1.4	2.4	137.1	0.9	0.3	0.3	2.9	79.5	1.2	1.1	0.3	0.3	1.6	31.5	0.0	0.8	0.2	0.3	2.3	933.0	0.2	1.1	2.3	1.6	1.6	691.9	55.2	0.2	4.0	135.2	0.9	0.3	0.3	1.7	0.2	0.4	11.2	1.5	0.4	0.0	0.4	0.1	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	1.3	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	2.2	0.0	987.1	0.0	0.1	0.0	2.5	0.1	4.8	0.2	1.4	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.2	1.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.6	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.4	1.7	3.2	6.5	0.7	10.3	1.1	3.0	0.6	3.4	1.1	3.6	3.0	1.3	770.7	1.0	0.0	0.0	0.8	0.9	4349.4	0.0	267.1	0.2	1.9	1.8	1.2	649.7	0.0	0.3	103.3	0.5	0.8	310.4	5.7	49.0	0.8	1.8	69.0	0.1	1.7	0.3	3767.6	0.0	1.9	0.3	0.0	0.0	1.2	0.0	1.0	3.0	0.8	1.0	0.0	0.7	492.7	3353.0	0.4	0.7	1.8	4572.2	9.3	0.4	2.3	0.0	3.9	1.1	0.3	0.9	0.9	2.7	0.5	11.1	1.1	2684.6	42.4
LINS1	"LINS, MRT27, WINS1"	ENSG00000140471	"Lines homolog 1"	Q8NG48	15	100559369-100603230	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038578, HPA038579"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA038578: AB_2676095, HPA038579: AB_10697393"	"unprognostic (9.87e-2)"	"unprognostic (3.32e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.37e-2)"	"unprognostic (6.16e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.28e-2)"	4.2	4.1	2.5	8.3	2.2	5.7	7.7	3.1	3.3	7.2	2.8	5.8	4.1	6.6	9.4	7.0	5.4	4.4	3.1	2.4	1.7	6.0	5.5	6.2	11.5	1.6	1.4	6.4	5.4	6.1	3.5	6.4	1.8	6.1	7.0	6.6	5.1	4.6	4.3	6.9	4.5	6.2	1.1	8.4	6.3	7.6	2.3	9.1	8.4	5.1	10.0	5.8	4.9	2.8	4.4	6.6	8.2	8.2	5.9	8.0	7.5	6.8	7.6	7.6	8.1	6.2	8.4	11.6	3.9	6.2	5.7	18.5	7.8	8.6	7.9	4.0	11.1	10.4	10.7	4.9	4.9	8.9	6.3	7.7	7.4	5.9	9.4	7.6	9.0	6.4	17.3	9.1	4.7	5.7	5.3	7.6	9.6	16.7	8.1	7.8	13.1	10.8	6.6	11.8	4.2	5.5	6.3	6.1	10.2	10.4	10.3	6.7	6.5	9.5	8.5	6.8	8.9	9.7	13.4	10.5	6.1	11.4	7.7	12.4	7.9	11.7	16.3	7.5	23.9	12.7	25.7	18.1	8.4	11.9	35.0	25.1	10.4	15.0	6.7	6.8	17.6	10.5	2.5	2.2	3.1	3.3	2.4	1.7	1.6	1.4	1.8	1.1	2.3	2.8	7.7	19.2	5.9	0.0	16.6	0.0	9.7	0.0	11.4	16.1	11.3	8.3	0.0	5.7	2.5	12.9	18.8	8.8	20.4	4.9	5.9	5.9	10.8	6.6	11.4	5.7	4.9	11.6	0.0	5.1	5.5	7.2	15.3	6.3	1.3	10.3	7.1	7.6	15.3	16.8	0.0	5.8	0.0	6.0	0.0	1.7	12.2	6.9	0.0	0.0	7.9	9.3	26.8	0.0	0.0	5.4	3.2	7.2	12.5	9.0	10.5	4.7	7.3	16.0	13.1	8.5	5.8	20.7	12.9	9.9	0.0	12.4	29.8	18.9	4.8	7.5
LIPT2		ENSG00000175536	"Lipoyl(octanoyl) transferase 2"	A6NK58	11	74490519-74493724	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Ligase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 55.4;Late spermatids: 29.4;Proximal tubular cells: 17.7;Spermatocytes: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040249	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA040249: AB_10795275"	"unprognostic (8.80e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.11e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (6.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.35e-1)"	1.3	2.0	1.8	1.6	2.0	2.1	2.4	1.8	1.8	1.5	1.2	2.1	3.7	1.6	3.2	1.8	3.2	1.9	1.5	1.6	1.8	4.6	3.1	1.7	2.2	2.4	1.9	3.4	2.9	2.1	2.1	2.1	2.4	1.8	2.3	1.9	2.1	2.7	8.0	1.6	3.6	0.6	1.8	2.1	3.5	12.3	2.8	2.7	3.0	7.1	2.2	1.7	1.2	3.3	2.1	3.3	6.6	3.1	2.1	0.4	6.9	0.8	1.5	3.3	2.3	9.8	3.0	11.5	4.0	0.6	8.0	3.2	2.8	1.9	1.2	2.2	2.6	4.0	3.2	2.9	2.9	4.4	5.0	1.4	2.2	2.2	2.2	1.5	0.2	12.7	3.0	4.1	1.3	4.0	6.6	6.1	4.9	13.0	2.6	4.3	7.0	3.7	2.6	7.3	5.5	3.6	5.6	2.0	8.1	6.2	5.6	3.2	0.6	1.0	2.1	1.5	1.8	5.7	5.8	9.3	0.6	2.7	2.9	0.1	4.7	7.5	5.5	3.0	7.6	10.6	7.3	6.6	5.3	10.5	13.3	10.9	1.1	8.4	3.4	6.3	3.7	4.8	1.8	2.0	1.8	1.8	1.6	1.8	2.4	1.9	2.4	1.8	2.8	3.3	0.6	0.0	0.0	1.0	2.5	0.8	1.1	2.9	4.0	0.9	1.7	1.9	1.1	2.8	1.4	3.7	0.0	13.2	0.7	0.9	5.9	2.6	55.4	1.5	0.7	1.0	0.0	4.0	0.3	4.4	14.1	1.4	2.0	1.1	0.0	1.9	2.2	4.2	5.4	3.3	0.2	3.1	4.1	1.3	0.0	29.4	1.8	2.3	1.8	0.0	0.7	9.8	2.1	0.5	1.1	2.8	0.5	1.2	0.8	1.0	4.3	17.7	1.9	1.6	0.0	1.3	0.9	46.7	10.7	2.9	0.6	8.1	1.4	3.0	3.1	0.3
LMX1B	NPS1	ENSG00000136944	"LIM homeobox transcription factor 1 beta"	O60663	9	126613928-126701032	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;salivary gland: 18.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.3;Breast myoepithelial cells: 7.2;Cardiomyocytes: 1.9;Early spermatids: 1.6;Spermatogonia: 2.1"	"Cancer enriched"	"Detected in some"	14	"breast cancer: 12.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HEK 293: 3.6;MCF7: 11.9;OE19: 10.4;T-47d: 8.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.3"	"Region enhanced"	"Detected in many"		"midbrain: 5.0"	"HPA073716, HPA075656"			Approved	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA073716: AB_2686630, HPA075656: "	"unprognostic (4.17e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.63e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-6)"	"unprognostic (1.13e-2)"	0.6	0.0	0.1	0.0	0.1	0.1	4.1	0.1	5.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	1.0	3.6	0.0	0.1	0.0	3.8	9.2	0.0	0.2	1.1	0.2	0.0	3.3	0.0	0.0	0.0	18.5	0.0	0.1	2.1	0.1	0.0	6.8	0.0	0.1	1.4	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.2	0.6	0.3	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.3	0.0	2.5	0.6	3.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	11.9	0.0	0.0	0.0	10.4	0.0	0.0	2.4	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.2	0.1	8.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	5.6	1.0	1.0	3.8	9.2	3.3	6.8	2.6	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	7.2	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	1.6	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
LNX1	"LNX, MPDZ, PDZRN2"	ENSG00000072201	"Ligand of numb-protein X 1"	Q8TBB1	4	53459301-53701405	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 77.5;Early spermatids: 171.7;Excitatory neurons: 123.8;Glandular and luminal cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"amygdala: 2.7;basal ganglia: 6.0;cerebral cortex: 10.3;hippocampal formation: 7.5;white matter: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002235, HPA071091"	Approved		Supported	"Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"	Cytosol	"HPA002235: AB_1079261, HPA071091: AB_2686344"	"unprognostic (4.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.67e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	21.9	2.5	2.7	2.1	6.0	1.0	14.3	0.1	10.3	6.1	0.0	6.7	9.4	4.2	0.6	24.4	6.4	5.5	8.7	7.5	0.1	10.6	4.4	2.7	2.1	0.0	0.1	2.1	16.3	11.9	4.3	24.6	0.4	5.9	6.9	3.8	25.1	7.2	5.9	11.8	9.0	3.0	0.0	0.9	9.5	4.4	0.6	3.3	17.9	12.0	4.1	4.3	7.9	3.1	1.4	0.5	1.6	0.9	2.7	5.8	8.0	1.2	0.6	0.0	0.0	2.9	8.9	1.7	1.1	4.3	0.4	1.4	0.0	0.2	0.0	0.4	4.6	2.2	1.5	1.5	1.3	2.4	0.7	4.4	0.2	0.3	0.0	1.9	2.7	0.8	1.9	0.8	6.4	4.5	2.2	1.7	4.3	17.7	0.7	1.2	0.6	0.7	5.6	8.2	2.2	2.1	0.6	10.8	0.9	9.1	5.7	1.1	7.8	10.0	2.6	3.1	1.6	3.6	0.5	1.1	8.7	2.0	1.5	0.3	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.0	0.7	0.4	0.2	0.2	0.0	2.7	6.0	0.1	10.3	7.5	0.1	0.0	0.1	0.4	0.0	0.6	3.1	77.5	0.0	3.9	4.9	1.7	8.2	18.0	14.5	24.5	7.5	13.3	7.1	1.6	12.8	15.5	7.3	6.2	30.6	1.5	18.5	19.6	13.7	171.7	37.7	7.6	16.0	13.8	3.6	123.8	11.7	22.1	4.8	14.3	83.0	2.5	1.5	2.9	6.2	2.5	42.1	42.2	13.4	14.2	0.3	2.1	47.9	4.4	1.3	5.4	11.2	0.4	2.2	2.1	43.7	4.0	12.3	26.5	8.6	0.9	8.5	14.5	2.9	17.9	5.8	0.0	10.0	2.2	0.9	2.6	32.2	11.9	14.9	1.9	1.4	14.2	15.2
LRCH1	"CHDC1, KIAA1016"	ENSG00000136141	"Leucine rich repeats and calponin homology domain containing 1"	Q9Y2L9	13	46553168-46753040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 89.2;Inhibitory neurons: 117.6;Microglial cells: 183.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 37.1"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021536	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Actin filaments, Cytosol"	Nucleoli	"HPA021536: AB_1853258"	"unprognostic (7.13e-3)"	"prognostic unfavorable (6.24e-4)"	"unprognostic (3.59e-2)"	"unprognostic (8.93e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.98e-2)"	15.1	5.0	4.7	10.7	4.7	8.9	14.6	37.1	6.2	15.9	4.2	15.2	7.9	16.3	7.7	10.0	11.8	12.6	8.4	5.7	6.1	14.9	12.2	13.8	16.3	6.5	7.0	10.1	5.6	5.4	5.8	18.2	7.8	10.8	10.0	10.3	10.0	12.0	3.9	17.9	11.6	17.6	7.9	14.6	13.0	4.6	6.8	18.5	6.5	7.5	15.7	13.5	9.7	7.5	7.4	10.4	9.2	9.6	6.6	12.5	23.6	12.4	16.1	15.0	14.2	23.5	12.3	23.4	3.4	11.7	9.8	10.4	7.1	12.5	21.6	24.2	6.6	21.0	4.3	11.1	8.2	13.8	34.5	7.9	9.7	13.9	16.8	12.3	13.1	15.6	4.2	6.9	11.2	14.2	14.8	17.3	5.2	46.3	5.5	8.0	10.0	6.3	28.1	7.5	14.5	14.6	7.0	6.8	18.8	16.2	5.3	18.3	12.5	8.8	6.0	11.0	11.9	1.3	3.7	10.6	10.3	11.9	10.8	0.6	0.9	0.9	1.5	0.7	0.8	2.2	1.1	1.0	0.8	2.7	0.8	0.9	0.3	2.5	0.5	1.0	0.8	0.9	4.7	4.7	37.1	6.2	5.7	6.1	6.5	7.0	7.8	7.9	6.8	7.5	61.5	6.4	6.1	24.8	26.7	37.5	10.5	6.2	27.3	8.3	12.0	11.8	7.2	17.2	6.5	22.0	22.9	13.4	8.4	6.8	9.8	8.3	1.6	5.4	6.5	32.5	1.8	9.9	89.2	4.2	12.7	14.3	18.8	13.7	27.9	2.8	17.5	9.3	13.4	3.3	117.6	10.6	8.2	16.9	30.7	2.1	13.1	12.3	30.2	183.6	8.4	5.5	8.2	64.8	9.7	13.5	5.5	17.0	12.4	12.9	8.0	8.4	2.6	8.5	13.1	15.6	18.6	1.7	4.1	15.9	33.2	9.7	14.7	15.3	7.8	9.2
LRRC28	"FLJ34269, FLJ45242, MGC24976"	ENSG00000168904	"Leucine rich repeat containing 28"	Q86X40	15	99251362-99390729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 159.2;Excitatory neurons: 127.4;Late spermatids: 406.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039378, HPA040784, HPA066130"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Mitochondria"		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Mitochondria"	"HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623"	"unprognostic (4.84e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.82e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (2.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.41e-1)"	8.1	7.8	4.4	4.4	5.1	8.6	6.4	4.5	5.8	6.1	4.3	8.0	16.9	5.8	7.4	9.7	4.8	9.1	9.7	5.3	3.9	19.4	47.1	5.3	6.9	3.7	3.5	4.9	19.5	9.4	4.1	6.1	3.5	5.3	9.7	6.8	6.1	6.6	18.3	10.4	16.5	7.9	3.3	4.9	8.2	28.5	3.9	22.6	6.6	18.4	9.4	6.5	6.3	4.4	4.0	9.8	9.5	12.3	13.2	18.7	4.0	4.2	11.9	7.1	8.3	7.4	8.6	8.2	7.6	10.1	8.7	8.8	7.0	13.5	10.3	5.0	10.2	5.5	4.0	7.7	11.7	5.5	8.6	11.1	18.2	6.7	13.4	16.0	22.7	13.0	4.9	8.1	14.9	8.0	15.2	8.9	4.0	31.2	3.7	9.3	8.0	7.6	15.1	12.8	4.3	5.5	10.1	5.4	16.4	14.4	8.4	10.2	8.3	7.0	4.8	5.4	8.4	15.9	24.1	5.1	8.8	5.4	13.3	23.4	9.3	32.0	7.2	7.8	5.8	6.2	6.7	7.7	8.4	5.8	6.2	5.4	5.0	5.1	8.0	6.9	10.4	6.1	4.4	5.1	4.5	5.8	5.3	3.9	3.7	3.5	3.5	3.3	3.9	4.4	13.2	16.0	4.1	29.0	13.5	13.8	14.5	14.5	12.5	19.9	8.9	12.4	13.4	12.8	11.0	11.0	22.9	17.5	11.4	18.6	27.4	12.7	159.2	7.4	8.4	11.9	9.1	12.4	127.4	29.5	22.6	8.5	15.8	6.5	2.5	15.0	12.8	37.0	19.3	21.9	86.8	16.0	20.3	19.8	20.1	406.4	12.8	15.3	14.2	37.5	19.1	14.4	14.4	63.3	63.0	14.8	24.2	8.6	14.7	8.4	72.3	74.1	10.1	19.8	0.0	10.7	11.7	77.1	39.0	15.1	15.8	13.0	11.3	18.0	19.5	15.4
LRRC31	FLJ23259	ENSG00000114248	"Leucine rich repeat containing 31"	Q6UY01	3	169839172-169869935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 21.7;salivary gland: 6.5;stomach 1: 10.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 8.9;Enteroendocrine cells: 10.3;Intestinal goblet cells: 23.5;Paneth cells: 6.0;Undifferentiated cells: 5.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.9;HAP1: 1.4;OE19: 8.8;RPTEC TERT1: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA058013			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA058013: "	"unprognostic (5.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"		"unprognostic (9.90e-2)"	"unprognostic (4.40e-2)"		"unprognostic (7.90e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.20e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.96e-3)"	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	1.4	0.0	17.5	8.4	0.1	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	5.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	21.7	0.1	6.5	0.0	0.0	0.0	9.6	0.4	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.8	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	1.0	0.3	0.0	10.3	0.0	0.3	0.0	0.0	0.0	3.1	3.0	0.0	0.0	0.0	2.4	0.1	0.0	0.2	23.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.1	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.4
LRRC66		ENSG00000188993	"Leucine rich repeat containing 66"	Q68CR7	4	51993702-52017620	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 22.5;skeletal muscle: 8.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.9;Distal enterocytes: 9.0;Excitatory neurons: 9.4;Gastric mucus-secreting cells: 6.1;Inhibitory neurons: 7.3;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 8.8;Paneth cells: 7.3;Proximal enterocytes: 21.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.5;CAPAN-2: 2.0;OE19: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014549, HPA027839"	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA014549: AB_1853062, HPA027839: AB_10602705"	"unprognostic (1.10e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.06e-1)"	0.4	0.3	0.9	0.9	1.0	0.0	0.3	1.3	1.4	0.6	0.5	6.1	22.5	0.5	0.2	0.1	0.5	1.8	1.0	1.0	0.8	1.1	0.5	0.2	0.1	1.2	0.8	0.4	0.3	0.3	2.4	0.0	1.2	0.5	5.8	0.8	0.3	0.2	8.0	0.2	18.7	0.6	0.8	0.3	5.0	0.8	1.1	0.1	0.2	2.1	0.0	0.5	0.3	1.2	0.0	0.0	0.1	0.2	0.6	1.5	0.0	0.2	0.4	0.1	0.3	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.3	0.3	0.1	0.5	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	1.3	1.4	1.0	0.8	1.2	0.8	1.2	0.8	1.1	1.2	0.2	0.0	0.0	5.9	0.1	0.0	0.0	0.2	0.0	1.6	0.1	0.4	1.1	1.5	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.2	1.3	0.4	0.2	0.1	0.0	0.0	9.4	1.2	0.0	0.6	6.1	0.2	0.0	0.1	0.7	0.1	0.0	0.0	7.3	4.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.9	0.6	0.1	0.0	8.0	8.8	0.5	7.3	0.4	0.0	0.0	21.8	0.4	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1
LRRC73	"C6orf154, dJ337H4.2"	ENSG00000204052	"Leucine rich repeat containing 73"	Q5JTD7	6	43506969-43510686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 44.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 411.0;Spermatocytes: 121.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.1;MCF7: 3.2;OE19: 4.5;T-47d: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046698	Enhanced		Approved	Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA046698: AB_10959526"	"unprognostic (3.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.89e-2)"	0.2	6.4	4.6	0.0	4.8	0.0	0.3	0.0	8.9	0.9	0.6	0.4	0.6	0.6	0.3	0.2	5.1	0.5	1.5	5.6	2.4	2.6	0.5	0.9	0.0	1.3	1.4	0.9	1.2	2.9	4.7	0.2	1.5	1.0	0.1	1.3	0.6	0.6	0.0	0.3	0.2	0.3	0.2	0.5	1.0	44.2	3.5	0.0	1.1	0.0	0.0	0.4	0.3	3.7	0.3	0.7	0.4	3.1	0.5	1.5	0.1	0.1	0.9	0.2	0.1	0.0	0.1	0.1	0.0	0.5	0.4	1.2	0.3	0.4	0.0	0.0	0.5	0.0	0.2	0.1	0.4	0.0	0.0	0.2	0.6	1.0	0.1	1.5	0.1	0.1	0.2	0.3	0.6	3.2	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.8	0.0	1.1	1.3	0.3	0.2	0.1	0.0	3.2	0.0	0.1	0.2	0.3	1.1	0.1	0.3	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.8	0.0	8.9	5.6	2.4	1.3	1.4	1.5	0.2	3.5	3.7	0.3	0.0	0.0	1.0	0.0	0.4	3.1	0.7	0.0	5.6	0.8	1.3	1.0	1.5	1.6	3.7	0.0	0.1	0.0	1.0	7.9	0.6	411.0	27.1	4.0	0.6	5.4	0.0	3.3	0.9	0.1	0.8	1.5	1.3	0.0	0.6	0.0	0.8	0.1	28.6	3.3	2.2	0.0	0.0	0.0	58.3	4.4	0.4	1.8	0.0	0.0	8.7	0.0	0.0	0.3	0.2	0.1	4.1	0.0	2.8	2.2	9.4	12.6	8.4	6.6	0.3	0.9	121.6	12.4	0.0	0.0	0.3	0.1	7.1	0.8	0.6
LSM7	YNL147W	ENSG00000130332	"LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9UK45	19	2321520-2328611	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041850	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"		"HPA041850: AB_10964065"	"unprognostic (8.33e-2)"	"prognostic favorable (3.28e-4)"	"unprognostic (9.33e-2)"	"prognostic favorable (4.19e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.90e-2)"	"unprognostic (9.60e-3)"	"unprognostic (9.65e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.65e-3)"	"unprognostic (9.48e-3)"	"unprognostic (8.45e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (6.96e-4)"	62.0	54.2	54.0	51.5	55.3	111.9	64.7	58.1	84.1	77.3	52.5	73.9	62.3	63.7	22.9	88.9	61.8	20.7	64.1	53.9	58.4	64.7	65.8	53.3	70.9	58.1	58.4	74.6	53.2	33.2	80.5	38.5	56.9	63.5	32.7	15.1	52.7	31.9	68.3	69.9	77.7	28.2	58.0	82.5	55.8	44.0	55.8	77.6	50.9	31.0	46.2	62.9	68.5	61.2	276.5	171.3	167.5	192.4	74.3	70.8	139.6	131.7	93.6	147.2	114.1	326.3	105.8	329.4	139.5	105.4	84.9	140.4	161.1	183.3	68.6	232.3	376.0	230.3	152.3	430.5	73.7	437.9	164.8	83.2	106.6	97.9	99.0	62.9	129.5	251.3	296.6	245.6	66.5	357.2	381.5	371.7	314.3	246.6	228.9	276.0	185.3	479.5	91.2	221.5	311.0	224.3	147.8	113.9	179.3	87.1	96.8	301.5	135.7	106.9	146.5	176.6	250.1	210.1	259.3	425.4	103.9	388.2	186.8	120.3	202.8	189.5	162.3	244.9	162.9	469.0	224.7	189.8	279.6	410.8	214.8	197.1	43.9	187.3	209.6	291.2	243.0	242.2	54.0	55.3	58.1	84.1	53.9	58.4	58.1	58.4	56.9	58.0	55.8	61.2	153.9	96.1	81.3	17.0	276.3	231.0	196.8	348.4	162.8	44.3	188.3	328.5	99.5	88.6	183.4	126.9	33.3	377.6	142.1	221.5	195.6	210.7	12.9	186.1	197.8	130.0	168.0	154.1	7.6	220.1	353.0	157.9	136.6	232.9	115.9	252.0	83.9	88.0	220.4	35.3	9.5	350.5	219.7	115.1	270.7	21.0	115.5	144.6	140.5	12.2	159.0	104.4	171.0	9.5	19.0	262.0	229.6	90.7	210.1	298.0	215.3	198.0	132.2	62.5	85.5	138.4	168.5	61.4	223.3	257.2	216.4	242.6	164.3	165.5	357.3	236.7
LYSMD4	FLJ33008	ENSG00000183060	"LysM domain containing 4"	Q5XG99	15	99715697-99733561	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029152, HPA059824"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	"Actin filaments"	"HPA029152: AB_10602033, HPA059824: AB_2684135"	"unprognostic (2.43e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.30e-1)"	7.1	5.5	6.3	1.7	6.8	3.1	6.7	6.3	7.1	8.4	6.2	9.7	4.8	9.4	3.4	11.1	8.1	1.5	20.2	6.4	6.0	11.8	11.8	7.6	2.3	5.9	6.4	8.9	8.0	5.7	7.1	2.8	6.2	9.5	3.2	5.2	9.5	4.2	10.3	16.7	7.9	3.8	5.9	8.0	7.8	7.7	7.0	3.9	5.0	5.9	3.8	7.9	9.4	6.8	3.5	3.3	6.5	3.8	7.1	6.4	3.9	3.9	2.7	3.3	4.8	8.2	3.0	3.8	2.3	3.6	5.8	10.1	5.1	6.3	3.8	0.8	9.2	2.5	7.2	5.7	4.1	1.8	4.6	3.7	9.2	3.0	3.6	2.0	4.5	10.9	6.2	4.8	2.2	4.1	4.8	5.1	4.3	9.7	3.7	3.4	4.6	1.9	5.9	9.0	3.7	3.3	7.2	2.2	3.9	8.3	1.5	3.5	5.8	2.7	7.3	3.7	1.7	6.3	9.1	3.1	3.5	4.5	2.9	0.0	1.3	5.3	2.1	1.9	1.7	1.0	3.0	2.6	0.6	1.7	3.5	1.6	0.4	0.7	2.7	3.0	3.2	2.4	6.3	6.8	6.3	7.1	6.4	6.0	5.9	6.4	6.2	5.9	7.0	6.8	7.0	6.4	3.3	4.6	2.5	8.7	8.1	4.6	8.0	8.0	3.5	6.3	12.8	7.2	3.9	3.7	10.4	2.6	4.9	4.4	1.9	4.1	7.3	1.3	3.0	4.8	3.0	6.1	9.8	9.7	2.0	6.8	3.6	1.7	0.0	2.9	3.9	3.4	4.3	10.1	11.4	6.2	6.1	2.2	3.7	8.1	5.3	3.9	1.8	8.4	8.1	11.6	3.1	6.0	7.4	7.2	3.0	6.8	3.9	2.1	3.9	5.3	2.5	10.0	13.1	3.9	5.7	12.7	11.3	8.1	9.1	1.4	2.9	2.2	2.6	3.5
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348381-69354234	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 10588.1;salivary gland: 21115.5;stomach 1: 8941.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 3106.1;Kupffer cells: 2841.2;Langerhans cells: 4859.1;Macrophages: 4870.7;monocytes: 7063.0;Pancreatic endocrine cells: 3152.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 976.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 25266.2;myeloid DC: 14438.7"	"Group enriched"	"Detected in all"	20	"dendritic cells: 14438.7;monocytes: 25266.2"	"Cell line enriched"	"Detected in many"	13	"OE19: 12130.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	1500000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	95.8	27.8	3.5	802.1	4.0	10588.1	128.2	3.7	18.5	156.2	11.4	309.0	3605.0	65.7	4.2	106.3	33.9	1054.6	34.8	2.6	4.3	32.4	138.0	1355.2	739.7	8.0	7.3	20.4	63.1	13.8	7.2	91.3	12.2	40.2	273.8	4.4	21115.5	21.8	34.0	58.7	1322.2	123.9	5.4	621.0	8941.1	21.8	10.9	321.8	27.8	36.4	652.8	428.5	16.2	11.7	0.6	0.1	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0	0.3	9.5	6.5	4.2	1.5	0.0	3.6	1.2	0.0	0.0	0.2	1.2	0.1	62.4	1.0	960.4	0.0	110.6	50.5	0.0	0.1	0.0	0.0	0.2	0.0	0.3	7.7	0.3	0.0	0.2	2.6	109.5	2.3	12130.8	0.2	1.6	1.4	16.7	0.3	0.5	0.8	3.6	0.5	0.1	0.5	0.7	0.0	489.0	0.6	0.0	2.6	2.3	0.9	2.6	1.1	1.2	0.1	518.5	0.0	443.4	25266.2	298.2	32.6	4798.4	52.3	100.5	20.1	22.7	14438.7	20.8	20.0	17.8	1007.7	108.1	880.1	301.2	31.1	25392.1	3.5	4.0	3.7	18.5	2.6	4.3	8.0	7.3	12.2	5.4	10.9	11.7	24.0	86.6	285.8	0.0	80.8	57.2	1.7	1.2	1.2	0.3	1205.7	32.3	0.2	734.9	51.1	27.6	0.0	5.6	39.6	32.1	0.0	55.1	1.9	2.6	1.9	25.1	12.5	264.6	0.2	547.3	9.4	26.8	3106.1	2.9	123.6	0.5	29.6	25.4	887.1	0.0	0.2	112.4	0.0	2841.2	4859.1	17.4	4.1	4870.7	53.4	0.0	7063.0	0.1	176.1	0.0	0.3	3152.5	600.5	2.2	9.0	2.7	41.8	6.6	33.8	1.0	39.5	7.4	9.9	0.7	3.9	1.5	38.2	8.5	50.6	0.3	111.4	38.3
LYZL4	"LYC4, MGC26768"	ENSG00000157093	"Lysozyme like 4"	Q96KX0	3	42397083-42410610	"Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"testis: 52.1"	"Group enriched"	"Detected in some"	46	"Early spermatids: 386.3;Late spermatids: 158.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"OE19: 3.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA038806	Approved				"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA038806: AB_10674841"					"unprognostic (4.03e-1)"							"unprognostic (5.68e-1)"		"unprognostic (1.06e-1)"				0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	386.3	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	158.8	3.1	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	5.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAD2L1BP	"CMT2, dJ261G23.1, KIAA0110"	ENSG00000124688	"MAD2L1 binding protein"	Q15013	6	43629540-43640941	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028729			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA028729: AB_2672752"	"unprognostic (2.60e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.25e-3)"	13.3	16.2	13.6	14.1	13.8	53.5	17.3	14.1	15.8	14.6	15.4	25.9	23.6	12.4	17.3	17.6	16.7	14.4	25.4	14.3	14.9	17.5	21.9	14.9	21.7	13.8	13.2	13.0	16.7	21.1	12.6	14.0	14.2	14.4	27.7	15.2	22.8	13.5	28.5	13.2	18.8	14.5	13.6	17.4	19.3	20.4	14.3	29.3	15.6	44.6	26.6	21.4	10.6	13.8	53.9	24.4	37.7	42.2	32.1	34.7	22.7	31.7	50.9	68.5	63.8	50.3	21.4	41.6	17.6	37.3	62.2	34.4	59.2	43.9	52.6	38.5	46.0	51.5	26.1	43.8	34.6	30.6	29.9	35.3	53.0	51.1	31.0	34.5	52.2	32.8	67.2	21.8	48.4	50.6	27.4	56.5	23.3	221.1	31.3	31.3	29.3	39.4	48.9	42.5	44.7	45.3	22.8	34.5	152.2	28.6	40.6	80.3	28.7	36.5	30.7	24.4	51.3	27.7	25.8	99.0	33.2	51.3	41.0	105.4	41.4	49.4	46.3	42.8	46.5	52.6	54.7	51.4	52.7	47.9	56.5	51.2	35.2	55.6	41.3	34.9	78.9	43.6	13.6	13.8	14.1	15.8	14.3	14.9	13.8	13.2	14.2	13.6	14.3	13.8	11.6	25.6	12.7	3.3	18.2	14.4	20.5	44.9	17.6	12.8	11.6	9.3	10.8	15.7	32.5	3.7	12.5	21.1	11.1	30.7	27.4	28.0	47.0	13.2	8.6	12.5	17.4	20.6	3.0	21.2	21.5	12.0	14.3	10.8	31.6	7.8	11.4	12.7	17.6	10.1	3.2	17.1	32.6	10.4	8.6	36.5	12.2	19.6	28.4	1.9	17.3	13.9	11.3	3.0	5.0	24.7	29.5	12.0	11.1	11.5	28.2	21.2	21.1	15.1	26.3	8.3	13.4	26.4	18.3	12.6	9.7	6.2	14.8	11.9	23.4	27.2
MAGEA12	"CT1.12, MAGE12"	ENSG00000213401	"MAGE family member A12"	P43365	X	152733757-152737669	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.8"	"Group enriched"	"Detected in some"	16	"Spermatocytes: 9.4;Spermatogonia: 20.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 10.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 143.0;HMC-1: 57.8;K-562: 89.5;OE19: 112.7;SH-SY5Y: 48.2;U-2 OS: 87.2;U-266/70: 69.2"															NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"								"unprognostic (3.47e-2)"	"unprognostic (4.54e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.25e-1)"		"unprognostic (1.60e-3)"		"unprognostic (8.57e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.78e-1)"		"unprognostic (4.06e-2)"	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.4	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	5.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.0	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	0.0	112.7	41.6	0.1	0.0	1.1	0.0	0.1	3.3	48.2	0.0	24.3	13.3	0.0	0.7	0.2	0.4	0.1	87.2	12.7	6.5	69.2	0.1	0.1	0.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.7	0.4	0.4	0.4	0.4	0.4	0.3	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.4	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEA2	"CT1.2, MAGE2, MAGEA2A"	ENSG00000268606	"MAGE family member A2"	P43356	X	152749863-152753884	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 76.1;HMC-1: 45.6;K-562: 65.7;OE19: 123.5;SH-SY5Y: 49.6;SK-BR-3: 48.6;U-266/70: 120.9;U-266/84: 87.8"															NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"													"unprognostic (3.67e-1)"									0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	5.7	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	45.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.7	27.0	0.0	0.0	0.0	0.0	0.0	123.5	3.2	0.1	0.0	0.1	0.0	0.0	19.6	49.6	0.0	48.6	13.5	0.2	0.0	5.5	0.3	0.5	3.7	1.1	0.4	120.9	87.8	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEA3	"CT1.3, HIP8, HYPD, MAGE3, MGC14613"	ENSG00000221867	"MAGE family member A3"	P43357	X	152698767-152702347	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"testis: 8.0"	"Group enriched"	"Detected in some"	16	"Spermatocytes: 35.7;Spermatogonia: 54.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 264.2;K-562: 174.3;OE19: 379.3;PC-3: 155.9;SH-SY5Y: 153.4;SK-BR-3: 184.7;U-266/70: 242.7;U-266/84: 291.4"															NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"								"unprognostic (1.29e-1)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.48e-1)"					"unprognostic (2.53e-3)"	"unprognostic (3.95e-2)"		"unprognostic (2.92e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.1	0.0	0.0	0.0	0.0	70.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	264.2	0.4	0.0	0.0	0.0	0.1	0.0	0.1	48.8	1.2	0.0	0.0	112.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	174.3	16.6	0.0	0.0	0.1	0.3	0.0	379.3	155.9	0.3	0.0	3.1	0.0	0.0	33.6	153.4	0.0	184.7	9.1	0.1	1.8	11.1	1.0	10.1	19.0	10.2	15.2	242.7	291.4	0.1	1.1	0.0	105.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.7	54.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0
MAGEA6	"CT1.6, MAGE-3b, MAGE3B, MAGE6"	ENSG00000197172	"MAGE family member A6"	P43360	X	152766136-152769747	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 7.1"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 29.8;Spermatogonia: 49.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 210.0;HMC-1: 156.5;K-562: 136.8;OE19: 272.9;PC-3: 148.1;SK-BR-3: 138.3;U-266/70: 176.3;U-266/84: 119.7"															NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"					"unprognostic (3.09e-1)"			"unprognostic (5.94e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.74e-1)"					"unprognostic (5.33e-2)"	"unprognostic (8.33e-2)"		"unprognostic (6.00e-2)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	17.6	0.0	0.3	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	210.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	50.8	1.1	0.0	0.0	156.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.8	75.4	0.0	0.2	0.4	0.0	0.2	272.9	148.1	0.1	0.0	8.5	0.0	0.0	7.8	58.3	0.0	138.3	20.2	0.1	2.2	10.1	0.7	64.2	100.7	3.7	19.9	176.3	119.7	0.2	1.2	0.0	77.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	29.8	49.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MAGEA9B		ENSG00000267978	"MAGE family member A9B"	P43362	X	149581653-149587453	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"testis: 10.0"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 39.6;Spermatogonia: 16.0"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"OE19: 82.4;RT4: 131.1;U-266/70: 55.1;U-266/84: 73.7"									"HPA045401, HPA051687"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA045401: AB_2679315, HPA051687: "															"unprognostic (6.12e-3)"		"unprognostic (3.26e-1)"	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.0	0.1	82.4	0.0	0.2	0.0	6.3	0.0	131.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	55.1	73.7	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	39.6	16.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MANSC1	"FLJ10298, LOH12CR3"	ENSG00000111261	"MANSC domain containing 1"	Q9H8J5	12	12326056-12350242	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 70.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"neutrophil: 98.3"	"Lineage enriched"	"Detected in many"	39	"granulocytes: 98.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 50.7;OE19: 54.3;RPTEC TERT1: 25.9"	"Low region specificity"	"Detected in all"							"HPA007955, HPA007956"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		44000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Vesicles"		"HPA007955: AB_1079306, HPA007956: AB_1079305"	"unprognostic (5.41e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.46e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.15e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.03e-2)"	18.9	12.1	3.4	4.3	4.1	3.5	19.5	3.9	6.5	16.9	5.0	22.9	11.7	22.1	11.5	42.3	16.6	10.2	11.2	4.1	3.0	13.2	9.7	12.3	2.3	3.2	3.3	11.3	25.2	11.3	17.9	9.5	3.2	15.1	15.8	5.4	70.0	10.8	4.0	21.7	15.2	12.1	2.6	11.3	21.5	8.4	3.8	1.4	13.8	4.4	6.4	16.3	20.6	4.0	0.3	5.7	1.8	0.1	5.6	5.5	6.2	3.9	4.6	2.0	2.5	4.8	18.2	0.0	4.2	3.9	2.1	0.8	7.1	3.3	1.5	0.0	6.9	8.3	6.4	4.2	0.9	1.4	2.3	3.5	5.3	1.3	0.9	13.8	50.7	0.1	5.6	0.1	0.6	11.0	0.0	0.6	6.5	54.3	3.0	0.2	0.0	0.1	25.9	18.8	2.6	10.3	2.1	16.9	6.0	2.8	15.4	5.0	20.5	2.8	2.3	0.7	5.5	0.4	0.2	2.8	2.0	0.0	2.1	6.6	1.2	1.0	0.1	0.9	0.0	0.2	0.3	0.0	0.6	0.4	2.5	0.4	98.3	0.6	0.4	0.1	0.0	0.6	3.4	4.1	3.9	6.5	4.1	3.0	3.2	3.3	3.2	2.6	3.8	4.0	29.0	9.6	21.2	8.8	3.3	4.0	7.1	7.2	6.2	6.1	21.2	13.5	2.6	28.6	11.9	23.9	8.4	35.4	4.5	33.6	1.9	19.0	0.9	15.1	5.2	28.8	21.7	3.6	16.6	37.9	7.4	10.4	23.0	20.5	2.5	8.6	37.1	9.8	8.0	10.1	13.5	33.4	8.2	5.5	0.7	2.2	13.7	2.0	0.0	15.0	2.7	11.4	9.2	7.5	11.4	16.3	25.2	16.6	1.0	7.4	16.7	3.0	18.1	13.1	0.0	4.8	6.5	2.1	1.5	22.1	4.7	17.0	3.0	9.7	26.5	8.8
MAPRE3	"EB3, RP3"	ENSG00000084764	"Microtubule associated protein RP/EB family member 3"	Q9UPY8	2	26970637-27027219	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 146.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 428.2;Late spermatids: 311.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009263	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"			"HPA009263: AB_1078716"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	24.0	23.1	100.7	7.3	102.4	1.3	23.6	73.5	133.2	26.6	50.8	25.4	7.2	24.8	10.4	12.2	42.2	12.6	45.2	108.8	105.2	30.4	37.6	17.8	5.9	94.4	82.9	46.1	14.7	36.8	101.7	10.8	98.1	26.1	9.8	70.5	18.3	15.0	146.6	43.3	10.5	12.9	66.5	15.8	23.2	56.4	107.0	7.6	24.4	56.8	6.5	22.0	19.0	95.8	19.8	15.2	13.6	24.0	24.4	13.5	3.9	15.3	12.2	12.7	12.9	5.7	25.8	0.0	14.4	19.1	33.5	10.1	7.6	16.3	7.5	16.5	18.7	2.9	8.1	1.3	22.4	2.3	36.5	11.1	28.5	6.4	11.9	34.6	3.1	1.7	19.4	15.1	7.7	9.0	0.1	1.0	6.0	69.2	23.9	0.1	0.3	2.0	8.8	13.0	34.4	17.0	10.6	7.5	11.0	8.9	8.0	1.4	3.3	11.1	11.4	16.0	13.7	11.5	4.4	0.1	39.9	1.5	22.6	0.2	1.3	0.3	0.7	1.4	0.4	0.6	0.3	0.2	0.8	0.3	0.5	0.1	3.5	0.5	1.7	0.0	0.1	0.7	100.7	102.4	73.5	133.2	108.8	105.2	94.4	82.9	98.1	66.5	107.0	95.8	13.7	3.2	2.8	25.8	2.6	8.8	21.8	15.2	11.4	44.0	6.4	8.8	8.3	5.7	6.6	3.7	25.0	1.4	1.6	32.3	17.6	11.5	428.2	64.7	11.2	5.5	25.1	2.5	43.7	4.6	4.6	11.2	11.2	4.1	38.1	13.8	14.3	8.6	2.1	58.9	45.0	1.9	18.3	2.8	4.5	311.4	12.8	4.6	7.2	5.6	0.8	69.3	4.1	26.2	27.4	12.0	8.4	11.7	2.7	9.6	0.2	6.8	48.8	44.6	32.9	10.2	14.0	21.0	14.4	6.5	13.8	18.9	3.4	38.6	3.0	15.0
ME1		ENSG00000065833	"Malic enzyme 1"	P48163	6	83210402-83431051	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Excitatory neurons: 117.1;Inhibitory neurons: 70.6;Kupffer cells: 74.4;Muller glia cells: 100.6;Oligodendrocyte precursor cells: 123.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"MAIT T-cell: 16.0"	"Lineage enriched"	"Detected in many"	10	"T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 139.4;OE19: 158.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006493	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA006493: AB_1078272"	"unprognostic (7.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.12e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (7.98e-3)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.41e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.51e-2)"	41.4	44.4	13.4	5.2	15.4	0.4	29.9	14.5	18.1	8.0	8.5	7.7	21.7	4.2	6.5	28.6	4.2	15.5	18.6	13.1	17.4	3.6	9.8	8.8	4.2	15.0	19.1	10.8	3.4	19.9	12.5	2.9	18.3	8.4	11.0	30.0	10.3	17.2	34.7	14.4	10.4	7.8	13.4	7.3	23.8	16.1	16.8	5.6	6.7	30.5	4.5	15.3	12.0	13.5	29.0	59.1	1.4	0.0	48.0	44.4	0.1	18.4	47.0	19.2	37.1	139.4	24.9	0.0	46.8	43.4	38.2	29.8	43.4	16.4	20.9	0.0	24.4	0.0	33.8	0.0	61.4	14.3	50.3	49.0	32.3	38.7	26.3	32.1	30.4	0.0	20.4	0.1	26.4	32.7	0.0	16.2	0.0	158.3	23.0	0.0	48.5	27.9	56.8	13.7	5.8	14.9	31.2	45.7	1.0	25.0	0.0	34.5	32.4	11.9	14.1	3.9	0.1	10.9	13.3	0.1	0.0	0.0	35.9	0.0	1.6	0.0	0.8	0.3	16.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	13.4	15.4	14.5	18.1	13.1	17.4	15.0	19.1	18.3	13.4	16.8	13.5	0.9	19.2	12.1	71.8	0.6	1.9	5.1	12.5	6.8	17.1	2.5	0.9	41.0	7.2	12.7	5.5	2.1	0.6	0.5	12.7	1.9	12.3	5.5	0.7	6.8	2.3	0.0	0.0	117.1	9.5	0.9	8.5	62.7	0.2	0.0	11.2	4.2	12.1	7.1	13.5	70.6	4.1	8.2	74.4	25.6	6.5	25.7	16.7	0.0	23.4	5.5	100.6	0.0	123.6	38.6	15.0	4.5	37.2	0.5	5.2	15.2	3.1	7.2	7.5	0.0	4.5	8.3	7.5	2.3	22.3	3.4	0.8	1.8	33.6	8.9	3.3
MEA1	MEA	ENSG00000124733	"Male-enhanced antigen 1"	Q16626	6	43011143-43016868	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 804.1;Late spermatids: 2062.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017921, HPA073087"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA017921: AB_1853708, HPA073087: "	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.74e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.56e-2)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (2.07e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.58e-2)"	48.6	56.1	96.7	41.3	99.3	39.6	48.4	96.0	114.3	58.3	91.5	54.4	36.5	49.9	65.9	51.0	55.1	33.1	42.6	100.3	110.1	62.4	52.7	38.4	45.1	98.9	98.6	59.4	46.1	69.3	59.0	43.6	101.2	53.0	46.3	55.6	45.8	52.4	30.4	55.4	39.7	53.4	95.5	43.8	46.0	222.9	102.1	70.9	45.6	33.8	61.5	58.9	49.4	96.8	200.9	113.7	166.9	133.0	147.6	97.7	66.3	130.6	137.9	156.8	172.3	169.9	51.6	103.6	133.9	159.9	232.8	99.7	128.8	177.7	147.0	119.8	176.3	192.7	121.8	188.1	76.4	142.7	97.8	79.0	87.5	211.3	137.3	162.0	96.8	166.7	132.9	113.4	176.0	384.7	193.0	165.5	78.3	569.8	99.1	93.3	98.6	104.2	112.4	186.9	160.3	112.0	100.5	86.2	155.3	134.2	130.8	154.9	73.1	175.8	141.2	115.3	229.4	128.0	113.4	174.1	88.3	105.4	146.3	229.1	112.3	214.8	128.9	136.0	118.7	190.3	116.3	126.8	119.8	180.7	115.6	122.7	104.7	145.5	161.6	117.3	158.3	201.2	96.7	99.3	96.0	114.3	100.3	110.1	98.9	98.6	101.2	95.5	102.1	96.8	45.1	25.6	16.7	10.1	46.9	66.3	73.6	129.3	85.4	19.6	56.9	69.8	28.2	42.9	78.1	55.2	4.2	111.8	32.8	56.7	168.3	89.4	804.1	36.2	27.1	51.1	29.9	42.7	11.5	92.4	101.5	52.0	36.7	29.3	46.9	38.9	45.3	54.0	108.1	16.8	11.6	48.7	89.5	39.2	55.3	2062.6	63.3	51.6	67.6	5.6	70.1	98.5	68.0	7.5	11.9	80.5	61.4	59.8	55.0	84.7	82.8	142.2	73.0	23.4	118.3	26.8	102.8	285.9	98.1	73.6	69.6	85.0	51.1	35.0	49.9	86.3
MED20	"DKFZp586D2223, PRO0213, SRB2, TRFP"	ENSG00000124641	"Mediator complex subunit 20"	Q9H944	6	41905354-41921139	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040717	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Centrosome	Nucleoplasm	"HPA040717: AB_10794146"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.58e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.31e-1)"	8.1	11.8	6.3	7.7	7.3	6.1	10.9	9.1	8.0	10.6	7.9	10.6	10.5	9.7	13.5	9.8	9.9	7.7	11.6	6.5	7.1	12.8	10.4	7.4	10.0	6.6	6.6	8.2	9.3	10.6	6.4	13.6	7.0	11.2	11.8	5.9	8.7	10.2	14.5	9.7	8.7	12.0	5.8	9.2	9.7	7.4	7.2	12.7	11.9	16.6	13.3	10.2	7.6	9.0	28.5	23.0	25.7	32.1	23.1	24.8	31.7	18.2	17.1	25.9	20.5	29.5	20.3	41.4	34.3	23.0	15.5	22.0	39.7	26.4	31.2	22.2	14.7	37.5	19.6	28.6	23.9	30.5	22.2	18.6	36.8	22.5	33.3	19.6	33.9	36.4	49.0	19.3	32.7	25.7	36.3	22.3	35.1	93.5	19.3	48.0	29.4	15.1	34.9	19.9	23.7	18.6	25.3	12.6	26.5	28.7	24.7	32.4	33.2	18.2	38.9	11.4	22.5	19.3	27.1	85.7	9.9	33.3	26.3	18.7	24.9	18.4	10.7	29.4	14.0	19.0	7.3	12.2	26.1	23.6	9.4	11.3	9.3	17.4	20.7	23.5	14.4	16.7	6.3	7.3	9.1	8.0	6.5	7.1	6.6	6.6	7.0	5.8	7.2	9.0	4.4	9.6	3.9	2.3	6.6	3.7	4.2	7.2	6.8	2.4	7.0	5.1	5.2	2.8	6.8	7.3	0.0	22.7	7.3	6.6	7.9	6.9	0.6	5.1	7.1	4.2	9.6	8.0	2.8	3.3	18.6	5.0	6.1	6.7	7.0	8.3	8.6	8.3	8.7	1.7	2.8	5.6	14.2	6.3	2.6	0.7	3.4	3.7	1.8	4.7	6.3	3.7	7.2	5.5	3.0	4.9	3.1	6.8	5.7	4.7	5.8	10.1	4.6	4.2	0.0	3.6	4.9	8.3	13.6	5.8	5.7	24.9	3.0	7.1	7.2	5.4
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 11.8;pancreas: 4.0;salivary gland: 5.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 27.4;Late spermatids: 18.2"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"OE19: 1.6;RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA055697	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA055697: AB_2682890"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.1	0.0	0.0	0.4	0.0	0.2	1.1	0.0	0.4	0.0	0.2	1.5	11.8	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.9	0.0	0.0	0.0	9.6	0.0	0.0	0.9	0.5	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	27.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
MGAT3	GNT-III	ENSG00000128268	"Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase"	Q09327	22	39457012-39492194	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.0;intestine: 28.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Bipolar cells: 30.7;Excitatory neurons: 25.1;Inhibitory neurons: 27.4;Oligodendrocytes: 45.7;Proximal enterocytes: 37.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.4;eosinophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 65.1;HMC-1: 56.0;OE19: 58.8;U-266/70: 73.6;U-266/84: 32.6;U-698: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017598	Approved				"Intracellular and membrane"	NA	NA		170000	"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA017598: AB_1853853"	"unprognostic (1.41e-3)"	"unprognostic (5.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.71e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.35e-3)"	"unprognostic (6.77e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (5.04e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.92e-2)"	7.8	1.1	26.8	4.0	20.9	10.8	6.4	7.6	47.0	6.2	0.0	5.2	21.5	3.8	0.8	1.1	3.4	3.8	4.8	30.3	10.0	3.0	0.2	14.9	7.6	28.1	15.6	1.2	3.1	0.4	1.8	10.5	21.8	1.2	4.6	6.7	1.8	1.0	1.5	2.3	28.4	2.8	4.8	4.8	7.4	5.4	23.9	1.8	1.5	1.8	9.0	1.6	1.5	27.3	0.3	0.4	10.4	1.0	0.0	0.0	65.1	0.5	0.7	0.5	0.0	14.9	3.7	23.4	8.1	0.0	0.2	1.3	5.4	0.0	0.1	0.0	0.5	18.9	0.0	0.2	0.2	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	15.8	2.9	0.0	0.2	0.6	1.4	3.1	58.8	0.0	1.2	0.0	3.9	0.4	0.6	6.0	4.4	0.0	0.0	0.0	18.5	0.8	1.0	0.0	0.1	8.1	0.1	0.1	73.6	32.6	32.6	0.2	0.1	1.7	1.4	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.8	20.9	7.6	47.0	30.3	10.0	28.1	15.6	21.8	4.8	23.9	27.3	2.0	44.8	3.0	6.5	2.2	0.4	0.1	1.8	0.0	30.7	0.6	1.1	1.9	1.5	3.7	0.0	6.2	5.5	0.0	4.1	0.0	0.0	19.1	0.9	11.0	2.5	7.8	13.7	25.1	0.2	12.0	2.3	10.2	2.0	2.5	0.0	0.0	0.0	1.5	13.5	27.4	3.8	2.0	0.0	2.3	16.6	4.4	0.9	0.0	0.0	0.1	1.5	0.0	21.6	45.7	1.8	6.1	3.8	1.7	0.3	37.4	1.8	5.2	2.3	6.6	0.3	4.3	0.7	1.2	0.2	0.6	3.7	0.5	0.6	4.5	1.5
MGST2	MGST-II	ENSG00000085871	"Microsomal glutathione S-transferase 2"	Q99735	4	139665768-139740745	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 393.2"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 441.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 194.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 276.3;OE19: 558.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010690, HPA010707"	Enhanced		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Endoplasmic reticulum"	"HPA010690: , HPA010707: AB_1853922"	"unprognostic (9.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (3.22e-9)"	"unprognostic (4.10e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.01e-2)"	61.8	92.7	43.5	30.4	42.9	42.6	66.6	45.1	60.6	63.6	54.8	112.5	132.5	39.2	82.1	177.6	70.8	87.6	118.3	42.6	45.7	99.2	393.2	49.0	36.0	46.6	44.6	26.3	66.2	102.0	44.6	75.6	46.5	74.9	121.2	7.8	90.6	50.0	104.2	97.1	143.5	57.4	46.6	60.5	72.5	50.6	45.3	35.1	45.8	118.4	64.6	86.7	78.4	48.9	40.8	58.5	28.7	0.3	4.8	15.4	17.7	7.2	66.1	3.2	10.7	62.3	276.3	0.1	158.2	17.5	13.6	74.8	52.7	81.2	4.9	22.3	47.7	174.9	57.3	251.5	13.3	152.7	130.0	53.0	197.2	2.1	12.5	63.9	166.3	0.3	75.9	25.7	23.3	33.9	0.2	24.7	6.5	558.9	59.4	12.7	33.4	54.0	153.0	87.4	71.9	21.6	53.2	83.2	64.8	2.0	52.9	202.2	104.9	5.6	27.3	7.8	6.4	29.7	22.5	9.7	3.8	254.8	12.6	43.8	103.8	30.4	4.1	64.8	2.9	1.3	7.6	3.5	147.0	2.4	2.3	2.6	17.7	26.4	22.2	194.6	37.7	39.4	43.5	42.9	45.1	60.6	42.6	45.7	46.6	44.6	46.5	46.6	45.3	48.9	327.9	25.6	36.6	5.5	7.7	61.1	295.9	316.7	75.7	7.8	99.1	57.3	100.5	205.9	185.5	95.6	25.0	85.3	71.0	168.3	90.1	121.0	6.3	132.5	27.1	238.4	121.8	60.2	19.4	138.6	62.8	31.8	90.2	172.9	43.2	56.9	203.1	419.3	378.1	6.7	24.2	215.1	170.9	107.8	77.8	12.8	44.4	85.3	39.2	49.6	83.6	14.1	27.8	11.6	4.7	121.8	213.1	33.4	7.1	94.6	441.1	277.2	126.6	3.5	13.1	44.6	49.6	4.6	15.1	264.0	124.9	67.2	15.2	43.6	258.2	344.9
MGST3	GST-III	ENSG00000143198	"Microsomal glutathione S-transferase 3"	O14880	1	165631213-165661796	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 2092.0;Syncytiotrophoblasts: 2371.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 793.9;OE19: 781.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053311, HPA077929"	Enhanced		Approved	Nucleoplasm		NA	NA		27000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA053311: AB_2682108, HPA077929: "	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	260.2	163.3	218.0	57.7	224.9	126.2	196.5	245.4	273.1	96.6	214.1	219.6	358.6	91.9	520.6	97.6	112.3	114.4	770.2	232.6	258.0	254.3	166.8	117.5	48.9	239.5	228.8	118.0	90.1	139.1	86.1	173.2	248.3	113.4	217.8	89.9	164.0	114.8	568.0	87.8	301.6	118.8	227.4	54.4	163.0	64.2	230.3	51.9	142.9	578.7	47.7	107.2	90.0	240.5	178.2	128.0	150.0	106.1	533.4	312.1	653.1	158.1	244.2	119.1	205.2	126.8	219.1	10.9	117.1	198.6	117.8	204.7	36.2	155.2	118.5	793.9	94.5	27.1	84.7	60.4	144.9	45.0	58.9	284.2	107.5	178.0	62.3	239.4	202.0	54.2	72.3	65.6	233.6	37.0	48.9	97.4	292.3	781.6	165.8	44.8	63.0	22.2	599.8	159.4	104.1	134.2	148.7	181.1	313.2	308.4	139.1	215.9	174.7	135.8	82.6	92.9	110.8	49.7	37.0	5.8	239.8	109.7	92.3	44.8	172.9	81.2	107.2	150.2	107.9	79.3	130.5	117.3	138.0	78.2	81.4	89.1	32.3	62.3	195.0	58.2	125.5	185.0	218.0	224.9	245.4	273.1	232.6	258.0	239.5	228.8	248.3	227.4	230.3	240.5	915.1	102.5	164.8	48.3	87.6	228.3	251.8	603.8	111.0	144.6	177.0	267.6	670.1	301.7	292.6	557.3	266.9	2092.0	96.5	500.3	1001.8	380.2	18.2	325.6	132.6	268.0	152.8	785.4	75.8	425.9	1327.2	300.3	193.7	257.7	91.8	519.5	257.7	295.0	837.4	131.2	86.4	302.9	374.3	130.0	243.1	46.1	388.0	234.9	519.4	43.1	296.6	257.9	87.6	45.8	90.6	401.8	613.9	399.8	92.9	173.9	1004.1	1227.6	459.9	162.5	506.2	197.5	652.1	23.1	40.4	157.1	232.6	2371.4	123.1	288.6	440.7	237.6
MICALL2	"FLJ23471, JRAB, MGC46023, MICAL-L2"	ENSG00000164877	"MICAL like 2"	Q8IY33	7	1428465-1459470	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 103.2;Distal enterocytes: 85.4;Gastric mucus-secreting cells: 171.8;Proximal enterocytes: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 27.7;OE19: 30.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA025695	Enhanced					NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA025695: AB_10610140"	"unprognostic (2.46e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.23e-3)"	"unprognostic (3.51e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (6.53e-9)"	"unprognostic (1.95e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.84e-2)"	4.9	18.4	1.0	4.9	0.2	7.6	4.7	0.5	2.4	6.8	0.0	13.9	12.4	5.2	0.2	8.2	5.5	3.4	4.9	0.8	0.3	8.1	5.4	7.9	2.2	0.3	1.5	1.4	4.6	0.7	6.6	0.7	0.4	9.5	1.8	0.0	8.3	2.1	1.5	6.8	18.6	2.2	0.0	15.4	12.8	2.7	1.2	1.7	6.7	0.0	1.0	9.8	6.2	0.9	16.6	1.8	0.5	2.2	1.7	4.2	4.5	7.6	2.9	3.4	1.2	2.2	6.3	0.3	4.6	2.4	6.9	9.4	0.0	8.8	0.2	1.2	2.0	11.0	3.0	1.3	2.1	0.5	27.7	5.5	2.0	2.4	0.3	2.1	3.9	1.5	18.3	0.5	1.6	17.4	0.4	17.6	1.5	30.2	5.3	2.9	3.1	11.7	2.3	4.5	0.4	1.5	6.3	11.5	6.0	0.7	9.6	6.3	13.4	2.5	19.6	9.3	7.7	0.8	0.2	0.0	8.1	6.0	16.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.5	2.4	0.8	0.3	0.3	1.5	0.4	0.0	1.2	0.9	5.3	3.2	10.8	103.2	2.0	8.7	7.0	39.0	16.5	1.9	13.2	10.9	7.7	18.6	22.5	14.7	2.1	0.5	1.9	85.4	1.9	11.4	5.9	13.5	7.7	10.0	6.0	7.8	13.0	15.4	6.6	9.9	171.8	14.3	5.7	5.4	10.4	3.2	3.3	3.3	10.0	49.0	18.3	3.5	6.2	5.3	4.1	3.3	3.6	4.7	2.3	1.2	0.0	29.1	5.7	18.4	51.9	0.4	1.5	12.8	70.2	1.5	25.3	1.6	6.6	4.1	11.4	5.3	6.2	14.6	6.1	1.2	1.7	3.3	36.9	8.0
MIEN1	"C17orf37, C35, MGC14832, ORB3, Rdx12, XTP4"	ENSG00000141741	"Migration and invasion enhancer 1"	Q9BRT3	17	39728496-39730532	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	14	"OE19: 1667.9;SK-BR-3: 502.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056650, HPA061344"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA056650: , HPA061344: AB_2684484"	"unprognostic (2.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.37e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.22e-3)"	29.1	35.9	33.4	17.5	35.4	27.0	31.5	36.2	44.8	31.1	34.2	42.4	26.3	29.0	14.6	47.3	27.2	12.1	49.5	32.5	35.3	57.2	53.7	29.6	20.2	34.5	34.8	18.5	40.7	21.6	39.6	13.5	34.5	46.3	12.8	4.8	46.2	13.8	47.2	35.0	37.5	9.5	32.9	36.2	48.5	41.3	35.4	13.9	37.0	5.3	13.7	31.0	32.0	37.2	38.8	59.7	13.4	34.5	16.3	12.0	16.2	40.7	21.4	24.2	23.6	12.9	27.2	28.1	55.5	15.1	39.0	47.1	15.6	13.8	8.2	58.2	65.8	26.5	29.8	36.5	28.2	33.9	39.2	10.8	23.3	11.7	12.0	18.8	15.6	52.9	38.2	48.9	14.7	22.5	70.1	38.2	12.5	1667.9	26.4	32.2	23.6	56.8	12.2	21.8	43.6	41.7	40.8	502.3	70.7	12.0	66.1	48.1	41.5	16.4	41.8	78.9	47.1	62.3	62.8	55.1	64.5	41.1	32.4	138.5	76.2	107.3	80.1	100.9	43.4	109.2	56.2	72.3	54.5	88.3	43.9	63.1	132.9	58.7	104.2	79.4	94.6	119.9	33.4	35.4	36.2	44.8	32.5	35.3	34.5	34.8	34.5	32.9	35.4	37.2	59.8	44.8	64.2	7.8	60.9	60.2	138.1	185.1	95.6	25.7	127.0	114.2	59.6	82.9	129.3	99.3	4.2	150.2	69.1	226.6	303.3	137.0	136.2	81.6	48.7	58.9	188.8	72.0	11.0	176.1	74.4	50.9	76.5	77.3	81.8	43.8	54.7	118.9	148.0	35.3	9.6	178.3	254.3	101.3	42.8	76.7	42.3	81.3	138.7	12.2	80.1	90.7	130.7	4.5	20.8	216.8	283.7	49.7	54.0	194.8	188.5	224.9	122.1	17.3	46.0	31.5	61.1	108.5	68.0	131.7	70.3	266.1	65.4	51.7	128.1	204.0
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889400	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 108.0;Oligodendrocytes: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 64.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favorable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	6.3	9.6	3.7	6.2	4.3	5.3	11.1	3.2	5.0	7.5	13.4	12.9	8.8	7.2	12.4	11.5	17.3	7.7	18.4	14.4	4.0	25.4	12.0	7.1	5.1	4.0	5.0	5.4	8.2	14.6	5.4	4.7	4.6	10.9	13.1	6.1	9.7	8.7	13.9	21.4	7.6	7.8	4.0	4.3	8.6	9.8	3.7	6.0	11.1	16.9	7.8	7.7	6.4	4.9	14.6	16.1	7.8	18.4	17.4	23.4	16.6	10.3	16.0	15.1	12.7	21.7	28.1	17.0	10.2	8.4	13.3	35.8	18.1	21.6	18.8	9.9	11.5	7.4	7.0	18.8	14.3	17.5	3.9	11.6	26.4	15.7	13.9	12.7	19.2	12.7	14.5	2.7	24.0	10.8	12.6	9.8	10.8	64.8	16.1	13.8	21.0	14.8	33.7	9.6	18.2	6.1	11.0	17.8	21.8	9.8	18.3	9.7	10.7	9.2	7.6	15.3	11.2	2.6	4.0	9.1	15.9	8.8	11.7	0.0	3.0	1.3	7.4	3.7	9.3	8.7	7.1	6.8	6.5	7.2	6.7	6.7	0.0	10.3	12.0	5.5	5.2	4.0	3.7	4.3	3.2	5.0	14.4	4.0	4.0	5.0	4.6	4.0	3.7	4.9	2.5	16.0	8.6	18.9	5.9	39.9	7.7	13.8	6.2	3.6	6.2	5.8	108.0	11.5	12.6	9.2	6.2	9.8	2.4	8.2	29.4	23.4	8.2	26.0	8.5	5.4	6.0	4.6	43.8	10.6	9.3	8.0	7.1	8.5	2.5	4.2	3.6	5.9	9.7	15.2	47.5	7.1	14.2	3.5	5.0	7.4	6.8	4.3	5.4	12.2	3.4	5.5	5.2	18.1	62.8	8.6	7.0	8.6	4.9	7.5	6.6	25.6	46.3	11.4	0.0	7.3	5.7	9.7	19.0	10.1	42.3	5.1	4.0	8.9	13.6	5.6
MISP3		ENSG00000141854	"MISP family member 3"	Q96FF7	19	14072536-14075062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 19.3;Breast myoepithelial cells: 20.8;Collecting duct cells: 14.7;Distal tubular cells: 35.2;Endometrial ciliated cells: 12.4;Exocrine glandular cells: 11.5;Proximal tubular cells: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.3;OE19: 11.3;RPMI-8226: 6.3;U-266/84: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042225	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"			"HPA042225: AB_10795396"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.76e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.52e-4)"	"prognostic favorable (3.11e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.78e-2)"	1.4	2.1	7.2	0.3	7.3	0.5	2.0	7.6	10.3	2.0	6.3	7.6	3.9	1.0	0.4	3.0	3.0	0.3	6.3	7.6	8.1	17.7	5.6	2.9	0.0	7.4	7.4	0.5	12.1	2.8	2.6	0.5	7.6	3.6	1.4	1.1	7.8	1.0	2.5	7.9	5.2	0.1	7.7	1.3	11.1	0.9	7.5	0.2	3.0	1.0	0.1	1.7	2.8	7.8	1.7	0.9	0.3	0.7	0.6	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.3	0.1	1.1	0.1	0.0	0.6	0.8	0.0	0.0	2.1	1.5	0.2	0.3	0.8	0.1	0.1	0.3	0.1	0.0	0.0	0.1	0.7	0.2	1.0	0.2	5.3	0.0	3.0	0.3	0.7	0.0	11.3	0.7	0.5	0.1	6.3	1.1	0.0	1.5	0.4	0.0	0.5	0.6	0.0	0.9	0.0	0.1	0.0	0.4	0.5	0.0	3.6	4.3	0.4	0.8	1.3	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	7.2	7.3	7.6	10.3	7.6	8.1	7.4	7.4	7.6	7.7	7.5	7.8	3.2	9.6	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	19.3	20.8	0.0	0.0	1.8	14.7	0.0	0.2	3.7	0.0	35.2	2.5	0.0	12.4	0.8	0.7	0.0	0.0	0.0	11.5	0.1	1.0	0.0	5.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	1.3	0.0	0.0	22.8	2.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.0	1.5	0.3	0.0	0.0
MMP20		ENSG00000137674	"Matrix metallopeptidase 20"	O60882	11	102576832-102625332	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Amelogenesis imperfecta"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	7	"Early spermatids: 91.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"OE19: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA					"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (4.62e-3)"		"unprognostic (2.61e-2)"	"unprognostic (1.68e-3)"		"unprognostic (1.75e-1)"		"unprognostic (2.13e-1)"		"unprognostic (3.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.58e-5)"	"unprognostic (6.10e-2)"		"unprognostic (2.35e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	12.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.4
MOAP1	"MAP-1, PNMA4"	ENSG00000165943	"Modulator of apoptosis 1"	Q96BY2	14	93182199-93184923	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000939, HPA076948"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Cell Junctions"	"HPA000939: AB_1079402, HPA076948: "	"unprognostic (9.40e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (7.37e-9)"	"unprognostic (1.98e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (6.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	17.7	32.2	39.9	11.3	39.8	40.5	19.0	17.8	54.6	25.8	9.4	36.2	13.9	20.9	26.8	17.4	24.0	17.1	55.8	46.4	59.2	30.8	20.3	21.5	19.4	30.1	25.1	19.1	19.3	45.7	37.0	16.2	39.9	32.4	15.9	92.4	20.9	30.6	44.2	17.5	22.2	22.3	22.1	19.2	26.6	10.3	33.7	23.2	24.1	34.6	17.6	24.1	12.3	38.8	9.8	8.2	19.1	25.0	16.3	6.4	11.1	10.2	14.4	12.4	11.5	8.4	8.9	30.4	19.7	14.6	8.5	16.5	13.9	12.7	13.9	10.7	15.8	16.2	17.4	11.5	19.7	15.8	25.0	9.3	18.4	7.6	13.4	30.3	15.9	35.6	6.2	15.6	11.5	40.4	24.1	10.8	7.5	20.8	8.6	12.7	23.3	14.7	29.4	28.7	36.7	31.0	9.1	16.4	48.4	14.8	25.3	12.1	14.6	4.1	5.6	9.9	5.1	30.9	31.3	15.1	12.8	10.2	7.5	53.5	5.9	19.6	15.5	6.9	19.8	6.8	19.1	19.4	6.2	11.9	23.1	21.1	6.1	16.1	8.8	5.4	16.6	12.1	39.9	39.8	17.8	54.6	46.4	59.2	30.1	25.1	39.9	22.1	33.7	38.8	20.4	32.1	32.1	11.8	21.8	16.2	18.2	11.4	13.1	91.8	18.7	12.4	71.9	24.3	13.9	20.2	50.1	28.9	33.7	10.2	41.1	36.2	4.7	26.5	15.3	18.2	48.5	9.9	37.4	15.1	5.7	16.3	12.2	60.6	27.8	36.0	16.8	8.2	16.5	84.1	35.0	21.0	34.6	13.7	9.8	1.7	17.7	15.9	12.4	12.2	16.1	85.4	50.4	18.1	16.3	22.3	7.5	27.4	15.8	21.2	15.7	19.4	7.5	96.0	19.7	15.5	21.8	27.9	22.2	10.5	15.5	47.7	28.2	23.7	16.2	23.9
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 739.7;tongue: 559.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 950.0;Distal tubular cells: 1721.8;Proximal tubular cells: 573.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	61.7	39.6	105.9	33.4	119.5	57.0	52.8	129.7	153.1	52.4	108.0	97.7	84.8	35.7	44.8	71.5	34.7	41.7	739.7	101.2	127.8	259.9	411.2	44.6	44.3	119.2	123.9	43.4	66.0	141.8	38.1	23.7	119.5	43.5	89.9	57.3	87.7	42.3	319.4	40.9	63.8	38.5	117.1	35.0	96.1	22.2	121.5	48.6	82.9	559.2	44.2	47.4	34.9	132.4	25.6	7.5	31.3	107.7	88.4	49.8	45.2	29.1	47.1	45.1	43.9	38.8	17.9	53.6	50.9	45.4	36.1	24.5	47.0	36.7	31.9	36.1	79.0	27.5	35.4	132.6	36.6	104.9	34.1	40.0	51.0	36.8	26.7	13.7	36.9	80.8	94.2	84.1	28.6	40.5	73.1	193.7	16.1	148.0	35.5	39.1	51.7	134.9	85.4	20.5	96.7	85.7	33.6	145.8	34.0	25.9	34.5	154.3	25.3	25.7	26.8	91.6	30.0	55.8	42.2	46.3	23.5	127.0	42.1	60.7	60.0	90.1	41.7	98.3	39.4	33.1	48.5	45.1	72.2	25.4	44.7	43.3	54.6	40.5	128.5	43.0	69.1	49.8	105.9	119.5	129.7	153.1	101.2	127.8	119.2	123.9	119.5	117.1	121.5	132.4	56.1	118.6	48.0	64.6	51.7	45.6	44.2	83.6	29.0	61.1	74.2	79.1	950.0	187.3	67.6	106.7	10.4	22.0	54.2	219.1	1721.8	89.3	66.8	73.7	50.7	51.7	37.2	72.6	49.0	140.3	78.3	74.1	63.7	93.2	71.0	28.0	47.5	391.0	121.4	48.8	74.7	122.1	166.8	89.6	81.7	10.2	66.5	80.3	129.9	20.6	104.7	199.9	58.7	32.2	108.0	65.2	125.0	89.9	114.5	32.0	162.0	573.6	46.3	66.7	92.1	76.9	80.4	163.2	79.6	67.3	55.8	24.4	58.4	39.9	146.7	53.6
MPPE1	"Cdc1, PGAP5"	ENSG00000154889	"Metallophosphoesterase 1"	Q53F39	18	11882622-11908366	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, GPI-anchor biosynthesis, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 100.8;neutrophil: 293.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 293.9"	"Cell line enhanced"	"Detected in all"		"OE19: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012639	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA012639: AB_1854088"	"unprognostic (9.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (6.45e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.79e-2)"	"unprognostic (6.15e-2)"	14.9	13.1	11.3	20.0	11.7	28.3	15.4	11.0	11.9	16.1	11.7	21.5	17.7	17.0	20.6	17.2	16.4	21.8	18.6	10.9	11.9	28.8	23.8	25.6	16.0	12.6	11.8	12.7	31.8	20.1	15.0	14.1	12.5	16.3	21.4	15.9	15.0	19.0	23.5	29.0	20.3	15.8	10.6	15.9	22.8	8.5	12.1	16.0	47.1	11.7	14.7	14.9	13.7	13.1	7.8	11.1	8.4	19.9	22.9	26.7	7.9	18.6	26.0	10.6	16.5	20.8	21.6	15.8	39.2	17.6	10.7	8.6	5.8	10.1	9.9	17.7	10.4	4.6	22.9	4.9	31.9	20.3	30.9	40.1	13.3	9.4	6.6	15.7	6.5	13.9	5.8	14.5	17.8	18.1	15.1	13.6	5.6	65.9	3.1	6.0	5.4	18.8	17.2	11.9	11.8	6.7	17.1	13.5	16.0	9.3	9.8	25.9	13.5	21.4	8.3	20.5	10.3	22.6	21.5	19.7	15.8	10.4	21.5	20.6	42.9	100.8	24.8	34.5	18.1	17.9	15.2	23.9	37.3	21.7	18.5	23.8	293.9	29.2	24.6	29.6	27.0	31.8	11.3	11.7	11.0	11.9	10.9	11.9	12.6	11.8	12.5	10.6	12.1	13.1	19.3	57.7	33.0	13.4	24.5	18.0	16.2	20.7	12.5	17.4	14.6	11.6	2.4	24.3	23.1	22.0	12.5	27.9	35.7	43.9	21.5	30.5	20.5	17.9	14.8	15.5	9.6	13.3	20.9	41.9	32.5	16.6	29.6	22.6	27.8	23.5	15.7	27.6	25.4	8.4	21.4	23.4	14.2	33.2	25.7	36.0	12.8	24.8	19.6	20.6	24.2	23.3	52.5	12.5	24.4	36.3	18.4	15.1	16.0	10.1	36.3	27.0	26.7	20.5	13.1	17.2	13.9	7.0	8.7	21.8	20.0	16.7	33.7	16.4	16.1	22.0
MRM1	FLJ22578	ENSG00000278619	"Mitochondrial rRNA methyltransferase 1"	Q6IN84	17	36601583-36608964	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA021598	Supported		Supported	Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA021598: AB_1854097"	"unprognostic (9.07e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.74e-2)"	3.4	6.0	2.2	1.1	2.6	2.1	3.9	1.8	4.5	4.5	1.1	6.0	2.8	4.5	1.4	5.2	4.1	0.3	7.4	2.0	2.3	5.7	7.3	2.8	3.0	2.2	2.2	5.0	6.2	2.6	2.9	0.7	2.3	4.8	3.1	0.6	4.1	2.4	8.1	3.6	6.0	0.7	1.8	5.9	4.6	2.3	2.5	1.9	4.2	4.7	0.6	5.8	4.3	2.6	1.5	8.7	0.0	5.0	4.3	5.1	15.5	0.3	0.0	0.0	0.0	0.7	0.2	0.7	9.5	0.0	4.0	20.0	0.2	0.4	0.0	7.5	2.9	15.2	5.1	8.9	2.2	7.9	7.5	4.0	0.4	10.2	0.0	1.4	5.2	6.7	9.9	4.9	6.0	0.2	14.6	4.6	0.2	19.9	0.1	12.1	0.0	19.5	4.4	9.3	4.1	3.1	0.0	6.1	6.5	5.5	6.8	2.6	2.0	5.0	8.9	5.7	0.1	11.9	15.3	6.5	0.0	8.0	4.0	0.0	2.0	0.0	2.8	3.0	5.3	4.4	2.2	2.7	2.1	3.9	3.5	3.8	0.0	6.0	1.5	2.4	2.0	2.4	2.2	2.6	1.8	4.5	2.0	2.3	2.2	2.2	2.3	1.8	2.5	2.6	1.3	0.0	1.5	4.9	3.8	1.1	2.9	2.7	2.8	1.1	2.6	1.7	7.8	2.8	1.6	3.7	4.2	7.0	0.6	5.3	9.8	4.2	0.1	1.0	2.9	2.9	1.8	5.0	9.6	1.8	7.4	1.8	3.1	1.3	0.0	3.9	1.8	2.1	6.2	6.7	8.2	5.3	2.0	1.0	0.4	0.0	3.4	1.5	1.8	0.0	2.2	1.7	2.1	5.5	4.0	2.2	5.4	1.5	2.2	5.6	5.4	5.1	0.6	1.2	0.0	1.9	2.0	1.3	3.0	3.3	0.4	1.8	2.2	4.5	9.0	2.2
MRPL14	"MRP-L32, RPML32"	ENSG00000180992	"Mitochondrial ribosomal protein L14"	Q6P1L8	6	44113451-44127452	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 182.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 622.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038769, HPA076790"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA038769: AB_10673288, HPA076790: AB_2686815"	"unprognostic (4.58e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.20e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.46e-5)"	"unprognostic (7.13e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (3.27e-2)"	26.5	41.0	25.7	22.4	26.1	20.7	25.0	25.2	28.5	23.7	24.7	38.0	36.1	29.4	25.5	41.9	22.9	16.2	48.8	25.8	25.3	34.7	80.3	57.8	26.0	25.5	24.7	16.2	24.9	20.6	23.2	26.3	25.5	25.0	34.8	23.6	30.0	19.2	182.1	43.4	29.5	27.7	25.8	26.0	30.1	51.4	26.2	35.3	24.3	109.4	28.6	35.9	27.6	26.5	216.0	90.2	62.5	87.1	53.0	51.4	79.6	78.5	77.8	102.6	101.6	189.1	73.8	93.1	86.7	67.4	98.2	85.9	71.2	127.9	80.8	111.2	193.8	96.1	77.2	235.1	65.3	92.1	64.8	48.2	68.5	96.7	57.1	78.7	85.9	78.8	205.9	58.3	91.7	216.3	111.4	144.6	54.8	622.6	85.8	78.8	70.2	126.7	170.8	104.9	138.8	54.2	50.4	97.5	101.7	53.9	89.5	93.1	69.1	90.4	135.6	65.6	137.9	71.9	68.3	221.8	102.3	90.5	67.4	45.3	115.6	26.3	79.0	113.7	95.1	111.9	100.3	90.5	108.3	105.3	79.2	81.1	6.7	171.4	78.4	122.2	76.1	107.1	25.7	26.1	25.2	28.5	25.8	25.3	25.5	24.7	25.5	25.8	26.2	26.5	48.2	375.0	250.0	3.6	64.5	231.1	200.5	362.7	65.4	29.8	126.6	146.3	136.9	112.9	217.2	57.0	31.3	179.5	51.1	257.9	203.5	205.3	293.1	94.9	66.0	82.0	93.4	78.4	5.0	220.2	206.2	76.4	82.0	101.5	44.4	83.4	50.3	341.2	279.8	33.7	5.3	158.3	219.7	52.0	164.6	122.9	74.6	66.1	69.4	3.7	152.9	66.0	85.5	4.5	7.3	333.0	278.5	53.4	73.7	376.8	203.7	258.7	157.5	70.0	46.0	63.3	149.4	199.2	122.3	116.6	281.3	160.1	56.3	100.5	199.5	376.3
MRPL2	"CGI-22, MRP-L14, RPML14"	ENSG00000112651	"Mitochondrial ribosomal protein L2"	Q5T653	6	43054029-43059438	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007455, HPA064814"	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA007455: AB_1079410, HPA064814: AB_2685358"	"unprognostic (2.31e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (6.01e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.78e-1)"	26.5	32.4	27.9	12.6	28.8	20.0	26.0	31.0	37.6	23.2	27.9	27.5	25.6	23.5	13.7	24.6	22.2	10.1	48.2	28.3	31.7	33.7	51.2	18.6	13.4	29.8	28.9	24.5	27.1	29.6	29.5	13.3	30.1	22.0	16.8	10.9	22.6	17.6	75.1	25.1	20.3	12.0	27.4	19.9	23.6	19.7	29.0	17.7	26.7	56.7	14.4	22.6	21.4	28.9	47.9	43.1	20.3	39.3	28.4	20.7	38.9	20.4	24.8	47.3	41.3	109.0	15.4	61.8	42.3	24.6	36.2	49.9	50.5	48.7	27.8	30.4	90.9	46.8	34.9	109.5	57.2	43.5	21.0	27.6	51.4	52.5	82.8	22.6	32.6	68.7	84.6	36.6	23.6	84.0	48.1	127.1	22.7	175.7	49.5	59.0	25.1	77.3	38.2	26.3	51.3	27.4	18.2	39.4	73.4	18.6	41.4	73.9	27.3	27.6	40.0	35.7	58.7	47.7	44.9	115.2	21.5	65.2	27.8	17.5	37.8	30.2	28.4	40.9	36.5	46.5	31.8	33.6	54.3	48.6	32.7	32.3	9.8	38.5	33.7	56.1	39.2	31.3	27.9	28.8	31.0	37.6	28.3	31.7	29.8	28.9	30.1	27.4	29.0	28.9	36.8	22.4	18.6	5.5	27.5	24.3	32.0	86.5	19.4	22.7	25.9	30.0	37.5	38.6	48.9	60.7	27.1	74.0	21.3	43.1	185.9	59.1	94.0	30.6	34.1	32.1	30.6	35.3	5.3	53.7	53.1	31.1	30.1	32.5	28.5	43.1	33.2	75.9	49.3	5.0	5.8	44.2	69.2	23.7	26.6	37.0	55.0	22.9	53.4	2.8	41.3	44.7	43.3	2.0	5.5	44.2	51.3	51.6	35.6	31.6	77.6	159.4	40.4	23.4	26.3	32.5	82.7	53.1	41.7	35.7	27.1	63.5	27.2	59.0	65.7	28.7
MRPL24	MRP-L18	ENSG00000143314	"Mitochondrial ribosomal protein L24"	Q96A35	1	156737303-156741590	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 213.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030295, HPA054323"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA030295: AB_10600932, HPA054323: AB_2732583"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.47e-1)"	"unprognostic (8.75e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.94e-1)"	78.1	93.8	75.4	43.0	78.6	24.0	69.8	79.6	81.2	51.3	71.4	70.3	40.7	58.3	94.6	55.4	72.7	33.8	108.4	74.0	77.4	77.9	130.6	37.2	46.1	77.7	75.9	65.6	100.2	86.1	41.1	41.5	78.9	49.1	67.8	26.9	71.2	65.7	149.6	50.7	41.8	76.6	76.3	43.1	62.0	37.4	77.3	42.8	52.5	143.0	57.1	67.1	48.0	82.0	146.0	238.2	50.2	62.0	157.0	167.6	98.7	115.6	72.2	153.6	86.5	96.5	149.7	112.1	189.3	153.2	74.9	141.3	121.8	238.9	153.3	136.6	152.7	104.9	164.9	94.7	176.8	115.9	70.8	156.5	205.0	232.3	243.4	92.9	136.4	136.5	105.4	129.2	155.1	259.9	130.6	115.2	93.0	495.3	289.8	83.7	134.7	229.1	192.3	105.2	64.0	129.4	70.3	391.6	192.5	95.4	233.9	130.6	104.1	141.8	108.9	141.1	200.3	144.1	131.5	116.1	133.8	135.5	143.8	38.3	62.3	11.2	63.1	77.4	95.8	87.2	82.3	77.5	81.5	86.9	81.4	86.0	3.3	97.1	75.0	68.4	72.0	93.5	75.4	78.6	79.6	81.2	74.0	77.4	77.7	75.9	78.9	76.3	77.3	82.0	26.3	32.1	31.6	3.9	33.7	30.5	67.0	65.4	39.3	13.8	46.8	51.3	157.0	80.1	49.1	42.3	4.2	92.4	27.5	28.0	154.6	53.5	26.7	31.5	45.0	40.9	36.0	22.9	5.7	76.6	87.9	51.0	36.7	37.0	60.3	30.9	35.7	133.6	79.7	15.2	6.3	45.7	36.7	27.3	29.4	13.4	55.9	29.1	74.7	1.9	47.9	22.2	36.0	4.5	10.0	40.2	35.3	53.0	43.4	53.7	44.9	213.2	41.7	13.7	32.9	53.0	62.0	46.8	48.5	66.1	36.7	40.8	28.7	59.7	69.5	62.1
MRPS10	FLJ10567	ENSG00000048544	"Mitochondrial ribosomal protein S10"	P82664	6	42206807-42217861	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 295.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029133, HPA029134"	Supported		Approved	"Actin filaments,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Actin filaments"	"HPA029133: AB_10600084, HPA029134: AB_10600058"	"unprognostic (1.06e-1)"	"unprognostic (3.90e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.37e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.50e-3)"	"unprognostic (5.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.04e-2)"	24.7	24.0	16.3	20.3	17.1	24.1	21.6	16.8	18.4	19.4	16.1	20.3	19.1	18.3	18.1	43.3	14.5	15.9	46.6	17.3	17.7	29.1	37.5	15.7	24.3	16.5	16.8	14.6	17.2	22.9	13.2	21.6	16.7	18.4	23.6	18.3	19.9	17.0	73.6	18.4	17.7	22.1	16.1	18.8	18.3	16.2	17.5	24.9	24.1	61.8	27.7	24.2	23.7	18.0	99.4	35.1	36.1	61.8	49.4	47.6	32.2	64.3	63.3	61.0	53.3	40.3	38.2	70.2	41.7	60.2	68.3	35.3	60.3	87.5	81.6	64.5	49.3	62.5	30.9	67.2	51.4	93.1	38.8	41.3	65.9	57.2	121.1	41.4	62.8	73.5	110.5	53.4	74.7	63.5	61.0	67.1	30.7	295.3	57.1	51.7	54.3	66.8	105.1	44.2	55.0	40.6	36.9	49.9	122.0	33.5	83.0	125.2	40.7	51.7	51.0	50.3	96.9	39.6	64.4	149.1	35.3	91.7	52.6	22.4	26.0	20.1	23.9	30.4	28.2	30.1	29.2	28.7	29.4	27.1	29.6	28.9	13.1	29.8	28.8	37.7	35.1	28.0	16.3	17.1	16.8	18.4	17.3	17.7	16.5	16.8	16.7	16.1	17.5	18.0	40.4	22.4	21.6	6.8	41.8	40.5	53.6	61.5	22.8	26.8	35.3	33.4	131.8	20.0	39.6	38.6	31.3	102.0	48.0	25.2	92.0	66.5	7.6	35.3	52.4	41.3	14.9	74.5	7.6	47.0	67.5	42.9	23.4	26.8	32.9	46.1	24.7	58.9	52.8	32.0	9.0	27.6	67.1	24.4	28.0	8.8	28.9	34.8	30.2	2.8	110.6	47.8	60.8	7.5	9.5	61.1	30.5	36.5	41.9	64.9	30.0	86.9	60.5	57.3	19.7	35.2	43.0	75.5	83.8	62.2	40.6	75.4	33.8	65.7	35.3	69.4
MRPS18A	"FLJ10548, MRPS18-3"	ENSG00000096080	"Mitochondrial ribosomal protein S18A"	Q9NVS2	6	43671202-43687791	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 370.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035450, HPA035451"	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA035450: AB_10670701, HPA035451: AB_10602029"	"unprognostic (9.85e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.35e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.03e-5)"	"unprognostic (9.35e-2)"	34.5	44.1	37.0	21.0	37.9	21.5	33.3	37.8	43.4	31.5	53.8	42.6	36.3	32.4	20.9	58.3	30.1	20.4	66.7	39.2	37.7	46.9	63.3	25.6	22.7	38.8	38.1	21.9	32.3	39.1	19.5	22.7	37.7	39.5	45.4	15.0	35.1	26.8	149.4	41.7	31.3	27.1	38.2	32.1	56.1	17.5	39.4	26.4	28.4	103.4	33.1	34.8	33.9	38.1	71.0	57.7	45.2	63.9	45.2	30.4	51.4	32.9	50.2	78.6	77.3	118.7	28.4	29.6	55.4	46.0	64.1	56.6	64.3	92.5	40.9	45.6	76.5	55.7	44.3	104.5	78.1	76.1	32.4	41.4	73.5	66.6	100.6	40.2	59.9	73.0	97.9	61.4	47.0	115.2	58.3	63.4	33.6	370.3	46.2	48.8	35.9	95.9	59.1	79.9	72.5	38.9	34.7	64.5	121.8	32.1	65.5	106.7	32.6	49.4	56.4	40.2	60.2	67.1	60.2	110.3	66.2	52.8	134.8	106.6	69.8	76.8	79.1	60.9	74.8	135.4	73.6	76.0	82.3	98.3	73.0	67.9	32.5	93.3	45.2	91.2	86.9	84.1	37.0	37.9	37.8	43.4	39.2	37.7	38.8	38.1	37.7	38.2	39.4	38.1	27.1	32.1	24.5	5.2	31.8	33.4	44.6	97.7	12.0	13.6	29.1	26.4	1.3	30.0	61.2	33.1	2.1	72.7	15.6	96.0	99.7	78.2	16.5	26.2	26.2	25.3	32.3	23.5	5.1	67.4	64.0	24.6	56.6	43.7	26.6	28.8	30.4	51.8	51.1	8.4	4.5	73.4	73.2	17.5	19.8	35.2	22.7	16.5	40.9	7.5	51.7	23.4	29.9	9.0	5.2	69.3	94.2	21.1	42.9	45.0	73.4	115.4	34.7	15.5	32.9	24.7	25.8	27.3	36.2	31.0	27.3	67.5	19.5	61.7	97.2	77.9
MRPS35	"MDS023, MRPS28"	ENSG00000061794	"Mitochondrial ribosomal protein S35"	P82673	12	27710822-27756295	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 242.6;Proximal tubular cells: 231.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038513	Supported		Approved	Mitochondria,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA038513: AB_10794084"	"prognostic unfavorable (9.41e-4)"	"unprognostic (8.35e-2)"	"prognostic favorable (5.01e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.51e-5)"	"unprognostic (4.63e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.25e-1)"	27.3	42.1	25.0	26.8	26.1	31.2	42.7	26.7	33.4	23.8	28.0	59.2	52.6	25.8	29.4	35.8	29.4	24.1	62.2	26.0	27.2	78.6	77.7	21.6	31.9	25.7	26.0	26.2	27.8	46.9	14.0	29.1	26.5	31.5	61.1	18.4	29.6	24.1	83.3	23.5	46.4	29.8	26.7	21.0	43.9	18.0	26.4	28.3	44.2	72.5	32.1	35.3	20.4	27.9	95.0	102.1	42.4	65.1	58.9	71.8	156.0	61.4	52.6	84.4	76.2	125.0	132.4	88.2	87.5	63.3	65.5	70.0	88.0	77.9	99.1	74.2	82.8	100.2	39.2	103.7	58.5	138.1	51.1	61.4	95.1	71.1	143.2	77.3	69.6	73.0	110.1	58.6	77.9	57.9	96.7	227.0	158.9	231.8	147.7	101.1	109.8	145.3	130.8	77.3	24.0	48.5	84.4	131.0	106.1	93.9	133.6	108.2	54.5	51.4	54.9	117.8	111.4	22.8	36.9	186.8	68.6	104.5	68.5	11.0	21.5	7.8	15.1	38.3	24.1	20.7	18.9	18.7	30.5	19.7	22.3	20.4	1.2	25.9	46.4	14.4	26.4	23.8	25.0	26.1	26.7	33.4	26.0	27.2	25.7	26.0	26.5	26.7	26.4	27.9	25.0	73.7	40.3	13.4	38.2	47.3	42.3	65.0	46.1	20.8	49.8	43.8	94.8	50.1	55.4	51.5	4.2	104.0	21.2	51.8	242.6	92.0	12.6	42.0	42.4	30.1	60.3	26.3	28.0	59.2	113.4	35.9	72.4	40.0	54.5	34.5	18.9	67.1	73.1	18.5	28.0	81.2	40.7	38.4	28.8	9.1	25.4	42.9	42.7	8.4	64.7	27.1	34.0	19.6	25.4	62.2	52.3	24.5	32.1	55.4	63.6	231.4	70.2	18.0	26.3	35.8	39.8	23.9	27.2	68.7	52.1	61.7	34.8	83.8	116.5	46.1
MS4A8	"CD20L5, MS4A4, MS4A8B"	ENSG00000166959	"Membrane spanning 4-domains A8"	Q9BY19	11	60699585-60715807	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 129.7;intestine: 197.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 376.4;Enteroendocrine cells: 473.4;Ionocytes: 140.4;Proximal enterocytes: 694.6;Respiratory ciliated cells: 502.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.9;RPMI-8226: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007319	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA007319: AB_1854138"	"unprognostic (7.28e-3)"	"unprognostic (2.11e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.52e-2)"			"unprognostic (9.41e-2)"	"unprognostic (4.89e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-9)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-2)"		"unprognostic (1.59e-3)"	0.0	0.8	1.6	3.5	1.3	0.0	0.0	0.0	1.1	25.6	5.4	18.2	189.8	8.2	0.0	0.3	129.7	10.8	0.0	0.6	0.4	0.1	0.0	16.6	0.2	0.0	0.2	0.3	2.2	0.7	7.5	0.1	0.0	1.7	16.9	0.0	0.6	7.1	4.6	0.0	197.7	1.0	0.0	0.0	45.7	0.5	0.9	0.1	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	0.0	1.1	0.6	0.4	0.0	0.2	0.0	0.0	0.9	0.0	0.0	6.4	6.4	0.0	0.2	0.0	0.2	11.9	0.0	0.0	0.0	0.0	0.3	18.6	58.8	1.8	0.0	0.0	0.0	15.0	0.0	0.3	1.3	376.4	3.2	0.3	473.4	0.0	0.4	2.5	0.0	2.0	14.3	11.6	1.3	0.0	0.0	0.0	0.0	0.0	0.1	42.5	140.4	0.0	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	46.1	0.0	0.0	1.7	694.6	0.2	502.8	0.0	0.0	0.0	3.5	0.3	0.7	0.0	0.0	0.0	0.5	0.2	24.7	0.4
MSRB2	"CBS-1, CBS1, CGI-131, MSRB, PILB"	ENSG00000148450	"Methionine sulfoxide reductase B2"	Q9Y3D2	10	23095579-23122013	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 269.1;Proximal tubular cells: 463.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027933	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA027933: AB_10601867"	"unprognostic (4.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	16.2	17.3	29.0	6.6	30.8	7.7	11.0	29.5	40.5	13.2	26.8	22.7	9.4	15.8	16.8	10.8	17.6	7.7	61.6	29.5	32.2	19.0	31.0	9.8	3.9	30.4	30.9	11.9	5.4	23.1	14.4	8.2	30.5	14.3	11.4	13.1	9.1	19.5	42.2	5.5	11.9	16.3	29.1	9.3	11.4	3.9	30.8	8.4	14.1	51.7	4.1	17.1	11.0	29.4	7.3	10.4	19.0	11.6	19.3	17.3	5.7	11.5	6.4	7.2	8.3	7.2	15.5	5.9	10.0	24.6	10.9	4.6	6.3	8.6	5.9	40.3	7.0	4.3	17.7	4.1	27.2	0.9	5.0	22.2	14.3	8.4	2.0	15.7	10.4	11.5	5.9	10.3	16.0	21.9	7.0	5.5	10.5	41.4	6.0	8.0	10.9	1.5	9.1	2.8	3.8	26.1	14.2	12.4	23.9	15.9	8.4	17.1	7.7	6.2	5.8	14.0	6.9	13.3	4.4	0.2	8.8	12.7	5.3	0.9	1.4	2.3	0.3	1.1	0.3	0.2	0.3	0.2	0.8	0.0	0.6	0.4	3.4	0.2	0.8	1.6	0.4	0.2	29.0	30.8	29.5	40.5	29.5	32.2	30.4	30.9	30.5	29.1	30.8	29.4	29.0	0.0	16.4	27.1	11.4	18.2	52.1	33.1	59.2	68.2	69.6	79.1	269.1	80.1	21.1	90.1	22.9	116.1	10.6	86.7	176.1	130.4	1.4	49.3	71.6	34.4	55.7	30.7	9.5	63.4	61.2	70.7	23.4	46.5	29.2	114.0	42.1	195.4	109.6	112.7	16.9	54.8	26.4	70.5	25.1	4.4	49.7	54.2	72.9	11.2	29.7	126.6	7.2	14.6	26.1	90.3	79.6	62.4	24.7	34.9	80.8	463.9	24.3	57.5	59.2	52.6	71.6	4.4	7.7	66.7	17.5	69.6	13.5	60.9	71.0	54.3
MTCL1	"CCDC165, KIAA0802, SOGA2"	ENSG00000168502	"Microtubule crosslinking factor 1"	Q9Y4B5	18	8705661-8832778	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 90.1;intestine: 28.1;retina: 34.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 26.0;Excitatory neurons: 86.4;Granulosa cells: 28.9;Inhibitory neurons: 80.4;Oligodendrocyte precursor cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	9	"cerebellum: 90.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 32.0"	HPA046245	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA046245: AB_10962580"	"unprognostic (2.64e-1)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.30e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (2.82e-1)"	"unprognostic (3.67e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.08e-2)"	1.6	0.9	0.0	2.5	0.6	0.5	1.4	90.1	10.1	4.7	0.0	28.1	1.8	2.3	0.7	2.7	1.0	8.1	2.9	0.7	0.5	2.5	1.3	1.2	0.8	4.9	2.6	1.1	3.7	2.8	5.6	2.3	7.3	1.7	1.7	34.0	1.4	3.0	2.1	2.5	4.3	5.2	0.9	0.6	8.9	8.0	0.0	3.7	0.4	1.1	0.5	9.4	4.6	6.3	16.8	35.3	17.4	10.2	7.6	14.1	0.7	22.9	16.9	18.6	13.4	10.4	5.8	10.5	12.8	16.1	13.9	2.5	5.5	9.4	8.5	2.1	4.5	5.1	10.1	9.4	10.9	0.1	7.3	8.3	6.8	10.5	7.2	12.1	14.8	8.8	1.1	17.8	8.7	5.0	0.7	2.5	7.9	40.2	15.2	14.0	12.5	3.8	26.9	29.9	39.3	8.8	10.5	3.0	2.7	14.3	1.0	0.6	28.2	33.8	17.6	27.4	23.8	3.4	2.8	5.1	8.4	0.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	90.1	10.1	0.7	0.5	4.9	2.6	7.3	0.9	0.0	6.3	0.4	0.0	1.1	9.4	1.3	0.0	2.8	0.0	4.6	0.0	1.5	1.9	6.5	8.6	0.6	1.8	0.0	5.0	1.8	1.8	1.9	5.6	26.0	2.8	2.3	2.1	1.2	4.6	86.4	3.5	0.4	1.5	5.6	7.8	2.5	28.9	4.6	1.0	0.6	0.0	80.4	1.5	0.0	0.6	0.0	8.8	1.2	0.3	0.0	8.4	0.1	0.0	0.0	24.1	18.3	8.6	0.2	0.4	1.9	4.6	0.2	1.9	0.0	0.0	0.0	0.8	1.9	0.9	5.2	3.0	0.0	1.0	0.4	1.3	1.2	1.3
MTERF3	"CGI-12, FLJ10939, MTERFD1"	ENSG00000156469	"Mitochondrial transcription termination factor 3"	Q96E29	8	96239398-96261610	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007355			Supported	Mitochondria,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA007355: "	"unprognostic (4.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.75e-3)"	"unprognostic (3.11e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (5.88e-5)"	"unprognostic (8.67e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.74e-3)"	15.0	16.3	16.3	15.3	16.9	11.5	17.9	18.6	21.8	14.0	20.9	14.7	12.6	13.5	22.9	11.6	12.7	12.4	27.8	16.1	17.3	18.3	23.1	12.1	18.2	16.4	16.3	12.1	15.5	22.3	12.6	16.7	17.2	13.5	14.4	16.0	12.9	17.2	30.2	17.0	11.5	16.6	15.9	16.0	12.7	11.8	16.6	16.7	11.9	38.2	19.4	16.4	12.0	17.8	41.1	25.9	38.1	30.3	26.4	27.4	17.5	30.8	25.0	43.9	44.2	18.8	29.6	36.5	63.3	18.2	22.5	22.8	39.7	24.1	53.2	35.6	29.3	52.5	20.6	22.8	37.1	17.9	20.7	27.5	35.4	35.6	33.5	22.9	36.5	39.0	45.1	18.7	44.7	26.9	76.6	52.8	19.8	71.6	39.8	45.9	31.2	28.8	32.7	21.8	25.9	20.4	23.0	6.6	33.8	24.5	34.3	25.0	16.3	30.9	20.8	36.0	27.7	21.3	28.9	43.2	33.4	47.3	41.3	39.5	13.4	6.1	15.6	15.9	22.6	20.4	17.7	17.8	20.2	17.7	19.8	20.2	2.2	23.8	15.8	24.3	18.6	10.1	16.3	16.9	18.6	21.8	16.1	17.3	16.4	16.3	17.2	15.9	16.6	17.8	10.4	3.2	6.9	7.8	10.8	0.0	21.2	0.0	10.8	0.0	6.6	8.5	31.2	5.7	5.6	5.5	0.0	30.4	10.8	0.9	13.7	12.5	5.6	6.2	10.1	8.1	0.0	12.4	12.9	9.8	21.0	12.7	4.1	5.4	6.3	11.2	6.1	8.0	16.2	0.0	12.6	3.6	0.0	5.2	0.0	4.1	13.7	7.1	0.0	4.7	16.0	0.0	15.5	7.5	14.2	7.7	3.3	13.9	7.0	22.9	3.3	11.1	5.1	0.0	13.1	10.3	9.9	28.2	21.2	9.1	0.0	17.4	8.8	9.5	5.3	11.7
MTIF3	"IF-3mt, IF3(mt)"	ENSG00000122033	"Mitochondrial translational initiation factor 3"	Q9H2K0	13	27435643-27450591	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 610.0;Proximal tubular cells: 475.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039791	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA039791: AB_10795296"	"unprognostic (1.82e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.27e-2)"	"prognostic favorable (8.41e-4)"	61.8	55.0	59.5	29.2	59.8	17.1	51.0	61.0	93.4	36.7	60.4	46.7	42.8	28.4	67.1	39.9	30.4	37.0	133.4	59.0	61.7	63.1	65.5	29.2	44.5	60.9	60.2	37.1	54.4	43.4	50.8	30.9	60.9	45.3	44.6	74.7	82.9	43.9	90.8	39.9	41.8	30.5	58.8	49.6	48.1	61.8	60.6	47.3	36.9	109.8	46.1	36.7	34.0	62.0	29.9	21.9	48.5	23.5	53.2	78.8	22.6	44.0	51.1	33.8	33.8	28.3	37.5	33.3	28.4	50.8	22.8	25.1	27.2	37.1	46.3	34.3	31.2	42.6	19.1	36.7	52.2	43.8	38.8	44.6	65.5	27.7	35.1	75.6	60.0	33.8	24.0	13.6	51.2	54.0	39.7	54.2	24.4	100.1	24.0	22.8	24.3	37.5	69.8	31.3	32.9	20.6	28.4	39.1	50.7	51.8	31.3	62.5	38.1	21.4	12.5	56.1	29.5	10.0	14.9	19.1	21.5	44.3	31.1	85.8	53.0	75.4	30.8	51.2	32.9	49.1	38.9	31.1	55.2	42.8	34.0	35.2	36.5	37.2	48.3	88.2	47.4	41.3	59.5	59.8	61.0	93.4	59.0	61.7	60.9	60.2	60.9	58.8	60.6	62.0	88.5	28.9	47.4	29.0	74.0	34.0	34.0	103.9	43.9	0.0	91.6	95.4	179.1	87.2	76.3	115.8	0.0	102.6	60.4	102.2	326.8	89.6	610.0	93.7	63.4	70.3	64.1	59.7	22.8	104.1	67.0	62.7	47.4	74.5	71.7	50.6	79.9	223.0	102.3	0.0	26.4	112.8	103.7	114.8	50.2	283.4	139.8	67.7	106.7	24.4	106.4	0.0	80.3	30.7	43.7	98.3	108.8	124.8	71.1	43.7	142.8	475.5	83.2	0.0	124.9	48.8	69.2	243.6	87.6	62.8	42.5	56.8	58.5	69.6	96.8	44.8
MTMR11	CRA	ENSG00000014914	"Myotubularin related protein 11"	A4FU01	1	149928651-149936879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 26.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 139.2;Intestinal goblet cells: 79.2;Paneth cells: 98.9;Proximal enterocytes: 133.2;Undifferentiated cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.7;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.7;monocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 17.0;OE19: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030351, HPA072906"	Enhanced		Approved	Centrosome		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Centrosome		"HPA030351: AB_10602185, HPA072906: "	"unprognostic (1.14e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.12e-2)"	3.6	12.3	3.5	2.9	3.6	0.1	4.1	3.2	4.0	11.0	7.3	22.2	20.3	9.5	6.9	4.3	8.4	12.9	3.2	3.1	3.9	6.9	1.4	3.8	0.7	5.1	4.3	15.2	2.1	5.1	5.3	4.2	3.9	4.7	26.7	1.0	2.2	7.7	1.0	9.4	23.4	13.8	4.5	1.8	3.9	4.9	3.8	0.7	1.6	2.7	0.9	6.9	6.9	4.4	3.1	7.3	3.1	2.6	8.6	10.1	6.6	3.1	10.0	4.0	4.9	0.2	12.9	0.0	6.7	10.6	4.9	4.3	0.3	5.2	2.4	0.2	0.1	0.0	2.3	0.9	2.2	0.0	0.2	6.3	1.7	4.1	6.8	17.0	4.8	0.1	0.2	0.3	7.8	9.9	0.0	0.1	0.7	20.5	2.9	0.0	1.0	0.1	5.8	0.9	0.2	0.2	1.7	2.9	1.1	2.0	3.0	0.0	3.3	4.5	5.4	4.0	2.7	0.6	1.5	0.0	3.9	0.0	0.5	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	3.5	3.6	3.2	4.0	3.1	3.9	5.1	4.3	3.9	4.5	3.8	4.4	2.2	0.0	0.6	2.6	0.5	4.1	3.8	8.9	5.2	0.0	3.0	4.1	6.4	5.7	3.6	14.7	0.0	14.1	0.4	139.2	1.9	15.0	0.6	1.7	3.1	4.5	15.7	0.0	4.0	17.0	10.7	7.0	19.4	2.2	0.0	3.0	3.9	1.5	4.8	0.0	4.9	79.2	0.0	11.3	6.1	0.3	5.6	15.7	1.8	1.0	43.8	0.0	0.0	0.0	3.6	45.1	98.9	12.0	0.3	4.9	133.2	18.5	4.5	0.0	6.6	0.5	7.3	0.4	0.6	3.4	6.5	28.5	0.9	6.4	56.5	4.1
MTRF1	"MGC47721, MTTRF1, RF1"	ENSG00000120662	"Mitochondrial translation release factor 1"	O75570	13	41216369-41263577	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.6;Spermatocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043316	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA043316: AB_10795038"	"unprognostic (3.87e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.27e-3)"	"unprognostic (5.07e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.46e-2)"	5.1	9.7	5.7	8.7	5.8	10.9	6.9	6.6	8.1	6.2	10.1	8.4	10.8	6.2	12.0	8.5	5.1	11.0	7.2	5.7	6.1	11.7	11.4	5.8	12.5	6.5	5.9	6.1	12.4	7.5	6.7	6.0	6.8	7.3	11.9	5.1	6.7	6.2	13.8	10.0	9.3	6.9	5.6	11.4	10.8	14.0	6.3	10.2	7.1	12.7	11.6	7.1	6.2	6.1	9.2	12.1	14.8	12.6	16.2	18.7	10.0	13.0	9.3	15.4	15.2	29.0	23.1	25.3	8.6	10.5	25.4	26.3	21.7	14.0	20.6	15.6	18.0	23.8	17.9	23.7	10.3	21.3	21.6	10.6	12.7	14.0	8.3	11.7	22.3	26.0	15.9	5.9	18.9	9.1	18.9	21.8	13.8	33.6	9.1	14.8	12.4	12.0	16.0	7.8	3.7	8.9	11.9	10.7	12.6	17.8	7.3	11.2	9.8	12.4	5.3	11.7	12.9	6.8	12.0	22.4	17.3	14.8	13.2	3.3	2.5	4.9	3.9	3.3	5.2	5.0	2.8	4.0	5.4	2.8	5.4	7.9	1.5	3.2	2.5	3.4	4.8	2.5	5.7	5.8	6.6	8.1	5.7	6.1	6.5	5.9	6.8	5.6	6.3	6.1	3.7	3.2	3.6	5.5	8.3	3.6	5.3	8.8	5.2	0.0	4.6	4.7	9.4	10.0	9.5	9.2	0.0	7.2	10.0	4.3	11.7	6.2	28.6	5.0	4.7	4.8	4.2	7.4	10.1	7.5	9.2	5.1	7.1	4.4	5.1	5.7	5.7	4.6	6.1	0.0	9.4	4.6	14.2	3.5	1.6	8.0	1.5	6.2	1.8	6.5	5.4	0.0	3.1	10.1	11.7	7.2	4.4	3.8	7.5	3.7	5.2	15.5	3.9	0.0	0.0	5.6	5.4	26.6	8.7	6.4	3.4	4.2	7.6	7.3	5.7	6.2
MUC13	DRCC1	ENSG00000173702	"Mucin 13, cell surface associated"	Q9H3R2	3	124905442-124953819	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 614.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 853.2;Intestinal goblet cells: 418.5;Paneth cells: 641.9;Proximal enterocytes: 422.5;Undifferentiated cells: 207.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 198.4;stomach cancer: 152.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"OE19: 220.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045163, HPA079663"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA045163: AB_10960396, HPA079663: "	"unprognostic (8.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.64e-2)"	"prognostic unfavorable (9.73e-5)"	"unprognostic (2.05e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.42e-1)"	0.8	0.8	0.0	62.0	0.0	0.1	0.5	0.0	0.1	0.8	0.0	304.6	614.6	1.5	0.0	0.8	2.8	47.9	0.1	0.0	0.0	17.5	3.7	0.3	0.4	0.2	0.0	0.0	4.5	0.0	0.1	0.0	0.3	2.1	301.3	0.0	0.0	0.8	0.0	0.1	503.8	10.9	0.0	0.1	35.3	0.3	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.0	7.4	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.1	6.4	13.6	0.0	0.8	0.2	0.1	1.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.9	0.1	0.0	0.0	1.0	0.0	220.9	1.1	0.0	0.1	2.7	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	3.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	25.8	0.8	0.0	0.0	0.0	0.0	853.2	0.0	24.7	0.9	120.0	1.5	0.4	153.8	0.0	0.1	31.4	0.0	0.0	36.7	6.1	8.9	0.0	0.0	0.0	0.0	0.0	0.2	418.5	0.0	0.3	0.0	4.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.8	641.9	0.7	0.0	1.5	422.5	7.7	10.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	1.5	0.0	207.9	1.4
MUC5AC	MUC5	ENSG00000215182	"Mucin 5AC, oligomeric mucus/gel-forming"	P98088	11	1157953-1201138	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"stomach 1: 185.1"	"Cell type enriched"	"Detected in some"	248	"Gastric mucus-secreting cells: 10434.9"	"Group enriched"	"Detected in many"	4	"pancreatic cancer: 25.3;stomach cancer: 61.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"A549: 19.9;OE19: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002774, CAB009395, HPA040615"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB002774: , CAB009395: AB_2146854, HPA040615: AB_2677042"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.51e-2)"		"unprognostic (4.56e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (8.46e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.84e-1)"	"unprognostic (9.21e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.37e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	13.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	17.4	0.0	0.1	5.4	0.0	0.0	0.1	0.0	2.7	0.0	42.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.8	0.0	2.8	10434.9	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	4.1	0.0	0.0	0.2	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.1	0.0	30.0	8.9	0.0	0.0	10.0	0.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.1	7.9	0.0	0.0	28.1
MUC5B	"MG1, MUC5"	ENSG00000117983	"Mucin 5B, oligomeric mucus/gel-forming"	Q9HC84	11	1223066-1262172	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"salivary gland: 2621.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 443.2;Distal enterocytes: 158.4;Intestinal goblet cells: 210.1;Undifferentiated cells: 183.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"OE19: 113.9;PC-3: 120.0"	"Not detected"	"Not detected"							"HPA008246, CAB009396"	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		1300000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"CAB009396: AB_2282256, HPA008246: AB_1854203"	"unprognostic (2.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.76e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.80e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.57e-7)"	"unprognostic (2.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.13e-2)"	0.1	0.7	0.2	2.0	0.1	0.0	1.3	0.0	0.4	229.4	0.0	58.0	0.1	0.3	0.0	101.0	1.1	221.3	0.1	0.0	0.0	0.1	2.4	7.5	0.0	0.1	0.0	0.1	9.8	0.0	0.4	0.0	0.0	0.6	17.1	0.0	2621.9	0.0	0.3	0.4	2.6	0.6	0.0	0.0	6.9	0.3	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.2	0.0	113.9	120.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	2.3	0.0	0.0	6.7	0.6	0.0	6.4	4.3	12.4	443.2	64.0	0.0	0.0	0.1	0.0	158.4	0.0	0.9	0.0	1.4	0.8	0.9	24.5	0.0	0.1	0.0	0.1	1.1	12.8	7.2	4.5	0.0	0.0	1.2	0.2	0.0	0.0	210.1	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	53.4	0.0	1.4	1.3	0.1	0.2	24.5	0.0	0.0	0.0	3.0	0.0	0.5	1.6	0.0	0.1	0.7	0.1	183.1	1.1
MUC6		ENSG00000184956	"Mucin 6, oligomeric mucus/gel-forming"	Q6W4X9	11	1012823-1036718	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"pancreas: 171.2;stomach 1: 409.9"	"Cell type enriched"	"Detected in some"	4	"Gastric mucus-secreting cells: 278.8"	"Group enriched"	"Detected in many"	4	"pancreatic cancer: 42.9;stomach cancer: 58.0"	"Region enhanced"	"Detected in single"		"amygdala: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"OE19: 1.7"	"Not detected"	"Not detected"							CAB002165	Enhanced				"Secreted to digestive system"	NA	NA		75000		"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB002165: AB_442114"	"unprognostic (1.90e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.23e-2)"	0.5	0.2	1.2	0.0	0.6	0.0	0.9	0.3	0.5	26.3	0.0	3.0	15.6	2.1	0.9	5.2	2.5	0.3	0.2	0.8	0.0	2.6	5.4	0.2	0.0	0.0	0.0	0.2	171.2	0.0	0.2	0.0	0.0	4.3	0.0	0.0	0.1	28.0	0.1	0.1	0.1	0.0	0.0	0.3	409.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.3	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	11.3	2.8	1.7	54.3	0.0	9.2	0.0	0.0	0.2	0.1	0.0	12.2	0.1	0.5	0.1	0.1	0.0	0.0	1.2	19.1	0.0	0.1	278.8	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	59.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MUCL3	"bCX105N19.6, C6orf37, DPCR1, PBLT"	ENSG00000168631	"Mucin like 3"	Q3MIW9	6	30934523-30954221	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"stomach 1: 202.8"	"Cell type enriched"	"Detected in some"	20	"Pancreatic endocrine cells: 239.5"	"Group enriched"	"Detected in some"	9	"pancreatic cancer: 56.8;stomach cancer: 55.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014036	Enhanced					NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA014036: AB_1847841"	"unprognostic (2.81e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.13e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.58e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	10.5	0.0	9.9	0.0	0.0	0.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	202.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MYH4	"MYH2B, MyHC-2B, MyHC-IIb"	ENSG00000264424	"Myosin heavy chain 4"	Q9Y623	17	10443290-10469559	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"skeletal muscle: 10.6"	"Cell type enriched"	"Detected in single"	5	"Cardiomyocytes: 3.3"	"Cancer enriched"	"Detected in single"	115	"liver cancer: 9.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	25	"OE19: 9.0"									HPA001349	Supported		Uncertain	"Focal adhesion sites"		NA	NA		86000000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"		"HPA001349: AB_1079437"	"unprognostic (3.27e-2)"		"unprognostic (2.94e-2)"			"unprognostic (4.94e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.72e-1)"			"unprognostic (1.37e-1)"		"unprognostic (3.32e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.52e-4)"		"unprognostic (9.97e-2)"	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0
MYO18A	"KIAA0216, MysPDZ"	ENSG00000196535	"Myosin XVIIIA"	Q92614	17	29071122-29180398	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 404.2;tongue: 124.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 33.6;Oligodendrocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019646	Supported					NA	NA		3400000	"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA019646: AB_1854249"	"unprognostic (2.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.70e-2)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.95e-1)"	9.2	4.0	16.0	7.5	36.0	12.9	10.5	13.3	28.0	13.1	0.0	16.4	14.1	15.3	2.9	19.0	10.6	10.4	95.5	11.9	18.3	5.7	20.4	7.2	6.6	37.2	27.1	7.1	14.8	8.4	5.4	4.5	38.4	10.6	5.9	3.8	15.9	5.9	404.2	20.6	14.4	7.6	8.7	6.3	14.4	5.1	35.6	4.1	7.8	124.0	4.8	12.4	14.4	56.3	29.6	40.9	15.5	8.0	4.0	7.0	24.8	13.8	13.7	11.8	8.2	10.3	20.5	3.1	15.2	10.0	17.3	33.2	6.0	23.1	4.6	34.4	11.4	2.6	12.9	11.3	6.1	3.7	3.6	8.1	13.2	7.2	3.2	19.5	4.3	12.3	37.1	5.3	5.9	10.2	10.8	2.9	3.2	60.1	9.0	37.3	17.3	9.1	9.0	21.7	8.1	8.3	13.7	45.5	9.8	10.2	10.6	4.4	5.0	7.7	9.3	5.2	9.6	10.0	18.1	5.9	9.7	2.6	20.9	0.6	0.2	0.4	0.3	0.3	0.4	0.1	0.3	0.3	0.3	0.3	0.4	0.2	0.5	0.3	0.3	0.4	0.2	0.1	16.0	36.0	13.3	28.0	11.9	18.3	37.2	27.1	38.4	8.7	35.6	56.3	14.8	12.8	7.0	13.4	5.4	1.0	1.0	0.5	10.8	7.1	3.7	3.3	33.6	2.8	8.3	1.8	10.4	0.4	2.8	8.6	0.0	2.9	1.4	1.9	4.4	8.1	2.4	9.0	13.6	1.4	2.7	4.9	21.4	2.3	1.3	15.3	2.2	5.0	1.1	1.7	13.3	4.0	0.0	0.6	1.3	0.6	2.1	6.1	0.0	9.4	2.0	2.6	2.1	14.6	38.8	4.2	5.1	3.0	6.8	1.0	5.0	1.7	1.7	4.2	0.0	4.7	2.0	1.3	1.3	9.5	0.9	0.3	5.5	3.2	4.1	1.1
MYO1A	"DFNA48, MYHL"	ENSG00000166866	"Myosin IA"	Q9UBC5	12	57028517-57051198	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 330.0"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 174.5;Proximal enterocytes: 690.2"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8"	"Region enhanced"	"Detected in many"		"white matter: 8.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 43.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053490	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA053490: AB_2682168"	"unprognostic (2.77e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.26e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.72e-2)"	0.2	0.2	0.1	5.1	0.4	0.1	0.1	0.8	0.2	0.0	0.7	68.3	330.0	0.4	0.0	0.2	0.1	4.1	0.0	0.1	0.2	0.1	0.1	0.2	0.3	2.1	2.0	0.0	0.2	0.0	0.1	0.2	1.8	0.1	65.7	0.1	0.0	0.2	0.1	0.1	309.8	3.0	3.7	0.1	16.3	1.0	0.6	0.4	0.0	0.0	0.1	0.0	0.1	8.3	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	8.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	1.5	0.1	43.3	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.2	0.1	0.2	2.1	2.0	1.8	3.7	0.6	8.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.9	4.3	0.1	0.0	0.0	0.0	0.0	174.5	0.0	0.1	0.7	0.3	0.0	0.1	24.7	0.0	0.1	0.0	0.0	0.1	26.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	85.4	0.0	0.3	1.0	1.2	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.3	66.8	0.0	0.1	0.0	690.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.4	0.1	0.0	0.4	0.0	102.3	0.1
N4BP2L2	"CG005, PFAAP5"	ENSG00000244754	"NEDD4 binding protein 2 like 2"	Q92802	13	32432417-32538885	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039338, HPA039434, HPA059327"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA039338: AB_2676453, HPA039434: AB_10673143, HPA059327: AB_2683981"	"unprognostic (1.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.81e-2)"	"unprognostic (6.83e-2)"	"unprognostic (6.51e-2)"	"unprognostic (8.95e-2)"	"unprognostic (6.29e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.03e-3)"	29.0	28.4	29.7	19.9	33.1	26.4	40.9	39.3	36.3	28.7	25.8	26.0	17.9	39.1	37.8	23.3	27.3	29.0	42.7	26.6	29.2	30.8	36.8	34.9	28.4	28.3	28.4	47.5	18.1	33.7	23.0	23.4	29.4	36.1	28.2	38.0	24.0	30.3	65.3	29.2	24.9	31.6	30.0	31.7	26.1	20.0	27.9	33.0	36.6	60.8	25.0	31.5	19.8	37.0	18.1	13.7	35.0	25.4	31.6	39.1	29.7	34.0	31.8	28.3	25.7	24.1	44.7	19.4	18.2	37.4	44.7	30.2	36.1	32.6	37.7	46.7	17.9	35.6	30.9	29.4	50.1	46.0	20.3	42.4	42.4	26.1	31.2	47.7	43.9	34.4	28.6	18.2	39.8	24.1	36.1	44.5	31.4	79.2	15.6	29.7	32.0	21.5	36.2	24.9	12.8	32.1	22.2	25.0	48.4	39.9	27.6	64.7	33.5	15.4	17.1	17.1	16.4	17.3	19.6	16.4	21.2	30.5	25.7	35.4	13.7	29.3	17.1	16.4	23.7	18.1	20.3	18.0	13.0	16.1	23.4	20.1	20.3	21.2	23.0	16.6	20.1	12.2	29.7	33.1	39.3	36.3	26.6	29.2	28.3	28.4	29.4	30.0	27.9	37.0	269.4	173.1	174.2	321.3	275.3	137.9	319.5	236.5	166.8	222.0	167.1	144.8	186.6	138.7	180.1	217.0	248.1	182.4	311.3	208.5	92.0	132.9	132.3	164.3	180.6	199.5	175.8	118.9	354.5	74.7	81.8	189.0	175.8	139.2	212.8	256.3	198.5	134.6	119.1	249.0	386.1	173.0	217.7	161.6	129.6	140.2	370.0	175.9	124.5	244.5	308.4	108.4	382.1	367.4	586.4	116.7	282.3	301.7	187.9	253.3	338.7	92.3	175.1	335.8	315.5	234.5	197.3	187.6	89.8	89.3	137.7	191.5	292.6	180.5	122.4	275.1
NAPG		ENSG00000134265	"NSF attachment protein gamma"	Q99747	18	10525905-10552764	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008208, HPA011389"	Enhanced		Approved	"Plasma membrane"		NA	NA		8800	"Cluster 49: Eosinophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"HPA008208: AB_1854305, HPA011389: AB_1854306"	"unprognostic (1.23e-1)"	"unprognostic (7.64e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.46e-3)"	"unprognostic (5.85e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.96e-2)"	11.3	14.8	18.4	9.7	18.6	7.2	11.8	21.1	25.3	10.5	13.9	11.9	9.3	10.7	12.0	12.1	11.0	13.4	19.9	25.9	20.8	16.4	13.6	9.7	9.6	30.3	20.1	7.5	12.6	12.4	9.9	13.9	32.6	13.7	13.7	12.6	11.7	10.7	10.2	9.9	10.7	11.8	19.4	9.4	13.7	7.4	20.1	9.0	14.5	14.6	11.2	14.3	10.1	21.7	9.4	5.6	9.6	8.3	27.1	18.4	14.0	19.8	28.1	19.0	24.0	12.4	14.1	12.3	15.5	27.3	17.4	9.0	12.7	17.7	26.9	11.0	7.8	9.2	9.8	12.8	25.9	26.0	16.6	20.3	20.6	21.8	16.2	12.4	18.0	16.0	15.1	29.0	28.2	13.2	20.0	11.1	7.7	72.3	8.3	8.7	15.8	21.2	22.5	22.0	38.3	10.1	16.1	16.9	23.1	15.5	7.7	17.2	20.5	29.8	14.4	27.8	21.2	18.8	20.4	13.6	20.1	17.7	14.2	12.5	4.9	14.1	5.1	6.1	4.7	7.5	4.1	5.2	3.8	3.3	5.6	4.8	8.1	5.8	6.1	4.1	4.4	3.1	18.4	18.6	21.1	25.3	25.9	20.8	30.3	20.1	32.6	19.4	20.1	21.7	32.2	28.9	34.7	33.6	29.1	24.3	31.1	26.9	21.6	62.0	21.8	17.4	35.1	21.5	27.5	27.6	12.5	23.6	32.9	30.8	41.1	53.3	18.1	27.9	33.2	23.4	23.4	33.2	68.5	42.5	30.3	25.3	28.5	49.5	45.0	13.6	20.0	21.7	25.4	45.4	53.8	22.3	28.5	22.1	16.1	4.6	7.8	24.5	26.6	30.9	22.4	31.3	22.6	34.7	52.9	77.7	34.1	21.1	36.2	34.8	20.8	39.5	20.8	34.0	26.3	30.5	29.6	26.6	39.9	30.8	21.2	45.1	26.2	28.4	19.0	56.5
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435968-78574874	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favorable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	7.3	11.9	10.7	6.8	12.3	6.2	11.1	12.4	13.3	9.6	19.8	11.3	10.3	9.1	11.2	8.1	9.9	7.0	11.7	10.4	11.7	19.0	23.5	7.6	9.6	11.7	13.9	11.4	10.6	11.4	7.6	8.0	13.1	10.8	10.9	13.4	10.7	7.3	23.5	7.2	9.7	7.4	11.3	7.4	9.9	7.5	11.4	11.7	11.5	19.6	9.7	8.7	8.1	12.3	16.7	22.8	23.5	15.4	16.1	13.5	19.5	13.5	13.1	20.6	16.9	39.4	17.4	40.9	34.1	8.7	19.8	21.5	39.9	26.3	28.3	27.0	21.3	28.9	17.3	33.7	13.3	31.3	10.1	9.4	16.8	18.1	32.0	18.3	17.9	33.7	44.5	11.0	23.1	19.4	32.7	50.3	25.6	67.3	27.3	33.6	38.2	55.5	27.2	23.0	27.8	17.5	20.1	25.4	35.5	25.1	24.1	12.3	10.9	27.7	32.8	32.0	23.1	18.1	33.1	91.1	5.4	27.7	19.2	9.5	9.3	4.4	11.1	10.4	13.8	17.6	12.8	12.5	16.6	15.0	18.5	16.7	2.0	20.3	12.8	12.7	10.5	10.3	10.7	12.3	12.4	13.3	10.4	11.7	11.7	13.9	13.1	11.3	11.4	12.3	5.8	19.2	26.4	27.7	14.5	13.5	14.2	12.0	12.5	5.2	9.4	6.5	8.8	5.7	10.3	5.5	2.1	20.0	4.4	4.0	29.4	9.5	13.1	10.1	7.4	6.6	12.0	9.2	34.7	7.3	23.6	9.0	10.2	9.0	8.2	14.0	2.5	19.8	12.4	0.0	45.1	8.3	22.4	6.3	11.6	5.4	7.8	6.3	17.8	45.0	2.9	6.3	4.1	42.7	47.7	7.5	9.9	4.9	14.6	17.5	7.0	28.9	10.2	9.0	6.6	7.5	8.8	8.6	19.5	12.0	13.8	15.3	7.8	9.0	14.6	10.7
NDUFA1	"CI-MWFE, MWFE"	ENSG00000125356	"NADH:ubiquinone oxidoreductase subunit A1"	O15239	X	119871832-119876662	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 3202.9;Distal tubular cells: 2191.3;Proximal tubular cells: 1764.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029768, HPA054359"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Mitochondria	"HPA029768: AB_2673192, HPA054359: AB_2682461"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (4.77e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-3)"	260.4	276.7	541.8	179.3	547.2	316.3	275.0	560.4	746.6	226.5	637.9	467.4	387.4	132.4	323.9	145.0	193.2	133.0	983.7	539.2	555.3	495.1	449.6	153.8	186.7	549.0	541.6	149.3	228.5	773.9	121.4	171.4	551.2	185.8	371.3	398.6	280.0	240.2	1381.0	90.8	334.6	180.7	545.6	169.4	297.4	65.8	551.2	273.2	173.3	1367.9	219.4	228.5	90.5	549.6	436.8	561.9	342.0	365.6	466.3	317.8	423.6	346.6	395.9	297.8	368.1	326.5	377.8	385.1	509.4	431.0	514.7	416.5	555.7	392.8	354.6	492.2	751.7	380.6	1110.1	750.5	357.0	575.9	387.2	485.4	577.0	296.5	232.5	413.2	389.1	372.4	230.9	553.4	435.6	965.3	412.5	563.2	489.1	1214.3	988.4	405.3	315.2	1169.8	887.0	765.2	255.9	319.8	714.9	871.1	479.6	476.5	224.2	653.8	395.1	209.4	198.2	422.7	672.5	469.4	798.3	524.9	377.5	719.5	262.1	1064.7	680.6	822.0	486.1	726.1	468.4	560.6	540.8	516.7	745.6	447.7	435.9	523.1	851.5	468.5	815.5	809.1	675.4	780.5	541.8	547.2	560.4	746.6	539.2	555.3	549.0	541.6	551.2	545.6	551.2	549.6	251.9	160.3	188.6	10.7	261.6	213.7	251.4	991.0	194.1	156.2	268.0	322.7	3202.9	511.9	445.8	562.8	79.2	396.5	273.9	1264.2	2191.3	503.6	34.2	332.0	237.9	228.9	459.0	272.3	12.3	512.5	416.1	266.9	322.1	348.9	210.3	177.5	260.3	1022.5	661.7	82.4	14.8	907.2	581.8	413.5	350.6	43.8	294.5	329.3	570.9	14.0	492.3	364.2	277.1	8.0	16.5	506.4	1024.5	285.1	389.2	228.8	1546.3	1764.0	443.2	231.2	216.9	208.4	289.9	50.8	105.2	394.3	249.3	380.6	255.7	126.7	887.7	339.3
NDUFA3	B9	ENSG00000170906	"NADH:ubiquinone oxidoreductase subunit A3"	O95167	19	54102728-54109257	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 625.9;skeletal muscle: 492.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1133.8;Late spermatids: 2033.9;Proximal tubular cells: 1213.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 74.0"	"Low region specificity"	"Detected in all"							HPA046976	Supported					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA046976: AB_10960994"	"unprognostic (3.04e-2)"	"unprognostic (4.12e-3)"	"unprognostic (9.53e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.00e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (9.91e-2)"	"unprognostic (3.24e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.24e-2)"	"prognostic favorable (4.80e-4)"	134.4	192.6	20.7	3.2	21.1	6.5	108.0	27.2	28.0	96.2	23.5	142.8	11.2	102.6	5.2	127.7	95.8	5.4	625.9	21.3	21.4	259.5	248.2	102.5	5.1	22.3	20.2	104.5	124.0	4.8	225.9	3.3	21.4	122.5	8.1	6.5	113.4	3.7	492.4	84.8	117.6	4.0	17.3	133.5	160.7	164.3	24.3	3.5	152.4	10.8	5.4	97.6	92.3	26.6	9.1	9.7	8.4	11.6	10.3	10.7	5.2	7.6	9.3	6.5	7.3	10.1	7.2	8.2	5.3	7.4	6.1	6.6	6.9	16.7	3.5	11.5	32.0	9.5	9.6	11.9	7.6	9.2	2.3	6.2	15.1	5.2	8.5	3.1	11.7	7.3	4.9	3.5	6.9	32.3	7.3	10.5	7.4	74.0	15.2	4.3	5.0	17.7	4.9	23.2	14.1	6.9	6.9	17.7	4.3	10.3	23.4	9.6	8.7	7.4	4.5	4.0	13.2	6.9	5.7	3.9	9.1	10.5	4.5	25.2	12.9	20.9	12.6	15.3	13.0	18.4	13.0	12.9	14.3	16.1	13.5	13.6	12.5	18.0	12.3	23.7	14.5	22.3	20.7	21.1	27.2	28.0	21.3	21.4	22.3	20.2	21.4	17.3	24.3	26.6	146.9	96.1	117.4	4.6	168.1	39.8	53.5	266.5	58.6	37.7	196.2	212.6	1133.8	203.0	171.4	393.6	10.4	164.1	158.3	544.0	815.9	183.6	497.6	239.6	124.9	118.2	300.5	169.0	5.2	192.5	171.9	122.9	174.8	180.2	116.5	138.3	194.9	527.7	306.9	23.5	6.4	380.2	209.5	267.4	114.4	2033.9	163.1	181.6	218.7	1.9	300.4	146.3	265.7	3.0	7.7	204.2	448.8	141.4	232.7	67.5	705.7	1213.0	225.1	71.0	85.5	62.5	125.8	215.3	69.8	122.6	62.5	148.4	168.6	75.3	404.2	66.6
NDUFA8	"MGC793, PGIV"	ENSG00000119421	"NADH:ubiquinone oxidoreductase subunit A8"	P51970	9	122144058-122159779	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 380.1;tongue: 363.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 579.5;Distal tubular cells: 614.3;Early spermatids: 499.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041510, HPA041600"	Enhanced		Supported	Mitochondria		NA	NA		25000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041510: AB_10794379, HPA041600: AB_10796778"	"unprognostic (2.90e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (4.17e-6)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.62e-2)"	54.2	74.2	139.4	33.9	146.0	28.6	53.9	146.0	159.3	44.8	142.6	101.4	65.8	46.6	86.8	57.1	62.3	39.3	380.1	144.7	148.4	97.9	81.5	37.0	43.0	141.4	139.7	35.7	46.1	137.4	56.9	48.2	141.6	57.9	88.2	72.0	72.3	61.9	259.1	44.2	53.6	73.9	138.7	41.4	75.3	95.5	145.8	48.6	53.3	363.3	56.2	57.8	40.9	141.7	84.8	154.1	99.5	132.0	105.7	96.4	123.3	96.0	114.1	130.0	108.5	197.0	81.9	123.1	92.6	113.6	234.6	206.8	191.3	208.7	127.0	121.5	132.6	96.9	254.2	172.6	113.3	172.7	95.5	106.1	200.3	130.0	82.9	118.1	189.1	134.8	151.0	89.6	150.3	215.6	108.1	112.1	91.2	377.1	293.1	85.0	156.7	179.4	189.4	116.0	172.1	67.6	151.0	176.7	122.6	100.9	187.6	82.1	123.2	71.2	70.9	135.2	109.3	100.1	176.1	123.8	148.0	110.7	120.2	17.4	82.1	66.8	78.3	100.9	76.2	88.0	71.3	77.3	109.2	92.8	76.0	80.3	13.7	79.0	88.7	114.2	91.9	74.7	139.4	146.0	146.0	159.3	144.7	148.4	141.4	139.7	141.6	138.7	145.8	141.7	70.6	28.9	40.4	16.3	38.6	48.3	73.8	298.1	43.9	47.2	61.0	73.5	579.5	48.6	128.0	82.8	29.2	130.5	34.1	87.3	614.3	103.8	499.0	80.1	52.4	98.5	77.4	100.6	19.4	101.6	113.1	70.3	47.9	52.9	20.3	68.5	60.7	110.9	124.4	45.4	26.0	105.7	185.1	40.5	42.0	121.1	56.5	48.8	94.3	18.7	72.9	91.3	65.9	14.1	17.9	100.8	80.3	75.2	56.9	91.1	163.4	249.8	113.0	59.0	26.3	52.5	114.8	294.9	116.2	67.0	56.8	126.6	36.6	104.4	136.3	86.4
NDUFC1	KFYI	ENSG00000109390	"NADH:ubiquinone oxidoreductase subunit C1"	O43677	4	139266880-139302551	"Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"heart muscle: 83.5;skeletal muscle: 268.3;tongue: 158.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1840.3;Distal tubular cells: 1136.7;Proximal tubular cells: 1449.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044556, HPA062427"	Enhanced		Approved	Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA044556: AB_10794402, HPA062427: "	"unprognostic (6.07e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (7.25e-4)"	9.5	15.3	19.9	8.0	20.4	9.1	11.0	22.4	28.6	7.4	21.3	18.6	23.8	8.1	14.3	10.5	10.5	5.4	83.5	19.6	20.8	26.7	24.1	8.8	10.1	20.3	21.0	10.0	14.8	22.9	15.8	5.9	21.6	9.7	19.0	23.5	18.9	14.4	268.3	13.2	18.6	7.4	19.5	10.4	17.0	12.7	20.5	8.6	14.8	158.5	11.0	8.6	7.9	22.4	21.4	5.9	19.2	30.8	17.7	22.7	20.5	20.1	13.1	11.1	10.4	13.1	23.7	7.7	7.7	15.5	14.9	10.5	38.6	18.2	15.0	13.0	13.5	11.9	13.5	23.0	18.1	11.2	10.1	24.5	18.2	14.4	21.6	16.8	17.5	17.8	25.3	33.8	11.0	17.8	17.8	32.1	16.3	44.1	11.7	14.9	10.6	52.6	24.6	14.2	14.6	14.7	13.8	23.2	10.5	15.6	23.7	23.2	8.1	24.2	6.4	13.0	13.5	23.2	49.5	18.5	18.9	26.7	13.8	26.2	10.1	13.1	8.5	10.3	11.6	7.1	11.7	11.5	8.9	15.9	10.5	11.4	3.0	10.1	14.2	16.2	18.2	10.8	19.9	20.4	22.4	28.6	19.6	20.8	20.3	21.0	21.6	19.5	20.5	22.4	201.8	89.8	145.7	15.7	95.8	140.2	173.3	402.7	185.0	120.4	240.3	349.6	1840.3	221.6	240.1	439.6	33.3	147.4	71.7	343.0	1136.7	270.3	409.9	333.5	115.5	162.7	221.4	175.2	10.9	336.9	166.2	176.9	158.0	196.8	73.3	151.2	133.5	432.9	225.1	119.5	14.3	340.5	276.7	102.0	65.7	70.9	169.3	115.6	266.8	6.5	185.5	446.6	79.3	8.0	13.3	265.3	355.8	206.5	155.6	173.7	471.7	1449.6	297.1	139.1	98.6	159.3	184.4	439.0	197.4	290.1	179.3	118.1	83.5	224.7	343.7	176.0
NDUFV2	CI-24k	ENSG00000178127	"NADH:ubiquinone oxidoreductase core subunit V2"	P19404	18	9102630-9134345	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 606.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003404, HPA077896"	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No		7600	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA003404: AB_1079466, HPA077896: AB_2686866"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.95e-3)"	97.4	171.6	94.3	69.2	97.4	149.8	101.7	106.8	139.7	63.9	106.0	124.2	102.3	69.7	91.1	142.6	64.0	68.7	419.3	96.7	106.0	180.7	404.2	88.6	105.0	105.9	104.4	52.4	111.6	136.7	72.1	73.7	105.9	88.5	119.8	129.9	97.4	72.4	606.9	94.7	100.5	80.6	103.7	86.4	133.8	79.6	102.7	90.2	72.7	538.3	105.1	122.1	76.5	104.6	136.5	139.8	159.1	148.4	116.6	164.0	133.4	165.4	266.5	217.7	205.5	265.1	109.4	209.4	149.5	158.6	200.3	66.9	157.5	175.5	208.8	104.6	136.6	133.0	135.3	364.8	133.6	373.8	159.2	139.2	144.3	134.9	146.2	156.8	239.3	184.3	216.5	644.0	204.6	171.6	263.5	328.9	131.4	750.5	172.3	124.5	118.2	794.2	354.3	218.7	167.0	122.3	164.6	188.0	220.3	113.6	174.2	282.8	145.8	273.4	194.3	198.8	223.0	180.4	292.3	237.1	195.4	166.0	181.0	250.8	161.8	194.2	118.1	196.1	148.3	237.6	176.9	140.5	237.9	201.1	153.5	142.7	76.0	124.2	187.9	315.1	231.9	231.8	94.3	97.4	106.8	139.7	96.7	106.0	105.9	104.4	105.9	103.7	102.7	104.6	107.3	80.1	145.8	17.6	143.1	148.0	319.0	629.4	159.4	101.2	165.0	167.3	69.9	178.7	339.5	150.8	87.6	344.1	146.6	211.0	876.5	415.2	271.5	160.3	108.2	117.3	106.5	165.4	32.9	531.4	323.3	122.0	144.3	183.9	120.3	109.7	96.4	351.5	313.5	94.2	37.3	201.7	480.1	115.7	267.1	186.2	122.1	170.2	231.3	17.8	293.2	167.1	96.8	32.2	46.5	530.3	201.2	102.0	244.9	554.3	349.9	810.6	293.4	184.2	105.2	124.0	196.3	217.4	175.0	226.5	147.6	289.4	165.7	266.7	227.3	469.0
NECAP1	DKFZP566B183	ENSG00000089818	"NECAP endocytosis associated 1"	Q8NC96	12	8076939-8097881	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053980, HPA063300"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Vesicles	Cytosol	"HPA053980: AB_2682331, HPA063300: AB_2684981"	"unprognostic (1.73e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.06e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.56e-1)"	"unprognostic (5.79e-3)"	"unprognostic (5.72e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.94e-2)"	11.7	23.7	25.4	11.8	23.2	8.0	13.6	19.3	39.6	14.9	1.0	17.8	15.6	10.2	8.7	12.1	15.5	9.9	12.7	25.5	44.0	15.8	14.4	11.2	8.0	13.0	11.1	16.1	22.3	27.5	24.7	15.9	17.8	15.7	16.9	42.5	15.9	12.4	7.9	9.4	15.6	11.4	13.8	10.1	16.1	13.6	15.2	14.2	12.6	12.2	10.4	16.9	10.1	15.9	20.4	18.8	12.6	17.6	29.6	22.0	28.2	41.8	26.6	36.1	36.2	40.9	23.1	9.2	7.3	20.9	26.2	14.0	35.2	23.1	31.2	28.2	27.4	11.6	21.2	21.4	26.9	10.7	29.2	28.7	26.3	40.4	48.0	27.7	26.2	15.0	27.3	14.8	38.8	25.8	17.3	2.8	35.1	57.2	15.4	6.8	32.0	9.7	24.6	32.0	20.7	14.3	21.3	29.7	15.9	40.7	10.1	8.9	26.6	16.9	33.3	20.3	30.1	9.4	18.4	19.9	30.6	11.7	26.0	28.8	16.6	36.4	10.9	15.7	12.7	9.8	10.3	11.2	11.9	10.2	12.1	11.0	28.7	10.6	22.7	7.2	16.8	13.0	25.4	23.2	19.3	39.6	25.5	44.0	13.0	11.1	17.8	13.8	15.2	15.9	18.9	38.5	24.0	11.4	36.1	25.5	22.0	16.0	25.6	49.0	17.5	10.5	10.4	7.2	18.7	23.9	27.1	14.6	32.9	19.8	25.4	15.3	25.4	11.3	20.9	18.1	16.2	17.0	29.4	16.7	14.5	17.9	17.3	16.1	29.2	33.5	15.4	15.2	13.8	28.6	28.4	16.1	12.2	19.8	39.0	13.7	23.3	22.4	28.4	11.2	14.8	30.7	20.6	14.6	21.3	19.0	16.0	14.7	33.7	21.8	23.9	17.8	13.1	46.3	6.6	17.7	21.3	17.4	22.3	21.0	21.3	22.4	35.6	25.2	14.1	22.0
NEK5		ENSG00000197168	"NIMA related kinase 5"	Q6P3R8	13	52033611-52129092	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.1;choroid plexus: 7.4;fallopian tube: 8.8;testis: 10.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 57.9;Endometrial ciliated cells: 75.8;Late spermatids: 32.0;Respiratory ciliated cells: 98.6;Spermatocytes: 32.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.2;OE19: 2.4;T-47d: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035565, HPA041399"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA035565: AB_10672095, HPA041399: AB_2677453"	"unprognostic (4.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.57e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (9.44e-3)"	0.1	0.1	1.1	0.2	1.5	0.3	0.4	0.7	0.7	0.3	7.4	0.1	0.1	0.5	0.3	0.0	8.8	0.1	0.4	1.5	1.7	0.4	0.0	1.3	0.1	5.1	5.1	0.1	0.1	0.7	0.1	0.4	2.5	0.5	0.2	1.6	0.1	0.1	0.3	0.2	0.1	0.2	3.6	0.2	0.1	10.8	2.6	0.3	0.3	0.1	0.1	0.1	0.0	2.7	0.1	0.1	0.1	0.6	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.4	0.6	0.1	0.2	0.0	0.1	0.1	0.0	1.2	0.4	0.2	0.0	0.5	0.1	0.3	0.2	2.4	0.2	0.0	0.0	0.0	0.6	0.1	0.1	0.3	0.2	0.0	0.2	0.3	1.1	0.4	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.1	1.5	0.7	0.7	1.5	1.7	5.1	5.1	2.5	3.6	2.6	2.7	1.4	0.0	2.0	2.6	1.5	0.0	1.9	0.3	0.0	9.2	3.0	1.8	2.0	2.8	12.1	7.3	14.6	2.6	2.5	0.5	1.9	1.3	57.9	75.8	1.9	3.0	1.8	0.8	3.8	2.9	2.4	1.6	0.0	2.8	2.5	1.2	0.4	1.2	1.2	13.5	3.1	0.4	2.0	0.3	0.4	32.0	2.1	0.6	0.0	4.7	1.4	2.1	3.1	1.0	6.6	0.8	0.7	2.2	0.5	3.7	1.3	1.5	98.6	13.2	6.6	4.6	1.3	32.2	12.9	0.3	0.1	1.9	1.0	1.2	1.1	1.3
NELL1	"FLJ45906, IDH3GL"	ENSG00000165973	"Neural EGFL like 1"	Q92832	11	20669551-21575686	"Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.2;kidney: 16.6"	"Group enriched"	"Detected in some"	9	"Excitatory neurons: 279.0;Inhibitory neurons: 175.8;Oligodendrocyte precursor cells: 323.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051535	Approved				"Secreted in other tissues"	NA	NA		160000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA051535: AB_2681524"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.35e-4)"	"unprognostic (3.78e-4)"	"unprognostic (1.67e-2)"		"unprognostic (3.91e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.29e-1)"	0.3	0.1	4.5	0.1	5.5	0.0	0.0	0.0	8.2	0.3	0.0	0.2	0.0	0.3	1.6	0.6	0.1	0.4	0.0	10.2	2.0	16.6	0.0	0.4	0.0	2.4	1.9	0.1	0.0	0.0	3.5	0.0	2.5	5.1	0.3	0.8	0.4	2.5	0.0	0.6	0.1	0.1	0.0	0.1	0.6	1.0	1.5	1.2	0.0	0.3	0.7	0.1	0.6	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.0	0.0	0.7	0.0	0.0	0.1	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	5.5	0.0	8.2	10.2	2.0	2.4	1.9	2.5	0.0	1.5	4.2	0.1	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.8	0.7	0.0	0.0	1.8	0.0	0.8	0.0	0.0	5.9	0.0	28.8	0.8	0.1	0.0	0.0	0.0	279.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	175.8	0.0	0.0	0.0	0.0	22.3	0.3	0.0	0.0	13.1	0.0	0.0	0.0	323.2	7.6	0.0	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.2	0.5	0.0	0.0	0.7	0.1	0.0	0.0	0.2
NFYA	"CBF-B, HAP2, NF-YA"	ENSG00000001167	"Nuclear transcription factor Y subunit alpha"	P23511	6	41072945-41099976	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.4;Late spermatids: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009250, HPA050779"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB009250: AB_2152107, HPA050779: AB_2681234"	"unprognostic (2.56e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.62e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	10.8	8.9	13.3	14.0	18.1	40.7	15.6	14.3	13.2	11.3	9.6	11.9	9.9	14.9	14.7	10.8	11.6	12.5	8.8	12.5	13.4	10.1	14.3	11.8	19.5	15.8	16.6	18.7	11.5	15.3	9.0	13.8	15.5	13.6	14.6	21.5	9.4	8.0	9.3	10.6	11.2	10.8	13.6	14.5	12.6	38.5	14.8	41.5	18.4	12.4	20.5	14.6	9.4	24.3	32.8	26.3	49.2	82.7	19.9	19.3	20.9	24.2	22.4	37.2	31.4	34.6	23.3	39.4	19.7	16.0	19.6	21.0	30.1	29.1	40.9	28.4	38.0	51.7	23.2	49.4	14.1	55.0	43.3	12.3	24.4	29.8	40.0	18.1	32.6	64.5	51.4	46.4	36.9	32.4	62.5	22.1	22.1	95.8	25.9	50.3	27.1	29.6	27.2	43.8	49.8	34.3	21.1	18.9	37.5	31.2	17.7	55.1	32.2	65.7	35.6	13.2	46.9	18.2	19.8	64.2	13.0	46.2	26.5	2.7	2.9	4.8	5.8	3.9	7.6	3.7	5.4	6.4	3.3	4.1	5.7	6.3	8.0	6.5	3.5	4.3	6.7	3.2	13.3	18.1	14.3	13.2	12.5	13.4	15.8	16.6	15.5	13.6	14.8	24.3	7.6	9.6	3.9	6.2	11.1	14.5	9.9	4.2	2.8	4.1	13.2	7.1	4.7	11.5	5.3	11.0	4.2	7.7	11.7	9.3	1.9	11.3	41.4	7.4	7.7	7.5	4.8	12.2	4.4	7.4	12.5	6.8	5.1	8.1	2.5	11.9	7.5	7.0	10.0	0.0	5.1	4.2	4.1	9.3	14.0	44.4	3.7	6.4	7.2	10.3	7.2	3.3	7.2	5.0	13.8	9.6	9.6	3.0	5.6	12.8	5.1	2.6	6.9	5.0	0.0	4.3	8.3	20.0	8.2	6.3	15.9	10.8	10.1	5.6	7.6	18.7
NMT1	NMT	ENSG00000136448	"N-myristoyltransferase 1"	P30419	17	44957992-45109016	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 344.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022949, HPA022963"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		94000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Plasma membrane"	"HPA022949: AB_1854534, HPA022963: AB_1854535"	"unprognostic (1.40e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (4.96e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.17e-3)"	"unprognostic (9.45e-2)"	28.3	31.8	36.2	22.3	37.7	19.5	25.8	30.3	43.4	24.7	27.9	27.8	23.6	26.4	15.7	28.8	27.7	20.3	28.3	38.8	36.4	27.3	39.5	26.5	33.6	35.4	33.7	26.3	22.2	37.8	23.3	36.6	35.0	24.5	29.2	25.7	32.1	27.6	44.6	23.9	26.4	32.9	33.9	28.4	24.5	24.9	37.2	35.2	30.7	47.6	39.5	33.0	23.5	34.9	51.5	88.8	53.7	42.3	82.9	75.0	60.6	41.4	87.6	115.9	101.0	83.9	57.0	54.0	86.2	80.4	78.4	51.5	94.5	92.3	132.9	117.9	73.3	49.0	60.7	84.4	53.7	71.0	62.6	66.4	64.1	79.1	69.2	64.1	87.1	60.9	81.8	38.1	63.1	49.2	76.2	31.7	42.4	151.5	87.8	57.5	67.2	52.2	73.6	78.8	39.2	32.9	33.0	30.2	38.0	112.8	73.1	46.0	50.1	69.9	49.5	55.8	68.1	41.4	61.0	69.9	64.5	44.5	56.4	34.9	49.4	20.0	23.8	33.3	19.9	42.3	19.9	20.1	26.2	31.0	23.7	18.8	26.5	21.1	27.6	115.5	25.7	11.8	36.2	37.7	30.3	43.4	38.8	36.4	35.4	33.7	35.0	33.9	37.2	34.9	50.1	38.5	29.5	49.3	53.8	13.9	15.4	48.8	24.5	97.8	74.1	57.1	46.5	97.2	33.6	69.9	116.7	73.7	87.5	48.7	78.2	69.4	31.1	51.5	63.1	46.4	50.9	72.0	30.3	71.2	61.9	39.6	21.9	62.3	22.8	28.1	85.3	344.4	47.6	129.5	30.7	43.0	28.5	86.5	15.9	12.2	55.0	34.6	10.6	18.7	97.9	41.5	59.8	20.1	19.3	67.9	52.0	51.1	31.0	15.3	84.1	108.1	24.0	123.5	59.2	16.1	46.3	67.6	35.5	20.5	14.1	81.8	40.1	25.4	68.6	18.6
NOXO1	"P41NOXA, P41NOXB, P41NOXC, SH3PXD5, SNX28"	ENSG00000196408	"NADPH oxidase organizer 1"	Q8NFA2	16	1978917-1984192	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 8.6;lymphoid tissue: 4.7;testis: 4.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.1;Intestinal goblet cells: 34.7;Paneth cells: 20.5;Undifferentiated cells: 42.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.7;HaCaT: 1.6;OE19: 4.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA071540	Enhanced					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA071540: AB_2686415"			"unprognostic (3.74e-1)"							"unprognostic (1.10e-1)"				"unprognostic (1.73e-2)"				0.1	0.2	0.6	4.7	0.8	0.3	0.4	0.5	1.6	0.6	1.0	8.6	3.1	0.3	1.1	0.9	0.2	0.3	0.1	0.6	0.4	0.6	2.3	0.3	0.4	1.1	0.2	0.3	0.4	0.1	0.9	0.0	1.3	0.6	5.9	0.3	2.4	0.2	0.5	0.5	3.4	0.5	0.1	0.3	0.3	4.8	0.5	1.0	0.2	0.0	1.6	0.4	0.3	0.8	0.1	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.3	2.7	0.2	0.1	0.0	0.0	1.6	0.0	0.1	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.4	0.1	0.4	0.1	0.4	0.0	0.6	0.1	0.0	0.0	0.1	1.4	0.0	0.0	4.3	0.0	0.2	0.4	0.0	0.3	0.0	1.4	0.0	0.6	0.5	0.1	0.1	1.0	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.3	0.6	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.5	1.6	0.6	0.4	1.1	0.2	1.3	0.1	0.5	0.8	0.1	0.0	0.0	0.3	0.4	0.3	1.3	9.0	2.8	0.1	7.1	1.8	0.0	1.5	10.6	5.5	0.0	0.8	0.1	52.1	0.0	1.0	6.2	2.9	0.3	0.1	6.6	0.0	1.1	1.9	2.9	0.1	4.6	2.0	0.0	0.2	0.4	0.4	0.3	0.0	0.9	34.7	6.1	0.3	0.3	1.5	0.6	0.1	0.0	0.0	0.6	0.6	0.0	0.0	0.2	1.0	20.5	0.4	0.0	3.3	14.4	1.0	10.6	0.0	0.0	0.0	0.6	3.2	3.3	1.5	0.4	1.5	0.2	0.2	42.4	5.7
NPRL2	"NPR2, NPR2L, TUSC4"	ENSG00000114388	"NPR2 like, GATOR1 complex subunit"	Q8WTW4	3	50347330-50350826	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038196, HPA038197"	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA038196: AB_10675631, HPA038197: AB_10671523"	"unprognostic (7.25e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.06e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.69e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.06e-2)"	4.9	9.2	9.4	5.0	9.7	5.1	7.4	10.0	11.0	9.0	9.4	8.3	5.3	5.3	11.1	6.8	8.8	6.2	10.3	10.0	11.1	9.3	12.9	5.1	8.0	9.7	10.7	7.8	16.4	12.1	9.0	5.7	10.1	7.7	8.5	5.7	12.1	8.1	14.7	7.5	5.6	6.9	10.0	6.8	7.2	7.8	9.9	9.6	8.3	18.0	9.2	5.8	5.3	10.3	12.2	11.9	7.9	14.5	22.5	11.8	8.2	6.4	16.5	17.1	16.8	9.3	11.0	13.9	9.5	11.9	8.6	6.7	18.1	18.5	12.3	10.0	12.9	16.6	10.0	18.2	20.2	20.7	21.9	14.3	19.3	21.8	15.0	11.5	16.8	20.2	9.5	13.6	14.7	2.4	19.3	14.8	8.7	37.2	33.4	7.1	5.0	34.5	19.7	12.1	6.0	14.1	7.3	11.1	12.5	8.2	17.5	10.4	6.0	7.2	9.2	13.8	11.7	16.8	22.0	11.8	14.6	25.5	7.3	40.6	17.4	46.7	72.7	18.1	63.4	23.2	36.4	62.7	20.6	21.1	30.8	48.5	22.9	64.1	20.8	16.6	49.8	50.7	9.4	9.7	10.0	11.0	10.0	11.1	9.7	10.7	10.1	10.0	9.9	10.3	13.4	9.6	11.9	7.8	19.0	12.0	9.8	26.7	14.8	18.4	18.2	19.9	13.2	15.7	16.3	14.7	20.9	27.4	31.4	15.8	37.2	15.9	94.6	8.1	9.4	11.3	11.9	30.3	7.2	15.0	21.5	12.9	18.3	7.1	19.0	12.6	11.7	14.8	14.7	25.2	7.9	20.9	38.7	13.2	10.3	66.6	19.3	7.4	12.4	2.8	15.0	15.0	68.0	5.0	6.5	12.2	12.8	15.1	19.4	7.7	30.7	30.0	15.6	26.4	6.6	11.1	22.1	16.8	14.9	15.4	12.5	9.0	29.3	16.0	18.8	7.7
NQO1	"DHQU, DIA4, DTD, NMOR1, QR1"	ENSG00000181019	"NAD(P)H quinone dehydrogenase 1"	P15559	16	69706996-69726668	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 522.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 539.8;Respiratory ciliated cells: 471.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 2434.0;OE19: 4177.0;SiHa: 2756.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007308, CAB012421"	Enhanced		Supported	Cytosol		NA	NA		490000	"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"CAB012421: , HPA007308: AB_1079501"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.76e-3)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.27e-1)"	100.9	95.1	88.9	20.7	97.2	0.8	264.8	88.1	165.6	24.3	113.4	85.6	106.8	16.1	27.2	162.2	29.3	183.1	24.3	86.7	95.0	93.9	5.6	36.5	4.8	83.5	86.2	8.9	9.2	19.5	15.3	12.0	85.9	20.7	74.0	21.4	47.7	25.1	34.2	11.7	56.1	35.0	83.0	22.8	522.7	6.4	93.6	4.3	112.7	27.0	16.5	79.0	34.2	86.8	224.2	2434.0	203.4	901.3	473.1	682.7	77.5	363.1	632.7	363.9	547.0	302.0	1395.7	7.1	433.1	1850.6	634.3	232.1	79.1	410.3	185.2	91.3	3.3	10.9	564.4	2169.9	631.7	53.8	170.6	166.2	246.8	642.8	74.4	537.9	903.9	18.5	95.3	16.3	1914.1	725.9	11.6	98.7	107.0	4177.0	237.1	18.9	44.0	101.6	708.3	781.5	73.0	17.2	2756.6	384.8	1690.4	226.6	631.3	173.1	626.5	368.8	155.8	140.0	297.1	12.7	53.1	11.2	470.2	29.1	1864.0	1.1	3.9	0.3	6.3	0.4	3.1	5.7	7.3	8.3	3.8	2.4	2.2	5.3	0.9	18.7	0.4	1.3	15.6	5.1	88.9	97.2	88.1	165.6	86.7	95.0	83.5	86.2	85.9	83.0	93.6	86.8	88.5	25.6	14.6	8.8	2.9	5.2	26.4	185.5	32.5	10.0	31.1	30.5	4.8	138.7	90.9	42.3	4.2	1.7	3.5	165.7	146.8	25.6	0.4	117.2	11.7	81.0	20.4	1.3	1.9	147.5	4.3	32.9	539.8	65.7	19.7	10.1	28.5	2.6	15.2	3.3	1.6	81.7	107.8	3.5	7.6	1.2	25.1	10.9	17.8	4.7	128.5	10.6	7.2	0.0	5.0	75.1	59.4	12.0	2.3	22.6	62.9	44.3	471.3	15.1	6.6	21.1	72.1	0.3	1.3	128.3	4.5	1.9	5.6	17.3	51.5	40.6
NRARP	MGC61598	ENSG00000198435	"NOTCH regulated ankyrin repeat protein"	Q7Z6K4	9	137299631-137302271	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 47.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 75.3;Basal keratinocytes: 97.0;Langerhans cells: 97.9;Squamous epithelial cells: 101.8;Suprabasal keratinocytes: 381.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 45.1;MCF7: 23.3;NTERA-2: 31.9;OE19: 30.8;T-47d: 23.1;TIME: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025729	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol	Nucleoplasm	"HPA025729: AB_1854633"	"unprognostic (9.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.73e-6)"	"unprognostic (2.85e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.28e-3)"	8.9	1.7	7.8	7.6	7.9	1.5	6.9	8.8	7.8	6.5	4.2	47.9	22.0	4.4	1.2	22.6	3.6	12.0	12.5	7.3	10.8	6.1	2.7	7.1	1.6	11.5	12.6	2.0	16.8	2.7	7.6	10.3	10.5	9.5	30.5	1.5	3.0	2.1	2.9	26.3	17.8	3.4	9.8	4.2	8.7	10.2	14.8	2.7	4.9	6.5	4.1	10.4	13.5	6.6	4.8	1.0	8.0	8.8	0.0	0.0	2.6	0.1	0.2	0.0	0.1	6.8	3.0	0.0	10.2	0.0	0.4	45.1	13.9	0.4	0.1	0.3	20.6	1.4	2.1	7.6	0.8	2.8	4.3	0.0	2.3	0.0	0.6	0.2	11.8	0.1	11.8	0.3	0.0	23.3	0.2	6.4	31.9	30.8	6.7	8.4	1.5	17.7	1.2	0.6	4.9	8.1	1.4	2.4	0.1	1.7	23.1	5.8	31.9	0.0	0.1	0.1	1.9	0.3	0.2	3.0	0.1	5.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	7.9	8.8	7.8	7.3	10.8	11.5	12.6	10.5	9.8	14.8	6.6	75.3	0.0	0.0	33.3	17.6	97.0	5.9	20.1	15.9	0.6	24.4	39.2	4.4	5.7	14.3	0.0	0.0	0.1	9.7	22.4	0.0	0.5	17.3	35.2	4.4	21.9	10.2	0.0	2.5	1.1	0.0	2.1	19.4	43.0	0.0	0.3	8.9	0.1	0.4	0.0	0.4	20.5	8.2	0.6	97.9	5.2	0.0	18.6	17.8	9.4	0.0	6.8	0.0	2.0	0.6	0.6	28.3	0.4	3.9	6.2	5.0	0.1	3.2	2.8	6.6	4.0	32.1	0.1	0.6	101.8	381.0	0.0	6.7	3.7	23.4	6.0
NSF	"SEC18, SKD2"	ENSG00000073969	"N-ethylmaleimide sensitive factor, vesicle fusing ATPase"	P46459	17	46590669-46757464	"Enzymes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 276.3;Inhibitory neurons: 284.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003154, CAB009324, HPA071089"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		59000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus"	"CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.95e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.74e-1)"	13.5	20.2	29.9	8.0	28.8	5.7	12.5	7.7	58.7	14.1	0.0	18.3	4.9	11.8	7.3	21.6	9.7	8.0	11.3	39.2	28.6	12.9	13.7	11.6	9.6	36.8	14.3	7.0	22.9	15.3	43.1	7.7	36.6	12.4	13.9	63.0	18.4	5.8	38.9	16.5	16.1	6.4	4.1	14.9	15.6	16.7	15.6	7.9	11.9	13.5	10.0	13.2	14.3	21.1	11.7	25.4	16.6	1.2	9.6	13.4	13.5	15.6	18.2	14.7	14.3	17.5	0.1	28.5	27.3	34.8	15.3	2.0	18.9	5.8	23.9	10.1	24.6	1.0	17.4	24.2	14.3	0.8	6.1	12.3	7.8	29.8	12.3	7.8	23.4	7.0	19.4	15.0	32.9	22.8	19.4	7.5	9.4	36.0	29.9	13.7	16.1	26.7	16.7	24.0	15.2	17.2	23.1	0.1	11.1	17.5	28.5	35.1	19.3	41.2	14.4	22.0	23.7	32.0	19.9	16.4	11.5	15.2	29.7	9.3	11.5	6.6	6.1	9.8	6.7	5.4	6.2	8.1	12.6	6.1	5.1	6.1	4.8	5.9	10.8	5.0	9.4	7.5	29.9	28.8	7.7	58.7	39.2	28.6	36.8	14.3	36.6	4.1	15.6	21.1	16.3	9.6	11.3	54.9	28.2	4.0	3.6	6.7	6.2	106.6	14.0	10.0	8.1	7.2	10.9	22.0	87.6	13.0	18.8	32.3	11.7	12.4	45.2	8.3	19.7	11.5	30.5	8.6	276.3	16.2	14.4	10.9	13.7	11.2	9.5	8.2	11.0	19.3	18.8	43.7	284.7	26.3	24.4	29.9	10.9	45.8	5.9	20.5	10.6	69.3	35.4	24.5	8.2	98.5	71.8	13.7	17.4	8.6	21.7	9.0	18.5	14.7	8.7	89.9	0.0	10.6	12.9	40.6	31.4	9.5	5.7	18.5	14.8	18.3	20.6	8.6
NSMCE3	"HCA4, MAGEG1, MAGEL3, NDNL2, NSE3"	ENSG00000185115	"NSE3 homolog, SMC5-SMC6 complex component"	Q96MG7	15	29264989-29269822	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Ubl conjugation pathway"	"Tumor antigen"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 83.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"OE19: 2.6"	"Low region specificity"	"Detected in single"													NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.66e-3)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (1.97e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.41e-2)"	3.8	5.1	0.5	0.1	0.4	0.0	3.6	0.4	0.6	3.1	0.0	4.1	0.1	5.0	0.1	2.5	4.0	0.1	4.6	0.6	0.1	3.1	4.0	3.4	0.2	0.2	0.1	4.7	2.9	0.2	5.9	0.1	0.3	2.8	0.2	0.4	3.1	0.2	4.0	2.4	4.3	0.1	0.0	5.3	3.4	6.3	0.3	0.2	4.1	0.0	0.1	3.7	2.6	0.2	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.0	2.6	0.0	0.1	0.2	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.6	0.6	0.1	0.2	0.1	0.3	0.0	0.3	0.2	29.6	16.0	9.5	0.0	68.0	0.0	28.1	0.0	29.0	39.7	15.0	21.7	0.0	10.0	0.6	9.2	10.4	22.9	80.2	2.3	15.6	22.5	23.9	15.6	26.1	19.6	13.3	9.0	0.0	16.3	14.0	20.9	11.2	14.0	5.1	22.3	21.0	15.4	20.8	43.7	0.0	4.4	0.0	17.1	0.0	72.8	23.3	34.8	0.0	0.0	20.3	41.5	39.1	0.0	0.0	12.1	4.5	31.6	77.7	19.1	4.6	26.9	2.9	41.2	26.3	30.9	28.0	83.8	31.7	12.9	0.0	11.8	80.6	36.6	4.8	18.5
OARD1	"C6orf130, dJ34B21.3, MGC19570, TARG1"	ENSG00000124596	"O-acyl-ADP-ribose deacylase 1"	Q9Y530	6	41033627-41097787	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 193.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 294.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029036	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA029036: AB_10602336"	"unprognostic (2.33e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (4.78e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	20.9	25.5	26.4	20.3	30.5	26.3	30.1	28.5	32.3	19.5	26.5	28.8	31.4	17.6	38.3	23.3	30.1	19.3	22.0	26.0	28.4	44.3	59.2	17.3	28.5	29.7	28.3	35.7	40.6	34.9	22.6	20.0	30.4	25.0	31.1	43.8	25.6	22.0	25.5	21.6	30.2	15.0	28.8	23.0	39.5	58.6	28.2	39.7	30.9	37.1	33.4	20.0	20.1	35.6	44.2	25.0	55.8	40.6	32.1	37.6	36.9	28.0	36.5	29.1	31.4	39.7	33.1	61.7	29.3	15.4	32.1	33.4	38.1	33.1	41.0	53.2	18.6	73.8	28.0	75.4	29.1	50.1	47.6	28.7	45.6	28.1	102.2	26.5	20.3	77.4	95.4	48.8	32.2	59.0	88.1	55.1	51.4	294.4	17.3	36.8	52.4	54.7	58.0	21.4	60.5	38.7	25.5	25.2	88.6	43.2	41.9	42.3	21.9	32.0	39.3	20.0	43.6	65.8	72.7	140.1	25.2	48.5	27.1	49.1	21.8	42.4	26.2	23.3	34.3	45.7	30.6	26.6	26.8	43.2	37.2	36.9	20.8	45.0	28.2	26.0	37.2	22.7	26.4	30.5	28.5	32.3	26.0	28.4	29.7	28.3	30.4	28.8	28.2	35.6	30.5	16.0	40.9	7.8	49.8	28.6	40.3	51.8	38.7	63.2	47.5	41.1	43.4	52.9	40.6	60.7	45.9	89.5	44.1	28.5	86.1	42.9	164.2	43.3	19.6	34.2	22.1	56.4	2.9	48.0	60.2	23.5	37.8	29.8	48.2	21.7	35.0	69.5	45.6	42.1	3.9	52.2	50.8	53.4	37.0	153.8	28.3	33.4	35.6	3.7	42.1	75.9	59.8	4.0	13.1	34.6	44.0	25.9	29.3	37.1	63.0	112.9	56.6	70.5	26.3	23.9	26.7	193.0	148.0	43.4	29.3	45.6	47.5	34.2	61.7	32.4
OAS1	"IFI-4, OIAS, OIASI"	ENSG00000089127	"2'-5'-oligoadenylate synthetase 1"	P00973	12	112905856-112933219	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 91.0;urinary bladder: 111.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 151.0;Hofbauer cells: 105.6;Paneth cells: 127.9;Urothelial cells: 171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 572.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 247.1;BJ hTERT+ SV40 Large T+ RasG12V: 336.6;OE19: 307.6;U-266/70: 272.9;U-266/84: 210.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003657, CAB021104"	Uncertain		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB021104: AB_10057722, HPA003657: AB_1854747"	"unprognostic (1.03e-1)"	"unprognostic (6.59e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.67e-2)"	"prognostic favorable (6.12e-6)"	17.0	11.5	6.8	27.3	7.3	14.3	13.1	6.5	9.7	29.6	6.1	49.0	51.7	8.0	8.1	57.1	10.0	22.5	9.5	6.6	6.9	22.3	38.6	23.1	27.2	15.4	8.0	8.1	4.4	9.0	8.3	20.4	11.5	9.1	45.1	1.5	91.0	7.3	2.4	10.3	39.8	14.6	21.2	50.5	43.6	4.8	8.4	28.1	7.7	7.4	25.6	111.1	22.7	9.9	4.7	24.4	0.0	0.1	9.4	6.6	1.5	0.1	38.8	247.1	336.6	18.5	34.1	42.3	12.2	0.3	121.8	10.8	0.2	4.2	2.2	21.0	0.0	0.7	35.2	4.6	2.9	0.6	1.4	0.5	7.2	8.0	0.0	3.1	13.5	0.7	0.0	17.4	0.2	0.4	0.6	17.0	0.7	307.6	22.5	5.8	0.2	20.5	11.6	89.4	0.2	0.9	3.7	4.2	85.2	0.4	0.9	5.1	50.4	0.0	0.5	3.2	0.4	272.9	210.3	23.9	2.9	6.6	1.4	6.3	253.6	3.2	26.5	403.9	25.3	108.8	36.3	34.3	153.9	93.1	14.3	18.8	24.4	24.9	572.0	144.5	108.7	217.8	6.8	7.3	6.5	9.7	6.6	6.9	15.4	8.0	11.5	21.2	8.4	9.9	23.0	3.2	2.2	0.0	21.1	3.4	16.6	24.0	10.8	0.2	6.0	8.1	3.1	14.3	35.4	5.5	0.0	12.6	31.5	151.0	5.9	19.5	0.4	1.9	3.6	17.2	4.2	3.6	0.6	12.0	36.4	11.1	28.5	4.1	5.1	15.4	14.3	11.9	105.6	0.0	1.0	59.3	26.4	36.9	11.4	1.2	7.2	52.9	5.4	13.1	36.2	15.0	18.6	3.5	0.1	19.5	127.9	10.5	24.1	7.4	50.9	25.4	17.5	0.4	6.6	3.0	7.5	0.0	0.5	18.3	2.3	5.7	9.1	12.7	14.6	171.9
ODR4	"C1orf27, FLJ20505, odr-4, TTG1"	ENSG00000157181	"Odr-4 GPCR localization factor homolog"	Q5SWX8	1	186375838-186421378	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 37.8;Glandular and luminal cells: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015988, HPA031352"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Plasma membrane"		"HPA015988: AB_1845644, HPA031352: AB_2673838"	"unprognostic (1.19e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (8.11e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.15e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.20e-2)"	11.9	14.4	7.5	7.2	9.2	15.0	14.0	10.4	10.1	13.3	8.4	10.8	13.4	9.4	17.2	7.8	8.8	10.6	10.0	7.6	8.2	16.7	21.8	9.5	6.7	8.9	8.6	10.3	29.1	32.4	12.4	14.2	9.2	16.6	12.7	15.2	21.7	12.2	9.0	10.3	13.6	8.8	8.7	8.5	13.1	8.3	8.2	6.4	19.9	9.5	7.1	11.5	8.2	11.9	12.6	13.9	15.1	12.1	17.5	16.3	28.8	19.9	12.2	12.7	12.8	28.2	29.7	8.7	23.5	9.9	11.6	32.3	11.4	10.9	12.5	7.1	10.9	8.2	17.7	15.9	16.4	13.8	9.6	12.5	21.3	15.4	24.1	13.2	13.8	9.0	32.1	17.3	15.3	13.5	9.7	14.3	21.6	46.0	5.0	11.2	10.5	25.0	26.1	12.9	11.0	17.2	15.1	33.0	24.5	26.9	29.1	12.4	13.2	18.1	11.5	12.2	18.9	20.2	13.3	13.3	9.8	7.4	16.7	1.4	9.0	2.5	3.0	8.9	4.5	3.6	3.8	4.2	7.6	2.3	4.7	3.6	3.9	10.0	11.4	4.8	5.7	3.9	7.5	9.2	10.4	10.1	7.6	8.2	8.9	8.6	9.2	8.7	8.2	11.9	28.1	28.9	37.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	18.8	16.5	0.0	0.0	29.7	25.8	0.0	22.0	12.6	0.0	9.8	22.8	0.0	26.8	27.0	9.8	0.0	0.0	0.0	25.4	25.7	12.3	0.0	38.6	12.6	26.4	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	6.7	0.0	0.0	0.0	0.0	24.7	0.0	0.0	4.0	0.0	0.0	10.7	15.3	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	28.0	6.9	29.0	0.0	0.0
OMP		ENSG00000254550	"Olfactory marker protein"	P47874	11	77102840-77103331	"Predicted intracellular proteins"	"Olfaction, Sensory transduction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;OE19: 1.4"	"Region enriched"	"Detected in some"	62	"olfactory bulb: 96.7"	"Low region specificity"	"Detected in some"									NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"						"unprognostic (2.22e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.53e-2)"	"unprognostic (3.54e-1)"		"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.94e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.17e-2)"	0.0	0.4	0.3	0.2	0.2	1.1	0.0	0.8	0.5	0.1	0.0	1.5	2.6	0.0	0.0	0.4	0.1	1.2	0.1	0.4	0.5	0.5	1.4	0.0	0.1	1.0	0.3	0.1	0.1	0.0	0.0	0.0	1.1	0.2	1.9	0.0	0.1	0.1	0.1	0.0	2.5	0.2	0.3	0.1	1.0	0.3	0.4	0.0	0.2	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.0	0.8	0.1	1.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.8	0.5	0.4	0.5	1.0	0.3	1.1	0.3	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OVGP1	"CHIT5, MUC9"	ENSG00000085465	"Oviductal glycoprotein 1"	Q12889	1	111414319-111427735	"Plasma proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	134	"fallopian tube: 2071.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 9.7;Excitatory neurons: 10.4;Glandular and luminal cells: 12.0;Inhibitory neurons: 8.5;Syncytiotrophoblasts: 17.4"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 58.7;ovarian cancer: 27.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 4.9;OE19: 6.4;SK-BR-3: 5.0"	"Region enhanced"	"Detected in many"		"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA031666, HPA062205"	Enhanced		Supported	Vesicles,Microtubules	"Secreted in female reproductive system"	NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles	Microtubules	"HPA031666: , HPA062205: AB_2684710"	"unprognostic (1.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (8.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-3)"	"prognostic favorable (3.93e-5)"	4.1	1.6	7.6	1.1	7.8	1.9	3.5	8.0	10.6	3.8	5.8	3.4	1.1	15.4	5.1	3.0	2071.7	1.1	2.3	7.7	7.0	5.0	8.0	3.9	2.2	7.3	6.9	6.7	1.5	6.8	2.4	2.0	7.2	5.5	2.2	4.3	4.2	1.5	2.6	7.6	5.2	1.4	6.5	4.6	2.8	9.2	6.9	1.2	2.4	1.0	2.0	4.6	3.8	8.2	0.4	0.4	0.9	0.5	1.8	2.0	1.7	0.2	1.4	0.3	0.7	0.6	0.0	0.8	1.7	0.6	0.0	0.5	0.3	0.3	0.5	2.0	4.9	0.3	0.8	2.4	0.6	0.9	2.2	1.8	2.9	0.0	1.0	1.4	0.4	3.2	0.3	1.5	0.1	0.5	0.6	1.2	0.2	6.4	1.7	0.6	0.2	0.7	1.4	3.7	0.6	0.6	0.1	5.0	0.7	2.4	0.3	0.8	0.8	0.1	0.2	2.5	0.7	1.8	0.5	0.4	0.2	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	7.8	8.0	10.6	7.7	7.0	7.3	6.9	7.2	6.5	6.9	8.2	1.2	0.0	1.1	3.3	0.6	3.1	1.1	0.3	0.0	2.1	1.7	1.9	0.6	0.0	0.5	0.0	0.0	5.6	0.2	1.1	1.9	0.2	4.0	9.7	0.7	1.6	0.0	0.0	10.4	0.0	2.6	0.6	0.0	12.0	0.0	1.0	1.4	2.9	0.6	0.0	8.5	1.5	2.0	0.6	1.4	6.1	1.5	0.5	0.0	3.7	0.0	0.4	0.0	1.5	2.4	0.2	0.5	1.9	0.1	1.6	0.6	2.8	1.3	0.6	0.0	0.7	1.1	3.8	0.7	1.0	3.1	17.4	0.8	0.2	1.6	1.6
P3H4	"LEPREL4, NO55, SC65"	ENSG00000141696	"Prolyl 3-hydroxylase family member 4 (inactive)"	Q92791	17	41801947-41812604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 3.9;MAIT T-cell: 5.0;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.7;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.9;NK-cell: 8.5"	"Group enriched"	"Detected in many"	10	"NK-cells: 8.5;T-cells: 5.0"	"Cell line enriched"	"Detected in many"	13	"OE19: 1032.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022520			Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum, Vesicles"		"HPA022520: "	"unprognostic (9.11e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (8.69e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (4.48e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.96e-3)"	5.1	11.6	5.4	5.5	5.6	0.5	4.9	7.3	6.6	10.0	7.5	6.2	7.6	10.7	4.9	2.8	7.7	6.8	8.8	4.6	6.8	7.8	2.3	6.0	2.7	5.2	4.9	7.9	12.9	11.5	10.5	12.1	4.9	7.3	4.2	1.3	10.4	7.2	4.8	7.4	6.5	10.1	4.5	3.3	5.2	2.3	6.6	1.3	12.2	2.0	1.6	7.2	6.4	4.5	9.2	45.0	27.4	70.8	29.1	28.1	26.9	75.5	33.6	25.6	35.0	22.3	12.4	1.4	30.6	58.7	19.5	16.4	23.6	32.3	10.1	21.0	35.5	11.4	44.1	30.3	35.4	2.3	3.6	29.5	9.5	22.3	20.3	61.0	32.6	3.2	2.2	11.6	16.7	31.6	0.6	6.8	17.1	1032.2	25.2	25.3	30.1	31.4	16.5	2.7	13.2	29.0	13.3	81.2	28.9	18.1	46.8	7.4	34.3	24.5	35.7	46.2	34.1	10.7	2.6	0.2	37.7	11.1	38.5	0.0	0.2	0.0	3.9	0.0	5.0	0.6	2.5	2.7	0.2	0.6	3.0	3.9	0.0	8.5	0.0	0.0	0.7	1.5	5.4	5.6	7.3	6.6	4.6	6.8	5.2	4.9	4.9	4.5	6.6	4.5	7.3	0.0	7.8	12.1	1.5	0.0	5.4	0.0	6.2	3.6	11.6	10.8	10.7	11.5	1.8	5.5	8.4	10.8	3.6	7.2	7.9	21.6	0.5	2.7	25.3	11.0	2.4	7.0	6.4	6.5	27.3	26.6	16.8	7.7	1.3	17.7	11.0	1.9	2.8	26.9	4.4	13.0	0.0	1.2	0.0	0.8	21.1	1.0	0.0	4.7	1.2	9.6	13.4	6.0	1.5	7.1	9.5	20.7	2.8	9.6	26.8	5.9	0.7	2.7	19.7	13.1	16.7	2.7	10.0	1.9	0.0	5.3	3.2	19.1	9.8	2.0
PAQR8	"C6orf33, LMPB1, MPRB"	ENSG00000170915	"Progestin and adipoQ receptor family member 8"	Q8TEZ7	6	52361421-52407777	"Predicted membrane proteins, Transporters"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 144.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 168.5;Distal enterocytes: 154.3;Microglial cells: 74.0;Oligodendrocytes: 298.2;Paneth cells: 80.7;Proximal enterocytes: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 41.8;OE19: 87.9;SuSa: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064625			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus"	"HPA064625: AB_2685304"	"prognostic favorable (4.61e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.23e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.66e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.14e-2)"	"prognostic favorable (6.40e-4)"	2.7	4.0	83.7	9.2	113.9	1.2	2.3	122.9	86.7	4.7	42.0	38.9	19.3	5.1	8.0	17.6	6.3	6.0	3.5	74.4	89.7	8.0	1.5	7.3	10.3	133.8	110.7	24.3	2.8	5.2	2.2	7.0	123.1	4.3	36.7	2.9	2.2	23.3	0.9	3.1	33.7	6.3	102.8	6.2	32.3	3.7	106.4	9.2	2.8	1.5	7.6	9.7	5.5	144.9	0.9	1.0	10.7	4.6	6.3	10.2	7.3	3.2	12.1	2.0	4.4	4.1	3.8	1.1	1.2	2.2	4.7	0.4	1.4	5.3	3.2	14.8	1.7	6.6	1.0	41.8	1.7	1.8	0.9	2.9	0.7	1.4	7.5	7.4	11.5	12.9	1.5	6.4	8.3	1.5	4.4	6.1	5.4	87.9	0.5	11.5	1.7	2.8	12.4	3.1	4.0	8.7	0.8	0.3	12.4	34.4	0.3	14.7	4.8	4.0	1.6	1.2	1.9	1.9	2.6	1.6	3.7	16.9	21.5	3.0	3.2	1.4	2.8	0.6	4.2	1.1	8.3	5.7	7.0	1.0	17.8	8.3	0.6	8.5	0.6	3.5	6.2	4.2	83.7	113.9	122.9	86.7	74.4	89.7	133.8	110.7	123.1	102.8	106.4	144.9	4.9	3.2	10.6	168.5	3.6	2.0	3.7	3.1	0.6	2.1	0.7	1.3	4.4	14.3	3.5	3.7	8.4	1.7	7.6	154.3	0.0	4.4	0.5	12.2	3.9	7.4	22.9	4.2	21.1	1.1	3.1	6.8	18.8	7.5	4.5	23.7	4.2	0.2	8.8	0.0	19.4	45.5	6.1	19.8	3.5	1.6	5.6	7.3	14.2	74.0	11.4	4.2	3.1	19.1	298.2	4.9	80.7	10.1	0.6	6.6	100.5	0.1	8.9	3.3	0.0	1.0	3.6	12.1	3.3	5.3	1.0	0.8	9.2	10.0	42.5	7.3
PCCB		ENSG00000114054	"Propionyl-CoA carboxylase subunit beta"	P05166	3	136250340-136337896	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 202.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 316.7;Late spermatids: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036939, HPA036940"	Enhanced				"Intracellular and membrane"	NA	NA		120000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA036939: AB_10671366, HPA036940: AB_10669779"	"unprognostic (2.74e-1)"	"unprognostic (7.88e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.47e-7)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.13e-1)"	34.4	75.1	23.3	15.2	33.6	37.9	27.5	31.4	29.3	17.5	35.5	43.6	38.1	13.8	13.9	26.3	19.2	17.0	94.6	23.6	28.5	88.9	202.1	14.8	16.2	31.1	29.4	12.1	32.0	57.0	15.6	19.6	30.4	23.7	41.9	17.2	23.6	21.7	83.8	15.1	27.5	22.6	27.1	12.7	26.1	38.8	29.8	21.1	37.9	91.4	20.7	20.5	11.4	47.8	64.8	45.8	42.4	64.4	30.2	34.5	75.4	33.0	35.5	49.1	69.6	67.9	44.7	80.3	89.4	46.6	44.0	35.1	50.3	44.0	69.4	47.8	43.0	140.8	49.5	101.4	66.4	107.3	60.2	40.8	41.4	31.0	69.4	30.5	56.1	131.6	104.5	41.0	38.0	123.1	109.3	63.1	36.0	96.8	40.9	29.3	34.6	116.6	89.9	69.4	84.0	62.9	84.4	48.9	77.5	35.2	98.3	62.9	42.0	24.5	26.0	69.2	29.6	78.3	70.0	66.9	34.9	41.7	29.9	7.3	29.5	7.5	22.6	30.8	25.4	21.7	14.7	23.2	44.6	19.8	15.1	18.7	2.7	25.9	28.7	38.5	14.8	22.6	23.3	33.6	31.4	29.3	23.6	28.5	31.1	29.4	30.4	27.1	29.8	47.8	5.6	9.6	14.0	16.0	9.2	4.1	9.4	37.9	3.4	16.0	12.5	5.3	51.1	8.6	28.4	20.2	10.4	57.1	8.0	15.1	39.2	24.6	316.7	14.1	9.5	8.1	9.1	53.2	16.5	14.0	27.1	13.6	14.8	14.1	29.2	18.1	9.3	76.3	35.1	11.8	22.7	15.1	24.4	11.7	5.2	159.0	13.7	11.4	19.6	16.9	16.5	11.8	10.3	22.1	50.9	14.4	16.7	10.9	22.6	10.4	19.2	97.3	23.6	13.2	13.1	13.6	13.1	11.3	29.0	16.2	3.3	50.9	9.9	52.8	25.1	12.2
PCSK6	"PACE4, SPC4"	ENSG00000140479	"Proprotein convertase subtilisin/kexin type 6"	P29122	15	101289784-101525202	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 153.6;liver: 160.0;lymphoid tissue: 81.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 231.6;Horizontal cells: 196.9;Oligodendrocytes: 561.9;Theca cells: 106.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 47.2;CACO-2: 35.7;HEK 293: 60.3;Hep G2: 53.8;OE19: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004774	Uncertain				"Secreted to extracellular matrix"	NA	NA		480000	"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA004774: AB_1079583"	"prognostic favorable (9.99e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.06e-7)"	"unprognostic (2.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-2)"	5.3	2.2	17.5	3.0	67.3	1.1	11.2	57.8	37.0	2.2	4.2	16.5	6.8	2.0	3.3	9.0	2.8	3.1	20.0	19.3	34.1	3.2	160.0	3.6	2.5	113.0	64.5	6.1	2.6	0.6	5.1	32.0	95.6	3.1	14.8	7.6	2.8	0.6	11.4	10.1	10.1	3.6	42.9	81.4	9.8	13.0	54.0	20.9	2.2	16.3	1.8	3.7	2.6	153.6	19.7	14.6	2.6	0.9	0.2	0.4	47.2	0.7	2.5	0.0	0.1	35.7	8.3	0.4	2.4	0.6	1.1	11.4	12.5	1.5	0.0	2.8	60.3	33.5	8.4	53.8	1.6	4.5	0.4	0.3	7.5	0.2	0.2	0.2	0.1	4.3	24.5	0.2	0.0	8.8	0.1	4.7	9.3	65.9	6.5	0.2	0.4	4.4	4.4	25.4	7.3	8.6	26.2	1.5	9.1	6.6	2.2	21.9	0.2	0.3	1.2	0.3	0.2	0.5	0.6	0.7	0.2	0.6	7.3	0.8	0.2	0.9	0.2	0.4	0.3	0.5	0.4	0.2	0.1	1.0	0.6	0.5	0.4	3.3	1.3	0.4	0.1	1.2	17.5	67.3	57.8	37.0	19.3	34.1	113.0	64.5	95.6	42.9	54.0	153.6	1.7	3.2	0.6	2.9	1.3	0.4	0.3	0.9	0.6	1.7	15.4	6.6	2.0	8.6	1.4	1.8	20.9	6.7	0.6	22.6	0.0	0.6	1.6	4.7	21.6	4.9	0.0	3.2	19.4	0.8	24.3	15.5	1.5	6.9	0.0	4.2	12.5	231.6	1.4	196.9	30.8	3.7	0.0	5.2	1.1	2.4	10.5	1.7	0.0	5.6	1.0	1.7	3.1	25.6	561.9	7.3	8.2	0.0	0.0	1.7	2.3	0.1	1.2	1.6	0.0	2.0	1.0	4.7	2.4	0.9	0.1	3.3	1.0	106.5	8.5	0.2
PDX1	"IDX-1, IPF1, MODY4, PDX-1, STF-1"	ENSG00000139515	"Pancreatic and duodenal homeobox 1"	P52945	13	27920000-27926313	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 41.8;pancreas: 13.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Ductal cells: 13.3;Enteroendocrine cells: 13.8;Exocrine glandular cells: 9.8;Gastric mucus-secreting cells: 4.6"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 8.4;pancreatic cancer: 8.6;stomach cancer: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;HEK 293: 2.3;HeLa: 5.9;OE19: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025873, HPA059146"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB025873: , HPA059146: AB_2683927"		"unprognostic (2.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.75e-3)"			"unprognostic (7.10e-3)"			"unprognostic (3.83e-2)"	"unprognostic (1.65e-1)"		"unprognostic (1.04e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	41.8	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	13.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	4.0	2.3	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	15.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.3	0.0	0.0	0.0	0.0	13.8	0.0	0.0	9.8	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0
PDZD11	PDZK11	ENSG00000120509	"PDZ domain containing 11"	Q5EBL8	X	70286595-70290514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003972	Approved				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA003972: AB_1855165"	"unprognostic (1.51e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.75e-1)"	"unprognostic (3.52e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.72e-3)"	27.6	35.6	67.6	19.5	67.6	11.0	33.4	67.9	85.9	30.5	67.9	39.5	33.4	26.1	43.2	41.3	31.1	27.8	51.2	66.6	71.9	44.2	35.4	21.4	27.7	68.3	70.1	26.4	22.8	53.2	29.4	22.3	73.1	31.1	44.7	51.8	30.4	32.6	24.1	32.8	31.7	35.2	67.4	23.0	27.9	10.9	70.7	36.2	37.8	40.8	35.8	37.5	28.8	70.5	75.5	83.7	56.1	63.0	90.6	107.3	47.8	79.4	88.0	115.4	107.0	80.6	92.9	40.2	95.7	140.4	130.0	55.7	92.4	107.2	130.4	56.5	75.6	26.4	79.2	62.1	80.9	36.4	34.8	110.8	73.4	128.0	78.6	108.7	95.0	49.7	42.5	140.9	187.8	113.0	58.9	49.2	44.4	167.6	148.1	41.4	113.3	79.6	99.7	67.4	60.5	61.0	87.7	67.3	86.1	66.5	62.2	31.8	75.5	82.9	70.5	128.2	79.0	30.8	58.8	42.1	120.0	52.1	99.0	17.9	25.6	18.2	40.1	47.6	44.9	37.1	41.3	45.5	38.5	37.0	25.2	36.5	10.6	36.5	62.1	28.9	77.4	34.8	67.6	67.6	67.9	85.9	66.6	71.9	68.3	70.1	73.1	67.4	70.7	70.5	26.6	12.8	11.8	4.6	12.3	24.6	28.8	76.2	22.8	26.0	30.4	42.7	45.0	24.3	36.6	33.1	4.2	42.0	16.7	39.0	117.4	46.1	0.6	25.1	32.4	25.4	18.5	20.2	3.2	41.1	61.0	35.0	16.8	25.7	26.6	29.8	20.0	20.5	62.6	32.0	3.6	48.2	48.8	27.5	18.8	1.0	30.4	22.1	30.2	4.7	27.9	71.3	16.5	3.5	2.5	55.9	52.3	38.0	23.2	18.6	66.7	92.0	27.7	21.7	39.5	19.9	40.4	7.7	19.8	44.9	28.1	26.8	22.1	52.5	43.9	33.8
PDZD3	"FLJ22756, IKEPP, PDZK2"	ENSG00000172367	"PDZ domain containing 3"	Q86UT5	11	119185457-119190223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 19.3;kidney: 17.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 93.4;Gastric mucus-secreting cells: 30.5;Paneth cells: 74.8;Proximal enterocytes: 79.1;Proximal tubular cells: 29.5;Undifferentiated cells: 21.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.3;renal cancer: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA077887	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA077887: "	"unprognostic (2.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.58e-3)"	"unprognostic (9.00e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.41e-3)"	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	17.1	0.0	0.0	0.0	1.0	2.8	0.1	0.0	0.0	17.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	19.3	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.3	8.6	0.0	0.0	6.2	0.0	0.0	93.4	3.9	0.1	0.0	0.2	0.1	0.2	1.2	0.0	0.0	0.2	0.0	0.4	30.5	0.1	0.0	0.1	1.1	0.1	0.2	0.0	0.0	8.5	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	74.8	0.0	0.2	0.1	79.1	29.5	0.7	0.7	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.1	21.0	0.1
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963865-42979181	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 76.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	11.6	20.5	24.9	9.2	25.2	9.5	12.1	23.9	27.7	19.1	25.5	16.3	9.3	15.5	7.7	16.4	22.7	9.6	18.7	25.1	25.5	16.5	27.7	10.0	14.5	27.2	25.5	26.1	76.2	15.2	24.3	9.6	24.2	21.6	7.8	9.9	14.8	11.4	23.4	14.0	16.3	9.6	23.9	17.5	16.3	16.2	25.1	14.7	19.8	15.0	10.4	17.3	15.7	25.2	35.0	16.4	8.1	30.6	29.6	28.3	8.4	6.0	9.4	4.8	10.0	10.5	10.1	14.1	8.2	14.3	20.5	32.2	28.7	31.1	5.0	27.6	15.2	4.7	24.4	6.2	20.0	4.8	9.4	35.5	35.5	19.9	5.5	39.1	24.7	18.9	25.2	14.1	10.7	3.9	12.7	15.8	10.0	78.8	14.3	26.8	14.3	5.8	12.3	10.0	25.4	11.1	5.6	21.9	32.7	13.1	43.2	21.2	14.0	15.2	2.9	7.5	14.0	21.0	19.8	19.7	5.2	24.6	12.4	1.3	1.3	2.1	1.2	1.1	2.1	1.0	1.8	2.5	1.9	1.9	2.2	2.1	0.8	2.0	0.7	1.0	0.9	1.1	24.9	25.2	23.9	27.7	25.1	25.5	27.2	25.5	24.2	23.9	25.1	25.2	5.6	6.4	2.6	19.9	5.6	5.0	10.2	6.2	10.8	15.2	11.8	12.7	4.1	10.0	5.6	7.3	2.1	11.4	5.4	10.2	13.7	2.8	2.5	17.6	10.6	5.8	5.4	1.7	24.6	1.5	6.7	9.2	11.2	9.1	0.0	19.8	8.6	14.1	5.8	21.9	22.4	8.5	6.1	9.7	3.2	3.6	14.6	5.4	8.8	9.4	4.5	11.8	9.2	13.0	16.6	1.9	10.4	9.4	3.1	6.3	15.1	13.9	14.3	7.0	0.0	13.0	6.6	7.3	2.6	6.3	5.5	7.4	7.8	26.1	10.5	6.6
PGAP3	"CAB2, MGC9753, PER1, PERLD1, PP1498"	ENSG00000161395	"Post-GPI attachment to proteins phospholipase 3"	Q96FM1	17	39671122-39696797	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"OE19: 800.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016591	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA016591: AB_1855203"	"unprognostic (1.29e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.57e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.94e-2)"	10.5	11.9	17.0	5.6	17.2	5.0	12.9	14.0	19.6	14.6	16.2	18.6	14.9	11.3	18.3	25.8	15.9	13.4	14.8	17.5	16.7	20.6	35.6	12.1	7.4	14.9	15.4	13.5	27.1	22.7	14.9	11.8	14.6	18.5	13.7	7.1	25.1	11.7	8.3	21.0	17.1	6.1	14.7	12.3	16.6	9.1	16.5	4.8	27.1	4.5	7.5	12.2	13.7	15.5	3.7	9.6	7.7	7.0	7.9	8.1	7.9	4.3	10.1	6.7	6.1	5.4	23.8	4.2	19.7	8.3	2.2	12.6	2.4	2.9	3.1	8.6	7.7	5.2	6.0	9.3	10.6	12.9	12.8	14.9	15.0	3.1	6.8	7.6	2.2	1.9	4.9	9.6	6.1	8.7	2.9	11.7	7.6	800.4	2.1	3.2	4.7	12.1	10.7	12.0	7.1	4.7	11.9	134.0	6.9	0.8	11.4	12.4	3.4	7.2	7.6	3.5	3.3	8.5	2.0	1.4	8.1	4.9	8.1	2.6	7.2	4.6	15.2	11.6	8.3	8.1	10.6	12.5	5.7	7.7	10.1	10.1	2.0	10.4	4.3	3.9	5.4	7.3	17.0	17.2	14.0	19.6	17.5	16.7	14.9	15.4	14.6	14.7	16.5	15.5	6.5	3.2	14.9	7.8	3.7	3.8	3.3	5.6	3.4	12.6	9.1	7.0	7.7	14.3	10.1	14.7	8.4	8.1	5.3	20.3	1.9	7.6	0.1	3.5	4.5	5.0	8.4	3.0	9.0	11.1	6.5	5.1	9.2	5.7	8.9	6.8	4.6	9.0	4.4	13.5	6.3	15.3	8.2	5.1	2.8	0.1	3.1	3.7	1.8	2.8	1.9	7.5	4.1	9.0	6.1	6.3	13.9	1.5	2.8	3.7	22.9	3.4	4.9	22.1	0.0	5.0	3.3	0.7	2.4	8.1	2.8	10.4	4.9	5.8	13.3	3.1
PGAP4	"C9orf125, MGC12992, TMEM246"	ENSG00000165152	"Post-GPI attachment to proteins GalNAc transferase 4"	Q9BRR3	9	101473170-101533537	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	16	"Cardiomyocytes: 52.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 25.5;hTERT-RPE1: 28.8;OE19: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011318, HPA054041"	Uncertain		Approved	Mitochondria		NA	Yes				"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA011318: AB_2668482, HPA054041: AB_2682353"	"unprognostic (2.58e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.52e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (1.55e-8)"	"unprognostic (1.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.16e-2)"	3.9	10.3	21.5	2.2	21.3	0.5	2.4	18.9	26.2	16.6	4.5	13.4	8.4	7.1	3.7	14.4	13.7	6.8	30.4	24.9	26.1	4.7	2.4	5.4	0.4	17.9	13.4	19.5	11.1	16.6	12.3	0.6	26.1	6.9	11.2	9.9	6.1	9.4	4.8	12.0	7.6	6.7	9.6	1.6	16.0	2.8	19.2	0.9	4.2	6.1	2.4	6.4	11.9	20.3	0.0	14.6	11.3	0.0	0.3	0.2	0.0	9.8	14.1	7.0	13.8	0.7	7.8	0.0	3.2	17.9	0.8	23.1	0.0	16.1	4.2	0.0	5.8	8.1	10.3	0.0	0.5	0.0	0.0	6.2	25.5	0.0	3.8	28.8	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.0	14.0	48.1	0.0	0.0	5.7	0.0	10.5	2.7	18.9	17.8	5.5	0.0	0.0	2.7	0.0	13.8	0.0	10.7	6.6	0.0	0.0	1.0	0.0	0.0	15.2	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	21.3	18.9	26.2	24.9	26.1	17.9	13.4	26.1	9.6	19.2	20.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHF5A	"bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7"	ENSG00000100410	"PHD finger protein 5A"	Q7RTV0	22	41459717-41468692	"Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028885	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028885: AB_10602079"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.91e-2)"	26.0	21.1	26.5	23.0	29.7	58.2	27.7	30.0	30.6	23.3	28.9	25.1	22.7	22.9	26.0	29.0	22.8	19.6	20.9	26.7	28.5	25.5	30.9	20.1	35.5	28.9	28.5	20.7	26.2	25.1	21.5	25.6	29.7	19.7	28.8	24.5	21.0	19.1	35.8	27.7	22.4	22.6	28.8	26.4	26.0	18.8	28.2	52.2	19.7	29.0	41.9	30.6	23.7	33.9	80.5	56.8	95.0	62.8	68.7	51.7	65.9	80.1	65.5	102.9	86.4	78.4	46.5	115.4	45.7	60.1	72.1	60.7	130.2	95.3	115.6	71.7	136.5	71.8	86.9	92.2	71.9	190.3	54.9	50.4	72.9	81.3	100.5	41.7	73.8	80.6	97.5	71.8	74.9	107.5	154.8	124.3	96.1	220.8	82.2	115.4	84.9	81.5	68.6	63.1	46.6	38.9	87.9	57.4	90.0	66.6	45.9	96.8	50.7	54.0	95.6	44.1	97.9	58.9	112.3	194.9	52.2	82.6	59.0	32.8	47.0	57.9	36.0	45.2	47.2	47.6	41.1	45.6	49.2	42.6	40.2	39.5	55.6	47.6	44.1	41.7	47.8	59.3	26.5	29.7	30.0	30.6	26.7	28.5	28.9	28.5	29.7	28.8	28.2	33.9	36.4	22.4	13.9	2.3	52.3	77.2	78.1	81.1	58.1	24.6	35.1	35.4	10.6	41.5	33.5	11.0	4.2	93.0	42.3	27.2	46.9	58.5	14.7	26.6	20.7	43.7	15.0	56.1	3.5	56.2	115.0	36.2	20.4	25.5	33.7	20.9	37.5	24.7	58.7	13.5	3.7	32.1	63.1	38.8	55.9	9.1	42.3	37.3	33.8	2.8	67.5	47.3	59.8	5.5	8.2	64.5	32.5	41.8	41.6	84.4	41.1	42.1	24.3	28.2	98.6	32.3	38.6	63.5	88.1	59.0	91.6	109.2	42.3	20.2	41.9	95.7
PHGR1		ENSG00000233041	"Proline, histidine and glycine rich 1"	C9JFL3	15	40351033-40356434	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 2541.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 19911.4;Intestinal goblet cells: 8220.0;Paneth cells: 9497.7;Proximal enterocytes: 51149.4"	"Group enriched"	"Detected in many"	16	"colorectal cancer: 248.3;stomach cancer: 94.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"OE19: 833.5"									HPA068787	Enhanced		Approved	Vesicles		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA068787: AB_2686035"	"prognostic favorable (2.05e-4)"		"unprognostic (1.73e-1)"				"unprognostic (5.18e-2)"				"unprognostic (1.18e-1)"	"unprognostic (2.80e-1)"		"unprognostic (1.20e-1)"			"unprognostic (1.27e-2)"	3.7	0.4	0.1	88.8	0.2	0.2	11.1	0.3	0.1	0.8	0.0	2541.0	881.0	1.2	0.0	2.0	3.5	0.3	0.3	0.1	0.1	1.9	1.0	0.2	1.2	0.1	0.1	0.5	1.9	0.0	0.5	0.0	0.1	2.5	370.7	0.0	0.3	3.0	0.4	3.7	2320.2	17.3	0.1	0.4	177.1	0.3	0.1	0.0	0.4	0.0	0.0	5.6	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.0	0.1	833.5	0.3	0.1	0.0	10.8	0.0	1.5	61.5	7.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	46.0	0.0	0.2	0.3	0.0	0.0	40.2	38.0	0.0	117.2	0.0	0.0	0.0	0.0	0.1	19911.4	0.0	2.5	0.1	0.0	0.0	0.2	1938.2	0.0	0.0	0.2	0.0	0.5	884.8	0.1	213.9	0.0	0.0	0.6	0.0	0.0	0.0	8220.0	20.3	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	9497.7	0.0	2.1	1.1	51149.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	32.6	0.0	4881.6	1.0
PIAS3	"FLJ14651, ZMIZ5"	ENSG00000131788	"Protein inhibitor of activated STAT 3"	Q9Y6X2	1	145848522-145859836	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006389, HPA067383"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA006389: AB_2667576, HPA067383: AB_2685828"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.06e-1)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (5.14e-2)"	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-2)"	21.9	11.5	11.3	12.8	10.8	4.9	23.3	10.2	12.2	35.2	13.5	24.5	7.6	32.0	7.9	37.3	37.2	12.1	18.1	10.9	12.8	13.7	7.2	17.9	9.1	11.7	12.2	23.4	13.1	14.4	15.4	10.7	11.7	21.6	8.0	9.8	29.2	21.1	25.8	34.4	14.6	23.6	11.3	13.3	21.7	11.1	13.9	13.5	14.9	14.5	17.9	29.1	34.9	10.7	34.6	23.5	23.8	21.1	35.9	67.3	14.5	31.8	43.6	35.5	39.3	19.3	22.2	17.8	33.6	54.8	15.0	35.0	12.4	50.4	29.9	19.4	18.3	8.2	15.9	10.4	35.8	14.7	38.8	55.2	32.3	32.9	18.6	45.6	52.0	15.8	13.2	24.0	74.7	57.6	15.8	7.8	37.0	97.3	37.7	24.6	16.2	11.7	28.2	20.5	8.1	37.9	30.7	16.9	15.5	27.0	78.0	22.1	80.7	47.2	34.8	31.7	20.9	32.6	15.7	11.5	45.8	10.9	23.9	8.9	9.1	10.7	10.6	8.7	11.4	5.4	6.7	11.6	6.8	3.6	6.2	6.0	2.2	15.2	12.5	8.4	8.1	7.0	11.3	10.8	10.2	12.2	10.9	12.8	11.7	12.2	11.7	11.3	13.9	10.7	14.7	22.4	11.5	8.5	8.6	10.7	7.9	15.4	19.4	10.2	16.2	16.5	0.9	4.3	22.8	16.5	12.5	3.7	10.0	2.1	1.9	7.9	2.3	29.4	14.8	12.3	4.2	2.1	4.2	7.7	7.3	11.9	13.3	19.1	10.8	4.9	13.2	3.8	5.2	10.1	3.9	6.2	12.2	4.4	7.0	3.9	14.3	4.1	5.4	7.5	13.1	4.2	8.2	6.6	7.4	12.7	2.0	13.2	4.8	9.2	2.1	1.8	37.6	11.8	26.3	7.0	13.6	4.0	11.4	19.9	16.3	4.0	8.6	6.0	2.8	10.4
PIGC		ENSG00000135845	"Phosphatidylinositol glycan anchor biosynthesis class C"	Q92535	1	172370189-172444086	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036663	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA036663: AB_10669912"	"unprognostic (3.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.72e-3)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (7.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.43e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-1)"	18.2	20.8	12.8	13.0	13.2	27.2	21.8	13.8	16.2	21.4	13.8	20.7	15.4	24.3	38.9	16.6	23.5	18.1	14.9	13.3	14.4	20.0	16.0	15.0	19.7	14.1	13.8	22.4	25.9	19.6	18.1	20.2	14.4	16.4	19.3	17.7	20.7	17.5	13.6	40.7	21.6	18.9	13.6	20.3	19.6	18.3	13.7	27.6	15.3	11.1	20.9	18.8	18.8	14.5	33.3	28.1	37.2	25.5	27.8	25.0	27.8	21.1	23.5	35.6	30.9	25.6	47.6	17.7	30.4	25.4	28.3	35.0	24.6	30.8	28.6	39.5	28.4	21.8	25.5	31.9	30.6	44.9	27.4	37.4	36.0	25.6	27.9	27.7	23.0	33.5	33.5	32.9	29.2	17.3	34.4	40.1	38.5	67.4	38.7	27.9	30.3	31.9	55.5	24.1	19.5	37.1	30.5	35.6	50.3	52.4	31.9	31.6	21.0	22.6	37.8	28.0	22.8	21.8	33.1	27.6	16.2	29.0	43.9	71.5	28.1	55.6	35.4	26.9	29.8	37.2	40.6	37.4	24.3	33.8	60.1	43.4	18.2	51.6	29.5	24.1	40.0	40.9	12.8	13.2	13.8	16.2	13.3	14.4	14.1	13.8	14.4	13.6	13.7	14.5	19.4	9.6	10.3	0.0	24.2	13.5	19.7	31.2	18.2	15.7	20.9	29.5	20.7	17.2	17.7	29.5	8.4	61.6	23.9	20.6	33.2	31.9	78.2	15.2	19.3	20.0	7.8	58.9	0.0	41.1	50.9	31.0	15.8	18.6	7.6	21.6	22.9	15.4	35.3	20.2	0.0	19.6	32.6	23.7	16.9	80.8	47.2	20.0	26.6	0.0	27.6	30.1	42.2	0.0	0.0	34.8	27.6	40.6	12.4	14.2	25.2	20.9	20.1	17.9	32.9	22.2	18.7	30.0	18.8	17.7	19.0	23.7	29.1	21.5	18.9	15.5
PIP5K1B	"MSS4, STM7"	ENSG00000107242	"Phosphatidylinositol-4-phosphate 5-kinase type 1 beta"	O14986	9	68705240-69009176	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 97.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 127.4;Early spermatids: 100.0;Inhibitory neurons: 270.1;Muller glia cells: 120.2"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 10.1;pancreatic cancer: 3.4;stomach cancer: 9.4;testis cancer: 3.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"eosinophil: 34.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 34.5"	"Cell line enhanced"	"Detected in some"		"AF22: 43.8;HEL: 17.0;Hep G2: 13.4;OE19: 73.1;U-266/70: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009687	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Vesicles	"HPA009687: AB_1855391"	"unprognostic (2.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.03e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	4.2	11.9	5.6	6.0	5.3	16.1	4.9	18.4	8.1	6.3	97.3	31.2	34.8	7.5	1.7	1.2	6.0	4.0	32.2	12.3	10.7	7.8	0.3	12.9	2.6	7.9	11.2	1.0	8.6	13.7	6.6	6.5	6.3	3.1	29.1	38.0	16.4	9.6	2.9	2.3	30.8	2.9	4.0	2.6	26.1	24.7	11.4	1.0	1.2	5.1	3.6	3.3	2.5	3.7	0.0	0.0	43.8	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	4.6	0.0	3.6	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.8	17.0	0.3	13.4	0.0	0.9	4.4	0.0	2.0	0.0	0.0	0.0	0.1	0.5	0.9	9.3	0.3	1.1	0.1	0.2	2.3	73.1	1.4	1.4	0.1	0.3	0.3	3.4	0.9	0.1	0.0	0.1	0.5	1.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	17.0	3.5	2.3	0.0	3.1	0.0	5.6	0.5	34.5	0.0	0.0	0.0	4.7	0.3	0.1	0.1	5.4	0.7	0.1	1.7	0.0	0.2	1.4	1.6	0.3	5.6	5.3	18.4	8.1	12.3	10.7	7.9	11.2	6.3	4.0	11.4	3.7	3.6	35.3	34.4	28.7	19.2	0.6	3.2	0.5	0.6	5.1	4.7	3.3	61.6	2.8	2.8	5.5	2.1	21.3	0.0	127.4	27.4	1.6	100.0	12.8	13.6	3.3	37.0	53.6	84.7	14.0	1.3	3.1	40.2	27.5	5.7	3.8	1.4	0.0	3.9	0.0	270.1	32.6	14.2	1.0	1.3	47.6	2.5	5.6	5.4	60.0	2.6	120.2	0.0	80.9	6.4	5.2	46.6	1.5	43.2	2.5	39.2	1.4	6.5	3.3	26.3	2.5	32.2	39.0	4.5	0.7	0.3	8.8	2.1	0.9	29.7	9.8
PIWIL1	"CT80.1, HIWI, PIWI"	ENSG00000125207	"Piwi like RNA-mediated gene silencing 1"	Q96J94	12	130337887-130372637	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, Endonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"testis: 42.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 123.0;Early spermatids: 48.6;Rod photoreceptor cells: 177.9;Spermatocytes: 125.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 6.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;OE19: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066880	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA066880: "	"unprognostic (1.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.22e-1)"		"unprognostic (1.48e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.36e-2)"	"unprognostic (9.85e-6)"	"unprognostic (3.83e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	42.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.0	1.3	0.3	0.7	0.0	8.1	0.7	0.1	1.0	1.5	0.1	1.8	123.0	0.5	0.1	0.7	0.0	0.3	48.6	0.4	0.3	1.4	1.2	0.0	4.4	0.0	0.3	0.6	0.0	0.6	0.0	0.1	1.1	0.0	0.4	1.7	5.8	0.6	0.0	1.9	3.1	30.6	2.8	0.5	0.0	0.0	0.8	12.2	4.1	1.0	0.4	0.6	0.3	2.2	0.1	0.4	0.4	0.9	0.1	177.9	0.0	0.0	0.2	125.6	5.3	0.0	1.3	1.0	0.6	0.5	0.5	0.2
PLA2G2A	"PLA2B, PLA2L"	ENSG00000188257	"Phospholipase A2 group IIA"	P14555	1	19975431-19980416	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	"Antimicrobial, Bacteriolytic enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 1302.4;intestine: 1973.9;placenta: 756.7;urinary bladder: 813.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 536.5;Exocrine glandular cells: 1031.5;Fibroblasts: 656.0;Intestinal goblet cells: 393.6;Paneth cells: 574.1;Prostatic glandular cells: 921.1;Undifferentiated cells: 861.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 875.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 645.0;OE19: 2384.4"					"Not detected"	"Not detected"			HPA015236	Enhanced				"Secreted to blood"	NA	NA	1000000	680000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"			"HPA015236: AB_10601047"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.77e-15)"	"unprognostic (2.72e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	1302.4	7.0	0.1	280.2	0.1	0.0	27.4	0.1	0.7	5.4	2.9	1474.0	786.8	4.3	3.3	29.3	14.8	57.7	137.4	0.0	0.2	6.6	238.6	16.8	5.4	0.6	0.7	44.1	7.8	0.9	2.5	756.7	0.2	203.9	1668.0	0.1	24.6	6.1	6.0	18.1	1973.9	164.4	0.1	0.4	11.6	36.8	1.3	1.7	11.1	114.2	15.0	813.6	12.1	0.1	0.0	0.0	1.6	0.0	248.3	0.0	8.5	0.0	0.1	0.1	0.0	11.2	0.0	0.0	1.1	0.0	0.8	18.7	0.0	0.0	0.0	0.1	0.3	0.0	0.3	645.0	0.0	0.1	1.1	2.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.4	2384.4	0.0	0.0	0.0	7.6	0.0	198.2	1.0	4.7	0.0	20.1	0.0	31.1	0.1	0.0	0.0	0.0	0.0	44.7	0.2	0.4	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.7	0.0	0.2	0.6	0.7	0.2	0.1	1.3	0.1	20.6	6.4	6.7	0.0	9.1	13.9	10.8	0.2	0.6	0.9	1.0	0.8	14.9	12.8	9.3	0.0	0.0	3.6	0.4	536.5	1.9	0.7	4.0	0.7	43.1	6.9	62.3	13.5	0.0	1031.5	4.6	656.0	6.1	0.6	4.5	0.0	30.0	310.9	9.5	0.0	0.0	393.6	2.0	18.8	31.1	11.6	171.2	3.5	14.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	574.1	1.2	2.6	921.1	328.2	0.2	1.9	0.0	0.0	2.4	37.8	0.9	1.5	4.9	16.8	6.8	6.2	0.1	861.9	32.2
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828949-186988981	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 87.2;seminal vesicle: 48.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 33.4;Glandular and luminal cells: 28.1;Microglial cells: 115.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 6.8;eosinophil: 7.8;intermediate monocyte: 8.4;myeloid DC: 7.7;non-classical monocyte: 4.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.7;granulocytes: 7.8;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 52.4;OE19: 84.4;RPMI-8226: 73.4;U-2197: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	9.9	12.7	2.4	6.3	3.4	4.8	6.5	2.8	3.7	14.5	3.2	11.9	11.1	10.2	11.7	7.5	24.9	6.2	6.3	2.4	3.3	10.8	2.1	5.9	5.3	4.4	3.5	6.4	7.6	87.2	2.0	5.8	4.0	8.8	8.1	0.8	6.3	48.3	0.5	9.5	8.2	10.5	4.1	6.6	5.3	2.8	3.1	1.5	2.6	2.1	2.9	29.1	8.4	3.9	0.0	39.7	0.2	0.0	23.8	9.5	0.0	1.5	15.1	1.8	3.2	0.3	15.5	0.0	0.0	0.0	6.8	2.8	24.6	7.4	0.8	12.5	0.6	7.6	52.4	0.0	14.7	11.1	3.8	5.4	5.0	19.5	4.0	2.4	16.5	3.4	16.7	5.9	0.0	0.0	0.0	0.0	2.1	84.4	5.1	0.0	0.0	73.4	0.1	5.4	0.2	0.0	5.9	2.0	7.3	0.7	0.8	15.0	3.3	14.3	1.9	66.3	3.2	2.3	0.0	0.0	5.3	32.4	20.7	0.2	6.8	7.8	0.0	8.4	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.6	1.1	4.0	3.1	0.0	1.7	2.4	3.4	2.8	3.7	2.4	3.3	4.4	3.5	4.0	4.1	3.1	3.9	0.6	0.0	1.1	0.3	0.2	21.4	4.3	4.6	10.2	0.2	2.9	2.9	2.3	0.0	4.9	0.0	0.0	0.1	3.2	1.6	1.9	2.1	0.9	33.4	1.7	6.6	1.2	3.0	8.1	0.0	0.1	11.2	7.1	28.1	10.8	3.3	1.1	0.2	6.6	0.0	5.8	2.6	2.0	7.9	8.3	1.3	10.5	11.5	5.4	115.2	3.7	0.0	1.0	2.0	0.4	1.7	7.3	14.7	0.0	2.3	2.0	0.3	2.3	0.5	0.0	1.2	5.0	0.6	0.3	5.2	8.9	0.0	1.0	1.2	4.8	13.4
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 78.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 74.5;Distal enterocytes: 21.7;Gastric mucus-secreting cells: 18.3;Glandular and luminal cells: 17.1;Suprabasal keratinocytes: 13.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 11.1;RT4: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles	Nucleoplasm	"HPA042713: AB_10793982, HPA056752: AB_2683226"	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.0	0.0	0.1	0.4	0.3	0.3	2.4	0.1	0.1	5.7	0.0	6.4	6.7	0.0	1.6	5.7	0.1	0.1	0.3	0.1	0.0	7.8	0.2	12.2	0.1	0.0	0.0	0.0	0.1	2.9	1.7	0.1	0.0	4.3	3.8	0.2	2.6	0.4	2.9	78.1	4.2	0.1	0.0	0.1	2.4	0.1	0.0	4.4	1.9	0.5	0.3	1.2	11.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.1	0.1	0.0	0.0	0.0	0.0	8.3	0.4	0.0	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	74.5	0.0	0.0	5.5	2.7	1.3	0.6	0.0	1.2	0.3	2.9	0.0	0.5	5.5	0.0	1.7	0.0	21.7	3.9	0.4	0.0	7.3	1.0	0.1	0.0	0.0	0.0	1.3	0.7	0.1	18.3	17.1	2.5	0.0	0.0	0.0	0.1	0.0	0.0	7.7	4.1	0.0	0.3	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	0.0	0.3	3.1	10.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	5.6	13.8	1.2	0.6	0.0	6.7	2.0
PLB1	"FLJ30866, PLB"	ENSG00000163803	"Phospholipase B1"	Q6P1J6	2	28457145-28644142	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 39.0"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 112.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"classical monocyte: 3.0;eosinophil: 3.0;intermediate monocyte: 4.4;myeloid DC: 5.7;neutrophil: 8.8;non-classical monocyte: 5.0"	"Group enriched"	"Detected in many"	40	"dendritic cells: 5.7;granulocytes: 8.8;monocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;OE19: 7.8;RT4: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (2.18e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.91e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.61e-9)"	"unprognostic (2.48e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.99e-2)"	"unprognostic (8.03e-2)"	1.8	5.7	3.4	1.8	3.3	5.0	1.8	1.0	3.0	1.9	2.2	1.5	0.7	1.6	1.7	1.0	1.3	1.5	1.2	2.7	2.6	0.7	0.5	1.6	0.4	2.4	2.3	0.9	0.6	0.3	1.6	2.1	2.0	2.1	1.8	0.1	1.4	1.5	2.0	7.9	39.0	2.7	2.5	4.1	0.9	2.6	2.9	0.6	2.0	0.6	0.3	1.7	1.3	1.6	0.4	0.0	2.4	0.0	0.5	0.3	3.6	0.1	1.0	0.2	0.2	2.5	0.2	0.2	0.2	0.4	1.0	0.5	0.0	1.9	0.2	0.1	0.0	0.2	0.4	0.4	0.8	0.4	0.1	0.4	1.1	0.4	0.5	0.4	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	7.8	0.5	0.0	0.4	0.0	1.1	2.7	1.0	0.2	0.1	0.1	0.2	0.2	0.0	1.3	0.2	0.2	0.7	0.1	0.1	0.5	0.1	0.0	0.8	1.8	0.0	0.0	3.0	3.0	0.0	4.4	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	8.8	0.0	5.0	0.3	0.1	1.1	3.4	3.3	1.0	3.0	2.7	2.6	2.4	2.3	2.0	2.5	2.9	1.6	0.6	0.0	0.6	0.7	0.3	0.4	1.0	0.6	0.6	0.1	1.6	1.5	1.6	0.0	1.5	0.0	0.0	0.5	2.1	6.5	1.9	1.6	27.0	2.4	1.0	1.5	1.2	0.0	3.2	0.9	23.2	0.6	0.0	1.1	5.7	0.1	1.1	0.0	12.5	0.0	3.4	5.4	0.0	17.4	10.1	18.3	1.2	12.5	0.0	15.0	4.8	0.3	0.0	1.5	0.4	1.0	2.6	0.7	0.5	0.4	112.6	0.0	1.5	0.0	0.0	1.1	0.3	1.0	0.9	0.3	0.4	8.2	1.5	0.6	2.5	1.6
PLCD3		ENSG00000161714	"Phospholipase C delta 3"	Q8N3E9	17	45108959-45133354	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 195.8;Paneth cells: 104.7;Urothelial cells: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025711, HPA053665"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA025711: AB_1855320, HPA053665: AB_2732580"	"unprognostic (3.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.96e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (3.34e-3)"	13.5	34.3	42.2	5.1	49.7	2.0	11.7	50.5	36.0	12.4	27.9	34.2	2.5	13.2	1.5	14.7	10.1	6.4	34.1	33.8	42.5	9.6	1.4	7.7	1.0	69.8	50.5	18.9	2.7	1.3	7.6	5.8	46.4	13.0	15.3	14.4	10.8	5.4	85.7	20.6	6.5	5.1	62.8	2.0	21.0	10.8	59.4	0.9	5.3	56.5	1.5	30.4	11.9	54.0	23.1	56.2	4.1	8.1	5.9	12.8	28.0	12.3	27.3	11.2	10.5	13.7	40.9	0.8	43.5	29.0	9.2	51.9	6.3	53.1	4.4	11.6	21.0	0.9	62.6	18.1	30.3	1.3	3.2	13.7	21.0	10.4	13.7	28.5	7.0	2.5	5.0	1.7	12.1	36.2	3.7	5.4	4.9	109.9	55.0	8.1	9.2	1.5	35.8	45.1	1.1	7.2	13.3	22.1	12.5	8.5	47.0	2.5	14.3	6.9	37.9	9.3	14.8	2.1	2.6	1.8	11.4	1.5	5.7	0.7	0.3	0.5	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.2	0.0	0.1	0.1	0.1	42.2	49.7	50.5	36.0	33.8	42.5	69.8	50.5	46.4	62.8	59.4	54.0	8.7	12.8	1.3	22.9	1.0	7.6	16.3	12.2	21.1	29.8	6.8	9.3	26.9	14.3	4.9	7.3	25.0	3.9	0.9	195.8	1.9	6.7	15.8	3.3	12.7	9.0	4.9	0.0	1.3	3.5	13.1	10.6	29.6	9.6	1.3	6.5	10.4	0.7	1.6	6.7	3.7	15.1	4.1	1.4	1.9	5.5	19.9	1.6	3.6	1.0	1.2	8.9	0.0	0.0	0.1	30.0	104.7	33.1	1.1	28.7	4.2	2.0	2.7	40.0	6.6	16.8	4.9	2.3	7.6	3.8	5.7	7.3	1.1	7.0	46.2	88.6
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	93993931-94332823	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;Astrocytes: 69.5;Distal enterocytes: 79.6;Inhibitory neurons: 83.9;Muller glia cells: 82.7;Oligodendrocyte precursor cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.8	2.6	4.5	2.8	4.1	0.2	2.7	3.1	5.6	8.0	7.0	12.6	4.0	9.0	5.3	1.7	4.4	2.5	12.4	3.9	4.7	8.4	0.7	7.3	0.7	3.9	4.8	3.9	14.7	0.8	4.4	2.9	4.0	3.8	7.5	7.3	2.3	5.4	4.1	1.1	5.2	4.2	3.2	6.2	8.3	2.0	5.4	0.5	9.8	6.3	0.6	5.6	5.6	4.2	4.0	6.7	1.8	1.1	0.7	3.2	1.9	2.8	0.6	0.3	0.4	5.3	1.3	0.8	1.3	2.3	1.3	2.6	2.2	0.4	0.6	0.4	2.3	0.5	4.0	0.5	0.0	0.9	0.3	1.8	0.0	1.1	0.0	6.8	0.0	0.4	0.5	0.3	4.2	0.3	0.8	0.9	0.7	7.9	5.0	0.1	3.9	0.2	0.2	10.3	0.9	1.5	3.3	3.6	0.7	4.1	3.5	0.6	0.6	3.0	5.9	2.0	4.4	0.6	0.3	0.4	3.5	1.1	2.2	0.1	0.1	0.0	0.3	0.2	0.2	0.5	0.3	0.2	0.1	0.7	0.5	0.4	0.1	0.2	0.2	0.2	0.1	0.1	4.5	4.1	3.1	5.6	3.9	4.7	3.9	4.8	4.0	3.2	5.4	4.2	8.2	70.5	5.4	69.5	7.0	8.2	9.7	6.8	2.2	12.2	3.6	3.6	34.7	4.3	12.3	0.0	0.0	3.7	2.9	79.6	1.9	1.1	20.7	26.7	18.4	9.7	1.8	0.0	3.1	6.4	2.5	15.3	29.6	10.6	0.0	7.2	4.2	1.6	0.7	6.7	83.9	9.7	4.1	2.4	5.2	5.3	12.2	1.3	7.2	5.6	1.2	82.7	4.1	123.1	2.4	4.2	54.8	23.3	0.9	7.5	11.0	2.5	10.6	18.7	6.6	30.8	37.7	3.7	8.0	1.7	7.4	1.9	4.3	3.7	41.1	10.5
PLEKHM1	KIAA0356	ENSG00000225190	"Pleckstrin homology and RUN domain containing M1"	Q9Y4G2	17	45435900-45490749	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.5"	"Cell line enhanced"	"Detected in many"		"OE19: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025018, HPA039473"	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles	Nucleoli	"HPA025018: AB_1855465, HPA039473: AB_2676526"	"unprognostic (1.52e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.28e-6)"	"unprognostic (8.71e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	7.0	6.4	2.9	5.5	2.9	9.7	6.2	3.5	3.8	12.9	3.2	6.5	3.5	5.7	1.0	31.7	5.9	5.3	6.2	2.8	3.1	3.6	3.6	8.8	4.8	3.7	3.1	4.9	6.1	4.4	5.7	2.9	3.2	5.1	3.6	1.6	14.4	0.9	12.3	11.8	6.2	2.0	2.8	6.8	5.6	3.4	3.4	5.4	6.5	7.2	4.8	6.8	13.6	3.7	7.3	11.0	1.7	5.4	8.4	4.8	0.1	3.3	4.9	1.9	2.6	4.2	6.0	5.2	3.4	3.9	14.1	1.7	4.1	1.9	1.6	13.7	3.5	0.0	5.6	6.9	2.0	0.0	4.3	2.2	4.9	0.9	8.0	3.8	10.0	0.0	5.2	6.2	9.1	6.0	5.2	1.1	1.7	26.6	9.0	2.8	5.6	5.3	6.0	16.8	3.2	2.1	3.2	4.5	5.2	4.8	10.1	5.3	19.1	12.7	3.6	5.2	5.9	0.6	6.2	1.8	7.7	2.8	5.8	2.8	1.2	1.0	0.2	0.3	0.0	1.2	0.6	0.2	0.3	0.3	0.2	0.0	6.5	0.7	0.4	0.2	0.5	0.2	2.9	2.9	3.5	3.8	2.8	3.1	3.7	3.1	3.2	2.8	3.4	3.7	12.6	12.8	18.1	7.8	17.5	18.0	18.1	10.3	6.8	10.4	11.7	8.4	8.7	15.7	12.7	12.9	16.7	4.8	24.3	25.6	5.9	8.1	4.3	24.9	11.1	12.1	13.8	10.8	13.5	8.2	4.7	12.1	19.9	27.9	1.3	5.4	12.8	8.1	9.1	16.8	13.3	13.0	4.1	27.9	15.2	2.0	7.2	21.1	7.2	9.4	13.7	7.3	14.4	7.5	20.8	18.3	17.7	7.9	22.9	27.2	8.6	10.5	11.9	8.2	0.0	17.7	7.6	7.6	3.7	10.0	16.3	8.6	18.5	9.3	12.2	43.1
PLEKHS1	"bA211N11.2, C10orf81, FLJ23537"	ENSG00000148735	"Pleckstrin homology domain containing S1"	Q5SXH7	10	113751262-113783429	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 30.5;cervix: 63.6;intestine: 43.9;pancreas: 36.9;salivary gland: 57.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 35.1;Club cells: 70.7;Endometrial ciliated cells: 33.8;Exocrine glandular cells: 31.1;Ionocytes: 38.7;Proximal enterocytes: 42.1;Respiratory ciliated cells: 157.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.1;OE19: 53.5;RT4: 22.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037583			Approved	Vesicles,Centrosome		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Centrosome	Vesicles	"HPA037583: AB_10671762"	"unprognostic (2.64e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.36e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.00e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (1.03e-4)"	0.3	0.1	0.0	7.3	0.0	0.3	30.5	0.0	0.3	63.6	0.0	3.6	43.9	1.8	3.9	1.0	9.4	2.7	0.4	0.0	0.0	0.9	0.1	6.7	0.2	0.2	0.0	0.1	36.9	0.1	0.2	0.1	0.0	6.0	4.7	0.4	57.0	3.3	0.0	0.8	38.7	0.5	0.0	0.2	8.8	0.9	0.0	0.1	0.1	0.0	2.8	1.5	0.0	0.1	0.2	1.4	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.1	0.7	0.2	10.1	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.0	53.5	0.0	0.2	6.4	0.3	1.7	22.3	0.1	0.2	0.1	1.4	0.0	0.0	6.3	0.0	0.0	0.2	0.2	0.2	0.5	4.7	0.2	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	3.2	3.2	0.3	0.0	0.1	0.3	35.1	0.0	0.0	16.6	8.3	0.4	0.0	70.7	0.0	0.0	0.0	0.1	6.7	0.0	4.9	13.2	33.8	0.3	0.5	0.0	0.0	0.2	31.1	0.0	0.6	3.1	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	5.6	38.7	0.0	0.0	5.3	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.2	2.8	0.4	0.0	1.4	42.1	0.3	157.3	0.0	0.0	0.3	3.7	0.2	0.1	0.6	0.0	0.0	0.3	0.0	12.1	0.5
PLPP2	"LPP2, PAP-2c, PPAP2C"	ENSG00000141934	"Phospholipid phosphatase 2"	O43688	19	281040-291403	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 204.5;Ductal cells: 352.1;Proximal enterocytes: 209.8;Rod photoreceptor cells: 234.9;Urothelial cells: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.2;MAIT T-cell: 6.6"	"Lineage enriched"	"Detected in single"	41	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"A549: 144.1;CAPAN-2: 154.6;OE19: 255.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055540, HPA058428"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA055540: AB_2682839, HPA058428: "	"prognostic unfavorable (4.55e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.21e-8)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-3)"	4.8	13.2	37.7	8.5	61.6	0.0	36.9	57.1	50.0	63.4	26.2	40.5	62.7	16.8	8.4	27.2	81.8	52.4	1.7	38.8	43.5	11.5	3.7	8.3	1.4	57.3	53.6	2.7	37.3	19.5	11.8	3.6	56.2	31.7	32.1	29.6	105.7	32.9	0.6	53.2	51.0	6.4	44.8	4.7	50.3	7.6	49.2	5.2	5.7	0.5	6.0	36.5	14.2	83.9	85.5	144.1	2.1	0.1	0.0	0.3	0.2	8.2	0.0	25.3	18.9	41.7	154.6	0.0	88.3	11.9	0.1	45.3	0.0	17.6	11.1	0.8	2.6	0.0	55.9	0.0	28.6	0.0	5.5	5.2	7.6	12.7	16.7	53.4	4.2	0.0	0.7	0.1	0.0	98.5	0.4	0.1	61.5	255.8	0.0	0.0	0.0	2.4	62.1	13.7	17.4	40.9	23.3	38.3	60.3	5.8	50.0	2.5	4.5	55.7	36.5	0.5	61.9	0.8	101.7	70.4	15.5	0.0	46.9	0.0	0.0	0.0	3.2	0.0	6.6	0.0	1.3	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	37.7	61.6	57.1	50.0	38.8	43.5	57.3	53.6	56.2	44.8	49.2	83.9	17.0	6.4	7.5	0.0	1.5	0.0	134.2	0.0	8.0	19.7	137.1	149.9	0.0	204.5	35.3	22.0	10.4	0.5	2.7	77.0	3.9	352.1	0.3	115.2	9.2	15.2	8.5	0.0	0.0	139.5	15.1	3.0	91.3	90.1	1.3	0.0	0.0	0.5	0.9	16.8	0.0	38.8	0.0	1.0	0.0	1.6	0.0	1.9	0.0	0.0	2.6	21.7	0.0	0.0	0.0	128.8	85.2	0.0	1.6	97.4	209.8	1.4	91.1	234.9	0.0	0.8	2.7	0.6	35.1	20.3	0.0	0.8	3.5	0.1	87.2	205.8
PLS1	"I-plastin, Plastin-1"	ENSG00000120756	"Plastin 1"	Q14651	3	142596393-142713664	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 315.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 471.4;Intestinal goblet cells: 147.9;Paneth cells: 200.5;Proximal enterocytes: 335.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 36.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.6;NK-cells: 3.2;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"A-431: 90.0;BEWO: 112.3;OE19: 166.4;RPTEC TERT1: 143.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055744, HPA061936"	Enhanced					NA	NA		56000000	"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055744: AB_2682903, HPA061936: "	"unprognostic (1.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (3.14e-2)"	"prognostic favorable (8.76e-6)"	"unprognostic (1.99e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.82e-2)"	1.6	3.9	0.8	18.8	1.3	7.4	5.7	2.7	2.2	10.1	11.7	144.2	191.6	3.3	3.1	9.6	7.7	27.7	1.2	1.1	1.4	26.7	27.5	14.8	1.7	3.3	0.3	0.9	12.2	15.7	6.2	1.5	3.2	3.1	139.1	24.9	9.1	1.9	0.9	3.6	315.6	4.3	0.3	0.9	45.8	7.5	0.4	5.9	7.7	0.9	2.9	19.6	3.7	1.4	90.0	69.2	4.8	10.4	0.7	0.0	112.3	1.7	2.3	9.4	20.1	31.7	68.8	15.2	35.8	0.1	31.9	18.9	18.8	28.7	20.0	5.5	27.0	27.2	10.2	11.4	0.9	13.0	1.7	0.1	4.7	17.8	11.4	14.8	4.5	16.4	11.8	1.7	1.1	21.0	21.4	7.0	18.9	166.4	25.9	8.7	20.3	12.7	143.6	81.7	24.1	9.7	10.0	7.0	7.8	13.3	55.6	2.2	1.2	1.1	11.3	3.5	21.3	12.7	12.6	18.1	3.2	12.8	3.5	1.9	0.2	2.6	1.5	0.2	2.0	0.3	1.8	2.0	0.4	0.3	2.2	2.6	1.8	3.2	0.2	0.5	1.3	1.0	0.8	1.3	2.7	2.2	1.1	1.4	3.3	0.3	3.2	0.3	0.4	1.4	0.6	54.5	38.0	1.3	1.6	2.9	4.1	23.2	2.8	3.4	9.7	4.2	3.1	54.3	46.8	44.1	16.7	5.8	0.7	471.4	21.5	21.8	64.3	22.2	1.8	0.7	53.9	5.9	18.7	34.0	1.9	1.1	50.0	26.8	8.9	32.3	1.1	31.5	0.6	5.0	25.2	147.9	24.4	1.6	1.0	20.5	1.2	1.4	1.8	5.6	0.8	2.8	0.0	4.0	3.1	70.2	200.5	0.0	2.8	6.8	335.1	40.6	42.2	13.4	0.0	1.2	1.9	4.6	4.1	7.6	3.3	1.4	1.8	1.3	85.2	20.7
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B actin binding protein"	Q8WVV4	X	85277396-85379717	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.2;skin 1: 123.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 129.8;Gastric mucus-secreting cells: 48.9;Intestinal goblet cells: 61.1;Paneth cells: 62.5;Proximal enterocytes: 73.6;Squamous epithelial cells: 39.2;Undifferentiated cells: 51.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Group enriched"	"Detected in some"	5	"OE19: 179.0;RT4: 78.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		200000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.7	0.3	0.1	6.1	0.1	0.2	11.0	0.8	0.3	6.4	0.0	54.2	34.4	0.2	0.5	33.1	6.2	9.0	10.6	0.1	0.0	1.4	0.4	1.8	0.5	0.0	0.0	0.1	6.9	0.0	0.3	1.0	0.0	2.9	50.9	0.4	8.5	1.3	0.8	123.9	43.4	2.0	0.0	3.5	23.7	0.2	0.0	0.5	0.5	0.0	12.0	14.3	14.7	0.0	3.7	22.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.5	23.9	12.0	3.3	0.0	0.1	23.7	5.1	0.4	0.0	2.4	0.1	4.4	0.1	0.1	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.3	0.7	3.9	0.0	9.6	0.1	0.2	0.0	179.0	0.0	0.2	1.0	0.1	0.0	78.2	0.1	0.1	0.0	6.0	0.0	1.8	2.4	1.0	0.2	0.1	0.1	0.2	0.3	2.0	4.8	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	1.2	9.1	4.9	7.9	12.0	0.0	2.5	0.8	24.2	8.6	10.2	5.5	0.0	3.2	0.0	129.8	0.0	13.8	0.0	0.3	0.0	1.7	22.8	0.0	0.4	15.6	0.6	3.4	48.9	0.2	0.0	0.0	0.4	0.2	0.3	0.0	0.4	61.1	6.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.4	24.8	62.5	0.0	0.2	3.9	73.6	0.1	9.5	0.0	0.0	0.1	0.9	0.0	0.1	39.2	28.6	5.3	0.3	0.0	51.1	17.1
POLR1C	"AC40, RPA39, RPA40, RPA5, RPAC1, RPC40"	ENSG00000171453	"RNA polymerase I and III subunit C"	O15160	6	43509702-43562419	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 306.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031010			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA031010: AB_10603131"	"unprognostic (2.84e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (1.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	15.5	19.2	16.0	12.3	16.0	7.7	20.3	15.7	20.9	15.3	19.8	18.4	13.1	15.1	15.7	21.3	21.0	9.5	13.3	16.0	16.4	17.6	17.7	11.0	13.9	15.9	15.9	14.4	15.5	17.1	13.8	12.2	16.2	14.4	15.5	6.6	15.8	12.0	15.3	20.5	10.9	14.8	16.0	12.7	14.6	20.1	16.3	12.5	16.1	13.4	20.8	23.4	15.5	17.1	76.0	61.7	26.6	72.3	40.0	43.0	42.1	45.3	33.5	49.7	42.2	82.5	25.2	85.2	48.3	44.2	42.5	45.2	64.7	57.6	57.6	45.4	67.7	58.3	57.2	115.7	50.1	90.0	39.1	38.7	54.8	67.9	85.4	29.4	39.6	35.4	136.9	24.5	44.0	106.4	47.4	65.0	49.2	306.8	52.9	31.9	41.8	57.6	60.7	104.1	49.0	32.8	39.6	34.1	62.2	19.4	36.9	77.9	47.6	35.3	48.1	38.4	72.3	35.1	85.0	146.0	24.1	60.9	40.0	5.7	30.0	4.6	34.1	24.0	46.5	51.1	40.4	34.1	42.4	55.0	55.1	49.6	2.7	41.7	20.5	38.6	32.7	34.0	16.0	16.0	15.7	20.9	16.0	16.4	15.9	15.9	16.2	16.0	16.3	17.1	13.0	12.8	17.7	9.8	24.9	61.8	50.6	34.3	42.1	8.2	24.0	23.6	5.2	17.2	30.4	5.5	6.2	29.7	15.3	11.3	15.6	26.7	13.5	23.4	15.9	18.6	13.1	12.8	13.6	24.4	18.9	21.5	25.0	14.2	14.0	14.4	15.7	11.9	13.3	5.0	12.3	17.4	28.5	5.2	17.0	8.3	11.5	8.5	21.4	11.2	8.3	7.1	14.4	14.1	10.2	21.0	11.5	11.7	13.1	29.2	5.0	27.5	48.5	15.4	6.6	29.1	45.6	34.4	43.3	26.4	40.9	13.5	17.4	21.5	19.9	37.0
POLR2K	"RPB10alpha, RPB12"	ENSG00000147669	"RNA polymerase II, I and III subunit K"	P53803	8	100150623-100154003	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047477			Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"		"HPA047477: "	"unprognostic (3.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.75e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.75e-3)"	"unprognostic (5.73e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.07e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.43e-2)"	55.2	73.7	65.1	40.9	67.7	66.8	70.4	70.2	110.9	55.3	62.9	51.4	37.7	49.6	71.2	45.0	39.8	41.6	63.8	67.3	72.1	74.5	69.9	48.6	57.9	68.9	67.8	43.4	33.9	80.8	48.4	48.1	69.1	52.1	54.0	61.3	47.5	54.2	45.5	37.3	38.8	47.0	69.0	42.7	47.2	33.2	67.8	64.1	63.3	58.7	58.2	61.4	36.0	70.7	152.7	75.8	95.3	67.3	100.3	91.0	63.9	109.9	90.5	110.1	132.6	46.7	101.5	100.7	214.7	87.8	64.1	67.8	103.4	91.1	144.3	164.8	114.5	138.3	88.8	100.4	79.1	90.3	95.2	74.6	119.0	87.3	88.7	71.1	101.4	116.6	109.7	96.0	108.6	96.5	228.0	132.5	98.9	216.5	148.1	88.7	55.1	146.5	138.4	84.5	199.3	130.1	75.6	65.9	169.9	92.1	134.7	136.0	78.7	64.1	92.3	100.4	119.0	98.1	169.2	160.6	121.8	156.3	102.4	72.5	33.3	50.4	47.8	44.6	58.3	65.6	61.5	60.5	43.1	46.7	54.1	57.9	12.6	58.0	42.5	67.4	70.3	55.7	65.1	67.7	70.2	110.9	67.3	72.1	68.9	67.8	69.1	69.0	67.8	70.7	120.5	67.3	57.8	8.8	101.3	162.6	162.9	263.8	82.6	57.5	115.9	123.3	93.4	82.9	152.2	147.1	16.7	134.7	126.5	75.0	440.3	146.0	6.3	113.1	80.9	101.5	122.1	95.9	18.2	130.1	197.0	105.2	60.1	95.2	109.2	52.1	79.2	122.7	154.1	48.8	17.9	116.9	213.6	72.2	103.9	17.6	117.1	78.6	136.9	8.4	144.3	115.7	122.6	12.1	17.4	141.3	72.0	121.5	127.2	224.7	108.1	388.5	127.8	64.9	72.3	96.8	148.0	139.1	166.6	103.0	170.1	137.6	127.9	92.9	98.8	261.3
PPFIBP2	Cclp1	ENSG00000166387	"PPFIA binding protein 2"	Q8ND30	11	7513298-7657127	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.4;Extravillous trophoblasts: 56.2;Oligodendrocytes: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 80.5;OE19: 100.4;RT4: 105.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001935, HPA003911"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA001935: AB_1079667, HPA003911: AB_1079666"	"unprognostic (4.14e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.20e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.26e-5)"	"unprognostic (6.66e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (5.39e-8)"	"unprognostic (1.78e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.52e-2)"	"prognostic favorable (1.34e-5)"	10.8	11.7	21.5	12.0	34.2	7.6	16.6	24.9	24.4	14.7	51.3	22.4	26.4	6.7	33.5	27.3	17.2	15.7	13.0	21.8	26.2	19.0	35.4	11.6	15.2	27.4	29.8	14.3	9.4	66.5	4.8	21.0	29.0	18.2	26.5	2.8	54.8	32.8	33.4	33.2	26.0	5.4	20.6	11.1	44.1	31.5	31.7	4.5	37.5	21.4	25.0	29.5	21.8	43.8	2.0	32.7	5.3	3.1	6.1	0.4	80.5	7.1	16.1	4.1	4.0	26.7	4.6	9.7	3.7	4.1	15.1	14.2	21.0	2.1	3.7	3.9	2.4	0.0	0.3	17.1	8.4	19.6	9.3	10.7	7.6	0.0	4.5	0.4	1.5	2.0	0.9	26.5	4.0	15.9	0.0	19.0	37.8	100.4	0.1	3.3	0.1	17.4	0.1	105.0	1.5	12.4	1.1	28.9	21.9	14.6	4.0	14.7	0.5	1.9	2.8	6.4	0.7	14.1	11.1	8.3	2.3	4.5	13.0	3.4	9.1	6.5	3.1	11.2	2.3	12.7	5.0	2.1	8.3	7.2	6.6	5.2	4.2	2.6	14.4	0.6	1.1	5.2	21.5	34.2	24.9	24.4	21.8	26.2	27.4	29.8	29.0	20.6	31.7	43.8	1.7	16.0	13.6	3.9	21.2	5.5	18.7	4.5	10.2	1.5	10.1	7.7	5.2	11.5	13.7	14.7	18.8	9.1	1.6	29.8	9.8	5.8	53.4	6.7	4.8	3.2	3.6	0.0	3.8	9.6	56.2	7.7	40.2	35.7	7.0	0.6	1.1	17.3	7.1	0.0	6.0	23.2	8.2	10.4	7.2	47.2	4.7	11.3	16.0	17.8	15.7	1.7	3.1	49.8	70.5	6.9	22.8	7.2	9.0	13.4	26.8	19.7	7.5	3.3	0.0	5.7	10.2	22.2	2.6	10.7	9.9	4.8	2.0	1.2	18.0	18.6
PPM1N	FLJ40125	ENSG00000213889	"Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)"	Q8N819	19	45488777-45502510	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 213.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 123.1;Rod photoreceptor cells: 74.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"non-classical monocyte: 142.4"	"Lineage enriched"	"Detected in all"	11	"monocytes: 142.4"	"Cell line enhanced"	"Detected in many"		"OE19: 24.1;RT4: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043577			Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"HPA043577: "	"unprognostic (2.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.11e-16)"	"unprognostic (3.42e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.86e-3)"	2.0	0.8	15.5	2.0	14.7	2.6	3.3	14.5	19.9	2.0	14.5	2.6	0.6	0.7	1.3	2.6	0.9	1.4	1.3	15.1	15.0	1.4	2.6	2.5	3.0	14.7	14.7	0.6	0.5	2.1	1.1	4.7	15.1	1.2	1.3	25.8	0.9	2.0	213.3	3.1	1.6	1.2	13.7	9.2	2.8	5.3	14.3	2.3	1.1	0.2	3.4	2.4	1.6	16.2	2.6	7.1	1.2	5.1	5.9	7.8	14.7	1.9	3.0	0.6	2.3	1.7	15.8	11.1	3.2	1.8	4.1	7.6	3.0	2.2	0.9	10.9	4.5	9.0	2.7	1.9	1.4	0.8	18.1	3.2	3.6	3.1	1.9	4.0	1.0	4.4	10.3	9.6	1.0	1.9	3.1	4.6	4.0	24.1	1.4	2.0	1.5	3.0	3.4	29.9	5.8	6.8	1.0	11.1	9.2	8.8	3.8	2.7	1.5	8.2	4.7	4.3	1.4	1.7	4.5	2.3	6.1	2.3	7.2	6.7	4.4	3.2	6.4	22.5	5.5	6.3	3.9	6.2	12.8	3.6	4.3	7.9	6.5	3.1	142.4	2.4	4.5	5.7	15.5	14.7	14.5	19.9	15.1	15.0	14.7	14.7	15.1	13.7	14.3	16.2	6.4	0.0	2.7	1.0	7.5	3.4	14.7	6.2	17.6	14.1	5.9	32.5	2.3	17.2	2.5	3.7	31.3	3.2	6.0	5.5	0.0	2.9	12.5	2.0	3.9	3.5	3.0	0.8	1.1	1.8	123.1	6.5	3.1	7.4	7.0	1.0	5.3	1.3	20.1	1.7	1.4	4.2	0.0	15.5	15.7	4.9	0.9	15.2	1.8	1.0	6.1	7.3	20.6	0.0	0.3	3.1	4.7	0.7	1.7	6.7	6.9	0.6	0.8	74.3	0.0	25.6	5.5	2.9	9.1	3.4	4.1	8.5	7.5	0.3	3.1	8.4
PPP2R5D	"B56D, B56delta"	ENSG00000112640	"Protein phosphatase 2 regulatory subunit B'delta"	Q14738	6	42984553-43012342	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029045, HPA029046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA029045: AB_10598912, HPA029046: AB_10600988"	"unprognostic (2.25e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.96e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (6.05e-2)"	23.2	20.2	29.9	17.5	32.5	18.3	20.2	25.7	38.1	30.9	17.2	27.2	29.7	28.7	4.3	24.3	28.5	15.2	30.3	33.1	26.8	18.2	20.8	18.7	19.9	31.0	26.6	28.6	19.1	24.5	15.9	18.1	30.8	24.8	23.5	29.7	19.8	21.2	40.6	27.8	35.8	30.6	21.1	18.7	22.3	28.6	29.6	44.4	18.3	41.2	24.0	24.7	27.4	31.2	71.3	38.0	72.6	88.2	61.0	63.6	32.6	38.3	39.9	108.5	86.6	58.7	24.9	55.8	36.3	71.8	67.3	38.6	108.6	66.4	94.6	45.3	67.5	62.9	51.2	81.8	33.5	51.4	43.6	45.6	47.3	88.5	35.1	54.1	87.2	68.7	67.4	41.1	63.0	44.0	114.9	40.0	26.2	228.1	36.3	86.3	73.8	37.3	45.3	39.0	77.9	45.7	56.2	38.7	47.3	63.2	47.9	55.5	57.1	57.2	50.9	55.8	61.4	39.6	54.6	109.0	21.2	48.0	51.6	18.4	13.8	21.9	18.4	11.6	19.2	10.1	16.9	21.2	13.7	9.2	12.8	15.6	8.1	14.3	8.9	14.4	23.9	20.1	29.9	32.5	25.7	38.1	33.1	26.8	31.0	26.6	30.8	21.1	29.6	31.2	6.2	9.6	6.7	6.8	7.6	8.4	2.9	5.1	13.1	12.9	6.9	6.6	4.9	4.3	6.3	7.3	10.4	7.5	10.1	15.7	5.9	6.9	6.4	7.7	19.9	7.4	9.0	12.4	10.5	7.8	11.0	9.7	7.1	9.5	8.2	10.8	6.4	11.3	9.2	3.3	10.3	8.3	8.2	6.2	5.2	7.0	9.6	6.9	10.6	3.7	6.8	8.1	3.1	3.0	5.3	9.8	9.0	14.7	7.7	3.7	35.7	5.2	5.1	7.5	6.6	8.7	10.8	8.3	10.2	13.3	9.5	4.5	11.1	6.1	13.0	2.5
PRADC1	"C2orf7, hPAP21, MGC13004, PAP21"	ENSG00000135617	"Protease associated domain containing 1"	Q9BSG0	2	73228010-73233239	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 126.6"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 144.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051066	Approved				"Secreted to blood"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA051066: AB_2681333"	"unprognostic (2.94e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (8.54e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.99e-3)"	"unprognostic (3.56e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.23e-2)"	22.8	35.9	46.0	9.8	48.1	8.7	19.3	48.6	50.6	15.1	54.1	29.0	25.2	12.6	16.3	25.8	11.3	9.8	101.4	45.8	46.9	27.0	71.5	12.7	9.2	47.6	47.3	11.0	41.6	21.2	23.1	8.2	47.4	19.3	21.4	15.5	29.1	14.7	126.6	20.6	22.1	14.8	46.7	23.6	27.1	31.3	49.0	11.0	17.9	107.1	9.9	23.1	16.3	46.4	21.7	16.6	16.2	31.3	49.3	19.2	22.6	37.8	15.1	32.5	18.7	46.6	20.6	23.3	20.2	38.0	29.3	19.5	25.8	22.7	23.0	36.2	28.2	36.7	21.4	35.2	15.3	20.3	33.7	25.0	13.5	29.2	15.4	9.4	30.5	39.0	32.4	46.1	37.8	41.9	51.7	34.0	5.2	93.7	74.2	31.0	68.6	71.8	18.6	19.0	34.5	12.3	18.1	42.5	15.7	17.3	22.5	15.7	18.9	37.6	16.6	32.9	31.8	52.2	43.9	22.3	24.0	39.6	15.7	15.6	35.0	35.4	24.8	84.3	20.1	17.5	23.8	23.6	36.3	21.8	22.3	19.5	5.0	39.2	105.3	73.3	31.1	48.2	46.0	48.1	48.6	50.6	45.8	46.9	47.6	47.3	47.4	46.7	49.0	46.4	21.7	9.6	4.6	10.1	11.0	15.6	11.3	34.5	4.6	15.2	23.3	23.9	62.6	15.7	20.0	14.7	8.4	25.7	25.4	44.7	72.4	23.3	57.3	12.1	9.3	17.7	32.3	4.2	6.9	46.9	47.2	20.4	13.7	6.0	28.6	4.8	30.7	63.0	49.1	11.8	6.9	47.7	44.7	25.5	14.0	144.3	16.8	19.3	16.0	1.9	7.2	31.4	21.6	6.0	7.0	23.2	31.2	16.1	29.2	10.7	101.4	65.2	15.8	28.3	32.9	19.1	19.1	61.5	21.1	30.1	24.0	13.5	9.7	27.2	50.2	15.4
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 16.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 173.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"NK-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;HHSteC: 2.0;hTERT-RPE1: 6.7;MCF7: 1.6;OE19: 3.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 15.7"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA050343: AB_2681099, HPA060467: AB_2684287"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (4.06e-2)"	1.6	0.2	3.7	0.5	4.8	0.0	1.1	0.1	4.1	1.3	16.2	1.1	7.4	1.0	2.1	0.3	1.4	1.1	5.4	2.8	0.6	6.8	0.2	2.5	0.5	0.5	1.7	1.5	5.8	0.9	0.6	0.1	0.9	0.7	0.2	0.0	0.4	2.2	0.4	0.5	2.6	0.2	0.0	2.1	9.3	0.7	4.1	0.1	8.0	0.6	0.3	0.9	1.1	1.5	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.1	1.8	0.0	0.0	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	3.7	4.8	0.1	4.1	2.8	0.6	0.5	1.7	0.9	0.0	4.1	1.5	4.5	35.3	10.5	173.7	0.1	0.6	0.3	2.1	0.6	0.1	0.2	0.3	5.2	22.8	6.3	7.3	0.0	0.0	0.1	0.2	5.9	10.0	0.3	0.2	0.0	2.1	5.4	0.8	1.2	4.9	4.2	0.6	30.5	0.4	0.0	0.3	0.0	0.0	0.0	1.7	1.0	0.9	0.0	0.0	0.4	0.2	1.5	0.1	0.0	14.0	0.0	1.4	0.0	6.6	1.8	7.1	0.8	1.9	0.1	0.8	0.5	0.2	1.9	0.3	0.0	3.3	9.0	0.3	1.8	0.2	0.0	0.0	0.4	0.0	1.5	0.2
PRKAG1		ENSG00000181929	"Protein kinase AMP-activated non-catalytic subunit gamma 1"	P54619	12	49002274-49018807	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 339.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077805			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA077805: AB_2686855"	"unprognostic (3.24e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (2.84e-7)"	"unprognostic (1.45e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.49e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (3.40e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.97e-2)"	"unprognostic (5.57e-2)"	42.8	54.5	36.4	29.8	40.5	47.4	50.5	39.9	46.3	37.6	41.9	40.7	32.6	32.9	59.1	44.2	33.4	31.3	80.9	38.2	38.6	50.5	49.4	30.8	38.7	34.5	35.5	25.6	37.4	59.1	33.9	35.1	36.5	37.7	47.8	42.3	36.1	39.9	122.7	43.0	29.9	44.8	33.5	28.6	33.5	33.5	34.9	41.8	37.7	112.4	50.8	40.1	30.8	41.5	79.8	45.8	50.5	76.3	157.8	141.6	33.2	85.5	117.4	84.4	55.7	50.9	66.1	50.4	72.9	98.9	53.9	65.4	42.5	115.6	80.4	69.6	57.1	70.4	66.5	34.2	120.2	97.7	54.6	110.0	94.6	65.9	141.4	123.6	90.3	67.6	60.1	70.0	108.6	52.8	45.8	31.5	29.1	339.6	96.8	24.1	53.3	59.7	114.0	67.6	42.1	57.7	61.0	99.1	142.5	39.7	134.1	49.5	72.5	44.4	52.3	87.7	63.5	109.1	113.3	36.0	89.3	69.9	34.5	87.3	59.8	59.9	53.0	58.7	50.0	51.9	46.1	47.6	68.7	51.3	41.3	43.0	70.9	71.8	56.0	45.2	66.8	73.0	36.4	40.5	39.9	46.3	38.2	38.6	34.5	35.5	36.5	33.5	34.9	41.5	20.2	9.6	22.7	16.6	31.2	20.0	30.3	64.5	11.4	29.2	24.3	20.8	49.8	18.6	29.9	36.8	37.5	65.6	30.5	24.5	76.3	48.3	11.3	11.4	21.3	21.9	21.0	30.3	18.1	46.4	57.7	26.7	15.8	12.9	21.5	31.4	30.4	23.2	52.2	15.2	24.1	31.6	63.1	36.2	26.5	15.7	36.7	26.7	37.4	9.4	55.5	41.6	55.6	23.1	21.1	47.8	16.5	27.1	25.0	24.2	38.6	69.3	19.2	30.1	19.7	18.5	27.5	49.3	43.9	19.1	26.0	67.0	26.3	33.6	32.2	23.6
PRKCG	"MGC57564, PKCÃŽÂ³, PKCC, PKCG, SCA14"	ENSG00000126583	"Protein kinase C gamma"	P05129	19	53879190-53907652	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"brain: 103.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 22.6;Glandular and luminal cells: 5.1;Horizontal cells: 5.0;Inhibitory neurons: 12.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 103.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.2;OE19: 4.0;SH-SY5Y: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054560	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA054560: AB_2682523"	"unprognostic (7.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.22e-7)"	"unprognostic (2.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	0.1	0.0	47.5	0.2	44.8	0.9	0.0	5.8	64.8	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.5	0.1	0.0	103.3	4.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	1.8	3.9	1.4	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.0	0.5	0.1	0.6	0.0	0.6	5.2	12.6	3.4	0.0	0.2	0.0	0.0	0.0	18.3	0.1	2.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.6	0.1	0.6	0.0	0.2	0.2	1.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.2	0.2	0.0	0.3	4.0	0.1	0.4	0.2	0.0	0.4	0.0	0.0	1.5	0.6	0.0	0.0	0.7	0.7	0.0	0.4	0.0	0.7	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.5	44.8	5.8	64.8	103.3	4.0	0.0	3.5	0.0	0.6	12.6	18.3	1.1	0.0	0.0	1.0	0.7	0.1	0.1	0.0	0.0	0.0	2.3	4.6	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	4.2	1.2	2.0	0.5	0.0	0.0	22.6	0.0	0.2	0.6	2.0	5.1	0.0	0.0	0.0	0.0	0.1	5.0	12.8	1.5	0.0	0.0	0.0	1.8	0.0	0.6	0.0	2.8	0.0	0.0	0.0	3.0	2.0	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.2	0.0	4.0	0.4	2.9	0.9	0.1	0.0	0.0	0.2	0.0	0.4	0.1
PRODH	"HSPOX2, PIG6, PRODH1, PRODH2, TP53I6"	ENSG00000100033	"Proline dehydrogenase 1"	O43272	22	18912777-18936553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 49.2;skin 1: 39.8"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 183.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 91.3;RPTEC TERT1: 35.9"									HPA020361	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"	"unprognostic (2.46e-2)"	"prognostic favorable (1.54e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.94e-2)"	7.9	0.7	5.8	0.4	6.4	0.0	8.5	3.1	9.0	5.0	34.0	3.1	5.6	1.5	0.1	11.6	5.8	0.1	18.6	6.5	2.8	16.7	15.6	20.6	0.2	7.3	4.7	0.5	1.4	0.0	5.4	0.2	2.5	3.2	0.3	0.6	4.2	0.2	49.2	39.8	32.5	0.0	3.3	0.5	3.5	1.7	7.6	0.3	7.4	6.2	0.8	4.2	8.5	3.4	0.0	0.8	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.3	0.0	0.0	2.9	3.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	4.5	91.3	0.0	0.0	0.0	0.4	35.9	0.9	0.1	0.2	0.8	1.4	0.3	5.2	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	6.4	3.1	9.0	6.5	2.8	7.3	4.7	2.5	3.3	7.6	3.4	0.1	16.0	25.6	183.1	0.0	5.1	0.3	13.1	0.0	0.0	0.2	0.1	1.8	0.0	11.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.6	1.2	0.2	0.4	3.5	0.0	0.5	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	2.0	0.0	1.5	0.1	0.0	0.1	21.4	17.8	0.0	0.6	0.0	14.1	2.1	0.0	2.3	0.0	0.0	0.0	8.0	0.1	21.0	0.1	0.0	1.1	0.6	0.2	0.4	1.0	15.2	0.0	0.3	0.0	1.6	0.2
PRR15		ENSG00000176532	"Proline rich 15"	Q8IV56	7	29563835-29567293	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 62.6;intestine: 81.4;stomach 1: 49.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 263.0;Granulosa cells: 194.2;Proximal enterocytes: 122.4;Respiratory ciliated cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.7;HaCaT: 45.1;OE19: 97.7;RT4: 34.5;SK-BR-3: 74.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA040996, HPA048121"	Enhanced		Uncertain	"Vesicles,Cell Junctions"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Cell Junctions"	"HPA040996: AB_2677241, HPA048121: AB_2680271"	"unprognostic (5.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (1.83e-6)"	"unprognostic (1.30e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.58e-2)"	6.5	0.7	0.6	4.8	0.4	1.1	9.2	0.1	0.7	62.6	0.0	81.4	72.3	18.1	21.6	1.0	9.0	7.8	1.3	0.4	1.0	16.9	0.3	2.3	0.4	0.6	0.4	5.9	3.0	1.4	3.0	4.8	0.5	2.5	52.6	0.0	7.5	3.1	0.2	0.3	72.4	2.3	0.6	0.2	49.3	0.9	1.3	0.1	1.1	0.0	0.7	16.6	0.5	0.6	16.8	23.3	0.0	0.0	8.7	10.7	29.3	0.7	1.1	0.4	0.2	20.5	38.7	0.0	4.1	5.5	0.6	45.1	4.9	0.0	0.0	0.0	3.3	1.3	4.5	22.7	2.8	0.0	0.1	0.1	7.3	0.0	1.7	0.0	0.1	1.5	0.0	0.0	0.0	3.9	0.6	3.2	3.5	97.7	18.5	0.1	0.0	21.4	26.5	34.5	0.5	0.3	2.3	74.9	0.0	12.8	5.4	0.0	19.9	0.5	0.0	0.1	0.9	1.8	3.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.4	0.1	0.7	0.4	1.0	0.6	0.4	0.5	0.6	1.3	0.6	1.8	0.0	0.5	0.0	0.4	0.1	1.2	11.0	0.0	0.0	10.0	7.1	0.5	12.8	16.4	38.6	0.0	14.2	0.2	263.0	29.4	6.9	0.8	31.3	2.3	1.2	8.4	0.0	0.1	21.8	9.9	1.3	16.8	34.7	0.0	194.2	0.4	0.2	2.7	0.0	0.0	45.3	26.4	0.0	0.3	0.1	1.5	2.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	14.4	58.5	2.2	0.1	3.0	122.4	14.4	63.1	0.0	0.0	0.0	7.8	0.0	0.4	1.2	0.0	6.3	0.6	0.4	56.9	23.3
PRR15L	"ATAD4, MGC11242"	ENSG00000167183	"Proline rich 15 like"	Q9BU68	17	47951967-47957883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 178.4;pancreas: 103.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 203.0;Distal tubular cells: 170.2;Intestinal goblet cells: 127.8;Paneth cells: 226.4;Proximal enterocytes: 263.7;Undifferentiated cells: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 205.6"	"Not detected"	"Not detected"							HPA022918	Approved		Approved	Cytosol		No	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA022918: AB_2060743"	"unprognostic (9.91e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (6.29e-13)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.36e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.34e-2)"	2.2	0.1	0.0	7.9	0.1	0.1	38.8	0.2	0.2	13.4	9.5	111.2	178.4	1.4	18.3	12.9	26.5	22.0	0.4	0.8	0.0	28.0	1.9	21.7	0.2	0.1	0.0	0.3	103.9	0.8	8.5	0.0	0.0	17.7	124.3	0.0	51.8	15.8	0.1	10.0	128.5	3.3	0.0	0.0	84.4	2.5	0.0	0.4	67.8	0.0	2.0	2.7	6.7	0.1	3.8	0.6	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	8.6	5.8	0.2	0.3	0.0	0.0	20.5	0.0	0.1	0.0	0.4	0.7	0.2	0.0	2.6	0.0	0.4	0.4	0.0	4.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	19.7	0.4	0.4	0.0	205.6	0.7	0.3	0.0	1.4	1.1	2.6	11.7	0.5	0.0	35.7	0.0	0.0	24.1	0.0	0.1	0.3	0.0	0.7	0.1	0.1	0.1	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	22.4	19.8	0.3	0.1	0.0	2.6	2.4	0.0	0.0	16.7	8.9	0.1	80.1	19.8	16.5	0.0	0.0	0.1	203.0	170.2	35.6	5.5	9.8	0.3	0.2	31.6	0.0	0.1	36.1	0.0	0.4	55.5	3.9	0.0	0.0	0.0	0.8	0.1	0.0	0.1	127.8	24.4	0.0	0.0	9.0	1.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.6	226.4	0.4	0.2	15.6	263.7	30.0	19.2	0.0	0.0	0.0	1.0	11.1	0.1	7.3	0.0	0.0	0.6	0.0	100.9	9.9
PRR4	"LPRP, PROL4"	ENSG00000111215	"Proline rich 4"	Q16378	12	10845849-10849475	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	45	"salivary gland: 6616.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 92.8;Cone photoreceptor cells: 139.7;Horizontal cells: 85.8;Rod photoreceptor cells: 119.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"OE19: 2.8"									HPA042133	Supported				"Secreted to digestive system"	NA	NA		14000000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA042133: AB_10793979"	"unprognostic (1.34e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.57e-6)"	"unprognostic (2.81e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-2)"	1.9	2.0	0.6	0.0	0.6	0.1	9.7	0.6	1.8	0.1	0.6	0.2	7.6	0.0	0.0	148.1	0.0	0.0	0.4	0.6	0.6	0.2	0.2	74.4	0.0	0.8	0.6	0.1	2.7	0.0	2.0	0.1	0.6	4.0	0.0	0.0	6616.8	0.1	0.8	73.4	0.2	0.0	0.6	0.1	66.0	0.5	0.6	0.0	0.1	0.0	0.5	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	2.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	1.8	0.6	0.6	0.8	0.6	0.6	0.6	0.6	0.6	0.3	3.2	0.0	0.0	22.0	3.1	6.8	19.9	9.6	92.8	7.5	2.8	1.8	7.2	8.2	1.8	139.7	16.4	20.1	6.3	1.9	0.1	10.2	0.1	0.2	9.6	16.2	14.1	0.0	0.4	2.5	9.3	10.7	0.1	8.9	0.4	14.6	5.9	7.7	85.8	0.0	6.4	24.4	8.7	6.0	13.9	21.8	6.1	28.4	0.0	7.9	18.2	56.7	0.0	0.0	3.4	14.4	24.5	17.1	9.3	7.9	0.2	6.8	119.2	13.1	23.0	7.1	13.5	5.7	8.1	2.3	4.0	20.1	0.5	9.6	4.0
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1923	"pancreas: 341429.7"	"Cell type enriched"	"Detected in some"	28	"Exocrine glandular cells: 57138.3"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"OE19: 10.6;RPMI-8226: 4.5;U-2 OS: 2.8"									"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		100000000000	"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Endoplasmic reticulum"	"CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favorable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.12e-1)"	45.2	9.9	0.0	4.7	0.0	0.0	25.7	0.0	0.0	19.9	0.0	11.2	54.5	8.9	0.8	15.2	5.6	0.0	51.0	0.0	0.0	9.6	29.7	6.4	6.5	0.0	0.0	177.5	341429.7	0.1	10.3	13.9	0.0	15.2	0.0	0.0	44.2	4.2	8.9	12.1	12.7	0.0	0.0	13.4	77.1	6.9	0.0	0.0	6.4	0.0	0.0	4.7	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	100.7	0.0	0.1	0.0	3.6	0.0	0.0	0.0	57138.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	119.4	0.6	0.0	0.0	0.0	1985.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.2	0.2
PSAPL1		ENSG00000178597	"Prosaposin like 1"	Q6NUJ1	4	7430285-7434930	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"skin 1: 98.5;stomach 1: 38.6"	"Cell type enriched"	"Detected in some"	13	"Gastric mucus-secreting cells: 41.8"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.7;melanoma: 2.5;pancreatic cancer: 2.0;stomach cancer: 3.0;urothelial cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 16.6;OE19: 32.2;RPMI-8226: 24.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA		31000		"Cluster 61: Skin - Cornification"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA038013: AB_10673652, HPA038482: AB_2676037"		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.3	0.0	0.0	0.0	0.3	0.0	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	98.5	0.0	0.0	0.0	0.0	38.6	3.4	0.1	0.2	0.0	0.0	3.1	0.0	0.2	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0
PSMG2	"CLAST3, HCCA3, HsT1707, MDS003, MGC15092, PAC2, TNFSF5IP1"	ENSG00000128789	"Proteasome assembly chaperone 2"	Q969U7	18	12658043-12725740	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 537.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 436.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041517, HPA046741"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA041517: AB_2677530, HPA046741: AB_2679780"	"unprognostic (2.28e-2)"	"unprognostic (9.44e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (5.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.75e-3)"	65.6	50.3	43.5	44.8	43.4	91.9	65.2	47.0	54.8	53.0	43.2	56.3	48.3	49.0	67.5	63.5	47.7	53.2	47.3	43.5	44.9	57.2	65.6	44.3	65.1	44.7	42.8	60.6	55.9	31.1	31.8	52.9	44.4	42.5	60.5	25.1	46.6	47.9	50.9	56.0	47.8	53.0	46.9	43.8	53.7	89.7	42.9	67.6	49.6	39.5	63.7	63.8	52.0	49.2	82.6	51.3	58.2	74.0	100.1	142.5	75.0	81.3	115.7	131.1	147.8	89.1	84.6	90.6	64.6	86.2	108.3	49.8	93.7	99.9	112.2	48.6	52.4	50.1	43.0	101.8	100.7	170.7	78.7	116.8	76.0	80.7	107.6	81.3	92.5	78.7	77.4	112.9	102.4	83.0	109.9	226.1	46.2	436.4	67.8	78.8	87.5	130.2	121.0	106.3	69.6	52.5	77.5	88.1	78.1	56.3	75.8	136.2	63.5	148.9	203.3	131.3	89.4	101.1	142.9	111.1	90.1	88.5	63.3	84.9	89.3	87.6	65.3	95.1	77.6	70.3	84.0	74.8	80.5	62.5	74.6	72.2	30.9	73.9	111.6	65.7	108.2	91.7	43.5	43.4	47.0	54.8	43.5	44.9	44.7	42.8	44.4	46.9	42.9	49.2	96.1	51.3	50.1	42.7	76.4	91.0	98.8	145.2	80.8	25.1	81.4	99.2	36.0	82.9	80.9	82.8	22.9	183.0	80.9	70.8	154.6	110.5	537.7	59.8	75.8	83.9	68.6	97.2	50.1	110.8	140.3	99.3	59.1	53.3	60.9	74.9	101.7	53.1	147.6	25.2	50.3	87.8	54.9	133.0	88.7	140.8	134.2	100.2	72.9	26.2	130.7	63.8	50.4	34.7	38.5	103.2	84.2	97.0	67.1	126.1	120.6	193.8	68.7	21.4	85.5	78.4	89.8	344.9	216.8	119.5	90.1	186.3	78.8	122.3	103.6	130.7
PTGR1	"LTB4DH, ZADH3"	ENSG00000106853	"Prostaglandin reductase 1"	Q14914	9	111549722-111599893	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 278.5;liver: 594.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 791.5;Proximal enterocytes: 1230.1;Proximal tubular cells: 581.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 5.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 5.9"	"Cell line enhanced"	"Detected in many"		"OE19: 909.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036724	Enhanced					NA	NA		2400000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"			"HPA036724: AB_10670239"	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (5.53e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	44.9	87.7	14.6	11.5	16.3	3.0	37.2	15.4	21.6	35.9	16.7	37.4	232.9	32.4	39.1	112.0	71.5	75.3	29.2	22.6	16.0	234.3	594.1	22.1	7.3	13.0	14.4	25.1	16.7	43.9	23.3	15.3	13.4	60.4	33.9	22.6	47.5	31.1	13.0	31.0	278.5	38.1	11.8	7.9	86.0	8.3	16.4	6.4	27.9	29.0	31.6	88.8	44.4	14.4	49.1	207.1	60.6	0.1	220.1	220.4	45.1	79.4	121.8	74.4	81.2	52.9	67.4	0.1	22.9	78.0	153.9	60.7	47.5	83.4	90.3	0.1	15.4	12.5	129.3	279.0	50.4	7.4	25.6	157.3	127.3	99.8	51.1	88.2	201.0	0.0	8.7	0.1	148.5	16.1	0.4	2.0	22.8	909.3	49.8	0.2	17.1	1.4	82.8	152.8	68.4	3.4	98.9	30.0	31.7	59.6	94.6	34.8	161.8	15.4	29.3	169.7	15.0	0.1	0.5	0.3	72.0	0.1	18.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.3	14.6	16.3	15.4	21.6	22.6	16.0	13.0	14.4	13.4	11.8	16.4	14.4	28.9	19.2	28.3	16.6	4.3	38.6	57.6	135.5	66.6	18.7	43.7	41.4	37.4	271.7	78.4	141.6	25.0	47.0	6.4	34.4	150.6	73.4	4.2	100.3	36.2	26.1	26.5	18.7	38.4	178.3	32.5	48.6	174.3	89.3	1.3	35.0	49.6	791.5	53.4	0.0	31.2	76.1	59.0	26.8	16.7	3.6	33.2	15.9	35.6	12.2	22.6	47.0	0.0	17.1	16.1	139.6	86.3	39.5	0.5	63.8	1230.1	581.3	80.3	46.4	13.1	17.4	61.8	15.2	5.3	242.9	30.5	20.5	5.8	46.8	145.9	156.5
PTPN2	"PTPT, TC-PTP, TCELLPTP, TCPTP"	ENSG00000175354	"Protein tyrosine phosphatase non-receptor type 2"	P17706	18	12785478-12929643	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015004, HPA046176"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA015004: AB_2669131, HPA046176: AB_2679569"	"unprognostic (5.83e-3)"	"unprognostic (8.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.20e-8)"	"unprognostic (3.19e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.61e-3)"	23.4	15.2	10.0	32.8	10.8	57.2	23.7	21.0	17.1	19.9	15.6	22.2	18.9	16.0	20.4	20.0	17.4	22.4	14.7	11.0	10.4	17.3	25.8	26.3	44.4	12.3	10.4	26.8	33.1	14.1	18.3	19.5	11.8	17.6	24.1	20.2	29.4	13.5	16.7	21.0	19.5	16.9	10.7	28.5	18.0	13.6	10.0	99.8	17.5	11.9	43.5	37.2	19.9	14.3	34.8	20.7	23.7	7.9	26.5	47.4	23.0	22.7	50.2	47.5	42.2	45.4	48.8	54.3	37.2	23.6	53.2	20.4	39.0	62.2	62.1	21.2	23.5	38.4	17.7	47.6	36.4	91.1	35.1	40.2	57.6	43.3	85.1	29.2	24.6	58.1	37.9	71.6	38.6	39.9	91.3	74.5	28.5	141.7	24.0	30.4	37.3	61.9	40.2	54.6	42.3	22.0	46.0	26.7	41.8	25.1	22.4	51.5	18.8	59.8	58.0	45.1	49.8	22.6	24.5	77.8	28.3	49.3	25.7	23.7	52.6	39.2	37.0	47.7	50.4	54.4	43.7	41.4	62.5	39.5	31.6	34.9	19.0	64.1	46.7	53.0	57.3	40.7	10.0	10.8	21.0	17.1	11.0	10.4	12.3	10.4	11.8	10.7	10.0	14.3	25.8	35.3	77.0	38.5	82.4	59.9	106.0	88.0	61.5	44.1	37.0	50.5	15.0	47.1	84.4	14.7	104.3	54.1	130.4	32.2	13.7	55.1	24.3	51.0	44.8	32.0	32.3	40.8	81.1	68.8	52.5	38.1	24.5	78.7	56.4	53.1	20.3	27.9	51.3	15.2	60.5	35.0	69.2	99.2	92.5	23.2	29.2	93.4	23.2	44.0	137.0	17.6	128.8	22.6	55.0	40.0	45.1	25.6	120.2	126.4	29.9	23.1	55.4	84.5	19.7	35.4	33.8	23.3	61.3	40.0	50.2	81.1	84.2	65.2	39.5	152.4
PTPRH	SAP-1	ENSG00000080031	"Protein tyrosine phosphatase receptor type H"	Q9HD43	19	55181247-55209506	"Enzymes, Metabolic proteins, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 24.2;intestine: 68.6;stomach 1: 23.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 123.6;Gastric mucus-secreting cells: 60.1;Paneth cells: 94.9;Proximal enterocytes: 113.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 11.8;K-562: 15.0;OE19: 30.9;SK-MEL-30: 22.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042300			Approved	Mitochondria		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA042300: AB_10796900"	"unprognostic (1.87e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.57e-3)"	"unprognostic (5.01e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-11)"	"unprognostic (4.08e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.57e-1)"	1.3	16.9	1.7	3.6	4.4	0.0	0.6	5.2	3.0	0.8	0.9	27.9	67.7	0.7	0.1	0.3	0.5	24.2	1.1	1.7	3.4	0.2	13.3	0.1	0.1	7.1	4.9	0.3	4.6	0.1	5.1	0.1	5.7	0.2	21.2	1.3	0.1	0.0	0.0	0.1	68.6	2.1	3.8	22.2	23.6	0.8	4.8	0.0	0.1	0.0	0.1	5.7	0.6	7.2	6.9	4.2	0.0	1.6	1.3	3.6	0.1	0.1	3.6	0.7	1.4	1.8	9.5	0.0	0.3	0.6	8.2	0.0	0.0	0.0	0.8	0.1	0.1	0.5	0.1	4.9	11.8	0.0	4.8	1.0	2.9	2.3	3.6	0.4	0.2	0.0	15.0	0.6	0.0	0.0	0.0	0.3	0.0	30.9	9.8	0.0	0.0	0.5	0.0	0.0	0.4	1.0	0.0	4.2	22.4	0.0	0.0	1.9	0.0	1.0	1.4	0.5	0.1	0.0	3.7	0.0	1.1	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	4.4	5.2	3.0	1.7	3.4	7.1	4.9	5.7	3.8	4.8	7.2	0.3	0.0	0.0	0.0	0.4	1.8	2.8	1.9	0.0	0.1	0.2	0.3	0.6	21.5	3.8	1.8	0.0	0.0	0.0	123.6	0.0	15.5	0.0	1.2	1.0	0.5	4.8	0.0	0.8	25.8	0.1	1.1	60.1	0.5	0.0	4.1	0.7	5.7	0.2	16.8	0.7	20.8	0.0	0.0	1.1	0.3	0.0	0.4	0.0	1.0	0.6	0.2	1.0	0.0	5.8	26.9	94.9	0.0	0.4	3.4	113.1	0.0	4.5	0.5	0.0	3.1	1.8	0.3	0.2	0.0	1.1	0.1	0.5	3.6	18.7	19.7
R3HDML	dJ881L22.3	ENSG00000101074	"R3H domain containing like"	Q9H3Y0	20	44337043-44351238	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"intestine: 2.4"	"Cell type enriched"	"Detected in single"	5	"Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	5	"colorectal cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;OE19: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA070264	Enhanced				"Secreted - unknown location"	NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"				"HPA070264: AB_2686244"	"unprognostic (1.89e-1)"		"unprognostic (2.23e-1)"				"unprognostic (9.86e-2)"	"unprognostic (9.12e-2)"	"unprognostic (6.06e-3)"		"unprognostic (2.64e-1)"			"unprognostic (6.32e-2)"	"unprognostic (4.95e-3)"			0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.7	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RAB11A	YL8	ENSG00000103769	"RAB11A, member RAS oncogene family"	P62491	15	65726054-65891989	"Predicted intracellular proteins"	"Cell cycle, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 969.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013097, HPA051697, HPA060686"	Approved		Enhanced	"Vesicles,Centriolar satellite"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Vesicles, Centriolar satellite"		"CAB013097: AB_2533987, HPA051697: AB_2732569, HPA060686: AB_2684342"	"unprognostic (4.15e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.74e-3)"	"unprognostic (6.85e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.83e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.46e-5)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.21e-1)"	140.0	231.6	79.7	123.9	86.4	126.0	150.1	83.4	105.0	159.3	78.5	223.8	139.8	117.4	130.9	480.0	146.1	185.1	156.3	86.1	97.4	162.9	124.1	148.1	141.2	87.0	83.0	104.9	107.6	192.5	106.8	214.4	101.3	150.3	224.2	99.0	195.1	126.2	119.6	288.5	158.9	149.2	87.2	183.9	216.2	201.8	86.0	143.6	155.3	109.6	246.0	269.8	232.2	86.7	285.2	330.3	330.1	240.8	294.7	275.0	431.1	297.0	300.4	264.4	313.0	305.8	497.4	370.7	295.8	342.6	262.3	429.0	525.0	393.2	248.2	243.7	314.9	445.3	219.9	274.1	224.7	211.5	254.0	282.8	438.1	260.2	214.7	281.7	595.2	197.8	364.5	214.3	378.1	283.7	209.9	167.3	275.9	1057.4	185.9	176.3	250.5	346.3	716.1	734.7	237.4	251.9	214.0	335.6	286.5	387.8	445.0	243.0	453.7	208.4	296.4	203.1	267.8	112.2	289.5	288.8	193.7	353.5	228.8	183.5	154.8	235.2	56.7	133.9	58.8	78.8	85.3	68.6	137.1	64.1	78.9	63.6	232.8	71.3	154.6	87.6	109.5	340.2	79.7	86.4	83.4	105.0	86.1	97.4	87.0	83.0	101.3	87.2	86.0	86.7	155.7	57.7	57.8	15.3	90.2	192.2	180.2	375.2	134.3	42.3	107.5	69.6	89.5	105.8	245.4	187.6	33.3	326.4	76.0	313.4	346.3	360.6	413.1	119.3	72.7	260.7	206.2	91.1	31.3	337.0	340.4	96.9	149.9	194.5	74.9	75.9	235.2	88.4	239.2	57.2	27.7	227.4	244.1	114.8	214.2	80.9	97.3	148.1	186.7	42.2	217.8	137.9	65.9	25.6	21.9	391.1	277.0	86.5	72.1	187.6	205.8	271.5	240.0	36.1	46.0	45.2	161.5	407.5	95.3	225.5	284.4	969.3	96.6	97.6	209.2	360.8
RAB12		ENSG00000206418	"RAB12, member RAS oncogene family"	Q6IQ22	18	8609437-8639382	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 193.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 96.4;Inhibitory neurons: 46.3;Microglial cells: 45.9;Oligodendrocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040727	Approved		Approved	Vesicles		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA040727: AB_10794858"	"unprognostic (7.92e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.11e-2)"	36.8	26.2	27.0	17.8	29.8	13.6	27.9	31.6	33.9	28.3	21.6	34.9	11.8	29.7	19.6	28.8	26.7	18.5	85.4	30.0	31.3	31.4	36.5	30.3	20.9	25.3	27.3	31.0	13.4	21.7	21.3	30.0	25.8	22.7	16.9	22.6	18.0	29.7	193.8	31.5	20.2	34.3	28.3	28.0	19.2	12.0	32.7	15.2	19.8	106.6	20.8	29.0	25.3	27.2	33.1	19.4	22.1	23.2	64.3	54.2	12.2	44.0	60.2	49.1	57.4	26.3	29.7	11.3	41.7	53.1	36.8	20.6	25.7	47.1	59.3	4.5	20.8	9.7	20.7	27.7	59.5	12.8	9.8	53.9	65.2	36.3	45.9	50.6	60.2	10.0	15.0	15.8	48.2	35.9	14.8	12.9	14.3	113.8	18.0	10.2	53.6	10.9	48.5	43.8	36.5	25.8	33.6	45.1	57.6	31.0	13.2	19.5	50.6	56.6	33.0	57.2	67.7	10.6	6.6	9.8	42.4	11.8	37.0	4.5	0.9	1.0	0.8	1.5	1.1	1.3	0.9	0.9	0.7	1.1	1.1	1.1	1.6	1.5	2.4	1.7	1.0	0.5	27.0	29.8	31.6	33.9	30.0	31.3	25.3	27.3	25.8	28.3	32.7	27.2	34.1	12.8	19.3	31.6	3.8	6.5	1.7	1.9	2.8	15.1	11.6	12.2	96.4	1.5	8.3	3.7	6.2	1.8	7.1	1.6	3.9	2.3	0.0	8.1	14.1	16.1	5.4	3.2	41.6	1.3	1.4	14.5	4.6	7.6	6.3	9.4	16.4	16.0	1.7	11.8	46.3	2.5	2.0	16.6	12.3	0.4	3.4	9.3	3.6	45.9	4.5	14.1	2.1	23.6	43.3	3.2	1.7	4.5	2.4	6.3	2.2	5.9	7.0	7.7	0.0	13.2	13.6	1.0	1.5	4.5	8.4	1.1	4.5	12.3	3.1	4.5
RAB25	CATX-8	ENSG00000132698	"RAB25, member RAS oncogene family"	P57735	1	156061160-156070504	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 423.3;skin 1: 210.0"	"Cell type enhanced"	"Detected in many"		"Paneth cells: 249.6;Squamous epithelial cells: 300.6;Undifferentiated cells: 244.6;Urothelial cells: 232.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 120.9;CAPAN-2: 119.9;MCF7: 171.5;OE19: 392.3;RT4: 153.4;SK-BR-3: 243.3;T-47d: 227.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010872, CAB033645"	Enhanced		Uncertain	"Cell Junctions,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions, Cytosol"		"CAB033645: AB_1128883, HPA010872: AB_1079729"	"unprognostic (2.43e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.38e-6)"	"unprognostic (2.31e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.94e-2)"	0.6	0.1	0.1	10.2	0.1	0.1	52.0	0.3	0.3	76.2	0.0	86.2	72.9	7.3	37.5	423.3	47.5	26.4	0.1	0.0	0.0	41.6	1.7	39.2	0.4	0.1	0.1	0.4	57.1	68.9	27.5	12.4	0.1	36.3	78.1	0.0	105.3	28.4	0.9	210.0	65.6	3.7	0.2	0.2	80.9	0.3	0.1	10.1	50.6	0.0	44.0	69.9	148.2	0.3	93.3	0.0	0.0	0.0	0.0	0.0	120.9	0.0	0.0	0.0	0.0	90.4	119.9	0.0	0.1	0.0	0.0	109.5	0.0	51.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	105.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	171.5	0.0	0.4	4.8	392.3	0.0	0.1	0.0	0.3	0.0	153.4	13.3	0.0	0.0	243.3	0.3	21.1	227.9	0.4	0.0	0.2	0.2	0.0	0.2	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.0	0.2	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.3	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.3	1.2	28.9	41.0	0.0	1.5	55.1	102.9	113.9	74.0	0.0	121.4	137.7	0.1	94.4	98.7	86.5	0.0	102.1	2.3	197.8	166.3	170.4	0.0	58.6	6.4	2.6	85.4	0.0	0.1	150.3	30.0	2.3	96.4	66.2	5.7	0.0	0.0	0.4	7.3	0.0	0.1	208.5	89.5	0.0	5.8	0.0	0.3	2.1	21.4	0.0	3.6	0.0	0.0	0.0	0.1	197.3	249.6	0.0	0.3	114.0	195.9	35.5	66.3	0.0	0.0	0.0	6.8	0.2	1.1	300.6	154.7	80.3	2.7	0.0	244.6	232.3
RAB2A	RAB2	ENSG00000104388	"RAB2A, member RAS oncogene family"	P61019	8	60516936-60623644	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018781	Approved					NA	NA		170000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB018781: AB_654960"	"prognostic unfavorable (8.22e-4)"	"unprognostic (1.84e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (9.02e-4)"	"unprognostic (1.25e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (5.10e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.09e-1)"	67.0	52.0	42.6	36.5	49.0	48.7	49.1	38.4	63.0	48.5	30.2	54.4	49.1	45.5	48.9	83.2	32.1	37.7	70.2	48.5	52.3	63.3	70.3	40.9	26.4	41.4	41.7	35.0	43.2	68.6	39.0	51.2	44.4	55.0	48.3	41.2	54.5	37.7	115.8	42.1	53.0	40.0	42.2	33.5	60.6	27.4	44.9	31.2	62.4	69.1	27.8	48.4	59.9	42.2	121.6	68.6	46.2	40.4	152.8	105.9	65.7	101.5	72.5	50.3	58.5	29.5	92.0	39.0	40.2	129.4	83.7	70.8	55.4	64.9	69.2	59.8	45.9	56.3	30.1	40.8	112.9	17.3	48.8	113.9	86.6	57.0	68.6	101.1	62.9	32.6	36.0	51.0	80.1	40.4	75.1	29.3	42.6	176.5	30.6	45.6	20.2	33.9	94.2	55.0	31.6	63.2	43.8	84.2	92.0	60.3	84.1	40.3	104.2	66.9	64.3	100.4	63.0	64.7	49.4	43.6	97.3	37.7	82.7	230.0	164.4	241.2	88.0	149.3	81.5	112.3	90.0	101.2	147.7	108.9	92.2	100.1	310.9	130.2	152.0	97.1	117.7	129.3	42.6	49.0	38.4	63.0	48.5	52.3	41.4	41.7	44.4	42.2	44.9	42.2	167.5	157.0	129.0	67.3	99.3	214.4	197.0	267.0	135.5	102.2	152.6	148.2	182.0	117.2	190.7	165.5	16.7	214.4	112.2	198.6	426.5	266.4	404.2	133.2	200.4	163.8	178.6	56.0	103.7	278.1	365.2	194.9	107.6	197.1	92.5	103.6	121.3	261.9	204.2	124.5	89.6	332.0	266.5	100.2	146.1	111.6	175.2	129.4	279.3	89.0	159.3	153.6	129.8	133.7	124.9	324.4	168.6	165.5	143.8	315.2	200.2	366.4	142.1	60.8	170.9	149.3	236.2	219.7	106.2	210.6	241.5	467.8	102.8	162.7	169.9	335.6
RAB40B	"RAR, SEC4L"	ENSG00000141542	"RAB40B, member RAS oncogene family"	Q12829	17	82654973-82698698	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.5"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 134.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 33.2;OE19: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076172			Approved	Vesicles		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA076172: "	"unprognostic (2.21e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.34e-2)"	"prognostic favorable (9.77e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.14e-2)"	"prognostic favorable (2.95e-6)"	"unprognostic (1.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.13e-2)"	"unprognostic (9.83e-3)"	8.5	8.6	53.6	2.0	63.1	0.8	9.8	52.1	60.5	8.7	25.7	13.2	7.4	8.7	14.7	9.2	7.6	5.3	19.0	52.1	44.4	19.4	14.7	5.2	2.0	58.0	55.1	12.4	6.7	5.0	15.9	3.1	52.7	9.4	7.8	3.4	9.7	5.4	42.5	13.0	6.2	4.1	51.6	4.2	17.5	5.1	53.2	2.1	6.2	19.7	2.3	11.3	9.3	75.5	7.3	11.7	3.5	10.5	8.6	10.7	5.2	7.9	2.2	4.9	1.6	3.8	1.9	1.0	15.4	8.0	3.1	13.1	6.8	6.4	4.3	0.6	33.2	2.8	12.2	10.9	4.3	0.8	3.1	9.2	10.2	2.8	2.2	4.7	4.6	7.0	8.5	1.0	6.7	9.7	2.8	6.4	0.7	40.6	15.3	6.8	9.1	6.3	17.2	13.3	19.1	12.1	5.6	5.0	11.1	16.0	10.8	5.9	9.4	13.7	4.1	14.5	6.5	5.5	4.7	10.5	3.2	1.9	2.4	1.4	0.5	0.0	0.9	1.2	1.3	2.7	1.2	1.6	0.8	0.8	1.6	0.8	0.1	2.0	3.3	6.5	1.8	0.7	53.6	63.1	52.1	60.5	52.1	44.4	58.0	55.1	52.7	51.6	53.2	75.5	19.0	9.6	8.8	22.5	5.8	30.0	28.4	21.4	19.9	11.4	30.0	37.1	32.8	44.3	13.4	14.7	0.0	2.5	9.9	40.0	82.2	22.1	37.3	25.2	17.8	14.6	21.0	6.1	39.2	8.7	5.6	22.2	61.7	59.9	1.3	4.9	15.4	21.3	6.8	33.7	17.6	48.0	73.2	3.2	11.0	26.6	20.2	5.8	48.0	9.4	2.7	11.7	11.3	21.1	134.8	10.3	42.4	18.4	18.6	55.5	43.7	86.7	12.2	11.3	26.3	17.4	17.0	5.0	11.4	30.0	29.1	1.2	6.5	18.5	44.7	99.0
RAB4A	"HRES-1/RAB4, RAB4"	ENSG00000168118	"RAB4A, member RAS oncogene family"	P20338	1	229271062-229305894	"Enzymes, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 32.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 32.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"				"unprognostic (9.21e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.72e-2)"	12.1	12.9	29.7	7.6	27.4	7.2	19.4	27.9	35.7	19.4	24.0	17.9	17.0	12.5	13.4	17.7	15.2	15.0	38.5	24.5	27.3	15.8	30.8	10.9	10.9	25.7	31.4	15.6	24.7	14.3	9.1	11.3	26.0	34.3	19.1	17.3	38.8	20.9	34.2	16.9	13.4	13.4	25.7	7.8	26.7	11.4	34.3	12.4	19.8	35.0	11.8	15.4	13.9	27.7	10.3	13.8	22.6	15.7	31.7	35.1	18.9	15.4	18.3	9.2	8.8	25.6	16.8	0.0	25.1	20.7	7.7	11.1	15.2	21.6	12.9	13.1	30.7	13.9	11.8	40.2	20.5	28.2	10.9	27.1	30.4	6.4	8.9	27.1	20.8	14.9	14.8	0.0	16.1	13.3	14.4	18.8	20.4	63.1	19.1	4.6	3.6	7.2	48.6	24.4	19.4	25.3	12.7	19.1	27.6	11.9	18.1	49.5	14.6	0.0	7.3	14.6	21.4	11.9	11.8	0.1	6.4	23.9	21.8	21.4	5.5	32.7	2.2	6.5	2.2	3.0	2.9	2.9	6.8	3.7	1.8	2.4	1.2	2.2	4.2	3.8	3.7	3.5	29.7	27.4	27.9	35.7	24.5	27.3	25.7	31.4	26.0	25.7	34.3	27.7	43.9	16.0	22.1	37.5	48.4	137.0	155.0	135.3	153.1	29.4	82.3	88.8	91.7	154.4	60.5	44.1	47.9	77.7	61.1	81.9	113.5	89.0	158.0	81.7	45.7	45.3	48.6	52.0	23.6	115.4	88.5	47.2	68.3	47.1	24.8	41.5	52.5	119.2	67.8	30.3	24.2	82.6	79.3	78.4	96.3	169.4	46.6	76.0	64.0	16.9	80.4	33.2	50.4	23.6	38.0	84.9	105.7	83.8	47.6	145.2	73.0	128.1	63.2	58.4	46.0	41.6	46.0	92.6	35.2	83.8	122.6	58.0	50.5	39.5	110.5	161.9
RALBP1	"RIP, RIP1, RLIP76"	ENSG00000017797	"RalA binding protein 1"	Q15311	18	9475009-9538114	"Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	Transport	"GTPase activation, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 480.1;Extravillous trophoblasts: 518.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"neutrophil: 195.6"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 195.6"	"Cell line enhanced"	"Detected in all"		"OE19: 239.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046010, HPA046651"	Approved		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Nuclear membrane, Vesicles"	"CAB046010: AB_11126824, HPA046651: AB_2679738"	"unprognostic (1.23e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.47e-4)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.39e-6)"	"unprognostic (1.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-1)"	29.7	20.4	42.7	23.4	44.1	30.7	27.8	45.8	82.2	26.8	38.6	34.1	18.7	22.1	23.5	50.3	24.8	20.3	28.5	40.7	45.1	42.7	19.9	22.6	24.0	44.1	48.0	26.3	15.4	47.9	16.8	31.4	44.4	32.6	25.4	13.5	25.0	48.2	38.5	75.9	20.4	21.1	43.6	26.5	25.7	13.0	45.3	29.3	22.9	32.5	25.4	33.8	33.3	45.1	58.9	37.6	34.2	39.0	38.3	60.7	43.3	67.7	38.1	35.6	38.0	42.6	57.5	70.5	47.0	64.8	50.2	32.8	48.1	52.7	44.2	71.4	38.5	38.5	34.6	32.7	31.2	114.8	43.0	42.0	52.2	49.6	48.7	47.7	60.6	64.6	53.7	67.7	56.2	46.3	70.7	50.9	25.4	239.5	31.9	93.6	59.4	54.2	48.4	80.7	44.7	34.8	58.2	52.8	30.9	52.3	32.9	53.8	67.4	105.0	76.9	72.3	81.9	38.7	42.9	77.9	45.6	53.4	40.5	13.0	9.6	15.7	10.3	10.6	8.7	9.9	8.7	8.8	8.7	7.5	7.3	9.4	195.6	14.8	17.8	19.8	6.4	4.5	42.7	44.1	45.8	82.2	40.7	45.1	44.1	48.0	44.4	43.6	45.3	45.1	101.8	57.7	35.7	15.3	48.0	156.4	80.9	59.9	112.7	42.6	96.0	102.2	64.8	88.6	64.6	480.1	29.2	104.2	70.9	122.6	123.3	119.4	16.1	99.1	82.6	86.9	74.2	175.7	25.4	90.7	518.6	71.6	56.1	179.4	40.5	85.8	78.9	88.3	70.1	52.2	26.7	87.7	109.9	92.8	69.7	9.5	72.7	78.4	58.7	20.6	99.6	47.6	83.4	17.1	25.3	166.3	78.2	87.3	63.2	174.4	61.0	115.0	38.6	37.3	65.7	76.8	105.6	66.7	80.0	149.6	242.5	44.6	62.6	128.4	90.1	216.4
RALGPS1	"KIAA0351, RALGEF2, RALGPS1A"	ENSG00000136828	"Ral GEF with PH domain and SH3 binding motif 1"	Q5JS13	9	126914774-127223166	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 87.8;Cone photoreceptor cells: 104.3;Excitatory neurons: 105.6;Inhibitory neurons: 164.4;Oligodendrocytes: 161.3;Rod photoreceptor cells: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014749	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA014749: "	"unprognostic (3.49e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.47e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.02e-3)"	"unprognostic (3.49e-1)"	"prognostic favorable (6.20e-11)"	"unprognostic (4.79e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.24e-3)"	3.7	3.4	15.3	3.7	13.8	3.2	6.6	18.8	16.3	5.4	5.9	12.5	30.6	4.7	9.3	7.7	8.5	6.4	13.0	13.4	14.7	14.6	2.7	6.5	4.4	18.7	13.8	4.1	11.3	15.9	18.8	3.9	20.2	7.9	13.0	30.7	13.1	8.2	9.4	10.0	29.1	4.5	13.6	5.2	18.2	10.6	16.4	4.8	13.8	6.0	6.4	8.5	5.9	22.0	3.5	3.1	8.1	8.0	1.5	1.1	8.8	1.1	1.1	1.7	2.4	8.6	5.8	5.8	0.8	1.4	10.3	12.0	2.5	1.4	1.0	2.3	4.9	0.4	4.3	1.5	1.2	1.0	6.3	0.7	4.9	0.8	1.0	1.4	2.8	13.3	0.8	5.8	0.4	6.5	1.1	0.9	2.2	33.6	2.7	3.9	1.9	11.2	3.4	8.6	7.4	11.1	3.4	10.5	2.5	5.6	9.5	0.5	1.3	0.7	2.4	1.6	1.3	10.5	10.8	3.0	3.2	1.0	1.2	0.0	0.1	0.7	0.1	0.0	0.2	2.3	0.3	0.2	0.0	0.7	0.1	0.1	0.9	0.8	0.1	0.7	0.1	0.1	15.3	13.8	18.8	16.3	13.4	14.7	18.7	13.8	20.2	13.6	16.4	22.0	6.2	6.4	4.1	87.8	11.2	2.7	4.4	3.6	2.2	36.8	8.5	5.1	10.2	17.2	10.2	11.0	104.3	9.6	3.6	18.8	5.9	6.1	27.6	11.8	2.6	2.3	7.8	0.0	105.6	6.4	1.0	3.2	34.7	7.2	0.0	6.5	3.3	2.1	2.6	45.4	164.4	16.8	12.2	2.5	2.8	41.4	1.5	2.7	1.8	31.9	3.5	12.4	8.2	68.3	161.3	8.9	14.7	3.8	5.5	6.2	56.9	3.9	13.4	119.0	6.6	5.8	3.2	31.3	12.3	11.6	4.7	4.0	4.7	4.4	17.8	9.1
RALYL	HNRPCL3	ENSG00000184672	"RALY RNA binding protein like"	Q86SE5	8	84182787-84921844	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 19.8;brain: 68.1;kidney: 19.2"	"Cell type enriched"	"Detected in some"	5	"Excitatory neurons: 2828.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055868, HPA059112"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA055868: AB_2682950, HPA059112: AB_2683908"				"unprognostic (1.13e-5)"	"unprognostic (1.62e-1)"		"unprognostic (7.48e-2)"		"unprognostic (1.36e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.82e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.52e-1)"			0.1	19.8	31.9	0.2	35.2	0.2	0.1	68.1	40.2	0.0	0.0	0.7	0.3	0.1	0.7	0.0	0.6	5.0	2.3	27.0	27.5	19.2	0.3	0.1	0.1	12.3	17.3	0.0	2.3	0.0	6.1	1.2	22.7	0.2	0.4	9.0	0.6	2.0	0.2	0.2	0.6	0.1	7.6	2.4	0.5	0.4	26.5	0.0	0.1	0.3	0.1	0.1	0.1	28.5	0.1	0.0	4.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	31.5	0.2	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	35.2	68.1	40.2	27.0	27.5	12.3	17.3	22.7	7.6	26.5	28.5	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	38.5	1.0	0.6	5.0	21.5	0.0	7.3	2.1	0.0	0.0	0.0	178.1	1.0	2.2	0.0	0.0	0.9	1.8	0.0	2828.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	33.7	531.4	0.6	0.0	0.0	0.0	1.5	0.3	0.0	0.0	68.4	0.0	32.8	0.0	495.6	36.3	0.1	0.0	0.0	0.0	0.0	11.7	19.4	0.0	5.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	4.0	0.1	0.1
RAP1GAP	"KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII"	ENSG00000076864	"RAP1 GTPase activating protein"	P47736	1	21596215-21669363	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 152.4;thyroid gland: 162.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 64.1;Distal tubular cells: 72.4;Excitatory neurons: 82.0;Horizontal cells: 92.5;Intestinal goblet cells: 112.6;Oligodendrocyte precursor cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 46.3;OE19: 162.8;SCLC-21H: 52.1"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 231.1"	"HPA001922, CAB003851"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"CAB003851: AB_562338, HPA001922: AB_1079743"	"unprognostic (1.17e-2)"	"unprognostic (4.33e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.35e-2)"	"prognostic favorable (1.12e-6)"	"unprognostic (1.11e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.64e-2)"	0.6	80.8	74.0	2.6	118.6	0.8	4.4	24.6	91.9	7.5	0.0	19.7	12.4	1.9	1.9	7.5	4.2	24.9	9.5	76.2	34.5	152.4	36.1	14.2	1.0	35.8	22.0	1.6	106.2	57.1	37.9	2.1	32.8	12.8	17.3	27.3	88.7	0.8	0.2	3.5	21.7	0.7	15.8	1.2	110.8	3.6	32.4	0.5	162.8	0.3	0.9	4.0	3.4	67.3	6.2	46.3	0.5	3.6	0.0	0.0	0.8	0.0	0.1	0.1	0.0	4.3	6.4	0.1	4.6	0.2	30.2	7.9	4.4	0.3	0.1	1.0	2.3	2.2	4.3	22.1	0.7	0.0	6.6	0.3	3.1	0.0	0.0	0.0	0.0	22.1	29.6	1.1	0.0	15.6	7.7	0.7	2.8	162.8	7.0	4.3	1.2	1.1	10.2	3.4	52.1	9.3	7.7	27.4	8.9	1.8	2.7	5.2	0.1	0.0	3.1	0.0	0.1	0.6	0.1	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.0	118.6	24.6	91.9	76.2	34.5	35.8	22.0	32.8	15.8	32.4	67.3	0.0	9.6	29.3	10.4	0.5	1.3	1.1	1.1	0.6	64.1	8.5	5.6	5.1	25.8	4.5	14.7	0.0	0.2	0.1	4.3	72.4	25.1	0.8	3.1	0.6	0.4	6.7	4.0	82.0	28.8	1.4	1.0	17.3	8.0	0.0	6.2	0.4	8.5	0.3	92.5	45.8	112.6	6.1	0.6	0.3	0.3	0.0	0.6	16.0	3.7	0.6	11.5	0.0	51.8	18.6	15.3	17.2	0.0	0.2	5.0	6.0	13.5	1.2	7.3	0.0	0.0	0.7	1.0	3.6	0.5	1.1	1.5	0.3	2.5	7.7	2.6
RASEF	"FLJ31614, RAB45"	ENSG00000165105	"RAS and EF-hand domain containing"	Q8IZ41	9	82979590-83063177	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 41.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 101.7;Gastric mucus-secreting cells: 356.8;Prostatic glandular cells: 106.4;Respiratory ciliated cells: 100.6;Urothelial cells: 107.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 53.2;RT4: 38.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021431, HPA078596"	Approved		Uncertain	Microtubules		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Microtubules		"HPA021431: AB_1856087, HPA078596: "	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	1.1	1.6	16.2	2.8	15.4	3.6	17.6	21.2	21.9	2.9	18.0	15.2	6.3	2.7	10.2	7.1	6.3	12.6	1.1	13.9	9.2	5.3	2.4	8.2	1.5	10.0	6.3	1.5	23.1	5.3	3.9	3.4	9.8	15.2	15.2	5.1	15.3	3.8	1.9	3.8	8.6	1.1	1.0	1.5	41.0	4.0	9.8	3.4	25.9	0.0	3.5	13.8	2.3	24.7	14.0	15.5	1.8	1.5	0.3	0.5	5.6	1.0	0.2	1.6	3.9	8.7	16.9	2.3	13.7	0.4	11.0	16.3	0.3	0.4	1.9	1.4	17.3	1.9	11.9	2.2	0.2	1.7	1.6	0.3	6.7	7.6	0.2	2.1	0.1	2.4	2.5	16.8	0.2	27.2	2.3	1.8	10.5	53.2	6.1	2.5	4.8	6.0	18.0	38.5	5.6	8.3	2.8	26.8	1.1	6.7	22.9	2.0	2.6	2.6	14.6	2.1	1.7	11.3	10.1	1.4	5.8	1.0	3.0	6.5	2.0	1.9	3.7	1.4	3.5	3.9	3.5	2.9	1.1	5.3	3.8	3.3	9.8	3.6	1.6	3.8	2.9	0.7	16.2	15.4	21.2	21.9	13.9	9.2	10.0	6.3	9.8	1.0	9.8	24.7	0.7	76.9	101.7	0.3	1.1	0.8	5.4	7.9	4.0	1.1	61.3	21.1	0.6	42.9	59.7	9.2	4.2	5.5	0.5	61.8	7.9	35.4	0.6	39.7	7.9	4.5	3.6	0.8	1.0	37.4	10.3	5.7	356.8	88.2	22.1	0.4	0.7	1.7	0.8	0.0	0.6	85.7	48.8	0.0	0.4	2.1	0.3	4.2	1.8	4.7	1.6	0.1	0.0	0.0	0.2	46.2	40.0	0.0	1.5	106.4	10.4	8.3	100.6	1.3	0.0	0.7	2.8	0.5	4.8	28.2	0.9	7.5	3.1	1.2	35.7	107.7
RBIS	C8orf59	ENSG00000176731	"Ribosomal biogenesis factor"	Q8N0T1	8	85214048-85220421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 56.0;Cytotrophoblasts: 105.8;dendritic cells: 39.1;Extravillous trophoblasts: 123.8;Hofbauer cells: 102.1;Syncytiotrophoblasts: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044805, HPA071903"			Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA044805: AB_2679095, HPA071903: AB_2686469"	"unprognostic (1.61e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.84e-3)"	74.4	69.3	55.7	51.0	56.1	83.2	95.2	57.4	72.4	85.3	57.0	81.0	60.6	67.0	91.1	90.2	72.2	42.8	101.1	54.6	58.2	88.5	86.2	52.3	70.8	56.9	55.6	82.7	103.1	60.6	68.9	45.6	57.5	71.6	56.8	45.8	75.2	41.4	78.0	63.9	66.3	48.8	58.5	75.4	99.0	41.5	56.1	75.1	61.3	68.6	71.3	73.9	73.5	59.8	166.6	83.1	122.6	79.4	73.4	140.2	94.8	107.6	102.7	123.1	120.5	97.2	140.0	42.1	86.8	71.8	116.2	112.9	84.8	118.2	138.1	116.6	92.5	242.1	74.2	145.8	87.0	92.5	105.7	120.0	137.0	79.4	99.7	133.3	106.4	145.3	111.9	97.8	103.7	131.0	205.8	173.1	36.1	372.8	143.3	86.9	100.6	188.2	121.2	104.7	40.7	87.1	81.7	132.8	161.0	145.5	154.4	135.9	81.8	78.1	164.9	87.5	104.2	114.1	144.8	197.4	155.8	116.8	88.9	76.6	55.2	39.2	63.5	71.7	76.7	89.3	83.7	78.9	96.9	77.7	95.8	95.0	14.1	104.7	64.4	118.7	90.8	71.0	55.7	56.1	57.4	72.4	54.6	58.2	56.9	55.6	57.5	58.5	56.1	59.8	56.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	105.8	39.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	123.8	27.8	0.0	0.0	0.0	0.0	0.0	0.0	102.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	76.9	7.6	0.0	0.0	0.0
RBM4B	"MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B"	ENSG00000173914	"RNA binding motif protein 4B"	Q9BQ04	11	66664998-66677887	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042174, HPA047849"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (2.10e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.71e-2)"	8.1	16.2	25.9	11.1	26.2	4.9	10.7	36.5	31.5	21.9	23.2	15.2	10.0	19.8	20.4	13.7	18.7	10.4	10.9	25.7	27.7	15.2	14.3	9.4	16.1	25.2	24.9	30.0	13.6	13.1	23.6	13.1	25.3	18.6	12.0	34.5	15.3	14.9	16.3	18.8	14.5	14.5	24.7	15.6	12.6	16.2	26.2	13.3	16.1	15.3	17.3	14.0	15.5	29.9	21.3	21.0	45.1	37.7	21.7	22.3	15.3	19.9	20.0	21.9	22.3	29.5	21.9	23.8	27.9	25.5	21.5	27.2	30.1	27.7	23.2	23.0	20.4	25.7	26.6	31.9	15.9	26.4	24.4	23.3	18.6	22.5	19.1	25.1	21.5	19.0	20.0	23.1	29.8	34.3	16.5	20.4	26.7	47.8	27.9	33.4	35.8	24.4	20.2	21.1	27.7	25.2	23.9	12.1	47.3	28.8	32.3	24.7	20.1	24.1	24.6	23.7	18.3	11.2	20.5	24.2	22.2	18.4	21.7	26.4	15.1	43.9	16.1	22.6	15.7	34.6	14.9	15.8	18.2	28.9	18.1	13.5	9.8	22.6	25.9	15.1	12.2	13.8	25.9	26.2	36.5	31.5	25.7	27.7	25.2	24.9	25.3	24.7	26.2	29.9	7.5	12.8	5.9	15.3	25.9	8.0	14.7	29.8	24.5	36.3	14.4	13.6	6.9	12.8	15.9	18.4	33.3	36.5	11.5	8.1	11.7	11.9	26.5	13.4	12.8	9.5	19.2	12.0	20.0	5.8	16.5	14.9	11.2	11.7	8.9	17.0	12.8	9.0	13.0	25.2	25.8	11.7	26.4	9.8	6.1	53.9	18.3	9.8	16.0	11.2	10.5	23.3	13.4	29.1	31.1	4.7	12.4	13.5	13.4	7.0	21.2	13.4	22.6	60.4	6.6	12.0	14.2	50.8	42.8	13.6	7.1	22.2	14.6	12.2	10.9	5.7
RBX1	"BA554C12.1, RNF75, ROC1"	ENSG00000100387	"Ring-box 1"	P62877	22	40951347-40973309	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003038			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA003038: AB_1079827"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (5.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	37.8	46.8	82.3	33.4	85.6	63.4	45.1	88.4	105.1	38.5	79.7	36.6	26.3	34.3	59.2	53.5	31.4	22.3	72.7	82.9	86.5	49.4	38.9	37.5	44.5	88.2	84.1	26.9	24.7	38.3	34.5	40.9	87.3	32.8	32.8	45.3	33.1	26.9	83.2	43.3	33.1	32.7	89.7	39.8	37.5	24.8	84.1	59.3	35.8	100.5	51.6	36.4	37.7	93.6	111.1	62.2	114.4	57.9	79.9	94.9	64.3	86.6	80.0	128.2	112.9	101.4	52.5	96.7	57.3	86.3	50.8	62.3	110.6	100.2	135.1	113.9	174.7	60.4	84.0	126.1	68.2	148.3	74.8	79.1	79.1	93.0	66.6	73.3	110.5	57.8	72.2	95.6	115.1	136.7	90.2	170.1	63.7	216.3	64.8	116.8	80.0	122.5	149.3	71.0	54.1	34.9	76.5	76.3	82.7	63.8	65.8	99.5	74.8	77.9	81.1	66.4	84.5	80.0	78.9	146.5	98.0	74.7	88.6	151.8	128.1	108.7	79.9	133.9	76.0	114.7	99.2	85.7	129.7	102.4	85.5	93.8	42.3	89.2	154.6	211.1	137.6	250.2	82.3	85.6	88.4	105.1	82.9	86.5	88.2	84.1	87.3	89.7	84.1	93.6	224.9	230.8	144.8	23.5	173.6	300.9	207.2	567.7	129.1	90.4	189.6	237.9	515.4	171.6	300.0	224.3	25.0	507.3	238.6	181.8	508.7	346.8	41.1	227.4	170.6	222.1	162.1	638.3	29.9	333.6	637.9	211.2	107.6	180.4	129.8	140.0	167.4	254.8	431.3	89.2	29.7	205.1	349.9	236.7	334.2	79.4	185.8	270.7	341.5	15.0	532.3	264.5	228.6	18.6	49.6	377.7	229.8	177.1	180.8	269.5	300.5	586.5	314.3	163.7	118.3	160.0	256.3	220.2	242.9	237.5	370.7	675.9	175.3	185.7	207.1	248.8
RDH10	SDR16C4	ENSG00000121039	"Retinol dehydrogenase 10"	Q8IZV5	8	73294602-73325281	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Club cells: 131.7;Collecting duct cells: 204.1;Muller glia cells: 342.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 143.6;BJ: 107.4;CACO-2: 97.0;HDLM-2: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049199			Supported	"Lipid droplets"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	"Lipid droplets"		"HPA049199: AB_2680673"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.88e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.23e-2)"	43.3	6.2	4.2	23.4	5.3	3.3	10.5	4.1	4.1	18.2	16.0	16.6	32.4	14.1	3.9	19.8	7.8	30.2	11.6	4.9	5.9	43.8	41.0	13.6	11.0	11.5	6.8	5.0	34.5	8.4	26.8	36.3	6.4	21.5	15.2	86.3	39.2	13.1	6.9	8.3	30.7	14.9	5.8	7.2	24.8	16.6	20.4	6.1	6.5	8.2	8.8	69.2	11.3	6.7	13.8	39.2	4.3	17.9	143.6	10.5	39.0	107.4	17.4	4.1	6.8	97.0	38.6	9.6	13.9	60.4	6.3	35.6	19.6	15.5	8.4	110.7	49.0	17.0	37.6	30.1	5.6	8.2	18.0	6.3	19.6	16.5	15.3	18.3	15.6	9.4	20.0	13.7	7.0	6.1	8.5	3.4	5.2	84.0	19.0	7.4	4.4	5.8	28.2	19.4	2.6	3.4	9.1	66.3	5.5	5.4	13.1	4.2	24.0	6.3	10.6	28.9	8.3	8.8	10.0	7.8	5.0	7.3	14.7	1.2	0.1	0.2	0.3	0.1	0.2	0.1	0.3	0.4	0.2	0.0	0.6	0.3	0.1	0.0	0.1	0.0	0.2	0.1	4.2	5.3	4.1	4.1	4.9	5.9	11.5	6.8	6.4	5.8	20.4	6.7	14.5	12.8	29.8	3.6	2.5	13.5	9.7	75.6	16.5	3.2	29.1	25.5	9.1	25.8	131.7	204.1	22.9	19.1	11.2	25.5	3.9	16.3	80.6	38.3	50.0	9.7	4.2	1.3	1.4	17.6	23.8	44.6	49.5	71.5	2.5	1.2	3.3	49.2	20.9	3.3	1.0	16.8	40.7	5.4	7.8	9.9	2.8	10.0	17.8	6.5	1.9	342.1	3.1	4.5	2.0	56.9	31.5	3.8	6.4	41.2	47.7	22.6	44.2	16.2	0.0	11.4	20.5	11.0	8.0	24.7	13.9	42.0	7.1	1.6	24.2	17.7
RDM1	"MGC33977, RAD52B"	ENSG00000278023	"RAD52 motif containing 1"	Q8NG50	17	35918066-35930773	"Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 11.9"	"Group enriched"	"Detected in some"	15	"Early spermatids: 59.4;Late spermatids: 81.9;Spermatocytes: 25.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 11.5;JURKAT: 17.7"	"Low region specificity"	"Detected in all"							"HPA024794, HPA067546"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoli	Cytosol	"HPA024794: AB_1856039, HPA067546: AB_2732769"	"unprognostic (9.36e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-8)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.53e-1)"	0.1	0.1	0.6	0.5	0.4	0.5	0.3	1.2	0.6	0.2	0.1	0.5	0.8	0.0	0.5	0.3	0.2	0.1	0.0	0.6	0.5	0.1	0.2	0.1	1.1	0.2	0.3	0.0	0.0	0.0	0.3	0.4	0.4	0.1	0.8	0.4	0.0	0.1	0.0	0.7	0.6	0.1	0.0	0.3	0.4	11.9	0.5	2.4	0.3	0.0	1.5	0.1	0.1	0.3	4.8	4.2	1.8	2.4	0.1	0.0	1.9	0.9	0.1	1.1	2.1	7.0	6.6	5.6	2.2	0.4	5.1	0.9	3.6	2.9	3.6	2.6	11.5	2.9	2.0	0.0	0.0	0.3	1.5	0.0	0.4	0.3	0.6	1.5	0.1	17.7	2.1	0.0	0.4	4.3	1.5	3.0	0.7	9.0	3.1	1.1	0.0	0.0	1.3	2.4	2.8	1.1	0.4	1.4	3.7	5.1	8.9	0.7	0.0	0.1	2.6	0.0	0.6	5.5	1.5	2.2	2.9	1.7	1.0	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.8	2.6	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.5	0.2	0.6	0.4	1.2	0.6	0.6	0.5	0.2	0.3	0.4	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.0	0.0	0.4	0.6	0.6	0.0	0.1	0.0	0.0	3.7	0.4	0.1	0.0	0.1	59.4	0.9	0.2	0.1	1.2	0.4	0.6	0.0	1.0	0.3	0.5	0.3	0.0	1.5	0.4	0.6	1.8	0.0	0.3	0.7	0.0	0.0	0.3	81.9	0.6	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.4	0.1	0.2	0.1	0.2	0.2	0.0	0.0	0.3	0.2	25.6	2.7	0.4	0.0	0.7	0.6	0.1	1.6	0.7
REG4	"GISP, REG-IV, RELP"	ENSG00000134193	"Regenerating family member 4"	Q9BYZ8	1	119794017-119811580	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 662.5"	"Cell type enriched"	"Detected in some"	7	"Intestinal goblet cells: 3458.1"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 180.6;pancreatic cancer: 215.1;stomach cancer: 162.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"naive CD8 T-cell: 24.6"	"Lineage enriched"	"Detected in single"	101	"T-cells: 24.6"	"Cell line enriched"	"Detected in some"	60	"OE19: 6164.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025867, HPA046555"	Enhanced				"Secreted to digestive system"	NA	NA		460000	"Cluster 32: T-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB025867: , HPA046555: AB_2679696"	"unprognostic (3.22e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.64e-2)"		"unprognostic (7.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.12e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.32e-3)"	0.7	0.0	0.0	34.4	0.1	0.3	0.0	0.1	0.2	0.4	0.1	236.2	264.5	0.5	0.0	1.5	0.0	0.5	0.0	0.1	0.1	0.7	0.3	0.0	1.6	0.1	0.1	0.0	133.7	0.0	0.0	0.0	0.2	2.6	314.0	0.0	2.3	0.2	0.0	0.0	662.5	8.5	0.0	0.2	19.0	2.4	0.1	0.4	0.0	0.0	0.8	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.3	2.3	0.1	6164.0	102.7	0.0	0.0	0.8	0.0	29.2	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.8	24.6	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	10.8	0.0	0.0	0.0	441.8	0.0	0.0	1.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3458.1	0.0	0.0	0.0	25.9	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	140.0	0.0	0.1	3.8	178.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	2.9	0.1	52.0	0.2
RETNLB	"FIZZ2, HXCP2, RELMb"	ENSG00000163515	"Resistin like beta"	Q9BQ08	3	108743424-108757384	"Predicted secreted proteins, Transporters"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"intestine: 245.5"	"Cell type enriched"	"Detected in some"	38	"Intestinal goblet cells: 210.1"	"Cancer enriched"	"Detected in some"	10	"colorectal cancer: 16.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"OE19: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049152	Enhanced				"Secreted to blood"	NA	NA	123000			"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA049152: AB_2680655"			"prognostic favorable (6.86e-5)"			"unprognostic (1.19e-3)"		"unprognostic (3.37e-2)"		"unprognostic (4.69e-2)"				"unprognostic (2.67e-2)"	"unprognostic (5.78e-2)"		"unprognostic (4.26e-1)"	0.1	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	75.7	16.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	245.5	0.0	0.0	0.1	0.0	0.0	34.5	0.8	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	2.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	210.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.5	0.0
RFLNA	"Cfm2, FAM101A, FLJ44614, RefilinA"	ENSG00000178882	"Refilin A"	Q6ZTI6	12	123973241-124316024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 94.7"	"Cell type enriched"	"Detected in some"	22	"Pancreatic endocrine cells: 113.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 13.8;HUVEC TERT2: 19.8;LHCN-M2: 34.8;OE19: 37.0;RH-30: 11.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA058911, HPA078021"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA058911: AB_2683853, HPA078021: AB_2732368"	"unprognostic (1.71e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.78e-4)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.16e-5)"	"unprognostic (8.87e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.77e-8)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	3.4	1.1	3.2	2.2	3.8	0.0	1.8	5.7	3.2	10.2	5.4	15.2	13.9	1.7	0.4	0.6	2.9	0.6	0.7	2.7	3.4	2.4	0.1	1.2	0.2	19.1	4.2	2.9	0.3	0.3	2.1	0.6	19.4	4.3	10.4	0.3	2.2	0.3	5.5	1.3	15.2	0.5	3.9	0.1	94.7	0.2	3.7	0.2	0.1	3.2	0.1	0.5	1.3	3.4	0.0	0.0	2.7	0.0	0.0	0.0	3.5	0.0	0.0	0.4	0.4	1.8	1.3	0.0	0.1	4.9	0.2	0.0	2.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.2	0.8	0.0	13.8	0.1	0.8	19.8	2.1	0.0	0.0	34.8	0.0	0.1	0.0	2.9	37.0	0.0	0.0	11.1	0.2	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.8	5.7	3.2	2.7	3.4	19.1	4.2	19.4	3.9	3.7	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	0.0	0.1	0.5	0.1	0.0	0.0	0.0	2.6	0.1	0.6	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RIDA	"HRSP12, P14.5, PSP, UK114"	ENSG00000132541	"Reactive intermediate imine deaminase A homolog"	P52758	8	98102344-98117171	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"kidney: 496.2;liver: 1536.9"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1579.1"	"Group enriched"	"Detected in all"	5	"liver cancer: 162.2;renal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 191.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022856, HPA023489"	Enhanced					NA	NA		5000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA022856: AB_1858253, HPA023489: AB_1858252"	"unprognostic (1.67e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.20e-2)"	"prognostic favorable (9.61e-6)"	"unprognostic (6.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-2)"	50.1	48.4	93.1	11.4	96.4	7.5	19.1	95.5	131.7	11.2	83.8	24.5	30.5	8.4	22.7	14.3	9.4	22.7	32.3	89.2	95.0	496.2	1536.9	9.5	10.1	91.6	97.8	23.4	27.0	24.6	10.0	10.8	95.5	19.3	24.6	26.6	16.4	11.6	40.0	10.6	21.8	10.8	92.6	7.4	24.8	17.2	100.0	11.2	15.9	41.0	12.3	15.5	7.9	91.0	44.0	37.5	29.3	36.6	65.5	50.4	33.0	39.7	28.0	26.4	31.0	51.4	28.4	62.5	49.6	29.4	34.5	30.8	65.4	56.9	52.5	22.3	28.6	45.0	25.6	55.6	29.9	17.6	7.0	44.4	19.5	36.6	39.9	32.4	34.2	65.3	82.7	12.9	35.5	57.8	35.6	50.1	47.0	191.4	67.8	41.0	21.7	18.4	64.6	31.6	32.2	15.7	25.5	17.4	29.2	37.4	44.5	23.5	20.9	20.6	12.5	33.7	16.3	31.2	46.1	30.9	35.0	39.0	13.2	0.2	9.0	5.6	6.6	7.8	8.7	13.8	9.4	10.1	11.1	11.5	12.0	13.0	1.9	10.3	8.3	8.5	13.9	8.1	93.1	96.4	95.5	131.7	89.2	95.0	91.6	97.8	95.5	92.6	100.0	91.0	7.8	25.6	22.4	0.0	7.4	0.0	0.0	0.0	0.0	0.0	13.8	15.1	0.0	0.0	1.8	47.8	0.0	31.1	3.2	0.0	285.7	19.7	0.0	25.1	12.3	5.0	0.0	0.0	0.0	8.5	29.9	7.9	0.0	9.4	2.5	17.7	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.8	0.0	0.0	1579.1	5.8	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	14.4	6.3	22.3	0.0	0.0
RNF128	"FLJ23516, GRAIL"	ENSG00000133135	"Ring finger protein 128"	Q8TEB7	X	106693794-106797016	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.1;liver: 124.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Cholangiocytes: 50.1;Distal enterocytes: 49.3;Gastric mucus-secreting cells: 54.6;Hepatocytes: 76.9;Proximal enterocytes: 85.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.9;CAPAN-2: 35.0;Hep G2: 30.6;OE19: 96.2;RPTEC TERT1: 30.5;RT4: 88.8;WM-115: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019675	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA019675: AB_2670225"	"unprognostic (1.78e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.92e-4)"	"unprognostic (2.14e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.07e-7)"	"unprognostic (1.11e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.30e-3)"	0.7	35.0	2.6	1.8	2.4	0.0	7.9	1.9	2.4	0.6	0.8	21.8	62.1	0.1	0.5	4.6	1.0	33.1	0.5	2.5	4.2	31.5	124.6	14.7	0.2	2.7	2.2	2.0	16.4	0.7	6.6	11.1	3.3	2.8	19.6	0.1	28.6	2.1	8.9	6.9	60.8	0.6	1.6	0.1	46.9	0.6	4.3	2.8	29.4	4.1	0.2	20.0	2.0	1.6	11.1	0.0	0.0	0.0	3.4	1.8	41.9	0.1	0.3	0.0	0.0	18.8	35.0	0.0	0.0	0.6	0.4	13.3	0.1	0.0	0.0	0.0	20.6	0.0	0.3	30.6	0.0	0.0	0.0	0.1	14.4	0.0	0.1	2.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.4	96.2	0.3	0.0	0.1	0.1	30.5	88.8	0.2	0.0	0.0	2.3	2.2	0.3	2.3	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	15.1	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	1.9	2.4	2.5	4.2	2.7	2.2	3.3	1.6	4.3	1.6	0.1	67.3	19.6	6.2	0.5	6.8	6.6	13.1	10.2	0.0	9.7	4.2	0.5	50.1	15.0	33.1	0.0	23.4	0.1	49.3	0.0	14.7	0.1	0.0	0.0	0.3	24.7	2.7	17.9	15.6	3.3	0.3	54.6	0.0	0.0	0.1	1.8	76.9	1.9	0.0	19.6	33.3	2.0	2.7	0.4	0.2	0.0	0.4	3.6	3.7	0.0	0.0	0.0	25.1	13.8	25.6	23.6	0.0	0.0	1.9	85.4	25.3	8.7	0.0	0.0	0.0	1.3	0.0	2.0	11.5	5.3	16.6	0.2	0.5	28.7	8.5
RNF39	"FAP216, HZFw1, LIRF"	ENSG00000204618	"Ring finger protein 39"	Q9H2S5	6	30070266-30075887	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 24.5;skin 1: 63.3;vagina: 21.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 79.9;Basal respiratory cells: 96.2;Club cells: 55.7;Prostatic glandular cells: 57.2;Urothelial cells: 233.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 4.5;U-266/84: 3.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 8.1"	"Group enriched"	"Detected in many"	4	"cerebellum: 9.0;cerebral cortex: 8.0;hippocampal formation: 4.4"	"CAB019278, HPA047115"	Uncertain		Approved	"Vesicles,Plasma membrane,Centrosome"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Plasma membrane, Centrosome"		"CAB019278: , HPA047115: AB_2679938"	"unprognostic (1.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.08e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.06e-4)"	"unprognostic (5.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.57e-2)"	1.1	0.8	0.0	0.0	0.1	0.0	8.6	0.1	0.3	16.8	0.0	0.6	0.2	0.6	0.0	24.5	1.4	0.1	0.3	0.1	0.1	0.4	0.2	1.9	0.0	0.2	0.0	1.3	1.7	0.1	1.4	0.0	0.2	7.2	0.0	0.5	15.8	0.1	0.4	63.3	0.5	0.0	0.0	0.2	8.3	1.6	0.1	0.0	0.4	0.0	0.4	3.9	21.6	0.1	1.2	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.2	1.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.7	0.0	0.9	0.3	0.2	0.0	0.4	0.0	0.5	0.0	4.5	0.0	0.1	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.8	3.6	0.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.1	0.3	3.2	2.7	0.0	0.0	17.8	79.9	96.2	42.1	0.5	23.7	28.6	0.3	7.2	55.7	0.0	0.0	0.0	0.8	1.8	0.0	6.4	0.6	3.6	2.4	1.1	0.0	0.0	0.0	3.3	0.0	1.2	17.3	20.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	14.2	0.0	2.1	0.0	1.2	0.4	3.6	0.0	0.6	0.0	0.0	0.0	0.0	24.2	2.2	1.2	0.0	57.2	0.1	0.0	13.0	0.4	0.0	0.0	3.0	0.1	0.4	11.3	23.9	0.7	0.6	0.0	0.9	233.1
RNF43	"DKFZp781H0392, FLJ20315, URCC"	ENSG00000108375	"Ring finger protein 43"	Q68DV7	17	58353676-58417595	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 67.7;Intestinal goblet cells: 41.6;Undifferentiated cells: 63.6"	"Cancer enriched"	"Detected in many"	4	"colorectal cancer: 41.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 17.0;CACO-2: 24.7;Hep G2: 49.4;OE19: 54.7"									HPA008079	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA008079: AB_1856371"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.79e-1)"	"prognostic favorable (6.04e-9)"	"unprognostic (3.61e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	0.2	10.9	1.7	2.0	3.1	0.7	5.5	9.6	2.7	2.6	1.5	13.4	22.7	1.7	4.4	10.4	4.8	2.7	2.7	2.0	1.3	6.1	9.1	3.6	0.4	1.8	3.4	0.9	8.2	5.2	4.3	4.8	1.9	9.4	19.3	1.2	9.3	4.8	0.3	11.3	16.9	0.6	1.4	0.5	5.8	3.4	2.3	3.7	1.9	0.0	1.5	2.1	5.2	1.4	1.1	17.0	2.7	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	24.7	8.2	0.0	8.5	0.0	1.9	4.6	0.6	6.8	0.0	8.6	11.3	1.9	0.8	49.4	0.0	0.2	0.1	0.0	13.4	0.0	2.1	0.0	0.0	0.2	0.2	0.4	0.0	0.2	0.1	0.2	0.4	54.7	1.0	0.3	0.0	2.2	5.9	9.0	1.6	0.1	1.6	0.7	0.5	5.4	2.0	0.1	0.0	0.0	1.8	0.0	0.0	0.6	1.4	0.1	0.3	0.0	3.8	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.2	0.0	1.7	3.1	9.6	2.7	2.0	1.3	1.8	3.4	1.9	1.4	2.3	1.4	0.3	3.2	8.9	29.0	2.5	9.6	17.5	14.1	67.7	2.5	17.3	13.6	4.0	17.2	5.8	18.4	2.1	26.0	2.2	33.0	15.6	5.3	1.2	14.6	1.1	1.8	15.5	0.8	1.8	2.7	3.1	0.7	9.7	12.7	0.0	7.2	0.7	11.9	2.6	5.0	1.3	41.6	12.2	0.8	0.9	1.5	0.3	1.3	14.2	4.7	2.8	12.0	10.3	0.0	0.7	6.2	21.1	0.4	1.0	9.9	28.7	2.9	5.6	2.8	0.0	0.5	1.1	1.0	0.8	28.4	6.1	5.9	3.1	0.4	63.6	6.3
RPL30	L30	ENSG00000156482	"Ribosomal protein L30"	P62888	8	98024851-98046469	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002651	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		310000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA002651: AB_1079842"	"unprognostic (3.28e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (1.41e-9)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.97e-3)"	2169.1	1286.7	1542.9	1403.8	1616.7	3766.6	4078.2	1552.0	2178.4	2624.2	1490.6	1879.4	1171.1	1990.6	2424.1	1907.8	2592.8	1319.4	1503.2	1501.7	1591.6	1375.6	2352.0	1477.3	3296.1	1596.1	1538.2	5616.9	2583.9	1413.7	1079.4	1341.1	1621.2	1773.7	1967.2	634.7	2148.1	1530.1	2778.6	2895.1	1788.4	1618.1	1613.6	1983.8	1841.8	658.7	1566.5	3112.9	1744.0	2442.9	3898.8	2116.9	2144.4	1661.2	3358.5	2302.6	2395.7	2319.1	3463.7	6460.5	2290.5	1929.4	3501.7	3277.9	2880.0	2560.3	3121.6	4403.5	4934.1	2851.4	1408.4	2158.4	3072.1	3675.9	3436.7	1734.7	2547.3	3817.6	2173.7	3445.6	5063.9	2047.0	1830.0	5463.0	5859.2	2408.7	6912.4	3818.6	3479.7	3804.8	2814.6	2850.5	2866.9	4562.1	4848.6	3870.2	2142.9	8254.3	3304.7	2578.5	1815.0	4130.4	2718.3	3174.1	3464.7	2947.9	1117.1	2785.7	4699.0	2414.5	3667.8	4793.0	1873.6	1253.2	1328.9	1885.1	2357.7	2931.8	2681.4	3686.5	1758.0	4203.3	1869.4	1087.1	1542.9	674.9	2014.7	1325.2	2975.8	3533.8	3482.3	2704.0	1937.3	3224.2	4471.8	3686.3	520.5	2037.1	1212.6	1921.8	2476.6	4634.7	1542.9	1616.7	1552.0	2178.4	1501.7	1591.6	1596.1	1538.2	1621.2	1613.6	1566.5	1661.2	3373.1	852.5	1462.3	22.2	6269.8	3791.4	4320.2	2146.2	5538.1	251.5	4342.6	9218.9	66.3	1441.3	1424.1	555.4	139.7	2675.7	4184.6	1233.9	1792.1	1872.1	1333.5	1359.6	3432.8	2196.1	1647.4	2350.9	24.2	3733.5	3914.4	2206.6	1829.8	1820.2	1560.7	3526.6	2224.6	2204.3	2298.9	144.7	28.3	3237.2	642.9	2912.4	4020.1	2532.2	4373.5	3115.9	1988.6	33.7	3957.1	1623.5	3901.2	18.1	54.5	2580.0	2676.0	2403.1	3084.7	4207.4	2142.3	2511.0	640.5	392.2	1406.8	3481.1	2754.6	926.1	635.4	5831.2	4174.6	2901.7	5319.1	2561.6	3407.3	4410.9
RPL7L1	dJ475N16.4	ENSG00000146223	"Ribosomal protein L7 like 1"	Q6DKI1	6	42879616-42889925	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046049, HPA050478"			Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Mitochondria"		"HPA046049: AB_10964167, HPA050478: AB_2681138"	"unprognostic (1.03e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.31e-3)"	"unprognostic (4.58e-2)"	37.2	39.5	26.1	31.7	28.0	22.6	40.2	27.2	33.5	28.2	20.6	30.4	25.4	30.0	34.0	35.4	34.2	21.5	30.8	28.7	27.3	37.7	48.4	25.2	34.4	23.7	24.1	33.6	32.2	45.4	29.1	31.7	24.2	33.7	34.1	20.0	28.0	27.7	45.5	33.9	23.4	33.4	24.0	27.1	28.6	16.1	26.6	37.1	35.9	44.4	42.8	35.6	27.0	25.9	155.6	48.4	84.2	135.5	77.5	99.5	57.1	121.3	87.8	115.0	94.6	120.4	57.6	231.4	107.0	102.6	93.4	72.5	193.4	147.6	189.4	121.9	144.6	123.7	64.5	109.9	85.2	192.5	91.6	102.5	110.6	151.0	144.7	77.5	114.7	100.2	243.1	77.6	106.2	113.3	110.5	124.2	85.1	472.2	70.3	124.9	94.3	147.1	89.7	96.6	160.1	97.8	103.7	78.2	131.3	66.1	105.0	183.1	110.1	110.5	91.9	88.4	211.3	96.7	163.8	343.2	61.7	178.7	117.7	7.3	13.1	12.4	16.0	15.8	20.3	14.9	15.7	17.0	12.5	17.4	16.5	16.0	2.8	19.7	14.9	14.5	14.3	13.6	26.1	28.0	27.2	33.5	28.7	27.3	23.7	24.1	24.2	24.0	26.6	25.9	56.2	76.9	103.0	12.7	69.3	57.1	89.3	70.6	67.7	62.6	49.2	61.8	42.2	61.5	71.2	42.3	33.3	88.2	77.7	23.9	86.1	92.2	12.6	68.4	96.6	71.6	94.4	73.0	25.9	66.9	84.1	67.5	42.8	44.9	51.2	120.6	51.8	65.0	53.0	72.3	23.3	44.4	54.9	45.0	34.4	12.5	79.2	44.5	30.2	8.4	75.8	78.6	64.9	12.5	15.6	81.3	30.8	71.5	56.1	83.8	25.1	79.8	71.3	69.7	52.6	89.9	64.0	54.9	75.6	65.8	60.2	80.0	65.6	117.8	52.5	58.9
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021623-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029904, HPA029905"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: AB_2673244"	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	30.0	34.6	19.4	27.4	19.7	28.7	28.7	21.5	23.2	26.0	19.8	29.0	20.8	25.5	22.9	37.8	23.2	19.0	30.1	20.3	22.3	35.1	37.3	25.5	32.3	21.3	20.9	18.4	35.8	34.7	31.9	24.2	22.0	28.5	24.3	16.6	27.1	25.0	51.3	34.3	25.9	29.7	20.8	33.3	30.6	17.7	21.0	31.1	23.4	34.8	35.2	30.0	26.4	20.8	141.5	77.9	75.8	111.3	79.7	74.0	63.6	108.9	97.7	136.1	132.6	141.9	59.8	64.7	86.3	113.8	100.1	73.5	127.7	131.8	149.3	82.5	129.9	104.1	82.7	153.2	92.3	87.5	77.7	75.6	79.0	163.0	69.1	48.7	112.2	57.6	128.2	68.4	127.8	148.1	106.0	95.6	84.3	249.7	79.6	98.7	74.7	74.9	83.2	130.5	96.4	84.5	80.1	72.8	129.1	70.6	100.1	106.0	91.2	125.1	95.1	83.4	173.8	63.8	103.9	172.0	54.5	108.6	119.1	2.4	2.2	2.0	3.3	3.0	2.7	4.5	2.4	4.2	2.3	1.4	2.2	4.5	2.5	2.0	2.4	6.0	1.4	0.8	19.4	19.7	21.5	23.2	20.3	22.3	21.3	20.9	22.0	20.8	21.0	20.8	26.8	0.0	15.6	4.6	14.7	13.4	11.2	13.5	5.7	16.1	19.7	22.1	15.1	20.0	14.1	20.2	16.7	29.3	33.1	12.7	13.7	33.7	10.1	18.3	26.5	18.5	13.9	4.6	8.1	44.8	41.8	18.0	12.8	18.0	6.3	27.3	21.0	36.0	29.1	18.5	8.1	12.6	12.2	16.6	11.7	23.0	11.8	20.0	14.2	2.8	26.1	36.9	20.6	6.6	9.6	44.0	7.4	18.8	18.8	17.7	12.4	20.5	10.0	20.3	6.6	19.3	24.7	9.5	10.6	16.5	18.6	33.7	16.5	61.5	14.2	14.3
RSPH1	"CILD24, FLJ32753, RSP44, RSPH10A, TSGA2"	ENSG00000160188	"Radial spoke head component 1"	Q8WYR4	21	42472486-42496246	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"fallopian tube: 161.5"	"Group enriched"	"Detected in many"	8	"Endometrial ciliated cells: 857.0;Respiratory ciliated cells: 1058.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 3.0"	"Group enriched"	"Detected in some"	4	"MCF7: 11.0;OE19: 39.0;RPTEC TERT1: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016816, HPA017382"	Enhanced		Supported	Centrosome		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Centrosome		"HPA016816: AB_1858393, HPA017382: AB_1858392"	"unprognostic (1.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.22e-3)"	"unprognostic (1.99e-1)"	0.4	3.5	12.7	0.8	13.3	0.3	2.1	10.7	11.8	6.7	30.2	4.0	7.5	5.4	17.0	0.9	161.5	3.0	0.2	11.9	13.1	7.7	0.6	14.2	0.3	20.1	25.0	1.2	3.2	5.1	25.9	0.1	20.4	3.2	3.6	12.4	1.4	3.3	0.7	3.6	5.6	1.0	17.0	0.2	5.2	30.9	14.1	1.5	8.0	0.1	0.3	1.5	0.8	15.5	1.6	1.2	0.1	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	3.4	0.1	0.5	0.0	0.4	1.9	0.0	0.5	0.0	0.2	0.1	5.4	0.5	0.0	0.0	0.1	0.2	0.3	0.8	0.0	0.1	0.0	0.0	0.9	0.0	0.2	0.0	11.0	0.1	0.2	0.3	39.0	0.5	0.0	0.4	0.0	15.4	1.3	2.5	0.9	2.4	3.7	0.3	0.0	4.2	0.4	0.2	0.0	0.1	0.1	0.0	0.4	2.5	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	3.0	0.1	0.1	12.7	13.3	10.7	11.8	11.9	13.1	20.1	25.0	20.4	17.0	14.1	15.5	0.4	0.0	6.2	6.5	0.9	5.1	4.5	64.6	2.8	13.3	7.2	5.8	0.6	24.3	107.1	18.4	37.5	0.1	2.9	10.5	39.2	12.6	73.9	857.0	6.2	1.3	9.0	0.0	11.5	3.8	0.0	2.7	4.6	13.9	0.0	0.4	0.0	0.2	0.1	3.3	5.9	13.5	61.1	0.0	0.0	113.4	1.8	0.9	0.0	0.0	1.0	19.9	0.0	0.5	0.3	1.9	11.2	2.6	0.8	9.5	21.4	15.7	1058.1	28.1	0.0	0.9	23.9	79.3	16.8	0.7	4.5	0.8	1.3	2.1	10.6	6.4
RUSC1	NESCA	ENSG00000160753	"RUN and SH3 domain containing 1"	Q9BVN2	1	155320894-155331114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028510, HPA029922, HPA029923"	Approved		Enhanced	Cytosol		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA028510: AB_10599847, HPA029922: AB_10611390, HPA029923: AB_10602288"	"unprognostic (1.98e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.78e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (9.24e-6)"	"unprognostic (7.59e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.40e-1)"	27.0	26.6	42.0	11.6	40.7	12.8	23.2	39.9	66.0	38.0	11.3	39.2	21.6	28.8	8.7	49.5	24.8	16.8	28.8	38.9	41.1	32.1	12.6	23.7	10.7	55.2	34.0	27.5	22.5	11.7	45.0	18.2	53.2	32.1	22.9	11.9	32.0	20.3	14.1	37.3	29.9	18.6	28.3	18.0	27.3	6.6	41.4	18.6	19.3	13.3	11.3	26.6	39.2	41.0	70.4	43.5	24.5	36.4	29.6	32.1	47.2	32.7	20.8	42.2	47.1	50.1	45.2	13.7	24.4	33.2	24.2	95.1	38.3	47.4	18.2	18.8	48.8	19.8	44.7	26.6	24.5	19.9	32.9	33.0	29.3	42.5	14.6	20.4	43.9	29.7	30.5	9.4	36.9	133.4	25.0	25.3	48.4	128.4	68.3	33.6	17.1	24.3	40.3	52.7	25.2	40.5	27.6	76.9	16.8	39.8	114.8	33.6	20.2	54.0	44.4	51.4	65.8	7.4	18.0	8.6	38.2	26.5	15.0	5.8	8.0	4.0	6.3	9.8	7.2	3.6	5.1	6.4	8.8	1.5	2.8	6.0	1.1	3.3	25.2	8.4	5.5	5.4	42.0	40.7	39.9	66.0	38.9	41.1	55.2	34.0	53.2	28.3	41.4	41.0	18.2	9.6	12.7	4.9	8.0	28.0	20.1	29.5	22.8	16.9	21.3	19.3	10.2	15.7	27.9	18.4	6.2	30.8	14.8	82.2	23.5	22.4	0.4	9.9	14.7	20.0	15.6	14.5	23.8	17.7	76.6	19.1	25.5	23.6	8.2	9.8	16.4	7.8	21.0	37.0	30.5	51.7	18.3	12.8	20.3	0.5	18.3	11.9	19.6	6.5	11.7	13.4	15.5	7.1	8.2	25.6	43.7	18.0	8.4	29.4	51.8	27.9	10.4	7.0	19.7	12.7	22.2	2.3	8.9	41.4	34.9	38.0	15.2	6.7	40.1	26.0
S100A10	"42C, ANX2LG, CAL1L, CLP11, P11"	ENSG00000197747	"S100 calcium binding protein A10"	P60903	1	151982915-151993859	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1760.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 3820.4;Langerhans cells: 3945.6;Pancreatic endocrine cells: 4570.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 2005.4;monocytes: 1235.2;T-cells: 1180.0"	"Cell line enhanced"	"Detected in all"		"OE19: 4936.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003340, CAB025484"	Enhanced		Approved	Mitochondria		Yes	No		270000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"CAB025484: , HPA003340: AB_1856531"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.33e-4)"	"prognostic unfavorable (1.00e-4)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.84e-4)"	775.1	376.9	71.1	244.8	76.6	133.7	519.6	75.5	139.8	478.0	78.5	867.3	461.4	110.1	56.7	1760.5	188.7	212.4	340.9	72.4	132.8	735.0	157.7	689.8	133.3	148.2	105.0	234.0	145.0	36.3	71.0	326.9	108.5	164.9	924.2	51.3	422.8	105.0	106.0	483.4	448.0	288.2	98.2	111.2	189.1	145.8	138.8	118.3	143.5	145.4	289.8	338.4	803.1	110.3	1251.3	1085.9	3.4	241.6	1351.4	1711.3	972.5	730.1	912.1	613.8	606.5	1975.4	1671.4	2.3	689.1	1208.0	661.7	2227.5	337.0	2786.6	495.3	242.5	127.1	163.8	461.5	468.1	507.0	60.2	126.7	470.8	2195.5	660.6	738.6	487.6	1326.0	78.9	2.9	3.6	753.8	940.0	11.0	376.5	163.6	4936.7	1671.4	1.6	242.4	27.1	2348.3	317.0	11.1	9.5	1259.2	374.3	539.8	1213.0	882.2	130.5	1654.9	285.5	737.2	1362.3	459.2	34.4	7.8	225.2	1709.5	51.7	977.8	359.5	1235.2	299.7	425.7	758.7	443.3	232.4	652.3	539.0	2005.4	140.1	237.7	363.1	43.6	355.0	664.7	329.6	1180.0	1313.4	71.1	76.6	75.5	139.8	72.4	132.8	148.2	105.0	108.5	98.2	138.8	110.3	1197.3	2554.5	537.7	3.9	244.0	1594.8	1171.4	2183.2	795.6	11.6	241.1	281.4	111.2	693.4	994.6	950.9	4.2	1271.5	476.2	3820.4	1524.1	1811.7	314.2	901.0	104.6	1061.2	1078.1	114.2	0.4	2105.0	527.4	1751.3	432.8	1270.7	289.5	840.0	864.5	206.9	1023.1	16.8	0.9	1723.1	272.6	795.2	3945.6	274.2	647.1	1338.1	1632.8	28.1	1544.2	24.8	285.3	4.0	0.6	4570.5	3391.8	64.7	244.5	2782.5	2146.1	495.6	620.3	32.5	144.7	801.6	529.5	30.4	115.9	1940.1	1242.0	375.8	801.0	38.5	1998.0	2290.6
S100A5	S100D	ENSG00000196420	"S100 calcium binding protein A5"	P33763	1	153537147-153541765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 3.6;thyroid gland: 5.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;Distal tubular cells: 3.9;Extravillous trophoblasts: 8.5;Langerhans cells: 3.1;Theca cells: 6.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.0;granulocytes: 1.4;T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"OE19: 34.3;RPTEC TERT1: 11.9;RT4: 19.9;SCLC-21H: 17.3"	"Region enriched"	"Detected in many"	86	"olfactory bulb: 980.0"	"Region enriched"	"Detected in single"	15	"olfactory bulb: 5.6"	HPA064184			Approved	Nucleoplasm		Yes	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA064184: AB_2685206"	"unprognostic (6.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.63e-5)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"		"unprognostic (1.52e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.68e-3)"	0.2	0.1	0.3	0.1	0.3	0.7	0.2	0.9	0.8	0.3	0.1	0.2	1.5	0.6	0.1	0.9	0.5	1.0	0.1	0.3	0.4	2.9	0.0	0.5	1.5	0.4	0.3	0.1	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.1	3.6	0.3	0.0	0.3	0.4	1.2	0.1	0.4	0.7	5.2	0.1	0.4	1.1	0.3	0.4	2.2	5.7	0.0	0.0	0.6	0.4	0.4	1.0	1.3	0.7	1.4	0.6	4.2	0.0	3.7	2.1	0.4	1.7	0.1	1.0	0.9	0.5	0.0	2.7	2.6	0.2	0.4	0.0	3.5	0.0	1.1	2.7	0.8	0.5	0.5	0.0	0.7	0.2	3.0	0.2	0.5	1.3	0.2	34.3	9.7	0.0	1.8	1.1	11.9	19.9	17.3	0.0	0.2	9.0	0.8	1.5	0.0	0.5	0.4	0.1	1.3	2.6	1.7	0.0	0.9	0.0	0.5	0.7	0.4	0.0	0.7	1.4	1.2	0.1	4.6	0.5	2.6	1.3	1.8	0.3	1.4	0.6	1.2	0.0	0.4	3.0	3.9	0.7	0.3	0.3	0.9	0.8	0.3	0.4	0.4	0.3	0.5	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.2	3.7	0.0	0.1	0.2	0.1	3.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	8.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.0	0.6	3.1	0.0	0.3	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.6	6.8	0.3	0.6
S100A6	"2A9, CABP, CACY, PRA"	ENSG00000197956	"S100 calcium binding protein A6"	P06703	1	153534599-153536244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 37545.1;Urothelial cells: 17431.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 17071.6;RPTEC TERT1: 20988.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002601, HPA007575, CAB040549, CAB047354"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		7000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859"	"unprognostic (8.80e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-2)"	"prognostic favorable (7.56e-4)"	1873.9	666.6	435.5	1129.7	452.5	2003.6	1499.2	456.2	549.9	2306.1	425.9	2872.2	1504.1	1058.4	404.8	1300.4	879.9	1485.5	1046.0	425.8	593.7	2326.6	91.9	2216.9	365.1	520.2	488.9	556.8	204.2	68.4	311.2	709.2	489.1	827.7	2252.2	36.6	1123.5	1169.3	478.1	858.6	1367.0	965.1	488.8	519.1	1586.3	170.1	573.3	191.6	970.0	1010.8	504.8	3867.5	1276.0	530.4	3666.6	4412.8	4.3	330.6	7597.2	10482.0	9.3	4560.1	13403.9	2582.7	3352.7	273.3	8022.5	4.5	1319.7	7774.8	2078.7	1589.3	80.7	7340.5	1322.0	1340.0	1.6	731.2	2579.1	255.8	2730.2	28.1	458.7	4550.0	6406.8	2638.7	4734.2	3259.1	6078.3	0.7	3.2	12.3	7052.7	589.4	11.4	292.3	9.6	17071.6	7563.4	5.5	463.0	1250.1	20988.4	3918.8	1019.8	142.6	6251.9	6380.9	4628.4	3.7	835.3	1095.9	7473.3	2228.2	489.8	4463.8	7452.6	8.8	11.9	15.5	8619.0	728.4	4773.0	5517.3	6053.2	2413.8	1806.1	3258.0	1983.1	937.8	1664.9	1773.1	4240.8	583.7	1037.2	1378.3	9637.7	297.4	3066.5	2145.0	2217.6	8320.4	435.5	452.5	456.2	549.9	425.8	593.7	520.2	488.9	489.1	488.8	573.3	530.4	1177.8	4708.3	2663.1	17.6	343.0	1488.3	6868.7	7856.4	2416.5	4.9	1494.4	1445.2	326.6	1474.1	7013.9	8165.9	0.0	1368.2	999.9	8832.0	7446.5	6206.3	21.3	1148.6	3473.2	1801.5	2035.6	637.5	14.7	9903.1	2440.0	4102.1	2276.3	814.3	1817.4	126.3	946.3	21.6	2430.3	58.9	7.1	6823.9	5706.7	2853.5	7378.0	115.0	3013.4	3110.9	3070.0	30.0	6073.8	168.0	926.9	7.5	23.0	37545.1	9094.3	1143.8	346.6	9900.7	8570.5	224.3	4962.3	8.7	131.5	3234.0	2978.8	28.7	13.2	1718.7	997.6	1573.4	1283.0	5881.5	3218.9	17431.0
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693878-6697170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 1410.7;stomach 1: 1742.0;urinary bladder: 1777.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 1088.3;Gastric mucus-secreting cells: 2306.9;Syncytiotrophoblasts: 2773.6;Urothelial cells: 4448.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 1789.3;eosinophil: 836.9;neutrophil: 2961.8"	"Lineage enriched"	"Detected in many"	73	"granulocytes: 2961.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 879.0;Hep G2: 1283.2;hTCEpi: 1185.6;OE19: 4335.4;RT4: 2619.8;SK-BR-3: 1057.4"									"HPA019502, HPA075251"	Enhanced		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA019502: AB_1856530, HPA075251: "	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	14.0	1.7	1.0	42.4	1.4	1410.7	7.4	1.6	6.3	15.0	1.4	155.6	13.2	5.9	0.0	340.6	6.9	52.1	2.7	1.4	0.9	2.1	8.8	14.7	1.0	1.1	1.1	0.5	4.7	0.4	1.7	474.7	3.2	25.5	176.0	0.1	8.2	0.5	0.4	20.9	23.8	16.6	0.6	34.3	1742.0	1.4	1.0	10.6	0.6	12.2	96.9	1777.0	34.5	1.1	115.2	89.1	0.0	0.1	0.0	0.5	879.0	0.0	1.0	0.0	0.0	5.2	17.6	0.7	40.1	0.6	1.2	137.6	0.5	1.1	0.0	54.7	0.0	1.9	106.7	1283.2	0.0	53.4	3.2	0.6	1185.6	0.0	1.1	0.2	0.2	0.8	3.1	0.0	0.0	214.5	1.6	126.5	1.5	4335.4	149.6	0.9	0.5	0.5	0.0	2619.8	1.1	0.7	156.8	1057.4	2.4	39.9	31.0	169.6	0.5	0.0	1.4	0.2	0.9	1.2	0.7	0.8	0.1	479.1	0.2	1789.3	40.6	836.9	1.4	9.5	1.1	0.4	1.7	1.1	1.6	0.5	0.3	0.8	2961.8	0.1	5.7	0.4	1.1	16.7	1.0	1.4	1.6	6.3	1.4	0.9	1.1	1.1	3.2	0.6	1.0	1.1	0.9	9.6	48.6	0.0	6.2	1.1	318.3	568.6	4.0	0.0	3.4	3.6	1.2	27.1	1088.3	1.8	0.0	550.7	2.2	322.2	0.0	4.8	12.3	37.5	38.9	8.7	16.6	0.0	0.0	31.1	783.4	13.8	2306.9	202.5	31.6	0.0	1.4	7.4	69.2	0.0	0.0	443.7	152.5	11.8	1.0	7.4	0.0	11.0	8.8	0.0	5.6	0.0	2.1	0.0	0.1	828.1	580.9	0.0	5.9	288.4	2.2	0.5	301.5	0.0	0.0	0.1	32.1	0.5	0.6	18.6	6.3	2773.6	9.8	0.1	173.2	4448.3
SAP25	FLJ00248	ENSG00000205307	"Sin3A associated protein 25"	Q8TEE9	7	100572228-100573900	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 70.9;Rod photoreceptor cells: 57.8;Spermatogonia: 86.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 30.4;NB-4: 69.1;OE19: 117.4;U-937: 27.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA062610			Approved	"Nuclear bodies"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear bodies"		"HPA062610: AB_2684806"	"unprognostic (1.70e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.09e-5)"	"unprognostic (6.89e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.96e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.52e-6)"	"unprognostic (7.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-3)"	8.8	4.5	18.7	17.9	21.0	28.9	4.7	19.9	26.2	11.1	18.0	5.8	6.5	4.8	0.3	4.4	9.3	5.0	6.6	18.6	20.5	15.8	7.0	14.7	28.6	22.1	19.3	23.2	6.5	1.0	12.9	5.3	20.9	11.0	1.7	13.5	8.3	2.4	3.9	6.1	20.0	2.0	18.5	47.4	5.6	25.4	21.6	17.6	15.8	1.1	8.2	5.0	7.4	24.9	4.0	1.4	2.8	1.6	0.2	0.4	6.4	3.0	0.6	1.9	0.9	3.1	4.1	2.0	1.8	0.0	0.2	4.2	0.5	0.9	0.2	3.9	2.3	3.7	3.6	1.0	0.6	4.2	30.4	0.8	1.9	1.1	0.4	1.5	0.6	8.0	4.7	7.7	0.4	9.2	7.8	69.1	4.3	117.4	1.5	16.7	0.9	3.1	0.3	1.2	1.6	5.0	0.4	3.7	4.5	3.1	5.6	15.8	3.2	2.9	6.1	2.7	2.9	13.1	3.4	1.6	0.9	27.4	3.0	0.9	0.2	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	1.1	0.0	0.2	0.3	0.0	0.0	18.7	21.0	19.9	26.2	18.6	20.5	22.1	19.3	20.9	18.5	21.6	24.9	2.2	0.0	4.1	11.1	6.7	0.0	1.3	0.0	1.2	23.7	4.6	5.3	0.0	7.2	1.3	0.0	70.9	2.6	8.7	3.1	0.0	1.9	1.4	2.1	2.0	1.7	0.0	3.4	0.9	0.7	0.7	1.3	4.1	3.2	1.3	6.0	2.5	1.1	3.1	21.9	0.9	2.3	0.0	8.5	0.0	4.6	3.4	10.7	0.0	9.4	6.5	8.0	5.2	2.5	8.2	2.0	1.9	1.2	4.1	2.8	4.9	0.3	0.0	57.8	6.6	1.5	1.8	17.2	86.6	1.5	0.0	3.6	8.2	0.9	1.5	1.8
SARAF	"MGC8721, TMEM66"	ENSG00000133872	"Store-operated calcium entry associated regulatory factor"	Q96BY9	8	30063003-30083208	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040400			Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA		41000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"	"Rods & Rings"	"HPA040400: AB_2676962"	"unprognostic (1.11e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.38e-3)"	"unprognostic (7.86e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.03e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-1)"	139.9	294.5	208.6	169.1	228.0	253.0	169.9	187.2	246.6	153.8	196.2	143.0	123.9	152.1	408.6	91.0	205.9	182.1	151.8	234.6	308.8	205.2	302.3	167.5	218.9	214.0	258.8	255.7	231.4	236.5	138.9	309.2	247.6	228.2	143.5	219.1	212.9	172.7	111.1	70.8	140.5	139.1	219.5	159.0	161.1	104.3	290.5	243.4	245.4	129.0	186.5	141.0	64.0	218.5	119.9	112.4	147.9	79.9	209.3	149.8	69.7	139.2	247.0	128.5	173.7	72.2	139.9	80.9	183.5	156.0	134.7	97.7	100.8	112.4	146.9	33.6	49.5	112.2	87.3	119.2	189.6	48.8	130.6	175.2	260.0	121.6	125.5	257.4	192.0	150.7	128.4	191.2	142.9	74.2	128.4	88.8	96.0	253.6	61.3	98.7	88.4	107.4	220.3	100.4	48.6	162.5	140.6	160.5	208.2	115.7	112.2	93.3	144.0	89.6	230.5	35.0	56.5	103.4	110.6	81.0	215.8	118.4	146.5	964.6	252.9	443.1	321.2	253.2	364.8	233.1	473.0	377.9	247.0	302.4	776.2	543.6	478.1	258.8	335.3	212.0	483.8	920.3	208.6	228.0	187.2	246.6	234.6	308.8	214.0	258.8	247.6	219.5	290.5	218.5	179.8	169.9	147.6	79.0	458.5	0.0	331.6	0.0	154.8	291.5	247.8	166.2	135.4	261.7	82.3	211.5	123.0	235.9	566.8	142.2	127.2	387.5	629.8	235.9	114.8	170.8	115.3	145.4	128.0	358.9	254.5	181.7	170.7	133.6	223.3	325.7	240.2	273.4	292.0	139.7	157.8	122.0	0.0	448.6	0.0	908.1	218.7	387.9	0.0	60.9	298.5	317.2	358.4	82.9	111.7	250.1	137.0	294.2	505.1	280.7	252.6	289.7	212.1	252.5	177.5	203.7	177.1	194.7	133.9	133.4	0.0	276.9	794.4	167.8	115.9	310.6
SCYL3	"PACE-1, PACE1"	ENSG00000000457	"SCY1 like pseudokinase 3"	Q8IZE3	1	169849631-169894267	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005624	Approved		Uncertain	"Nuclear bodies,Microtubules"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Microtubules	"Nuclear bodies"	"HPA005624: AB_1854916"	"unprognostic (2.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (8.36e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.17e-2)"	"unprognostic (8.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.54e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (8.85e-4)"	5.6	5.8	2.7	7.4	3.0	4.0	10.9	4.0	3.5	6.7	5.0	7.8	7.7	7.0	8.3	7.3	6.3	7.6	5.2	3.0	3.0	7.5	11.3	6.2	10.5	2.9	2.8	7.6	6.1	12.0	4.1	8.1	3.1	7.6	9.6	11.4	8.2	6.7	7.9	7.7	6.8	6.2	2.9	7.5	7.7	6.6	3.0	9.7	7.6	9.1	9.8	7.3	6.5	3.9	4.1	5.2	7.9	5.5	9.9	7.2	9.1	6.3	8.1	7.2	6.7	4.8	7.7	8.4	4.5	6.5	4.0	9.4	4.7	5.5	6.4	15.5	4.4	5.8	6.1	3.1	7.0	8.5	7.3	7.0	5.4	5.0	6.8	6.7	6.9	9.2	9.4	10.8	6.9	3.2	6.9	6.5	6.4	27.5	2.5	6.3	4.3	10.1	7.6	7.3	5.9	8.6	5.0	16.3	10.1	11.2	9.1	7.8	5.2	5.1	3.4	6.2	5.1	14.4	13.7	9.9	3.9	6.3	5.7	13.5	3.2	8.6	6.3	3.4	8.5	6.7	8.3	7.0	5.1	6.2	7.0	5.8	6.7	10.7	3.8	11.5	8.1	4.8	2.7	3.0	4.0	3.5	3.0	3.0	2.9	2.8	3.1	2.9	3.0	3.9	5.9	6.4	14.4	11.8	9.6	2.4	2.5	3.6	6.2	10.2	9.6	8.3	4.2	22.8	7.8	1.8	10.4	17.6	19.0	14.0	9.8	7.4	5.1	11.1	8.2	6.6	9.1	4.2	15.8	9.1	5.1	5.1	7.1	5.8	5.7	7.2	11.0	13.2	6.5	10.1	12.5	10.4	8.2	11.4	3.5	2.6	4.4	5.3	1.8	9.4	8.4	10.0	16.5	17.6	14.1	6.2	10.2	5.7	10.5	4.7	13.3	6.4	9.0	19.9	6.6	5.5	5.4	10.9	6.8	8.3	1.8	11.6	11.0	6.3	10.3	3.3
SDCBP2	"SITAC18, ST-2"	ENSG00000125775	"Syndecan binding protein 2"	Q9H190	20	1309909-1329139	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 141.8;intestine: 136.9;stomach 1: 101.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 782.5;Pancreatic endocrine cells: 755.4;Paneth cells: 948.5;Proximal enterocytes: 470.3;Urothelial cells: 641.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.6;OE19: 57.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005804, HPA064490"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA005804: , HPA064490: AB_2732713"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.78e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.37e-4)"	7.3	3.4	19.9	10.1	20.7	0.7	6.9	16.3	24.3	25.8	15.2	85.8	136.9	5.7	9.0	141.8	4.3	41.8	4.6	19.6	20.2	16.0	18.1	20.9	1.3	17.2	17.9	3.5	15.2	2.5	3.9	3.3	17.4	6.5	55.5	1.0	29.8	2.5	2.8	62.9	133.0	3.6	16.9	3.1	101.8	5.6	20.3	1.5	14.6	1.4	13.7	38.2	49.9	18.0	10.9	0.5	1.4	0.5	5.8	5.1	0.9	3.2	6.3	2.8	2.7	2.3	18.6	1.1	2.1	1.2	2.0	8.2	0.5	15.5	1.4	0.4	1.0	0.9	0.6	1.5	5.8	1.1	1.2	1.8	10.8	2.2	2.2	6.0	9.6	2.0	1.5	0.7	1.1	2.6	1.7	3.0	1.3	57.3	0.7	1.6	0.7	2.2	1.2	14.4	2.4	1.9	1.5	9.3	3.6	0.6	0.4	0.9	6.5	1.5	0.6	2.8	1.2	2.8	2.7	1.1	0.7	4.1	0.9	0.1	0.8	1.9	0.9	0.3	0.7	0.2	1.2	0.9	1.0	0.4	1.0	1.8	0.8	0.9	0.6	0.7	2.3	0.7	19.9	20.7	16.3	24.3	19.6	20.2	17.2	17.9	17.4	16.9	20.3	18.0	15.6	16.0	4.2	0.0	4.1	55.7	112.0	198.1	3.4	1.0	4.9	4.8	0.8	72.9	172.6	16.5	0.0	1.8	1.0	782.5	27.4	114.5	17.1	25.8	11.7	14.1	35.9	0.0	0.0	209.7	1.1	4.6	201.8	85.4	8.9	1.0	7.1	5.1	0.9	1.7	0.0	150.8	156.6	1.9	6.4	1.9	1.5	1.8	8.8	0.0	2.3	1.0	2.1	0.0	0.0	755.4	948.5	0.0	0.7	107.0	470.3	1.8	89.6	0.9	0.0	1.7	9.9	5.0	7.6	31.1	95.6	1.6	3.5	2.0	109.2	641.9
SDHAF1	LYRM8	ENSG00000205138	"Succinate dehydrogenase complex assembly factor 1"	A6NFY7	19	35995188-35996312	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA064277, HPA074563"			Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA064277: AB_2685231, HPA074563: "	"unprognostic (2.01e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.47e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.59e-2)"	15.4	16.2	13.7	6.3	15.2	4.2	16.1	17.8	15.5	19.1	13.3	21.5	13.6	16.3	6.1	16.3	17.0	4.8	15.0	14.1	14.4	18.5	32.7	12.8	9.5	16.0	14.4	15.0	24.7	9.6	20.1	5.5	16.3	16.5	5.0	6.8	16.9	6.6	19.0	18.3	18.9	3.0	15.4	19.1	18.9	9.9	14.5	8.5	16.4	7.6	6.0	18.7	16.6	18.4	9.6	24.7	7.2	16.7	6.9	8.7	12.5	9.2	9.8	9.8	11.3	17.8	7.1	17.8	17.3	6.1	6.7	9.5	9.5	5.1	4.7	33.6	22.3	7.9	10.7	23.6	8.4	9.5	12.5	7.7	16.4	6.0	6.4	3.9	5.5	18.5	24.6	18.9	4.3	23.5	18.2	18.6	11.2	31.4	11.8	19.6	8.0	20.3	9.7	12.2	28.2	21.1	14.8	23.9	16.5	5.9	13.7	15.9	7.3	11.2	16.8	10.7	14.2	25.4	12.6	21.0	9.8	18.1	10.1	45.6	34.0	55.2	40.3	40.7	43.8	43.0	43.4	39.5	35.8	46.5	47.8	40.5	19.2	57.7	45.7	45.0	49.6	32.1	13.7	15.2	17.8	15.5	14.1	14.4	16.0	14.4	16.3	15.4	14.5	18.4	18.7	6.4	4.1	4.6	24.6	30.0	11.4	9.7	14.2	20.9	27.1	26.4	9.5	17.2	5.9	18.4	6.2	25.1	19.9	21.7	27.4	21.9	25.0	7.9	15.8	16.9	28.8	8.8	4.0	29.6	37.7	20.0	16.3	7.3	4.5	17.3	19.6	19.9	22.7	18.5	4.6	32.7	10.2	19.6	18.5	6.5	23.0	12.1	24.9	3.7	28.2	16.6	32.0	3.0	8.1	22.9	37.2	29.3	16.8	23.1	54.1	32.8	3.3	14.8	26.3	10.9	13.8	10.5	13.9	16.1	41.6	23.1	20.1	25.4	32.0	16.4
SEC61B		ENSG00000106803	"SEC61 translocon subunit beta"	P60468	9	99222064-99230615	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 1573.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049407	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Endoplasmic reticulum"		"HPA049407: AB_2680750"	"unprognostic (1.11e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.96e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.75e-1)"	173.5	235.8	101.0	154.7	104.0	255.5	153.4	104.3	120.8	179.4	105.3	139.3	155.0	167.7	259.4	169.8	155.0	129.8	106.7	104.4	110.8	213.7	465.3	169.0	184.0	104.5	102.1	158.5	546.0	145.9	209.5	98.3	105.8	168.0	102.8	48.5	347.7	124.3	61.0	122.5	132.9	106.3	106.8	173.1	186.5	76.4	103.8	188.8	179.8	44.2	146.7	148.8	139.1	111.6	226.5	213.3	244.1	243.7	234.5	296.0	293.9	327.6	335.8	299.9	259.2	307.3	172.6	305.3	244.3	298.7	328.9	272.0	171.9	259.5	143.1	325.4	238.7	160.7	200.7	440.3	509.9	278.9	198.3	268.0	389.4	237.3	210.3	268.1	369.8	246.7	255.0	581.1	285.6	407.7	255.6	404.9	196.3	533.9	497.7	244.2	207.7	398.1	332.3	158.3	252.7	179.2	183.6	421.1	441.5	190.8	163.4	378.6	265.1	215.3	260.0	363.5	277.7	312.0	226.6	200.7	359.3	176.6	145.6	875.3	460.3	453.3	354.6	387.9	480.8	356.5	389.3	360.4	481.0	257.1	242.9	267.7	388.5	325.7	350.8	1661.8	388.0	525.0	101.0	104.0	104.3	120.8	104.4	110.8	104.5	102.1	105.8	106.8	103.8	111.6	255.6	102.5	206.1	18.3	370.9	395.8	308.3	712.8	213.9	59.3	499.1	530.7	55.5	271.7	416.8	200.5	31.3	336.6	605.9	239.9	633.9	498.6	184.2	274.7	410.2	286.1	302.0	226.8	16.2	792.5	577.9	343.2	214.1	391.3	214.8	258.8	213.8	822.0	509.8	53.8	15.5	534.0	406.9	295.3	553.2	51.8	328.0	316.3	496.2	17.8	1573.9	197.3	284.2	15.6	25.9	633.4	280.0	304.3	1190.6	654.2	290.3	767.6	331.4	81.5	138.1	237.1	404.7	218.4	171.0	337.5	443.4	553.8	270.1	333.0	334.0	501.5
SEH1L	"SEC13L, Seh1, SEH1A, SEH1B"	ENSG00000085415	"SEH1 like nucleoporin"	Q96EE3	18	12947133-12987536	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039964	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA039964: AB_10795241"	"unprognostic (5.14e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.81e-3)"	"unprognostic (5.91e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.05e-2)"	17.4	12.0	15.8	16.5	17.0	12.8	14.5	14.8	22.9	12.5	12.5	15.0	11.6	13.7	12.2	19.7	12.1	9.8	15.6	19.8	18.3	14.9	22.4	12.3	19.8	12.2	12.1	12.1	15.1	10.7	14.2	12.6	12.7	11.1	13.9	6.5	11.9	9.1	37.3	15.8	12.0	13.4	13.4	13.2	12.0	15.0	16.6	23.8	12.5	26.9	21.5	19.2	13.2	17.8	53.6	40.6	30.9	49.2	21.2	31.5	45.1	45.5	46.3	52.3	59.8	104.7	27.5	114.8	54.0	53.1	46.8	26.6	72.8	52.0	67.5	31.9	46.8	71.6	38.4	62.3	47.7	197.0	45.4	22.5	40.1	60.6	88.8	21.8	27.7	51.6	98.1	41.5	42.9	57.9	106.3	84.4	39.2	215.5	41.9	70.6	71.8	74.6	40.6	53.4	59.8	35.7	58.2	43.7	47.9	22.3	27.3	64.7	22.4	53.5	123.6	81.4	80.7	30.6	48.1	122.1	35.1	70.1	35.0	4.1	23.5	5.6	14.0	31.6	18.5	23.7	16.3	17.0	37.8	23.9	20.9	18.0	2.6	23.6	26.4	20.6	12.2	22.6	15.8	17.0	14.8	22.9	19.8	18.3	12.2	12.1	12.7	13.4	16.6	17.8	13.1	6.4	20.2	8.5	26.5	54.7	47.0	24.6	40.9	8.0	16.3	12.8	14.0	14.3	18.3	12.9	12.5	23.6	16.1	12.9	9.8	15.0	9.2	18.5	19.2	19.3	19.2	26.1	15.3	13.3	31.8	17.9	15.8	27.6	7.6	17.8	13.2	21.6	21.3	3.3	10.1	20.3	14.2	13.2	20.4	11.4	9.3	19.7	16.0	12.2	16.9	5.8	7.2	6.0	13.3	16.0	15.3	10.9	23.9	46.7	11.5	16.5	8.5	10.1	13.1	26.8	22.3	16.9	14.0	41.6	59.8	23.7	16.0	19.6	24.9	43.0
SERGEF	"DelGEF, Gnefr"	ENSG00000129158	"Secretion regulating guanine nucleotide exchange factor"	Q9UGK8	11	17788048-18013047	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 155.4;Excitatory neurons: 114.9;Inhibitory neurons: 123.9;Late spermatids: 258.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037811, HPA037812, HPA074086"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA037811: AB_10672726, HPA037812: AB_2675680, HPA074086: AB_2686658"	"unprognostic (2.67e-2)"	"unprognostic (7.15e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.56e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.82e-2)"	16.1	17.5	35.9	9.4	37.4	6.4	16.4	49.6	42.8	19.5	32.2	25.4	7.4	16.8	18.4	12.5	16.5	9.9	18.9	39.0	39.1	19.6	14.0	14.0	10.7	37.4	53.9	27.5	23.1	17.1	36.8	5.7	43.8	21.3	12.3	22.5	15.1	18.0	22.7	20.2	13.8	16.4	34.8	12.8	19.7	5.0	37.3	12.3	27.7	21.7	13.5	21.5	17.7	39.1	10.8	13.2	10.6	22.3	19.1	18.6	7.2	9.0	18.3	9.5	12.0	8.5	3.7	9.5	11.0	12.2	26.1	14.5	37.3	27.6	7.5	21.0	37.7	15.3	10.6	36.3	21.5	13.5	16.6	17.7	27.4	4.8	20.4	28.6	10.5	20.8	9.2	17.6	15.2	16.0	14.0	30.0	8.9	33.7	16.2	18.3	13.0	10.0	21.2	16.1	27.1	5.9	15.8	16.1	17.1	21.1	7.2	12.1	6.2	8.9	12.1	13.1	10.2	12.3	16.1	12.9	15.5	15.4	10.2	15.6	21.3	17.1	34.5	17.6	28.6	25.5	35.5	25.8	26.1	18.7	34.8	30.5	2.3	22.4	17.5	10.5	41.4	25.9	35.9	37.4	49.6	42.8	39.0	39.1	37.4	53.9	43.8	34.8	37.3	39.1	12.7	6.4	6.8	58.4	14.3	26.5	25.3	30.5	15.9	14.1	18.5	20.8	11.6	10.0	13.6	11.0	2.1	6.4	14.4	7.8	39.2	17.1	155.4	3.3	5.1	9.0	48.5	7.4	114.9	24.5	12.5	14.4	4.6	5.2	14.5	26.7	12.5	14.7	14.3	11.8	123.9	14.7	34.6	17.8	14.9	258.3	19.6	9.3	21.4	44.0	12.9	31.7	17.5	82.9	46.5	14.0	9.8	21.4	11.6	18.7	12.3	46.0	7.6	10.9	6.6	13.3	16.9	9.0	7.6	8.7	20.2	3.1	18.2	15.6	13.0	20.0
SGK2		ENSG00000101049	"Serum/glucocorticoid regulated kinase 2"	Q9HBY8	20	43558968-43588237	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.5;kidney: 53.6;liver: 63.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 76.5;Distal tubular cells: 76.3;Hepatocytes: 32.8;Paneth cells: 21.7;Proximal enterocytes: 23.8;Proximal tubular cells: 25.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 20.5;CAPAN-2: 14.2;Hep G2: 18.7;OE19: 61.7;RPTEC TERT1: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008859, HPA011387"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA008859: AB_2668159, HPA011387: AB_1856744"	"unprognostic (1.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.98e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.72e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (5.65e-4)"	23.5	1.4	4.9	1.5	14.8	0.5	6.1	12.6	10.5	3.5	0.7	37.7	31.6	1.8	33.8	1.0	3.7	10.0	1.2	6.0	7.7	53.6	63.2	1.0	0.2	18.1	13.3	6.6	16.2	0.5	3.0	0.8	14.3	2.6	40.5	5.6	1.8	2.9	0.4	6.2	20.1	1.6	11.8	1.1	22.8	1.8	13.3	0.3	1.7	0.4	0.3	4.2	3.0	24.5	0.0	20.5	0.3	0.1	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.6	14.2	0.1	8.7	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.4	0.0	18.7	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	0.4	0.2	0.1	0.0	0.1	0.1	0.5	0.1	61.7	0.0	0.1	0.1	0.0	25.4	4.2	0.2	1.0	0.0	1.2	0.1	0.4	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	14.8	12.6	10.5	6.0	7.7	18.1	13.3	14.3	11.8	13.3	24.5	0.3	0.0	0.0	4.9	0.2	0.1	0.1	0.2	0.0	0.8	0.3	0.8	4.9	8.6	0.0	11.0	0.0	5.1	0.0	76.5	76.3	6.8	0.3	0.9	0.5	0.6	1.8	0.0	0.7	6.3	1.3	0.4	11.2	2.4	0.0	0.7	0.7	32.8	0.7	6.7	1.3	4.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	3.5	20.7	2.5	21.7	0.4	0.0	0.1	23.8	25.5	0.2	0.8	0.0	0.2	0.4	0.1	0.1	0.0	0.1	17.1	0.2	0.0	7.7	0.3
SGSM1	"KIAA1941, RUTBC2"	ENSG00000167037	"Small G protein signaling modulator 1"	Q2NKQ1	22	24806169-24927578	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.5;heart muscle: 11.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 97.0;Inhibitory neurons: 76.4;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 58.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.9;RPMI-8226: 2.2;SCLC-21H: 2.0;SH-SY5Y: 1.3;U-266/84: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003986	Approved					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA003986: AB_1856513"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.40e-4)"	"unprognostic (4.79e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.61e-6)"	"unprognostic (1.46e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.93e-2)"	0.5	3.3	12.5	0.4	11.5	0.2	0.9	6.8	12.9	1.2	4.3	2.0	0.4	0.6	1.0	0.3	4.7	0.6	11.5	10.1	20.5	1.8	0.1	1.1	0.4	11.2	15.4	1.8	3.6	7.8	10.5	0.3	19.0	1.6	1.6	1.5	1.3	0.8	0.6	3.2	0.9	0.5	7.5	0.3	2.9	1.8	18.2	0.3	2.1	0.2	0.3	1.7	1.1	9.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.9	0.3	0.0	0.0	2.2	0.0	0.3	2.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.1	12.5	11.5	6.8	12.9	10.1	20.5	11.2	15.4	19.0	7.5	18.2	9.4	1.4	3.2	6.9	2.6	0.7	3.8	9.8	0.1	2.2	3.2	1.5	1.9	26.4	1.5	1.5	5.5	4.2	0.3	3.2	3.1	3.9	1.7	0.5	10.3	0.9	3.7	17.3	0.0	97.0	1.9	0.1	4.5	7.1	6.6	1.3	0.1	11.4	0.1	1.9	1.7	76.4	6.4	0.0	0.3	8.4	0.5	0.3	0.8	10.6	12.2	0.1	2.1	5.2	33.7	58.6	1.3	5.4	0.4	0.5	5.6	0.5	0.7	1.5	1.5	13.1	3.1	2.5	1.2	7.9	0.4	3.8	0.3	2.3	0.3	4.8	4.8
SGSM3	"DJ1042K10.2, RabGAP-5, RABGAP5, RUSC3, RUTBC3"	ENSG00000100359	"Small G protein signaling modulator 3"	Q96HU1	22	40370591-40410289	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Gastric mucus-secreting cells: 176.4;Intestinal goblet cells: 135.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048980	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA048980: AB_2680585"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-3)"	"unprognostic (3.02e-2)"	"prognostic favorable (4.47e-5)"	"unprognostic (1.81e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.70e-3)"	"unprognostic (7.53e-2)"	"unprognostic (3.57e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.98e-3)"	24.8	42.6	34.6	26.1	34.8	19.3	29.4	27.3	43.6	37.3	32.6	46.6	32.8	31.9	14.5	49.2	37.1	28.7	37.0	33.2	33.3	36.4	37.3	33.8	32.9	36.5	34.3	30.8	107.7	24.7	55.0	21.9	34.8	62.6	24.3	11.0	70.1	25.9	34.2	36.7	46.1	17.4	27.6	51.5	91.4	39.8	33.6	27.5	48.7	23.4	28.3	33.1	35.6	31.9	37.8	21.1	30.6	34.1	33.2	18.1	43.4	35.0	22.9	26.0	33.7	12.0	30.9	23.3	23.7	37.9	15.6	30.0	29.2	42.9	10.4	58.4	68.8	15.9	56.9	11.3	31.6	23.1	33.1	30.2	29.5	29.1	17.4	29.2	46.0	48.6	19.8	31.4	19.4	60.5	32.1	23.5	20.5	75.8	14.0	59.3	19.3	51.1	26.8	33.0	18.8	24.2	38.6	55.4	27.5	24.2	46.3	38.9	40.2	8.8	31.8	23.4	20.6	47.1	23.2	31.0	37.4	19.0	22.9	1.1	14.6	16.3	18.7	15.7	15.6	17.7	11.5	14.9	18.9	22.3	13.8	11.3	3.3	35.4	11.9	31.6	11.7	15.8	34.6	34.8	27.3	43.6	33.2	33.3	36.5	34.3	34.8	27.6	33.6	31.9	5.3	3.2	10.3	14.0	32.8	11.5	32.4	33.1	14.8	57.0	12.1	7.1	8.3	27.1	42.1	7.3	18.8	42.8	23.9	46.4	1.9	20.2	17.5	5.1	3.8	14.3	31.3	18.1	27.1	45.3	54.3	14.0	176.4	6.7	15.9	3.1	21.8	24.0	24.2	26.9	34.6	135.3	50.8	17.2	8.3	31.7	22.7	11.8	16.0	13.1	21.6	13.4	30.9	15.6	15.1	21.3	40.6	19.2	30.5	46.1	36.2	4.4	60.2	34.0	39.5	14.4	13.8	83.5	44.4	19.8	10.4	45.6	16.7	3.3	47.7	60.0
SH3BGRL2		ENSG00000198478	"SH3 domain binding glutamate rich protein like 2"	Q9UJC5	6	79631329-79703655	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 161.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 156.3;Excitatory neurons: 86.5;Intestinal goblet cells: 87.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 50.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 81.6;HEL: 41.8;OE19: 99.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047486	Approved		Supported	Nucleoplasm		NA	NA		2000000	"Cluster 34: Basophils - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA047486: AB_2680065"	"unprognostic (3.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.21e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.53e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.33e-1)"	26.4	6.9	18.8	7.5	18.6	1.7	21.6	15.6	27.5	22.3	15.1	50.5	35.2	9.9	24.7	55.1	17.8	23.2	6.8	21.4	21.8	15.7	53.1	12.7	5.5	26.7	22.0	4.1	23.3	31.5	16.6	24.0	28.1	26.2	47.9	26.0	161.7	11.4	4.8	11.3	35.6	15.8	24.1	6.6	68.9	2.1	24.2	4.8	59.1	10.1	10.7	12.7	19.7	22.5	8.5	1.5	7.6	1.6	6.7	5.6	18.0	0.5	5.6	1.9	4.0	81.6	16.3	0.1	11.4	0.5	1.6	3.9	7.0	9.2	6.7	0.0	10.2	41.8	1.8	15.8	2.8	1.7	1.1	3.1	7.3	5.8	3.3	2.7	23.8	0.0	16.8	0.0	0.7	1.3	0.0	0.2	6.5	99.7	2.8	0.0	2.2	0.2	2.0	27.3	20.3	22.3	0.5	2.4	0.6	10.3	0.4	3.5	13.6	5.2	3.4	0.1	4.9	12.0	6.0	0.0	0.9	0.0	1.6	11.1	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.0	2.2	0.0	0.0	0.1	0.0	8.8	18.8	18.6	15.6	27.5	21.4	21.8	26.7	22.0	28.1	24.1	24.2	22.5	83.2	6.4	24.8	20.9	0.9	2.2	4.6	3.3	2.2	13.5	14.8	9.9	6.1	52.9	21.4	22.0	8.4	40.4	1.7	156.3	0.0	14.8	18.1	14.3	3.7	33.8	12.6	7.4	86.5	13.0	3.7	4.6	81.1	21.0	0.0	2.0	44.6	69.6	4.1	13.5	38.1	87.8	4.1	2.9	2.1	20.3	0.6	21.6	16.0	11.2	4.6	8.6	0.0	33.7	24.9	15.0	76.0	4.5	1.3	19.7	48.7	11.3	24.6	12.2	0.0	3.7	4.7	2.5	1.2	21.5	0.9	52.7	1.0	1.8	67.2	29.9
SH3YL1	"DKFZP586F1318, Ray"	ENSG00000035115	"SH3 and SYLF domain containing 1"	Q96HL8	2	217730-266398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 606.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 223.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030926, HPA030927"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA030926: AB_10670148, HPA030927: AB_10669874"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.57e-3)"	"unprognostic (9.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.81e-1)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.22e-3)"	13.6	32.0	26.6	11.9	27.7	11.6	54.8	27.5	37.2	31.8	28.3	45.6	35.1	27.0	40.8	43.8	43.6	45.2	11.0	26.8	25.5	145.6	11.6	35.7	22.1	27.4	26.8	28.6	161.6	55.7	33.9	26.9	27.8	34.4	53.2	10.7	114.0	24.3	13.4	75.0	51.7	11.9	26.4	16.0	72.3	17.0	27.9	15.4	59.2	8.3	28.0	49.3	27.1	33.1	12.7	2.4	13.5	6.0	18.1	16.8	9.0	15.7	17.4	5.8	6.0	33.6	46.3	0.6	7.3	13.8	3.9	51.6	3.4	67.6	5.4	10.2	2.4	3.0	3.9	10.9	14.5	1.5	3.8	18.6	68.2	3.5	11.0	28.7	8.7	17.2	0.9	2.3	12.0	37.1	13.4	6.9	4.4	223.4	2.6	6.4	4.1	0.9	41.4	69.8	5.5	9.1	2.6	64.1	11.9	17.5	44.0	10.6	6.6	2.9	0.8	16.9	6.9	1.7	0.1	1.2	28.8	20.7	9.8	38.9	2.5	1.9	4.5	3.1	14.3	12.6	22.4	11.5	6.1	10.1	33.9	20.5	1.5	22.9	4.9	5.5	30.6	8.2	26.6	27.7	27.5	37.2	26.8	25.5	27.4	26.8	27.8	26.4	27.9	33.1	14.8	57.7	116.7	51.2	29.7	82.7	173.5	174.4	42.7	19.3	140.2	130.3	6.6	313.1	139.7	101.2	22.9	197.7	15.8	84.5	291.6	129.2	136.6	148.5	32.3	15.9	49.1	3.8	62.3	143.9	69.9	22.6	31.1	216.6	15.8	51.9	19.2	7.9	26.5	26.9	57.1	97.4	109.9	9.5	17.0	113.1	36.7	14.9	72.9	23.4	15.2	9.4	30.9	44.2	87.2	104.6	115.3	41.0	4.7	166.3	125.1	606.2	85.2	9.7	26.3	20.4	20.5	63.3	23.2	29.5	115.4	247.0	35.7	37.1	123.8	245.3
SHB		ENSG00000107338	"SH2 domain containing adaptor protein B"	Q15464	9	37915898-38069227	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	22	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"OE19: 35.3"	"Low region specificity"	"Detected in all"							"CAB010161, HPA049911, HPA052108"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Nucleoplasm, Cytoplasmic bodies"	"CAB010161: AB_2187742, HPA049911: AB_2680949, HPA052108: AB_2681730"	"unprognostic (4.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.96e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-1)"	12.8	7.6	6.4	1.9	9.6	3.1	9.8	6.1	9.2	8.8	8.2	11.2	3.6	6.6	1.2	26.2	7.2	4.9	24.9	6.7	6.3	23.1	35.2	13.9	1.3	8.5	9.7	4.7	20.0	4.1	15.0	2.5	7.8	16.1	2.6	0.9	23.2	4.6	6.8	17.3	7.1	3.2	5.6	6.6	10.6	4.1	9.4	1.7	8.3	1.3	2.5	13.6	16.1	12.8	8.3	14.6	1.4	0.2	1.5	3.8	2.5	9.8	11.5	6.9	5.0	4.5	5.8	0.0	10.9	8.5	16.9	8.8	5.8	14.2	4.8	6.7	11.0	0.0	5.3	10.7	10.8	0.4	0.4	3.4	4.9	11.2	7.8	16.1	6.5	1.4	3.6	2.4	7.7	6.2	0.9	0.3	3.7	35.3	13.0	0.4	4.3	0.5	13.1	3.8	15.8	12.1	1.3	10.9	2.2	11.9	6.5	0.4	9.2	3.3	11.0	1.6	16.2	0.7	0.2	0.1	18.3	0.8	2.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	9.6	6.1	9.2	6.7	6.3	8.5	9.7	7.8	5.6	9.4	12.8	21.5	6.4	5.6	9.8	0.6	20.4	96.9	9.9	33.0	0.6	12.7	6.0	9.6	35.8	9.0	22.0	8.4	10.2	1.1	17.3	15.6	18.0	1.9	8.3	2.5	19.0	7.8	5.2	6.4	20.3	1.5	5.5	14.8	18.3	0.0	0.9	10.4	21.6	6.1	0.0	5.4	12.1	2.0	2.6	19.4	3.8	0.6	5.8	7.2	8.4	0.4	2.9	0.0	5.0	43.7	22.2	6.8	0.4	1.9	31.1	7.5	24.9	5.1	1.4	0.0	5.7	3.9	1.2	9.4	19.3	34.0	4.0	1.2	9.3	11.1	45.9
SHISA6	FLJ45455	ENSG00000188803	"Shisa family member 6"	Q6ZSJ9	17	11241213-11564063	"Predicted membrane proteins, Transporters"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 46.2;cervix: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.3;Excitatory neurons: 27.4;Inhibitory neurons: 181.4;Oligodendrocyte precursor cells: 77.4;Peritubular cells: 29.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	23	"OE19: 52.0"	"Low region specificity"	"Detected in all"							HPA023440	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA023440: AB_1848945"	"unprognostic (1.70e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.47e-2)"	1.7	0.6	17.7	0.0	11.0	0.0	1.1	23.2	25.3	16.8	0.8	0.6	0.2	6.2	0.7	0.8	1.8	0.3	0.8	46.2	18.9	1.9	0.0	0.2	0.0	43.3	25.5	0.6	1.0	3.4	0.2	0.1	24.4	4.3	0.4	1.1	0.2	7.3	0.7	0.8	0.3	0.5	44.8	0.0	4.2	2.9	34.7	0.0	0.5	1.3	0.0	1.1	3.4	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	52.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	11.0	23.2	25.3	46.2	18.9	43.3	25.5	24.4	44.8	34.7	27.0	0.9	0.0	0.0	50.3	0.0	0.1	0.1	0.0	1.2	4.0	1.8	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.5	16.9	1.6	1.2	0.0	27.4	0.0	0.0	2.1	0.0	0.5	0.0	5.6	0.4	0.0	0.1	0.0	181.4	0.0	0.0	0.0	0.3	15.2	5.0	0.0	1.8	12.2	0.0	0.8	0.0	77.4	2.4	0.0	0.0	29.0	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.2	1.7	0.4	2.5	0.1	0.1	0.0	0.1	4.4	0.2	0.2
SLC10A5		ENSG00000253598	"Solute carrier family 10 member 5"	Q5PT55	8	81693631-81695058	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.9;liver: 11.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 4.1;Enteroendocrine cells: 3.6;Gastric mucus-secreting cells: 6.1;Hepatocytes: 2.8;Proximal enterocytes: 7.2;Respiratory ciliated cells: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 3.6"	"Not detected"	"Not detected"							HPA025966	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA025966: AB_1856959"	"unprognostic (6.42e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.71e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.82e-7)"	0.1	0.2	0.9	0.3	0.9	0.0	0.2	1.8	1.4	0.3	0.0	2.8	3.2	0.3	0.7	0.3	0.3	1.7	0.2	0.8	0.9	1.8	11.3	0.2	0.0	0.6	0.7	0.3	1.0	0.2	1.0	0.0	0.7	0.6	3.7	0.5	0.3	0.2	0.2	0.4	3.9	0.2	0.2	0.3	3.4	0.1	1.0	0.1	0.5	0.3	0.2	0.3	0.2	0.8	0.2	0.2	0.2	0.3	0.2	0.5	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.4	0.5	0.0	0.0	0.2	0.3	0.1	0.2	0.2	0.8	0.6	1.3	0.5	0.1	0.0	0.1	0.1	0.6	0.2	0.8	0.6	0.1	0.2	0.5	0.3	0.3	0.2	0.2	0.4	0.0	3.6	0.2	0.0	0.1	0.2	0.2	1.4	0.5	0.3	0.1	0.2	0.1	0.1	0.5	0.1	0.3	0.3	0.5	0.4	0.5	0.3	0.9	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	1.8	1.4	0.8	0.9	0.6	0.7	0.7	0.2	1.0	0.8	0.2	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.3	0.3	0.3	0.6	0.0	0.5	0.0	0.0	0.0	0.0	4.1	1.9	0.4	0.0	0.4	0.3	0.2	3.6	0.0	0.9	1.1	0.1	0.1	6.1	0.3	0.0	0.3	0.7	2.8	0.0	0.0	0.8	1.5	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.5	1.9	0.0	0.0	0.4	7.2	1.7	4.1	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.5	2.4	0.5
SLC12A2	"BSC, BSC2, NKCC1, PPP1R141"	ENSG00000064651	"Solute carrier family 12 member 2"	P55011	5	128083766-128189677	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 75.6"	"Cell type enhanced"	"Detected in all"		"Intestinal goblet cells: 480.6;Oligodendrocytes: 566.6;Undifferentiated cells: 370.0"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 54.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"OE19: 153.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020130, HPA063697"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles	"Plasma membrane"	"HPA020130: AB_1854502, HPA063697: AB_2685094"	"unprognostic (4.61e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.20e-3)"	"prognostic favorable (8.60e-4)"	"unprognostic (3.99e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.95e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.88e-3)"	8.4	17.5	15.0	10.8	48.4	4.4	43.9	46.3	23.2	7.2	40.4	48.5	41.7	8.4	2.4	4.6	6.0	39.4	6.1	13.5	31.1	6.6	4.2	10.3	5.6	40.8	43.1	5.4	6.1	14.7	5.5	4.9	38.6	23.5	58.9	16.8	75.6	2.6	15.4	28.4	49.1	10.2	27.1	4.5	61.8	8.0	32.4	4.1	8.6	8.3	6.0	7.3	3.5	64.8	13.5	65.3	65.8	25.6	16.1	10.4	13.6	12.2	9.1	8.6	8.9	26.4	20.9	19.9	16.1	10.6	7.8	39.5	12.7	14.0	13.2	20.0	15.8	5.7	11.4	3.8	4.9	7.3	9.5	11.1	5.0	19.1	11.2	6.4	14.2	8.5	9.4	13.2	13.4	14.2	13.0	6.1	7.7	153.6	21.1	7.1	18.5	8.2	10.0	45.0	11.5	7.3	24.6	10.6	9.9	7.0	5.9	3.7	24.1	21.2	14.2	16.3	15.7	11.0	10.7	21.6	11.2	4.2	17.6	0.3	0.4	0.2	1.1	0.7	1.9	1.7	1.0	1.4	0.6	2.1	1.1	1.6	0.2	2.4	0.5	6.4	1.1	0.3	15.0	48.4	46.3	23.2	13.5	31.1	40.8	43.1	38.6	27.1	32.4	64.8	38.3	16.0	46.2	23.8	20.5	22.9	20.1	44.9	10.8	76.6	186.9	86.7	18.0	137.2	52.1	33.1	127.2	1.4	34.4	48.2	1.9	68.6	55.8	33.1	43.1	44.2	74.4	2.5	160.6	48.2	2.7	21.3	199.3	38.4	18.4	28.8	12.8	8.8	4.2	80.8	73.2	480.6	57.0	8.6	12.0	95.3	85.4	11.4	204.5	105.9	2.5	22.6	11.3	55.3	566.6	50.1	60.6	29.0	20.2	131.6	38.8	10.6	19.6	86.4	72.3	33.9	64.3	29.1	27.1	14.9	30.0	1.4	21.1	14.1	370.0	21.5
SLC24A1	"CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX"	ENSG00000074621	"Solute carrier family 24 member 1"	O60721	15	65611366-65660995	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision"		"Congenital stationary night blindness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	34	"retina: 193.5"	"Cell type enriched"	"Detected in many"	11	"Rod photoreceptor cells: 338.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039370	Enhanced		Approved	Microtubules		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 79: Retina - Phototransduction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules		"HPA039370: AB_10960279"	"unprognostic (9.47e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.39e-3)"	"unprognostic (4.64e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.91e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (8.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.96e-2)"	4.0	3.0	2.4	1.9	2.2	1.8	4.9	5.7	2.7	4.8	2.5	2.6	2.2	3.8	4.7	2.4	5.1	3.8	1.6	2.1	2.1	5.1	2.9	3.1	3.3	2.3	2.3	5.4	2.9	3.8	2.7	3.6	2.3	3.2	2.4	193.5	2.6	3.1	1.0	5.1	3.0	2.9	2.3	3.9	2.5	4.1	2.1	2.4	5.1	1.3	1.8	3.0	3.2	2.5	1.5	3.0	3.2	2.9	4.7	7.9	4.0	3.7	4.2	3.7	2.4	1.4	6.5	2.1	12.4	3.7	1.3	4.1	3.9	4.2	2.1	2.2	2.8	4.6	2.5	6.8	6.8	3.1	6.0	6.7	5.9	2.1	12.3	5.1	6.4	4.8	5.0	7.0	6.0	6.4	2.0	2.8	4.1	13.5	1.2	2.0	1.0	1.4	5.6	6.0	1.5	2.1	1.0	2.8	8.0	4.4	6.0	4.2	9.3	3.7	3.7	1.4	2.6	2.8	5.5	2.4	3.9	6.4	3.1	2.6	0.4	0.7	0.4	0.4	0.5	0.4	0.4	0.4	0.3	1.0	0.3	0.4	0.6	0.8	0.2	0.8	0.1	0.1	2.4	2.2	5.7	2.7	2.1	2.1	2.3	2.3	2.3	2.3	2.1	2.5	4.0	6.4	5.1	5.2	3.4	1.5	1.4	1.2	1.8	29.8	3.5	2.8	2.3	0.0	3.8	0.0	27.1	4.2	1.6	2.9	0.0	1.5	1.6	6.3	5.4	15.6	1.8	1.7	2.2	1.3	2.7	2.6	4.1	7.9	2.5	4.7	3.6	1.4	1.9	20.2	2.0	2.5	2.0	3.1	1.6	2.5	3.1	2.7	1.8	4.7	1.2	26.1	2.1	3.0	1.4	2.6	0.5	2.2	3.3	1.4	2.6	0.7	4.1	338.3	0.0	3.4	2.5	20.3	10.1	2.9	1.0	2.5	2.5	8.3	2.6	0.9
SLC26A9		ENSG00000174502	"Solute carrier family 26 member 9"	Q7LBE3	1	205913048-205943460	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"salivary gland: 72.4;stomach 1: 33.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 50.1;Cardiomyocytes: 26.2;Gastric mucus-secreting cells: 29.0;Proximal tubular cells: 25.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.5;Hep G2: 5.1;OE19: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051485	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Cell Junctions"		"HPA051485: AB_2681503"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.01e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	1.3	0.2	0.0	0.0	0.1	0.0	7.7	0.0	0.3	0.3	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	72.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	33.9	0.0	0.1	0.0	0.4	0.3	5.3	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.3	0.0	0.1	0.1	0.0	3.2	50.1	1.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.2	0.0	2.7	1.8	0.0	0.0	0.0	0.0	1.9	4.3	0.5	0.2	0.0	0.3	0.0	0.0	0.1	2.2	0.0	1.7	29.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.0	0.4	0.0	25.4	2.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	1.5	0.0	0.4
SLC27A2	"ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS"	ENSG00000140284	"Solute carrier family 27 member 2"	O14975	15	50182196-50236385	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 157.7;liver: 288.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 265.5;Hepatocytes: 205.7;Proximal enterocytes: 81.0;Proximal tubular cells: 198.9;Respiratory ciliated cells: 70.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 49.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	30	"basophil: 63.5"	"Lineage enriched"	"Detected in many"	30	"granulocytes: 63.5"	"Cell line enhanced"	"Detected in many"		"A549: 50.0;HaCaT: 89.3;HL-60: 66.3;OE19: 101.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA026089	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA026089: AB_1857060"	"unprognostic (3.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.38e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.48e-6)"	"unprognostic (5.01e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (6.40e-4)"	4.8	16.0	1.7	2.9	2.0	6.5	13.3	1.7	3.2	1.6	9.2	18.2	11.1	0.3	65.9	2.6	10.9	2.3	0.0	2.7	2.4	157.7	288.0	1.7	1.5	0.8	1.1	0.1	7.2	4.1	12.4	17.3	0.8	5.4	16.2	3.4	0.9	1.0	0.0	1.2	21.3	0.8	0.8	0.4	1.8	0.9	2.5	0.5	4.6	0.0	1.7	3.6	1.2	0.7	0.0	50.0	0.0	0.0	0.0	0.0	0.1	0.9	0.4	0.9	1.3	26.2	6.9	0.0	0.6	1.2	0.6	89.3	22.8	0.7	2.3	36.0	27.9	37.5	43.0	23.6	0.5	66.3	25.8	0.0	2.1	0.2	0.1	0.0	0.0	16.9	11.6	0.0	0.0	8.3	1.8	44.5	1.7	101.8	1.8	0.0	0.0	1.8	4.7	45.7	40.4	2.6	8.7	1.1	0.0	1.1	4.7	22.8	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	21.2	0.0	63.5	0.0	0.9	0.8	0.0	0.7	0.3	0.7	0.8	0.0	0.2	0.1	0.2	0.3	2.0	0.0	0.0	0.9	0.5	1.7	2.0	1.7	3.2	2.7	2.4	0.8	1.1	0.8	0.8	2.5	0.7	0.3	0.0	1.1	0.7	2.2	1.0	1.3	8.7	1.2	1.1	1.1	0.3	0.3	0.0	13.6	9.2	0.0	265.5	1.6	17.2	11.7	0.6	0.7	9.8	0.1	0.8	4.2	8.0	4.9	2.0	7.6	0.9	1.5	0.7	6.3	0.1	3.9	205.7	16.4	1.7	6.6	18.9	10.2	3.2	0.3	0.9	0.3	1.2	0.0	1.0	0.0	0.6	1.0	0.0	0.4	1.4	26.6	0.0	0.8	3.3	81.0	198.9	70.2	1.9	0.0	0.0	1.0	4.4	4.2	5.1	0.3	54.9	4.6	0.2	25.9	4.9
SLC35B2	UGTrel4	ENSG00000157593	"Solute carrier family 35 member B2"	Q8TB61	6	44254096-44257890	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029638	Approved		Approved	Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA029638: AB_10602402"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (3.84e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	20.1	36.7	21.2	19.6	25.7	18.4	25.2	27.0	42.3	23.3	24.1	27.1	19.6	28.5	29.5	17.5	26.2	30.0	26.4	19.5	23.3	30.3	30.6	21.7	21.5	25.8	25.1	21.3	41.8	42.5	14.6	25.0	25.6	24.0	28.8	14.6	46.4	27.4	22.4	21.9	23.9	29.7	26.1	24.7	30.6	14.7	26.1	18.5	24.4	23.7	22.3	28.1	19.5	30.9	87.2	48.8	61.4	117.6	106.4	102.3	44.1	95.1	152.3	89.3	109.4	43.3	79.3	19.2	81.9	117.3	97.7	81.1	42.5	106.3	64.4	57.4	53.3	39.8	37.9	59.5	94.1	85.2	61.5	107.0	112.1	85.5	43.1	129.1	67.4	43.2	56.8	81.4	112.5	106.9	32.5	71.0	27.2	271.3	58.9	30.9	38.3	100.2	100.3	65.5	75.4	71.4	45.9	52.2	109.6	37.6	93.3	75.7	65.8	71.0	46.2	71.3	83.3	62.4	75.7	45.6	95.6	67.6	147.5	51.9	14.5	23.5	33.1	11.4	28.3	19.7	18.6	25.2	12.9	13.2	16.6	22.0	1.3	20.3	3.9	23.5	16.4	17.7	21.2	25.7	27.0	42.3	19.5	23.3	25.8	25.1	25.6	26.1	26.1	30.9	8.0	6.4	11.5	8.5	19.2	13.5	32.0	58.3	23.9	9.7	31.6	30.1	7.8	37.1	34.8	27.6	2.1	59.2	15.3	15.2	13.7	84.0	0.6	16.0	17.8	11.1	19.7	10.5	3.5	73.8	52.1	27.5	14.3	19.5	34.9	11.9	13.6	18.7	38.4	10.1	4.3	21.6	57.0	11.4	10.8	2.3	23.3	22.0	53.4	4.7	22.0	38.8	23.7	9.5	13.8	67.4	25.9	19.9	23.3	36.3	18.8	13.5	18.4	12.5	0.0	18.3	24.5	21.0	60.8	17.4	13.9	35.2	14.0	14.8	31.5	24.2
SLC44A4	"C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT"	ENSG00000204385	"Solute carrier family 44 member 4"	Q53GD3	6	31863192-31879046	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 132.0;prostate: 83.0;stomach 1: 83.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 546.0;Exocrine glandular cells: 213.4;Intestinal goblet cells: 327.8;Paneth cells: 299.3;Proximal enterocytes: 267.7;Respiratory ciliated cells: 406.7;Undifferentiated cells: 259.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 222.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046977, HPA054176"	Enhanced					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046977: AB_2679887, HPA054176: AB_2682404"	"unprognostic (5.84e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.75e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.06e-6)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (6.06e-4)"	0.8	8.2	0.0	2.5	0.0	1.0	5.3	0.0	0.0	22.4	0.0	132.0	100.8	5.9	2.5	2.0	46.9	18.8	0.0	0.0	0.0	32.1	0.4	14.9	0.1	0.3	0.1	1.6	8.9	0.0	16.1	3.5	0.1	83.0	30.3	0.0	42.6	3.9	0.0	1.1	86.8	2.9	0.0	1.6	83.4	0.7	0.0	0.2	1.9	0.0	0.7	11.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	14.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	3.7	22.4	36.0	0.0	3.8	0.5	23.0	71.4	0.6	0.3	14.6	6.1	0.4	38.6	180.2	66.2	0.0	0.3	0.5	546.0	3.9	111.2	2.3	127.4	8.9	6.2	46.7	0.0	0.1	213.4	0.5	2.4	208.5	67.5	2.5	1.1	0.4	0.0	0.5	0.0	0.1	327.8	91.6	0.0	0.0	3.2	1.5	2.5	0.0	0.0	1.6	0.7	0.0	0.0	0.0	184.0	299.3	0.4	0.3	142.0	267.7	61.5	406.7	0.6	0.0	0.8	11.9	0.2	0.2	0.5	0.4	0.7	2.3	5.5	259.6	139.4
SLC45A4	KIAA1126	ENSG00000022567	"Solute carrier family 45 member 4"	Q5BKX6	8	141207166-141308305	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 49.7;Cone photoreceptor cells: 54.2;Endometrial ciliated cells: 57.6;Glandular and luminal cells: 97.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"eosinophil: 8.3;neutrophil: 7.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 18.3;OE19: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023154	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA023154: AB_2191204"	"unprognostic (7.79e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.73e-6)"	"unprognostic (8.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.40e-2)"	3.5	2.5	3.8	3.7	4.8	5.8	2.9	1.2	16.6	7.1	14.7	4.4	2.3	4.3	1.5	3.3	7.1	2.7	6.6	5.1	1.5	10.2	0.9	6.7	2.7	6.6	1.0	3.1	7.9	2.5	14.9	5.0	6.6	6.6	1.6	5.4	7.8	5.3	4.6	5.7	4.1	1.7	0.7	4.8	12.5	13.7	2.2	2.3	5.8	1.4	2.0	3.4	2.8	6.1	4.6	9.8	3.7	5.9	0.3	0.3	16.1	2.5	1.5	2.2	1.7	6.4	12.2	0.9	11.8	1.0	3.1	3.7	2.1	1.2	1.0	7.2	3.3	2.7	3.1	0.0	1.7	1.1	18.3	0.8	1.9	1.6	0.9	0.5	1.5	5.0	5.6	0.7	0.8	11.9	11.0	2.5	4.7	30.8	4.1	3.3	0.2	3.1	8.9	7.9	5.5	4.6	2.7	0.8	4.5	2.6	1.9	7.2	0.8	0.0	2.4	3.8	4.9	3.9	12.7	1.3	2.1	4.3	4.0	1.1	0.1	8.3	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	7.0	0.2	0.1	0.3	0.2	0.1	3.8	4.8	1.2	16.6	5.1	1.5	6.6	1.0	6.6	0.7	2.2	6.1	3.3	9.6	12.7	6.5	3.0	2.7	6.6	3.6	5.2	33.1	6.4	5.8	13.5	15.7	8.9	49.7	54.2	8.7	7.5	14.7	0.0	9.3	12.5	57.6	10.8	3.4	2.4	0.0	29.0	2.7	0.8	2.9	37.2	97.1	1.3	1.8	1.1	0.0	6.7	3.3	21.7	7.7	8.2	2.5	3.3	5.9	2.1	8.6	3.6	7.5	1.8	4.3	5.2	6.6	0.9	7.8	4.5	2.2	5.3	6.0	3.7	3.2	22.3	9.2	0.0	1.5	3.2	5.7	2.6	4.4	2.4	16.3	4.6	4.0	5.1	11.3
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043261-32113029	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 528.1"	"Cell type enriched"	"Detected in many"	6	"Proximal enterocytes: 768.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"OE19: 34.2"	"Region enriched"	"Detected in single"	26	"cerebellum: 7.6"	"Low region specificity"	"Detected in many"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	4.2	0.1	0.0	9.7	0.2	0.1	12.3	0.0	10.7	528.1	0.5	3.5	5.1	1.1	26.9	75.2	0.1	0.0	6.6	1.7	2.1	0.3	0.1	0.0	0.0	1.6	0.3	1.0	0.0	0.1	3.0	9.7	0.2	19.0	2.4	0.3	13.5	302.4	0.7	0.0	2.9	7.2	2.3	0.5	0.1	0.0	0.0	4.0	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	34.2	0.0	0.0	0.0	2.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.2	0.1	0.0	0.0	0.3	0.2	0.6	1.7	4.2	0.0	0.0	11.6	6.5	115.2	115.8	8.2	0.0	0.0	0.0	0.2	19.8	0.0	3.0	38.4	2.4	1.4	1.0	25.4	0.0	0.4	1.4	0.0	1.4	5.6	10.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	34.1	0.0	0.0	0.0	71.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	32.6	1.5	0.0	17.6	768.7	6.4	2.0	0.0	0.0	0.0	0.7	10.1	4.2	2.0	5.5	0.0	0.1	0.1	41.2	6.7
SLC6A20	"IMINO, SIT1, XT3, Xtrp3"	ENSG00000163817	"Solute carrier family 6 member 20"	Q9NP91	3	45755449-45796536	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"choroid plexus: 59.2;intestine: 24.2"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 74.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.7;OE19: 3.9;SuSa: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (1.57e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.09e-2)"	0.2	0.1	0.4	0.7	1.7	0.4	0.4	1.8	4.7	1.3	59.2	0.5	24.2	0.8	0.1	0.1	0.2	6.9	0.2	2.0	0.2	1.9	0.1	1.9	0.3	0.3	0.3	0.1	3.0	0.1	1.3	0.1	0.4	0.4	0.2	0.5	0.7	0.1	0.8	0.7	17.6	0.3	0.3	0.1	5.2	0.4	0.7	0.9	0.1	0.5	0.1	0.0	0.1	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.5	0.0	0.2	1.7	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.4	3.9	0.1	0.2	0.0	0.2	0.1	0.1	0.1	0.2	0.8	0.1	0.0	1.1	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	1.7	1.8	4.7	2.0	0.2	0.3	0.3	0.4	0.3	0.7	0.6	0.1	0.0	5.0	0.0	0.1	0.5	0.6	0.6	0.0	0.3	0.7	0.4	1.2	17.2	2.7	0.0	0.0	0.1	0.2	3.5	0.0	13.7	0.6	1.7	0.5	0.1	0.0	0.0	1.4	0.2	0.1	0.7	17.9	2.1	0.0	0.2	0.4	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	9.4	1.2	1.2	0.4	2.3	74.7	3.5	1.4	0.3	0.0	0.6	0.3	0.2	0.2	0.0	0.3	0.0	0.3	0.1	7.0	4.2
SLC7A7	"LPI, y+LAT-1"	ENSG00000155465	"Solute carrier family 7 member 7"	Q9UM01	14	22773222-22829820	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 131.6;kidney: 300.6"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 216.5;Kupffer cells: 410.6;Macrophages: 146.2;monocytes: 164.0;Proximal enterocytes: 423.1;Proximal tubular cells: 327.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 299.9;intermediate monocyte: 410.0;non-classical monocyte: 457.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 457.1"	"Group enriched"	"Detected in many"	4	"BEWO: 217.2;CACO-2: 385.7;OE19: 329.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036227	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036227: AB_10696653"	"unprognostic (1.34e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-1)"	15.1	9.0	3.1	37.4	3.2	19.7	6.8	3.8	7.5	7.3	4.3	13.8	107.0	5.3	2.0	3.7	7.8	17.0	5.1	2.8	3.8	300.6	16.4	54.1	29.1	6.9	4.7	2.1	5.2	78.4	1.4	18.2	6.4	3.5	15.0	1.0	5.4	2.8	2.0	3.2	131.6	15.6	5.1	56.8	8.6	32.8	7.1	9.6	4.6	2.8	25.2	14.7	4.1	8.1	0.2	11.2	1.2	0.5	1.9	3.7	217.2	2.2	16.3	0.4	1.4	385.7	34.4	17.0	72.2	1.4	1.2	13.3	0.1	0.0	0.6	0.6	0.2	0.9	0.4	3.7	9.1	1.9	1.6	7.1	1.0	1.0	0.5	1.8	25.3	1.5	0.1	12.8	2.9	0.6	0.4	1.7	3.6	329.0	0.1	2.9	35.5	9.8	0.8	1.3	0.4	0.8	0.6	0.5	2.5	9.4	0.4	8.3	1.3	0.8	1.7	0.6	0.5	2.7	0.9	8.9	0.9	0.8	0.2	0.2	299.9	1.1	0.5	410.0	0.4	19.1	0.2	0.2	99.5	13.8	0.7	0.4	36.5	0.3	457.1	3.4	0.9	155.1	3.1	3.2	3.8	7.5	2.8	3.8	6.9	4.7	6.4	5.1	7.1	8.1	5.3	12.8	7.1	2.0	14.3	1.0	0.2	6.7	1.8	0.2	0.5	1.7	0.9	67.2	5.6	3.7	0.0	1.2	5.7	3.0	11.7	8.2	61.1	1.7	1.2	5.0	1.2	0.0	0.6	6.4	5.2	4.4	2.6	0.4	1.3	0.7	16.1	3.0	216.5	0.0	1.4	7.2	2.0	410.6	16.8	11.8	3.7	146.2	5.4	20.6	164.0	0.4	4.1	0.0	0.8	8.9	12.5	0.0	20.1	0.1	423.1	327.6	9.2	1.3	6.6	0.8	1.4	17.8	2.2	0.4	0.4	1.8	2.7	38.8	6.4	0.1
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619553-102711355	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.7;stomach 1: 26.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 41.3;Early spermatids: 46.5;Gastric mucus-secreting cells: 41.8;Intestinal goblet cells: 23.4;Late spermatids: 31.4;Paneth cells: 38.7;Undifferentiated cells: 29.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.0;OE19: 37.3;RT4: 16.9;SK-BR-3: 14.7;T-47d: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA035121: AB_10602894, HPA035122: AB_2674477"	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.0	0.1	1.4	2.1	0.7	0.0	1.4	0.8	1.5	1.4	0.2	20.0	6.3	0.1	3.9	0.3	0.3	1.1	0.0	1.9	0.9	5.4	0.0	0.1	0.1	1.4	0.7	0.0	0.0	5.8	1.0	0.0	1.5	5.8	20.7	0.1	4.9	2.1	6.4	0.8	3.4	0.7	0.8	0.0	26.4	5.7	1.2	0.4	1.0	6.2	4.5	1.0	0.0	0.5	10.0	6.1	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.2	0.0	3.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.3	3.4	2.9	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	7.7	0.0	0.1	0.2	37.3	5.0	0.0	0.1	0.0	1.1	16.9	0.1	0.0	0.0	14.7	0.0	0.0	18.5	0.0	0.0	0.0	0.7	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.8	1.5	1.9	0.9	1.4	0.7	1.5	0.8	1.2	0.5	0.0	0.0	0.0	2.0	0.3	0.4	0.2	0.1	0.0	0.0	1.1	0.1	0.8	0.0	0.3	9.2	0.0	0.5	0.0	41.3	0.0	0.2	46.5	0.5	0.2	0.3	9.7	0.0	3.0	0.0	0.0	0.0	41.8	3.1	0.0	0.0	0.0	0.0	0.1	0.0	14.6	23.4	6.1	0.0	0.4	31.4	0.6	0.0	0.0	5.6	0.0	0.5	0.0	1.0	1.0	8.5	38.7	0.0	0.2	4.1	3.2	1.4	0.1	0.1	0.0	0.5	0.1	4.5	0.2	0.0	0.6	0.3	0.2	0.0	29.6	0.8
SLC9A4	NHE4	ENSG00000180251	"Solute carrier family 9 member A4"	Q6AI14	2	102473226-102533972	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"stomach 1: 53.8"	"Group enriched"	"Detected in some"	12	"Collecting duct cells: 25.8;Gastric mucus-secreting cells: 54.0"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.3;OE19: 6.8;RT4: 4.1"	"Group enriched"	"Detected in some"	18	"hippocampal formation: 10.6;olfactory bulb: 6.8"	"Low region specificity"	"Detected in single"			HPA036096	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Plasma membrane"		"HPA036096: AB_2674939"	"unprognostic (1.41e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.09e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.17e-2)"	"unprognostic (5.35e-1)"	"unprognostic (9.44e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.04e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-2)"	0.0	0.0	0.4	0.1	0.5	0.8	0.2	0.7	0.7	0.3	0.0	0.0	2.0	0.1	0.1	1.5	0.1	1.2	0.6	0.4	0.4	8.6	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	1.3	0.5	1.4	0.4	0.0	0.0	0.0	0.2	53.8	0.3	0.2	0.1	0.1	0.0	0.5	0.4	0.1	0.6	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	2.3	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.5	6.8	0.2	0.0	0.2	0.1	0.0	4.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.5	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.7	0.7	0.4	0.4	0.1	0.1	0.2	0.0	0.2	0.6	0.0	3.2	3.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.4	0.0	0.9	25.8	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	54.0	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.0	0.0	0.0	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.1	0.4	0.0	0.3	0.3
SLCO2B1	"OATP-B, OATP2B1, SLC21A9"	ENSG00000137491	"Solute carrier organic anion transporter family member 2B1"	O94956	11	75100563-75206549	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 229.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 204.5;Hofbauer cells: 122.2;Kupffer cells: 155.8;Macrophages: 92.4;Microglial cells: 232.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 90.3;GAMG: 21.2;Hep G2: 20.4;HMC-1: 25.8;OE19: 111.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020659	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"			"HPA020659: AB_1857219"	"unprognostic (8.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.75e-3)"	"unprognostic (2.54e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	39.9	31.5	40.1	34.0	35.9	2.9	12.1	34.0	37.4	18.1	21.3	30.9	42.1	9.5	3.6	19.7	13.2	28.4	15.6	31.9	47.2	21.0	229.6	60.7	60.1	75.7	53.4	9.4	22.1	7.9	5.1	43.9	63.0	6.1	23.6	1.5	8.4	9.6	5.6	4.3	51.3	26.3	49.7	46.4	15.0	6.0	80.4	16.7	10.1	8.0	28.5	26.3	6.2	55.1	0.0	0.7	2.8	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	90.3	0.0	0.1	0.1	0.0	21.2	0.2	0.0	0.0	0.0	1.1	0.0	15.0	1.0	20.4	0.0	1.1	25.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.3	8.7	0.0	0.1	0.0	0.1	0.1	111.1	0.0	0.0	2.4	9.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.8	0.0	0.0	1.9	0.0	0.1	0.3	0.0	1.5	1.8	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	35.9	34.0	37.4	31.9	47.2	75.7	53.4	63.0	49.7	80.4	55.1	4.7	0.0	8.9	1.3	0.7	1.9	0.0	0.0	1.8	3.4	0.9	1.4	2.8	11.5	1.8	0.0	0.0	0.9	0.1	14.7	1.9	0.0	2.8	0.0	0.1	28.8	0.0	2.7	0.5	0.2	2.3	3.6	0.5	0.0	22.9	6.1	3.6	204.5	122.2	0.0	0.5	6.6	0.0	155.8	8.9	1.7	10.8	92.4	0.0	232.3	2.0	0.2	0.0	1.5	0.6	0.1	14.6	10.5	1.4	0.0	46.7	8.2	0.7	0.7	0.0	3.0	1.1	0.4	0.2	4.5	0.4	2.5	0.7	0.4	13.3	0.1
SMAGP	"hSMAGP, MGC149453, MGC149454"	ENSG00000170545	"Small cell adhesion glycoprotein"	Q0VAQ4	12	51244558-51270415	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 139.8;placenta: 102.1"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 1219.9;Syncytiotrophoblasts: 842.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 131.2;OE19: 163.9"	"Low region specificity"	"Detected in all"							HPA039711	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA039711: AB_10674985"	"unprognostic (2.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.52e-1)"	14.0	17.2	2.7	9.9	2.7	3.5	16.1	5.2	3.2	33.8	3.4	57.5	17.6	6.5	20.7	139.8	8.3	16.2	10.3	3.0	2.5	43.0	10.2	17.7	6.0	2.8	2.9	11.4	16.5	11.1	4.3	102.1	2.8	10.5	59.3	1.0	24.1	8.6	3.4	34.8	19.6	8.5	2.6	13.7	35.9	8.1	3.3	1.5	8.7	6.8	27.6	17.5	67.9	3.0	81.6	24.2	2.9	2.7	10.5	40.9	131.2	61.1	60.9	30.6	18.7	48.9	83.2	1.0	10.5	37.9	11.6	28.3	17.1	23.5	42.6	4.1	14.2	10.9	3.3	16.5	28.8	2.7	10.1	26.7	17.8	66.3	59.4	69.4	74.6	20.6	8.7	4.7	49.9	71.4	13.4	9.8	12.3	163.9	93.9	0.8	0.8	3.1	44.0	18.5	3.3	4.1	13.4	53.2	10.2	31.3	45.0	4.2	26.1	33.9	32.7	1.7	37.8	1.7	2.4	1.6	49.8	26.3	18.7	4.6	6.6	12.0	15.4	4.6	10.0	36.9	6.8	11.1	4.7	38.1	6.3	11.0	16.0	19.8	5.4	2.9	5.3	6.8	2.7	2.7	5.2	3.2	3.0	2.5	2.8	2.9	2.8	2.6	3.3	3.0	44.1	0.0	25.7	0.3	26.3	21.7	74.3	35.5	12.0	1.3	23.4	25.8	1.7	55.8	44.7	16.5	0.0	1219.9	21.7	85.0	49.0	43.6	11.7	4.8	2.3	60.9	20.4	8.6	0.6	108.7	108.0	11.4	47.9	8.7	12.7	19.7	51.4	6.7	96.8	1.7	0.5	121.5	26.4	6.3	11.2	3.2	13.1	6.1	14.2	6.5	7.9	4.1	38.1	0.0	0.5	142.5	88.1	9.8	5.7	73.7	35.0	22.6	17.4	1.7	26.3	4.8	11.1	6.2	31.3	80.7	29.7	842.5	13.8	9.8	121.7	105.2
SMIM2	"C13orf44, MGC5590"	ENSG00000139656	"Small integral membrane protein 2"	Q9BVW6	13	44143150-44161257	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 23.4"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 53.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.5;OE19: 4.8"					"Low region specificity"	"Detected in single"			"HPA026891, HPA077071"	Enhanced		Uncertain	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"		"HPA026891: AB_10602924, HPA077071: "	"unprognostic (4.34e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.87e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.05e-2)"	0.2	0.2	0.6	0.1	0.7	0.0	0.0	0.2	1.9	0.0	0.5	0.8	0.8	0.0	2.9	0.3	0.2	0.3	0.9	0.5	0.4	0.8	0.4	0.2	0.0	0.1	0.6	0.1	0.6	0.0	0.2	0.4	0.1	0.2	0.0	0.3	0.5	0.1	0.9	0.3	1.9	0.5	0.1	0.2	0.5	23.4	0.3	4.9	0.3	0.0	0.0	0.3	0.0	0.4	0.4	0.2	0.4	0.0	0.0	0.0	0.4	0.0	2.5	0.5	0.0	0.5	0.1	0.7	0.4	0.0	0.4	1.2	0.0	1.0	0.7	0.0	0.7	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.3	4.8	0.4	0.4	0.0	0.0	0.0	0.1	1.1	0.5	1.3	0.5	0.9	0.9	0.0	0.0	0.2	0.0	0.5	0.7	0.1	0.0	0.0	0.2	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.7	0.2	1.9	0.5	0.4	0.1	0.6	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0
SMIM6	"C17orf110, ELN"	ENSG00000259120	"Small integral membrane protein 6"	P0DI80	17	75646243-75647975	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.1;kidney: 22.1;stomach 1: 33.1;testis: 26.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 565.7;Endometrial ciliated cells: 233.1;Enteroendocrine cells: 197.1;Late spermatids: 1243.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	42	"plasmacytoid DC: 34.2"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 34.2"	"Cell line enhanced"	"Detected in some"		"A549: 11.7;CACO-2: 3.8;EFO-21: 8.7;HEL: 6.7;Hep G2: 3.6;OE19: 10.5;RPTEC TERT1: 4.2"									HPA065721	Uncertain		Approved	Nucleoplasm		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA065721: AB_2685546"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.06e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (2.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.64e-4)"	0.2	0.1	3.4	0.8	5.8	1.1	0.1	4.9	5.1	2.4	2.5	6.5	9.5	1.1	2.8	0.1	24.1	9.6	0.0	3.6	3.9	22.1	6.6	2.4	0.4	5.4	5.6	0.1	5.6	2.1	0.0	0.3	5.8	0.2	6.6	0.1	0.1	1.4	0.1	0.3	5.9	0.1	4.1	0.2	33.1	26.1	4.7	0.1	0.1	0.0	0.3	1.8	0.1	8.2	0.7	11.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	3.3	0.0	8.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	6.7	0.4	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.2	4.2	1.9	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	34.2	0.0	0.3	3.4	5.8	4.9	5.1	3.6	3.9	5.4	5.6	5.8	4.1	4.7	8.2	0.1	3.2	3.1	0.0	0.9	0.1	3.4	2.3	0.0	0.0	0.2	0.1	0.1	35.8	5.4	35.0	0.0	0.5	9.5	56.2	137.0	35.9	565.7	233.1	2.9	0.8	197.1	0.0	0.0	16.6	3.7	0.3	70.3	22.1	0.0	0.0	0.4	7.0	0.6	0.0	0.0	51.5	8.2	0.0	0.3	1243.9	6.5	1.4	0.0	0.0	1.6	0.0	0.0	0.0	4.5	55.8	129.5	1.9	0.5	2.6	32.7	24.5	38.4	0.0	6.6	0.2	0.4	5.2	2.6	0.0	0.0	4.1	0.9	0.0	4.4	9.6
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 156.3;Distal enterocytes: 291.5;Paneth cells: 157.5;Proximal enterocytes: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"basophil: 80.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 80.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.2;hTCEpi: 36.9;OE19: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"	No	No		26000000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	15.0	23.3	4.6	18.7	5.1	22.9	23.7	8.2	9.4	72.8	8.9	60.7	45.5	13.3	6.5	13.6	7.9	17.2	5.6	5.3	5.7	47.4	80.0	14.1	21.4	5.9	5.4	9.1	20.8	32.4	7.5	44.0	5.9	21.8	65.7	6.0	13.7	16.6	39.8	64.5	77.3	8.5	5.7	27.0	30.5	2.9	5.4	5.1	9.1	55.8	16.2	35.5	30.9	7.7	0.3	2.6	6.1	2.8	44.2	19.9	19.5	10.4	27.8	3.1	6.6	3.3	2.7	0.0	1.4	6.6	8.2	4.9	1.7	5.3	2.6	0.0	5.4	2.5	9.8	9.0	28.3	0.0	0.1	24.4	36.9	3.0	5.3	12.0	5.5	0.0	3.8	0.0	12.7	9.3	0.0	0.2	1.1	58.8	8.0	0.0	10.8	0.4	15.1	4.2	4.4	0.1	1.5	18.5	27.9	3.9	3.1	1.4	11.0	5.9	3.5	0.6	6.8	0.0	0.0	0.0	8.7	4.9	13.7	80.9	4.0	1.1	0.0	4.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	7.5	0.0	0.0	1.4	4.6	5.1	8.2	9.4	5.3	5.7	5.9	5.4	5.9	5.7	5.4	7.7	11.8	3.2	17.8	5.2	2.4	53.7	24.5	13.7	15.9	3.0	12.2	6.6	4.0	25.8	9.7	5.5	4.2	156.3	0.4	291.5	56.7	24.6	0.2	4.2	12.6	7.1	48.7	5.7	7.4	25.7	40.4	46.3	34.7	5.2	10.1	0.8	18.9	77.8	62.7	3.3	10.5	61.7	59.0	126.3	10.0	1.2	15.5	33.4	35.6	11.2	9.9	11.5	2.1	11.1	11.0	19.5	157.5	14.3	0.9	16.7	383.1	129.3	7.5	6.2	13.1	12.8	9.9	1.1	3.7	15.5	76.0	115.1	2.0	11.4	38.9	16.6
SNRPD1	"HsT2456, Sm-D1, SNRPD"	ENSG00000167088	"Small nuclear ribonucleoprotein D1 polypeptide"	P62314	18	21612314-21633524	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040516	Supported					NA	NA		480000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA040516: AB_10673236"	"unprognostic (1.83e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.61e-2)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-3)"	"prognostic favorable (7.90e-6)"	"unprognostic (1.87e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.83e-1)"	45.9	35.7	33.1	54.5	32.6	94.6	39.0	34.4	51.8	37.1	31.0	48.8	42.2	37.3	26.4	67.0	33.6	23.0	33.0	32.6	34.0	52.3	37.7	33.1	72.6	32.6	34.0	42.0	29.9	23.5	41.9	36.5	33.5	33.1	44.2	33.0	35.0	17.8	48.7	39.6	44.9	28.4	32.8	43.7	36.6	45.0	32.8	79.3	28.9	24.8	71.6	47.3	41.4	33.7	246.1	123.1	377.9	184.5	59.1	49.4	174.4	264.5	85.4	176.9	170.4	234.4	125.5	328.0	214.6	102.7	245.2	231.2	246.0	167.7	191.3	210.4	201.4	276.3	193.1	284.2	78.5	673.4	232.5	52.9	92.1	173.1	156.1	122.0	96.8	327.9	286.5	178.5	120.4	179.7	436.3	470.2	297.7	468.0	214.2	345.1	275.7	351.0	129.9	176.2	235.7	244.4	219.0	165.9	207.3	167.0	120.5	390.7	155.0	179.0	354.4	154.6	455.6	319.8	317.6	671.2	130.4	409.8	203.3	50.1	129.4	48.5	122.5	162.0	134.4	204.4	154.0	152.1	221.4	194.6	160.7	141.6	10.8	137.0	189.7	224.2	193.3	147.3	33.1	32.6	34.4	51.8	32.6	34.0	32.6	34.0	33.5	32.8	32.8	33.7	105.6	80.1	76.3	5.2	123.2	202.5	227.3	343.6	109.8	58.4	116.4	157.6	55.4	111.5	200.4	99.3	12.5	423.3	101.8	101.8	215.2	210.8	15.6	119.2	136.9	138.4	122.8	229.5	12.1	194.3	544.1	132.0	86.2	109.4	100.8	158.7	99.9	113.2	242.9	47.1	12.5	192.1	215.7	106.3	152.5	26.3	108.7	96.9	113.8	6.5	163.6	102.6	117.4	10.1	11.8	236.3	113.2	88.8	122.6	343.1	87.3	214.8	153.4	50.0	98.6	149.0	183.0	282.8	265.2	177.2	221.9	261.9	112.5	161.1	229.8	233.9
SNU13	"15.5K, FA-1, NHP2L1, SNRNP15-5, SPAG12, SSFA1"	ENSG00000100138	"Small nuclear ribonucleoprotein 13"	P55769	22	41673933-41690504	"Predicted intracellular proteins, Ribosomal proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 1057.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA029199	Uncertain					NA	NA		28000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"			"HPA029199: AB_10601041"	"unprognostic (3.02e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.43e-1)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.43e-1)"	64.9	125.6	156.5	74.5	157.7	135.7	80.7	146.4	159.5	81.8	134.4	77.8	64.9	64.6	99.0	65.5	91.2	55.7	145.1	159.1	191.3	75.7	65.2	61.9	97.4	159.5	159.4	96.7	74.8	113.6	52.7	67.5	173.3	65.8	73.5	85.5	74.8	70.9	187.1	73.3	56.1	71.4	150.1	71.2	66.3	94.9	173.3	98.2	90.1	178.0	108.4	88.7	34.0	151.9	222.8	100.2	151.8	203.7	192.7	173.5	160.1	212.6	181.4	303.0	259.6	215.1	195.0	148.6	165.5	183.6	91.6	160.3	183.6	239.0	205.5	178.1	428.0	163.0	191.1	313.1	249.5	345.3	217.9	157.7	247.0	226.6	330.2	142.1	175.2	161.2	227.3	244.8	200.6	262.7	238.0	369.7	215.6	852.4	240.8	252.7	126.7	505.5	279.6	128.9	135.9	125.0	102.4	249.4	333.7	160.6	116.8	218.1	125.1	152.6	175.3	191.0	166.8	273.7	366.5	353.6	206.9	195.5	218.1	205.5	224.8	210.8	210.5	233.3	225.3	357.4	252.0	226.6	240.3	311.2	266.1	247.4	67.5	205.3	208.5	288.2	346.2	339.9	156.5	157.7	146.4	159.5	159.1	191.3	159.5	159.4	173.3	150.1	173.3	151.9	217.9	80.1	121.9	0.0	265.1	0.0	390.5	0.0	196.9	160.1	224.4	272.3	0.0	190.1	65.0	185.8	25.0	367.3	205.8	42.1	655.4	310.0	1057.6	223.4	169.0	198.0	70.4	144.7	0.0	302.3	438.5	172.4	125.4	251.9	77.0	162.3	181.3	205.0	293.1	109.4	0.0	118.9	0.0	140.1	0.0	318.4	211.9	162.9	0.0	0.0	186.3	181.8	151.4	0.0	0.0	340.9	127.7	174.2	261.9	630.5	202.2	462.5	68.5	128.4	138.1	169.0	143.0	505.9	279.5	219.8	0.0	460.5	208.0	193.8	139.5	505.0
SPINK14	SPINK5L2	ENSG00000196800	"Serine peptidase inhibitor Kazal type 14 (putative)"	Q6IE38	5	148169733-148175398	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8;intestine: 1.0;liver: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"OE19: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"				"unprognostic (4.98e-2)"		"unprognostic (3.44e-1)"				"unprognostic (1.94e-2)"	"unprognostic (2.96e-2)"				"unprognostic (5.69e-1)"		"unprognostic (1.48e-3)"				0.0	0.0	2.3	0.0	1.3	0.0	0.8	0.5	3.3	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.6	0.0	1.1	0.1	0.0	1.6	1.0	0.0	0.0	0.0	0.0	0.2	2.5	0.1	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.3	0.5	3.3	0.9	0.6	1.6	1.0	2.5	1.0	1.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SPINK4	"MGC133107, PEC-60"	ENSG00000122711	"Serine peptidase inhibitor Kazal type 4"	O60575	9	33218365-33248567	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 980.5"	"Cell type enriched"	"Detected in some"	14	"Intestinal goblet cells: 8017.1"	"Group enriched"	"Detected in many"	20	"colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	12	"HMC-1: 175.7;OE19: 480.7"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Low region specificity"	"Detected in single"			HPA007286	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Secreted to digestive system"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA007286: AB_1080083"	"unprognostic (3.49e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.85e-5)"	"unprognostic (3.09e-4)"		"unprognostic (1.49e-1)"		"unprognostic (1.00e-1)"		"unprognostic (9.66e-2)"	"unprognostic (2.43e-1)"			"unprognostic (1.24e-1)"	"unprognostic (3.25e-1)"		"unprognostic (2.42e-3)"	1.4	0.6	0.0	84.2	0.0	0.6	0.1	0.7	0.3	0.0	0.1	639.5	263.4	1.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.1	0.1	0.0	0.9	2.1	0.9	0.0	0.1	0.0	980.5	92.1	0.1	0.5	0.2	0.1	638.1	42.2	0.0	0.2	1.4	0.3	0.0	0.1	0.0	0.0	0.0	17.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	3.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	11.7	27.8	1.1	0.0	0.0	175.7	0.0	0.0	0.0	0.4	0.5	0.0	0.1	4.1	0.3	0.0	3.9	0.4	2.3	0.0	480.7	0.4	0.0	0.0	0.2	0.0	0.5	0.4	1.4	15.2	3.1	0.0	0.1	14.2	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.3	0.1	1.4	0.3	0.0	1.8	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.3	0.0	0.0	0.0	21.7	0.1	0.0	0.0	0.0	0.0	5.5	12.5	0.1	0.0	56.5	0.0	0.2	1.0	0.1	0.0	0.6	88.2	0.0	0.0	0.0	0.0	0.0	43.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8017.1	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.5	0.1	0.1	106.8	0.0	0.1	0.2	541.4	0.0	0.0	129.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.1	191.5	0.2
SPIRE2	"KIAA1832, spir-2"	ENSG00000204991	"Spire type actin nucleation factor 2"	Q8WWL2	16	89818179-89871319	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 21.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 54.9;Gastric mucus-secreting cells: 46.9;Intestinal goblet cells: 43.8;Paneth cells: 39.9;Syncytiotrophoblasts: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 29.5;T-47d: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041413, HPA049415"	Uncertain		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	"Vesicles, Intermediate filaments"	"HPA041413: AB_2677464, HPA049415: AB_2680755"	"unprognostic (2.92e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.07e-3)"	"unprognostic (6.96e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (9.77e-5)"	"unprognostic (2.10e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.95e-3)"	"unprognostic (7.21e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.59e-2)"	1.6	2.1	8.8	1.2	9.0	1.2	1.9	12.5	12.3	2.5	3.8	15.7	7.8	1.7	1.8	2.9	6.1	2.0	0.9	9.1	7.6	4.5	6.5	2.3	0.5	9.8	7.9	1.8	2.2	3.6	21.5	4.5	10.4	4.7	8.2	3.1	2.5	3.1	0.6	2.0	9.2	1.0	5.5	1.0	14.4	5.0	7.5	0.4	6.9	0.0	0.4	6.1	2.2	8.5	0.4	8.4	5.2	4.2	1.4	0.9	17.5	2.7	1.6	3.9	1.6	3.2	9.0	5.8	1.2	0.8	4.0	9.0	2.2	0.3	1.1	2.2	10.1	1.3	7.1	8.9	1.4	0.3	1.8	1.8	2.0	1.2	1.0	0.5	0.2	0.5	9.2	1.4	1.1	12.8	0.1	2.2	5.7	29.5	5.3	4.6	1.9	1.3	2.0	8.6	13.6	7.0	11.6	5.0	5.1	4.4	18.8	3.0	0.4	2.3	4.9	3.3	2.5	0.7	3.7	0.5	3.5	2.1	4.9	2.4	0.5	0.3	0.4	0.3	0.2	0.4	0.3	0.2	0.1	0.7	0.4	0.4	2.0	0.5	0.5	0.6	0.2	0.3	8.8	9.0	12.5	12.3	9.1	7.6	9.8	7.9	10.4	5.5	7.5	8.5	0.7	6.4	4.8	10.7	0.6	0.9	5.1	1.7	2.2	13.0	4.3	2.8	2.4	14.3	2.4	12.9	4.2	15.7	2.1	54.9	3.9	1.5	3.1	11.9	2.6	1.1	15.7	0.0	20.2	0.4	3.6	1.4	46.9	3.2	0.0	4.2	0.0	2.4	2.7	23.5	23.6	43.8	2.0	1.0	1.1	2.5	0.9	1.4	0.0	1.9	0.2	2.8	1.0	7.1	4.1	1.5	39.9	1.9	0.7	5.0	29.8	0.8	13.5	10.7	0.0	2.8	1.6	6.0	8.8	3.8	0.6	70.5	1.3	5.7	33.5	30.2
SPOP	"BTBD32, TEF2"	ENSG00000121067	"Speckle type BTB/POZ protein"	O43791	17	49598884-49678163	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"				"unprognostic (1.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.83e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (1.89e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.29e-1)"	32.3	26.8	33.4	28.7	37.6	13.6	30.2	49.8	39.8	45.7	35.9	92.2	27.4	50.1	35.8	56.9	42.2	29.8	41.0	36.1	37.3	29.5	37.1	33.1	38.9	33.1	34.0	40.9	25.1	30.9	22.7	32.5	34.6	64.8	39.2	38.2	32.8	81.7	57.2	26.5	34.0	77.8	31.8	32.8	35.0	17.0	38.4	43.6	35.2	52.4	42.8	46.7	30.6	42.8	33.7	30.9	40.9	18.3	49.0	51.8	28.0	44.1	47.6	57.6	62.8	71.1	36.8	56.4	84.2	41.3	38.5	29.2	49.3	29.1	68.8	111.4	57.6	70.6	38.9	47.8	54.6	45.9	50.3	39.0	41.4	42.9	46.2	43.1	60.9	39.6	73.3	54.2	42.4	33.3	79.2	44.0	11.4	80.9	46.3	48.8	64.5	79.9	32.9	21.0	65.2	26.7	29.7	14.1	37.2	22.5	54.2	45.8	55.4	65.9	41.0	49.9	39.5	52.3	51.7	50.6	37.6	41.0	32.9	145.3	71.2	93.0	61.3	68.7	59.8	76.4	66.0	68.9	91.8	80.2	98.2	78.9	107.9	74.9	88.8	67.9	63.9	92.4	33.4	37.6	49.8	39.8	36.1	37.3	33.1	34.0	34.6	31.8	38.4	42.8	54.5	48.1	41.6	80.6	59.2	42.8	36.2	26.7	34.7	72.7	44.5	38.7	51.6	35.8	30.4	29.5	43.8	23.3	47.3	25.9	29.4	36.5	24.4	30.3	38.8	57.5	51.5	53.2	50.5	28.2	23.3	55.9	18.8	28.4	31.0	39.2	66.8	47.3	38.5	75.7	50.1	46.2	30.5	62.2	59.4	8.9	56.2	49.0	39.2	45.9	67.7	100.2	33.0	54.3	49.3	25.6	30.5	73.4	61.4	30.6	40.1	29.6	32.4	58.7	72.3	37.1	59.2	36.6	45.8	28.2	43.9	36.1	46.7	50.1	33.3	22.8
SRF	MCM1	ENSG00000112658	"Serum response factor"	P11831	6	43171269-43181506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 89.6;Enteroendocrine cells: 102.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001819, CAB005416"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"CAB005416: AB_2255249, HPA001819: AB_1079928"	"unprognostic (1.44e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.97e-2)"	29.7	16.7	16.0	27.0	15.3	27.3	24.7	12.4	18.7	31.2	12.4	82.6	13.4	69.3	12.4	33.3	49.2	26.5	61.2	17.6	11.6	17.0	20.2	28.6	21.4	14.1	12.7	27.6	21.8	18.5	18.8	17.4	11.8	38.7	14.9	8.8	16.8	45.5	55.4	21.2	29.3	48.2	12.1	22.3	37.0	12.6	13.4	21.4	23.9	32.7	16.5	54.5	25.7	16.7	38.4	15.0	34.2	22.6	19.8	16.2	50.2	34.2	28.0	29.0	17.9	40.4	11.1	48.1	30.5	36.7	36.7	30.4	35.0	30.2	25.5	53.5	34.4	43.6	30.7	40.2	37.7	41.2	50.9	27.8	32.3	44.8	32.7	27.4	24.5	41.0	31.6	36.8	22.2	41.1	51.2	35.9	23.8	85.7	18.3	38.7	34.9	17.3	21.3	24.5	20.0	18.1	28.0	21.1	34.2	26.2	21.7	75.6	29.9	34.2	26.4	33.4	59.5	25.4	22.6	80.6	21.4	29.2	23.5	0.4	0.4	0.8	0.8	0.8	0.6	0.5	0.4	0.6	0.5	0.5	0.3	0.6	1.2	0.3	0.6	1.0	0.6	0.3	16.0	15.3	12.4	18.7	17.6	11.6	14.1	12.7	11.8	12.1	13.4	16.7	17.1	38.5	22.5	3.9	8.8	78.0	64.3	22.6	38.1	5.7	64.0	52.1	89.6	18.6	21.7	11.0	20.9	9.7	9.4	29.8	0.0	13.6	4.7	23.8	24.6	17.5	102.2	20.2	4.9	20.0	22.6	17.0	18.3	29.5	7.6	20.6	17.2	50.6	12.7	10.1	3.5	39.1	8.2	11.3	18.8	1.1	12.5	11.6	24.9	0.0	8.0	12.5	5.2	1.5	2.8	21.5	19.6	29.0	6.5	17.8	11.1	3.8	20.3	7.5	13.1	23.6	21.8	5.2	3.3	28.7	66.9	12.2	10.5	8.9	25.6	30.2
SRMS	"C20orf148, dJ697K14.1, PTK70, SRM"	ENSG00000125508	"Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites"	Q9H3Y6	20	63540810-63547504	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"stomach 1: 1.6"	"Cell type enriched"	"Detected in single"	4	"Gastric mucus-secreting cells: 3.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.3;MCF7: 3.0;OE19: 4.4;RT4: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB044668, CAB044669, HPA073987"	Uncertain		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Intermediate filaments"	"Actin filaments, Cytosol"	"CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650"	"unprognostic (2.26e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.75e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.54e-3)"	0.0	0.0	0.1	0.2	0.1	0.1	0.4	0.6	0.2	0.0	0.0	0.7	0.2	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.8	0.0	0.0	0.4	0.2	0.0	0.1	0.9	1.6	0.2	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	1.3	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.1	0.0	4.4	0.4	0.0	0.1	0.0	0.0	6.0	0.4	0.5	0.1	1.2	0.2	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SRP14	"ALURBP, MGC14326"	ENSG00000140319	"Signal recognition particle 14"	P37108	15	40035690-40039181	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053738, HPA065118"			Approved	Nucleoplasm,Nucleoli		NA	NA		440000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA053738: , HPA065118: "	"unprognostic (2.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (2.20e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.41e-3)"	"unprognostic (4.94e-2)"	309.1	307.5	330.1	118.1	327.1	252.7	300.4	323.8	426.0	301.7	320.4	272.5	121.5	311.2	282.1	257.7	270.7	155.8	390.1	317.9	349.3	391.5	229.5	220.8	168.0	357.0	402.7	323.5	192.4	324.3	306.8	143.8	339.7	264.4	158.9	212.8	237.8	158.9	354.7	201.2	215.7	163.4	321.1	219.7	247.6	165.6	326.2	276.9	275.6	338.5	172.9	266.7	253.9	355.1	131.8	163.7	399.5	301.4	300.0	275.5	189.4	232.4	265.0	213.4	223.3	297.8	113.7	107.9	245.0	305.1	319.5	216.6	322.8	260.9	207.0	257.5	230.3	258.3	530.2	364.0	231.4	238.2	211.8	276.0	298.3	177.8	213.3	391.0	360.6	297.7	280.2	204.2	356.3	204.5	370.2	291.4	217.6	520.1	301.3	247.6	176.8	192.6	477.5	401.7	287.2	255.0	231.2	243.2	171.2	243.7	332.8	448.6	290.9	240.4	160.3	229.4	171.1	161.8	494.7	291.0	234.7	255.4	229.7	729.8	525.0	875.7	484.5	485.8	473.9	600.9	547.9	549.0	562.5	509.0	522.0	510.2	452.7	525.9	459.5	1148.0	755.1	1262.6	330.1	327.1	323.8	426.0	317.9	349.3	357.0	402.7	339.7	321.1	326.2	355.1	1378.8	461.6	415.0	83.2	577.0	667.1	861.7	1395.7	427.4	432.9	617.7	914.5	880.3	649.1	906.9	995.0	125.1	867.3	812.5	742.7	2551.3	1366.9	353.1	1215.7	729.8	957.7	554.0	619.4	39.4	1087.2	1100.4	699.1	324.7	1513.6	564.0	669.5	654.7	819.4	1022.1	348.3	56.1	676.9	1226.8	631.1	882.8	377.3	1039.8	645.8	789.8	36.5	1174.3	1262.8	619.0	39.2	76.0	1240.7	894.4	986.9	610.9	826.3	874.5	2276.2	935.5	477.3	624.5	651.9	749.3	779.9	643.1	631.5	710.3	758.8	644.1	831.9	673.2	975.0
SRP9		ENSG00000143742	"Signal recognition particle 9"	P49458	1	225777813-225790468	"Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		22000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (1.45e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.84e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-2)"	153.1	254.2	200.6	140.1	202.9	182.6	228.7	211.2	279.3	162.7	207.6	207.3	165.5	151.8	215.3	148.4	163.1	161.3	197.9	195.7	232.4	266.6	350.5	136.6	194.1	202.8	204.5	155.6	135.5	218.0	113.0	116.3	213.4	189.6	202.5	165.1	156.1	139.5	255.3	129.0	164.1	148.9	219.2	135.2	148.7	113.4	211.8	270.4	193.0	265.4	197.6	167.0	93.1	225.4	453.4	259.9	712.4	371.3	288.7	352.2	274.8	310.0	335.2	336.3	390.3	291.0	323.9	450.0	410.8	376.9	319.4	284.5	450.8	375.1	489.7	375.6	613.9	363.8	347.7	398.5	245.5	667.8	302.7	260.9	341.2	308.3	382.0	360.3	534.8	450.5	657.0	299.2	562.2	199.7	629.2	484.1	227.9	816.3	436.9	496.5	664.4	523.7	540.7	424.8	624.2	532.6	356.7	407.9	461.6	363.4	471.1	619.7	342.4	299.8	263.1	404.4	589.9	174.0	537.1	420.0	347.5	450.9	597.1	343.8	316.8	376.9	270.1	350.2	343.7	340.9	333.0	312.7	354.4	296.4	395.5	340.2	177.3	371.2	305.2	256.8	457.0	635.4	200.6	202.9	211.2	279.3	195.7	232.4	202.8	204.5	213.4	219.2	211.8	225.4	217.7	105.8	96.0	30.7	162.9	262.8	185.6	410.5	126.3	67.5	234.4	181.0	157.6	205.9	224.8	174.7	31.3	221.7	145.4	151.0	598.7	256.4	39.1	228.8	121.3	174.3	239.9	223.2	21.3	186.2	259.0	171.4	135.1	158.9	84.3	204.3	127.5	201.2	207.5	63.9	29.3	244.8	518.8	129.4	213.9	34.9	187.4	128.0	316.6	15.9	177.2	556.2	201.8	25.6	40.4	179.2	172.0	212.5	154.7	249.8	152.7	537.3	236.7	101.1	131.5	114.1	208.0	302.6	123.1	190.2	290.2	199.1	167.8	322.8	248.0	264.2
ST3GAL1	"SIAT4A, SIATFL, ST3GalA.1, ST3O"	ENSG00000008513	"ST3 beta-galactoside alpha-2,3-sialyltransferase 1"	Q11201	8	133454848-133571940	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 75.9;PC-3: 131.8;RT4: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040466	Approved				"Intracellular and membrane"	NA	NA		860000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"			"HPA040466: AB_10805712"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.83e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.95e-2)"	25.7	22.5	8.8	22.8	8.6	22.6	12.2	5.3	9.4	11.4	12.3	6.5	3.6	11.6	12.7	14.0	15.5	19.0	53.1	9.6	6.3	44.5	67.7	19.2	23.1	7.9	11.2	13.3	15.4	10.9	9.9	13.8	6.9	8.0	5.5	10.0	24.9	10.2	43.8	5.9	9.9	10.6	7.2	21.2	16.1	4.3	7.4	17.4	66.1	49.3	21.6	34.4	10.9	7.2	14.0	6.6	3.0	8.3	28.6	15.0	14.4	15.4	35.5	5.7	4.4	13.3	15.1	3.3	10.3	28.2	2.7	4.2	9.4	11.3	4.9	37.6	1.7	28.4	22.5	25.4	22.0	5.9	22.1	17.8	5.7	19.5	11.7	27.2	26.4	7.5	0.5	42.5	4.4	14.9	8.4	8.0	2.1	75.9	131.8	9.9	3.7	24.3	2.7	102.2	0.7	2.0	6.8	23.3	6.9	15.4	4.3	8.1	26.3	18.3	28.5	15.7	6.9	53.0	39.3	3.6	41.7	19.8	18.5	47.8	8.8	41.7	24.1	8.1	22.9	22.7	25.2	28.3	5.3	38.6	34.4	32.4	16.1	43.2	20.4	12.6	17.2	18.9	8.8	8.6	5.3	9.4	9.6	6.3	7.9	11.2	6.9	7.2	7.4	7.2	29.4	6.4	56.8	38.2	68.4	5.7	14.4	14.8	21.1	13.4	13.7	8.4	63.2	12.8	22.2	1.8	2.1	9.7	65.5	4.6	5.9	41.3	3.4	8.9	29.2	44.3	0.0	38.5	36.7	25.4	53.5	47.8	10.7	28.1	8.8	12.1	37.9	159.8	37.8	60.6	34.6	0.6	16.2	52.5	29.0	2.1	36.7	48.8	14.2	49.6	59.8	11.5	47.4	5.0	2.4	39.4	0.0	71.8	29.1	10.9	0.0	48.5	6.5	23.3	13.1	28.1	23.6	0.2	2.8	30.0	3.4	26.4	79.9	6.5	0.3	43.6
ST6GALNAC1	"SIAT7A, ST6GalNAcI"	ENSG00000070526	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1"	Q9NSC7	17	76624761-76643786	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 61.1;intestine: 195.9;stomach 1: 64.9"	"Cell type enriched"	"Detected in many"	5	"Intestinal goblet cells: 801.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 8.9;naive CD4 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	32	"T-cells: 8.9"	"Group enriched"	"Detected in some"	4	"K-562: 65.5;OE19: 107.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014767, HPA014975"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		3500000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	Nucleoplasm	"HPA014767: , HPA014975: AB_1857529"	"unprognostic (4.59e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.87e-3)"	"unprognostic (5.58e-2)"	1.9	0.1	6.0	12.6	5.6	2.8	2.0	5.7	9.2	61.1	4.5	155.3	62.5	5.1	3.9	24.4	3.8	18.3	3.4	5.5	6.0	0.4	0.1	5.7	1.2	6.1	6.0	0.8	0.7	0.1	0.0	2.1	6.4	6.9	195.9	1.0	26.3	0.5	1.4	0.9	75.8	5.4	5.8	14.6	64.9	3.1	6.1	0.2	0.3	0.9	2.3	3.1	4.5	5.6	0.2	2.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	3.4	0.2	11.9	0.0	0.0	12.4	0.0	2.9	0.0	0.0	0.0	19.5	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	65.5	0.0	0.0	0.0	0.2	0.2	0.0	107.5	0.4	0.0	0.0	0.4	0.1	0.7	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.1	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	1.3	0.9	6.0	5.6	5.7	9.2	5.5	6.0	6.1	6.0	6.4	5.8	6.1	5.6	8.6	16.0	7.5	0.7	0.3	0.1	5.7	90.2	12.0	0.1	0.1	0.0	2.0	17.2	143.4	0.0	0.0	0.3	0.0	133.3	0.0	1.4	0.3	85.1	7.6	27.2	33.0	6.7	0.4	18.2	0.1	1.3	65.7	77.6	0.0	0.3	8.6	0.0	0.3	0.0	0.3	801.0	50.8	0.0	0.0	0.9	1.5	1.1	0.0	18.7	0.0	0.0	0.0	1.5	0.3	42.8	76.1	0.0	0.0	2.4	51.6	0.0	117.4	1.2	0.0	0.3	5.3	0.4	0.1	12.8	0.1	0.1	1.8	63.3	123.1	24.5
STARD10	"CGI-52, NY-CO-28, PCTP2, SDCCAG28"	ENSG00000214530	"StAR related lipid transfer domain containing 10"	Q9Y365	11	72754729-72794047	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 709.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 520.2;Hepatocytes: 660.0;Intestinal goblet cells: 717.9;Late spermatids: 2055.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 21.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 617.7;OE19: 1316.9;SK-BR-3: 427.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026661	Uncertain		Supported	Cytosol		NA	NA		13000	"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA026661: AB_1857538"	"prognostic favorable (6.92e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.24e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.04e-1)"	11.8	178.2	35.1	17.7	37.6	10.3	62.1	39.2	41.8	71.9	40.9	180.6	48.5	27.3	102.9	52.0	26.4	59.5	72.5	33.9	34.1	50.1	709.7	37.7	14.5	38.0	33.0	31.0	212.6	73.2	36.2	40.2	38.2	86.2	188.1	18.7	94.5	30.9	66.7	62.6	66.0	26.7	29.9	20.2	266.9	184.3	34.4	15.6	47.9	157.9	21.8	24.5	41.1	35.7	51.2	15.3	7.7	28.7	9.8	9.6	98.3	5.6	26.2	17.3	17.3	209.8	36.7	4.4	16.7	19.2	42.3	31.8	23.4	46.8	20.2	28.3	9.0	5.9	11.1	217.6	35.2	1.6	10.0	6.6	127.0	19.1	26.7	47.2	17.8	10.0	12.1	21.5	3.9	617.7	4.8	11.1	3.4	1316.9	20.1	4.5	13.3	3.4	23.5	61.4	13.0	10.1	8.6	427.4	73.3	32.8	235.5	6.3	13.6	17.0	11.4	6.0	10.1	22.2	19.8	7.5	4.3	5.6	6.5	12.9	2.6	16.0	1.6	1.1	1.2	4.2	1.5	1.7	1.2	2.4	1.6	1.6	21.7	7.5	0.6	2.6	2.1	1.1	35.1	37.6	39.2	41.8	33.9	34.1	38.0	33.0	38.2	29.9	34.4	35.7	10.6	35.3	74.1	8.1	18.1	31.5	76.3	41.0	25.0	10.5	163.3	125.3	45.3	270.2	76.4	55.2	22.9	212.8	17.1	362.8	123.3	70.7	520.2	26.5	6.8	18.5	302.2	22.9	11.6	94.3	93.1	21.1	372.1	25.3	25.4	10.1	30.0	660.0	26.4	33.7	13.9	717.9	85.5	26.0	34.4	2055.8	26.1	12.3	16.0	5.6	7.7	64.4	7.2	8.0	11.8	93.9	398.9	25.2	13.3	150.9	73.5	58.0	34.5	16.6	6.6	11.3	19.6	101.2	22.7	30.2	55.0	352.2	15.6	7.7	440.7	132.7
SUCLA2	LINC00444	ENSG00000136143	"Succinate-CoA ligase ADP-forming subunit beta"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 232.2;tongue: 271.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 256.2;Late spermatids: 314.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.22e-4)"	53.9	40.6	28.4	20.2	30.8	13.6	38.7	36.6	39.2	32.4	33.6	37.1	58.2	27.2	24.8	33.1	24.7	20.3	100.2	30.7	38.2	77.5	29.0	18.2	22.0	30.6	30.0	30.9	25.4	71.2	20.4	28.1	32.3	35.8	36.3	44.2	33.9	31.3	232.2	20.5	44.7	33.1	30.6	19.9	29.7	17.9	33.8	30.7	36.4	271.9	23.9	26.0	25.3	35.1	44.9	49.5	60.6	37.1	68.4	51.3	38.9	64.8	72.4	66.9	44.5	91.3	47.9	61.3	49.3	63.9	39.9	60.0	81.9	61.9	81.6	59.8	75.9	69.2	45.8	58.0	47.6	69.9	38.9	48.4	71.2	45.3	52.6	54.4	49.0	70.7	47.7	21.1	65.8	31.4	73.1	80.8	64.4	150.2	64.7	60.9	55.4	49.3	94.4	41.9	34.7	41.2	54.5	49.3	39.1	66.5	43.8	60.8	39.0	36.2	24.1	53.0	45.7	23.0	37.4	72.7	22.8	50.9	54.8	12.6	50.2	27.8	34.4	53.7	41.9	34.6	38.0	42.2	62.5	33.1	47.7	47.5	8.8	51.8	46.1	49.8	46.6	36.5	28.4	30.8	36.6	39.2	30.7	38.2	30.6	30.0	32.3	30.6	33.8	35.1	20.8	25.6	16.8	17.6	20.1	32.4	37.7	57.5	21.1	44.8	28.9	26.5	148.8	17.2	40.2	31.3	12.5	48.7	18.1	29.1	164.4	32.3	256.2	50.9	32.0	22.0	19.2	21.0	37.0	17.8	42.7	37.7	19.9	52.6	33.7	25.2	16.1	14.7	29.9	45.4	39.0	19.5	71.2	16.7	20.4	314.2	37.0	21.7	42.7	21.5	24.9	43.3	13.4	26.2	38.2	20.2	30.6	46.3	22.1	35.9	62.3	127.4	29.9	42.4	39.5	33.3	50.0	36.3	29.0	22.8	31.7	52.1	19.7	47.3	30.4	39.0
SUCLG1		ENSG00000163541	"Succinate-CoA ligase GDP/ADP-forming subunit alpha"	P53597	2	84423528-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 554.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 935.2;Proximal enterocytes: 647.5;Proximal tubular cells: 2949.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA		350000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Plasma membrane, Cytosol"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	118.7	73.3	70.6	43.1	73.2	48.2	80.0	76.2	92.5	49.9	91.1	156.9	231.1	42.4	78.8	86.9	54.6	41.9	258.1	71.1	74.5	554.0	193.0	41.6	47.8	71.7	70.2	45.7	93.6	244.2	46.8	48.8	72.9	54.3	165.9	38.4	120.6	66.6	274.1	55.4	195.4	63.5	73.8	39.6	81.1	36.9	73.3	61.7	97.6	368.1	63.1	66.4	58.5	76.9	90.2	94.9	73.8	91.1	137.8	91.2	127.7	98.4	85.2	126.0	91.2	224.5	72.0	122.4	67.0	119.8	100.2	126.8	156.7	118.4	149.8	119.3	141.4	105.9	75.4	129.2	116.0	110.6	82.7	109.1	95.6	106.3	143.7	76.7	115.1	97.9	110.1	98.1	117.5	137.4	158.2	101.1	39.4	334.1	170.0	98.3	172.6	134.5	172.2	106.4	89.8	49.3	78.9	163.7	162.3	69.0	99.8	85.4	93.1	96.6	94.6	119.9	124.9	84.2	131.0	107.8	113.9	150.4	88.0	101.6	91.0	80.8	79.0	110.2	88.5	70.2	72.0	88.4	115.4	55.4	79.1	84.3	49.7	102.3	114.3	63.2	107.7	142.7	70.6	73.2	76.2	92.5	71.1	74.5	71.7	70.2	72.9	73.8	73.3	76.9	52.7	64.1	96.5	32.7	61.0	35.4	108.9	129.6	44.3	33.3	105.0	109.1	408.6	131.5	115.2	141.6	22.9	232.3	49.9	218.1	935.2	131.8	49.2	67.1	56.9	57.0	106.3	68.4	45.8	113.2	129.3	69.8	79.5	80.8	91.3	46.0	57.5	210.0	131.7	45.4	43.5	202.1	105.8	71.3	46.0	35.9	54.7	82.2	119.2	16.9	89.8	68.2	58.7	28.1	46.2	67.1	215.4	74.1	57.1	64.2	647.5	2949.2	83.7	36.1	52.6	61.1	98.3	138.9	54.4	111.3	41.3	188.4	64.4	90.7	388.7	111.0
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming subunit beta"	Q96I99	3	67360460-67654612	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 278.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 402.3;Proximal tubular cells: 354.4;Undifferentiated cells: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Approved	"Plasma membrane,Mitochondria"		NA	NA		300000	"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Plasma membrane"	"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favorable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	66.7	44.9	16.1	36.7	17.9	18.6	48.7	17.1	19.6	42.1	22.4	169.7	136.6	32.6	32.2	50.5	39.1	48.4	85.5	14.2	17.6	147.3	278.0	34.0	39.3	19.0	17.3	39.0	47.8	34.6	10.2	28.1	19.5	49.3	146.1	7.3	46.8	42.3	154.0	26.1	132.2	40.0	17.7	44.8	110.6	10.4	18.1	24.7	49.3	130.6	35.5	39.3	24.0	18.8	43.8	37.4	36.3	44.6	59.7	102.5	44.2	51.3	74.4	58.9	65.4	41.7	95.1	55.7	16.3	72.5	38.8	22.0	28.5	70.8	75.9	23.8	19.5	50.5	31.2	65.5	76.8	67.2	33.9	77.3	60.3	46.2	105.2	73.0	63.6	41.8	39.1	49.5	129.9	30.6	25.5	21.2	34.1	199.2	23.0	17.6	56.1	83.8	100.0	66.9	7.1	24.5	81.5	92.7	68.8	24.3	71.6	42.5	55.9	58.2	38.2	64.5	61.8	33.4	52.2	39.0	85.5	51.6	70.0	17.3	36.3	13.0	30.8	44.3	37.6	45.5	44.6	39.5	24.6	42.5	68.4	53.1	1.6	68.0	37.4	9.8	45.4	48.5	16.1	17.9	17.1	19.6	14.2	17.6	19.0	17.3	19.5	17.7	18.1	18.8	40.2	35.3	50.8	66.6	48.5	37.1	44.7	38.9	21.1	2.9	54.1	29.1	172.0	84.4	51.7	80.9	8.4	55.4	31.7	223.5	244.6	85.1	3.2	49.6	43.4	40.1	58.2	17.2	6.2	80.9	44.9	47.5	90.7	46.8	30.4	31.4	45.0	402.3	56.5	5.0	5.3	212.1	40.7	68.6	49.2	5.4	41.3	36.3	42.7	90.9	35.5	29.2	36.0	72.4	60.0	59.2	164.0	47.4	30.3	41.2	222.2	354.4	58.7	4.5	32.9	41.6	50.5	1.6	6.3	55.6	49.3	38.0	48.6	78.5	306.6	50.9
SUGT1	SGT1	ENSG00000165416	"SGT1 homolog, MIS12 kinetochore complex assembly cochaperone"	Q9Y2Z0	13	52652709-52700909	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015942, HPA043949"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB015942: , HPA043949: AB_2678745"	"unprognostic (3.66e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.96e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-1)"	27.4	31.4	33.4	25.5	38.1	32.0	23.6	38.6	55.6	23.0	33.1	25.5	27.3	19.6	20.3	30.1	19.4	19.6	37.0	34.8	37.0	31.7	36.5	22.5	27.4	34.8	34.8	21.5	30.6	19.8	26.9	25.9	36.9	19.6	26.9	22.2	25.2	16.3	29.6	24.5	26.8	22.1	35.3	23.2	26.8	34.5	36.4	29.8	21.1	28.1	29.9	27.3	24.3	48.1	47.0	50.2	72.9	55.6	70.4	57.0	69.8	100.8	66.3	61.7	49.0	110.3	114.7	102.4	27.9	62.8	89.5	79.0	90.6	57.9	90.0	85.3	37.7	95.1	65.8	84.4	51.1	74.8	68.7	40.0	51.7	63.9	48.2	79.0	105.0	64.8	90.5	32.7	95.7	33.4	70.3	136.6	85.3	183.9	47.8	79.6	42.4	44.4	108.0	51.7	24.1	30.7	52.1	42.2	49.8	82.6	43.5	70.3	76.1	51.3	59.9	59.6	87.6	25.7	38.9	91.5	30.8	59.2	75.5	63.6	29.0	49.0	24.3	34.5	23.9	30.9	31.4	33.2	32.9	30.3	23.8	26.6	4.1	33.2	34.1	41.0	46.0	25.2	33.4	38.1	38.6	55.6	34.8	37.0	34.8	34.8	36.9	35.3	36.4	48.1	82.1	38.5	36.0	22.2	46.1	39.8	65.4	68.2	38.1	52.6	40.6	55.8	126.2	32.9	51.8	51.5	25.0	67.0	78.3	52.3	78.2	88.3	185.6	112.0	79.0	65.9	34.1	65.2	19.9	89.0	143.0	60.9	50.0	75.1	36.8	49.7	43.5	38.3	97.8	50.5	23.0	58.2	54.9	44.5	43.9	95.7	58.7	54.3	48.0	13.1	123.7	91.8	58.7	21.1	47.6	85.2	55.0	59.8	58.3	44.1	74.3	100.9	67.8	56.6	26.3	72.4	92.1	146.7	101.0	45.7	43.2	74.4	61.1	56.1	55.5	52.3
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552172-48599425	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 286.0;skin 1: 186.5;vagina: 145.9"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 62.3;Proximal enterocytes: 75.9;Squamous epithelial cells: 56.0;Suprabasal keratinocytes: 137.4;Urothelial cells: 114.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 74.2;MCF7: 46.8;OE19: 122.9;T-47d: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041724, HPA043539, HPA076510"	Enhanced		Enhanced	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Cytosol	"HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: "	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.3	0.2	0.5	0.4	0.4	0.1	11.5	0.6	0.8	74.4	0.4	0.8	9.3	0.5	6.8	286.0	1.2	2.7	0.2	0.5	0.5	13.0	0.3	9.4	0.0	0.5	0.7	0.1	0.7	7.9	0.4	1.5	0.5	22.6	0.2	0.0	53.6	3.7	0.4	186.5	18.2	0.1	0.4	0.1	3.5	0.5	0.9	0.4	1.9	0.0	28.3	0.7	145.9	0.5	12.6	15.8	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.9	74.2	0.1	0.1	0.0	0.7	3.9	0.1	0.3	0.0	0.5	0.4	0.0	0.5	0.5	0.0	0.0	7.2	0.2	2.1	0.0	0.0	0.1	0.0	0.8	0.1	0.1	0.0	46.8	0.0	0.5	0.0	122.9	0.0	0.1	0.0	0.1	0.0	3.5	0.2	0.1	0.0	6.2	0.3	0.0	36.7	0.1	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.5	0.1	0.0	0.3	0.2	0.6	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.5	0.4	0.6	0.8	0.5	0.5	0.5	0.7	0.5	0.4	0.9	0.5	0.4	19.2	0.5	1.0	0.0	24.1	30.5	11.6	0.0	0.0	16.8	12.4	0.6	5.7	40.2	9.2	0.0	3.2	0.0	4.4	0.0	12.2	0.0	15.7	1.4	0.9	4.8	0.0	1.0	1.2	3.1	1.2	2.6	17.5	0.0	0.1	0.0	0.3	0.7	0.0	0.9	12.6	24.4	0.0	4.8	0.9	0.3	0.4	12.4	1.0	0.0	1.6	0.0	0.5	0.8	18.5	7.9	0.0	0.0	62.3	75.9	1.3	6.7	0.6	0.0	0.1	2.2	0.2	11.1	56.0	137.4	1.9	0.6	2.0	9.2	114.6
SURF1		ENSG00000148290	"SURF1 cytochrome c oxidase assembly factor"	Q15526	9	133351758-133356676	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Disease variant, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033946	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB033946: AB_2302648"	"unprognostic (1.87e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (6.92e-9)"	"unprognostic (3.91e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.98e-1)"	41.8	54.3	31.8	9.8	32.9	16.8	39.9	32.3	41.3	33.6	34.2	53.8	18.8	32.8	38.5	34.9	34.5	12.7	70.6	31.0	31.8	59.0	93.1	33.4	16.7	31.9	32.3	31.7	79.4	34.8	41.2	11.9	31.7	42.5	20.8	8.9	42.4	21.4	80.2	41.4	41.1	13.8	32.1	39.9	65.4	33.9	33.8	20.3	43.7	41.2	21.8	45.6	31.8	32.4	9.6	21.8	16.5	23.5	39.7	22.0	35.6	11.5	27.8	18.9	16.5	29.6	32.6	13.0	16.3	18.2	27.6	27.8	20.4	27.6	15.0	23.8	13.3	13.2	31.5	23.4	46.9	21.1	13.5	26.3	47.8	13.2	32.1	23.1	14.9	33.2	13.7	26.3	21.0	42.4	26.7	21.8	18.6	86.9	22.1	18.2	24.7	40.8	31.4	20.4	16.2	45.0	26.2	34.2	30.6	22.4	50.1	15.8	12.2	23.3	14.3	16.1	11.6	32.2	51.9	16.3	22.1	10.3	24.0	10.7	11.6	24.1	6.6	7.8	7.9	23.9	9.8	9.0	10.2	19.3	14.0	7.7	11.1	6.5	7.1	13.4	14.9	5.6	31.8	32.9	32.3	41.3	31.0	31.8	31.9	32.3	31.7	32.1	33.8	32.4	46.2	28.9	29.6	5.2	55.6	46.5	54.9	56.1	43.3	24.4	85.5	97.3	94.6	75.8	44.0	68.0	6.2	93.4	55.7	114.0	137.0	90.4	48.3	54.5	25.2	36.8	53.8	32.2	4.8	101.0	87.5	38.3	41.8	36.9	22.9	44.3	50.3	158.1	101.1	28.6	5.6	74.3	99.7	93.2	83.6	127.1	52.2	60.3	69.4	4.7	96.9	95.2	62.8	4.5	10.4	71.9	102.1	48.2	74.3	56.1	215.0	174.5	45.1	25.3	32.9	41.5	56.6	66.2	94.4	50.4	49.0	80.6	51.5	52.6	79.6	63.4
SUSD1	DKFZP761E1824	ENSG00000106868	"Sushi domain containing 1"	Q6UWL2	9	112040783-112175297	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 25.2;Kupffer cells: 31.2;NK-cells: 25.7;Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"eosinophil: 11.0;plasmacytoid DC: 44.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 44.2;granulocytes: 11.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.7;HEL: 56.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048554	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		2300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA048554: AB_2680439"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.29e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (3.63e-6)"	"unprognostic (2.14e-3)"	"unprognostic (8.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	7.9	8.9	3.2	8.7	3.8	14.1	4.5	0.1	4.8	5.8	2.2	8.9	7.3	3.3	3.6	2.6	4.1	6.5	5.8	3.3	9.1	12.1	3.4	9.6	8.6	3.0	7.5	1.2	4.0	9.0	4.0	15.3	8.0	4.7	9.4	3.2	5.3	5.3	1.4	1.8	8.6	8.0	3.1	8.2	10.5	4.7	7.3	5.9	4.1	2.1	5.9	12.0	2.2	2.8	2.8	18.7	12.9	0.0	9.4	6.2	41.1	11.8	15.8	16.3	20.8	37.3	24.5	0.3	13.0	20.7	1.1	8.4	4.7	2.1	12.1	50.7	3.9	56.3	13.0	25.7	11.4	14.9	17.4	7.8	1.7	9.0	0.3	11.1	38.9	8.1	31.5	2.3	10.4	3.5	2.1	9.2	4.2	46.1	3.0	12.6	3.0	0.0	3.9	9.7	4.5	10.8	6.5	1.4	0.1	7.1	2.2	16.2	29.7	0.3	6.0	1.8	0.1	0.7	0.7	1.0	11.1	5.8	3.6	6.1	2.4	11.0	2.7	2.9	0.8	0.1	0.7	1.9	1.7	0.3	0.3	1.9	0.9	3.1	5.3	44.2	0.2	2.0	3.2	3.8	0.1	4.8	3.3	9.1	3.0	7.5	8.0	3.1	7.3	2.8	3.1	0.0	4.8	1.6	3.4	0.5	1.7	1.6	0.0	0.3	2.4	1.0	2.0	1.5	4.5	12.9	0.0	9.0	24.3	7.0	0.0	7.0	1.8	6.0	5.4	2.9	4.2	3.0	25.2	7.1	10.5	5.0	8.6	7.8	5.7	4.5	7.1	0.4	16.3	0.0	21.9	4.3	2.0	31.2	6.0	1.8	0.0	21.5	0.0	13.1	19.8	0.3	25.7	38.2	1.2	11.1	3.4	1.9	1.4	2.6	2.7	2.9	5.3	1.4	0.0	4.0	3.9	0.5	0.4	1.8	0.9	8.6	6.1	1.2	6.4	9.5
SYT5		ENSG00000129990	"Synaptotagmin 5"	O00445	19	55171196-55180289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 72.6;pituitary gland: 59.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Enteroendocrine cells: 57.6;Excitatory neurons: 20.3;Late spermatids: 41.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 27.1;HMC-1: 60.2;K-562: 22.7;OE19: 95.7;SCLC-21H: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078390	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA078390: AB_2732382"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.76e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.15e-3)"	"unprognostic (3.71e-7)"	"unprognostic (7.09e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.55e-1)"	0.2	9.7	40.1	1.9	46.0	0.5	0.1	0.0	72.6	0.8	0.0	2.0	1.3	0.1	0.0	0.2	0.2	0.2	0.2	53.4	58.5	0.1	0.1	0.2	0.2	12.2	20.3	0.0	2.5	0.7	59.3	0.0	22.1	0.1	0.7	4.4	0.0	0.0	0.1	0.8	1.1	0.5	13.3	0.1	1.9	5.4	32.4	0.2	0.1	0.0	0.3	0.1	0.3	39.9	0.2	0.2	0.4	0.4	0.9	0.0	0.3	0.6	0.0	0.0	0.9	0.0	1.1	1.7	27.1	0.0	0.8	0.7	0.0	0.0	0.0	0.3	0.1	0.3	0.2	0.1	1.1	0.1	60.2	0.7	0.2	0.0	0.1	0.0	0.5	0.5	22.7	3.8	0.0	0.6	0.5	0.0	0.1	95.7	3.8	0.1	0.4	0.3	0.0	0.1	15.9	7.1	0.0	1.1	0.9	0.0	0.5	0.1	0.1	1.4	1.3	1.7	0.1	0.2	1.4	0.9	0.5	0.1	0.3	1.4	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.1	0.5	0.2	0.1	0.1	0.9	0.3	0.1	0.2	0.1	0.1	40.1	46.0	0.0	72.6	53.4	58.5	12.2	20.3	22.1	13.3	32.4	39.9	0.2	0.0	0.0	3.3	1.0	0.6	0.1	1.4	0.0	2.8	0.1	0.6	1.1	0.0	0.4	0.0	4.2	0.0	1.0	0.8	0.0	0.3	15.4	9.1	0.3	0.1	57.6	2.7	20.3	0.4	0.1	0.3	5.6	0.2	0.0	0.7	0.4	0.0	0.2	6.7	11.9	0.8	4.1	0.6	0.0	41.4	0.3	0.1	0.0	3.7	0.1	0.4	0.0	1.5	2.5	0.9	0.1	0.4	0.1	0.1	2.1	0.0	4.0	0.4	0.0	0.0	0.7	8.2	7.6	0.0	0.1	0.0	1.0	0.2	0.6	0.4
SYTL2	"CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2"	ENSG00000137501	"Synaptotagmin like 2"	Q9HCH5	11	85694224-85811159	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 74.2;stomach 1: 127.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 382.2;granulocytes: 130.8;Intestinal goblet cells: 185.9;Respiratory ciliated cells: 138.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 14.0;MAIT T-cell: 23.7"	"Lineage enriched"	"Detected in many"	5	"T-cells: 23.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 91.1;OE19: 148.1;RH-30: 175.8;RPTEC TERT1: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039651	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane"	"HPA039651: AB_10795153"	"unprognostic (8.07e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (9.34e-4)"	"unprognostic (6.60e-3)"	"unprognostic (2.19e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (9.07e-4)"	16.7	9.6	19.3	12.9	24.6	3.3	16.0	8.7	35.7	10.7	11.9	51.7	21.6	9.1	16.3	17.0	7.6	27.8	8.4	29.0	25.1	20.2	6.9	14.8	11.1	26.4	14.0	4.8	2.7	6.4	6.1	18.2	17.9	13.6	74.2	13.3	8.9	9.8	5.1	6.8	25.0	10.2	15.6	10.4	127.7	5.1	13.8	7.1	4.7	2.7	6.8	50.9	7.4	29.1	3.5	8.0	12.2	1.0	2.8	15.4	0.2	30.3	39.4	26.3	59.2	34.7	4.5	0.7	11.1	21.3	38.0	22.3	0.8	2.7	34.5	2.4	0.2	0.0	0.2	0.3	1.8	2.7	0.5	19.6	3.8	56.8	0.8	6.2	0.2	1.0	0.4	0.4	33.6	91.1	0.1	0.9	20.6	148.1	13.6	1.3	175.8	0.1	124.2	46.8	0.3	0.6	6.7	5.4	3.0	10.2	0.6	0.5	0.1	40.8	15.6	25.9	1.5	0.2	0.0	16.1	41.9	0.5	25.7	0.0	0.0	0.0	14.0	0.0	23.7	0.0	2.8	8.4	0.0	0.1	2.3	4.1	0.0	4.6	0.1	1.0	1.1	2.6	19.3	24.6	8.7	35.7	29.0	25.1	26.4	14.0	17.9	15.6	13.8	29.1	7.5	22.4	32.5	15.3	3.0	3.6	11.7	15.8	1.8	10.4	45.4	14.0	2.3	8.6	62.1	68.0	8.4	0.7	45.6	115.2	0.0	9.1	1.2	8.0	2.2	6.4	19.2	4.0	103.9	16.9	0.4	11.5	382.2	2.3	130.8	0.8	5.0	0.5	0.5	1.7	23.2	185.9	2.0	5.9	5.0	0.9	1.8	4.6	10.6	20.6	1.6	14.0	63.8	35.7	91.9	16.5	40.6	30.1	31.6	30.7	16.3	8.6	138.4	8.1	32.9	42.1	59.8	3.6	2.6	2.2	5.7	0.4	50.1	2.3	36.7	60.9
TAB1	MAP3K7IP1	ENSG00000100324	"TGF-beta activated kinase 1 (MAP3K7) binding protein 1"	Q15750	22	39399778-39437060	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032328, HPA039988, HPA057104"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear speckles"		"CAB032328: AB_2281637, HPA039988: AB_2676787, HPA057104: AB_2683338"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.73e-3)"	"unprognostic (9.23e-3)"	"unprognostic (4.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	13.1	14.8	18.2	9.0	20.6	9.7	12.9	17.0	19.8	18.2	10.6	18.9	10.7	16.5	6.2	13.8	15.9	7.4	17.0	17.3	16.1	12.4	16.6	11.0	11.1	18.7	19.3	20.5	15.6	10.0	10.5	8.6	17.7	16.7	5.4	12.2	13.7	10.9	19.9	17.4	13.5	8.7	15.8	15.9	14.7	10.2	18.5	11.9	13.3	10.7	7.8	17.9	14.9	20.6	15.0	15.3	15.2	17.5	15.8	13.2	13.5	12.3	15.1	18.4	17.3	14.2	10.6	22.5	9.4	12.0	10.3	18.0	15.5	18.0	7.2	17.6	24.8	9.9	19.0	14.2	13.7	18.8	18.3	13.5	15.7	13.9	15.1	14.0	13.6	13.5	18.4	15.0	9.3	9.7	14.6	15.6	10.6	23.6	15.4	26.0	21.6	22.6	14.4	15.7	13.5	9.9	17.4	21.5	15.4	9.4	17.6	20.4	11.8	12.8	20.2	9.9	10.1	23.6	16.2	16.4	15.1	13.1	12.8	0.8	5.6	4.1	4.3	4.3	3.4	3.3	2.6	3.5	5.0	3.2	4.1	3.9	0.7	3.3	4.5	2.3	2.8	4.3	18.2	20.6	17.0	19.8	17.3	16.1	18.7	19.3	17.7	15.8	18.5	20.6	6.0	3.2	6.7	17.9	7.0	2.0	2.8	4.0	6.8	55.2	5.9	6.9	7.4	8.6	4.1	3.7	18.8	12.4	4.7	4.9	0.0	6.2	1.6	4.5	7.0	5.4	11.4	6.9	9.1	3.8	7.9	6.2	7.1	4.4	5.1	12.5	2.2	4.7	7.1	28.6	12.6	4.8	0.0	6.0	1.0	3.2	7.8	6.4	5.4	9.4	8.6	12.1	8.2	7.5	18.6	5.4	4.1	9.1	8.4	2.8	7.6	5.4	4.7	18.8	6.6	6.4	7.4	8.2	9.1	5.5	3.3	5.6	8.1	10.3	4.9	1.8
TAF8	"FLJ32821, TAF(II)43, TBN"	ENSG00000137413	"TATA-box binding protein associated factor 8"	Q7Z7C8	6	42050513-42087461	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031730, HPA031731, HPA031734"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA031730: AB_2674016, HPA031731: AB_2674017, HPA031734: AB_10603994"	"unprognostic (7.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.46e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.01e-3)"	"unprognostic (6.74e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.26e-2)"	13.7	9.8	5.9	12.8	6.4	21.1	10.8	4.2	6.8	8.5	7.8	9.8	10.5	8.8	6.8	10.1	7.5	8.4	18.0	5.3	5.3	11.3	8.6	9.5	15.6	6.4	5.5	8.0	7.4	16.0	6.6	12.7	5.3	9.0	9.2	8.7	9.5	8.9	16.9	8.5	8.5	10.1	4.4	11.6	10.8	7.9	6.4	23.6	13.9	15.4	15.0	9.8	8.6	7.1	17.2	18.4	14.9	16.7	16.5	15.1	13.6	7.9	13.7	20.4	20.9	31.8	10.0	26.2	16.4	11.5	20.9	12.5	24.5	16.7	15.7	22.6	23.6	33.4	23.3	15.7	20.2	19.5	23.4	20.6	13.0	14.6	18.4	10.0	23.0	31.8	41.7	26.6	11.5	22.7	17.9	29.2	9.3	45.5	8.4	36.1	17.7	20.2	18.0	13.9	15.4	13.7	14.3	11.0	15.7	12.2	16.5	23.6	21.2	18.1	18.8	8.2	16.3	23.0	24.4	55.5	8.3	21.2	10.4	23.0	17.0	27.0	16.0	18.2	11.1	18.2	14.4	12.6	17.8	18.3	14.7	14.4	19.9	10.8	37.4	26.5	13.4	11.0	5.9	6.4	4.2	6.8	5.3	5.3	6.4	5.5	5.3	4.4	6.4	7.1	16.8	19.2	21.1	14.0	17.2	7.0	13.1	14.8	14.2	16.0	14.1	10.4	28.6	10.0	17.4	11.0	31.3	22.1	21.0	12.3	31.3	9.5	12.0	26.5	12.8	16.9	9.0	21.9	7.6	9.9	8.6	11.7	6.6	47.4	19.0	14.2	9.7	9.6	13.5	21.9	8.2	13.3	14.2	21.6	9.5	17.5	14.9	13.1	7.2	13.1	19.3	10.7	33.0	18.6	14.2	8.8	8.3	11.7	19.0	14.4	10.5	16.5	9.8	23.2	13.1	10.6	13.3	15.3	12.9	12.0	8.4	21.5	19.8	19.4	11.1	15.0
TBC1D10A	"AC004997.C22.2, EPI64, TBC1D10"	ENSG00000099992	"TBC1 domain family member 10A"	Q9BXI6	22	30291990-30326947	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007725, HPA008142, HPA076041"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA007725: AB_2667907, HPA008142: AB_1080209, HPA076041: AB_2686772"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.52e-2)"	22.6	17.0	6.9	10.2	8.2	8.2	23.7	5.8	10.2	29.6	9.3	18.3	8.6	14.7	4.6	44.1	14.9	12.7	11.2	7.5	9.3	21.3	17.9	23.7	17.2	7.4	8.1	21.1	10.8	24.5	19.5	17.5	7.0	21.3	5.5	10.8	23.2	12.9	5.6	45.3	17.3	6.8	6.2	24.2	17.3	21.6	9.7	18.4	19.0	6.9	10.4	19.9	39.9	6.4	18.9	7.1	2.9	9.0	8.4	10.8	23.9	10.7	14.9	11.8	18.7	8.4	7.2	9.5	10.2	17.8	16.2	18.3	4.3	9.9	6.2	7.2	12.4	2.6	6.4	6.0	21.9	3.7	12.9	14.0	15.5	23.4	4.0	12.3	5.5	20.5	5.1	8.8	8.9	22.1	26.9	7.9	1.9	33.9	9.5	12.3	12.4	8.8	11.6	17.9	4.9	3.8	11.0	15.7	24.5	7.8	13.8	2.3	10.8	22.9	10.4	13.1	5.8	8.8	4.2	8.3	15.6	5.6	13.1	37.5	14.9	37.9	26.6	30.1	29.3	13.4	30.9	27.2	21.7	20.7	40.7	34.0	10.6	24.3	45.5	37.5	28.8	28.4	6.9	8.2	5.8	10.2	7.5	9.3	7.4	8.1	7.0	6.2	9.7	6.4	27.8	6.4	3.4	24.8	18.2	49.2	40.2	40.3	32.5	7.8	18.4	12.4	2.7	14.3	23.6	5.5	18.8	57.6	19.5	26.8	23.5	20.1	10.7	8.8	5.4	14.4	10.7	3.0	3.0	10.2	80.6	18.3	19.4	16.4	9.5	20.1	11.0	8.6	27.5	1.7	3.5	14.2	18.3	12.9	46.0	6.9	21.8	15.9	26.6	10.3	78.1	28.1	28.8	2.5	1.0	18.7	18.7	9.1	12.3	24.3	14.9	20.5	6.6	39.3	39.5	7.4	17.1	33.2	13.5	27.6	37.1	116.3	28.0	20.2	11.0	28.3
TBCC	CFC	ENSG00000124659	"Tubulin folding cofactor C"	Q15814	6	42744498-42746103	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035073, HPA035074"	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA035073: AB_10602897, HPA035074: AB_2674448"	"unprognostic (7.16e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.23e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.76e-3)"	10.4	15.0	15.9	17.8	15.8	39.6	9.9	15.4	18.3	9.9	12.3	17.0	14.5	14.4	12.9	16.1	15.6	10.1	16.0	16.4	16.3	11.9	13.1	11.6	29.1	18.0	14.1	12.2	14.9	11.3	11.1	7.6	18.8	11.3	9.9	15.4	14.5	11.8	26.7	16.8	23.5	10.7	15.2	30.1	15.5	18.0	14.7	21.9	14.0	14.4	19.5	13.1	10.0	16.6	34.5	11.2	16.9	31.7	23.9	16.0	22.3	23.2	26.1	25.3	27.4	17.4	13.3	31.0	18.3	22.7	21.0	29.5	22.9	23.2	14.0	17.0	25.0	16.3	16.7	29.7	27.2	17.9	25.5	26.2	27.8	19.7	16.1	22.7	20.1	17.1	37.8	27.4	22.9	42.4	14.8	34.3	15.8	93.5	30.4	14.8	20.3	20.3	24.5	18.6	64.7	28.1	15.1	25.8	41.1	15.4	28.3	59.7	21.9	24.1	21.6	19.6	32.3	36.1	43.7	53.0	11.8	24.2	23.7	139.1	91.4	174.5	105.5	79.2	108.9	101.7	111.9	116.7	83.5	90.9	129.6	119.9	162.1	170.8	74.1	142.3	154.8	170.4	15.9	15.8	15.4	18.3	16.4	16.3	18.0	14.1	18.8	15.2	14.7	16.6	19.3	3.2	24.0	2.6	50.8	25.1	25.9	49.3	51.2	55.0	25.4	29.1	6.8	24.3	25.7	11.0	41.7	21.4	83.8	25.1	33.2	38.6	30.3	23.0	21.2	20.9	45.3	13.0	7.0	30.9	23.5	17.1	18.3	22.9	31.0	21.0	19.6	10.0	18.8	18.5	7.8	21.2	71.2	16.2	27.8	10.2	17.7	15.9	28.4	8.4	33.6	46.3	77.2	5.0	12.8	28.5	27.0	20.7	37.1	15.9	29.8	23.9	22.0	51.7	19.7	13.0	46.1	50.1	22.7	30.7	24.9	21.1	80.2	26.6	22.3	22.1
TC2N	"C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N"	ENSG00000165929	"Tandem C2 domains, nuclear"	Q8N9U0	14	91779746-91867536	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 103.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 84.6"	"Group enriched"	"Detected in many"	47	"NK-cells: 39.2;T-cells: 84.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.1;OE19: 63.8;RT4: 37.3;SK-BR-3: 43.9;T-47d: 22.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA027549	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nuclear bodies"		"HPA027549: AB_10603346"	"unprognostic (5.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.86e-4)"	"unprognostic (3.00e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (6.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.09e-2)"	14.3	2.3	0.1	14.2	0.7	5.1	27.7	0.2	0.5	9.5	1.4	16.5	12.1	11.4	5.1	21.6	11.8	25.2	8.5	0.2	0.3	6.9	2.9	14.4	22.0	3.1	0.5	6.5	103.0	19.8	6.9	1.5	1.6	17.2	15.2	0.5	46.5	7.8	3.1	13.7	14.5	5.8	1.4	11.1	24.9	5.9	0.7	11.5	12.5	1.2	24.5	18.4	13.9	0.7	9.2	1.5	0.0	0.0	1.6	0.0	12.2	0.0	0.2	0.0	0.0	6.5	19.1	6.0	0.4	0.1	0.2	1.0	9.0	9.0	0.0	0.1	4.7	0.0	2.4	0.0	0.0	0.0	0.0	0.2	9.3	0.0	0.5	0.0	0.0	0.5	0.1	4.7	0.0	16.3	0.0	0.0	1.3	63.8	0.0	0.1	0.0	0.0	4.3	37.3	7.0	0.0	0.8	43.9	0.0	2.4	22.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	38.4	0.1	84.6	0.7	42.0	49.0	0.1	0.2	33.6	28.7	1.3	39.2	0.2	0.2	14.8	22.5	0.1	0.7	0.2	0.5	0.2	0.3	3.1	0.5	1.6	1.4	0.7	0.7	10.0	41.7	79.6	0.7	12.4	53.4	31.3	38.1	33.6	0.4	94.3	34.3	0.9	48.6	73.1	25.8	0.0	1.0	39.6	50.2	1.9	73.3	18.5	51.4	13.6	10.9	31.8	1.7	14.4	211.7	3.6	21.2	124.4	118.6	7.0	2.5	5.7	0.6	0.3	0.0	1.8	58.5	48.8	3.0	12.7	32.7	56.8	4.0	60.5	10.3	3.1	3.5	53.5	0.5	1.6	91.7	40.0	12.8	15.6	49.1	13.6	7.5	81.0	0.1	0.0	13.2	4.5	33.8	11.8	45.4	82.5	5.5	111.0	0.1	51.7	86.8
TCN1	"TC1, TCI"	ENSG00000134827	"Transcobalamin 1"	P20061	11	59852800-59866489	"Plasma proteins, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"salivary gland: 776.3"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 52.0;Cholangiocytes: 62.9;Club cells: 94.9;Exocrine glandular cells: 372.3;Glandular and luminal cells: 84.7;Urothelial cells: 61.0"	"Cancer enriched"	"Detected in many"	4	"pancreatic cancer: 124.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	149	"basophil: 2374.2"	"Lineage enriched"	"Detected in many"	1592	"granulocytes: 2374.2"	"Cell line enriched"	"Detected in some"	21	"OE19: 159.0"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		4000000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"				"prognostic favorable (1.90e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.07e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (1.56e-8)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	0.1	0.2	0.0	0.7	0.0	190.7	5.4	0.0	0.2	31.7	0.0	0.2	9.6	3.1	0.0	23.0	1.4	173.8	0.1	0.0	0.0	0.1	0.4	1.4	0.3	0.0	0.0	0.0	5.3	108.5	0.2	0.5	0.0	1.2	0.8	0.0	776.3	0.0	0.1	0.9	1.0	0.0	0.0	4.5	76.3	0.3	0.0	1.3	0.0	0.0	0.9	15.5	10.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	2.2	0.0	0.8	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	159.0	7.5	0.0	0.2	0.0	1.5	0.0	0.0	0.0	7.3	0.0	1.6	0.0	0.0	3.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	2374.2	0.0	0.3	0.0	0.1	0.2	0.2	0.3	0.0	0.2	0.1	0.2	0.4	15.9	0.1	1.4	0.1	0.3	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	19.2	52.0	0.0	0.0	21.9	4.2	0.2	62.9	94.9	23.9	0.0	0.0	0.5	0.3	0.0	23.7	0.4	2.2	8.0	0.4	0.0	0.0	0.1	372.3	0.0	0.1	3.6	84.7	0.0	0.0	0.0	0.3	0.2	0.0	0.1	1.2	12.2	0.6	0.3	0.0	0.3	0.9	0.0	0.0	0.7	0.0	0.0	0.5	0.0	46.5	0.0	0.0	0.1	5.0	0.0	0.3	11.7	0.0	0.0	0.0	2.5	0.0	0.0	6.0	0.1	0.0	0.5	0.0	0.2	61.0
TECR	"GPSN2, MRT14, SC2, TER"	ENSG00000099797	"Trans-2,3-enoyl-CoA reductase"	Q9NZ01	19	14517085-14565980	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1013.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029780, HPA056488"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		10000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA029780: AB_10603348, HPA056488: AB_2683149"	"unprognostic (9.73e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.60e-4)"	102.7	162.6	189.0	43.1	201.7	74.2	100.4	220.8	237.5	156.8	216.5	78.5	106.1	53.2	103.2	373.2	87.1	49.7	78.4	180.1	200.0	112.2	133.9	67.8	55.7	209.6	191.2	80.9	105.5	306.1	78.7	68.0	212.2	85.7	59.3	82.8	222.3	83.5	366.3	263.5	95.9	36.7	207.6	75.4	81.7	182.7	199.9	65.8	92.7	209.6	85.3	51.6	185.9	230.2	220.5	162.1	149.5	169.6	214.7	97.2	156.9	62.8	175.2	196.3	242.9	225.3	246.2	113.8	127.4	134.2	152.4	328.8	158.1	254.3	84.0	192.3	165.9	193.7	225.4	254.6	129.7	139.5	143.7	144.9	201.8	174.3	96.1	98.4	93.7	169.2	128.9	391.5	104.0	289.3	170.1	248.3	155.6	556.1	227.6	154.4	96.1	521.1	275.1	115.8	183.2	113.0	103.1	278.4	139.6	77.2	151.3	274.4	55.2	160.5	66.8	141.0	212.6	118.4	119.8	122.7	163.8	212.6	162.2	55.6	72.7	52.5	137.8	106.4	148.8	100.1	180.1	159.1	124.2	99.1	207.1	164.5	32.7	183.7	83.9	137.1	290.1	170.9	189.0	201.7	220.8	237.5	180.1	200.0	209.6	191.2	212.2	207.6	199.9	230.2	60.4	73.7	71.1	47.7	87.6	169.5	227.5	297.9	125.7	90.8	161.1	155.6	52.9	120.1	221.5	165.5	123.0	509.5	88.1	159.2	56.7	166.2	443.9	102.2	40.1	64.7	100.0	80.1	15.3	225.1	525.5	81.8	89.7	64.2	36.1	90.1	73.2	143.1	188.0	112.7	19.2	144.0	199.4	113.8	99.3	1013.1	72.7	77.8	163.7	18.7	61.6	577.9	103.0	12.5	46.5	104.8	128.2	60.2	206.1	110.2	343.2	202.9	213.1	177.5	65.7	68.4	286.7	215.0	134.2	255.3	239.7	486.2	117.7	116.0	216.2	196.5
TEF	KIAA1655	ENSG00000167074	"TEF transcription factor, PAR bZIP family member"	Q10587	22	41367333-41399326	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (6.75e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-3)"	"unprognostic (7.87e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.12e-2)"	"unprognostic (7.17e-3)"	"prognostic favorable (3.47e-11)"	"unprognostic (7.54e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.55e-2)"	15.6	14.3	29.7	5.2	41.8	0.8	12.8	43.7	51.4	14.9	5.4	20.1	8.0	16.0	10.3	14.9	18.7	8.2	32.4	40.3	13.9	19.1	18.6	14.4	7.8	21.3	16.9	35.5	23.2	46.8	21.2	4.4	21.8	13.9	10.9	25.5	29.0	24.1	44.0	25.6	11.0	9.6	9.2	11.0	13.3	12.1	21.8	9.1	28.7	39.9	8.3	15.1	11.9	35.5	4.5	2.1	6.9	8.0	11.4	6.7	5.0	3.3	16.1	4.6	6.4	5.9	11.1	12.7	4.7	16.6	6.8	9.5	2.1	7.8	5.3	5.8	3.2	2.6	4.3	3.8	5.0	3.9	3.6	9.4	12.5	6.0	14.0	11.1	3.2	2.7	1.2	10.7	2.3	10.5	3.3	2.8	4.0	31.1	5.2	9.3	4.4	5.5	3.5	9.9	6.5	3.3	15.0	3.3	6.8	5.6	5.5	4.4	4.8	12.7	13.6	5.2	5.3	11.0	8.5	8.1	12.4	3.4	13.7	0.0	0.2	0.8	0.6	0.7	0.9	0.4	0.6	0.6	0.2	0.1	0.7	0.5	0.4	0.1	0.4	0.8	0.5	0.3	29.7	41.8	43.7	51.4	40.3	13.9	21.3	16.9	21.8	9.2	21.8	35.5	9.8	16.0	9.9	21.2	1.3	6.6	3.2	4.9	12.5	41.9	4.3	6.9	13.1	20.0	3.3	18.4	8.4	4.4	0.7	18.7	11.7	3.4	11.3	1.3	5.6	7.0	7.7	0.4	14.2	6.1	0.6	13.2	3.6	1.7	4.5	6.5	6.4	33.4	1.3	32.0	15.0	6.0	8.2	4.1	4.0	23.2	17.1	1.7	5.4	1.9	2.3	27.3	2.1	9.0	17.4	3.9	4.4	25.6	1.2	3.6	11.2	5.6	5.5	13.7	6.6	19.6	9.0	3.7	5.7	6.7	8.7	1.4	1.9	9.1	4.6	2.4
TEP1	"p240, TLP1, TP1, TROVE1, VAULT2"	ENSG00000129566	"Telomerase associated protein 1"	Q99973	14	20365667-20413501	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 23.9;Gastric mucus-secreting cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029206			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"HPA029206: AB_10601271"	"unprognostic (4.53e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (9.58e-4)"	"unprognostic (2.27e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.00e-1)"	9.4	7.8	3.4	12.1	4.1	5.1	8.7	3.2	4.0	7.8	6.0	17.4	28.0	6.9	7.3	6.8	7.2	10.7	6.8	3.3	4.3	6.5	6.5	11.0	15.0	6.0	5.3	6.2	6.2	13.7	5.7	6.6	5.1	7.9	17.9	5.0	8.3	6.3	10.3	7.9	15.5	9.7	3.8	14.8	9.6	2.3	5.8	10.2	8.1	5.1	15.1	7.5	7.8	5.2	9.2	4.2	4.1	4.5	26.1	9.9	7.3	6.8	6.0	4.0	5.1	8.7	10.2	8.1	4.2	17.0	7.3	9.3	3.5	13.6	6.8	7.8	3.5	9.5	9.4	5.7	7.5	8.0	16.1	14.1	11.8	6.5	5.2	17.1	15.2	6.7	3.1	5.8	14.0	5.4	4.7	5.8	1.8	28.4	3.6	12.2	10.2	2.8	13.2	13.8	1.2	1.9	5.4	12.8	4.2	11.8	6.5	4.9	20.1	15.5	10.6	4.9	1.9	12.9	6.9	5.1	3.7	6.9	5.5	3.6	2.3	0.0	1.0	2.8	1.0	1.7	0.5	1.0	0.8	2.4	0.5	0.6	4.5	0.5	2.9	5.4	0.6	0.3	3.4	4.1	3.2	4.0	3.3	4.3	6.0	5.3	5.1	3.8	5.8	5.2	3.7	9.6	14.1	13.1	8.4	2.8	4.8	3.1	2.8	0.3	3.2	2.8	3.2	8.6	5.6	1.8	2.1	2.0	14.3	23.9	1.9	4.8	0.2	2.9	4.2	5.8	4.2	2.1	1.9	5.1	2.5	3.4	25.5	4.2	10.8	2.6	8.2	4.9	6.4	0.0	2.1	12.8	0.0	10.4	4.6	1.3	5.0	10.2	5.4	16.9	12.9	2.6	7.2	4.5	3.9	6.0	12.8	3.8	8.4	5.1	21.8	3.8	12.2	2.6	0.0	5.1	6.1	0.0	0.6	2.4	1.4	1.9	5.0	2.2	8.3	4.9
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"	Q07654	21	42311667-42315651	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 305.8;intestine: 355.3;salivary gland: 340.2;thyroid gland: 416.7"	"Cell type enriched"	"Detected in many"	10	"Intestinal goblet cells: 33890.3"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 765.0"	"Region enriched"	"Detected in single"	6	"midbrain: 1.9"	"Immune cell enriched"	"Detected in single"	9	"eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 58.7;OE19: 126.6;T-47d: 27.8;TIME: 105.0"									"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA	151000000	6500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Nucleoli	"CAB020681: , HPA035464: AB_2674636"	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	11.5	5.9	0.1	27.8	0.1	2.2	26.3	0.3	0.2	305.8	0.1	355.3	208.0	2.8	0.5	22.7	49.8	82.8	3.5	0.1	0.1	5.7	6.6	9.9	3.5	0.1	1.9	3.5	6.1	0.0	1.3	0.1	0.2	9.8	305.8	0.1	340.2	1.6	0.9	6.7	290.6	8.4	0.1	23.1	7.4	0.5	0.2	1.8	416.7	1.7	0.9	3.6	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	58.7	0.0	0.7	0.1	126.6	12.1	0.0	9.0	0.3	0.1	0.0	16.1	0.1	0.0	1.7	0.0	0.0	27.8	0.0	105.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	1.9	0.2	0.1	0.2	0.1	36.9	16.0	25.3	0.0	15.4	41.6	15.1	196.3	3.4	0.1	804.5	444.7	21.6	919.3	595.9	22.0	0.0	0.6	3.4	2188.7	0.0	9.4	0.5	29.3	1.4	322.8	770.9	0.0	0.0	67.8	0.7	21.5	71.4	11.4	59.2	2.0	170.3	5.8	2.1	5.0	0.0	33890.3	3263.2	3.4	42.4	9.0	2.5	2.8	96.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	1855.5	7.9	6.1	73.0	2788.7	0.1	453.2	0.1	0.0	1.1	28.2	1.0	0.3	4.3	38.6	0.8	14.9	0.6	1376.3	107.7
THUMPD2	"C2orf8, MGC2454"	ENSG00000138050	"THUMP domain containing 2"	Q9BTF0	2	39736060-39779267	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043042, HPA058025"	Approved		Uncertain	Nucleoplasm		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA043042: AB_10964424, HPA058025: "	"unprognostic (6.30e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.48e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-3)"	2.4	2.0	2.6	0.5	2.5	1.7	2.1	2.9	3.0	1.9	2.6	1.9	0.5	1.7	0.2	3.5	1.5	0.5	3.3	2.6	2.6	2.4	2.3	2.2	1.4	2.6	2.8	3.2	2.2	0.5	2.3	0.4	2.6	2.0	0.7	0.4	2.1	0.4	6.0	2.5	2.0	0.4	2.4	2.5	2.2	0.9	2.6	2.0	2.1	4.0	1.5	2.1	2.4	2.8	4.9	4.7	1.0	6.5	2.3	3.3	2.7	1.3	2.5	3.0	3.1	5.0	4.5	7.8	2.7	1.6	7.6	2.0	9.7	4.4	3.2	13.1	10.8	4.7	3.0	5.7	4.1	6.3	2.4	3.9	3.2	3.1	1.0	2.9	4.9	1.5	5.9	1.8	6.1	2.3	3.3	5.0	0.0	13.0	2.9	3.4	4.2	5.4	2.9	2.6	5.7	3.1	1.3	5.6	3.2	0.4	1.8	3.9	2.5	4.0	2.5	1.1	3.6	2.4	3.1	5.1	2.0	11.4	3.2	0.0	0.6	0.0	0.1	0.4	0.6	0.7	0.4	0.1	0.5	0.3	0.6	0.4	0.1	0.4	0.1	0.9	0.1	0.6	2.6	2.5	2.9	3.0	2.6	2.6	2.6	2.8	2.6	2.4	2.6	2.8	17.4	25.6	20.6	26.8	17.8	14.3	29.0	19.5	15.9	26.8	14.4	29.8	23.7	8.6	20.3	14.7	18.8	11.5	23.0	7.2	19.6	16.6	4.5	7.5	16.9	13.7	9.6	23.8	42.2	13.7	13.6	18.4	17.9	10.9	7.0	19.2	10.0	9.9	11.3	6.7	41.6	8.1	8.2	10.9	7.7	4.0	28.0	10.0	5.4	45.0	11.8	12.1	15.5	45.2	30.3	16.7	17.1	25.6	8.2	23.7	10.3	16.4	10.9	21.1	6.6	20.5	16.0	9.1	19.7	16.9	13.5	6.8	12.6	22.2	13.5	22.7
TIAF1		ENSG00000221995	"TGFB1-induced anti-apoptotic factor 1"	O95411	17	29073521-29078857	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.0;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 37.4"															NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"				"unprognostic (1.16e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.16e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.03e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-8)"	"unprognostic (1.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	2.4	1.7	7.5	1.1	11.2	1.3	2.2	9.7	11.1	4.4	2.9	3.1	1.5	3.0	2.2	4.2	2.4	1.0	5.9	7.4	9.5	3.3	9.0	2.4	1.4	13.2	10.3	2.8	2.2	0.5	3.0	0.7	14.8	3.4	1.2	3.0	2.1	0.9	6.7	4.0	3.0	1.1	6.9	3.5	2.3	2.3	11.0	1.4	2.1	1.1	1.6	2.4	4.1	16.4	0.6	0.2	1.0	0.5	0.6	0.7	0.7	0.7	0.3	0.4	0.4	0.8	0.8	0.5	0.5	0.9	0.9	1.7	0.7	0.7	0.9	0.7	0.4	0.2	1.4	0.6	0.2	0.9	0.7	0.5	0.4	1.1	0.3	2.0	0.2	1.6	1.9	1.2	0.6	0.5	0.8	1.9	0.1	37.4	0.6	7.0	0.5	0.8	1.2	0.4	0.7	0.3	0.3	3.3	0.3	2.1	0.5	2.9	0.2	0.6	0.6	0.3	0.5	0.4	0.9	0.3	0.8	0.8	0.5	0.2	0.1	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.0	0.3	0.1	0.2	0.5	0.1	0.2	0.4	0.0	0.0	7.5	11.2	9.7	11.1	7.4	9.5	13.2	10.3	14.8	6.9	11.0	16.4	0.5	3.2	2.0	0.0	0.1	0.4	0.3	0.0	0.0	1.6	0.2	0.1	0.9	0.0	0.6	0.0	0.0	0.1	1.7	0.3	0.0	0.1	0.4	0.1	0.3	0.5	0.0	0.0	0.0	0.2	0.3	0.6	1.1	0.1	0.0	1.1	1.1	0.9	0.9	0.0	0.0	0.6	0.0	0.6	0.4	0.2	0.0	0.6	0.0	0.0	0.4	0.2	1.0	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.5	0.1	0.0	0.9	6.6	0.5	0.4	0.2	0.2	0.5	0.3	0.0	0.3	0.3	0.2	0.8
TJAP1	"PILT, TJP4"	ENSG00000137221	"Tight junction associated protein 1"	Q5JTD0	6	43477523-43506556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030164, HPA030165, HPA030166"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA030164: AB_10599849, HPA030165: AB_2673350, HPA030166: AB_10601858"	"unprognostic (5.05e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.03e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (4.27e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-3)"	"unprognostic (7.51e-3)"	24.4	32.1	25.5	17.3	36.6	18.5	24.4	28.2	32.8	31.8	23.5	30.1	20.3	31.1	10.1	16.7	28.8	13.4	24.8	26.3	29.3	21.8	25.9	21.7	20.6	34.0	33.3	37.2	33.2	13.2	24.5	14.9	31.2	31.3	9.2	11.3	24.0	14.5	44.1	19.7	25.9	15.1	25.7	32.2	26.0	20.3	35.1	17.1	30.4	16.7	14.9	28.7	23.5	49.4	40.6	15.7	27.1	40.7	21.5	20.1	30.0	25.1	26.8	26.2	28.4	23.8	17.2	22.4	18.6	23.3	25.0	35.0	22.9	30.0	16.8	38.7	35.2	28.5	30.8	26.3	25.8	29.2	39.6	23.0	39.7	32.6	28.6	20.7	17.4	28.6	24.9	41.2	23.5	22.5	28.7	48.3	23.7	69.0	23.9	34.2	17.8	24.0	16.3	22.1	17.8	24.7	21.4	13.0	33.5	16.7	23.2	56.7	15.3	34.9	26.9	29.3	37.9	30.0	26.9	40.0	15.3	33.1	30.2	13.6	7.1	5.7	7.1	8.2	9.2	6.3	5.8	6.2	5.4	6.7	6.5	7.2	4.0	5.5	7.5	5.7	3.5	7.1	25.5	36.6	28.2	32.8	26.3	29.3	34.0	33.3	31.2	25.7	35.1	49.4	10.9	12.8	10.3	12.1	10.3	7.5	14.7	9.3	13.6	11.1	9.9	13.0	7.7	10.0	6.3	12.9	29.2	21.3	7.3	7.2	3.9	10.0	1.4	7.3	10.6	10.5	11.4	7.8	11.6	8.4	18.6	10.6	8.6	9.8	14.7	21.9	8.2	8.3	9.8	8.4	9.4	8.5	14.2	7.7	8.7	2.2	10.5	9.1	5.4	14.0	8.3	10.0	6.2	19.6	117.1	9.5	7.2	12.8	10.2	14.9	7.9	6.2	5.9	15.2	6.6	9.5	10.0	14.1	14.8	4.9	3.7	18.7	9.8	10.6	7.0	9.0
TM2D3	"BLP2, FLJ22604"	ENSG00000184277	"TM2 domain containing 3"	Q9BRN9	15	101621444-101652391	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054064	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA054064: AB_2682366"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.78e-2)"	32.2	38.3	58.9	23.5	62.8	28.2	33.9	57.0	74.7	36.7	51.4	31.1	24.6	40.8	43.5	23.9	34.2	29.6	47.8	62.0	70.1	32.2	58.1	28.1	30.5	54.9	58.7	55.7	30.3	40.6	35.7	31.7	58.5	32.7	24.2	32.3	34.4	35.3	44.5	27.0	26.2	32.1	55.9	29.2	29.1	28.0	61.1	29.5	45.2	55.7	31.7	32.8	28.5	58.0	20.1	48.9	25.6	46.6	71.9	53.1	31.3	25.9	42.6	30.0	33.4	26.4	55.5	32.5	34.9	35.5	50.7	45.9	40.3	33.3	23.7	31.2	88.4	48.7	39.9	45.4	47.2	38.4	55.8	44.2	66.3	18.1	37.4	42.1	42.1	41.5	40.6	47.8	47.9	40.8	28.3	40.2	39.5	90.4	16.2	33.9	32.3	51.0	61.5	52.0	34.3	31.3	35.8	37.4	54.3	43.7	35.5	49.8	33.7	31.6	32.5	21.2	28.9	45.0	71.2	35.3	26.9	47.5	26.7	36.4	40.6	81.9	41.2	41.9	46.4	30.6	33.6	31.6	29.1	44.8	44.1	41.4	69.6	52.4	32.4	24.6	38.4	41.3	58.9	62.8	57.0	74.7	62.0	70.1	54.9	58.7	58.5	55.9	61.1	58.0	52.4	25.6	28.7	22.2	55.8	66.3	58.5	142.3	32.5	47.1	42.6	45.8	35.7	35.8	67.9	42.3	33.3	73.7	51.9	23.0	19.6	61.0	8.0	28.1	38.2	48.8	27.0	30.3	41.5	42.3	64.7	53.7	23.0	44.8	25.3	37.6	60.3	56.6	32.3	69.0	55.3	23.2	91.6	42.1	36.4	10.8	73.7	39.2	26.6	37.5	44.4	60.6	56.7	29.1	45.8	27.8	20.7	62.8	41.3	66.6	32.6	39.5	47.2	46.8	72.3	40.1	67.0	89.3	84.2	25.0	55.4	91.0	55.1	21.5	27.8	40.0
TMCO1	"HP10122, TMCC4"	ENSG00000143183	"Transmembrane and coiled-coil domains 1"	Q9UM00	1	165724293-165827755	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, Glaucoma, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054768, HPA078775"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"HPA054768: AB_2682597, HPA078775: "	"unprognostic (1.22e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (5.17e-7)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (5.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.80e-2)"	67.5	92.5	46.4	51.6	50.2	48.4	91.1	53.8	63.5	74.0	72.2	127.0	115.7	55.9	111.5	58.5	65.9	80.1	56.4	46.4	55.6	110.3	162.5	55.0	62.4	54.1	55.5	59.5	73.5	143.6	33.8	57.4	55.0	79.6	128.7	74.3	77.8	69.9	48.7	39.3	108.9	61.4	56.6	46.5	80.7	75.4	49.8	89.3	103.8	48.0	70.8	97.7	29.1	60.6	158.4	172.1	132.2	77.9	243.9	120.7	126.9	259.4	191.7	156.0	162.1	249.9	229.2	99.1	267.4	195.9	67.1	214.7	171.8	140.3	175.1	252.0	164.2	121.1	180.3	158.7	195.1	216.6	154.1	159.0	173.9	179.5	142.6	148.4	117.1	122.6	329.7	186.0	227.3	123.1	172.1	160.6	169.4	527.6	197.3	125.0	143.4	256.1	204.7	198.4	133.5	235.4	201.3	209.2	170.9	195.0	277.1	275.7	121.5	138.9	116.5	123.8	248.3	357.4	521.1	346.5	111.4	139.7	187.4	213.3	172.2	172.9	159.7	169.4	170.4	151.8	168.7	173.1	135.5	132.6	134.3	156.5	132.1	156.6	201.7	243.8	207.1	290.3	46.4	50.2	53.8	63.5	46.4	55.6	54.1	55.5	55.0	56.6	49.8	60.6	124.0	96.1	70.7	23.8	95.6	84.8	89.8	264.5	75.1	79.1	142.9	135.9	62.6	224.4	181.1	213.3	68.8	136.1	138.9	371.5	43.0	202.3	82.2	131.4	147.9	92.7	88.6	75.5	20.7	191.7	148.4	113.1	64.2	154.7	76.5	71.9	106.7	326.0	140.9	75.7	24.9	137.0	227.9	106.4	76.0	151.6	123.6	92.7	99.6	16.9	78.9	236.7	152.4	25.6	23.3	227.0	215.7	129.4	153.5	73.6	290.0	151.5	175.2	75.9	124.9	67.7	101.7	232.1	87.7	89.4	92.9	111.4	109.2	117.6	143.6	94.5
TMED3	"C15orf22, p24B, p24g4, p24gamma4"	ENSG00000166557	"Transmembrane p24 trafficking protein 3"	Q9Y3Q3	15	79311112-79427432	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 409.4"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049314, HPA076949"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA049314: AB_2680708, HPA076949: AB_2686820"	"prognostic unfavorable (7.71e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.85e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.09e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.52e-1)"	25.9	26.2	19.6	23.1	19.2	37.0	66.4	21.5	20.5	56.6	30.6	49.9	25.4	38.3	138.7	132.3	38.7	37.8	41.9	20.8	31.9	34.7	12.4	30.9	26.0	22.4	22.0	30.9	246.7	54.9	89.6	42.4	26.5	60.0	55.4	11.3	409.4	54.6	4.6	106.8	26.6	37.3	21.6	32.4	73.1	35.0	22.6	23.1	76.3	7.2	37.8	48.7	75.1	25.1	68.1	169.0	31.9	63.6	220.3	167.5	69.0	153.0	206.7	103.3	126.9	141.4	123.3	31.5	117.3	236.0	135.9	124.5	95.7	98.5	53.0	62.7	145.6	104.5	143.0	110.3	131.5	112.2	200.4	126.5	144.4	59.6	86.9	123.5	120.8	105.9	47.1	0.6	101.4	144.3	32.1	106.0	45.7	251.6	92.2	39.1	47.4	158.9	94.2	51.4	99.4	48.8	80.6	162.1	159.3	103.5	141.5	81.7	98.5	85.2	75.7	2.2	111.4	61.7	78.8	44.1	109.8	180.7	103.1	74.9	69.8	95.1	58.1	85.3	62.7	75.5	57.2	63.9	106.7	63.6	71.4	69.1	6.0	61.4	95.7	109.1	73.1	92.2	19.6	19.2	21.5	20.5	20.8	31.9	22.4	22.0	26.5	21.6	22.6	25.1	9.9	28.9	43.6	6.8	41.2	95.8	109.4	125.6	64.9	14.9	153.8	132.8	16.9	55.8	108.5	57.0	8.4	167.8	40.7	67.7	23.5	143.4	48.9	31.6	39.6	31.7	83.9	33.7	10.0	250.5	294.5	68.1	54.6	70.4	47.0	44.0	65.7	6.4	100.5	13.5	10.2	219.3	87.5	52.7	54.4	118.6	49.7	49.2	85.4	9.4	60.0	38.0	44.3	17.1	12.9	173.3	79.9	27.4	71.1	165.2	43.9	28.9	37.7	17.0	19.7	25.6	57.0	51.1	60.3	104.7	121.8	172.4	30.4	64.6	126.4	200.1
TMEM11	"C17orf35, PM1, PMI"	ENSG00000178307	"Transmembrane protein 11"	P17152	17	21197954-21214176	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051795, HPA062854"	Uncertain		Supported	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA051795: AB_2681612, HPA062854: AB_2684882"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.45e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.61e-2)"	17.6	11.7	18.9	12.4	19.3	37.7	10.8	21.1	25.1	10.6	18.4	13.9	12.5	11.8	18.6	14.2	9.4	9.0	21.3	19.1	19.9	9.9	9.9	11.8	13.8	20.3	19.3	12.2	30.4	14.9	1.3	17.1	19.8	12.2	10.0	10.9	23.7	9.1	81.3	16.8	14.2	9.8	18.7	11.5	13.2	7.7	19.8	15.8	12.6	54.1	9.8	15.6	1.9	19.8	25.3	27.5	22.7	22.1	33.9	24.1	31.2	38.9	17.7	35.8	31.3	74.5	13.5	27.4	29.7	36.3	29.0	35.0	30.0	35.8	17.9	23.2	46.5	19.8	27.0	32.1	36.8	25.1	22.0	26.5	27.7	36.4	26.2	17.2	22.8	19.3	23.0	9.5	26.9	39.9	37.8	46.6	30.5	68.8	15.3	27.2	49.8	19.6	25.2	21.3	13.8	24.0	17.6	19.0	36.9	87.2	18.4	24.8	21.4	25.1	29.7	42.5	49.3	9.6	13.2	69.3	24.9	31.9	22.6	31.2	70.6	76.2	33.1	58.9	29.6	49.4	33.1	31.8	47.1	47.4	37.0	31.8	58.4	40.8	67.9	38.8	40.3	68.1	18.9	19.3	21.1	25.1	19.1	19.9	20.3	19.3	19.8	18.7	19.8	19.8	35.0	48.1	21.8	5.5	26.0	84.9	61.9	77.7	35.3	32.9	40.2	39.9	49.9	22.8	49.1	36.8	18.8	80.7	36.6	49.4	50.9	55.3	20.7	23.9	23.6	36.8	31.9	51.3	4.4	40.5	80.9	33.9	20.9	29.1	27.3	23.1	32.2	28.1	54.3	23.5	5.1	67.4	73.2	25.3	34.5	16.3	35.8	26.3	40.9	8.4	48.6	31.6	33.0	6.0	8.0	47.4	60.6	57.6	19.9	63.6	55.0	55.9	33.0	39.9	32.9	25.7	42.0	40.4	38.4	34.7	92.6	90.8	28.7	31.3	49.6	80.2
TMEM126A	"DKFZp586C1924, OPA7"	ENSG00000171202	"Transmembrane protein 126A"	Q9H061	11	85647967-85656547	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046648	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA046648: AB_2679737"	"unprognostic (3.79e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.60e-5)"	"unprognostic (8.25e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.17e-1)"	31.9	28.0	40.3	23.1	41.5	43.8	33.5	41.4	52.3	21.8	39.5	28.0	32.6	20.0	31.2	27.2	19.8	19.9	82.1	41.4	42.3	33.1	49.0	20.5	27.3	40.7	40.6	21.0	33.9	26.3	22.2	22.8	41.5	23.5	29.3	23.9	31.3	19.5	81.6	19.4	26.0	27.6	41.1	21.0	32.8	38.5	41.4	24.2	26.6	98.7	27.8	30.5	20.1	42.4	46.7	53.2	50.9	33.0	67.2	66.7	38.0	55.9	60.1	82.3	77.6	65.9	67.5	25.4	61.3	69.2	32.0	48.9	53.8	59.5	70.7	72.5	31.0	72.5	56.9	73.7	82.4	89.0	54.8	58.0	65.8	73.1	78.0	43.5	71.6	72.2	51.1	39.0	86.2	57.5	48.6	112.3	48.1	175.1	68.4	48.3	49.5	79.2	54.5	57.0	34.3	34.7	49.4	72.9	44.7	44.5	88.1	64.4	42.8	70.4	52.7	134.6	65.3	27.5	54.4	70.4	37.0	63.6	85.2	6.6	23.9	11.6	21.2	28.1	26.0	29.8	26.4	23.8	32.9	27.3	24.4	24.1	1.9	15.1	23.4	24.7	26.4	18.7	40.3	41.5	41.4	52.3	41.4	42.3	40.7	40.6	41.5	41.1	41.4	42.4	40.5	28.9	24.3	12.7	39.6	31.7	55.3	87.9	29.6	14.8	45.8	62.1	110.8	28.6	57.5	38.6	6.2	67.8	38.5	23.6	146.8	51.0	147.8	26.8	32.8	36.7	21.7	46.1	8.6	93.2	73.3	40.8	23.4	24.2	37.4	33.6	26.7	68.5	94.6	8.4	9.0	46.6	40.7	54.4	43.3	80.6	29.5	48.4	33.8	5.6	66.3	35.1	38.1	8.5	11.8	64.5	34.8	26.7	45.4	73.4	61.8	109.4	39.7	21.9	19.7	40.0	40.9	119.0	57.9	49.4	42.1	52.9	42.1	42.2	57.1	71.2
TMEM126B	HT007	ENSG00000171204	"Transmembrane protein 126B"	Q8IUX1	11	85628573-85636539	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014480, HPA019186"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA014480: AB_1858083, HPA019186: AB_1858084"	"unprognostic (1.11e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.70e-3)"	"unprognostic (4.42e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.66e-2)"	16.1	16.7	29.2	13.0	29.4	6.5	19.3	28.9	38.9	18.2	25.9	21.4	19.6	19.3	30.7	14.3	15.8	17.3	24.7	30.4	31.7	15.3	17.2	15.8	18.7	29.7	30.0	16.4	15.9	11.0	20.8	13.3	30.9	17.0	17.6	18.6	15.7	14.1	16.2	13.8	19.8	21.4	30.1	16.5	17.6	10.9	30.2	16.0	16.8	20.1	17.5	18.6	14.8	32.3	37.9	29.8	33.1	16.0	60.2	49.6	10.6	33.1	36.1	25.6	38.1	84.8	37.1	39.9	72.2	27.1	28.6	45.0	53.2	33.0	23.8	56.5	49.7	30.1	49.1	36.1	35.6	75.4	34.7	37.9	38.3	38.6	47.0	41.1	38.6	49.5	72.5	31.2	58.8	47.9	29.4	91.3	36.1	129.6	50.1	25.0	25.4	33.6	49.5	42.1	30.8	19.1	31.2	24.9	31.9	42.5	50.1	45.4	20.5	38.2	26.5	96.9	35.4	14.6	91.1	47.7	19.4	60.4	20.6	21.5	15.6	7.9	19.0	18.2	24.8	18.3	23.4	23.5	20.1	17.7	23.3	23.4	5.9	23.4	14.5	18.4	25.9	15.9	29.2	29.4	28.9	38.9	30.4	31.7	29.7	30.0	30.9	30.1	30.2	32.3	44.9	22.4	40.7	16.6	34.6	26.1	32.2	80.8	22.8	32.5	36.8	31.1	87.3	54.3	57.2	40.5	14.6	41.0	54.2	33.6	168.3	76.0	5.4	27.2	39.2	46.1	34.6	34.5	19.3	49.0	54.5	45.1	15.8	25.8	42.5	27.8	42.5	43.6	84.1	23.5	20.1	41.3	81.4	47.4	44.6	8.3	66.5	43.5	72.9	9.4	48.8	79.0	80.3	20.6	29.7	51.5	52.8	88.4	22.4	35.3	56.5	162.9	51.3	31.2	39.5	30.0	43.8	34.4	46.8	23.1	36.9	25.2	49.7	45.4	52.0	45.4
TMEM141	MGC14141	ENSG00000244187	"Transmembrane protein 141"	Q96I45	9	136791344-136793317	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 580.8;Distal tubular cells: 626.1;Intestinal goblet cells: 547.5;Paneth cells: 682.0;Proximal enterocytes: 633.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 228.2;T-47d: 221.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014615, HPA050244"	Approved		Supported	"Cell Junctions,Mitochondria"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Cell Junctions"	"HPA014615: AB_2204756, HPA050244: AB_2681061"	"unprognostic (2.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	32.7	44.1	37.9	23.3	40.1	40.2	48.7	43.8	42.6	36.4	39.7	120.5	48.4	25.2	63.6	109.6	48.2	27.9	74.0	36.8	41.3	116.8	134.7	39.3	21.1	42.1	40.2	33.4	74.0	83.0	62.2	41.9	44.4	132.3	112.2	12.2	61.5	28.5	38.1	68.7	60.6	22.4	40.0	38.7	76.2	33.1	41.1	29.8	66.3	35.8	26.4	39.2	49.5	44.1	55.0	35.9	34.9	21.1	42.2	34.1	69.9	30.8	47.4	35.9	29.0	47.9	47.5	53.4	44.1	32.5	32.0	78.2	14.0	87.8	11.6	38.7	27.5	30.4	18.0	52.3	60.8	31.1	35.5	33.1	146.4	26.7	79.0	42.3	54.6	67.4	28.9	26.7	48.2	102.0	42.0	21.2	16.7	228.2	43.8	34.6	37.6	156.1	82.1	28.4	55.3	25.7	32.9	125.7	35.1	27.1	221.4	28.9	38.5	24.6	19.9	46.3	19.5	17.0	29.7	28.2	39.9	44.2	37.2	19.5	29.5	20.4	23.1	44.2	20.6	18.2	15.1	16.0	24.1	23.0	20.6	19.5	7.3	29.9	37.4	90.6	16.4	29.1	37.9	40.1	43.8	42.6	36.8	41.3	42.1	40.2	44.4	40.0	41.1	44.1	62.0	57.7	79.0	6.5	39.6	40.7	99.3	120.5	55.2	13.8	128.7	152.9	42.3	124.4	100.9	117.7	8.4	182.4	64.0	580.8	626.1	179.2	48.4	80.1	50.4	48.5	206.9	53.6	8.2	78.5	141.7	59.1	76.5	148.2	41.8	67.5	56.0	171.7	148.5	5.0	6.4	547.5	109.9	61.6	29.8	134.9	37.6	53.7	85.4	2.8	85.7	61.1	78.2	2.5	11.7	90.1	682.0	29.7	34.8	193.7	633.0	459.2	60.9	30.0	46.0	32.4	46.9	57.2	53.5	156.7	62.8	274.3	42.7	65.1	460.1	125.9
TMEM147	"MGC1936, NIFIE14"	ENSG00000105677	"Transmembrane protein 147"	Q9BVK8	19	35545600-35547526	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (6.98e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (4.98e-6)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-1)"	78.5	153.3	75.1	36.6	80.3	41.8	71.1	84.8	85.8	72.7	117.4	67.6	43.2	77.5	101.8	105.0	64.1	36.3	112.2	74.1	83.1	96.5	63.8	68.2	29.9	80.8	79.0	69.1	149.6	129.5	76.1	46.1	79.6	54.8	54.0	42.0	80.6	58.1	137.7	118.9	52.3	57.5	80.9	58.6	84.0	76.3	80.3	26.7	99.7	85.8	45.1	77.2	73.5	85.2	161.2	353.2	68.9	162.0	298.4	135.8	110.5	94.3	167.2	124.6	115.2	168.6	96.9	93.3	156.8	156.4	135.1	62.8	119.9	147.4	101.7	140.8	156.3	99.3	98.9	200.3	237.2	145.4	105.6	148.8	226.3	117.5	291.5	107.2	115.6	126.8	127.9	325.2	134.1	201.6	82.4	80.8	96.9	492.8	141.3	79.1	62.3	225.4	198.5	164.6	60.5	101.0	93.7	215.3	204.9	69.2	78.2	121.4	73.8	140.5	109.9	81.0	205.0	165.9	182.2	52.8	122.3	195.7	115.6	41.0	219.7	103.3	100.6	212.6	142.6	177.0	135.9	116.3	199.9	149.0	101.0	102.6	12.2	106.1	154.0	237.5	147.1	237.4	75.1	80.3	84.8	85.8	74.1	83.1	80.8	79.0	79.6	80.9	80.3	85.2	74.4	44.8	44.1	7.2	71.5	101.2	135.7	195.5	63.2	55.3	167.2	165.1	101.5	118.7	110.2	156.3	18.8	176.3	63.2	59.6	111.6	223.0	102.5	56.4	72.5	96.8	88.9	42.5	6.0	255.2	228.7	94.7	51.0	68.1	50.2	90.9	82.8	95.5	260.6	45.4	8.0	105.9	140.4	133.6	113.3	333.8	139.4	96.5	240.1	7.5	83.7	138.9	71.1	10.1	12.2	179.9	74.1	121.1	136.0	349.1	100.3	277.1	77.9	62.8	118.3	58.1	138.9	327.9	155.7	94.9	167.8	138.3	60.6	86.1	144.3	200.6
TMEM238L	LINC00675	ENSG00000263429	"Transmembrane protein 238 like"		17	10794913-10804099	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	6	"intestine: 37.5;stomach 1: 45.2;urinary bladder: 21.8"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 16.5;Theca cells: 4.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"OE19: 6.4;RT4: 4.1"	"Not detected"	"Not detected"													NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (7.23e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.30e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.19e-2)"	0.1	0.1	0.5	1.8	0.6	0.0	1.7	0.4	0.6	1.6	0.0	37.1	18.2	0.1	0.7	5.4	0.4	2.7	0.0	0.4	0.5	2.1	0.8	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.0	0.5	0.6	37.5	0.0	0.6	3.4	0.0	1.1	16.6	1.3	0.4	0.0	45.2	0.3	0.9	0.0	0.0	0.0	0.4	21.8	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	0.6	0.4	0.5	0.5	0.5	0.5	0.4	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0
TMEM45B	"BC016153, FLJ40787"	ENSG00000151715	"Transmembrane protein 45B"	Q96B21	11	129815848-129860003	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.5;intestine: 136.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 325.6;Paneth cells: 221.6;Proximal enterocytes: 288.7;Respiratory ciliated cells: 133.9;Undifferentiated cells: 122.2;Urothelial cells: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 3.0;naive CD4 T-cell: 3.6;neutrophil: 11.7"	"Group enriched"	"Detected in many"	14	"granulocytes: 11.7;T-cells: 3.6"	"Group enriched"	"Detected in some"	5	"OE19: 333.1;RT4: 133.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015474, HPA015878"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA015474: , HPA015878: AB_2205046"	"unprognostic (4.92e-3)"	"unprognostic (7.94e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	0.7	0.6	1.5	8.3	1.6	1.1	13.2	1.9	1.8	14.9	7.6	95.1	136.4	1.1	13.6	66.5	21.7	24.1	0.1	2.1	2.0	20.6	24.7	6.0	0.9	1.5	2.8	0.2	1.2	12.4	4.2	1.4	1.5	3.6	94.6	0.4	15.4	8.2	0.3	25.4	127.4	2.8	0.9	0.8	24.3	0.3	2.0	0.4	6.5	0.0	15.0	30.8	27.3	1.4	0.1	0.1	0.1	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	39.1	16.8	0.2	7.0	0.0	0.2	22.3	0.0	0.0	0.0	0.1	0.5	0.3	2.1	40.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.4	0.2	0.2	0.1	0.0	13.3	0.2	1.5	0.2	333.1	49.2	0.3	0.1	2.6	21.0	133.1	4.1	0.6	0.2	10.8	0.1	0.1	37.1	0.2	0.3	0.2	0.3	0.4	0.1	0.2	0.1	0.4	0.1	0.3	0.1	1.2	0.5	0.1	0.2	0.1	0.2	0.2	3.0	0.8	0.0	0.4	3.6	0.6	11.7	0.5	0.1	0.3	0.5	0.9	1.5	1.6	1.9	1.8	2.1	2.0	1.5	2.8	1.5	0.9	2.0	1.4	0.1	19.2	12.5	0.3	1.1	3.3	16.4	29.1	0.0	0.1	6.7	2.5	0.8	18.6	68.8	46.0	0.0	3.8	0.0	325.6	13.7	26.9	0.4	27.7	2.9	1.0	55.4	0.0	0.8	8.6	0.8	0.8	17.9	29.5	2.5	0.3	0.4	8.4	0.5	0.0	0.4	49.3	20.3	0.6	0.4	0.3	0.3	2.9	3.6	2.8	0.1	0.1	0.0	0.0	0.3	50.2	221.6	0.0	0.0	23.8	288.7	1.4	133.9	0.2	0.0	0.7	3.6	0.1	0.2	4.4	20.9	0.4	1.8	0.1	122.2	162.0
TMEM63B	"C6orf110, dJ421H19.2, DKFZp434P0531"	ENSG00000137216	"Transmembrane protein 63B"	Q5T3F8	6	44126914-44155519	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 163.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029249, HPA029250, HPA029251"	Uncertain		Enhanced	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Actin filaments"		"HPA029249: AB_2672965, HPA029250: AB_2672966, HPA029251: AB_2672967"	"unprognostic (8.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.15e-1)"	12.4	19.6	18.1	9.5	18.9	17.9	12.6	18.9	24.7	17.8	15.1	24.6	17.1	11.4	12.1	34.6	10.7	12.8	26.5	25.1	21.0	17.1	39.2	38.3	5.8	19.9	17.5	12.1	12.6	20.2	15.6	13.6	20.4	17.4	19.4	31.6	20.9	8.6	51.6	41.4	18.5	9.9	15.7	9.8	25.4	31.0	19.8	8.6	16.2	21.2	8.6	18.8	23.2	18.3	41.7	23.1	21.1	34.6	32.3	18.6	34.6	17.0	22.8	18.7	17.7	16.1	15.7	7.2	25.5	25.3	30.1	37.8	25.6	62.6	12.3	20.6	19.5	20.8	17.2	49.1	22.2	4.6	19.2	24.8	55.5	26.2	16.7	37.8	18.9	15.3	67.7	11.2	22.0	42.7	4.6	10.3	11.4	163.7	11.2	5.8	14.0	13.2	52.2	44.5	24.3	18.8	15.2	35.5	35.8	26.0	40.1	11.6	21.8	23.8	27.0	17.9	20.7	14.0	11.1	8.8	35.9	6.6	30.7	0.2	0.4	0.2	0.2	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.2	0.2	0.4	0.2	18.1	18.9	18.9	24.7	25.1	21.0	19.9	17.5	20.4	15.7	19.8	18.3	7.2	16.0	19.7	17.6	3.3	13.6	14.9	41.3	21.1	18.4	11.2	9.3	3.8	10.0	25.1	11.0	16.7	14.1	4.2	75.1	1.9	17.0	72.9	10.6	8.9	6.9	18.6	28.4	26.3	15.2	16.6	11.0	45.9	25.1	0.0	11.0	11.7	43.4	26.4	16.8	28.4	32.4	30.5	11.7	11.4	87.6	11.8	9.1	7.2	15.0	8.5	9.4	5.2	21.6	12.1	32.5	45.7	9.1	6.4	21.9	32.7	10.8	15.7	27.6	6.6	10.4	12.0	2.1	14.7	19.4	18.3	20.0	5.5	7.1	24.3	29.4
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464300-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 280.4;stomach 1: 146.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 404.8;Gastric mucus-secreting cells: 155.4;Paneth cells: 368.3;Prostatic glandular cells: 203.4;Proximal enterocytes: 159.6;Urothelial cells: 166.6"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 22.8;MCF7: 10.5;OE19: 35.9;RT4: 57.8;SK-BR-3: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA034493, HPA035787"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favorable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.6	0.2	0.4	13.9	0.4	0.1	20.1	0.2	0.4	5.0	3.1	104.0	78.5	1.0	2.8	36.1	10.7	24.1	0.2	0.3	0.3	47.7	33.5	39.9	0.2	0.4	0.3	0.2	111.4	4.0	1.5	0.2	0.3	280.4	78.0	0.2	76.2	7.7	0.1	7.3	89.6	3.3	0.1	0.2	146.2	1.5	0.3	0.8	19.2	0.1	10.2	35.7	7.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.1	22.8	3.3	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	3.7	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	10.5	0.3	1.0	2.3	35.9	0.2	0.1	0.0	2.6	1.3	57.8	0.2	0.7	0.3	11.7	0.3	0.4	8.8	0.0	0.0	0.1	0.6	0.6	0.1	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.3	0.5	0.1	51.3	109.8	0.0	1.7	0.3	30.9	6.8	0.0	0.0	34.0	25.8	0.6	32.9	42.1	47.8	0.0	0.7	1.1	404.8	23.5	39.2	21.3	7.4	0.5	1.3	18.0	2.7	0.2	60.4	0.1	1.0	155.4	5.8	7.0	0.0	0.4	32.0	0.1	0.0	0.1	84.1	44.7	0.3	0.3	4.8	0.0	2.0	10.6	0.0	0.6	0.0	0.0	0.0	0.0	65.1	368.3	0.0	0.0	203.4	159.6	3.8	36.6	0.0	0.0	1.6	2.0	0.4	1.4	2.1	0.1	0.3	1.1	0.0	105.7	166.6
TNFSF15	"MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A"	ENSG00000181634	"TNF superfamily member 15"	O95150	9	114784652-114806039	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 9.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 25.6;Basal squamous epithelial cells: 14.8;Endometrial ciliated cells: 15.7;Glandular and luminal cells: 28.9;Squamous epithelial cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 13.2;hTEC/SVTERT24-B: 8.6;HUVEC TERT2: 16.7;OE19: 16.0;RT4: 16.5;TIME: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA012948, HPA046522"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted to blood"	NA	NA	1110000		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA012948: AB_1858024, HPA046522: AB_2679683"	"unprognostic (3.41e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.46e-3)"	0.8	0.7	0.1	2.5	0.2	0.1	0.9	0.1	0.5	1.5	0.1	2.3	9.5	1.0	0.9	1.2	0.9	1.9	0.0	0.1	0.2	4.5	0.2	4.1	0.8	0.3	0.1	0.1	0.1	0.8	0.1	4.4	0.2	4.1	2.0	0.0	4.8	1.9	0.1	0.6	3.5	2.0	0.0	0.5	2.9	0.1	0.2	0.6	0.9	0.0	1.0	4.7	0.7	0.4	0.5	4.4	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.1	0.2	3.0	1.6	0.0	0.0	0.5	13.2	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	8.6	0.0	0.0	16.7	0.0	0.0	0.9	0.4	0.6	0.0	0.0	0.3	16.0	0.0	0.0	0.1	0.0	0.1	16.5	0.1	0.0	0.0	0.7	0.0	5.6	1.2	0.0	7.7	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.3	0.1	0.2	0.0	0.2	0.4	0.2	12.8	12.1	0.0	0.1	0.5	7.7	25.6	14.8	0.3	3.7	3.7	0.6	1.5	4.9	7.3	0.0	0.7	0.4	8.0	0.0	4.9	0.7	15.7	2.9	0.3	0.0	0.0	0.1	2.0	0.2	1.2	8.2	28.9	0.0	0.0	0.0	0.0	2.3	0.0	0.7	2.4	2.0	0.3	5.1	0.1	0.0	5.0	0.0	0.0	5.3	0.1	0.0	0.0	0.1	1.3	0.5	0.4	1.2	4.9	8.9	9.3	1.0	0.3	0.0	0.4	3.0	0.0	0.0	13.7	0.6	0.3	1.0	0.1	7.4	6.5
TNNI3	"CMD2A, CMH7, TNNC1"	ENSG00000129991	"Troponin I3, cardiac type"	P19429	19	55151767-55157773	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	622	"heart muscle: 10813.5"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 12618.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.0;HMC-1: 20.3;K-562: 39.1;OE19: 54.6"	"Region enhanced"	"Detected in many"		"olfactory bulb: 10.9"	"Low region specificity"	"Detected in many"			"CAB009349, HPA046428"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		2400000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Vesicles	"CAB009349: AB_793465, HPA046428: AB_2679661"	"unprognostic (2.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.62e-3)"	"unprognostic (9.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.02e-3)"	"unprognostic (8.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.82e-2)"	1.1	3.0	0.3	0.0	0.5	0.0	17.3	0.2	0.4	0.7	0.7	0.7	0.0	0.3	0.1	0.8	6.2	0.9	10813.5	0.6	0.2	1.0	1.1	7.3	1.6	0.5	2.8	1.4	2.3	0.2	0.6	1.0	1.3	2.4	0.0	0.2	1.3	0.0	6.5	1.2	0.6	0.0	0.6	0.4	0.7	3.7	0.3	0.1	1.5	2.4	0.0	0.4	0.6	0.3	1.2	0.6	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.4	0.0	0.3	1.8	6.3	0.0	1.1	1.1	1.2	0.3	0.0	0.0	13.0	3.0	0.0	1.9	0.5	0.0	20.3	0.0	0.6	0.1	0.3	0.1	0.1	0.8	39.1	0.8	0.0	0.6	0.2	0.0	0.7	54.6	0.5	1.9	0.4	0.1	1.8	0.0	0.1	2.2	0.0	0.0	0.2	0.0	2.8	9.5	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.6	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.4	0.6	0.2	0.5	2.8	1.3	0.6	0.3	0.3	0.1	0.0	0.0	0.0	0.2	6.9	0.0	0.8	13.6	0.0	1.0	0.9	12618.4	8.6	1.8	5.5	0.0	1.4	0.1	0.4	0.0	0.7	56.2	3.5	0.1	131.3	1.8	0.0	0.0	0.2	0.5	202.7	0.0	1.3	0.0	996.2	0.0	0.0	2.2	1.7	0.2	0.4	2.0	0.3	0.7	222.9	0.3	4.6	1.8	1.9	0.0	4.2	0.0	0.0	0.1	1.0	0.0	1.9	0.0	0.0	0.0	0.1	11.2	0.5	0.0	0.4	123.6	6.4	16.1	0.7	2.8	2.5	0.6	1.2	1.0	0.1
TOMM6	"OBTP, Tom6"	ENSG00000214736	"Translocase of outer mitochondrial membrane 6"	Q96B49	6	41787662-41789898	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 18.7;Astrocytes: 31.0;Club cells: 10.5;Excitatory neurons: 16.5;granulocytes: 8.8;Inhibitory neurons: 15.5;Microglial cells: 10.3;Oligodendrocyte precursor cells: 12.1;Oligodendrocytes: 26.3;Respiratory ciliated cells: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 2247.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004801	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA004801: AB_1859553"																		176.9	267.7	240.1	136.8	246.2	228.0	219.9	246.7	320.8	158.4	254.4	158.2	101.8	139.7	270.3	234.0	162.9	96.2	285.9	245.2	248.1	271.8	232.2	143.6	207.5	243.9	242.9	179.0	208.3	193.3	143.2	141.2	245.5	177.6	177.1	128.8	166.1	120.3	272.4	196.4	134.8	132.3	250.1	200.3	170.2	133.9	245.5	192.6	161.4	232.8	260.9	166.5	153.9	254.2	647.0	319.0	372.7	382.2	337.6	398.5	391.6	312.2	324.8	390.3	380.4	559.4	295.3	289.3	373.3	370.1	445.4	201.2	597.3	523.3	505.9	409.8	619.8	525.5	382.4	928.6	264.9	708.7	328.6	362.0	529.4	431.8	366.2	277.1	480.4	407.1	1335.5	350.4	481.7	766.0	519.4	1124.8	329.7	2247.1	312.6	373.3	234.1	865.3	540.1	329.3	327.6	458.7	213.0	369.5	548.5	389.7	451.6	1411.8	342.8	272.0	340.9	274.2	478.8	318.6	751.6	1314.8	155.9	586.7	362.7	119.3	439.5	259.3	291.7	448.3	283.7	419.2	294.4	291.2	454.1	380.7	329.3	324.1	55.9	230.6	475.3	474.6	303.3	674.5	240.1	246.2	246.7	320.8	245.2	248.1	243.9	242.9	245.5	250.1	245.5	254.2	0.0	3.2	18.7	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.5	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	10.3	0.0	0.0	0.0	12.1	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TPPP3	"CGI-38, p20, p25gamma"	ENSG00000159713	"Tubulin polymerization promoting protein family member 3"	Q9BW30	16	67389809-67393518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 858.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 962.0;Melanocytes: 501.6;Respiratory ciliated cells: 1825.2;Suprabasal keratinocytes: 495.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 61.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 65.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 59.9;OE19: 40.8;RH-30: 31.1;SCLC-21H: 47.8;SH-SY5Y: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047629, HPA061691"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		43000	"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"		"HPA047629: AB_2680108, HPA061691: "	"unprognostic (1.63e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.86e-3)"	44.3	27.1	199.2	8.0	200.1	1.0	81.0	186.0	225.7	50.3	168.7	96.4	23.7	29.3	9.7	99.3	858.4	21.9	81.4	188.1	222.0	60.7	4.4	148.0	4.4	258.7	291.6	8.6	23.9	13.6	40.7	78.5	231.2	18.9	14.1	9.6	39.5	13.3	72.2	170.5	38.0	21.4	223.6	17.7	43.6	15.4	228.3	4.7	18.4	55.8	9.1	32.8	36.4	296.2	0.4	59.9	0.6	0.4	0.4	9.4	0.2	1.7	0.4	0.4	0.9	3.9	12.0	0.0	0.9	0.8	0.2	11.3	9.2	0.0	0.1	0.0	3.5	0.0	1.5	1.7	0.1	0.0	0.0	2.4	0.3	3.6	0.0	1.8	0.6	0.0	0.1	0.0	5.4	0.3	0.0	0.2	1.9	40.8	0.0	0.0	31.1	0.2	0.0	0.0	47.8	20.7	0.0	0.1	2.4	1.5	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.9	0.0	25.4	12.4	0.0	37.6	0.2	0.0	0.0	0.0	33.1	0.1	0.0	0.0	5.8	0.0	65.8	0.3	0.0	9.4	199.2	200.1	186.0	225.7	188.1	222.0	258.7	291.6	231.2	223.6	228.3	296.2	14.7	16.0	129.8	17.0	0.2	303.9	8.8	92.5	5.7	3.8	5.9	5.0	4.1	30.0	160.4	18.4	4.2	8.3	0.2	28.4	5.9	166.8	60.1	962.0	30.9	31.6	177.9	0.0	0.5	1.8	4.3	141.9	7.1	14.7	25.4	1.0	5.0	0.1	2.9	0.0	0.7	65.1	132.2	3.8	82.5	23.7	29.2	13.7	501.6	1.0	10.7	68.7	1.0	1.0	30.0	8.4	39.7	3.4	0.0	5.6	29.8	0.9	1825.2	8.9	236.7	259.3	163.7	8.1	5.8	1.6	495.3	80.0	5.5	0.8	27.3	10.1
TPRG1	"FAM79B, FLJ41238, FLJ43694"	ENSG00000188001	"Tumor protein p63 regulated 1"	Q6ZUI0	3	188947214-189325304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 50.6;vagina: 32.3"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 199.7"	"Cancer enriched"	"Detected in many"	4	"breast cancer: 7.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.6;Karpas-707: 4.7;OE19: 23.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044751, HPA060187"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA044751: AB_2679073, HPA060187: AB_2684217"	"prognostic favorable (5.43e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.52e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	10.6	1.9	0.5	1.8	0.6	0.0	23.3	0.6	0.7	23.3	3.5	0.5	0.3	3.0	2.8	50.6	8.4	2.9	2.0	0.4	0.7	0.4	9.0	4.4	0.9	2.2	0.7	2.2	0.6	0.1	0.2	1.2	1.0	1.2	0.3	0.4	6.1	1.3	9.1	25.1	0.7	3.0	0.6	0.7	0.5	4.8	3.6	1.5	1.3	0.4	9.0	1.0	32.3	2.0	0.9	0.2	0.3	0.0	2.0	1.7	0.0	0.0	0.0	0.1	0.1	1.1	2.2	1.3	3.4	0.1	0.6	0.2	0.0	0.0	0.0	9.6	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.0	0.5	0.0	0.0	0.0	4.7	0.2	0.4	0.0	0.0	0.6	23.4	0.3	0.0	0.0	1.7	0.0	1.8	0.0	0.0	0.2	0.5	0.0	0.7	4.1	0.6	0.0	0.1	0.3	0.0	0.3	4.3	3.7	0.4	0.1	0.0	0.1	0.0	1.5	0.0	3.8	1.2	0.5	0.1	3.0	4.0	0.4	0.0	0.6	1.5	0.7	0.0	1.1	0.0	3.8	0.9	0.5	0.6	0.6	0.7	0.4	0.7	2.2	0.7	1.0	0.6	3.6	2.0	0.9	38.5	1.7	3.6	0.9	5.6	19.9	10.5	13.6	1.3	9.8	31.1	0.8	0.0	6.4	0.0	0.0	0.4	5.3	0.2	0.0	0.3	199.7	1.2	1.1	1.0	0.0	2.7	2.8	0.6	0.2	5.5	0.5	0.2	1.3	0.3	0.0	8.4	4.8	0.0	7.9	0.3	2.0	3.5	2.7	24.4	7.2	2.5	0.0	3.7	0.6	0.2	2.1	9.5	2.1	4.5	0.1	3.0	5.6	1.7	0.2	0.2	1.0	0.2	0.0	30.7	5.3	5.1	1.1	4.3	5.8	0.3	14.4	1.2	0.2	5.7
TPRG1L	"FAM79A, FLJ21811, RP11-46F15.3"	ENSG00000158109	"Tumor protein p63 regulated 1 like"	Q5T0D9	1	3625015-3630127	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 126.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063163, CAB079051"		Supported	Approved	Vesicles,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Cytosol"		"CAB079051: , HPA063163: AB_2684953"	"unprognostic (1.92e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.46e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.83e-3)"	"prognostic favorable (1.76e-9)"	"unprognostic (1.53e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-1)"	45.7	37.3	80.3	21.4	84.6	35.4	36.5	58.7	92.7	39.5	56.9	49.4	50.1	36.5	40.7	56.8	48.1	37.7	52.5	87.7	81.1	65.6	85.5	34.4	27.4	80.3	74.7	49.0	38.1	38.4	47.0	24.0	83.9	33.3	46.4	49.8	39.9	47.0	67.6	54.7	54.4	35.7	62.9	30.2	40.5	18.7	80.3	25.0	43.5	70.0	38.5	41.7	39.8	76.9	31.3	22.0	13.3	23.9	98.1	67.8	12.2	45.4	62.4	41.3	27.2	41.5	27.9	11.5	39.6	62.5	22.2	48.1	16.1	42.0	34.7	36.7	25.7	16.0	24.4	48.4	59.4	23.6	18.3	51.3	60.7	34.2	34.7	50.2	59.0	19.7	11.6	39.8	58.3	14.3	17.1	24.2	17.9	71.5	50.9	14.2	19.8	27.8	42.5	32.3	37.1	36.6	24.3	49.8	50.6	30.2	31.2	20.3	67.7	34.5	10.2	79.3	13.1	35.9	49.8	13.0	20.4	51.2	4.6	20.7	3.6	5.6	5.9	2.9	7.6	4.9	6.7	6.0	3.2	6.2	6.2	7.2	18.9	3.2	3.1	8.9	4.1	3.8	80.3	84.6	58.7	92.7	87.7	81.1	80.3	74.7	83.9	62.9	80.3	76.9	21.1	16.0	17.8	9.4	9.3	12.0	10.1	9.2	6.8	50.4	15.6	16.9	39.7	12.8	8.8	11.0	8.4	10.6	23.0	69.8	11.7	18.0	3.0	30.1	13.3	16.8	19.2	11.0	12.8	35.4	12.3	20.3	11.7	19.5	8.2	8.2	28.2	61.4	15.7	126.2	10.1	29.2	20.3	18.6	9.7	4.1	18.6	12.8	7.2	2.8	14.0	71.3	20.6	4.5	6.6	33.8	27.4	21.4	9.7	10.8	62.3	37.6	22.9	38.0	6.6	16.3	19.9	7.0	12.8	21.0	18.9	9.2	12.9	21.8	28.4	9.4
TRAPPC6A	"HSPC289, MGC2650, TRS33"	ENSG00000007255	"Trafficking protein particle complex 6A"	O75865	19	45162928-45178237	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 246.5;Proximal tubular cells: 303.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 164.5;U-266/70: 135.3"	"Low region specificity"	"Detected in all"							HPA043043	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA043043: AB_10794650"	"unprognostic (2.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.86e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (2.23e-6)"	"unprognostic (3.85e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.05e-2)"	27.3	32.7	25.4	14.1	28.9	48.7	31.0	27.9	35.1	20.5	19.9	33.1	18.3	21.6	19.5	25.4	29.1	15.9	21.4	24.3	25.5	57.5	59.8	18.6	34.2	30.0	27.2	23.0	28.9	17.1	20.5	12.7	29.2	39.1	11.5	4.6	30.7	16.8	35.2	56.0	28.1	7.0	27.0	42.4	32.2	24.8	26.6	20.6	38.4	15.8	17.4	23.7	24.5	33.2	7.6	42.1	9.4	18.7	15.7	11.3	18.3	2.3	8.2	2.6	5.8	12.6	38.2	76.1	40.0	4.8	22.0	15.8	3.3	6.8	1.1	42.5	30.8	28.0	3.5	14.0	33.0	12.3	28.2	27.8	37.9	2.0	12.8	10.4	8.9	48.8	27.6	57.7	4.1	104.0	30.5	42.0	11.9	164.5	21.0	52.8	10.2	93.9	27.2	26.6	44.2	18.3	16.4	77.9	29.1	16.0	45.1	39.3	3.5	6.3	6.8	4.4	2.7	135.3	43.0	57.0	14.4	25.6	10.5	25.7	59.5	30.5	78.2	60.3	94.8	92.1	105.5	81.8	91.2	93.7	110.4	95.1	4.8	113.6	62.8	87.6	112.7	86.2	25.4	28.9	27.9	35.1	24.3	25.5	30.0	27.2	29.2	27.0	26.6	33.2	28.8	44.8	51.7	5.2	61.6	58.1	64.3	149.3	55.2	13.6	66.6	71.4	17.9	68.6	71.5	58.8	2.1	122.7	63.4	41.7	246.5	53.4	15.1	56.8	26.9	33.7	83.8	23.8	2.7	42.1	43.7	24.8	29.6	65.2	40.6	63.9	42.1	113.7	72.0	13.5	2.3	84.6	148.5	56.6	67.3	94.0	19.3	45.3	108.5	5.6	114.2	54.9	60.8	4.5	10.7	24.4	73.8	10.5	39.9	35.1	61.8	303.6	62.0	13.6	13.1	23.9	34.4	14.2	68.9	43.0	83.5	88.5	72.1	72.7	81.8	71.6
TRAPPC8	"GSG1, HsT2706, KIAA1012, TRS85"	ENSG00000153339	"Trafficking protein particle complex 8"	Q9Y2L5	18	31829197-31953136	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041107	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Microtubules	"HPA041107: AB_10793869"	"unprognostic (4.04e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.62e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.06e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.35e-3)"	"prognostic favorable (1.85e-9)"	"unprognostic (3.55e-2)"	"unprognostic (7.03e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.92e-1)"	10.5	9.9	5.4	10.1	6.1	10.2	9.8	8.5	6.7	9.3	11.3	9.9	10.2	8.5	5.9	11.5	9.6	7.6	10.5	5.8	5.6	12.7	18.1	8.9	13.0	6.3	5.2	9.0	9.8	14.6	7.1	9.7	5.8	8.3	10.9	20.9	10.4	8.7	16.9	13.6	11.9	9.4	5.0	10.7	10.0	30.2	5.5	16.3	12.4	12.4	13.4	9.2	9.7	8.7	12.3	10.2	11.9	9.0	17.3	16.3	13.0	16.0	16.9	14.7	14.4	7.0	9.1	17.6	12.6	15.5	13.4	18.4	17.2	9.1	20.2	19.8	8.0	14.4	9.5	8.7	13.5	42.4	16.1	14.9	12.1	13.8	19.6	16.4	17.0	14.6	21.2	15.7	15.0	8.4	18.2	14.5	11.9	36.1	8.7	19.0	14.1	18.5	14.4	19.1	9.0	10.6	20.5	12.2	14.3	18.7	13.5	18.3	20.8	15.5	7.8	5.7	9.9	19.6	23.5	25.9	15.0	18.2	16.3	8.7	1.6	1.7	1.0	1.5	2.2	1.3	1.4	1.2	1.6	1.4	1.2	1.3	2.3	1.9	1.5	1.2	1.7	0.7	5.4	6.1	8.5	6.7	5.8	5.6	6.3	5.2	5.8	5.0	5.5	8.7	16.9	28.9	15.1	44.1	26.3	18.0	8.7	10.0	31.9	12.2	14.3	9.7	21.6	21.5	14.6	11.0	29.2	11.2	19.9	27.3	1.9	11.0	35.3	23.4	14.9	16.1	12.6	20.0	68.1	9.4	9.6	14.8	32.6	17.4	3.8	11.1	19.6	34.2	16.6	11.8	71.6	14.7	8.2	24.0	13.3	42.4	15.5	22.3	10.6	43.1	23.4	11.0	23.7	55.3	82.8	14.2	10.1	9.4	18.7	16.1	26.2	15.5	25.8	24.7	13.1	14.8	14.3	88.8	47.4	21.8	27.1	20.5	16.6	11.6	13.7	15.5
TRAPPC9	"IKBKBBP, KIAA1882, MRT13, NIBP, T1, TRS120"	ENSG00000167632	"Trafficking protein particle complex 9"	Q96Q05	8	139727725-140458579	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 89.5;Excitatory neurons: 121.8;Inhibitory neurons: 136.3;Late spermatids: 119.0;Microglial cells: 105.9;Oligodendrocyte precursor cells: 93.5;Oligodendrocytes: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026579			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA026579: AB_1854459"	"unprognostic (1.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (5.11e-6)"	"unprognostic (2.09e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.62e-1)"	8.6	13.4	10.3	6.9	11.0	11.1	8.9	10.7	12.7	10.3	12.5	11.1	8.0	11.3	5.1	12.3	12.2	5.8	15.0	10.8	10.3	13.8	11.6	9.5	8.0	13.1	14.1	10.5	11.9	27.4	20.7	7.2	13.9	11.7	6.0	14.2	11.6	8.3	33.5	11.4	10.9	7.2	10.2	11.3	12.5	9.0	11.9	11.3	12.9	17.6	6.8	11.1	10.8	13.0	9.6	16.6	7.4	20.8	15.5	9.0	4.9	6.0	9.9	3.1	5.0	6.2	11.2	11.6	14.0	11.9	4.7	12.2	10.0	9.4	3.4	16.8	6.1	18.6	9.8	6.2	11.2	4.7	14.5	8.9	9.3	2.5	7.9	11.1	12.9	13.1	6.7	10.1	5.1	27.0	29.2	6.2	2.3	31.3	14.0	12.2	2.7	19.4	11.6	11.6	19.1	10.6	9.8	4.7	10.6	7.6	15.3	6.8	7.7	4.6	7.9	10.8	4.9	14.1	10.9	7.8	9.6	10.1	7.4	15.4	3.5	2.9	4.2	3.3	4.6	2.7	2.9	3.3	3.5	4.4	2.8	3.6	5.0	4.9	3.4	4.2	2.1	3.5	10.3	11.0	10.7	12.7	10.8	10.3	13.1	14.1	13.9	10.2	11.9	13.0	5.1	3.2	8.3	89.5	9.6	2.3	4.7	3.1	5.7	14.2	5.5	4.1	13.9	5.7	5.3	11.0	20.9	10.9	5.4	15.2	9.8	6.5	47.9	8.4	3.7	6.5	30.5	3.4	121.8	6.2	4.4	5.3	29.6	10.2	8.8	7.9	4.6	9.2	7.5	28.6	136.3	14.4	10.2	10.5	3.7	119.0	5.9	10.3	10.6	105.9	5.3	13.6	11.3	93.5	170.6	5.1	6.6	7.9	11.0	3.7	13.4	19.9	15.7	13.7	6.6	9.0	5.3	3.6	6.6	8.7	3.0	14.6	10.5	8.6	12.0	5.4
TRIM16	EBBP	ENSG00000221926	"Tripartite motif containing 16"	O95361	17	15627960-15684311	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 145.9"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 153.4;Squamous epithelial cells: 95.5;Urothelial cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"T-reg: 45.1"	"Lineage enriched"	"Detected in many"	12	"T-cells: 45.1"	"Cell line enhanced"	"Detected in all"		"A549: 283.8;HaCaT: 229.0;HeLa: 203.8;OE19: 364.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023623, HPA066431"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA		19000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: AB_2685668"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.94e-3)"	"unprognostic (3.75e-2)"	"unprognostic (4.65e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (6.71e-4)"	18.3	32.7	14.1	7.8	16.2	17.4	13.4	17.7	21.5	44.9	10.3	14.1	22.8	6.1	4.9	145.9	8.8	16.3	23.1	13.5	15.8	8.5	5.9	14.5	9.7	16.9	16.0	7.3	6.0	3.6	4.4	34.5	17.2	10.2	11.2	3.6	38.0	11.7	28.1	44.9	12.5	9.0	15.8	6.0	31.7	12.7	17.2	10.1	18.7	27.2	37.3	35.7	70.2	22.1	91.5	283.8	8.6	19.4	40.4	46.1	9.6	14.8	51.9	17.9	25.0	17.2	115.6	9.8	54.7	64.7	106.9	229.0	25.6	65.7	12.0	120.0	16.4	4.5	203.8	9.5	67.1	5.4	9.6	25.7	40.9	39.3	22.3	49.6	38.8	11.4	5.7	45.8	49.2	32.2	20.2	11.7	13.1	364.2	17.0	8.7	71.8	6.9	92.4	116.0	6.4	17.7	64.7	72.2	22.1	49.7	10.9	12.6	61.0	22.5	26.3	10.9	51.3	11.1	12.9	1.0	34.6	12.6	58.3	0.4	3.8	1.0	1.2	1.1	0.8	0.5	4.9	1.5	2.6	0.6	1.3	2.6	0.6	0.9	0.5	0.4	45.1	2.3	14.1	16.2	17.7	21.5	13.5	15.8	16.9	16.0	17.2	15.8	17.2	22.1	34.9	38.5	2.6	14.0	5.3	30.8	59.0	55.6	10.2	7.2	11.8	5.7	12.5	10.0	73.5	11.0	18.8	13.6	2.8	9.9	0.0	49.1	1.1	16.5	9.9	28.7	4.2	9.0	9.6	17.3	8.4	9.6	34.7	25.7	4.5	12.4	3.6	3.2	4.0	3.3	14.0	21.7	28.5	2.9	8.6	3.9	7.2	2.9	7.2	11.2	13.0	6.6	4.1	18.6	19.2	153.4	26.9	4.5	3.7	29.5	4.3	6.2	33.5	8.4	6.6	5.8	14.0	10.3	12.1	95.5	77.6	4.7	5.9	60.9	18.4	111.9
TRIQK	"C8orf83, DKFZp779L1068, LOC286144, PRO0845"	ENSG00000205133	"Triple QxxK/R motif containing"	Q629K1	8	92883532-93017673	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 32.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (3.47e-3)"	"unprognostic (3.09e-1)"	"unprognostic (6.03e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.13e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.23e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.79e-2)"	12.8	21.9	12.3	7.7	15.7	14.5	14.5	18.6	14.9	19.4	10.5	20.7	12.4	12.5	9.7	9.8	15.7	22.9	20.1	13.7	13.5	19.4	31.3	17.0	5.3	13.4	12.6	19.6	18.0	20.6	10.7	19.6	14.0	18.1	21.0	12.4	11.1	10.2	2.4	5.7	12.1	11.4	14.2	13.2	17.5	6.5	13.5	7.3	23.4	5.6	5.2	15.5	7.9	17.0	7.4	9.2	19.8	7.0	27.1	42.8	6.6	26.4	28.4	14.7	20.9	1.3	22.9	0.0	31.6	24.9	9.8	11.9	16.1	15.9	23.7	0.0	7.6	28.9	10.1	15.6	22.9	8.1	24.0	32.0	35.4	8.0	27.1	33.3	15.7	16.3	5.6	16.7	21.3	19.7	13.1	6.3	6.8	31.3	33.8	0.0	20.5	9.6	27.8	9.1	11.4	16.0	10.0	3.9	25.6	16.3	27.2	7.1	20.5	21.8	6.7	38.3	8.3	5.8	0.0	0.0	33.8	0.1	22.5	0.9	17.0	15.9	0.1	18.8	8.1	2.8	0.9	0.7	9.4	1.9	0.0	0.0	14.6	2.0	32.9	2.5	0.2	4.7	12.3	15.7	18.6	14.9	13.7	13.5	13.4	12.6	14.0	14.2	13.5	17.0	19.0	19.2	17.9	21.9	4.0	15.0	21.4	17.1	22.8	18.9	17.7	12.4	13.8	25.8	14.1	16.5	6.2	7.3	2.1	16.2	50.9	14.8	7.0	21.3	27.7	17.8	19.2	6.7	36.8	16.4	23.8	23.5	20.9	24.5	2.5	11.7	17.2	18.3	11.9	6.7	43.6	35.6	12.2	20.0	13.6	8.0	16.4	18.5	23.2	31.9	24.3	22.8	3.1	34.7	56.3	12.5	14.0	21.8	1.0	22.2	17.0	39.1	29.5	6.3	32.9	18.4	18.2	12.1	5.3	12.3	8.4	3.7	3.3	21.6	20.0	22.6
TROAP	TASTIN	ENSG00000135451	"Trophinin associated protein"	Q12815	12	49323236-49331731	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.0;lymphoid tissue: 36.7;testis: 29.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.5;Erythroid cells: 75.6;Late spermatids: 70.2;Spermatocytes: 29.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.6"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044102	Uncertain					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA044102: AB_10963691"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (3.43e-3)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.17e-2)"	1.3	1.5	0.2	7.3	0.3	51.0	1.4	0.2	0.7	2.8	0.2	6.7	9.0	1.2	0.5	13.5	0.7	0.8	0.8	0.2	0.2	0.9	1.6	2.4	11.2	0.4	0.2	0.8	0.8	0.7	0.4	5.1	0.3	0.9	9.2	0.6	2.5	0.4	0.3	7.7	7.6	2.8	0.1	7.0	5.4	29.1	0.5	36.7	0.8	0.3	14.5	1.9	5.3	0.3	95.9	73.9	92.4	69.7	2.8	6.2	71.2	45.4	43.4	129.5	73.1	163.7	73.5	64.6	21.9	33.7	70.7	74.6	70.4	44.0	75.7	51.9	101.8	90.9	120.4	53.7	1.9	66.5	93.8	1.5	6.0	86.9	59.8	21.1	75.1	68.0	57.2	108.9	52.7	123.0	122.9	101.8	43.4	269.3	110.2	62.5	78.6	83.9	31.7	35.0	59.9	41.0	56.0	107.4	32.7	53.6	88.2	50.1	25.0	33.5	91.2	69.4	124.8	58.3	68.8	83.0	32.3	73.8	38.4	0.2	0.0	0.1	0.1	0.0	0.2	1.4	2.1	2.3	0.3	1.4	0.1	0.5	0.0	2.0	0.1	0.0	8.6	0.5	0.2	0.3	0.2	0.7	0.2	0.2	0.4	0.2	0.3	0.1	0.5	0.3	0.1	0.0	0.0	0.0	4.6	3.8	1.5	2.8	1.2	0.6	2.1	2.8	0.5	0.0	1.8	0.0	0.0	14.1	1.0	3.7	0.0	0.7	71.5	1.9	1.3	1.9	1.2	75.6	0.0	0.7	23.6	3.3	10.2	2.7	0.0	16.0	5.7	1.1	15.7	0.0	0.0	7.9	10.2	6.7	3.7	70.2	1.8	4.0	1.8	0.0	0.9	0.0	6.2	0.0	0.0	0.8	1.8	0.4	17.0	1.1	0.7	0.1	0.2	0.4	0.0	0.7	3.5	29.1	9.3	15.6	2.0	4.0	2.5	0.9	12.7	3.6
TSPAN8	"CO-029, TM4SF3"	ENSG00000127324	"Tetraspanin 8"	P19075	12	71125085-71441898	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 951.1;stomach 1: 631.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1688.5;Ductal cells: 943.3;Intestinal goblet cells: 886.7;Paneth cells: 2225.8;Proximal enterocytes: 3546.1;Undifferentiated cells: 1583.9"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 283.9;pancreatic cancer: 156.9;stomach cancer: 194.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"OE19: 2160.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA022273, CAB026009, HPA044337"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB026009: , HPA022273: , HPA044337: AB_2678899"	"unprognostic (1.64e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (9.66e-5)"	"unprognostic (1.88e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.97e-2)"	"prognostic favorable (7.36e-5)"	11.1	9.7	1.9	126.9	5.2	0.0	17.0	6.1	7.1	28.6	1.6	951.1	916.0	12.5	11.7	5.5	13.4	208.2	5.5	1.8	3.4	57.6	53.2	23.0	4.6	12.4	4.9	41.8	60.0	0.4	2.5	2.0	10.5	163.9	862.0	0.3	76.4	10.8	63.7	13.6	848.3	39.2	8.5	0.3	631.0	5.8	4.4	1.1	6.5	12.4	3.8	11.0	4.0	14.6	0.0	0.7	0.0	0.0	5.2	0.8	2.8	0.0	0.0	0.0	0.0	48.8	3.1	0.0	0.2	0.0	0.6	6.5	0.0	0.0	0.0	0.2	0.1	0.0	52.2	3.3	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.3	0.0	0.2	3.0	0.3	2160.7	173.3	0.2	0.0	4.9	34.1	41.0	4.1	7.7	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.3	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.2	6.1	7.1	1.8	3.4	12.4	4.9	10.5	8.5	4.4	14.6	0.8	0.0	2.2	0.0	6.1	20.8	32.5	14.0	0.6	0.3	8.5	1.8	0.3	346.0	76.7	44.1	0.0	1.2	0.0	1688.5	127.2	943.3	34.5	3.7	4.5	3.8	174.1	0.0	0.1	654.9	0.6	37.3	645.3	44.8	4.5	0.0	2.2	26.0	0.2	0.0	0.1	886.7	16.2	2.2	29.1	17.9	44.1	2.6	64.0	0.0	7.8	10.3	0.0	0.5	14.3	325.0	2225.8	32.0	2.2	376.2	3546.1	2.5	30.2	0.6	0.0	7.7	23.6	0.5	1.0	2.7	13.5	1.1	5.8	10.7	1583.9	46.0
TSPO2	"BZRPL1, dJ34B21.2"	ENSG00000112212	"Translocator protein 2"	Q5TGU0	6	41042467-41044337	"Predicted membrane proteins, Transporters"	Transport	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 50.1"	"Cell type enriched"	"Detected in some"	115	"Erythroid cells: 253.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA060691, HPA066996"			Enhanced	"Plasma membrane"		NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane"		"HPA060691: , HPA066996: AB_2685761"	"unprognostic (1.89e-3)"	"unprognostic (8.35e-3)"	"unprognostic (2.57e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.76e-2)"	0.0	0.0	0.1	0.1	0.6	50.1	0.0	0.1	0.7	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.4	0.5	0.6	0.2	0.1	0.8	0.4	0.1	0.1	0.0	0.0	1.2	0.9	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.7	0.0	0.2	1.3	0.5	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.4	0.0	11.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.7	0.1	0.4	0.8	0.4	0.9	0.2	0.8	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.9	0.3	0.1	0.0	0.0	0.0	253.9	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0
TST	RDS	ENSG00000128311	"Thiosulfate sulfurtransferase"	Q16762	22	37010859-37020183	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 561.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 565.8;Hepatocytes: 414.9;Paneth cells: 463.4;Proximal enterocytes: 278.5;Proximal tubular cells: 254.5;Undifferentiated cells: 217.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 177.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 25.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 25.0;granulocytes: 21.8;monocytes: 17.7"	"Cell line enhanced"	"Detected in many"		"OE19: 264.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003044, HPA003643, CAB009546"	Enhanced		Supported	Mitochondria		NA	NA		560000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411"	"unprognostic (3.09e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.96e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (7.59e-6)"	"unprognostic (6.08e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.04e-4)"	51.4	154.1	31.3	20.9	40.5	27.1	37.3	38.2	36.0	34.1	31.3	190.7	147.7	18.9	2.9	96.7	25.7	75.9	69.9	29.1	33.1	100.8	561.2	22.7	8.1	34.4	35.2	26.9	63.6	9.4	12.4	7.9	34.4	26.4	80.3	1.3	39.8	18.2	52.9	33.8	114.2	13.2	35.4	16.9	88.4	8.1	35.8	4.3	17.1	34.9	16.2	30.0	56.7	39.0	42.6	86.1	10.8	36.8	25.9	10.6	21.4	23.0	18.6	12.6	18.3	25.4	25.7	11.1	18.8	17.0	11.9	35.1	7.9	22.3	2.7	33.6	50.0	11.5	15.5	49.7	64.9	16.4	26.4	20.1	23.9	9.1	7.6	17.5	31.1	5.9	14.2	18.2	6.0	90.8	0.5	49.9	18.7	264.4	39.3	37.0	11.7	19.7	35.9	36.7	6.4	17.1	24.2	41.4	31.7	10.2	43.4	39.3	25.1	14.0	27.2	24.2	7.4	14.0	15.4	3.4	5.3	46.4	8.5	10.9	17.7	8.0	0.8	4.7	1.7	2.8	0.8	0.6	25.0	1.7	0.4	0.2	21.8	3.7	1.5	1.7	2.1	8.1	31.3	40.5	38.2	36.0	29.1	33.1	34.4	35.2	34.4	35.4	35.8	39.0	13.9	28.9	74.8	10.1	7.8	1.3	9.5	20.4	12.0	1.3	32.7	16.6	39.2	170.1	23.7	20.2	0.0	11.6	2.5	565.8	46.9	45.3	1.9	53.3	30.2	13.4	34.3	35.3	0.3	44.0	6.4	14.6	126.9	74.3	14.0	60.9	39.3	414.9	15.1	1.7	0.5	162.8	8.2	28.9	6.8	3.5	13.1	23.2	1.8	1.0	18.6	27.3	3.1	3.5	7.4	36.8	463.4	7.9	24.5	10.5	278.5	254.5	19.2	0.8	0.0	10.7	11.5	2.4	0.5	39.8	2.4	11.4	5.0	57.5	217.4	17.3
TTC13	FLJ22584	ENSG00000143643	"Tetratricopeptide repeat domain 13"	Q8NBP0	1	230906243-230978875	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 42.7;Excitatory neurons: 70.9;Inhibitory neurons: 76.7;Microglial cells: 56.2;Oligodendrocyte precursor cells: 41.7;Oligodendrocytes: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018022, HPA051558"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA018022: AB_2211524, HPA051558: AB_2681534"	"unprognostic (2.68e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.10e-2)"	"prognostic favorable (7.66e-4)"	"unprognostic (2.60e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.80e-2)"	"prognostic favorable (4.59e-5)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.60e-11)"	"unprognostic (4.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.54e-3)"	7.8	5.1	7.4	11.7	9.4	11.6	7.0	7.9	7.9	7.1	4.8	11.2	8.0	5.9	6.5	6.0	6.5	6.1	6.5	7.3	9.2	6.4	7.9	9.9	19.6	7.3	6.7	5.6	10.5	6.8	9.2	7.5	7.5	6.3	15.9	11.8	6.7	5.1	11.4	9.8	12.2	6.1	7.7	20.3	12.2	2.9	8.4	10.2	6.8	6.2	14.8	6.5	6.7	9.5	12.4	12.4	12.0	23.5	11.0	7.1	24.5	17.7	13.9	9.8	11.0	18.4	13.2	22.7	15.9	10.8	9.7	19.4	8.0	6.6	6.5	25.6	23.3	6.8	13.7	12.5	11.6	14.1	6.0	6.3	11.4	9.2	8.5	9.8	17.5	9.7	7.3	12.9	9.1	6.5	7.5	13.5	13.5	41.1	15.2	12.0	17.2	31.9	10.2	8.5	16.5	14.2	13.5	13.8	24.2	5.2	14.8	18.1	9.0	11.5	1.6	15.7	31.9	15.8	27.9	6.8	11.3	8.8	19.2	5.7	5.5	4.9	6.6	4.1	4.5	2.8	4.5	5.3	7.7	2.2	3.5	4.4	1.9	7.9	5.3	4.9	3.9	4.2	7.4	9.4	7.9	7.9	7.3	9.2	7.3	6.7	7.5	7.7	8.4	9.5	7.2	6.4	7.4	42.7	18.9	3.3	1.0	1.8	1.2	6.1	3.4	2.4	3.0	1.5	4.0	1.8	6.2	4.3	21.8	6.6	1.9	5.6	1.7	1.7	2.4	5.4	6.1	11.6	70.9	8.6	5.1	5.2	14.3	3.0	9.5	4.6	1.8	5.0	5.0	11.8	76.7	11.3	8.2	7.8	6.6	2.3	2.8	8.9	1.8	56.2	7.2	4.5	17.5	41.7	70.6	4.1	8.7	6.8	13.6	1.9	2.6	1.2	1.3	10.8	6.6	5.5	4.9	3.1	3.5	3.8	2.7	1.6	16.9	2.1	9.4	1.6
TUBA1C	"bcm948, MGC10851, MGC14580, TUBA6"	ENSG00000167553	"Tubulin alpha 1c"	Q9BQE3	12	49188736-49274600	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 479.4"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 1118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 98.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 4114.3"	"Low region specificity"	"Detected in all"							"HPA039247, HPA043684, HPA063394"	Supported		Supported	Microtubules		NA	Yes		160000000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.15e-2)"	"prognostic favorable (7.37e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (8.48e-8)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (5.64e-6)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.26e-7)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.45e-3)"	92.6	57.8	12.4	110.5	12.1	148.8	54.7	13.9	18.0	101.0	41.9	158.2	106.9	59.6	62.7	479.4	50.8	92.1	55.3	12.8	16.4	113.5	69.3	74.1	78.6	15.7	14.1	38.3	52.6	22.5	28.0	109.9	15.5	43.7	156.5	2.5	139.0	46.4	45.3	166.1	117.6	129.8	15.7	42.1	115.2	26.3	22.6	103.3	56.3	42.5	170.7	222.5	168.8	15.4	1295.3	987.5	211.7	363.9	220.5	368.4	816.3	1010.1	1126.1	1742.1	927.3	966.9	947.0	578.9	1053.2	1194.2	1047.3	580.5	1246.0	1412.1	1150.2	564.1	449.7	703.4	406.7	943.7	165.2	550.9	498.4	269.8	663.0	1485.6	619.9	550.6	1139.5	320.6	1026.8	308.3	1521.8	811.1	306.5	535.8	639.6	4114.3	1928.6	344.0	414.5	319.7	770.3	602.8	169.8	9.1	875.5	574.4	386.0	828.3	559.4	426.0	835.1	819.3	911.5	821.9	1717.4	101.6	306.5	565.2	431.6	536.1	725.9	98.8	14.6	29.9	12.3	17.3	19.7	10.5	13.1	11.7	27.0	7.4	7.0	7.9	12.2	13.6	13.1	21.6	17.6	20.8	12.4	12.1	13.9	18.0	12.8	16.4	15.7	14.1	15.5	15.7	22.6	15.4	94.3	118.6	136.1	2.6	54.9	194.5	354.2	317.7	306.7	1.3	61.3	75.8	0.9	45.8	150.9	58.8	0.0	291.9	50.1	432.7	70.5	285.8	7.9	107.7	65.8	83.0	77.5	155.5	2.1	559.2	1118.2	109.7	153.4	204.4	67.2	110.8	39.3	55.9	276.8	0.0	1.9	190.5	101.7	65.6	121.7	8.4	68.0	163.3	46.2	2.8	265.5	2.8	6.2	1.0	1.4	465.6	330.2	40.6	71.0	206.3	234.1	137.1	51.9	0.6	39.5	84.3	258.2	9.0	65.5	530.8	183.1	161.6	77.6	46.1	187.9	293.4
TVP23B	"CGI-148, FAM18B, FAM18B1, YDR084C"	ENSG00000171928	"Trans-golgi network vesicle protein 23 homolog B"	Q9NYZ1	17	18781111-18806714	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019585, HPA065603"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"HPA019585: AB_1848385, HPA065603: AB_2685517"	"unprognostic (1.91e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.13e-2)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.54e-1)"	"unprognostic (5.27e-1)"	"unprognostic (7.78e-2)"	"unprognostic (8.55e-2)"	26.4	43.2	11.1	20.0	11.7	19.9	30.3	12.8	15.1	38.2	23.3	25.8	29.9	26.5	40.4	52.3	34.5	30.4	22.8	10.6	13.5	31.0	44.0	20.8	25.4	12.3	13.0	30.1	33.6	47.8	32.7	29.6	13.0	33.5	31.2	32.1	34.3	24.4	17.3	19.3	23.8	21.7	13.1	17.4	40.5	34.9	12.4	20.4	46.9	16.2	31.4	32.7	34.2	13.3	55.0	63.8	23.6	26.2	68.8	60.9	56.1	93.5	75.0	42.8	54.6	37.6	38.7	17.9	33.9	60.3	42.6	74.1	19.2	40.2	63.2	44.3	39.7	17.0	47.1	46.3	48.0	13.0	35.6	31.6	95.7	46.0	67.7	78.7	36.0	12.6	14.0	13.1	62.9	27.6	17.2	18.3	11.0	99.2	25.6	17.4	52.1	23.1	52.7	36.0	13.4	29.9	49.8	32.4	60.4	129.0	46.9	19.7	41.6	32.7	28.1	69.8	57.5	25.9	31.7	9.5	50.2	22.2	68.2	54.4	20.4	44.6	29.7	27.4	40.5	32.1	33.0	32.1	17.3	26.9	34.8	34.8	24.2	32.3	27.1	27.9	26.3	32.1	11.1	11.7	12.8	15.1	10.6	13.5	12.3	13.0	13.0	13.1	12.4	13.3	10.0	12.8	13.2	9.4	29.4	25.2	28.1	70.4	54.7	8.6	16.5	9.7	4.2	10.0	42.4	9.2	10.4	13.3	15.7	8.5	11.7	13.9	8.6	21.7	16.1	12.9	6.1	17.2	8.1	11.6	30.3	19.1	40.2	16.2	22.2	7.1	11.0	10.3	10.0	1.7	8.8	14.6	44.7	10.3	10.7	4.2	16.8	16.0	26.6	11.2	9.1	9.1	17.5	14.1	12.8	16.5	10.7	17.0	62.1	28.5	12.0	14.0	60.0	11.1	13.1	9.0	17.0	50.8	43.0	65.5	30.5	26.1	23.7	8.9	8.6	32.4
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243810-110256507	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator	Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1058.8"	"Cell type enriched"	"Detected in all"	4	"monocytes: 15775.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 1642.2;granulocytes: 1355.4"	"Cell line enhanced"	"Detected in all"		"OE19: 3836.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		16000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	144.2	127.7	149.9	145.4	155.3	367.5	218.6	154.5	225.4	153.9	140.5	455.2	349.3	130.9	168.4	1058.8	240.7	142.1	90.8	156.2	161.7	430.6	436.0	158.4	131.6	163.3	156.2	83.8	119.1	73.0	61.2	105.8	163.0	113.6	435.0	46.2	391.7	128.9	84.8	240.1	332.2	140.3	158.1	105.4	222.7	36.6	156.4	261.3	93.8	76.4	208.3	218.1	230.8	164.8	672.9	920.0	238.7	265.6	601.0	782.3	352.7	792.5	756.2	555.6	419.4	606.8	785.6	598.9	331.5	754.7	1181.3	1464.8	351.0	1081.1	544.6	887.6	778.5	298.2	804.7	1061.8	684.7	747.2	864.2	556.2	703.5	809.0	607.8	504.7	498.7	369.7	515.9	553.1	775.4	557.1	621.9	1119.7	505.4	3836.3	1110.5	256.6	810.3	696.3	721.7	479.4	520.9	183.7	860.0	687.5	572.7	458.6	661.2	508.6	587.9	556.4	357.3	1050.2	1006.1	271.4	872.5	512.7	804.8	654.4	789.5	484.8	311.2	1355.4	169.2	195.5	165.2	154.2	237.7	207.3	475.7	75.9	87.4	129.3	1212.7	195.0	131.6	1642.2	337.0	279.2	149.9	155.3	154.5	225.4	156.2	161.7	163.3	156.2	163.0	158.1	156.4	164.8	458.7	391.0	298.2	12.4	165.9	1304.5	1072.4	3654.4	435.4	38.0	514.2	752.8	108.5	418.9	1810.0	263.0	20.9	637.2	443.0	1297.7	972.4	1172.8	31.2	1560.7	1465.0	587.0	556.4	388.4	18.2	1341.7	993.1	526.8	662.1	775.9	268.6	247.1	216.0	842.8	571.8	28.6	18.3	1111.2	2191.1	286.1	1752.9	31.6	403.2	682.7	763.1	10.3	15775.8	86.3	128.8	7.5	21.9	1994.7	1227.7	285.5	388.5	2151.2	1439.2	3670.6	1516.8	34.8	144.7	211.8	557.8	10.6	76.3	2725.7	1491.0	468.2	266.6	879.4	1621.8	1742.1
UBB	"FLJ25987, MGC8385"	ENSG00000170315	"Ubiquitin B"	P0CG47	17	16380798-16382745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013048, HPA041344, HPA049132"	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"			"CAB013048: AB_2533002, HPA041344: AB_2677422, HPA049132: AB_2680646"	"unprognostic (1.16e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.86e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.48e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-1)"	942.4	1676.7	1564.8	674.6	1589.2	2376.9	770.4	1662.2	2231.7	812.8	1565.4	1065.5	1179.6	788.9	1367.0	656.3	656.8	813.0	1668.3	1644.2	1719.8	1593.6	2982.1	1046.3	1002.7	1672.3	1765.4	726.2	1305.1	1677.7	1373.8	1012.3	1713.9	808.0	1097.8	566.0	1294.6	861.8	2656.6	692.3	1134.0	932.4	1670.6	1078.8	1245.6	1591.8	1597.4	1226.8	1181.5	2162.1	993.0	974.7	689.1	1980.8	1646.5	3022.4	1559.8	1912.1	1530.0	963.9	1131.3	1609.5	2166.2	2855.8	2453.4	2916.5	1270.4	1662.3	2631.3	1916.6	1678.5	1295.4	0.8	1054.2	3076.0	2126.4	2231.3	1649.8	1653.1	2183.7	1022.3	6.6	2162.4	1468.9	1010.2	2183.4	848.2	1486.0	1582.3	1562.2	1888.9	1530.9	1743.0	3858.5	2354.7	2086.6	1288.4	4642.0	1177.2	2185.1	1984.7	1484.1	2312.8	1911.4	1179.0	1757.0	2109.6	1239.7	1454.4	3025.5	1392.6	1936.0	1152.7	1417.8	867.8	1087.6	2507.7	845.7	1238.7	1366.4	1688.3	1757.9	1356.3	5348.4	1684.4	3262.9	2632.2	2121.6	2131.1	3065.4	2048.1	2372.7	1501.1	2872.4	1787.4	2146.5	981.5	3290.2	1875.7	2799.7	2592.8	7841.1	1564.8	1589.2	1662.2	2231.7	1644.2	1719.8	1672.3	1765.4	1713.9	1670.6	1597.4	1980.8	1607.0	1003.2	1168.4	46.7	786.3	979.5	1548.2	1890.9	796.2	426.2	763.6	1161.1	370.3	948.0	1262.5	551.8	120.9	1661.1	1082.7	1377.9	1829.3	1114.8	3648.2	961.6	510.0	870.9	922.4	4506.0	29.1	880.2	996.8	1202.3	1270.6	799.9	1800.7	412.4	669.3	1509.8	1168.9	233.9	37.3	1351.2	1310.2	589.0	1180.7	2126.9	592.4	826.6	1812.5	50.6	1001.9	912.0	1051.5	30.7	133.6	751.3	1879.5	775.2	700.4	974.6	1970.0	3101.7	2080.6	506.8	880.9	714.4	3554.9	3297.7	1090.7	739.1	1112.3	1815.4	1231.6	935.0	993.8	1036.2
UBQLN4	"A1U, C1orf6, UBIN"	ENSG00000160803	"Ubiquilin 4"	Q9NRR5	1	156035299-156053798	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061797	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA061797: AB_2684613"	"unprognostic (3.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.57e-1)"	18.9	19.4	39.9	14.6	47.9	9.1	19.1	34.3	52.5	31.6	27.3	24.5	13.6	24.3	15.3	33.7	26.7	11.5	26.7	40.8	40.2	25.7	31.7	20.8	15.0	38.1	38.3	21.1	32.2	25.6	11.3	15.5	37.7	25.4	15.5	18.3	23.3	19.6	59.7	27.0	18.8	22.9	37.1	20.2	28.2	19.8	40.0	14.1	17.7	39.5	17.0	26.1	26.0	39.8	45.9	54.1	50.8	50.1	34.1	21.0	50.0	37.8	20.7	37.2	27.8	49.0	40.5	77.7	33.9	34.7	20.1	50.2	51.8	40.8	35.2	65.9	54.9	42.8	31.5	47.7	21.9	46.4	77.3	15.9	51.6	51.3	41.5	32.6	44.8	24.4	81.4	42.1	34.0	56.3	51.4	46.5	69.8	117.2	49.8	64.8	37.4	76.9	30.2	45.7	37.3	108.0	38.0	93.2	38.7	49.0	90.1	50.4	43.7	34.3	44.9	35.3	41.4	92.7	79.4	83.2	21.0	45.9	49.1	9.7	0.7	0.4	1.5	0.7	1.9	1.1	1.1	1.6	0.5	0.8	0.8	1.2	0.0	1.2	0.1	1.2	1.0	0.7	39.9	47.9	34.3	52.5	40.8	40.2	38.1	38.3	37.7	37.1	40.0	39.8	8.6	6.4	5.3	9.8	8.4	13.4	9.4	9.1	18.2	6.8	17.2	9.9	4.3	17.2	8.5	23.9	6.2	8.1	8.1	9.6	3.9	11.6	0.8	5.0	10.2	9.3	10.7	6.3	5.9	10.9	9.1	7.4	7.1	8.9	1.3	13.4	11.7	22.7	9.9	6.7	6.6	10.8	8.2	8.4	7.2	4.9	6.5	8.3	17.8	9.4	15.6	7.3	5.2	4.5	9.2	13.1	6.9	9.1	13.0	25.3	8.2	12.1	5.4	6.0	0.0	10.7	7.8	4.9	5.6	21.0	14.6	8.2	7.7	4.8	15.0	14.3
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564029-42693505	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 138.5;Inhibitory neurons: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 38.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	11.0	10.7	8.5	12.7	10.1	17.9	12.9	14.1	11.1	10.3	11.3	12.7	14.4	10.9	11.2	9.5	9.4	8.6	11.2	9.0	8.8	12.1	17.2	11.9	12.7	9.0	8.7	12.2	15.6	15.0	8.8	11.7	9.3	10.5	13.8	29.7	12.0	10.0	22.8	12.2	13.8	10.6	8.6	15.3	12.2	6.2	9.1	13.5	13.3	22.3	11.5	10.8	10.4	14.2	18.5	9.0	10.4	16.4	20.9	20.0	14.0	13.8	14.9	12.0	12.4	13.2	7.4	12.5	10.7	15.0	13.9	18.1	15.1	11.8	15.2	17.1	10.6	20.0	13.3	17.3	17.0	19.6	13.1	14.1	12.7	12.0	12.9	14.8	13.7	17.9	23.7	15.4	11.7	14.9	15.4	17.1	9.5	36.2	8.7	13.6	15.5	19.0	13.8	15.7	12.4	9.8	14.0	13.3	13.9	15.7	13.0	18.7	19.8	10.8	8.4	13.5	10.1	14.1	13.4	18.9	5.7	14.5	6.8	17.7	7.1	15.2	6.5	7.3	5.4	5.2	4.2	5.1	5.5	5.2	4.3	4.8	38.5	5.9	9.8	4.1	5.3	3.4	8.5	10.1	14.1	11.1	9.0	8.8	9.0	8.7	9.3	8.6	9.1	14.2	33.5	16.0	24.6	82.6	33.9	16.6	18.1	14.9	28.5	43.0	20.4	15.9	39.3	30.0	22.1	20.2	60.5	17.4	46.6	51.6	17.6	18.5	12.4	27.5	30.8	24.8	12.6	75.1	138.5	15.3	13.4	26.5	34.1	32.9	20.3	31.3	21.8	35.0	13.2	63.9	142.7	22.5	14.2	26.7	28.6	3.9	25.4	26.1	19.6	87.1	43.0	23.5	32.0	123.1	131.4	15.0	29.1	24.0	50.6	22.8	37.2	11.7	27.9	53.5	39.5	30.0	27.2	11.2	10.9	28.1	16.2	17.2	44.0	24.0	21.5	22.7
UBR4	"KIAA0462, KIAA1307, RBAF600, ZUBR1"	ENSG00000127481	"Ubiquitin protein ligase E3 component n-recognin 4"	Q5T4S7	1	19074510-19210266	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Calmodulin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 271.0;Suprabasal keratinocytes: 252.9;Urothelial cells: 236.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 39.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013394, HPA021046"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA		15000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA013394: , HPA021046: AB_1858578"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.14e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.52e-1)"	56.2	62.8	48.2	23.0	46.0	79.8	49.8	38.7	48.4	57.4	47.6	69.6	20.9	61.7	35.7	55.4	52.3	29.6	58.7	45.8	46.0	74.7	82.7	71.9	25.7	51.5	46.4	75.3	53.5	35.5	70.7	27.5	54.9	67.2	22.7	44.6	48.0	27.0	129.1	161.9	59.7	26.0	35.2	62.8	70.6	105.3	45.9	34.6	56.5	45.0	25.7	90.0	59.2	44.7	61.4	60.7	53.5	39.7	97.6	50.0	46.2	46.5	48.8	49.5	44.7	97.2	51.3	36.6	42.3	61.7	43.3	40.8	42.3	46.3	46.0	30.6	37.5	83.8	63.3	64.1	68.6	51.9	53.4	45.0	57.9	100.8	96.3	48.1	54.9	63.7	58.5	32.9	47.6	43.6	24.7	62.9	43.5	124.3	33.6	34.0	41.7	31.0	44.7	35.2	37.7	37.4	55.0	31.1	39.9	48.6	21.7	40.4	85.9	57.4	36.1	69.0	52.8	38.8	25.2	41.5	39.3	79.3	50.3	39.8	28.7	4.7	4.9	5.9	4.2	7.4	4.4	2.9	14.2	4.0	3.9	3.7	15.4	4.4	2.1	6.5	3.4	8.3	48.2	46.0	38.7	48.4	45.8	46.0	51.5	46.4	54.9	35.2	45.9	44.7	28.1	35.3	37.6	85.5	30.3	271.0	124.6	28.9	28.5	57.5	22.1	23.9	19.1	37.1	30.4	31.3	152.2	24.7	34.2	31.6	13.7	41.3	21.4	39.8	32.0	30.8	17.5	48.4	58.9	40.9	17.0	32.2	44.9	50.4	19.6	32.9	31.1	94.1	63.2	79.1	61.8	29.2	12.2	43.0	48.7	28.7	30.7	46.4	49.8	34.7	64.4	28.8	21.6	51.8	44.5	61.0	16.7	35.7	26.4	59.1	57.9	135.6	39.1	48.5	19.7	28.3	30.1	44.8	21.0	28.0	252.9	33.9	32.7	34.5	20.1	236.5
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760270-233773300	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"intestine: 201.2;liver: 322.4"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 105.0"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;OE19: 64.5;RT4: 34.7"	"Not detected"	"Not detected"													NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"						"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.1	0.6	0.2	0.5	0.5	0.2	1.5	0.8	0.1	0.2	3.0	201.2	0.2	0.4	3.5	0.1	1.0	0.2	0.4	0.8	4.0	322.4	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.2	2.4	0.9	0.5	0.3	0.1	1.8	79.2	0.1	0.0	0.2	2.4	0.6	0.3	0.1	0.2	0.1	0.3	10.0	0.9	0.6	0.3	1.1	0.2	0.2	0.1	0.1	0.6	0.0	0.0	0.0	0.1	5.4	0.3	0.2	2.5	0.1	0.1	14.0	0.0	0.2	0.0	0.2	0.1	0.1	0.6	1.6	0.0	0.5	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.3	0.2	0.6	0.0	0.8	0.1	0.3	0.5	64.5	6.5	0.1	0.1	0.6	0.0	34.7	0.2	0.4	2.6	0.4	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.3	0.0	0.2	0.2	0.1	0.7	0.4	0.2	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	1.4	0.3	0.1	0.1	0.1	0.0	0.6	0.5	1.5	0.8	0.4	0.8	0.2	0.2	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	3.7	1.8	0.0	0.0	0.0	1.8	0.0	0.1	2.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	105.0	0.0	0.0	0.0	0.4	0.0	2.4	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.1	6.9	14.6	2.2	1.5	0.0	0.0	0.4	0.1	0.2	0.1	1.5	0.0	0.0	0.1	0.0	0.7	7.3
UGT1A6	"GNT1, HLUGP, UGT1F"	ENSG00000167165	"UDP glucuronosyltransferase family 1 member A6"	P19224	2	233691607-233773300	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 71.3;liver: 143.3;urinary bladder: 88.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 12.5;Early spermatids: 52.4;Gastric mucus-secreting cells: 14.3;Late spermatids: 23.3;Squamous epithelial cells: 17.3"	"Group enriched"	"Detected in many"	5	"liver cancer: 7.2;lung cancer: 3.1;renal cancer: 7.6;urothelial cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 1194.0"	"Not detected"	"Not detected"							"CAB009819, HPA054065, HPA056023"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Vesicles	"Endoplasmic reticulum"	"CAB009819: AB_2241481, HPA054065: AB_2682367, HPA056023: "		"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.43e-2)"		"unprognostic (6.03e-2)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.79e-1)"	"unprognostic (6.18e-2)"		"unprognostic (2.09e-3)"	"unprognostic (9.97e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.50e-2)"		"unprognostic (2.01e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	1.8	0.0	1.8	5.8	0.1	2.6	16.1	0.0	3.5	0.0	0.0	0.0	71.3	143.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	1.3	0.0	2.6	3.6	0.0	11.1	2.6	0.0	0.0	0.0	17.4	0.4	0.0	1.2	0.5	0.0	5.8	88.8	5.5	0.0	4.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	53.8	1.6	0.0	80.2	0.1	0.8	294.5	0.1	4.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.3	0.0	31.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.0	1194.0	0.0	0.1	0.2	0.1	3.2	149.0	0.0	0.0	7.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.2	12.5	0.0	0.0	0.0	0.3	0.0	2.9	1.8	0.0	0.0	0.0	0.4	0.0	0.0	52.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.5	0.0	0.0	0.4	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.5	1.8	0.1	0.0	0.0	0.0	0.0	1.2	0.2	17.3	1.1	0.0	0.0	0.0	0.1	3.0
UGT8	CGT	ENSG00000174607	"UDP glycosyltransferase 8"	Q16880	4	114598770-114678225	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 266.4"	"Cell type enriched"	"Detected in many"	8	"Oligodendrocytes: 821.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 6.9;naive B-cell: 10.7"	"Lineage enriched"	"Detected in single"	12	"B-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 58.4;OE19: 123.7;RPTEC TERT1: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014405, HPA065785"	Enhanced		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA014405: AB_1858606, HPA065785: AB_2685559"	"unprognostic (7.38e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.55e-5)"	"unprognostic (2.80e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.49e-1)"	0.6	0.6	58.6	4.6	153.7	1.1	4.6	166.2	94.5	7.0	9.7	26.8	30.3	3.8	0.3	1.5	4.4	11.0	0.3	66.2	94.7	31.0	0.2	1.1	4.9	220.9	132.8	0.4	8.5	0.2	0.2	0.2	200.6	0.5	27.7	2.2	7.3	0.7	0.5	2.2	27.7	1.6	139.2	1.7	16.8	5.0	132.4	0.6	13.5	0.4	5.0	0.6	0.6	266.4	0.6	0.2	4.4	0.6	0.3	0.0	0.7	0.2	0.0	0.1	3.4	17.7	58.4	17.6	1.2	0.2	13.8	25.8	0.0	0.1	0.1	0.3	14.3	0.3	24.6	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	5.4	0.1	0.2	16.1	3.0	0.1	0.3	0.3	1.7	6.4	123.7	8.8	1.6	28.9	0.3	55.2	0.6	31.4	4.6	0.2	5.4	0.8	1.1	0.9	5.4	1.0	1.1	19.2	0.7	19.6	6.3	0.8	0.6	29.2	0.9	17.9	0.2	0.0	0.8	0.0	0.0	0.6	6.9	0.0	0.0	0.0	10.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.3	58.6	153.7	166.2	94.5	66.2	94.7	220.9	132.8	200.6	139.2	132.4	266.4	0.1	6.4	1.5	1.0	22.0	0.0	1.8	0.3	6.8	0.0	5.7	6.1	0.8	8.6	3.9	25.8	0.0	0.0	0.1	19.0	9.8	1.4	9.2	9.6	1.7	0.5	48.4	0.0	1.0	13.1	0.0	0.6	19.4	21.4	0.0	0.2	0.0	0.0	0.0	0.0	3.7	27.9	0.0	0.0	0.0	3.5	1.2	0.5	1.8	2.8	0.0	0.0	0.0	98.5	821.1	10.8	14.6	0.0	4.0	0.7	24.2	1.4	1.5	0.0	0.0	0.0	0.4	20.9	34.0	5.9	0.1	0.0	0.4	0.1	26.9	0.9
UNC13B	"hmunc13, Munc13-2, UNC13, Unc13h2"	ENSG00000198722	"Unc-13 homolog B"	O14795	9	35161992-35405338	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 80.7;Cone photoreceptor cells: 95.9;Excitatory neurons: 60.4;Microglial cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024493, HPA062300"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments"		Yes	No				"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Nucleoplasm, Golgi apparatus, Intermediate filaments"	"HPA024493: AB_1858618, HPA062300: AB_2684742"	"unprognostic (9.73e-3)"	"unprognostic (2.33e-1)"	"prognostic favorable (4.96e-4)"	"unprognostic (6.56e-2)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (7.64e-2)"	"prognostic favorable (6.59e-5)"	"unprognostic (3.80e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.34e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.80e-2)"	12.6	12.8	10.5	5.6	13.3	1.0	10.3	6.6	14.5	12.5	15.7	22.2	11.6	10.1	7.7	17.5	10.4	11.5	13.6	11.4	7.2	21.8	12.8	38.9	1.8	8.3	9.5	7.3	21.3	15.0	11.5	6.0	7.8	22.6	25.0	41.2	17.8	23.3	24.2	12.3	13.4	11.9	7.3	4.7	17.9	15.6	10.6	3.0	12.2	10.4	5.0	10.2	12.7	9.0	9.8	12.8	13.9	22.6	26.3	14.6	11.8	15.7	7.1	11.4	15.3	10.7	4.5	0.0	7.0	20.6	20.1	4.7	35.4	18.2	14.5	0.0	11.3	5.9	36.6	13.9	12.7	2.2	6.4	11.6	14.0	18.0	18.5	18.2	37.3	15.8	13.5	8.1	13.5	7.5	2.1	0.2	12.6	30.2	13.3	0.1	8.6	3.4	15.5	12.6	14.9	15.7	11.0	6.8	11.4	23.0	11.6	7.5	34.5	7.8	7.2	12.3	12.2	12.7	16.2	0.0	8.5	18.4	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	13.3	6.6	14.5	11.4	7.2	8.3	9.5	7.8	7.3	10.6	9.0	6.7	57.7	80.7	28.7	0.8	3.1	1.1	2.1	3.4	42.3	7.3	4.4	11.4	18.6	16.7	9.2	95.9	3.7	0.1	24.4	3.9	6.0	6.9	8.2	5.1	8.5	24.6	1.7	60.4	12.2	2.1	4.8	16.3	13.9	2.5	8.7	5.7	12.5	4.9	6.7	17.7	31.9	0.0	2.4	3.0	12.3	2.1	3.7	7.2	73.1	0.1	5.7	0.0	42.3	36.7	7.8	11.9	3.0	4.2	11.7	10.5	7.8	10.0	40.8	6.6	8.4	6.5	8.7	7.5	14.3	7.4	2.9	1.0	5.7	19.5	5.7
UNC5CL	"MGC34763, ZUD"	ENSG00000124602	"Unc-5 family C-terminal like"	Q8IV45	6	41026895-41039221	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 37.1;kidney: 58.6;liver: 52.8;pancreas: 36.2;stomach 1: 23.6"	"Group enriched"	"Detected in many"	6	"Cholangiocytes: 30.0;Collecting duct cells: 22.0;Ductal cells: 25.7;Exocrine glandular cells: 68.6;Gastric mucus-secreting cells: 36.7;Hepatocytes: 30.0;Pancreatic endocrine cells: 19.8;Proximal enterocytes: 37.3;Proximal tubular cells: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"OE19: 44.8;RPTEC TERT1: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015725	Enhanced		Approved	Centrosome		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Centrosome		"HPA015725: AB_2669283"	"unprognostic (1.10e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.55e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.60e-6)"	1.2	1.0	1.3	1.0	1.6	0.9	1.6	1.3	1.7	1.5	1.2	3.1	37.1	1.1	0.3	1.3	1.9	9.2	1.2	1.3	1.3	58.6	52.8	2.1	1.0	1.7	1.4	1.5	36.2	0.3	0.8	0.4	1.6	1.5	1.3	0.8	1.7	0.6	0.7	1.9	29.4	0.4	1.4	3.3	23.6	2.2	1.5	2.7	1.6	0.2	0.7	1.1	1.1	2.3	0.5	0.2	0.6	0.9	0.2	0.1	0.6	0.0	0.1	0.0	0.0	7.0	0.1	0.1	2.5	0.0	0.0	0.2	0.1	0.2	0.1	1.1	1.3	0.6	0.0	3.8	0.1	0.3	0.2	0.1	0.6	0.0	0.4	0.1	0.0	2.8	0.5	0.4	0.0	0.1	0.9	2.3	0.2	44.8	0.2	0.9	0.1	0.5	13.0	0.0	0.6	0.6	0.0	0.0	1.3	0.7	0.1	0.2	0.2	0.0	0.4	0.3	0.1	4.3	2.3	0.6	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.3	1.6	1.3	1.7	1.3	1.3	1.7	1.4	1.6	1.4	1.5	2.3	0.3	3.2	1.1	4.2	1.3	0.8	0.6	0.4	0.6	0.6	1.0	1.0	0.8	30.0	0.3	22.0	4.2	0.4	1.8	2.3	3.9	25.7	2.4	0.6	0.3	0.4	1.2	0.4	0.3	68.6	0.8	0.5	36.7	1.6	0.0	0.3	1.4	30.0	0.3	1.7	0.2	5.0	0.0	0.8	0.3	0.4	0.3	0.8	1.8	0.0	0.8	0.2	2.1	0.0	3.5	19.8	3.1	0.7	0.3	0.6	37.3	41.8	0.9	0.3	0.0	0.3	0.4	0.9	0.8	0.5	0.1	0.8	1.0	0.1	5.4	0.4
UNC93A	"dJ366N23.1, dJ366N23.2"	ENSG00000112494	"Unc-93 homolog A"	Q86WB7	6	167271169-167316014	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"esophagus: 5.1;intestine: 9.6;liver: 14.1;skin 1: 19.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 11.0;Endometrial ciliated cells: 2.5;Erythroid cells: 2.7;Hepatocytes: 6.9;Intestinal goblet cells: 2.4;Proximal enterocytes: 3.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 7.4;Hep G2: 3.1;OE19: 7.5;SCLC-21H: 3.1"					"Not detected"	"Not detected"			HPA035729	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"			"HPA035729: AB_10696508"		"unprognostic (2.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.32e-1)"		"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.99e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.92e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.2	9.6	0.2	0.5	5.1	1.1	0.8	0.0	0.0	0.0	1.1	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	19.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.4	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	6.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0
UQCRB	"QCR7, QP-C, UQBP, UQCR6"	ENSG00000156467	"Ubiquinol-cytochrome c reductase binding protein"	P14927	8	96222947-96235546	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1306.1"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 5409.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043060	Approved					NA	NA		2200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043060: AB_10806376"	"unprognostic (5.48e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.47e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.01e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.66e-3)"	198.8	242.2	204.1	128.7	208.6	179.4	146.7	213.8	353.3	180.1	217.8	255.3	172.0	147.7	184.8	148.6	151.3	80.1	926.1	199.4	222.2	284.0	223.6	119.8	150.0	211.4	210.0	243.0	185.4	252.5	198.1	97.6	214.9	137.6	155.9	235.7	206.4	100.3	1306.1	107.0	155.6	129.1	217.9	128.9	193.1	67.8	209.8	145.1	121.1	822.2	160.0	176.0	153.5	216.3	338.9	150.1	202.0	126.9	280.8	287.7	129.6	267.9	202.2	147.6	158.0	132.3	157.2	146.2	395.7	218.5	153.0	162.1	187.1	252.1	193.2	221.6	136.6	483.3	312.6	235.6	208.9	269.5	197.0	337.3	217.3	170.1	258.8	469.7	214.5	246.7	258.2	244.2	225.2	206.1	432.6	406.1	117.8	705.2	227.7	190.4	131.0	274.3	290.5	258.5	182.1	181.3	163.0	60.8	434.5	268.5	250.1	440.2	260.0	92.7	144.4	165.8	288.6	211.2	172.2	344.5	153.2	353.9	104.4	134.4	143.7	141.5	123.0	240.0	152.2	211.3	194.1	156.2	162.1	165.5	235.4	224.3	102.5	130.5	290.1	139.4	241.3	224.4	204.1	208.6	213.8	353.3	199.4	222.2	211.4	210.0	214.9	217.9	209.8	216.3	361.3	445.5	566.8	40.8	601.2	302.2	509.6	1261.7	333.5	299.0	330.1	403.9	5409.1	859.3	687.3	332.9	116.7	637.3	578.6	812.3	2484.8	893.3	1127.8	663.6	588.1	474.6	730.7	467.4	42.9	926.7	513.3	508.6	372.6	525.9	587.0	399.0	732.5	1069.1	1143.8	126.2	50.7	1074.2	608.3	1670.2	624.3	290.2	863.9	661.6	820.0	22.5	1280.8	555.2	748.7	19.1	27.9	791.9	949.4	720.7	415.0	378.9	1166.7	2205.9	482.9	436.7	539.0	745.3	650.7	358.2	245.9	444.4	291.1	598.4	675.0	401.5	1078.0	588.9
UQCRFS1	"RIP1, RIS1, RISP, UQCR5"	ENSG00000169021	"Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1"	P47985	19	29205320-29213151	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 231.6;tongue: 285.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1474.9;Distal tubular cells: 1035.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041863, HPA050339"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041863: AB_10794638, HPA050339: AB_2681095"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (7.91e-3)"	"unprognostic (3.93e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.92e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-2)"	28.7	50.1	25.6	17.4	26.7	52.8	24.7	29.4	31.1	18.3	33.6	49.0	43.2	19.2	23.1	33.2	19.3	13.2	138.3	27.2	28.4	62.5	50.9	17.6	17.2	27.0	27.4	15.4	29.4	47.3	19.9	17.3	26.1	18.8	52.6	26.6	26.7	21.9	231.6	27.9	34.0	24.8	26.4	21.1	39.3	25.9	29.3	26.0	16.8	285.9	25.9	25.7	20.3	26.0	63.0	103.7	37.7	34.1	60.6	45.9	41.8	47.8	49.7	64.7	71.1	63.3	37.7	56.7	49.2	54.4	52.7	64.8	83.4	56.9	77.6	38.7	83.2	80.2	39.2	58.1	51.3	77.2	67.5	55.5	60.4	44.2	66.9	38.0	52.4	69.0	58.0	34.5	70.2	58.0	54.5	57.6	39.6	132.2	39.7	48.9	50.3	43.1	80.9	74.4	45.8	22.4	43.5	84.9	58.2	42.0	39.6	63.4	33.4	43.5	66.4	30.2	50.4	16.4	33.3	52.5	38.4	66.4	31.7	51.4	90.7	43.8	50.0	90.9	50.3	54.8	53.2	51.9	106.6	48.0	56.1	53.6	27.3	49.2	78.3	59.3	68.4	166.2	25.6	26.7	29.4	31.1	27.2	28.4	27.0	27.4	26.1	26.4	29.3	26.0	69.7	54.5	46.6	16.6	104.9	147.6	279.7	466.7	105.9	71.8	119.5	128.4	1474.9	161.5	201.4	114.0	16.7	282.0	116.8	321.6	1035.0	245.2	258.4	106.1	66.8	106.8	160.0	147.9	18.1	235.1	271.7	126.7	139.7	88.5	90.7	114.2	83.9	272.1	266.1	52.2	19.2	293.6	317.3	160.6	109.6	146.0	92.2	136.6	165.4	13.1	206.6	124.6	132.8	19.6	15.8	205.0	225.8	81.6	159.4	257.3	338.6	758.4	132.4	84.1	98.6	107.5	131.0	348.8	80.5	203.9	160.3	381.9	109.5	209.1	407.4	372.1
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Hearing"		"Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 97.8;kidney: 54.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 190.0;Muller glia cells: 163.6;Paneth cells: 203.0;Proximal enterocytes: 430.7;Proximal tubular cells: 190.3;Undifferentiated cells: 115.7"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 60.6;HeLa: 21.8;OE19: 57.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol		No	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.4	0.3	2.8	5.9	6.8	0.0	0.2	2.8	3.9	0.1	1.5	51.5	97.8	0.1	0.3	0.0	2.9	25.9	0.1	9.0	4.7	54.0	0.6	0.1	0.1	6.1	5.7	0.0	3.9	0.0	6.7	0.0	7.0	0.0	48.3	19.0	0.0	0.3	0.0	0.0	96.5	2.1	4.1	0.0	26.7	0.2	5.9	0.1	1.1	0.0	0.0	0.6	0.1	8.3	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	60.6	8.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.8	2.8	3.9	9.0	4.7	6.1	5.7	7.0	4.1	5.9	8.3	0.0	0.0	0.0	18.3	1.6	0.0	0.1	0.0	0.0	0.7	0.0	1.3	0.6	52.9	0.7	5.5	2.1	0.0	0.0	190.0	21.5	20.5	1.0	1.7	0.0	0.4	64.0	0.0	0.6	27.5	0.0	0.3	53.5	0.0	4.5	0.0	0.0	0.0	0.0	1.7	0.2	92.9	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	163.6	0.0	0.5	36.4	56.0	203.0	0.0	0.2	0.0	430.7	190.3	1.0	4.9	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.8	0.1	115.7	0.1
USH1G	"ANKS4A, FLJ33924, Sans"	ENSG00000182040	"USH1 protein network component sans"	Q495M9	17	74916083-74923256	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease variant, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 7.8;skin 1: 2.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 8.2;Late spermatids: 17.9;Muller glia cells: 11.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.8;hTCEpi: 1.6;K-562: 1.3;MCF7: 2.0;OE19: 1.9"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 9.9"	"Not detected"	"Not detected"			HPA024360	Uncertain					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA024360: AB_1858660"	"unprognostic (2.95e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.34e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.59e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.10e-4)"	"unprognostic (1.57e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.35e-2)"	0.0	0.9	0.2	0.0	0.2	0.1	0.0	1.2	0.2	0.3	0.0	0.0	0.1	0.8	1.9	7.8	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	0.0	0.0	2.8	0.2	0.5	0.0	0.0	0.0	1.8	0.6	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	2.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.2	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.3	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	2.3	0.4	0.0	0.0	1.7	0.6	0.0	0.2	0.0	0.0	0.1	0.2	0.4	1.6	0.3	0.3	0.0	0.1	0.0	0.1
USP54	"bA137L10.3, bA137L10.4, C10orf29, FLJ37318"	ENSG00000166348	"Ubiquitin specific peptidase 54"	Q70EL1	10	73497538-73625994	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 134.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 476.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047663, HPA063665"	Approved		Approved	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA047663: AB_2680116, HPA063665: "	"unprognostic (2.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.89e-3)"	"unprognostic (6.63e-4)"	"prognostic favorable (7.00e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.35e-2)"	"unprognostic (8.91e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.95e-3)"	"unprognostic (8.18e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	4.6	3.1	61.5	5.5	103.5	2.1	16.3	85.5	72.4	14.5	32.2	15.0	4.9	9.3	13.2	13.9	12.0	5.6	7.0	60.5	71.9	5.2	1.5	17.9	2.8	99.8	97.5	6.8	10.8	8.9	2.9	2.8	94.0	12.1	19.7	14.8	16.8	7.6	49.7	15.2	6.7	7.1	70.4	2.9	20.7	9.1	85.0	8.4	40.7	17.0	7.1	6.6	4.9	134.8	10.0	8.4	15.9	13.7	4.4	4.8	4.7	4.7	11.2	7.9	8.6	8.1	16.7	6.6	6.5	3.7	6.1	14.2	10.7	4.3	10.2	2.8	8.6	5.0	6.3	8.0	4.1	5.6	2.3	3.9	3.8	9.0	10.9	20.6	3.4	5.7	7.5	3.0	6.3	5.6	4.5	6.8	8.0	33.4	30.2	7.0	11.9	3.0	8.7	7.6	4.8	5.4	10.1	11.7	15.8	10.2	15.8	5.8	4.9	3.5	11.2	6.6	6.8	2.4	4.3	4.1	8.3	5.3	3.1	0.2	0.4	0.5	0.6	0.4	0.7	0.4	0.5	0.4	0.4	0.3	0.7	0.4	0.0	0.3	0.5	0.4	0.6	0.4	61.5	103.5	85.5	72.4	60.5	71.9	99.8	97.5	94.0	70.4	85.0	134.8	5.9	48.1	34.3	33.0	1.7	2.7	8.5	11.0	4.0	7.7	15.3	8.4	7.2	5.7	18.9	12.9	16.7	1.0	1.2	19.6	0.0	4.7	2.4	25.8	12.9	6.3	10.3	2.1	23.1	8.0	1.0	7.6	40.2	44.3	3.8	3.5	2.5	3.0	1.4	5.0	33.4	23.4	2.0	1.3	1.4	2.2	3.4	1.8	8.8	76.8	0.8	12.5	0.0	116.1	476.0	12.2	9.7	10.9	2.3	52.6	10.5	1.9	21.7	12.2	6.6	19.6	3.8	9.2	6.0	7.7	4.0	1.4	3.0	2.9	11.2	15.2
UST	2OST	ENSG00000111962	"Uronyl 2-sulfotransferase"	Q9Y2C2	6	148747030-149076990	"Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 339.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 15.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032022	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA032022: AB_10603326"	"unprognostic (3.43e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.22e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.25e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.02e-2)"	6.0	12.2	6.3	3.0	7.4	0.2	6.2	10.0	7.9	7.6	7.5	9.2	1.7	6.8	5.6	4.6	9.2	6.0	4.3	5.8	16.0	3.6	1.3	5.2	3.9	28.2	17.2	11.6	13.1	4.6	1.9	4.6	14.1	6.3	2.7	6.8	3.2	4.8	1.7	6.7	5.7	8.8	13.5	6.5	5.0	6.7	22.7	6.5	27.5	5.8	3.7	8.8	7.7	15.6	0.1	3.2	18.2	14.0	21.5	17.8	0.1	7.9	20.5	3.8	9.8	0.0	1.2	6.7	1.7	12.3	9.5	5.7	13.0	6.6	7.6	9.1	9.9	0.2	10.0	0.1	7.9	0.3	2.8	9.2	14.6	9.8	18.1	7.6	0.2	11.1	0.0	0.0	3.0	8.3	0.1	0.0	10.7	32.4	4.2	3.3	2.5	7.7	0.1	14.8	9.4	0.0	26.4	6.3	5.0	13.0	4.7	0.3	0.4	10.9	1.3	2.5	7.4	0.0	0.0	0.0	12.1	5.4	6.3	0.0	0.0	0.0	0.6	0.2	0.4	0.3	0.4	0.5	0.4	0.5	0.0	0.2	0.0	2.5	0.3	0.4	0.1	0.1	6.3	7.4	10.0	7.9	5.8	16.0	28.2	17.2	14.1	13.5	22.7	15.6	0.9	3.2	3.2	70.2	4.5	9.4	5.4	2.6	3.4	0.1	1.7	1.5	1.7	0.0	2.7	1.8	0.0	2.0	8.9	0.2	0.0	0.1	1.1	0.3	8.7	0.6	0.0	0.0	36.3	2.0	0.3	16.3	7.1	0.4	0.0	12.3	1.4	0.3	1.7	0.0	39.7	1.8	10.2	1.0	20.9	3.4	18.3	2.8	5.4	80.6	1.0	14.6	5.2	339.8	3.2	1.1	0.3	11.3	0.4	5.9	0.0	0.6	2.3	0.8	0.0	6.8	3.5	2.9	5.7	1.9	11.6	1.4	2.0	10.2	0.5	6.8
VILL		ENSG00000136059	"Villin like"	O15195	3	37988059-38007188	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 61.9;stomach 1: 97.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 221.7;Gastric mucus-secreting cells: 192.7;Paneth cells: 139.0;Proximal enterocytes: 165.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 22.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.0;OE19: 78.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA035675, HPA035676"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA035675: AB_10671223, HPA035676: "	"unprognostic (7.86e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (1.35e-4)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.43e-3)"	5.4	3.7	8.7	11.0	9.0	12.6	6.4	6.6	10.6	9.5	6.4	46.8	61.9	5.7	1.5	7.2	6.7	15.7	6.4	8.6	7.8	5.3	1.4	7.7	9.8	8.3	8.4	6.8	3.4	1.2	5.1	4.1	8.0	16.0	26.6	1.2	5.7	4.0	1.2	9.1	61.7	4.1	8.0	11.8	97.5	5.4	8.2	10.2	7.4	1.4	6.3	17.5	7.4	7.2	8.2	0.1	0.2	0.4	2.8	2.2	0.8	2.3	1.9	2.3	2.2	6.1	25.0	3.9	3.5	1.6	0.0	1.9	1.8	0.2	0.5	0.8	0.0	7.3	0.1	0.6	3.4	7.7	9.5	3.3	2.2	2.2	0.0	0.0	4.5	16.1	7.3	2.3	2.6	0.1	12.4	8.7	0.2	78.4	0.0	4.8	0.0	2.0	0.8	9.8	0.1	0.3	0.0	0.5	1.8	0.0	0.7	12.4	2.8	1.0	0.3	3.0	0.0	1.4	3.1	1.2	0.6	10.9	5.0	0.0	3.2	0.0	6.8	2.0	7.4	3.5	4.4	3.9	2.1	4.6	5.6	4.2	0.1	3.4	1.4	3.8	5.8	4.1	8.7	9.0	6.6	10.6	8.6	7.8	8.3	8.4	8.0	8.0	8.2	7.2	4.9	9.6	7.4	10.4	7.2	2.3	5.7	25.5	6.8	0.9	3.3	2.9	1.9	8.6	46.1	0.0	0.0	3.0	13.3	221.7	0.0	3.4	6.2	1.5	2.7	4.5	9.6	6.1	5.5	16.9	3.4	6.7	192.7	1.5	8.2	6.1	5.3	0.3	2.4	1.7	3.0	64.4	14.2	1.9	2.4	19.9	3.7	4.0	1.8	3.7	4.2	28.1	7.2	2.5	1.2	38.7	139.0	2.6	4.4	6.2	165.6	1.6	40.5	0.8	0.0	4.3	7.1	5.4	3.4	3.1	1.4	1.0	8.1	5.6	50.5	33.4
VMP1	"EPG3, TANGO5, TMEM49"	ENSG00000062716	"Vacuole membrane protein 1"	Q96GC9	17	59707192-59842255	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 984.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 3000.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 3000.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030773, HPA064780"	Approved		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Endoplasmic reticulum"	Nucleoli	"HPA030773: AB_10602248, HPA064780: AB_2685348"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.77e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-3)"	36.7	47.2	23.1	56.2	29.1	22.8	36.6	15.9	32.7	30.3	5.4	58.6	56.0	32.4	23.2	33.0	16.0	59.8	22.0	17.1	23.7	36.6	58.5	29.6	31.4	29.1	24.9	22.9	30.8	38.4	10.4	39.2	27.3	34.0	59.8	30.2	23.5	23.1	19.9	19.5	60.4	33.9	24.5	52.5	47.6	22.3	35.8	22.3	32.5	28.9	20.7	47.9	16.4	38.0	65.8	128.2	43.8	82.2	88.3	54.8	77.3	87.4	87.4	64.3	98.0	85.1	166.1	42.2	143.9	70.6	81.5	79.8	62.4	59.5	80.5	102.7	80.9	55.5	89.2	97.3	89.6	68.5	51.4	77.4	46.7	87.3	76.2	93.2	67.6	41.3	69.8	70.2	68.7	177.9	66.7	21.9	63.0	146.6	75.3	41.8	79.8	101.1	92.5	72.1	36.4	89.1	57.5	62.4	83.8	62.6	124.4	49.0	89.8	81.3	75.0	68.8	83.6	105.4	145.0	66.8	84.4	37.6	92.8	131.6	570.4	76.0	62.8	393.0	69.2	56.6	59.3	65.4	174.3	49.5	53.9	60.5	3000.2	69.0	666.9	59.2	73.9	501.6	23.1	29.1	15.9	32.7	17.1	23.7	29.1	24.9	27.3	24.5	35.8	38.0	164.8	89.8	124.1	35.3	68.6	161.1	984.4	188.9	665.9	36.1	429.1	187.1	27.9	125.8	273.3	275.8	58.4	91.7	71.0	511.1	23.5	223.1	7.2	372.8	197.7	148.2	310.6	29.9	80.1	137.9	123.5	193.6	367.0	708.6	135.4	111.2	48.2	108.4	121.7	28.6	84.6	254.1	168.9	335.2	270.7	11.5	35.8	322.6	129.9	45.0	231.1	50.4	51.5	51.8	141.2	160.7	508.1	35.3	92.5	553.1	361.1	72.6	289.7	51.6	92.1	59.2	293.5	83.6	44.6	672.6	129.7	175.8	127.3	67.5	241.7	629.2
VRK3		ENSG00000105053	"VRK serine/threonine kinase 3"	Q8IV63	19	49976468-50025946	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 135.6"	"Group enriched"	"Detected in all"	7	"Early spermatids: 557.6;Late spermatids: 1646.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056489	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA056489: AB_2683150"	"unprognostic (2.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.66e-4)"	17.4	23.3	25.9	17.6	26.6	23.6	17.7	26.1	28.6	17.9	30.2	21.9	25.8	15.9	19.5	17.6	33.2	20.9	17.5	25.4	27.9	36.5	35.6	16.9	28.5	27.6	31.1	21.2	22.1	15.9	20.6	16.9	30.4	20.2	22.0	64.8	21.9	15.4	26.9	16.8	32.9	14.1	25.2	26.0	21.6	135.6	27.9	35.6	19.7	17.4	25.7	18.0	16.8	29.3	31.0	31.3	22.6	24.5	29.2	26.9	23.3	21.7	25.7	31.6	34.5	16.8	33.7	37.1	15.2	21.2	22.1	22.5	21.3	18.6	25.5	32.6	43.5	28.9	20.4	29.4	21.9	36.7	48.7	24.2	27.3	18.3	19.2	28.4	26.5	39.9	35.8	53.7	23.2	13.0	49.7	24.5	12.2	54.6	26.7	39.3	23.9	47.6	27.2	32.2	25.3	12.3	21.5	26.0	24.7	20.0	23.9	38.5	20.2	32.2	18.6	13.1	17.1	34.3	47.4	19.6	25.8	22.3	22.5	110.0	42.8	81.1	53.7	46.1	43.3	58.9	48.7	51.9	47.9	53.3	49.2	45.3	112.5	82.7	55.1	45.4	76.1	48.4	25.9	26.6	26.1	28.6	25.4	27.9	27.6	31.1	30.4	25.2	27.9	29.3	19.6	6.4	28.6	10.1	26.6	6.6	16.0	27.2	6.8	34.3	17.9	14.5	8.4	24.3	29.8	14.7	143.9	43.8	27.9	49.9	31.3	31.0	557.6	50.7	12.0	16.0	22.2	38.7	13.9	32.7	38.6	15.5	18.8	26.8	18.3	24.1	28.5	44.5	34.8	32.0	15.9	35.4	34.6	25.4	9.3	1646.8	22.1	22.9	14.2	6.5	40.6	33.2	41.2	10.1	15.3	34.2	67.9	25.9	18.6	20.6	87.5	91.4	71.8	116.0	13.1	12.0	15.2	142.8	52.6	10.5	10.9	57.3	28.0	24.9	36.0	30.1
VSIG10		ENSG00000176834	"V-set and immunoglobulin domain containing 10"	Q8N0Z9	12	118063593-118136026	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 69.3;Proximal enterocytes: 106.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 33.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062022	Enhanced		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Centriolar satellite"	"HPA062022: AB_2732675"	"unprognostic (1.32e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-2)"	6.1	11.3	4.5	2.3	5.5	0.8	6.0	5.4	4.6	6.8	4.8	13.3	13.9	4.3	3.1	8.7	4.7	3.8	3.8	3.9	4.5	6.2	5.7	8.4	1.5	6.0	4.9	6.4	7.1	8.1	4.4	8.6	4.9	5.9	15.8	1.9	7.0	5.2	17.0	5.6	24.5	3.2	5.4	3.9	6.5	2.6	5.3	0.9	12.1	10.8	2.1	5.9	6.9	4.8	7.9	11.4	4.8	16.1	19.4	8.8	12.4	13.3	8.5	6.4	5.3	3.3	18.2	1.1	5.3	9.8	12.0	18.9	33.8	3.4	7.6	4.0	5.1	1.8	11.0	5.0	3.9	1.1	2.7	4.0	9.8	4.9	3.1	18.6	14.2	3.8	2.3	0.1	6.1	8.3	0.0	1.1	14.9	22.8	7.5	2.8	13.2	0.0	9.4	25.1	4.1	5.3	13.0	5.4	3.4	10.2	11.9	5.3	16.8	7.4	4.7	9.2	6.8	0.1	0.1	0.1	10.7	5.5	15.0	0.2	0.5	0.6	0.1	0.1	0.1	0.0	0.1	0.0	0.6	0.1	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.1	4.5	5.5	5.4	4.6	3.9	4.5	6.0	4.9	4.9	5.4	5.3	4.8	23.6	19.2	28.6	14.0	3.3	2.4	13.0	1.8	6.8	9.9	15.1	11.7	11.4	31.5	5.0	29.5	12.5	38.0	2.2	69.3	19.6	26.2	6.1	10.3	13.0	19.1	50.4	9.9	4.7	20.3	41.0	11.9	16.8	13.6	2.5	33.3	21.0	27.5	11.2	5.0	5.1	40.4	2.0	6.7	9.4	9.9	18.0	5.6	3.6	3.7	7.4	18.9	2.1	9.0	3.1	26.7	45.3	14.7	3.1	10.4	106.6	13.7	2.7	7.9	0.0	12.9	8.6	4.0	6.1	12.4	3.1	14.0	4.0	24.7	48.2	15.3
VSIG10L		ENSG00000186806	"V-set and immunoglobulin domain containing 10 like"	Q86VR7	19	51331536-51342124	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 20.3;esophagus: 62.3;salivary gland: 23.5;vagina: 22.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 10.1;Melanocytes: 5.4;Sertoli cells: 6.6;Squamous epithelial cells: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 4.7;OE19: 11.0;T-47d: 8.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA060453, HPA066745"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA060453: AB_2684280, HPA066745: AB_2685712"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (2.40e-3)"	"unprognostic (2.78e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.90e-4)"	"unprognostic (1.42e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.19e-3)"	0.2	0.1	0.1	0.0	0.4	0.1	0.8	0.8	0.5	20.3	0.0	0.1	0.0	0.0	0.0	62.3	0.1	0.3	0.1	0.1	0.7	0.1	0.7	0.1	0.1	0.5	1.0	0.2	0.0	0.0	0.1	0.0	0.8	1.2	0.0	0.0	23.5	0.1	0.1	10.6	0.2	0.0	0.1	0.1	0.1	0.3	0.6	0.1	0.1	0.0	6.3	0.2	22.3	0.7	0.0	0.9	0.0	0.3	0.4	0.1	0.2	0.1	0.0	0.0	0.1	0.3	0.7	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.5	0.1	0.2	4.7	0.0	0.0	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.4	1.3	0.0	0.4	0.0	0.1	0.6	11.0	0.4	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	8.4	0.0	0.0	0.0	0.1	0.7	0.0	1.1	0.7	0.1	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.5	0.1	0.7	0.5	1.0	0.8	0.1	0.6	0.7	1.2	0.0	0.5	1.3	0.8	0.6	1.1	0.6	1.8	1.6	2.2	1.8	0.9	0.0	0.1	0.0	0.0	0.4	0.2	0.9	0.0	1.1	0.2	0.0	0.3	0.5	1.2	0.0	0.6	0.0	0.9	1.6	1.1	0.2	1.3	1.0	1.4	1.2	4.5	10.1	1.0	0.5	0.0	3.2	0.9	0.7	2.1	2.4	5.4	1.0	1.1	1.4	0.0	0.0	0.9	0.4	1.3	4.1	0.1	1.0	1.6	0.9	0.0	0.6	6.6	1.5	1.2	0.5	2.6	6.1	0.4	0.5	0.4	2.2	0.7	0.7
VSIG2	"CTH, CTXL"	ENSG00000019102	"V-set and immunoglobulin domain containing 2"	Q96IQ7	11	124747474-124752255	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"stomach 1: 619.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 514.3;Gastric mucus-secreting cells: 623.4;Intestinal goblet cells: 285.6;Pancreatic endocrine cells: 260.2;Paneth cells: 509.9;Undifferentiated cells: 207.0;Urothelial cells: 285.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 87.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"OE19: 429.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035919, HPA050147"	Enhanced		Approved	Nucleoplasm		NA	NA		78000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA035919: AB_10669981, HPA050147: AB_2681032"	"unprognostic (1.64e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.36e-2)"	6.5	0.8	3.1	7.0	6.4	3.4	9.5	0.8	7.1	29.7	0.2	136.2	6.2	4.9	0.4	26.4	17.5	26.5	5.3	2.8	1.5	6.3	3.0	45.7	0.9	1.7	3.6	1.1	2.0	1.9	1.7	6.0	2.0	58.2	137.8	0.6	31.8	4.3	2.3	1.5	2.8	4.7	1.1	1.6	619.2	0.9	3.1	0.2	43.7	2.5	2.5	84.5	9.3	3.6	0.4	0.1	4.8	3.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.9	1.5	2.4	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.3	16.6	0.0	7.9	0.7	0.5	3.0	0.1	0.0	0.0	0.0	0.3	2.8	0.3	0.3	0.6	0.0	1.6	0.1	0.1	0.6	429.0	3.7	0.4	3.6	0.1	0.1	69.2	0.3	0.9	0.1	4.6	0.0	0.7	0.4	2.4	4.1	1.8	1.1	0.3	0.8	0.3	0.0	0.0	0.6	1.7	0.9	0.0	1.2	0.0	0.0	0.1	0.5	0.0	0.5	0.1	0.4	0.0	0.6	0.4	0.1	0.3	0.2	0.0	0.7	0.9	3.1	6.4	0.8	7.1	2.8	1.5	1.7	3.6	2.0	1.1	3.1	3.6	4.6	125.0	51.6	0.0	1.5	0.8	19.2	25.3	2.8	1.5	31.5	18.4	0.7	82.9	99.3	3.7	0.0	0.0	0.6	514.3	1.9	14.6	0.0	12.1	1.8	5.0	66.8	0.0	0.2	90.9	0.1	0.9	623.4	18.3	1.3	0.1	3.9	0.2	0.1	0.0	0.1	285.6	20.3	0.3	2.7	0.0	1.5	2.4	3.6	1.0	0.0	0.0	0.0	0.0	0.1	260.2	509.9	0.0	0.7	61.6	1.3	0.1	36.7	0.0	0.0	0.3	6.2	0.2	0.7	0.7	0.4	0.0	2.2	0.3	207.0	285.3
VSTM5	"C11orf90, LOC387804"	ENSG00000214376	"V-set and transmembrane domain containing 5"	A8MXK1	11	93818232-93850618	"Predicted membrane proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;placenta: 4.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Excitatory neurons: 5.2;Inhibitory neurons: 9.2;Syncytiotrophoblasts: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.2;OE19: 3.7;PC-3: 5.4;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029525, HPA063591"	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA029525: AB_10600789, HPA063591: AB_2732704"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-4)"	"unprognostic (2.45e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	0.2	0.2	2.2	0.1	1.9	0.0	0.4	1.0	3.4	1.1	0.1	1.1	0.1	0.4	1.2	0.1	0.2	0.4	0.1	1.8	3.7	0.8	0.0	0.1	0.0	3.1	2.0	0.1	0.5	0.1	0.6	4.4	3.3	0.5	1.7	0.5	0.4	0.4	0.0	0.1	0.7	0.7	1.4	0.0	1.9	0.2	3.3	0.0	0.1	0.0	0.1	0.2	0.1	2.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.5	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.4	0.0	0.0	0.1	0.0	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	1.0	3.4	1.8	3.7	3.1	2.0	3.3	1.4	3.3	2.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.9	0.5	0.5	0.3	0.0	0.1	0.0	0.0	22.3	0.1	1.1	0.0	0.4	0.0	0.3	0.2	0.1	0.0	0.0	5.2	3.0	0.7	0.3	1.5	0.7	0.0	0.1	0.0	0.0	1.5	0.0	9.2	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	1.1	2.1	0.4	0.0	0.1	0.5	1.5	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.1	5.9	0.0	0.0	1.6	0.1
WDR72	FLJ38736	ENSG00000166415	"WD repeat domain 72"	Q3MJ13	15	53513741-53762878	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 105.7;liver: 33.1;thyroid gland: 57.9"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 12.8;Collecting duct cells: 22.0;Glandular and luminal cells: 13.2;Hepatocytes: 44.3;Proximal tubular cells: 93.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.9;OE19: 18.3;RPMI-8226: 17.5;RPTEC TERT1: 10.1;SuSa: 15.2;U-266/70: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048212, HPA057410, HPA059819"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA048212: AB_2680315, HPA057410: AB_2683430, HPA059819: AB_2684133"	"unprognostic (6.39e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (3.33e-16)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (7.67e-2)"	0.1	0.0	0.1	0.2	0.1	0.0	0.8	0.0	0.1	7.2	0.0	0.6	2.6	1.4	0.5	0.4	2.6	3.9	0.1	0.0	0.1	105.7	33.1	0.8	0.1	0.1	0.4	0.2	3.5	1.8	0.3	0.1	0.1	0.1	0.8	0.7	18.4	0.6	0.0	2.0	0.9	0.0	0.0	0.1	1.1	0.5	0.1	0.0	57.9	0.0	0.0	1.7	0.0	0.3	0.0	9.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	3.2	0.1	6.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.9	18.3	0.1	0.0	0.1	17.5	10.1	3.5	1.9	0.0	0.0	0.1	0.0	15.2	2.4	0.0	0.1	0.3	0.5	0.0	0.1	7.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.1	6.4	3.6	0.0	0.5	0.1	1.1	0.0	0.6	0.5	0.0	0.1	0.6	12.8	0.0	22.0	0.0	0.6	0.0	0.2	9.8	3.2	1.2	4.9	1.0	0.1	0.0	0.0	0.4	0.5	2.1	0.2	0.0	13.2	0.0	0.0	0.0	44.3	0.1	3.3	0.5	0.0	0.0	0.6	0.0	0.3	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	93.2	0.1	0.1	0.0	0.0	0.1	1.0	1.6	0.9	0.4	0.1	0.7	0.0	0.3	6.4
XPO5	KIAA1291	ENSG00000124571	"Exportin 5"	Q9HAV4	6	43522334-43576038	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012357, HPA018402, HPA023959, HPA029909"	Enhanced		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245"	"unprognostic (6.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (6.16e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (4.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.48e-2)"	"unprognostic (5.66e-3)"	7.3	8.0	4.6	9.1	5.3	8.3	8.5	5.1	5.8	7.6	4.1	7.2	6.3	8.0	9.1	12.0	6.9	5.8	7.0	4.7	4.7	7.4	6.7	6.5	8.7	4.8	4.6	6.3	14.0	11.1	6.5	7.6	4.5	7.9	8.8	11.7	8.1	7.1	11.2	12.3	6.4	9.7	4.2	6.9	8.3	23.7	5.2	12.0	13.1	6.0	11.2	11.2	7.9	4.7	48.8	28.5	46.7	94.4	23.7	19.9	43.3	24.8	17.3	47.9	34.4	79.1	16.5	65.6	31.4	23.7	45.1	40.8	78.4	36.2	53.5	48.0	61.9	63.6	34.5	57.8	34.0	71.0	32.6	14.5	36.8	50.4	78.0	17.2	34.6	46.0	138.5	50.2	32.6	59.5	53.9	35.1	50.1	132.3	28.7	57.9	49.5	49.2	27.6	37.6	95.7	39.7	34.5	31.5	44.7	40.6	36.3	56.1	29.2	35.2	41.9	34.0	52.8	31.8	37.1	126.3	12.6	60.7	38.4	0.0	4.3	3.1	4.8	5.4	4.4	2.8	4.3	5.3	4.9	2.4	3.4	4.6	0.4	7.1	10.8	1.4	4.7	4.0	4.6	5.3	5.1	5.8	4.7	4.7	4.8	4.6	4.5	4.2	5.2	4.7	4.7	6.4	3.3	21.2	6.0	8.9	6.8	4.6	5.2	11.3	7.0	7.4	6.5	2.8	3.5	11.0	8.4	5.5	8.4	3.6	1.9	6.7	12.3	7.1	10.9	6.6	14.4	9.4	31.7	7.7	6.5	7.5	10.2	7.5	11.4	13.4	2.5	4.6	6.2	21.9	35.2	5.9	2.0	5.3	2.5	13.5	4.1	4.9	1.8	25.3	5.1	4.5	13.4	26.7	32.0	6.6	2.2	8.2	10.8	13.0	4.1	4.7	5.5	14.3	0.0	10.0	7.3	26.9	23.5	10.2	7.1	4.4	5.4	11.5	7.2	5.8
XRCC6	"D22S671, D22S731, G22P1, KU70, ML8"	ENSG00000196419	"X-ray repair cross complementing 6"	P12956	22	41621163-41664048	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 579.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004254, HPA047549, HPA062226"	Enhanced		Enhanced	Nucleoplasm		No	No		700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004254: AB_628453, HPA047549: AB_2680085, HPA062226: AB_2684716"	"unprognostic (5.55e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.95e-2)"	143.7	183.4	84.9	153.4	89.3	218.2	143.3	87.8	100.8	152.1	87.2	159.5	136.8	153.8	111.3	192.1	151.4	105.5	176.1	89.2	94.7	136.9	142.4	133.2	196.6	89.5	86.8	169.8	119.0	156.5	122.6	155.0	92.2	132.7	164.9	115.6	130.8	144.4	273.0	168.3	142.8	161.0	93.5	143.1	138.6	231.2	87.9	224.1	137.8	184.3	222.2	162.6	142.0	96.4	554.6	388.0	527.9	455.5	313.5	279.5	413.8	394.7	464.6	794.9	656.4	570.4	335.7	886.2	319.8	478.1	357.4	400.6	739.2	486.8	803.2	493.4	921.2	478.8	435.2	559.5	281.5	1142.2	520.5	252.7	323.1	501.2	275.0	319.8	505.6	371.6	470.2	360.1	523.1	589.9	589.0	390.6	482.1	1138.4	452.1	660.0	562.3	695.6	440.4	404.4	243.3	174.6	644.1	328.2	455.7	392.9	382.2	439.0	366.2	394.3	546.2	354.0	522.4	354.0	671.9	896.1	369.4	441.3	476.4	146.0	264.3	227.6	243.6	296.5	258.4	256.5	269.5	269.2	324.1	246.9	293.2	262.5	69.2	253.2	307.0	191.7	325.9	600.8	84.9	89.3	87.8	100.8	89.2	94.7	89.5	86.8	92.2	93.5	87.9	96.4	96.6	96.1	142.5	18.6	132.6	124.0	201.0	219.0	83.1	107.1	80.1	83.4	89.4	115.8	160.4	82.8	62.6	422.3	104.9	97.3	166.3	205.4	119.6	86.1	87.0	117.0	98.6	125.4	24.5	182.7	317.2	123.9	73.4	105.9	119.7	156.4	70.3	103.7	170.2	87.5	29.5	114.7	166.8	98.1	116.7	62.9	126.8	110.4	88.9	17.8	182.8	149.7	89.6	26.2	30.5	150.9	106.6	126.7	116.0	112.0	113.7	140.3	112.6	103.6	164.3	102.4	127.4	579.8	314.4	91.5	102.1	362.2	136.9	150.6	166.8	137.5
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511832-43516985	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 494.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: AB_2685095"	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	72.3	120.2	78.9	43.3	79.9	46.4	70.0	79.5	92.0	74.0	102.6	74.3	65.2	72.1	100.5	80.3	69.7	63.3	87.6	80.2	78.9	78.2	105.4	68.9	42.6	80.5	79.2	75.6	152.0	110.0	91.9	77.8	81.2	76.3	62.1	49.8	118.6	61.1	82.8	70.0	66.1	57.5	78.3	67.2	106.1	48.0	81.6	46.0	74.3	83.4	46.5	69.1	67.3	80.8	95.0	66.2	95.3	185.4	208.3	168.5	56.1	111.9	174.6	91.8	115.7	79.1	67.6	37.8	84.4	208.6	78.4	93.4	71.0	110.2	59.4	69.9	95.7	61.2	91.8	153.2	163.2	64.7	85.9	169.0	141.2	77.9	78.3	154.4	141.1	61.1	67.8	88.2	111.5	146.9	47.5	82.3	49.7	494.4	71.1	42.6	43.0	103.2	164.3	101.4	76.7	109.0	50.3	66.9	122.2	72.8	111.4	133.5	133.5	103.1	53.4	57.0	78.8	102.5	88.8	74.3	73.2	53.5	71.5	147.2	84.8	128.7	60.0	82.2	52.3	46.1	53.7	54.1	78.7	48.5	42.7	48.5	316.0	65.5	83.2	70.3	79.8	78.2	78.9	79.9	79.5	92.0	80.2	78.9	80.5	79.2	81.2	78.3	81.6	80.8	77.8	35.3	33.6	12.7	41.4	40.7	63.8	121.7	63.2	54.6	62.8	49.4	31.7	82.9	86.5	55.2	37.5	192.2	41.1	109.7	49.0	149.6	38.1	63.5	60.5	78.9	107.1	42.1	12.1	101.8	209.5	78.2	59.7	67.9	40.6	77.9	74.6	71.0	99.3	58.9	14.7	117.6	101.7	49.1	31.2	79.0	69.9	49.6	65.8	14.0	72.4	115.0	42.2	15.1	17.7	117.5	108.8	67.0	111.6	71.4	129.1	74.9	51.2	63.5	32.9	45.5	64.4	44.0	40.8	52.8	35.5	264.1	34.9	101.9	80.0	81.6
ZG16B	"HRPE773, JCLN2, PRO1567"	ENSG00000162078	"Zymogen granule protein 16B"	Q96DA0	16	2830169-2839585	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	717	"salivary gland: 63926.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 194.0;Basal respiratory cells: 181.6;Breast glandular cells: 154.9;Club cells: 343.9;Intestinal goblet cells: 232.2;Prostatic glandular cells: 398.1;Urothelial cells: 357.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 47.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.3;intermediate monocyte: 11.4;non-classical monocyte: 7.4"	"Lineage enriched"	"Detected in many"	7	"monocytes: 11.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 27.1;OE19: 57.5;SK-BR-3: 24.1;T-47d: 22.2"	"Not detected"	"Not detected"							"HPA041125, HPA053549"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		690000	"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Nucleoplasm	"HPA041125: AB_10794264, HPA053549: AB_2682184"	"unprognostic (5.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (3.48e-6)"	"unprognostic (1.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.33e-2)"	2.5	13.2	0.0	3.9	0.0	4.6	33.1	0.0	0.1	33.0	0.0	13.6	11.5	0.6	1.5	25.3	4.4	34.4	9.0	0.0	0.0	2.6	8.2	3.3	0.3	0.0	0.8	10.3	46.6	30.4	6.0	4.8	0.1	89.1	17.8	0.0	63926.2	7.1	6.1	47.7	9.6	0.4	0.0	4.2	33.2	4.4	0.0	0.2	2.9	0.1	5.9	11.2	16.3	0.0	0.0	1.1	0.0	0.0	0.3	1.9	0.2	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.3	0.0	0.2	2.1	0.0	4.4	0.0	0.0	0.0	9.0	2.8	2.4	1.6	0.0	0.0	0.1	0.2	0.0	1.2	0.1	0.0	0.0	0.2	3.6	0.2	27.1	0.0	0.4	0.1	57.5	5.0	0.0	0.0	8.6	0.2	6.3	0.0	0.0	0.1	24.1	0.0	0.1	22.2	0.0	3.1	0.1	0.5	1.9	0.1	0.0	0.5	0.3	0.3	6.5	0.3	1.7	6.3	0.0	0.0	11.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.4	1.2	7.4	0.0	0.5	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.5	9.1	194.0	181.6	0.0	0.0	154.9	82.5	0.0	70.1	343.9	1.8	0.0	0.1	2.0	107.1	0.0	5.9	7.7	3.5	1.6	2.8	58.2	0.4	0.0	28.1	3.2	1.8	21.9	13.0	5.7	1.7	0.7	0.1	14.6	0.0	0.0	232.2	140.4	4.6	0.5	5.7	0.0	4.4	83.6	0.0	5.6	0.0	0.0	0.0	0.0	46.4	65.3	0.0	0.0	398.1	12.5	0.0	74.7	0.0	0.0	0.0	19.2	1.4	0.6	9.5	24.0	0.3	2.5	21.3	76.7	357.4
ZNF318	"HRIHFB2436, ZFP318"	ENSG00000171467	"Zinc finger protein 318"	Q5VUA4	6	43307134-43369647	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 82.9;Spermatogonia: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"B-cells: 2.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027022, HPA027031"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA027022: AB_1859189, HPA027031: AB_1859190"	"unprognostic (1.64e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.61e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-2)"	8.1	6.4	6.4	12.4	5.5	11.4	7.9	11.7	8.8	14.2	1.9	9.3	7.2	11.5	10.6	6.4	9.7	7.0	7.0	6.3	5.3	6.4	8.1	7.5	25.6	3.7	4.6	11.9	8.2	10.8	7.3	8.0	3.6	9.7	8.0	21.2	7.5	8.1	8.5	12.0	9.7	9.0	3.1	14.4	6.3	26.2	4.8	13.3	12.5	6.3	25.0	8.9	10.0	6.9	26.4	6.2	18.0	29.9	15.4	13.7	9.3	11.6	14.3	12.8	11.1	6.6	3.2	41.5	6.4	14.4	15.0	11.4	20.0	9.5	16.6	11.8	10.7	11.4	8.1	10.7	7.7	20.2	9.2	8.8	9.8	10.8	9.6	10.8	10.2	11.3	15.6	19.3	13.8	9.0	6.4	12.8	8.1	42.9	5.9	7.6	17.9	6.4	7.1	5.9	16.6	10.2	8.6	7.2	9.0	13.8	9.1	27.6	10.6	17.9	9.2	12.2	11.4	12.4	10.9	28.2	5.6	15.1	10.2	0.0	0.3	0.0	0.5	0.2	0.1	0.6	0.4	0.3	0.3	2.1	0.3	0.3	0.1	0.3	0.1	0.3	0.5	0.2	6.4	5.5	11.7	8.8	6.3	5.3	3.7	4.6	3.6	3.1	4.8	6.9	7.8	9.6	14.5	10.7	29.9	9.7	4.4	5.6	12.0	18.1	6.5	6.9	9.5	8.6	6.4	9.2	8.4	5.8	6.8	5.2	3.9	5.2	30.7	9.2	13.3	7.8	5.4	8.2	19.9	4.7	4.4	10.4	5.1	6.3	6.3	20.6	11.7	19.4	6.6	25.2	18.9	5.1	6.1	11.1	7.2	16.5	6.2	10.7	3.6	4.7	9.7	9.4	16.5	15.6	17.5	4.2	8.2	9.8	5.1	3.0	11.4	3.9	6.8	11.8	26.3	13.6	8.7	82.9	46.3	9.0	5.1	1.8	8.8	8.9	8.3	2.0
ZNF33B	"KOX2, KOX31, ZNF11B"	ENSG00000196693	"Zinc finger protein 33B"	Q06732	10	42574185-42638570	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA005538, HPA056638"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoli fibrillar center, Endoplasmic reticulum"	Vesicles	"HPA005538: , HPA056638: AB_2683199"	"unprognostic (3.01e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.34e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.61e-2)"	4.7	9.8	3.9	5.9	4.9	3.1	20.6	9.8	5.1	9.5	9.5	9.1	8.9	11.7	7.6	7.4	18.6	8.6	5.3	4.8	6.6	18.5	10.3	8.9	9.4	4.9	4.0	23.5	34.1	15.2	10.0	7.2	5.1	12.6	10.4	10.4	18.6	10.4	3.9	12.2	9.7	5.2	2.5	10.3	14.3	4.7	5.3	8.0	18.3	4.9	8.9	9.0	9.0	3.7	13.2	3.3	8.5	8.8	3.1	0.4	10.6	8.1	6.2	5.1	7.1	7.3	14.9	19.9	4.8	3.1	7.7	10.9	16.5	5.6	5.7	11.8	12.4	7.9	12.7	11.9	3.6	18.8	6.2	5.1	20.1	3.1	17.0	13.4	4.4	10.8	10.9	14.7	3.1	5.7	7.5	4.5	9.3	6.5	7.7	8.0	8.5	8.5	13.4	17.2	15.3	14.9	5.1	10.5	5.1	7.7	13.4	5.7	5.3	2.6	12.3	4.5	8.6	9.5	15.5	6.1	1.8	13.9	2.4	19.4	7.5	7.1	10.7	6.7	15.1	20.1	15.4	10.8	6.7	15.4	19.5	13.7	2.4	8.3	5.5	11.1	13.4	9.0	3.9	4.9	9.8	5.1	4.8	6.6	4.9	4.0	5.1	2.5	5.3	3.7	10.0	80.1	37.8	14.0	17.7	4.8	18.0	5.5	18.2	15.4	26.0	27.8	31.5	34.3	30.0	20.2	10.4	18.6	13.4	9.7	21.5	27.0	2.4	37.2	6.0	14.1	25.3	17.1	25.6	36.1	16.8	10.0	14.8	14.5	8.2	23.8	16.4	10.8	8.4	10.1	48.2	17.6	4.1	13.6	3.6	3.8	20.5	9.3	7.2	36.5	17.9	10.2	21.6	30.7	14.1	25.8	21.4	11.7	15.2	13.0	21.2	27.0	47.6	9.6	0.0	9.0	8.5	9.0	11.3	11.8	4.0	11.5	17.0	22.6	18.5	12.8
ZNF565	FLJ36991	ENSG00000196357	"Zinc finger protein 565"	Q8N9K5	19	36182276-36246257	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.3;Late spermatids: 16.1;Oligodendrocytes: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 16.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.3"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA044123	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"		"HPA044123: AB_10794395"	"unprognostic (1.51e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (6.08e-3)"	"unprognostic (7.97e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.93e-4)"	2.9	2.6	4.6	2.0	7.0	3.7	3.4	5.7	5.8	2.8	2.5	2.5	2.1	3.2	3.0	2.4	3.1	2.2	2.3	4.9	5.5	2.5	3.0	2.2	2.3	6.9	6.3	5.0	2.5	2.9	2.7	2.2	6.4	3.1	2.7	3.5	3.7	2.5	4.2	3.1	2.0	2.9	4.4	2.2	3.0	6.8	5.6	2.2	3.1	4.6	2.8	2.7	2.5	12.1	2.7	4.1	4.7	3.2	7.2	4.9	1.3	2.8	4.5	3.3	5.6	2.2	2.4	2.2	3.4	3.6	1.5	1.6	2.4	2.0	5.3	3.7	0.9	3.8	3.6	3.2	3.0	2.7	2.5	5.4	5.8	2.1	5.5	3.5	3.9	2.5	2.6	2.6	4.0	3.6	3.2	0.7	1.8	6.4	1.8	2.5	2.8	2.0	3.3	3.8	3.5	3.7	2.3	2.5	2.6	2.9	1.6	2.7	3.3	4.3	2.6	3.4	3.9	0.8	1.3	1.4	4.4	2.1	2.2	16.3	2.7	4.3	2.7	2.7	3.0	2.1	3.2	2.7	3.1	2.0	3.6	2.7	1.2	3.1	3.3	1.6	1.8	1.9	4.6	7.0	5.7	5.8	4.9	5.5	6.9	6.3	6.4	4.4	5.6	12.1	3.3	3.2	1.1	5.9	1.6	2.2	7.1	2.3	4.6	4.2	2.0	1.8	2.9	0.0	1.0	1.8	6.2	1.4	1.9	1.1	0.0	2.5	23.3	2.6	3.8	3.4	1.2	0.0	10.2	2.9	2.1	3.8	7.1	3.9	0.0	3.7	2.9	1.1	1.6	1.7	12.4	0.9	2.0	2.7	0.6	16.1	5.3	1.6	0.0	5.6	1.7	2.9	6.2	5.5	21.2	2.6	0.4	2.6	1.5	5.2	1.6	1.6	3.2	4.6	6.6	7.7	3.3	10.8	8.1	2.7	1.4	2.1	2.8	2.5	1.8	4.3
ZNF683	"Hobit, MGC33414"	ENSG00000176083	"Zinc finger protein 683"	Q8IZ20	1	26361634-26374522	"Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 81.9"	"Group enriched"	"Detected in some"	12	"Early spermatids: 473.7;Late spermatids: 482.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 172.4;memory CD8 T-cell: 113.1"	"Lineage enriched"	"Detected in many"	15	"T-cells: 172.4"	"Group enriched"	"Detected in some"	8	"NB-4: 2.2;OE19: 4.8"					"Not detected"	"Not detected"			HPA023865	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"			"HPA023865: AB_2671333"	"unprognostic (3.95e-3)"	"unprognostic (5.58e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (2.90e-5)"	"unprognostic (9.17e-2)"	"unprognostic (8.98e-4)"	"unprognostic (7.90e-2)"	"unprognostic (5.05e-3)"	"unprognostic (5.81e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.54e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (3.45e-5)"	0.2	0.4	0.3	0.6	0.6	1.9	0.8	0.3	0.3	0.9	0.1	0.3	0.3	0.6	0.1	0.7	1.7	1.7	0.8	0.8	0.3	0.3	0.6	4.7	1.9	1.1	0.3	1.0	0.3	0.2	0.3	0.4	0.5	0.9	0.5	0.0	10.1	0.8	0.1	0.5	0.6	0.3	0.5	2.2	3.4	81.9	0.5	2.9	1.1	0.0	0.4	0.9	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.2	0.1	172.4	0.1	0.4	0.2	35.4	113.1	0.0	0.0	13.4	63.2	0.9	11.8	3.8	0.3	1.1	24.2	0.3	0.6	0.3	0.3	0.8	0.3	1.1	0.3	0.5	0.5	0.5	0.6	0.9	3.2	0.6	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.7	1.1	0.2	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	473.7	0.2	0.5	0.8	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.4	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	482.4	1.8	1.8	0.0	0.0	0.3	0.0	6.2	0.0	0.1	0.0	0.0	1.2	1.7	0.1	0.0	0.2	0.7	0.0	0.0	0.4	0.7	3.3	2.2	0.2	0.0	0.0	39.8	0.0	0.0	0.0
